Citrus Sinensis ID: 011153
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 492 | 2.2.26 [Sep-21-2011] | |||||||
| Q9CAL2 | 646 | Cysteine-rich receptor-li | yes | no | 0.981 | 0.747 | 0.668 | 0.0 | |
| Q9FNE1 | 651 | Cysteine-rich receptor-li | no | no | 0.910 | 0.688 | 0.507 | 1e-128 | |
| Q9LMB9 | 615 | Cysteine-rich receptor-li | no | no | 0.902 | 0.721 | 0.455 | 1e-111 | |
| Q9CAL3 | 649 | Cysteine-rich receptor-li | no | no | 0.932 | 0.707 | 0.448 | 1e-106 | |
| Q9M0G5 | 625 | Putative cysteine-rich re | no | no | 0.963 | 0.758 | 0.367 | 5e-86 | |
| Q9T0J1 | 665 | Cysteine-rich receptor-li | no | no | 0.936 | 0.693 | 0.361 | 4e-75 | |
| Q8S9L6 | 679 | Cysteine-rich receptor-li | no | no | 0.936 | 0.678 | 0.339 | 9e-71 | |
| Q9M0X5 | 675 | Cysteine-rich receptor-li | no | no | 0.928 | 0.677 | 0.344 | 1e-70 | |
| O65476 | 662 | Putative cysteine-rich re | no | no | 0.975 | 0.725 | 0.341 | 1e-67 | |
| Q9LDS6 | 656 | Putative cysteine-rich re | no | no | 0.969 | 0.727 | 0.339 | 4e-67 |
| >sp|Q9CAL2|CRK3_ARATH Cysteine-rich receptor-like protein kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 676 bits (1743), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 326/488 (66%), Positives = 390/488 (79%), Gaps = 5/488 (1%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
MD V+PL+ + Y VVNGTG +VYA+GEC+KDL DC+LCFAQ K +V +CLPFQ
Sbjct: 52 MDAVSPLVEAKGYGQVVNGTGNLTVYAYGECIKDLDKKDCDLCFAQIKAKVPRCLPFQKG 111
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGG-NNTVFGANAIELVRNLSVQ 119
TRGG+VF DGCY+RYDDY+F+NE+LS QDRTVC K+ G N TVF NA ELV+N+SV+
Sbjct: 112 TRGGQVFSDGCYIRYDDYNFYNETLSLQDRTVCAPKEITGVNRTVFRDNAAELVKNMSVE 171
Query: 120 AVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLN 179
AV+N GF+ G V + NV+VHGLAQCWE +N S C CL A RI SC EEGRVL+
Sbjct: 172 AVRNGGFYAGFV--DRHNVTVHGLAQCWETLNRSGCVECLSKASVRIGSCLVNEEGRVLS 229
Query: 180 AGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILA--TSAVALLLVFSLVAFFVRRKLLQ 237
AGCY+R+STQ+FYNNSG GNGG N L VILA +S VA +L+ S F ++++ +
Sbjct: 230 AGCYMRFSTQKFYNNSGNSTSDGNGGHNHLGVILAVTSSVVAFVLLVSAAGFLLKKRHAK 289
Query: 238 KRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVA 297
K+RE+KQLG+L + NKS L FSYE LE+AT+YF + NKLGQGGSGSVYKG L G+ VA
Sbjct: 290 KQREKKQLGSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVA 349
Query: 298 VKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF 357
VKRLF+NT QWVDHFFNEVNLIS ++HKNLVKLLGCSITGPESLLVYE++ NQSL D LF
Sbjct: 350 VKRLFFNTKQWVDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLF 409
Query: 358 VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
VR+DV+PL+W R+KIIL TAEG+AYLHEES LRIIHRDIKLSNILL+++FT +IADFGL
Sbjct: 410 VRKDVQPLNWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGL 469
Query: 418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477
RLFPED THIS +AGTLGYMAPEYVVRGKLTEKADVYSFGV++IEV+ KR N F Q+
Sbjct: 470 ARLFPEDKTHISTAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQD 529
Query: 478 SCSILQTV 485
+ SILQ+V
Sbjct: 530 AGSILQSV 537
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9FNE1|CRK42_ARATH Cysteine-rich receptor-like protein kinase 42 OS=Arabidopsis thaliana GN=CRK42 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 460 bits (1183), Expect = e-128, Method: Compositional matrix adjust.
Identities = 241/475 (50%), Positives = 307/475 (64%), Gaps = 27/475 (5%)
Query: 22 TASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFF 81
T S+YA +C DLSP+DC LC+A +T++ +CLP + R+F DGC+LRY+ Y+F+
Sbjct: 81 TTSIYALIQCHDDLSPSDCQLCYAIARTRIPRCLP----SSSARIFLDGCFLRYETYEFY 136
Query: 82 NESLS-SQDRTVCGSKDFGGNNTVFGAN-AIELVRNLSVQAVKNDGFFVGSVTFSKGNVS 139
+ES+S + D C N+TV ++ + AV+ GF V G
Sbjct: 137 DESVSDASDSFSCS------NDTVLDPRFGFQVSETAARVAVRKGGFGVA------GENG 184
Query: 140 VHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNAGCYLRYSTQRFYNNSGPDP 199
VH LAQCWE + C CLE AV + C + EGR +N GCYLRYS +FYN G
Sbjct: 185 VHALAQCWESLGKEDCRVCLEKAVKEVKRCVSRREGRAMNTGCYLRYSDHKFYNGDGHHK 244
Query: 200 --VPGNGGDNKLAVILATSAVALLLVFSLVAFFVRRKLLQKRRERKQLGALQVAVNKSKL 257
V N G +A++L TSA +L++ L + + K+ + ++E++ LG + N SK
Sbjct: 245 FHVLFNKG-VIVAIVLTTSAFVMLIL--LATYVIMTKVSKTKQEKRNLGLVSRKFNNSKT 301
Query: 258 NFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVN 317
F YETLEKAT+YF LGQGG+G+V+ G LP G+ VAVKRL +NT WV+ FFNEVN
Sbjct: 302 KFKYETLEKATDYFSHKKMLGQGGNGTVFLGILPNGKNVAVKRLVFNTRDWVEEFFNEVN 361
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
LISGI HKNLVKLLGCSI GPESLLVYE+VPN+SL LF + L+W R IIL T
Sbjct: 362 LISGIQHKNLVKLLGCSIEGPESLLVYEYVPNKSLDQFLFDESQSKVLNWSQRLNIILGT 421
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
AEGLAYLH S +RIIHRDIK SN+LLD++ KIADFGL R F D TH+S +AGTLG
Sbjct: 422 AEGLAYLHGGSPVRIIHRDIKTSNVLLDDQLNPKIADFGLARCFGLDKTHLSTGIAGTLG 481
Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVILLTWNI 492
YMAPEYVVRG+LTEKADVYSFGV+V+E+ C RIN F + +LQ V WN+
Sbjct: 482 YMAPEYVVRGQLTEKADVYSFGVLVLEIACGTRINAFVPETGHLLQRV----WNL 532
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMB9|CRK1_ARATH Cysteine-rich receptor-like protein kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 402 bits (1033), Expect = e-111, Method: Compositional matrix adjust.
Identities = 217/476 (45%), Positives = 305/476 (64%), Gaps = 32/476 (6%)
Query: 22 TASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFF 81
+ +Y F +C +DLS +DC CF + + ++ + + + GGR+ D C+LR+DD DF
Sbjct: 77 SPPIYVFLQCREDLSVSDCRHCFNESRLELER----KCSGSGGRIHSDRCFLRFDDRDFS 132
Query: 82 NESLSSQ-DRTVCGSKDFGGNNTVFGANAIELVRNLSVQAVKNDGFFVGSVTFSKGNVSV 140
E + D+ C ++ G F E + N++++AVKN GF SV ++ +V
Sbjct: 133 EEFVDPTFDKANC--EETGTGFGEFWRFLDEALVNVTLKAVKNGGFGAASVIKTE---AV 187
Query: 141 HGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNAGCYLRYSTQRFYNNSG---P 197
+ LAQCW+ ++ + C CL NA S + +C E R GCYL+YST +F++++ P
Sbjct: 188 YALAQCWQTLDENTCRECLVNARSSLRAC-DGHEARAFFTGCYLKYSTHKFFDDAAEHKP 246
Query: 198 DPVPGN--------GGDNKLAVILATSAVALLLVFSLVAFFVRRKLLQKRRERKQLGALQ 249
D N ++ LA +A++L ++ SL AF R++ +KR+
Sbjct: 247 DADQRNFIRSSFFPHLSDRDVTRLAIAAISLSILTSLGAFISYRRVSRKRK--------- 297
Query: 250 VAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWV 309
A S +NF YE LEKAT FH+S KLGQGG+GSVYKG LP G VAVK+LF+NT +W
Sbjct: 298 -AQVPSCVNFKYEMLEKATESFHDSMKLGQGGAGSVYKGILPDGRIVAVKKLFFNTREWA 356
Query: 310 DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEV 369
D FFNEVNLISG+ HKNLV+LLGCSI GP+SLLVYE+V N+SL LF++ V LSW+
Sbjct: 357 DQFFNEVNLISGVQHKNLVRLLGCSIEGPKSLLVYEYVHNRSLDQILFMKNTVHILSWKQ 416
Query: 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
R+ II+ +EGL YLH S+++IIHRDIK SNILLD + KIADFGL+R D T +
Sbjct: 417 RFNIIIGISEGLEYLHRGSEVKIIHRDIKTSNILLDRNLSPKIADFGLIRSMGTDKTQTN 476
Query: 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
+AGTLGY+APEY+++G+LTEKADVY+FGV++IE+V K+ N FTQ + S+L +V
Sbjct: 477 TGIAGTLGYLAPEYLIKGQLTEKADVYAFGVLIIEIVTGKKNNAFTQGTSSVLYSV 532
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL3|CRK2_ARATH Cysteine-rich receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 387 bits (993), Expect = e-106, Method: Compositional matrix adjust.
Identities = 214/477 (44%), Positives = 292/477 (61%), Gaps = 18/477 (3%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
M+ ++ + + + GTG + Y +C DL NDC LC+A+ +T + +C P
Sbjct: 59 MEKISTQVQTSGFGVALTGTGPDANYGLAQCYGDLPLNDCVLCYAEARTMLPQCYP---- 114
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQA 120
GGR+F DGC++R ++Y F+NE +D VCG+ N FG + +RN +A
Sbjct: 115 QNGGRIFLDGCFMRAENYSFYNEYKGPEDSIVCGNTT--RKNKTFGDAVRQGLRNAVTEA 172
Query: 121 VKNDGFFVGSVTFSKG-NVSVHGLAQCWEFVNGSACENCLENA-VSRIASCTQKEEGRVL 178
G+ S + + S LA CW ++ +C+ CLENA S + C EGR L
Sbjct: 173 SGTGGYARASAKAGESESESAFVLANCWRTLSPDSCKQCLENASASVVKGCLPWSEGRAL 232
Query: 179 NAGCYLRYSTQRFYNNSGPDPVPGNG---GDNKLAVILATSAVALLLVFSLVAFFV--RR 233
+ GC+LRYS Q F N +P NG G + V+ S+V + ++ V+ ++ RR
Sbjct: 233 HTGCFLRYSDQDFLNK-----IPRNGRSRGSVVVIVVSVLSSVVVFMIGVAVSVYICKRR 287
Query: 234 KLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGG 293
+ +KRR K + + + S LNF Y TLEKAT F +NKLGQGG G+VYKG LP G
Sbjct: 288 TIKRKRRGSKDVEKMAKTLKDSSLNFKYSTLEKATGSFDNANKLGQGGFGTVYKGVLPDG 347
Query: 294 EAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLL 353
+AVKRLF+N F+NEVN+IS + HKNLV+LLGCS +GPESLLVYE++ N+SL
Sbjct: 348 RDIAVKRLFFNNRHRATDFYNEVNMISTVEHKNLVRLLGCSCSGPESLLVYEYLQNKSLD 407
Query: 354 DNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413
+F + L W+ RY II+ TAEGL YLHE+S ++IIHRDIK SNILLD + AKIA
Sbjct: 408 RFIFDVNRGKTLDWQRRYTIIVGTAEGLVYLHEQSSVKIIHRDIKASNILLDSKLQAKIA 467
Query: 414 DFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
DFGL R F +D +HIS +AGTLGYMAPEY+ G+LTE DVYSFGV+V+E+V K+
Sbjct: 468 DFGLARSFQDDKSHISTAIAGTLGYMAPEYLAHGQLTEMVDVYSFGVLVLEIVTGKQ 524
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M0G5|CRK43_ARATH Putative cysteine-rich receptor-like protein kinase 43 OS=Arabidopsis thaliana GN=CRK43 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (815), Expect = 5e-86, Method: Compositional matrix adjust.
Identities = 189/514 (36%), Positives = 275/514 (53%), Gaps = 40/514 (7%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
+D + + ++ +G +Y +C+ DLS ++C+LC+++ + +C P
Sbjct: 55 LDAIRGDMRHVKFGTHEHGDPPERMYVLSQCVSDLSSDECSLCWSRATDLLSQCFP---- 110
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQA 120
GG DGC++R D+Y F+ E +S QD +C S + F E+ +++ A
Sbjct: 111 ATGGWFHLDGCFVRADNYSFYQEPVSHQDTKICASDK--EKSAEFKGLVKEVTKSIVEAA 168
Query: 121 VKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNA 180
+ GF V + +++V+GL CW +N C+ CL + + SC +EG LNA
Sbjct: 169 PYSRGFSVAKMGIR--DLTVYGLGVCWRTLNDELCKLCLADGALSVTSCLPSKEGFALNA 226
Query: 181 GCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLLV----FSLVAFFVRRK-- 234
GCYLRYS FYN G + + L I S V +L + + F++R
Sbjct: 227 GCYLRYSNYTFYNERGL--LAMSFTKENLTYIFVISMVGVLAIAAGFWCGKCFYMRTSPK 284
Query: 235 ------------LLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGS 282
L R K+ + + ++F Y TL+KATN F+ES KLG GG
Sbjct: 285 KKIKGTKTKKFHLFGHLRIEKE--SESICTESHLMSFEYSTLKKATNNFNESCKLGVGGY 342
Query: 283 GSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342
G V+KGTL G +A+KRL + + D NE+++IS HKNLV+LLGC T S +
Sbjct: 343 GEVFKGTLSDGREIAIKRLHVSGKKPRDEIHNEIDVISRCQHKNLVRLLGCCFTNMNSFI 402
Query: 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI 402
VYEF+ N SL LF + + L W+ R IIL TAEGL YLHE K IIHRDIK SNI
Sbjct: 403 VYEFLANTSLDHILFNPEKKKELDWKKRRTIILGTAEGLEYLHETCK--IIHRDIKASNI 460
Query: 403 LLDEEFTAKIADFGLVRLFPEDITHISA------TLAGTLGYMAPEYVVRGKLTEKADVY 456
LLD ++ KI+DFGL + +PE I A ++AGTLGYMAPEY+ +G+L+ K D Y
Sbjct: 461 LLDLKYKPKISDFGLAKFYPEGGKDIPASSLSPSSIAGTLGYMAPEYISKGRLSNKIDAY 520
Query: 457 SFGVVVIEVVCRKRINLFTQNSCSILQTVILLTW 490
SFGV+V+E+ R N F ++ L+T++ W
Sbjct: 521 SFGVLVLEITSGFRNNKFRSDNS--LETLVTQVW 552
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9T0J1|CRK26_ARATH Cysteine-rich receptor-like protein kinase 26 OS=Arabidopsis thaliana GN=CRK26 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 282 bits (721), Expect = 4e-75, Method: Compositional matrix adjust.
Identities = 182/504 (36%), Positives = 264/504 (52%), Gaps = 43/504 (8%)
Query: 19 GTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDY 78
G V + +C D+ C C A +++ P Q + ++YD C RY +
Sbjct: 71 GDSDEKVNSISQCRGDVKLEVCINCIAMAGKRLVTLCPVQ---KEAIIWYDKCTFRYSNR 127
Query: 79 DFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNL----SVQAVKNDGFFVGSVTFS 134
FN S ++ G+++F G+ + + L+ L SV F VG T
Sbjct: 128 TIFNRLEISPHTSITGTRNFTGDRDSWEKSLRGLLEGLKNRASVIGRSKKNFVVGE-TSG 186
Query: 135 KGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGR-VLNAGCYLRYSTQRFYN 193
++ GL QC ++ C CL +++I SC + G V++ C L Y+ RFY+
Sbjct: 187 PSFQTLFGLVQCTPDISEEDCSYCLSQGIAKIPSCCDMKMGSYVMSPSCMLAYAPWRFYD 246
Query: 194 ---NSGPDPVPG--------------NGGDNK---LAVILATSAVALLLVFSLVAFF--- 230
P VP G N+ A+I A+++VA++++F ++
Sbjct: 247 PVDTDDPSSVPATPSRPPKNETRSVTQGDKNRGVPKALIFASASVAIVVLFIVLLVVFLK 306
Query: 231 VRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTL 290
+RRK + E K ++ + F + L+ AT++F NKLG+GG G+VYKG L
Sbjct: 307 LRRKENIRNSENKHENE---NISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVL 363
Query: 291 PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350
G+ +AVKRL N Q F NE L++ + H+NLVKLLG SI G E LLVYEF+P+
Sbjct: 364 SDGQKIAVKRLSKNAQQGETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHT 423
Query: 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410
SL +F L WE+RYKII A GL YLH++S+LRIIHRD+K SNILLDEE T
Sbjct: 424 SLDKFIFDPIQGNELEWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTP 483
Query: 411 KIADFGLVRLFPEDITHISA----TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
KIADFG+ RLF DI H + + GT GYMAPEYV+ G+ + K DVYSFGV+V+E++
Sbjct: 484 KIADFGMARLF--DIDHTTQRYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEII 541
Query: 467 CRKRINLFTQNSCSILQTVILLTW 490
K+ + F+ + +I W
Sbjct: 542 SGKKNSGFSSEDS--MGDLISFAW 563
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S9L6|CRK29_ARATH Cysteine-rich receptor-like protein kinase 29 OS=Arabidopsis thaliana GN=CRK29 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (684), Expect = 9e-71, Method: Compositional matrix adjust.
Identities = 171/503 (33%), Positives = 255/503 (50%), Gaps = 42/503 (8%)
Query: 25 VYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFFNES 84
YA G C +++ +DC C + K P T+ V+Y C RY + +
Sbjct: 82 AYAIGLCRREVKRDDCVSCIQTAARNLTKQCPL---TKQAVVWYTHCMFRYSNRTIYGRK 138
Query: 85 LSSQDRTVCGSKDFGGNNTVF---GANAIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVH 141
++ + ++ N F ++ ++ ++ N + G+ + S G +
Sbjct: 139 ETNPTKAFIAGEEISANRDDFERLQRGLLDRLKGIAAAGGPNRKYAQGNGSASAGYRRFY 198
Query: 142 GLAQCWEFVNGSACENCLENAVSRIASCTQKEEG-RVLNAGCYLRYSTQRFYNNSG---P 197
G QC ++ C +CL I SC E G R + C R+ T RFY P
Sbjct: 199 GTVQCTPDLSEQDCNDCLVFGFENIPSCCDAEIGLRWFSPSCNFRFETWRFYEFDADLEP 258
Query: 198 DPVP------------------GNGGDNKL-AVILATSAVALLLVFSLVAFFVRRKLLQK 238
DP G GG + A+++ VALL + + R+ +
Sbjct: 259 DPPAIQPADSPQSAARTERTGKGKGGSKVIIAIVIPILLVALLAICLCLVLKWRKN--KS 316
Query: 239 RRERKQLGALQVAVNKSKLNFS--------YETLEKATNYFHESNKLGQGGSGSVYKGTL 290
+ K LG ++ + ++ FS +ETL+ AT+ F N+LG+GG GSVYKG
Sbjct: 317 GYKNKVLGKSPLSGSIAEDEFSNTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVF 376
Query: 291 PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350
P G+ +AVKRL N+ Q + F NE+ L++ + H+NLV+L+G I G E LLVYEF+ N
Sbjct: 377 PQGQEIAVKRLSGNSGQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNA 436
Query: 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410
SL +F + + L W VRYK+I A GL YLHE+S+ RIIHRD+K SNILLD+E
Sbjct: 437 SLDQFIFDTEKRQLLDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNP 496
Query: 411 KIADFGLVRLFP--EDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
KIADFGL +LF + +TH ++ +AGT GYMAPEY + G+ + K DV+SFGV+VIE++
Sbjct: 497 KIADFGLAKLFDSGQTMTHRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIIT 556
Query: 468 RKRINLFTQNSCSILQTVILLTW 490
KR N N + ++ W
Sbjct: 557 GKRNNNGGSNGDEDAEDLLSWVW 579
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 267 bits (683), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 171/496 (34%), Positives = 255/496 (51%), Gaps = 39/496 (7%)
Query: 25 VYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFFNES 84
VY C D+S C C A + L+ P + + ++YD C +RY N+S
Sbjct: 82 VYGVFLCRGDVSAEICRDCVAFAANETLQRCPRE---KVAVIWYDECMVRYS-----NQS 133
Query: 85 LSSQDRTVCG----SKDFGGNNTV--FGANAIELVRNLSVQAVKNDGFFVGSVTFSKGNV 138
+ Q R G +K N V F + L+ +++V+A + F
Sbjct: 134 IVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSRKFATEKANFTVFQ 193
Query: 139 SVHGLAQCWEFVNGSACENCLENAVSRIASCTQKE-EGRVLNAGCYLRYSTQRFYNNS-- 195
+++ L QC + CE+CL ++ + C + GRV+ C RY FYN +
Sbjct: 194 TIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNETIA 253
Query: 196 --------------GPDPVPGNGGDNKLAVILATS-----AVALLLVFSLVAFFVRRKLL 236
P +P G K ++ T+ +V +LL+ ++ RR+
Sbjct: 254 AAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARRRNN 313
Query: 237 QKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAV 296
+ E + L + ++ L F + +E ATN F ESNKLG GG G VYKG L GE V
Sbjct: 314 KLSAETEDLDEDGITSTET-LQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETV 372
Query: 297 AVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
A+KRL +TQ + F NEV++++ + H+NL KLLG + G E +LVYEFVPN+SL L
Sbjct: 373 AIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFL 432
Query: 357 FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
F + L W+ RYKII A G+ YLH +S+L IIHRD+K SNILLD + KI+DFG
Sbjct: 433 FDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFG 492
Query: 417 LVRLFPEDITHI-SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474
+ R+F D T + + GT GYM+PEY + GK + K+DVYSFGV+V+E++ +K + +
Sbjct: 493 MARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFY 552
Query: 475 TQNSCSILQTVILLTW 490
++ L T + W
Sbjct: 553 EEDGLGDLVTYVWKLW 568
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65476|CRK16_ARATH Putative cysteine-rich receptor-like protein kinase 16 OS=Arabidopsis thaliana GN=CRK16 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 257 bits (657), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 172/504 (34%), Positives = 250/504 (49%), Gaps = 24/504 (4%)
Query: 9 ARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFY 68
AR + G G +YA G C++ P C+ C +V+K Q F
Sbjct: 58 ARGGFYNASIGQGPDRLYASGTCIQGSEPELCSACIDSAFIRVIKKCHNQTEALDWSSFN 117
Query: 69 D--GCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQAVKN-DG 125
+ C +RY + FF + + DF N T F L+ + A+ + +
Sbjct: 118 EEYPCMIRYSNRSFFGLLEMTPFFKNYNATDFQVNLTEFYQKWEALMLGVIADAISSPNP 177
Query: 126 FFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIA-SCTQKEEGRVLNAGCYL 184
F G+ T G +V+ C + ++ C CL V SC+ K G + CY+
Sbjct: 178 KFYGAGTGKIGIQTVYAFVLCSKDISPWNCSRCLRGNVDNYKLSCSGKPRGHSFSPSCYM 237
Query: 185 RYSTQRFYN----NSGP---------DPVPGNGGDNKLAVILATSAVALLLVFSLVAFFV 231
R+ +FY + P + +GG IL + + L F + V
Sbjct: 238 RWDLYQFYGFIEYRASPTLPREKGRISELSDDGGKISTRNILG---ITVALAFFITVLLV 294
Query: 232 RRKLLQKRRERKQLGALQVAVNKS-KLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTL 290
L +RR+ Q A + + S L F ++ +E ATN F +SNKLG GG G V+KGT
Sbjct: 295 LGYALSRRRKAYQEFATENDITTSGSLQFDFKAIEAATNNFQKSNKLGHGGFGEVFKGTF 354
Query: 291 PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350
P G VAVKRL + Q + F NEV L++ + H+NLV+LLG S+ G E +LVYE++PN+
Sbjct: 355 PNGTEVAVKRLSKISGQGEEEFKNEVLLVAKLQHRNLVRLLGFSVEGEEKILVYEYMPNK 414
Query: 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410
SL LF + L W RY II G+ YLH++S+L IIHRD+K NILLD +
Sbjct: 415 SLDYFLFDHRRRGQLDWRTRYNIIRGVTRGILYLHQDSRLTIIHRDLKAGNILLDVDMNP 474
Query: 411 KIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
KIADFG+ R F D T + + GT GYM PEYV G+ + K+DVYSFGV+++E++ K
Sbjct: 475 KIADFGVARNFRVDQTEATTGRVVGTFGYMPPEYVANGQFSMKSDVYSFGVLILEIIVGK 534
Query: 470 RINLFTQNSCSI--LQTVILLTWN 491
+ + F + S+ L T + WN
Sbjct: 535 KSSSFHEIDGSVGNLVTYVWRLWN 558
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LDS6|CRK32_ARATH Putative cysteine-rich receptor-like protein kinase 32 OS=Arabidopsis thaliana GN=CRK32 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 256 bits (653), Expect = 4e-67, Method: Compositional matrix adjust.
Identities = 171/504 (33%), Positives = 257/504 (50%), Gaps = 27/504 (5%)
Query: 9 ARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFY 68
+R Y G G +YA G C+ P C+ C T +L+ P Q + R
Sbjct: 55 SRDGYYNGSVGEGPDRIYALGLCIPGTDPKVCDDCMQIASTGILQNCPNQTDSYDWRSQK 114
Query: 69 DGCYLRYDDYDFFNESLSSQDRTVCGSKD---FGGNNTVFGANAIELVRNLSVQAVKNDG 125
C++RY + FFN+ + + V G + F G+ + E + ++ + +
Sbjct: 115 TLCFVRYSNSSFFNK-MDLEPTMVIGDLNSGLFQGDLAAYTRTWEEFMNSMITRVGRTR- 172
Query: 126 FFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQK-EEGRVLNAGCYL 184
++ ++ G+ ++ L QC ++ CE C+ + V SC G + C+
Sbjct: 173 -YLADISPRIGSARIYALMQCIRGISSMECETCIRDNVRMYQSCCNGFIGGTIRKPVCFF 231
Query: 185 RYSTQRFYNNSGPDP-VPGNGGDNKLAVILATSAVALLLVFSLVAFFVRRKLLQKRRERK 243
R+ + G P +P D K ++T A+ ++V ++ + +L R+ R+
Sbjct: 232 RWDGSEYLGAFGDTPSLPPPSPDGK---TISTGAIVAVVVSVVIFVVLLALVLVIRKRRQ 288
Query: 244 QLGALQVAVNKS-----KLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAV 298
L+ + L F + TLE AT+ F +NKLG+GG G VYKG LP VAV
Sbjct: 289 SYKTLKPKTDDDMTSPQSLQFDFMTLEAATDKFSRNNKLGKGGFGEVYKGMLPNETEVAV 348
Query: 299 KRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV 358
KRL N+ Q F NEV +++ + HKNLV+LLG + E +LVYEFVPN+SL LF
Sbjct: 349 KRLSSNSGQGTQEFKNEVVIVAKLQHKNLVRLLGFCLERDEQILVYEFVPNKSLNYFLFG 408
Query: 359 RQD---VEP-----LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410
+ ++P L W+ RY II GL YLH++S+L IIHRDIK SNILLD +
Sbjct: 409 NKQKHLLDPTKKSQLDWKRRYNIIGGITRGLLYLHQDSRLTIIHRDIKASNILLDADMNP 468
Query: 411 KIADFGLVRLFPEDITHISA-TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
KIADFG+ R F D T + + GT GYM PEYV G+ + K+DVYSFGV+++E+VC K
Sbjct: 469 KIADFGMARNFRVDQTEDNTRRVVGTFGYMPPEYVTHGQFSTKSDVYSFGVLILEIVCGK 528
Query: 470 RINLFTQ--NSCSILQTVILLTWN 491
+ + F + +S L T + WN
Sbjct: 529 KNSSFYKIDDSGGNLVTHVWRLWN 552
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 492 | ||||||
| 255573959 | 649 | kinase, putative [Ricinus communis] gi|2 | 0.985 | 0.747 | 0.731 | 0.0 | |
| 225425611 | 649 | PREDICTED: cysteine-rich receptor-like p | 0.985 | 0.747 | 0.730 | 0.0 | |
| 147767572 | 690 | hypothetical protein VITISV_005912 [Viti | 0.985 | 0.702 | 0.732 | 0.0 | |
| 449434953 | 651 | PREDICTED: cysteine-rich receptor-like p | 0.985 | 0.745 | 0.692 | 0.0 | |
| 15223170 | 646 | cysteine-rich receptor-like protein kina | 0.981 | 0.747 | 0.668 | 0.0 | |
| 356567656 | 656 | PREDICTED: cysteine-rich receptor-like p | 0.979 | 0.734 | 0.665 | 0.0 | |
| 356502033 | 648 | PREDICTED: cysteine-rich receptor-like p | 0.979 | 0.743 | 0.662 | 0.0 | |
| 297841809 | 649 | kinase family protein [Arabidopsis lyrat | 0.981 | 0.744 | 0.664 | 0.0 | |
| 255567375 | 605 | kinase, putative [Ricinus communis] gi|2 | 0.961 | 0.781 | 0.522 | 1e-133 | |
| 449446869 | 601 | PREDICTED: cysteine-rich receptor-like p | 0.967 | 0.792 | 0.498 | 1e-131 |
| >gi|255573959|ref|XP_002527897.1| kinase, putative [Ricinus communis] gi|223532672|gb|EEF34454.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 747 bits (1928), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/495 (73%), Positives = 422/495 (85%), Gaps = 10/495 (2%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
+D VTPL+ARQ+Y AV+NGTG +VY +GECMKDL DCNLCFAQCKTQ+L+CLPFQLA
Sbjct: 56 LDAVTPLVARQQYGAVINGTGNTTVYTYGECMKDLDQTDCNLCFAQCKTQILRCLPFQLA 115
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDF-GGNNTVFGANAIELVRNLSVQ 119
TRGGR+FYDGCYLRYDDY FFNESL SQDRTVC S+DF GGN T++ NA+EL+RNLSV
Sbjct: 116 TRGGRLFYDGCYLRYDDYYFFNESLDSQDRTVCASEDFNGGNKTLYSDNAMELMRNLSVL 175
Query: 120 AVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLN 179
KNDGFFVGSV +KGN+SV+GLAQCWE VN SACE CL +AVS+I +CT KEEGRVLN
Sbjct: 176 TPKNDGFFVGSV--NKGNISVYGLAQCWELVNTSACETCLADAVSKITNCTPKEEGRVLN 233
Query: 180 AGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLLVFSL--VAFFVRRKLLQ 237
+GCYLRYSTQ+FYNNSGP NGG + LAVILA ++ ++ +V + FF+++++ +
Sbjct: 234 SGCYLRYSTQKFYNNSGPANA-DNGGSSHLAVILAAASSSVAVVLLVATAVFFMKKRVAE 292
Query: 238 KRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVA 297
KRR+RK+LGAL +AVN SKLNF+YE+LEKATNYFH SNKLGQGGSGSVYKG LP G+AVA
Sbjct: 293 KRRQRKELGALLIAVNNSKLNFTYESLEKATNYFHLSNKLGQGGSGSVYKGILPDGKAVA 352
Query: 298 VKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF 357
+KRL +NT QWVDHFFNEVNLIS I HKNLVKLLGCSITGPESLLVYE+VPNQSL D LF
Sbjct: 353 IKRLLFNTRQWVDHFFNEVNLISNIQHKNLVKLLGCSITGPESLLVYEYVPNQSLHDYLF 412
Query: 358 VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
V ++V+PL+WE+RYKIIL TAEGLAYLHEE++LRIIHRD+KLSN+LLDE+F KIADFGL
Sbjct: 413 VAKNVQPLTWEMRYKIILGTAEGLAYLHEETELRIIHRDVKLSNVLLDEDFLPKIADFGL 472
Query: 418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477
RLFPED THIS +AGTLGYMAPEY+VRGKLTEKADVYSFGV++IEVV KR N F Q+
Sbjct: 473 ARLFPEDKTHISTAIAGTLGYMAPEYIVRGKLTEKADVYSFGVLLIEVVSGKRNNSFVQD 532
Query: 478 SCSILQTVILLTWNI 492
S SILQ V WN+
Sbjct: 533 SGSILQMV----WNL 543
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225425611|ref|XP_002266015.1| PREDICTED: cysteine-rich receptor-like protein kinase 3 [Vitis vinifera] gi|297739090|emb|CBI28579.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 732 bits (1889), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/494 (73%), Positives = 417/494 (84%), Gaps = 9/494 (1%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
MD VTPLI+ QRYA V +GTG+ +V+ FGECM+DLS NDCNLCFA CKTQ+L+C+PFQ +
Sbjct: 58 MDQVTPLISTQRYADVTSGTGSTAVFLFGECMEDLSQNDCNLCFALCKTQLLRCVPFQKS 117
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQA 120
TRGGR FYDGCY+RYDDY FF+E+LS++D+TVCG+KDF G+ TVF ANAIELVRNLSV+A
Sbjct: 118 TRGGRSFYDGCYIRYDDYKFFDEALSAEDKTVCGTKDFSGDQTVFRANAIELVRNLSVEA 177
Query: 121 VKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNA 180
NDGFFVGSV ++ N+SV+GLAQCWEFV GSAC CL NA SRI C KEEGRVLNA
Sbjct: 178 PGNDGFFVGSV--NRSNISVYGLAQCWEFVKGSACAECLANATSRIGLCPPKEEGRVLNA 235
Query: 181 GCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILA--TSAVALLLVFSLVAFFVRRKLLQK 238
GCYLRYSTQ+FY+NS D V N G ++LA+IL +S+ ALLL+ ++ FFVR+K ++
Sbjct: 236 GCYLRYSTQKFYDNSTSDFVEENEGSSRLAIILGVTSSSFALLLIIAMTVFFVRKKRAKR 295
Query: 239 RRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAV 298
RRE+KQLG L VNKSKLNFSYETLEKATNYFH SNKLGQGGSGSVYKG +P G+ VA+
Sbjct: 296 RREKKQLGDLLATVNKSKLNFSYETLEKATNYFHHSNKLGQGGSGSVYKGIMPDGKVVAI 355
Query: 299 KRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV 358
KRLF+N+ QWVDHFFNEVNLISGI+HKNLVKLLGCSITGPESLLVYE+VPNQSL D L V
Sbjct: 356 KRLFFNSRQWVDHFFNEVNLISGIDHKNLVKLLGCSITGPESLLVYEYVPNQSLHDYL-V 414
Query: 359 RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418
+++ PL+WE+RYKI+L AEGLAYLHEES LRIIHRDIKLSN+LLDE+F AKIADFGL
Sbjct: 415 KRNAPPLAWEMRYKILLGIAEGLAYLHEESMLRIIHRDIKLSNVLLDEDFAAKIADFGLA 474
Query: 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478
RLFPED THIS +AGTLGYMAPEYVVRGKLTEK DVY FGV+VIEVVC KR N FTQ+S
Sbjct: 475 RLFPEDKTHISTAIAGTLGYMAPEYVVRGKLTEKVDVYGFGVLVIEVVCGKRNNSFTQDS 534
Query: 479 CSILQTVILLTWNI 492
SILQ V WN+
Sbjct: 535 FSILQMV----WNL 544
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147767572|emb|CAN64525.1| hypothetical protein VITISV_005912 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 730 bits (1884), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/494 (73%), Positives = 417/494 (84%), Gaps = 9/494 (1%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
MD VTPLI+ QRYA V +GTG+ +V+ FGECM+DLS NDCNLCFA CKTQ+L+C+PFQ +
Sbjct: 15 MDQVTPLISTQRYADVTSGTGSTAVFLFGECMEDLSQNDCNLCFALCKTQLLRCVPFQKS 74
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQA 120
TRGGR FYDGCY+RYDDY FF+E+LS++D+TVCG+KDF G+ TVF ANAIELVRNLSV+A
Sbjct: 75 TRGGRSFYDGCYIRYDDYKFFDEALSAEDKTVCGTKDFSGDQTVFRANAIELVRNLSVEA 134
Query: 121 VKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNA 180
NDGFFVGSV ++ N+SV+GLAQCWEFV GSAC CL NA SRI C KEEGRVLNA
Sbjct: 135 PGNDGFFVGSV--NRSNISVYGLAQCWEFVKGSACAECLANATSRIGLCPPKEEGRVLNA 192
Query: 181 GCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILA--TSAVALLLVFSLVAFFVRRKLLQK 238
GCYLRYSTQ+FY+NS D V N G ++LA+IL +S+ ALLL+ ++ FFVR+K ++
Sbjct: 193 GCYLRYSTQKFYDNSTSDFVEENEGSSRLAIILGVTSSSFALLLIIAMTVFFVRKKRAKR 252
Query: 239 RRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAV 298
RRERKQLG L VNKSKLNFSYETLEKATNYFH SNKLGQGGSGSVYKG +P G+ VA+
Sbjct: 253 RRERKQLGDLLATVNKSKLNFSYETLEKATNYFHHSNKLGQGGSGSVYKGIMPDGKVVAI 312
Query: 299 KRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV 358
KRLF+N+ QWVDHFFNEVNLISGI+HKNLVKLLGCSITGPESLLVYE+VPNQSL D L V
Sbjct: 313 KRLFFNSRQWVDHFFNEVNLISGIDHKNLVKLLGCSITGPESLLVYEYVPNQSLHDYL-V 371
Query: 359 RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418
+++ PL+WE+RYKI+L AEGLAYLHEES LRIIHRDIKLSN+LLDE+F AKIADFGL
Sbjct: 372 KRNAPPLAWEMRYKILLGIAEGLAYLHEESMLRIIHRDIKLSNVLLDEDFAAKIADFGLA 431
Query: 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478
RLFPED THIS +AGTLGYMAPEYVVRGKLTEK DVY FGV+VIEVVC KR N FTQ+S
Sbjct: 432 RLFPEDKTHISTAIAGTLGYMAPEYVVRGKLTEKVDVYGFGVLVIEVVCGKRNNSFTQDS 491
Query: 479 CSILQTVILLTWNI 492
SILQ V WN+
Sbjct: 492 FSILQMV----WNL 501
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434953|ref|XP_004135260.1| PREDICTED: cysteine-rich receptor-like protein kinase 3-like [Cucumis sativus] gi|449516641|ref|XP_004165355.1| PREDICTED: cysteine-rich receptor-like protein kinase 3-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 687 bits (1773), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/494 (69%), Positives = 393/494 (79%), Gaps = 9/494 (1%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
MD VTPLIA QR+AAV+NGTG +VYAFGECM DLS DC+LCFAQ KTQVL+CLPFQLA
Sbjct: 60 MDAVTPLIASQRFAAVINGTGNTTVYAFGECMNDLSQADCDLCFAQMKTQVLRCLPFQLA 119
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQA 120
TRGGR+FYDGC++RYD Y+FFNESLS+ DRTVCG D+ GN +VF +A++L RNLSV A
Sbjct: 120 TRGGRLFYDGCFVRYDYYNFFNESLSAVDRTVCGKLDYSGNRSVFSDSAMKLARNLSVVA 179
Query: 121 VKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNA 180
KNDGF VGSV F NVSV+GL QCW+FV GS+C CL +A I SC K EGRVLNA
Sbjct: 180 PKNDGFAVGSVDFR--NVSVYGLGQCWKFVRGSSCSKCLVDAAKEIGSCPPKSEGRVLNA 237
Query: 181 GCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLLVF--SLVAFFVRRKLLQK 238
GCY RYST++FY N+ GN +LA+ILA+ + A+ S V F RR++L+K
Sbjct: 238 GCYFRYSTEKFYFNTTATATGGNNS-RRLAIILASVSAAVAAALIISTVLFCARRRVLRK 296
Query: 239 RRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAV 298
R E++QLG L VNKSKLNFSYETLEKATNYF +SNKLGQGGSGSVYKGTL G VA+
Sbjct: 297 RNEKRQLGPLVAIVNKSKLNFSYETLEKATNYFDQSNKLGQGGSGSVYKGTLSDGRVVAI 356
Query: 299 KRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV 358
KRLF+NT QWVDHFFNEVNLISGI HKNLV LLGCSITGPESLLVYE+VPNQSL D LF
Sbjct: 357 KRLFFNTRQWVDHFFNEVNLISGIRHKNLVGLLGCSITGPESLLVYEYVPNQSLHDYLFG 416
Query: 359 RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418
++V+PLSW+ R+KI+L TAEGLAYLHEES ++IIHRDIKLSNILLD +FT KIADFGL
Sbjct: 417 NKNVQPLSWQSRFKIVLGTAEGLAYLHEESNVKIIHRDIKLSNILLDYDFTPKIADFGLA 476
Query: 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478
RL PED THIS +AGTLGYMAPEYVVRGKL+EKADVYSFGV IEV+ +R F Q+S
Sbjct: 477 RLLPEDKTHISTAIAGTLGYMAPEYVVRGKLSEKADVYSFGVFAIEVITGRRNGHFYQDS 536
Query: 479 CSILQTVILLTWNI 492
SILQ V WN+
Sbjct: 537 TSILQKV----WNL 546
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15223170|ref|NP_177210.1| cysteine-rich receptor-like protein kinase 3 [Arabidopsis thaliana] gi|75333658|sp|Q9CAL2.1|CRK3_ARATH RecName: Full=Cysteine-rich receptor-like protein kinase 3; Short=Cysteine-rich RLK3; Flags: Precursor gi|12325043|gb|AAG52470.1|AC010796_9 putative protein kinase; 41292-38663 [Arabidopsis thaliana] gi|332196954|gb|AEE35075.1| cysteine-rich receptor-like protein kinase 3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 676 bits (1743), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 326/488 (66%), Positives = 390/488 (79%), Gaps = 5/488 (1%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
MD V+PL+ + Y VVNGTG +VYA+GEC+KDL DC+LCFAQ K +V +CLPFQ
Sbjct: 52 MDAVSPLVEAKGYGQVVNGTGNLTVYAYGECIKDLDKKDCDLCFAQIKAKVPRCLPFQKG 111
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGG-NNTVFGANAIELVRNLSVQ 119
TRGG+VF DGCY+RYDDY+F+NE+LS QDRTVC K+ G N TVF NA ELV+N+SV+
Sbjct: 112 TRGGQVFSDGCYIRYDDYNFYNETLSLQDRTVCAPKEITGVNRTVFRDNAAELVKNMSVE 171
Query: 120 AVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLN 179
AV+N GF+ G V + NV+VHGLAQCWE +N S C CL A RI SC EEGRVL+
Sbjct: 172 AVRNGGFYAGFV--DRHNVTVHGLAQCWETLNRSGCVECLSKASVRIGSCLVNEEGRVLS 229
Query: 180 AGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILA--TSAVALLLVFSLVAFFVRRKLLQ 237
AGCY+R+STQ+FYNNSG GNGG N L VILA +S VA +L+ S F ++++ +
Sbjct: 230 AGCYMRFSTQKFYNNSGNSTSDGNGGHNHLGVILAVTSSVVAFVLLVSAAGFLLKKRHAK 289
Query: 238 KRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVA 297
K+RE+KQLG+L + NKS L FSYE LE+AT+YF + NKLGQGGSGSVYKG L G+ VA
Sbjct: 290 KQREKKQLGSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVA 349
Query: 298 VKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF 357
VKRLF+NT QWVDHFFNEVNLIS ++HKNLVKLLGCSITGPESLLVYE++ NQSL D LF
Sbjct: 350 VKRLFFNTKQWVDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLF 409
Query: 358 VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
VR+DV+PL+W R+KIIL TAEG+AYLHEES LRIIHRDIKLSNILL+++FT +IADFGL
Sbjct: 410 VRKDVQPLNWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGL 469
Query: 418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477
RLFPED THIS +AGTLGYMAPEYVVRGKLTEKADVYSFGV++IEV+ KR N F Q+
Sbjct: 470 ARLFPEDKTHISTAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQD 529
Query: 478 SCSILQTV 485
+ SILQ+V
Sbjct: 530 AGSILQSV 537
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567656|ref|XP_003552033.1| PREDICTED: cysteine-rich receptor-like protein kinase 3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 668 bits (1724), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/499 (66%), Positives = 390/499 (78%), Gaps = 17/499 (3%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
MD +TPL + AV NG+ A+VYAFGECM+DLS NDCNLC AQCKTQ+L CLPFQ
Sbjct: 54 MDALTPLTTSHGHGAVSNGSQNATVYAFGECMRDLSRNDCNLCLAQCKTQLLACLPFQRG 113
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDF------------GGNNTVFGAN 108
TRGGR+F+DGCYLRYDDY+FF E+ S QD TVCG+ ++ V+ AN
Sbjct: 114 TRGGRLFFDGCYLRYDDYNFFGETRSDQDTTVCGNNSNNNNSNSVANSATNSSSGVYKAN 173
Query: 109 AIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIAS 168
A+ LV NLS A K+DGFFVGSV + NV V+GLAQCWE+VNGSACE CL +AV+RI S
Sbjct: 174 AMALVLNLSELAPKSDGFFVGSV--ERKNVRVYGLAQCWEYVNGSACERCLADAVTRIGS 231
Query: 169 CTQKEEGRVLNAGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLL--VFSL 226
C +E R LNAGCYLRYS Q+FYNNSG P G G +LA ILA S+ AL L V +
Sbjct: 232 CA-TQEARALNAGCYLRYSAQKFYNNSGVVPTAGKHGKRRLAKILAASSAALALLLVIAT 290
Query: 227 VAFFVRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVY 286
V FF+R+ ++ +RRER+Q GAL VNKSKLN YE LEKATNYF+E+NKLGQGGSGSVY
Sbjct: 291 VVFFIRKNVVTRRRERRQFGALLDTVNKSKLNMPYEVLEKATNYFNEANKLGQGGSGSVY 350
Query: 287 KGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346
KG +P G VA+KRL +NTTQW DHFFNEVNLISGI+HKNLVKLLGCSITGPESLLVYE+
Sbjct: 351 KGVMPDGITVAIKRLSFNTTQWADHFFNEVNLISGIHHKNLVKLLGCSITGPESLLVYEY 410
Query: 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406
VPNQSL D+ VR+ +PL+WE+R+KI+L AEG+AYLHEES +RIIHRDIKLSNILL+E
Sbjct: 411 VPNQSLHDHFSVRRTSQPLTWEIRHKILLGIAEGMAYLHEESHVRIIHRDIKLSNILLEE 470
Query: 407 EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+FT KIADFGL RLFPED +HIS +AGTLGYMAPEYVVRGKLTEKADVYSFGV+VIE+V
Sbjct: 471 DFTPKIADFGLARLFPEDKSHISTAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLVIEIV 530
Query: 467 CRKRINLFTQNSCSILQTV 485
K+I+ + NS S+L TV
Sbjct: 531 SGKKISAYIMNSSSLLHTV 549
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356502033|ref|XP_003519826.1| PREDICTED: cysteine-rich receptor-like protein kinase 3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 667 bits (1722), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 324/489 (66%), Positives = 394/489 (80%), Gaps = 7/489 (1%)
Query: 1 MDIVTPLIARQRYAAVVNGT--GTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQ 58
++ +T L+ RQ+YA VV GT A+VYAFGEC KDL+ DC++CFAQCKT+VL+C PFQ
Sbjct: 52 LEALTALVTRQKYAFVVKGTTQNNATVYAFGECRKDLTKPDCDVCFAQCKTRVLRCSPFQ 111
Query: 59 LATRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSV 118
GG F+DGC+LRYD Y+FFNESLS QD TVCG++DF GN +V+ AN +ELVRNLS+
Sbjct: 112 RGIDGGMFFFDGCFLRYDGYNFFNESLSPQDFTVCGTEDFSGNWSVYKANTVELVRNLSI 171
Query: 119 QAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVL 178
+A KN+GFFVG V S+ NV+V+GLAQCW+F+NGSAC+NCL AV+RI SC K EG+ L
Sbjct: 172 EAPKNEGFFVGYV--SQRNVTVYGLAQCWKFMNGSACQNCLVEAVTRIDSCASKAEGKAL 229
Query: 179 NAGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILA--TSAVALLLVFSLVAFFVRRKLL 236
NAGCYLRYST FYN+S + N G LA+I+A ++++ALLL+ + V FFVR LL
Sbjct: 230 NAGCYLRYSTHNFYNSSNNNVPHENQGHKNLAIIVAVASASLALLLIVATVVFFVRTNLL 289
Query: 237 QKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAV 296
++RRER+Q GAL VNKSKLN YE LEKAT+YF SNKLG+GGSGSVYKG LP G +
Sbjct: 290 KRRRERRQFGALLNTVNKSKLNMPYEILEKATDYFSHSNKLGEGGSGSVYKGVLPDGNTM 349
Query: 297 AVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
A+KRL +NT+QW DHFFNEVNLISGI+HKNLVKLLGCSITGPESLLVYEFVPN SL D+L
Sbjct: 350 AIKRLSFNTSQWADHFFNEVNLISGIHHKNLVKLLGCSITGPESLLVYEFVPNHSLYDHL 409
Query: 357 FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
R++ + L+WEVR+KIIL TAEGLAYLHEES+ RIIHRDIKL+NIL+D+ FT KIADFG
Sbjct: 410 SGRKNSQQLTWEVRHKIILGTAEGLAYLHEESQ-RIIHRDIKLANILVDDNFTPKIADFG 468
Query: 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476
L RLFPED +H+S + GTLGYMAPEYVV GKLTEKADVYSFGV+++E++ K+ F +
Sbjct: 469 LARLFPEDKSHLSTAICGTLGYMAPEYVVLGKLTEKADVYSFGVLIMEIISGKKSKSFVE 528
Query: 477 NSCSILQTV 485
NS SILQTV
Sbjct: 529 NSYSILQTV 537
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297841809|ref|XP_002888786.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297334627|gb|EFH65045.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 664 bits (1713), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/489 (66%), Positives = 385/489 (78%), Gaps = 6/489 (1%)
Query: 1 MDIVTPLIARQRYAAVVN-GTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQL 59
MD V+PL+ + Y VVN G +VYA+GEC+KDL+ DC+LCFAQ K +V CLPFQ
Sbjct: 54 MDAVSPLVEAKGYGQVVNNANGNLTVYAYGECIKDLNKKDCDLCFAQIKAKVPICLPFQR 113
Query: 60 ATRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGG-NNTVFGANAIELVRNLSV 118
TRGG+VF DGCY+RYDDY+FFNE+L QDRTVC K+ G N TVF NA ELV+N+SV
Sbjct: 114 GTRGGQVFSDGCYIRYDDYNFFNETLGLQDRTVCAPKEITGVNRTVFRDNAAELVKNMSV 173
Query: 119 QAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVL 178
+AV+N GF+ G V + NV+VHGLAQCWE +N S C CL A I SC EEGRVL
Sbjct: 174 EAVRNGGFYAGFV--DRHNVTVHGLAQCWETLNRSGCVECLSKASVSIGSCLVNEEGRVL 231
Query: 179 NAGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILA--TSAVALLLVFSLVAFFVRRKLL 236
+AGCY+R+STQ+FYNNSG GNGG N L VILA +S VA +L+ S F ++++
Sbjct: 232 SAGCYMRFSTQKFYNNSGNSTSDGNGGHNHLGVILAVTSSVVAFVLLVSAAGFLLKKRHA 291
Query: 237 QKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAV 296
+K+RE+KQLG+L + NKS L FSYE LE+AT+YF + NKLGQGGSGSVYKG L G+ V
Sbjct: 292 KKQREKKQLGSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTV 351
Query: 297 AVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
AVKRLF+NT QWVDHFFNEVNLIS +NHKNLVKLLGCSITGPESLLVYE++ NQSL D L
Sbjct: 352 AVKRLFFNTKQWVDHFFNEVNLISQVNHKNLVKLLGCSITGPESLLVYEYIANQSLHDYL 411
Query: 357 FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
FVR+DV+PL+W R+KIIL TAEG+AYLHEES LRIIHRDIKLSNILL+++FT +IADFG
Sbjct: 412 FVRKDVQPLNWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFG 471
Query: 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476
L RLFPED THIS +AGTLGYMAPEYVVRGKLTEKADVYSFGV++IEV+ KR N F Q
Sbjct: 472 LARLFPEDKTHISTAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQ 531
Query: 477 NSCSILQTV 485
+ SILQTV
Sbjct: 532 EAGSILQTV 540
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255567375|ref|XP_002524667.1| kinase, putative [Ricinus communis] gi|223536028|gb|EEF37686.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 482 bits (1241), Expect = e-133, Method: Compositional matrix adjust.
Identities = 260/498 (52%), Positives = 338/498 (67%), Gaps = 25/498 (5%)
Query: 1 MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
M+ ++ LI +A + + +Y +C +DLS DC LC+A +T++ +CLP
Sbjct: 1 METLSQLITNSHFA-TYHLNSSLPMYVLAQCHQDLSQTDCLLCYAVSRTKIPRCLP---- 55
Query: 61 TRGGRVFYDGCYLRYDDYDFFNESLS-SQDRTVCGSKDFGGNN-----TVFGANAIELVR 114
+ R+F DGC+LRYD+Y+FF ES+S S D C ++ G+N F + +
Sbjct: 56 SVSARIFLDGCFLRYDNYNFFEESVSVSFDEVKCSQENVSGSNGENDKLRFVKSVEHAIG 115
Query: 115 NLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEE 174
N+S +AV+N GF V + V+ LAQCWE V C CL A + C K+E
Sbjct: 116 NVSSKAVENGGFGVVGIE------GVYALAQCWESVGKDGCRECLRKAGKEVKGCGAKKE 169
Query: 175 GRVLNAGCYLRYSTQRFYNNSGP----DPVPGNGGDNKLAVILATSAVALLLVFSLVAFF 230
GR LNAGCYLRYST+RFYN G + G G +AV+LA +AV +L +F++ A +
Sbjct: 170 GRGLNAGCYLRYSTERFYNVGGELEAGHTISGLG--VAIAVVLAAAAVLMLSIFAVYAVY 227
Query: 231 VRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTL 290
VRR ++ + ER L + + +K+ LNF YETLEKAT+YF+ S K+GQGG+GSVY GTL
Sbjct: 228 VRR--MKNKAERINLEKISINFSKTSLNFKYETLEKATDYFNASRKIGQGGAGSVYAGTL 285
Query: 291 PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350
P GE VAVKRL +NT QWVD FFNEVNLISGI HKNLVKLLGCSI GPESLLVYE+VPN+
Sbjct: 286 PNGETVAVKRLTFNTRQWVDEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNK 345
Query: 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410
SL +F + L+W+ R+ II+ TAEGLAYLH S+ RIIHRDIK SN+LLDE+FT
Sbjct: 346 SLDQFIFGKDKPTTLNWKQRFDIIVGTAEGLAYLHGGSQERIIHRDIKSSNVLLDEDFTP 405
Query: 411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
KIADFGLVR F D +H+S +AGT+GYMAPEY++RG+LTEKADVYSFGV+V+E+V KR
Sbjct: 406 KIADFGLVRCFGADKSHLSTGIAGTMGYMAPEYLIRGQLTEKADVYSFGVLVLEIVMGKR 465
Query: 471 INLFTQNSCSILQTVILL 488
N FT++S S+LQTV L
Sbjct: 466 CNAFTEDSKSLLQTVWQL 483
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449446869|ref|XP_004141193.1| PREDICTED: cysteine-rich receptor-like protein kinase 42-like [Cucumis sativus] gi|449515394|ref|XP_004164734.1| PREDICTED: cysteine-rich receptor-like protein kinase 42-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 476 bits (1225), Expect = e-131, Method: Compositional matrix adjust.
Identities = 248/497 (49%), Positives = 327/497 (65%), Gaps = 21/497 (4%)
Query: 1 MDIVTPLIARQRYAA-VVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQL 59
M+ ++ L+ + + VN T ++A +C DLS DC LC+A +T + +CLP
Sbjct: 1 MEAISELLTTRSWTTHFVNST--PPMFALSQCFNDLSHTDCLLCYAASRTSLPRCLPAIS 58
Query: 60 ATRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFG----GNNTVFGANAIELVRN 115
A R+F DGC+LRYD+Y F+ ES S +V + + G VFG N +V
Sbjct: 59 A----RIFLDGCFLRYDNYSFYKESTDSVRDSVNCTSELGEIDQSERLVFGENVRVVVET 114
Query: 116 LSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEG 175
++ +A++ GF +G V+ + GLAQCW V C CLE A I SC +EG
Sbjct: 115 VTTKAMEKGGFGMGEVS------GMFGLAQCWGSVEPEGCRACLEKAKRSIGSCLPSKEG 168
Query: 176 RVLNAGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLLVFSLVAFFVRRKL 235
R +NAGCYLRYST +FYN+ D + V +A ++ A L++F F ++
Sbjct: 169 RAMNAGCYLRYSTVKFYNDKDEDRDHDGFSGRRAVVTIALASAASLIIFFSAVFACYTRI 228
Query: 236 LQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEA 295
+ ++E+K+ + V++ S LNF YETLEKATNYF+ SNK+GQGG+GSVYKGTLP G+
Sbjct: 229 SKFKKEKKRQSLIPVSLKDSDLNFKYETLEKATNYFNLSNKIGQGGAGSVYKGTLPNGQI 288
Query: 296 VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDN 355
VAVKRL ++T QWVD FFNEVNLI GI HKNLV LLGCSI GPESLLVYEFV N SL
Sbjct: 289 VAVKRLVFHTRQWVDEFFNEVNLIRGIQHKNLVALLGCSIEGPESLLVYEFVSNGSLDHF 348
Query: 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415
+F + + LSW+ R+ II+ TAEGLA+LHE K+RIIHRDIK SN+LLDE F KIADF
Sbjct: 349 IFDKNKAQILSWKQRFNIIVGTAEGLAHLHEGCKIRIIHRDIKSSNVLLDENFNPKIADF 408
Query: 416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475
GL R F D +H+S +AGTLGYMAPEY+VRG+LTEKADVYSFGV+++E+VC +R + FT
Sbjct: 409 GLARHFGADQSHLSTGIAGTLGYMAPEYLVRGQLTEKADVYSFGVLILEIVCGRRNSSFT 468
Query: 476 QNSCSILQTVILLTWNI 492
+NS +LQTV W++
Sbjct: 469 ENSTPLLQTV----WDL 481
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 492 | ||||||
| TAIR|locus:2026785 | 646 | CRK3 "cysteine-rich RLK (RECEP | 0.487 | 0.371 | 0.754 | 9.6e-161 | |
| TAIR|locus:2026821 | 649 | CRK2 "cysteine-rich RLK (RECEP | 0.439 | 0.332 | 0.615 | 2.3e-99 | |
| TAIR|locus:2139845 | 625 | AT4G28670 [Arabidopsis thalian | 0.467 | 0.368 | 0.5 | 1.7e-82 | |
| TAIR|locus:2141762 | 665 | CRK26 "cysteine-rich RLK (RECE | 0.481 | 0.356 | 0.497 | 9.7e-72 | |
| TAIR|locus:2141201 | 679 | CRK29 "cysteine-rich RLK (RECE | 0.483 | 0.350 | 0.485 | 1.1e-68 | |
| TAIR|locus:2123126 | 666 | CRK31 "cysteine-rich RLK (RECE | 0.477 | 0.352 | 0.495 | 3.3e-67 | |
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.475 | 0.346 | 0.483 | 1.1e-66 | |
| TAIR|locus:2123056 | 656 | CRK32 "cysteine-rich RLK (RECE | 0.477 | 0.358 | 0.483 | 1.4e-64 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.443 | 0.325 | 0.502 | 2e-63 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.447 | 0.328 | 0.506 | 8.8e-63 |
| TAIR|locus:2026785 CRK3 "cysteine-rich RLK (RECEPTOR-like protein kinase) 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 941 (336.3 bits), Expect = 9.6e-161, Sum P(2) = 9.6e-161
Identities = 181/240 (75%), Positives = 208/240 (86%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT 305
G+L + NKS L FSYE LE+AT+YF + NKLGQGGSGSVYKG L G+ VAVKRLF+NT
Sbjct: 298 GSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRLFFNT 357
Query: 306 TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPL 365
QWVDHFFNEVNLIS ++HKNLVKLLGCSITGPESLLVYE++ NQSL D LFVR+DV+PL
Sbjct: 358 KQWVDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLFVRKDVQPL 417
Query: 366 SWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
+W R+KIIL TAEG+AYLHEES LRIIHRDIKLSNILL+++FT +IADFGL RLFPED
Sbjct: 418 NWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGLARLFPEDK 477
Query: 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
THIS +AGTLGYMAPEYVVRGKLTEKADVYSFGV++IEV+ KR N F Q++ SILQ+V
Sbjct: 478 THISTAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQDAGSILQSV 537
|
|
| TAIR|locus:2026821 CRK2 "cysteine-rich RLK (RECEPTOR-like protein kinase) 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 686 (246.5 bits), Expect = 2.3e-99, Sum P(2) = 2.3e-99
Identities = 133/216 (61%), Positives = 162/216 (75%)
Query: 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFN 314
S LNF Y TLEKAT F +NKLGQGG G+VYKG LP G +AVKRLF+N F+N
Sbjct: 309 SSLNFKYSTLEKATGSFDNANKLGQGGFGTVYKGVLPDGRDIAVKRLFFNNRHRATDFYN 368
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
EVN+IS + HKNLV+LLGCS +GPESLLVYE++ N+SL +F + L W+ RY II
Sbjct: 369 EVNMISTVEHKNLVRLLGCSCSGPESLLVYEYLQNKSLDRFIFDVNRGKTLDWQRRYTII 428
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
+ TAEGL YLHE+S ++IIHRDIK SNILLD + AKIADFGL R F +D +HIS +AG
Sbjct: 429 VGTAEGLVYLHEQSSVKIIHRDIKASNILLDSKLQAKIADFGLARSFQDDKSHISTAIAG 488
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
TLGYMAPEY+ G+LTE DVYSFGV+V+E+V K+
Sbjct: 489 TLGYMAPEYLAHGQLTEMVDVYSFGVLVLEIVTGKQ 524
|
|
| TAIR|locus:2139845 AT4G28670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 1.7e-82, Sum P(2) = 1.7e-82
Identities = 120/240 (50%), Positives = 158/240 (65%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
++F Y TL+KATN F+ES KLG GG G V+KGTL G +A+KRL + + D NE+
Sbjct: 317 MSFEYSTLKKATNNFNESCKLGVGGYGEVFKGTLSDGREIAIKRLHVSGKKPRDEIHNEI 376
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
++IS HKNLV+LLGC T S +VYEF+ N SL LF + + L W+ R IIL
Sbjct: 377 DVISRCQHKNLVRLLGCCFTNMNSFIVYEFLANTSLDHILFNPEKKKELDWKKRRTIILG 436
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE---DITHIS---A 430
TAEGL YLHE K IIHRDIK SNILLD ++ KI+DFGL + +PE DI S +
Sbjct: 437 TAEGLEYLHETCK--IIHRDIKASNILLDLKYKPKISDFGLAKFYPEGGKDIPASSLSPS 494
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVILLTW 490
++AGTLGYMAPEY+ +G+L+ K D YSFGV+V+E+ R N F ++ L+T++ W
Sbjct: 495 SIAGTLGYMAPEYISKGRLSNKIDAYSFGVLVLEITSGFRNNKFRSDNS--LETLVTQVW 552
|
|
| TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 577 (208.2 bits), Expect = 9.7e-72, Sum P(2) = 9.7e-72
Identities = 120/241 (49%), Positives = 157/241 (65%)
Query: 252 VNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDH 311
++ + F + L+ AT++F NKLG+GG G+VYKG L G+ +AVKRL N Q
Sbjct: 325 ISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSKNAQQGETE 384
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
F NE L++ + H+NLVKLLG SI G E LLVYEF+P+ SL +F L WE+RY
Sbjct: 385 FKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNELEWEIRY 444
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
KII A GL YLH++S+LRIIHRD+K SNILLDEE T KIADFG+ RLF D T T
Sbjct: 445 KIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDIDHTTQRYT 504
Query: 432 --LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVILLT 489
+ GT GYMAPEYV+ G+ + K DVYSFGV+V+E++ K+ + F+ + +I
Sbjct: 505 NRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISGKKNSGFSSEDS--MGDLISFA 562
Query: 490 W 490
W
Sbjct: 563 W 563
|
|
| TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 566 (204.3 bits), Expect = 1.1e-68, Sum P(2) = 1.1e-68
Identities = 117/241 (48%), Positives = 158/241 (65%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHF 312
N L +ETL+ AT+ F N+LG+GG GSVYKG P G+ +AVKRL N+ Q + F
Sbjct: 339 NTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQGDNEF 398
Query: 313 FNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK 372
NE+ L++ + H+NLV+L+G I G E LLVYEF+ N SL +F + + L W VRYK
Sbjct: 399 KNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLLDWVVRYK 458
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP--EDITH-IS 429
+I A GL YLHE+S+ RIIHRD+K SNILLD+E KIADFGL +LF + +TH +
Sbjct: 459 MIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFT 518
Query: 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVILLT 489
+ +AGT GYMAPEY + G+ + K DV+SFGV+VIE++ KR N N + ++
Sbjct: 519 SRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDLLSWV 578
Query: 490 W 490
W
Sbjct: 579 W 579
|
|
| TAIR|locus:2123126 CRK31 "cysteine-rich RLK (RECEPTOR-like protein kinase) 31" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 549 (198.3 bits), Expect = 3.3e-67, Sum P(2) = 3.3e-67
Identities = 118/238 (49%), Positives = 151/238 (63%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
L F + T+E AT+ F +NKLGQGG G VYKG LP +AVKRL N+ Q F NEV
Sbjct: 325 LQFDFTTIEVATDNFSRNNKLGQGGFGEVYKGMLPNETEIAVKRLSSNSGQGTQEFKNEV 384
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
+++ + HKNLV+LLG I E +LVYEFV N+SL LF + L W+ RY II
Sbjct: 385 VIVAKLQHKNLVRLLGFCIERDEQILVYEFVSNKSLDYFLFDPKMKSQLDWKRRYNIIGG 444
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI-SATLAGT 435
GL YLH++S+L IIHRDIK SNILLD + KIADFG+ R F D T + + GT
Sbjct: 445 VTRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRVDQTEDQTGRVVGT 504
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ--NSCSILQTVILLTWN 491
GYM PEYV G+ + K+DVYSFGV+++E+VC K+ + F Q +S L T + WN
Sbjct: 505 FGYMPPEYVTHGQFSTKSDVYSFGVLILEIVCGKKNSSFFQMDDSGGNLVTHVWRLWN 562
|
|
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 570 (205.7 bits), Expect = 1.1e-66, Sum P(2) = 1.1e-66
Identities = 114/236 (48%), Positives = 154/236 (65%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
L F + +E ATN F ESNKLG GG G VYKG L GE VA+KRL +TQ + F NEV
Sbjct: 333 LQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEV 392
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
++++ + H+NL KLLG + G E +LVYEFVPN+SL LF + L W+ RYKII
Sbjct: 393 DVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEG 452
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGT 435
A G+ YLH +S+L IIHRD+K SNILLD + KI+DFG+ R+F D T + + GT
Sbjct: 453 IARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANTKRIVGT 512
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVILLTW 490
GYM+PEY + GK + K+DVYSFGV+V+E++ +K + + ++ L T + W
Sbjct: 513 YGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGDLVTYVWKLW 568
|
|
| TAIR|locus:2123056 CRK32 "cysteine-rich RLK (RECEPTOR-like protein kinase) 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 538 (194.4 bits), Expect = 1.4e-64, Sum P(2) = 1.4e-64
Identities = 119/246 (48%), Positives = 155/246 (63%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
L F + TLE AT+ F +NKLG+GG G VYKG LP VAVKRL N+ Q F NEV
Sbjct: 307 LQFDFMTLEAATDKFSRNNKLGKGGFGEVYKGMLPNETEVAVKRLSSNSGQGTQEFKNEV 366
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD---VEP-----LSWE 368
+++ + HKNLV+LLG + E +LVYEFVPN+SL LF + ++P L W+
Sbjct: 367 VIVAKLQHKNLVRLLGFCLERDEQILVYEFVPNKSLNYFLFGNKQKHLLDPTKKSQLDWK 426
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
RY II GL YLH++S+L IIHRDIK SNILLD + KIADFG+ R F D T
Sbjct: 427 RRYNIIGGITRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRVDQTED 486
Query: 429 SAT-LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ--NSCSILQTV 485
+ + GT GYM PEYV G+ + K+DVYSFGV+++E+VC K+ + F + +S L T
Sbjct: 487 NTRRVVGTFGYMPPEYVTHGQFSTKSDVYSFGVLILEIVCGKKNSSFYKIDDSGGNLVTH 546
Query: 486 ILLTWN 491
+ WN
Sbjct: 547 VWRLWN 552
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 542 (195.9 bits), Expect = 2.0e-63, Sum P(2) = 2.0e-63
Identities = 110/219 (50%), Positives = 147/219 (67%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
L FS++T+E AT+ F +SN +G+GG G VY+G L G VAVKRL + Q + F NE
Sbjct: 331 LQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNEA 390
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
L+S + HKNLV+LLG + G E +LVYEFVPN+SL LF L W RY II
Sbjct: 391 VLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIGG 450
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGT 435
A G+ YLH++S+L IIHRD+K SNILLD + KIADFG+ R+F D + + +AGT
Sbjct: 451 IARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIAGT 510
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474
GYM+PEY +RG + K+DVYSFGV+V+E++ K+ + F
Sbjct: 511 FGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSF 549
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 540 (195.1 bits), Expect = 8.8e-63, Sum P(2) = 8.8e-63
Identities = 112/221 (50%), Positives = 149/221 (67%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
L Y T++ AT+ F ESNK+GQGG G VYKGTL G VAVKRL ++ Q F NEV
Sbjct: 334 LQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEV 393
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
L++ + H+NLV+LLG + G E +LVYE+VPN+SL LF L W RYKII
Sbjct: 394 VLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGG 453
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGT 435
A G+ YLH++S+L IIHRD+K SNILLD + KIADFG+ R+F D T + + + GT
Sbjct: 454 VARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGT 513
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476
GYM+PEY + G+ + K+DVYSFGV+V+E++ K+ + F Q
Sbjct: 514 YGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQ 554
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9CAL2 | CRK3_ARATH | 2, ., 7, ., 1, 1, ., - | 0.6680 | 0.9817 | 0.7476 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 492 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-39 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-23 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-21 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-19 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-16 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 5e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-13 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 4e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 1e-52
Identities = 70/192 (36%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 277 LGQGGSGSVYKGTLPG-GEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
LG+GG G+VY G+ VA+K + +++ ++ E+ ++ +NH N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
LV E+ SL D ++++ LS + +I+L EGL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKD--LLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIH 115
Query: 395 RDIKLSNILLDE-EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE-YVVRGKLTEK 452
RD+K NILLD K+ADFGL +L D + T+ GT YMAPE + +G +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 453 ADVYSFGVVVIE 464
+D++S GV++ E
Sbjct: 175 SDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 1e-49
Identities = 74/204 (36%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNL 327
+ KLG G G+VYK G G+ VAVK L + + E+ ++ ++H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
V+L+ LV E+ L D L PLS + KI L GL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHSN 117
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
IIHRD+K NILLDE KIADFGL + + + ++ T GT YMAPE V+ G
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-TFVGTPWYMAPE-VLLG 172
Query: 448 KL--TEKADVYSFGVVVIEVVCRK 469
K DV+S GV++ E++ K
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 62/198 (31%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
KLG+G G VY G+ VA+K + + + E+ ++ + H N+V+L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKIILSTAEGLAYLHEESKLR 391
+ LV E+ L D L + LS E R+ + L YLH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARF-YLRQILSALEYLH---SKG 117
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE 451
I+HRD+K NILLDE+ K+ADFGL R T GT YMAPE ++ +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVLLGKGYGK 175
Query: 452 KADVYSFGVVVIEVVCRK 469
D++S GV++ E++ K
Sbjct: 176 AVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 4e-46
Identities = 73/205 (35%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 276 KLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLV 328
KLG+G G VYKGTL VAVK L + + + F E +++ ++H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE-FLEEASIMKKLSHPNIV 64
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
+LLG G +V E++P LLD F+R+ E L+ + ++ L A+G+ YL S
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLD--FLRKHGEKLTLKDLLQMALQIAKGMEYLE--S 120
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY-----MAPEY 443
K +HRD+ N L+ E KI+DFGL R DI G MAPE
Sbjct: 121 K-NFVHRDLAARNCLVTENLVVKISDFGLSR----DIYEDDYYRKRGGGKLPIKWMAPES 175
Query: 444 VVRGKLTEKADVYSFGVVVIEVVCR 468
+ GK T K+DV+SFGV++ E+
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 6e-44
Identities = 67/196 (34%), Positives = 98/196 (50%), Gaps = 11/196 (5%)
Query: 276 KLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVK 329
KLG+G G VYKG L VAVK L + + Q ++ F E ++ ++H N+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
LLG +V E++ LL ++R++ LS L A G+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLS--YLRKNRPKLSLSDLLSFALQIARGMEYLES--- 120
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
IHRD+ N L+ E KI+DFGL R +D + + +MAPE + GK
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180
Query: 450 TEKADVYSFGVVVIEV 465
T K+DV+SFGV++ E+
Sbjct: 181 TSKSDVWSFGVLLWEI 196
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 5e-43
Identities = 67/207 (32%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 275 NKLGQGGSGSVYKGTLPGGE----AVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
KLG+G G VYKG L G + VAVK L + + D F E ++ + H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD-FLKEARVMKKLGHPNVV 59
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLD------NLFVRQDVEPLSWEVRYKIILSTAEGLA 382
+LLG LV E++ LLD +F + LS + + A+G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT-LGYMAP 441
YL + +HRD+ N L+ E+ KI+DFGL R +D + T + +MAP
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCR 468
E + G T K+DV+SFGV++ E+
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTL 203
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 5e-42
Identities = 70/198 (35%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 276 KLGQGGSGSVYKGTL-----PGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
KLG+G G VYKGTL VAVK L + Q + F E ++ ++H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHPNIV 64
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEE 387
KLLG ++V E++P LLD ++R+ + LS L A G+ YL
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLD--YLRKNRPKELSLSDLLSFALQIARGMEYLES- 121
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
IHRD+ N L+ E KI+DFGL R +D + + +MAPE + G
Sbjct: 122 --KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 448 KLTEKADVYSFGVVVIEV 465
K T K+DV+SFGV++ E+
Sbjct: 180 KFTSKSDVWSFGVLLWEI 197
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 1e-41
Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
LG+G GSVY GE +AVK L ++ + ++ E+ ++S + H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 332 GCSIT-GPESLLVY-EFVPNQSLLDNLFVRQDVEPLSWEV--RY-KIILSTAEGLAYLHE 386
G +L ++ E+V SL + + L V +Y + IL EGLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSS---LLKKFGKLPEPVIRKYTRQIL---EGLAYLHS 119
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVV 445
I+HRDIK +NIL+D + K+ADFG RL + + ++ GT +MAPE +
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 446 RGKLTEKADVYSFGVVVIEVVCRKR 470
+ AD++S G VIE+ K
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 6e-39
Identities = 66/197 (33%), Positives = 94/197 (47%), Gaps = 10/197 (5%)
Query: 270 YFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
F K+G+GG G VYK G+ VA+K + + + + NE+ ++ H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
K G + E +V EF SL D L S + Y + +GL YLH
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-IAY-VCKELLKGLEYLH--- 115
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVRG 447
IIHRDIK +NILL + K+ DFGL +L + T+ GT +MAPE +
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVINGK 172
Query: 448 KLTEKADVYSFGVVVIE 464
KAD++S G+ IE
Sbjct: 173 PYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-36
Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 22/212 (10%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNL 327
+ + +G+G G VYKG L G+ VA+K++ + + E++L+ + H N+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
VK +G T ++ E+ N SL + + P + + +GLAYLHE+
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQ---IIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVR 446
+IHRDIK +NIL ++ K+ADFG+ +L D++ A++ GT +MAPE V+
Sbjct: 119 G---VIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPE-VIE 172
Query: 447 GK-LTEKADVYSFGVVVIEVVCRKRINLFTQN 477
+ +D++S G VIE L T N
Sbjct: 173 MSGASTASDIWSLGCTVIE--------LLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (316), Expect = 4e-32
Identities = 72/227 (31%), Positives = 106/227 (46%), Gaps = 18/227 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINH-KN 326
+ KLG+G G VY + VA+K L + ++ V+ F E+ +++ +NH N
Sbjct: 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
+VKL LV E+V SL D L PLS I+ L YLH
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 387 ESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITH-----ISATLAGTLGYMA 440
IIHRDIK NILLD + K+ DFGL +L P+ + + +T GT GYMA
Sbjct: 120 ---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 441 PEYV---VRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQT 484
PE + + +D++S G+ + E++ +NS + QT
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223
|
Length = 384 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 65/191 (34%), Positives = 93/191 (48%), Gaps = 11/191 (5%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
KLG+G GSVYK G+ VA+K + + E++++ + +VK G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIK--VVPVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEESKLRII 393
+ +V E+ S+ D + + L+ E IL T +GL YLH + I
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNK--TLT-EEEIAAILYQTLKGLEYLH---SNKKI 121
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
HRDIK NILL+EE AK+ADFG V D T+ GT +MAPE + KA
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFG-VSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKA 180
Query: 454 DVYSFGVVVIE 464
D++S G+ IE
Sbjct: 181 DIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 7e-29
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 12/202 (5%)
Query: 268 TNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
+ K+G+G SG VYK T G+ VA+K++ Q + NE+ ++ H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRL-RKQNKELIINEILIMKDCKHPN 76
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
+V + G E +V E++ SL D + Q+ ++ + +GL YLH
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVLQGLEYLH- 133
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVV 445
+IHRDIK NILL ++ + K+ADFG +L E ++ GT +MAPE V+
Sbjct: 134 --SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR--NSVVGTPYWMAPE-VI 188
Query: 446 RGKL-TEKADVYSFGVVVIEVV 466
+ K K D++S G++ IE+
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 72/202 (35%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 275 NKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQW---VDHFFNEVNLISGINHKNLVKL 330
+G G + VY LP E VA+KR+ + + VD EV +S NH N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRI--DLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNL--FVRQDVEPLSWEVRYKIIL-STAEGLAYLHEE 387
+ G E LV ++ SLLD + + E +L +GL YLH
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD---EAIIATVLKEVLKGLEYLH-- 119
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF--PEDITHIS-ATLAGTLGYMAPEYV 444
IHRDIK NILL E+ + KIADFG+ D T T GT +MAPE +
Sbjct: 120 -SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 445 --VRGKLTEKADVYSFGVVVIE 464
V G KAD++SFG+ IE
Sbjct: 179 EQVHG-YDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 9e-28
Identities = 71/201 (35%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-CS 334
KLG G G V+ GT G VAVK L T + F E ++ + H LV+L CS
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--AEGLAYLHEESKLRI 392
P +V E++ SLLD L + E + + ++ AEG+AYL
Sbjct: 72 EEEP-IYIVTEYMSKGSLLDFL---KSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NY 124
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI--THISATLAGTLGYMAPEYVVRGKLT 450
IHRD+ NIL+ E KIADFGL RL +D A + + APE G+ T
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRFT 182
Query: 451 EKADVYSFGVVVIEVVCRKRI 471
K+DV+SFG+++ E+V R+
Sbjct: 183 IKSDVWSFGILLTEIVTYGRV 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
F KLG G G V++G VA+K L + F EV + + HK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 331 LG-CSITGPESLLVYEFVPNQSLLDNLFVR------QDVEPL---SWEVRYKIILSTAEG 380
CS+ P ++ E + SLL F+R V L + +V AEG
Sbjct: 68 FAVCSVGEP-VYIITELMEKGSLLA--FLRSPEGQVLPVASLIDMACQV--------AEG 116
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMA 440
+AYL E+ IHRD+ NIL+ E+ K+ADFGL RL ED+ ++S+ + A
Sbjct: 117 MAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTA 172
Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVCRKRI 471
PE G + K+DV+SFG+++ E+ ++
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFTYGQV 203
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 71/208 (34%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 272 HESNKLGQGGSGSVYKG-TLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLV 328
NK+G G G VY L GE +AVK R+ N + + +E+ ++ + H NLV
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
K G + + + E+ + L+ L + Y + L EGLAYLH
Sbjct: 63 KYYGVEVHREKVYIFMEYC-SGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSH- 118
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHIS--ATLAGTLGYMAPEYVV 445
I+HRDIK +NI LD K+ DFG V+L T +LAGT YMAPE +
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 446 RGKLTEK---ADVYSFGVVVIEVVCRKR 470
GK AD++S G VV+E+ KR
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 61/189 (32%), Positives = 99/189 (52%), Gaps = 10/189 (5%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
+G+G G V G G + VAVK L ++T F E ++++ + H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDYRG-QKVAVKCLKDDSTA-AQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRD 396
G +V E++ SL+D L R ++ + L EG+ YL E K +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYL--EEK-NFVHRD 127
Query: 397 IKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVY 456
+ N+L+ E+ AK++DFGL + S L + + APE + K + K+DV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFSTKSDVW 183
Query: 457 SFGVVVIEV 465
SFG+++ E+
Sbjct: 184 SFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 274 SNKLGQGGSGSVYKGTL--PG---GEAVAVKRLFYNTTQWVDH---FFNEVNLISGINHK 325
+LG+G G V G GE VAVK L N + H F E+ ++ ++H+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEILRTLDHE 66
Query: 326 NLVKLLGCS--ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
N+VK G G L+ E++P+ SL D L +D L + + +G+ Y
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS--SQICKGMDY 124
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG--YMAP 441
L + R IHRD+ NIL++ E KI+DFGL ++ PED + G + AP
Sbjct: 125 LGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 442 EYVVRGKLTEKADVYSFGVVVIEVV--CRK 469
E + K + +DV+SFGV + E+
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 7e-27
Identities = 69/198 (34%), Positives = 99/198 (50%), Gaps = 14/198 (7%)
Query: 276 KLGQGGSGSVYKGTL--PGGE--AVAVKRLFY-NTTQWVDHFFNEVNLISGINHKNLVKL 330
KLG G G V +G GG+ VAVK L + +D F E ++ ++H+NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESK 389
G +T P ++V E P SLLD L +S Y + A G+ YL ESK
Sbjct: 62 YGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV--QIANGMRYL--ESK 116
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGYMAPEYVVRG 447
R IHRD+ NILL + KI DFGL+R P++ H + L + APE +
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 448 KLTEKADVYSFGVVVIEV 465
+ +DV+ FGV + E+
Sbjct: 176 TFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 25/202 (12%)
Query: 277 LGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKL 330
LG G G+VYKG +P GE VA+K L T+ + +E +++ ++H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP------LSWEVRYKIILSTAEGLAYL 384
LG ++ + L+ + +P LLD +VR + L+W V+ A+G++YL
Sbjct: 75 LGICLS-SQVQLITQLMPLGCLLD--YVRNHKDNIGSQYLLNWCVQ------IAKGMSYL 125
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT-LGYMAPEY 443
E+ R++HRD+ N+L+ KI DFGL +L D A + +MA E
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 444 VVRGKLTEKADVYSFGVVVIEV 465
++ T K+DV+S+GV V E+
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 10/201 (4%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKR--LFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
++G+G G VY G+ +K L + + + NEV ++ +NH N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
+ +V E+ L + + ++ +P E + L YLH
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--- 122
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK-L 449
+I+HRDIK NI L K+ DFG+ ++ ++ T+ GT Y++PE + + K
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLAKTVVGTPYYLSPE-LCQNKPY 180
Query: 450 TEKADVYSFGVVVIEVVCRKR 470
K+D++S G V+ E+ K
Sbjct: 181 NYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 65/197 (32%), Positives = 93/197 (47%), Gaps = 21/197 (10%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
LG+G G V K T G+ A+K L + V+H E N++S INH +VK
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 330 LLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS-TAEGLAYLHEE 387
L + E L LV E+ P L +L S E R + + L YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFS-EERARFYAAEIVLALEYLHS- 111
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
L II+RD+K NILLD + K+ DFGL + + + + T GT Y+APE ++
Sbjct: 112 --LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN-TFCGTPEYLAPEVLLGK 168
Query: 448 KLTEKADVYSFGVVVIE 464
+ D +S GV++ E
Sbjct: 169 GYGKAVDWWSLGVLLYE 185
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-26
Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 10/198 (5%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLG G G V+ G G VA+K L + + F E NL+ + H LV+L +
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAV-V 70
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--AEGLAYLHEESKLRII 393
T ++ E++ N SL+D F++ E + + I ++ AEG+A++ ++ I
Sbjct: 71 TQEPIYIITEYMENGSLVD--FLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YI 124
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
HRD++ +NIL+ E KIADFGL RL ++ + + APE + G T K+
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 454 DVYSFGVVVIEVVCRKRI 471
DV+SFG+++ E+V RI
Sbjct: 185 DVWSFGILLTEIVTYGRI 202
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 63/192 (32%), Positives = 98/192 (51%), Gaps = 6/192 (3%)
Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+KLG G G VY+G VAVK L +T + V+ F E ++ I H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
P ++ EF+ +LLD L + + ++ V + + + YL +++ I
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 126
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
HRD+ N L+ E K+ADFGL RL D A + + APE + K + K+
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 454 DVYSFGVVVIEV 465
DV++FGV++ E+
Sbjct: 187 DVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 277 LGQGGSGSVYKGTLPG---GEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVK 329
LGQG G VY+G G GE VA+K + N + + F NE +++ N ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQD-------VEPLSWEVRYKIILSTAEGLA 382
LLG TG +L+V E + L L R+ + P + + ++ A+G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGYMAP 441
YL + +HRD+ N ++ E+ T KI DFG+ R ++ D + +MAP
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 442 EYVVRGKLTEKADVYSFGVVVIEVV 466
E + G T K+DV+SFGVV+ E+
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 7e-25
Identities = 67/199 (33%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 275 NKLGQGGSGSVYKGT--LPGGE--AVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLVK 329
+LG G GSV KG + G+ VAVK L F E ++++ ++H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
L+G G +LV E P LL L R+++ + + A G+AYL ESK
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE---LAHQVAMGMAYL--ESK 114
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYVVRG 447
+HRD+ N+LL AKI+DFG+ R + AT AG L + APE + G
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 448 KLTEKADVYSFGVVVIEVV 466
K + K+DV+S+GV + E
Sbjct: 174 KFSSKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 61/191 (31%), Positives = 95/191 (49%), Gaps = 8/191 (4%)
Query: 276 KLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDH-FFNEVNLISGINHKNLVKLLGC 333
LGQG SG VYK P G+ A+K++ + + E+ + +VK G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
E +V E++ SL D + + V + V I +GL YLH +K II
Sbjct: 68 FYKEGEISIVLEYMDGGSLAD---LLKKVGKIPEPVLAYIARQILKGLDYLH--TKRHII 122
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
HRDIK SN+L++ + KIADFG+ ++ E+ T GT+ YM+PE + + A
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVL-ENTLDQCNTFVGTVTYMSPERIQGESYSYAA 181
Query: 454 DVYSFGVVVIE 464
D++S G+ ++E
Sbjct: 182 DIWSLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 11/213 (5%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-CS 334
KLG G G V++G VAVK L T F E ++ + H L++L C+
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--AEGLAYLHEESKLRI 392
+ P +V E + SLL+ L Q + ++ I ++ A G+AYL ++
Sbjct: 72 LEEP-IYIVTELMKYGSLLEYL---QGGAGRALKLPQLIDMAAQVASGMAYLEAQN---Y 124
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
IHRD+ N+L+ E K+ADFGL R+ EDI + + APE + + + K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 453 ADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
+DV+SFG+++ E+V R+ + +LQ V
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 65/204 (31%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+ ++G G G VYK + GE VA+K + + E++++ H N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
G + + +V E+ SL D V + PLS + T +GLAYLHE K
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETGK 122
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA------GTLGYMAPEY 443
IHRDIK +NILL E+ K+ADFG+ ++AT+A GT +MAPE
Sbjct: 123 ---IHRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTPYWMAPEV 172
Query: 444 V---VRGKLTEKADVYSFGVVVIE 464
+G K D+++ G+ IE
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 277 LGQGGSGSVYKGTL----PGGEA--VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVK 329
LG+G G V+ G P + VAVK L + F E L++ H+N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVR-------------QDVEPLSWEVRYKIILS 376
G G ++V+E++ + L N F+R + L+ +I +
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDL--NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGT 435
A G+ YL + +HRD+ N L+ + KI DFG+ R ++ D +
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
+ +M PE ++ K T ++DV+SFGVV+ E+
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 81/233 (34%), Positives = 112/233 (48%), Gaps = 26/233 (11%)
Query: 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQ----WVDHFF 313
FS + EK E +G G G+VY + E VA+K++ Y+ Q W D
Sbjct: 8 FSKDDPEKLFTDLRE---IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-II 63
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI 373
EV + + H N ++ GC + + LV E+ S D L V + +PL EV
Sbjct: 64 KEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHK--KPLQ-EVEIAA 119
Query: 374 ILSTA-EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
I A +GLAYLH + IHRDIK NILL E T K+ADFG + + +
Sbjct: 120 ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFG-----SASLVSPANSF 171
Query: 433 AGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
GT +MAPE ++ G+ K DV+S G+ IE+ RK LF N+ S L
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP-PLFNMNAMSAL 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 9e-24
Identities = 66/197 (33%), Positives = 103/197 (52%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
P +V EF+ SLLD F+++ D + L + A+G+AY+ ++ IH
Sbjct: 72 EEP-IYIVTEFMGKGSLLD--FLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIH 125
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
RD++ +NIL+ + KIADFGL RL ++ + + APE + G+ T K+D
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 455 VYSFGVVVIEVVCRKRI 471
V+SFG+++ E+V + R+
Sbjct: 186 VWSFGILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 277 LGQGGSGSVYKGTL--PGGE----AVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVK 329
LG+G G VYKG L P +VA+K L + F E L+S + H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 330 LLG-CSITGPESLLVYEFVPNQSLLDNLFVR---QDVE----------PLSWEVRYKIIL 375
LLG C+ P +L +E++ + L + L DV L I +
Sbjct: 73 LLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL-FPEDITHISATLAG 434
A G+ YL S +HRD+ N L+ E T KI+DFGL R + D + +
Sbjct: 132 QIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
+ +M PE ++ GK T ++D++SFGVV+ E+
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-23
Identities = 67/211 (31%), Positives = 106/211 (50%), Gaps = 8/211 (3%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLG G G V+ GT G VAVK L T + F E ++ + H LV+L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
P +V E++ SLLD F++ + L + A G+AY+ ++ IH
Sbjct: 72 EEP-IYIVTEYMSKGSLLD--FLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
RD++ +NIL+ + KIADFGL RL ++ + + APE + G+ T K+D
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
V+SFG+++ E+V + R+ N+ +L+ V
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 3e-23
Identities = 68/211 (32%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYNT---------TQWVDHFFNEVNLISGINHKN 326
+G G GSVY G GE +AVK++ + +D E+ L+ + H+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 327 LVKLLGCSITGPESLLVYEFVPN---QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
+V+ LG S+ + E+VP +LL+N + E L VR + +GL Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE--ETL---VR-NFVRQILKGLNY 121
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS-----ATLAGTLGY 438
LH IIHRDIK +NIL+D + KI+DFG+ + + +L G++ +
Sbjct: 122 LHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
MAPE V + T KAD++S G +V+E++ K
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDH-FFNEVNLISGINHKNL 327
+ ++G+G G V+K GE VA+K++ + + E+ + H +
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV 61
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKIILSTAEGLAYLHE 386
VKLL G +LV E++P+ L + L R + PL +V+ + +G+AY+H
Sbjct: 62 VKLLDVFPHGSGFVLVMEYMPS-DLSEVL--RDEERPLPEAQVK-SYMRMLLKGVAYMH- 116
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE--YV 444
I+HRD+K +N+L+ + KIADFGL RLF E+ + + T Y APE Y
Sbjct: 117 --ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 445 VRGKLTEKADVYSFGVVVIE 464
R K D+++ G + E
Sbjct: 175 AR-KYDPGVDLWAVGCIFAE 193
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 4e-23
Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 15/197 (7%)
Query: 277 LGQGGSGSVYKGTL--PGGE--AVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V +G L PG + VA+K L + Q +D F E +++ +H N+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNIIRL 70
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G +++ E++ N SL + F+R++ + ++ A G+ YL S++
Sbjct: 71 EGVVTKSRPVMIITEYMENGSL--DKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEM 125
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG--TLGYMAPEYVVRGK 448
+HRD+ NIL++ K++DFGL R ED T G + + APE + K
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRL-EDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 449 LTEKADVYSFGVVVIEV 465
T +DV+SFG+V+ EV
Sbjct: 185 FTSASDVWSFGIVMWEV 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 4e-23
Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 23/204 (11%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLF-----YNTTQWVDHFFNEVNLISGINHKNLVKL 330
LG G GSVY+G L G+ AVK + + V E+ L+S + H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 331 LGCSITGPESLLVY-EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYLHE 386
LG ++L ++ E VP SL L + V I L T + GL YLH+
Sbjct: 68 LGTEREE-DNLYIFLELVPGGSLAKLL---KKYGSFPEPV---IRLYTRQILLGLEYLHD 120
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
+HRDIK +NIL+D K+ADFG+ + E S G+ +MAPE + +
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQ 175
Query: 447 -GKLTEKADVYSFGVVVIEVVCRK 469
G AD++S G V+E+ K
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 4e-23
Identities = 66/195 (33%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLGCS 334
K+G+G G VYKG L G VAVK + F E ++ +H N+VKL+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
+ +V E VP SLL F+R+ L+ + ++ L A G+ YL ESK IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLT--FLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT----LGYMAPEYVVRGKLT 450
RD+ N L+ E KI+DFG+ R E+ I G + + APE + G+ T
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 451 EKADVYSFGVVVIEV 465
++DV+S+G+++ E
Sbjct: 174 SESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 6e-23
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 34/215 (15%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQ----------WVDHFFNEVNLISGINHK 325
+G+G G VY + GE +AVK++ T V +E+ + ++H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 326 NLVKLLGCSITGPESLLVY-EFVPNQSLLDNL-----FVRQDVEPLSWEVRYKIILSTAE 379
N+V+ LG T E L ++ E+VP S+ L F Q V + + E
Sbjct: 69 NIVQYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLE 119
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA--GTLG 437
GLAYLH + I+HRD+K N+L+D + KI+DFG+ + +DI ++ G++
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK-SDDIYDNDQNMSMQGSVF 175
Query: 438 YMAPEYV--VRGKLTEKADVYSFGVVVIEVVCRKR 470
+MAPE + + K D++S G VV+E+ +R
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 7e-23
Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFY--NTTQWVDHFFNEVNLISGINHKNLV 328
E ++LG+G GSV K L + + E+ + +V
Sbjct: 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV 62
Query: 329 KLLGCSITGPESLL--VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE----GLA 382
K G + S + E+ SL D+++ + V+ + K++ AE GL+
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKK--VKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
YLH +IIHRDIK SNILL + K+ DFG+ E + ++ T GT YMAPE
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSLAGTFTGTSFYMAPE 173
Query: 443 YVVRGKLTEKADVYSFGVVVIEVV 466
+ + +DV+S G+ ++EV
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVA 197
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 9e-23
Identities = 65/201 (32%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLG G G V+ G VAVK L T V F E NL+ + H LV+L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQD-----VEPLSWEVRYKIILSTAEGLAYLHEESKL 390
++ E++ SLLD F++ D + P + +I AEG+AY+ ++
Sbjct: 72 KEEPIYIITEYMAKGSLLD--FLKSDEGGKVLLPKLIDFSAQI----AEGMAYIERKN-- 123
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
IHRD++ +N+L+ E KIADFGL R+ ++ + + APE + G T
Sbjct: 124 -YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 451 EKADVYSFGVVVIEVVCRKRI 471
K+DV+SFG+++ E+V +I
Sbjct: 183 IKSDVWSFGILLYEIVTYGKI 203
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 64/191 (33%), Positives = 95/191 (49%), Gaps = 10/191 (5%)
Query: 277 LGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLGCS 334
LG G GSV K +P G +A K + V E+ ++ +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
+ + EF+ SL D ++ + P+ E+ KI ++ EGL YL+ RI+H
Sbjct: 73 LNENNICMCMEFMDCGSL-DRIY--KKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMH 127
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
RDIK SNIL++ K+ DFG+ E I I+ T GT YM+PE + GK T K+D
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 455 VYSFGVVVIEV 465
V+S G+ +IE+
Sbjct: 185 VWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 65/222 (29%), Positives = 111/222 (50%), Gaps = 21/222 (9%)
Query: 247 ALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT 305
ALQ+ V+ + N+ K+G+G +G V T G VAVK++
Sbjct: 7 ALQLVVDPG------DPRSYLDNF----VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK 56
Query: 306 TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEP 364
Q + FNEV ++ H N+V++ + G E +V EF+ +L D + R + E
Sbjct: 57 QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQ 116
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
++ + L+ + L++LH + +IHRDIK +ILL + K++DFG ++
Sbjct: 117 IA-----TVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168
Query: 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+ +L GT +MAPE + R + D++S G++VIE+V
Sbjct: 169 VPR-RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 2e-22
Identities = 68/200 (34%), Positives = 106/200 (53%), Gaps = 14/200 (7%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLG G G V+ T VAVK + + V+ F E N++ + H LVKL +
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKL-HAVV 70
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQD---VEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
T ++ EF+ SLLD F++ D +PL + + AEG+A++ + +
Sbjct: 71 TKEPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSA--QIAEGMAFIEQRN---Y 123
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTE 451
IHRD++ +NIL+ KIADFGL R+ ED + + A + + APE + G T
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTI 182
Query: 452 KADVYSFGVVVIEVVCRKRI 471
K+DV+SFG++++E+V RI
Sbjct: 183 KSDVWSFGILLMEIVTYGRI 202
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 3e-22
Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 39/216 (18%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL--------FYNTTQWVDHFFNEVNLISGINHKN 326
KLG+G G VYK GE VA+K++ +T E++L+ + H N
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA------LREISLLKELKHPN 59
Query: 327 LVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTA----E 379
+VKLL I L LV+E+ + LD + P +I S
Sbjct: 60 IVKLL-DVIHTERKLYLVFEYCDMDLKKYLDKR--PGPLSP-------NLIKSIMYQLLR 109
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
GLAY H RI+HRD+K NIL++ + K+ADFGL R F + + + TL Y
Sbjct: 110 GLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYR 165
Query: 440 APEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLF 474
APE ++ K + D++S G + E++ K LF
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK--PLF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 73/222 (32%), Positives = 110/222 (49%), Gaps = 38/222 (17%)
Query: 277 LGQGGSGSVYK--------GTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
LG+G GSV T GE VAVK+L ++T + + F E+ ++ + H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNT---GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 329 KLLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA----EGLA 382
K G C G +L LV E++P SL D L ++ + ++ +L A +G+
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE------RLDHRKLLLYASQICKGME 122
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMA 440
YL R +HRD+ NIL++ E KI DFGL ++ P+D + G + + A
Sbjct: 123 YL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179
Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT--QNSCS 480
PE + K + +DV+SFGVV+ E LFT SCS
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYE--------LFTYSDKSCS 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 18/198 (9%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINH---KNLVKLL 331
+G+G G+VY+G +P G VA+K + +T V EV L+S + N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK--IILSTAEGLAYLHEESK 389
G + GP ++ E+ S VR ++ +Y II L Y+H K
Sbjct: 69 GSYLKGPRLWIIMEYAEGGS------VRTLMKAGPIAEKYISVIIREVLVALKYIH---K 119
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
+ +IHRDIK +NIL+ K+ DFG+ L ++ + S T GT +MAPE + GK
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS-TFVGTPYWMAPEVITEGKY 178
Query: 450 TE-KADVYSFGVVVIEVV 466
+ KAD++S G+ + E+
Sbjct: 179 YDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-22
Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 336 TGPESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
P +V E++ SLLD F++ + + L + A G+AY+ ++ +H
Sbjct: 72 EEP-IYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 125
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
RD++ +NIL+ E K+ADFGL RL ++ + + APE + G+ T K+D
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 455 VYSFGVVVIEVVCRKRI 471
V+SFG+++ E+ + R+
Sbjct: 186 VWSFGILLTELTTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 5e-22
Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKL 330
LGQG G VY + G +AVK++ ++ T + V+ E+ L+ + H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 331 LGCSITGPESLLVY-EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
GC + E+L ++ E++P S+ D L + L+ V K EG+ YLH
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVKDQL---KAYGALTETVTRKYTRQILEGVEYLHSN-- 123
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA--TLAGTLGYMAPEYVVRG 447
I+HRDIK +NIL D K+ DFG + + + ++ GT +M+PE +
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 448 KLTEKADVYSFGVVVIEVVCRK 469
KADV+S G V+E++ K
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 5e-22
Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 11/200 (5%)
Query: 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
Y K+G+G +G V T+ G+ VAVK++ Q + FNEV ++ H+N+
Sbjct: 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
V++ + G E +V EF+ +L D + R + E ++ + L+ + L+ LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA 134
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
+ +IHRDIK +ILL + K++DFG +++ +L GT +MAPE + R
Sbjct: 135 QG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSLVGTPYWMAPELISR 190
Query: 447 GKLTEKADVYSFGVVVIEVV 466
+ D++S G++VIE+V
Sbjct: 191 LPYGPEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 9e-22
Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 25/215 (11%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN--TTQWVDHFFNEVN 317
YE LE +G+G G+V K G+ + K + Y T + +EVN
Sbjct: 2 YEVLET----------IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVN 51
Query: 318 LISGINHKNLVKLLGCSITGPESLLVY---EFVPN---QSLLDNLFVRQDVEPLSWEVRY 371
++ + H N+V+ I + +Y E+ L+ +++ + + E +
Sbjct: 52 ILRELKHPNIVRYYD-RIIDRSNQTLYIVMEYCEGGDLAQLIQKC--KKERKYIEEEFIW 108
Query: 372 KIILSTAEGLAYLH--EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
+I+ L H + ++HRD+K +NI LD K+ DFGL ++ D + +
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFA 167
Query: 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
T GT YM+PE + EK+D++S G ++ E
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 56/194 (28%), Positives = 95/194 (48%), Gaps = 9/194 (4%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLG 332
+LG G SG V K P G+ +AVK + E++++ N +V G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
+ + E++ SL +++ + + KI ++ +GL YLHE K +I
Sbjct: 67 AFYNNGDISICMEYMDGGSLDK--ILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKI 122
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
IHRD+K SNIL++ K+ DFG+ + + ++ T GT YMAPE + + K
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFVGTSSYMAPERIQGNDYSVK 179
Query: 453 ADVYSFGVVVIEVV 466
+D++S G+ +IE+
Sbjct: 180 SDIWSLGLSLIELA 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 64/189 (33%), Positives = 97/189 (51%), Gaps = 6/189 (3%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLGCSI 335
LG+G G V+KGTL VAVK + Q + F +E ++ +H N+VKL+G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
+V E VP L F+R+ + L + K L A G+AYL ESK IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLS--FLRKKKDELKTKQLVKFALDAAAGMAYL--ESK-NCIHR 117
Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADV 455
D+ N L+ E KI+DFG+ R + I S + + APE + G+ + ++DV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 456 YSFGVVVIE 464
+S+G+++ E
Sbjct: 178 WSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 78/221 (35%), Positives = 108/221 (48%), Gaps = 23/221 (10%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQ----WVDHFFNEVNLISGINHK 325
F +++G G G+VY T E VAVK++ Y+ Q W D EV + + H
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD-IIKEVKFLQQLKHP 81
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYL 384
N ++ GC + + LV E+ S D L V + +PL EV I A +GLAYL
Sbjct: 82 NTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHK--KPLQ-EVEIAAITHGALQGLAYL 137
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
H + IHRDIK NILL E K+ADFG + + + GT +MAPE +
Sbjct: 138 HSHNM---IHRDIKAGNILLTEPGQVKLADFG-----SASKSSPANSFVGTPYWMAPEVI 189
Query: 445 V---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
+ G+ K DV+S G+ IE+ RK LF N+ S L
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKP-PLFNMNAMSAL 229
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 58/190 (30%), Positives = 90/190 (47%), Gaps = 8/190 (4%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-CSI 335
LG G G V+ G G VA+K + D F E ++ ++H NLV+L G C+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
P +V E++ N LL+ ++R+ L E + E + YL IHR
Sbjct: 71 QRP-IFIVTEYMANGCLLN--YLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHR 124
Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADV 455
D+ N L+ E+ K++DFGL R +D S + + PE + + K+DV
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 456 YSFGVVVIEV 465
+SFGV++ EV
Sbjct: 185 WSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 68/215 (31%), Positives = 102/215 (47%), Gaps = 29/215 (13%)
Query: 271 FHESNK---LGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
+ E+ + LG+G G VY L +A+K + +++V E+ L S + H+N
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE---VRY--KIILSTAEGL 381
+V+ LG + E VP SL L R PL + + K IL EGL
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQIL---EGL 121
Query: 382 AYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFG----LVRLFPEDITHISATLAGTL 436
YLH+ +I+HRDIK N+L++ KI+DFG L + P + T GTL
Sbjct: 122 KYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-----CTETFTGTL 173
Query: 437 GYMAPEYVVRGK--LTEKADVYSFGVVVIEVVCRK 469
YMAPE + +G AD++S G ++E+ K
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 1e-21
Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 22/197 (11%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGC 333
+G+G G VYK + VA+K + + ++ E+ +S + K G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
+ G + ++ E+ S LD L L I+ GL YLHEE K I
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEGK---I 120
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL------AGTLGYMAPEYVVRG 447
HRDIK +NILL EE K+ADFG+ +++T+ GT +MAPE + +
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVS-------GQLTSTMSKRNTFVGTPFWMAPEVIKQS 173
Query: 448 KLTEKADVYSFGVVVIE 464
EKAD++S G+ IE
Sbjct: 174 GYDEKADIWSLGITAIE 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFN--EVNLISGINHKNLVKLLG 332
K+G+G G VYK GE VA+K++ E+ L+ +NH N++KLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 333 CSITGPESL-LVYEFVPNQSLLDNL--FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
L LV+EF + +L ++ L + + +GLA+ H
Sbjct: 66 V-FRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---S 116
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTLGYMAPEYVVR 446
I+HRD+K N+L++ E K+ADFGL R F TH T Y APE ++
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW----YRAPELLLG 172
Query: 447 GKL-TEKADVYSFGVVVIEVVCRK 469
K + D++S G + E++ R+
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 2e-21
Identities = 61/193 (31%), Positives = 103/193 (53%), Gaps = 11/193 (5%)
Query: 276 KLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
K+G+G +G V T G+ VAVK++ Q + FNEV ++ +H+N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 335 ITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
+ G E +V EF+ +L D + R + E ++ + LS L+YLH + +I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQG---VI 140
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
HRDIK +ILL + K++DFG +++ +L GT +MAPE + R +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 454 DVYSFGVVVIEVV 466
D++S G++VIE++
Sbjct: 200 DIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 3e-21
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 6/212 (2%)
Query: 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
++G G G V+ G VA+K + D F E ++ ++H LV+L G
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEED-FIEEAQVMMKLSHPKLVQLYGV 67
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
LV+EF+ + L D ++R S E + L EG+AYL + +I
Sbjct: 68 CTERSPICLVFEFMEHGCLSD--YLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
HRD+ N L+ E K++DFG+ R +D S + + +PE K + K+
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 454 DVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
DV+SFGV++ EV + +++ +++T+
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENRSNSEVVETI 214
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 4e-21
Identities = 63/191 (32%), Positives = 107/191 (56%), Gaps = 14/191 (7%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
+G+G G+V +G G + VAVK + + T F E +++ ++HKNLV+LLG I
Sbjct: 13 IIGEGEFGAVLQGEYTG-QKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGV-I 68
Query: 336 TGPESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
+V E + +L++ L R + + + +++ L AEG+ YL ESK +++H
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFS--LDVAEGMEYL--ESK-KLVH 123
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
RD+ NIL+ E+ AK++DFGL R+ + + + T APE + K + K+D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179
Query: 455 VYSFGVVVIEV 465
V+S+GV++ EV
Sbjct: 180 VWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 4e-21
Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 8/197 (4%)
Query: 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNL 327
F NK+G+G G V+K A+K++ + + +E +++ ++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
++ + + +V E+ N L L Q PL + ++ + GLA+LH +
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHK-LLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
+I+HRDIK N+ LD KI D G+ +L D T+ + T+ GT Y++PE
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGTPYYLSPELCEDK 176
Query: 448 KLTEKADVYSFGVVVIE 464
EK+DV++ GVV+ E
Sbjct: 177 PYNEKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 6e-21
Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 13/197 (6%)
Query: 277 LGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKL 330
LG G G+VYKG +P GE VA+K L NT+ + +E +++G+ + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
LG +T L V + +P LLD +VR++ + + + + A+G++YL E +
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLD--YVRENKDRIGSQDLLNWCVQIAKGMSYLEE---V 128
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT-LGYMAPEYVVRGKL 449
R++HRD+ N+L+ KI DFGL RL D T A + +MA E ++ +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 450 TEKADVYSFGVVVIEVV 466
T ++DV+S+GV V E++
Sbjct: 189 THQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-21
Identities = 77/221 (34%), Positives = 109/221 (49%), Gaps = 23/221 (10%)
Query: 271 FHESNKLGQGGSGSVY-KGTLPGGEAVAVKRLFYN----TTQWVDHFFNEVNLISGINHK 325
F + ++G G G+VY + E VA+K++ Y+ +W D EV + I H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVKFLQRIKHP 85
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYL 384
N ++ GC + + LV E+ S D L V + +PL EV I A +GLAYL
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHK--KPLQ-EVEIAAITHGALQGLAYL 141
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
H + +IHRDIK NILL E K+ADFG I + + GT +MAPE +
Sbjct: 142 HSHN---MIHRDIKAGNILLTEPGQVKLADFG-----SASIASPANSFVGTPYWMAPEVI 193
Query: 445 V---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
+ G+ K DV+S G+ IE+ RK LF N+ S L
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKP-PLFNMNAMSAL 233
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 62/193 (32%), Positives = 98/193 (50%), Gaps = 11/193 (5%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
K+GQG SG+VY + G+ VA+K++ + NE+ ++ H N+V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
+ G E +V E++ SL D + E V + + + L +LH ++IH
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL----QALEFLHSN---QVIH 138
Query: 395 RDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
RDIK NILL + + K+ DFG ++ PE +T+ GT +MAPE V R K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 196
Query: 454 DVYSFGVVVIEVV 466
D++S G++ IE+V
Sbjct: 197 DIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 34/218 (15%)
Query: 277 LGQGGSGSVYKGTLPG---GEA---VAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVK 329
+GQG G V++ PG E VAVK L + F E L++ +H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVR---------------------QDVEPLSWE 368
LLG G L++E++ L N F+R + PLS
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDL--NEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITH 427
+ I A G+AYL E + +HRD+ N L+ E KIADFGL R ++ D
Sbjct: 131 EQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
S A + +M PE + + T ++DV+++GVV+ E+
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 70/221 (31%), Positives = 101/221 (45%), Gaps = 41/221 (18%)
Query: 270 YFHESNKLGQGGSGSV----YKGTLPG-GEAVAVKRL-----FYNTTQWVDHFFNEVNLI 319
Y + LG+G G V Y G GE VAVK L NT+ W E+N++
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWK----KEINIL 60
Query: 320 SGINHKNLVKLLGCSITGPES--LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
+ H+N+VK GC L+ E+VP SL D L P ++K+ L+
Sbjct: 61 KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-------P-----KHKLNLAQ 108
Query: 378 --------AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
EG+AYLH + IHRD+ N+LLD + KI DFGL + PE +
Sbjct: 109 LLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 165
Query: 430 ATLAGT--LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCR 468
G + + A E + K + +DV+SFGV + E++
Sbjct: 166 VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTH 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 64/201 (31%), Positives = 107/201 (53%), Gaps = 21/201 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEA----VAVKRLFYNTTQWVDHFFNEVN----LISGINHKNL 327
LG G G+V+KG +P G++ VA+K + + + F E+ + ++H +
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR---QTFQEITDHMLAMGSLDHAYI 71
Query: 328 VKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
V+LLG C G LV + P SLLD VRQ + L + + A+G+ YL E
Sbjct: 72 VRLLGICP--GASLQLVTQLSPLGSLLD--HVRQHRDSLDPQRLLNWCVQIAKGMYYLEE 127
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGYMAPEYVV 445
R++HR++ NILL + +IADFG+ L+P+D + + + +MA E ++
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 446 RGKLTEKADVYSFGVVVIEVV 466
G+ T ++DV+S+GV V E++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 74/210 (35%), Positives = 111/210 (52%), Gaps = 24/210 (11%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWV-DHFFNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA----EGLAY 383
VKLL T + LV+EF+ +Q L + D PLS + +I S +GLA+
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFM----DASPLS-GIPLPLIKSYLFQLLQGLAF 115
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI---THISATLAGTLGYMA 440
H R++HRD+K N+L++ E K+ADFGL R F + TH TL Y A
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRA 168
Query: 441 PEYVVRGKLTEKA-DVYSFGVVVIEVVCRK 469
PE ++ K A D++S G + E+V R+
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-20
Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 13/197 (6%)
Query: 277 LGQGGSGSVYKGT-LPGGEAV----AVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKL 330
LG G G+VYKG +P GE V A+K L T + F +E +++ ++H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
LG ++ P LV + +P+ LLD +V + + + ++ + A+G+ YL E
Sbjct: 75 LGVCLS-PTIQLVTQLMPHGCLLD--YVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--- 128
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT-LGYMAPEYVVRGKL 449
R++HRD+ N+L+ KI DFGL RL D +A + +MA E + K
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 450 TEKADVYSFGVVVIEVV 466
T ++DV+S+GV + E++
Sbjct: 189 THQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 67/195 (34%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 276 KLGQGGSGSVYKGT--LPGGE--AVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKL 330
+G+G G VY+G P E AVAVK T+ V + F E ++ +H ++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
+G IT +V E P L L V + L+ + Y LSTA LAYL ESK
Sbjct: 73 IGV-ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA--LAYL--ESK- 126
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
R +HRDI N+L+ K+ DFGL R ++ + ++ + +MAPE + + T
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186
Query: 451 EKADVYSFGVVVIEV 465
+DV+ FGV + E+
Sbjct: 187 SASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 3e-20
Identities = 62/198 (31%), Positives = 105/198 (53%), Gaps = 14/198 (7%)
Query: 277 LGQGGSGSVYKGTL--PGGE--AVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V++G L PG + AVA+K L Y Q D F +E +++ +H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASIMGQFSHHNIIRL 71
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G ++++ E++ N +L D D E S+++ ++ A G+ YL S +
Sbjct: 72 EGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQL-VGMLRGIAAGMKYL---SDM 126
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG--YMAPEYVVRGK 448
+HRD+ NIL++ K++DFGL R+ +D T G + + APE + K
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 449 LTEKADVYSFGVVVIEVV 466
T +DV+SFG+V+ EV+
Sbjct: 187 FTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 90.6 bits (224), Expect = 3e-20
Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN 323
+K T Y K+GQG SG+V+ + G+ VA+K++ + NE+ ++ +
Sbjct: 19 KKYTRY----EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK 74
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLA 382
+ N+V L + G E +V E++ SL D + E E + + + L
Sbjct: 75 NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALE 129
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAP 441
+LH ++IHRDIK N+LL + + K+ DFG ++ PE +T+ GT +MAP
Sbjct: 130 FLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAP 184
Query: 442 EYVVRGKLTEKADVYSFGVVVIEVV 466
E V R K D++S G++ IE+V
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 5e-20
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 34/214 (15%)
Query: 275 NKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF----FNEVNLISGINHKNLVK 329
++G+G G VYK GE VA+K++ + F E+ L+ + H N+V+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 330 LLG--CSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILST-AEGLAYL 384
L S +V+E++ + LLD+ V+ + E + K + EGL YL
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-----FT-ESQIKCYMKQLLEGLQYL 116
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE-- 442
H I+HRDIK SNIL++ + K+ADFGL R + + + TL Y PE
Sbjct: 117 HSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 443 -----YVVRGKLTEKADVYSFGVVVIEVVCRKRI 471
Y + D++S G ++ E+ K I
Sbjct: 174 LGATRY------GPEVDMWSVGCILAELFLGKPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 6e-20
Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 42/224 (18%)
Query: 277 LGQGGSGSVYKGT------LPGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLVK 329
LG+G G V K T G VAVK L N + + +E NL+ +NH +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 330 LLG-CSITGPESLLVYEFV-------------------------PNQSLLDNLFVRQDVE 363
L G CS GP LL+ E+ N S LDN D
Sbjct: 68 LYGACSQDGP-LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN----PDER 122
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
L+ + G+ YL E ++++HRD+ N+L+ E KI+DFGL R E
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 424 DITHISATLAGT-LGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+ +++ + + +MA E + T ++DV+SFGV++ E+V
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 6e-20
Identities = 74/221 (33%), Positives = 107/221 (48%), Gaps = 23/221 (10%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQ----WVDHFFNEVNLISGINHK 325
F + ++G G G+VY + E VA+K++ Y+ Q W D EV + + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHP 75
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYL 384
N ++ GC + + LV E+ S D L V + +PL EV + A +GLAYL
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHK--KPLQ-EVEIAAVTHGALQGLAYL 131
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
H + +IHRD+K NILL E K+ DFG I + GT +MAPE +
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFG-----SASIMAPANXFVGTPYWMAPEVI 183
Query: 445 V---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
+ G+ K DV+S G+ IE+ RK LF N+ S L
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKP-PLFNMNAMSAL 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 7e-20
Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 36/218 (16%)
Query: 277 LGQGGSGSVYKGTLPG-GEAVAVKRL---FYNTTQWVDHFFNEVNLISGIN-HKNLVKLL 331
+G+G +V + A+K L + V + E +++ +N H ++KL
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 332 GCSITGPESL-LVYEFVPNQSLLD--NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
+ E+L V E+ PN LL + D + R+ L YLH
Sbjct: 69 -YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK----CTRF-YAAEILLALEYLH--- 119
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS------------------- 429
IIHRD+K NILLD++ KI DFG ++ + + S
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
A+ GT Y++PE + + +D+++ G ++ +++
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 8e-20
Identities = 62/192 (32%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 276 KLGQGGSGSV-YKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
K+G+G +G V G VAVK + Q + FNEV ++ H+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
+ G E ++ EF+ +L D V Q L+ E + S + L YLH + +IH
Sbjct: 88 LVGEELWVLMEFLQGGALTD--IVSQ--TRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
RDIK +ILL + K++DFG +D+ +L GT +MAPE + R + D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 455 VYSFGVVVIEVV 466
++S G++VIE+V
Sbjct: 200 IWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 9e-20
Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 14/201 (6%)
Query: 277 LGQGGSGSVYKGTL----PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLL 331
+G+G G VY GTL AVK L T + V+ F E ++ +H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 332 GCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G + S L+V ++ + L + F+R + + + L A+G+ YL +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNPTVKDLIGFGLQVAKGMEYLASK--- 117
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL--GYMAPEYVVRG 447
+ +HRD+ N +LDE FT K+ADFGL R ++ ++ + L +MA E +
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 448 KLTEKADVYSFGVVVIEVVCR 468
K T K+DV+SFGV++ E++ R
Sbjct: 178 KFTTKSDVWSFGVLLWELMTR 198
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 72/209 (34%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 277 LGQGGSGSVYKGTL-----PGGEA--VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLV 328
LG G G VY+GT PG VAVK L T Q F E +L+S NH N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLF-VRQDVEP---LSWEVRYKIILSTAEGLAY 383
KLLG C + P+ +++ E + LL L R + L+ + I L A+G Y
Sbjct: 63 KLLGVCLLNEPQYIIM-ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 384 LHEESKLRIIHRDIKLSNILLDEE-----FTAKIADFGLVR-LFPEDITHISATLAGTLG 437
L ++ IHRD+ N L+ E+ KI DFGL R ++ D +
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+MAPE ++ GK T ++DV+SFGV++ E++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 70/212 (33%), Positives = 111/212 (52%), Gaps = 27/212 (12%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF----FNEVNLISGINHK 325
F + N++G+G G VY+ GE VA+K++ + + D E+ L+ + H
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHP 66
Query: 326 NLVKLLGCSITGP--ESL-LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYK-IILSTAE 379
N+V+L + G +S+ LV E+ SLLDN+ P S E + K ++L
Sbjct: 67 NIVELKEV-VVGKHLDSIFLVMEYCEQDLASLLDNM-----PTPFS-ESQVKCLMLQLLR 119
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
GL YLHE IIHRD+K+SN+LL ++ KIADFGL R + ++ + TL Y
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYR 175
Query: 440 APEYVVRG--KLTEKADVYSFGVVVIEVVCRK 469
APE ++ G T D+++ G ++ E++ K
Sbjct: 176 APE-LLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 30/203 (14%)
Query: 277 LGQGGSGSVYKGT--LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
LG G G VYK G A A K + + + ++ F E++++S H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFA-AAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQD---VEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
+ ++ EF +L D++ + + EP ++RY + E L +LH +
Sbjct: 72 FYENKLWILIEFCDGGAL-DSIMLELERGLTEP---QIRY-VCRQMLEALNFLHSH---K 123
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
+IHRD+K NILL + K+ADFG+ + T GT +MAPE V
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAPEVVA----C 177
Query: 451 E---------KADVYSFGVVVIE 464
E KAD++S G+ +IE
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 64/227 (28%), Positives = 100/227 (44%), Gaps = 36/227 (15%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF----FNEVNLISGINHK 325
+ KLG+G G VYK + G VA+K++ + + D F E+ ++ + H
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHP 67
Query: 326 NLVKLLGCSITGPESLL-----VYEFVPNQ-----SLLDNLFVRQDVEPLSWEVRYKIIL 375
N+V L+ ++ P+ VY P LL+N V+ + + +L
Sbjct: 68 NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQIKCYMLQLL 125
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG- 434
EG+ YLHE I+HRDIK +NIL+D + KIADFGL R + + G
Sbjct: 126 ---EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 435 ---------TLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
T Y PE ++ + T D++ G V E+ R+ I
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 276 KLGQGGSGSVYKG--TLPG---GEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
+LG+ G +YKG LPG + VA+K L N QW + F E +L++ ++H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE-FQQEASLMAELHHPNIV 70
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ---DVEPLSWE---VR--------YKII 374
LLG +++E++ L + L +R DV S E V+ I
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLA 433
+ A G+ YL S +H+D+ NIL+ E+ KI+D GL R ++ D +
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
+ +M PE ++ GK + +D++SFGVV+ E+
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 4e-19
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFY--NTTQWVDHFF----NEVNLISGINHKNLVK 329
LG G S Y+ + G +AVK++ Y NT+ + E+ L++ +NH ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
+LG + L E++ S+ L V GL+YLHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 390 LRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDIT---HISATLAGTLGYMAPEYVV 445
+IIHRD+K +N+L+D +IADFG T L GT+ +MAPE V+
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE-VL 180
Query: 446 RGK-LTEKADVYSFGVVVIEVVCRK 469
RG+ DV+S G V+IE+ K
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 52/172 (30%), Positives = 74/172 (43%), Gaps = 36/172 (20%)
Query: 313 FNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK 372
NE ++ +NH LV L Y F +N+++ D+ L ++RY
Sbjct: 48 LNERRILQELNHPFLVNLW------------YSFQDE----ENMYLVVDLL-LGGDLRYH 90
Query: 373 I--------------ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418
+ I L YLH + IIHRDIK NILLDE+ I DF +
Sbjct: 91 LSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIA 147
Query: 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
D ++ + +GT GYMAPE + R + D +S GV E + KR
Sbjct: 148 TKVTPD--TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 5e-19
Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 19/193 (9%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
L G G V+ T PG V ++ T + E L+ +NH +++++ ++
Sbjct: 74 LTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLI-----EAMLLQNVNHPSVIRMKDTLVS 128
Query: 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRD 396
G + +V +P+ S ++ + PL + I EGL YLH + RIIHRD
Sbjct: 129 GAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRD 182
Query: 397 IKLSNILLDEEFTAKIADFGLVRL---FPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
+K NI +++ I D G + P + LAGT+ APE + R K KA
Sbjct: 183 VKTENIFINDVDQVCIGDLGAAQFPVVAPAFL-----GLAGTVETNAPEVLARDKYNSKA 237
Query: 454 DVYSFGVVVIEVV 466
D++S G+V+ E++
Sbjct: 238 DIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 25/202 (12%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFN--EVNLISGIN-HKNLV 328
+LG G GSVY GE VA+K++ FY+ W + N EV + +N H N+V
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---W-EECMNLREVKSLRKLNEHPNIV 61
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
KL E V+E++ +L L + +P S V II +GLA++H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIH--- 116
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGL---VRLFPEDITHISATLAGTLGYMAPEYVV 445
K HRD+K N+L+ KIADFGL +R P ++S T Y APE ++
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS-----TRWYRAPEILL 171
Query: 446 R-GKLTEKADVYSFGVVVIEVV 466
R + D+++ G ++ E+
Sbjct: 172 RSTSYSSPVDIWALGCIMAELY 193
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 73/217 (33%), Positives = 108/217 (49%), Gaps = 35/217 (16%)
Query: 277 LGQGGSGSVYKGTLPGGE------AVAVKRLFYNTT-QWVDHFFNEVNLISGI-NHKNLV 328
LG+G G V K G + VAVK L + T + + +E+ ++ I HKN++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQ---------DVEPLSWEVRYKIILS-- 376
LLG C+ GP ++V E+ + +L D L R+ D P + K ++S
Sbjct: 80 NLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 377 --TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS---AT 431
A G+ +L SK + IHRD+ N+L+ E+ KIADFGL R DI HI T
Sbjct: 139 YQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRKT 191
Query: 432 LAGTLGY--MAPEYVVRGKLTEKADVYSFGVVVIEVV 466
G L MAPE + T ++DV+SFGV++ E+
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
F + ++G+G G VYKG E VA+K + ++ E+ ++S + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY--KIILSTAEGLAYLHE 386
+ G + G + ++ E++ S LD L +P E Y I+ +GL YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL------KPGPLEETYIATILREILKGLDYLHS 119
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA-TLAGTLGYMAPEYVV 445
E K IHRDIK +N+LL E+ K+ADFG+ + T I T GT +MAPE +
Sbjct: 120 ERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIK 174
Query: 446 RGKLTEKADVYSFGVVVIEV 465
+ KAD++S G+ IE+
Sbjct: 175 QSAYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT------QWVDHFFNEVNLISGINHKNLV 328
LG+G G+VY G G+ +AVK++ +T+ + + EV+L+ + H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
+ LG + + EFVP S+ L PL V K +G+AYLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVR---LFPEDITH--ISATLAGTLGYMAPEY 443
++HRDIK +N++L K+ DFG R TH + ++ GT +MAPE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 444 VVRGKLTEKADVYSFGVVVIEV 465
+ K+D++S G V E+
Sbjct: 180 INESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 277 LGQGGSGSVYKGTLPGGEA----VAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
LG+G GSV +G L + VAVK +L +T ++ F +E + +H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 331 LGCSITG------PESLLVYEFVPNQSLLDNLF-VRQDVEP--LSWEVRYKIILSTAEGL 381
+G P+ +++ F+ + L L R P L + K ++ A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDI---THISATLAGTLG 437
YL S IHRD+ N +L E+ T +ADFGL + ++ D I+ +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM---PVK 180
Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVVCR 468
++A E + T K+DV++FGV + E+ R
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATR 211
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 85.2 bits (210), Expect = 2e-18
Identities = 61/194 (31%), Positives = 98/194 (50%), Gaps = 13/194 (6%)
Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
K+GQG SG+VY + G+ VA+K++ + NE+ ++ + N+V L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYLHEESKLRII 393
+ G E +V E++ SL D + E E + + + L +LH ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 394 HRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
HRDIK NILL + + K+ DFG ++ PE +T+ GT +MAPE V R K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 195
Query: 453 ADVYSFGVVVIEVV 466
D++S G++ IE+V
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI 373
NE+ ++S + H N++ + L+ E+ +L D + VRQ + E+
Sbjct: 48 NEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWY 106
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
+ ++Y+H+ I+HRDIK NI L + K+ DFG+ ++ + + + T+
Sbjct: 107 LFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM-AETVV 162
Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
GT YM+PE K K+D+++ G V+ E++ KR
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 56/190 (29%), Positives = 89/190 (46%), Gaps = 6/190 (3%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
+LG G G V+ G VA+K + + F E ++ ++H LV+L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
+V EF+ N LL+ ++RQ LS ++ + EG+ YL S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLN--YLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADV 455
D+ N L+ K++DFG+ R +D S+ + + PE K + K+DV
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 456 YSFGVVVIEV 465
+SFGV++ EV
Sbjct: 185 WSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 68/212 (32%), Positives = 94/212 (44%), Gaps = 30/212 (14%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNL 327
LG G G VY+G G + VAVK L + Q F E ++S NH+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD----VEPLSWEVR--YKIILSTAEGL 381
V+L+G S ++ E + L F+R++ P S ++ A+G
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKS--FLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 382 AYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLAG---- 434
YL E IHRDI N LL AKIADFG+ R DI S G
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAM 182
Query: 435 -TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
+ +M PE + G T K DV+SFGV++ E+
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-18
Identities = 58/190 (30%), Positives = 97/190 (51%), Gaps = 6/190 (3%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
+LG G G V G G VA+K + + D F E ++ ++H+ LV+L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
+V E++ N LL+ ++R+ + ++ EG+AYL ESK + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLN--YLREHGKRFQPSQLLEMCKDVCEGMAYL--ESK-QFIHR 124
Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADV 455
D+ N L+D++ K++DFGL R +D S + + PE ++ K + K+DV
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 456 YSFGVVVIEV 465
++FGV++ EV
Sbjct: 185 WAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-18
Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 277 LGQGGSGSVYKGTL--PGGEA--VAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V +G L PG VA+K L Y Q D F +E +++ +H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNIIHL 70
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G +++ EF+ N +L + F+RQ+ + ++ A G+ YL S++
Sbjct: 71 EGVVTKSRPVMIITEFMENGAL--DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEM 125
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG------YMAPEYV 444
+HRD+ NIL++ K++DFGL R +D + T +LG + APE +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS--DPTYTSSLGGKIPIRWTAPEAI 183
Query: 445 VRGKLTEKADVYSFGVVVIEVV 466
K T +DV+S+G+V+ EV+
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 18/197 (9%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLG 332
N++G G G+VYK P G A+K ++ N V E+ ++ +NH N+VK
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
E ++ EF+ SL + + E +V +I+ G+AYLH + I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSL-EGTHIAD--EQFLADVARQIL----SGIAYLH---RRHI 189
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV----VRGK 448
+HRDIK SN+L++ KIADFG+ R+ + + ++++ GT+ YM+PE + G
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGA 248
Query: 449 LTEKA-DVYSFGVVVIE 464
A D++S GV ++E
Sbjct: 249 YDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 5e-18
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 30/203 (14%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRL----FY--------NTTQWVDH-FFNEVNLISGI 322
KLG+G GSVYK VKRL FY + +Q NE+ +++ +
Sbjct: 7 KLGKGSYGSVYK----------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV 56
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVE-PLSWEVRYKIILSTAEGL 381
NH N++ + G + +V E+ P L + R+ + + ++I + GL
Sbjct: 57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
LHE +I+HRD+K +NILL KI D G+ ++ +++ T GT YMAP
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK---TQIGTPHYMAP 170
Query: 442 EYVVRGKLTEKADVYSFGVVVIE 464
E + K+D++S G ++ E
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 66/209 (31%), Positives = 107/209 (51%), Gaps = 26/209 (12%)
Query: 276 KLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLV 328
+LGQG G VY+G + GEA VAVK + + + + F NE +++ G ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVE------PLSWEVRYKIILSTAEGL 381
+LLG G +L+V E + + L L +R + E P + + ++ A+G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG---- 437
AYL+ + + +HRD+ N ++ +FT KI DFG+ R DI G G
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185
Query: 438 -YMAPEYVVRGKLTEKADVYSFGVVVIEV 465
+MAPE + G T +D++SFGVV+ E+
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-18
Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
+G+G G V G G + VAVK + + T F E ++++ + H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDYRGNK-VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 337 GPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
L +V E++ SL+D L R L + K L E + YL + +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADV 455
D+ N+L+ E+ AK++DFGL + + + T + + APE + K + K+DV
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 456 YSFGVVVIEVVCRKRI 471
+SFG+++ E+ R+
Sbjct: 183 WSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
F + LG G G+VYKG +P GE VA+K L T+ + +E +++ +++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
++ +LLG +T L + + +P LLD +VR+ + + + + A+G+ YL
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 125
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT-LGYMAPEY 443
E R++HRD+ N+L+ KI DFGL +L D A + +MA E
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
++ T ++DV+S+GV V E++
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 9e-18
Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 30/213 (14%)
Query: 274 SNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWVDH---FFNEVNLISGINH 324
S +LGQG G VY+G G VA+K + N + F NE +++ N
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNC 68
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVE------PLSWEVRYKIILST 377
++V+LLG G +L++ E + L L +R ++E P S + ++
Sbjct: 69 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
A+G+AYL+ + +HRD+ N ++ E+FT KI DFG+ R DI G G
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKG 181
Query: 438 -----YMAPEYVVRGKLTEKADVYSFGVVVIEV 465
+M+PE + G T +DV+SFGVV+ E+
Sbjct: 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 30/209 (14%)
Query: 271 FHESNKLGQGGSGSVY----KGTLPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGIN 323
F ++GQGG G V+ K T GE VA+KR+ + ++ H E ++++
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDT---GEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK 59
Query: 324 HKNLVKLLGCSITGPESL-LVYEFVPN---QSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
+ LVKLL + E L L E+VP ++LL+NL V + R+ + AE
Sbjct: 60 SEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH-----ARFYM----AE 109
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
+ +L IHRD+K N L+D K+ DFGL + I + ++ G+ YM
Sbjct: 110 MFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYM 165
Query: 440 APEYVVRGK-LTEKADVYSFGVVVIEVVC 467
APE V+RGK D +S G ++ E +C
Sbjct: 166 APE-VLRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 54/190 (28%), Positives = 98/190 (51%), Gaps = 20/190 (10%)
Query: 296 VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
VAVK L + T+ + F E+ ++S + + N+++LLG ++ ++ E++ N L
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL-- 104
Query: 355 NLFVRQ-----------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL 403
N F+ Q ++ +S + + A G+ YL + L +HRD+ N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL 161
Query: 404 LDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
+ +T KIADFG+ R L+ D I + +MA E ++ GK T +DV++FGV +
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 463 IEV--VCRKR 470
E+ +C+++
Sbjct: 222 WEMFTLCKEQ 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 31/209 (14%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRLFYNTTQW---VDHFFNEVNLISGINHKNLVK 329
+ +G G V+ K T G+ A+K + VD E +++S +VK
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 330 LLGCSITGPESL-LVYEFVPN---QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
L S G ++L LV E++P SLL+N V L +V I L YLH
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDLASLLEN------VGSLDEDVARIYIAEIVLALEYLH 110
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-------LFPEDITHISATLAGTLGY 438
IIHRD+K NIL+D K+ DFGL + + D + GT Y
Sbjct: 111 ---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
+APE ++ ++ D +S G ++ E +
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 72/215 (33%), Positives = 108/215 (50%), Gaps = 31/215 (14%)
Query: 277 LGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTT-QWVDHFFNEVNLISGIN-HKN 326
LG+G G V + G + VAVK L N T + + +E+ L+ I HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQ--------DV-----EPLSWEVRYK 372
++ LLG C+ GP ++V E+ +L + L R+ D+ E LS++
Sbjct: 80 IINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
A G+ YL ES+ R IHRD+ N+L+ E+ KIADFGL R DI + T
Sbjct: 139 CAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGV-HDIDYYKKTS 194
Query: 433 AGTL--GYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
G L +MAPE + T ++DV+SFG+++ E+
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 61/198 (30%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
F + ++G+G G V+KG + V A+K + ++ E+ ++S + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
K G + G + ++ E++ S LD L + K IL +GL YLH E
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEIL---KGLDYLHSEK 121
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS-ATLAGTLGYMAPEYVVRG 447
K IHRDIK +N+LL E+ K+ADFG+ + T I T GT +MAPE + +
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQS 176
Query: 448 KLTEKADVYSFGVVVIEV 465
KAD++S G+ IE+
Sbjct: 177 AYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 73/199 (36%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 277 LGQGGSGSVY---KGTLP-GGEAVAVKRLFYNTTQWVDHF--FNEVNLISGINHKNLVKL 330
LGQG G V+ K T P G+ A+K L T + D E ++++ +NH +VKL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST-AEGLAYLHEESK 389
T + L+ +F+ +LF R E + E K L+ A L +LH
Sbjct: 64 HYAFQTEGKLYLILDFLRG----GDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---S 116
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA--GTLGYMAPEYVVRG 447
L II+RD+K NILLDEE K+ DFGL + E I H + GT+ YMAPE V R
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRR 173
Query: 448 KLTEKADVYSFGVVVIEVV 466
T+ AD +SFGV++ E++
Sbjct: 174 GHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 4e-17
Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 13/194 (6%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
K+GQG SG+VY + G+ VA++++ + NE+ ++ + N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYLHEESKLRII 393
+ G E +V E++ SL D + E E + + + L +LH ++I
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 394 HRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
HRDIK NILL + + K+ DFG ++ PE +T+ GT +MAPE V R K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 196
Query: 453 ADVYSFGVVVIEVV 466
D++S G++ IE++
Sbjct: 197 VDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 6e-17
Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKR--LF-YNTTQWVDHFFNEVNLISGINHKNLVKLL 331
K+G+G VYK L G VA+K+ +F + E++L+ ++H N++K L
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 332 GCSITGPESLLVYEFVPNQSL--LDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHE 386
I E +V E L + F +Q E W K + L ++H
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW----KYFVQLCSALEHMHS 124
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
+ RI+HRDIK +N+ + K+ D GL R F T + +L GT YM+PE +
Sbjct: 125 K---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-TTAAHSLVGTPYYMSPERIHE 180
Query: 447 GKLTEKADVYSFGVVVIEVVC 467
K+D++S G ++ E+
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-17
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 276 KLGQGGSGSVY----KGTLPGGEA--VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G G V+ LP + VAVK L + F E L++ + H+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVR--------------QDVEPLSWEVRYKIIL 375
G G L+V+E++ + L N F+R L+ I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDL--NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAG 434
A G+ YL + L +HRD+ N L+ + KI DFG+ R ++ D +
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
+ +M PE ++ K T ++D++SFGVV+ E+
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 7e-17
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 277 LGQGGSGSVYKG--TLPGGE--AVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V G LPG VA+K L Y Q D F +E +++ +H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-FLSEASIMGQFDHPNIIHL 70
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G ++V E++ N SL + F+R+ + ++ A G+ YL S +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSL--DAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDM 125
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG--YMAPEYVVRGK 448
+HRD+ NIL++ K++DFGL R+ +D T G + + APE + K
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 449 LTEKADVYSFGVVVIEVV 466
T +DV+S+G+V+ EV+
Sbjct: 186 FTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 9e-17
Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 22/209 (10%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNL 327
+ + K+G+G G VYK GE VA+K RL E++L+ +NH N+
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 328 VKLLGCSITGPESLLVYEFVPNQSL---LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
V+LL + + LV+EF+ + L +D+ + PL Y+++ +G+AY
Sbjct: 61 VRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL----QGIAYC 115
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF--P-EDITHISATLAGTLGYMAP 441
H R++HRD+K N+L+D E K+ADFGL R F P TH TL Y AP
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 168
Query: 442 EYVVRGKLTEKA-DVYSFGVVVIEVVCRK 469
E ++ + D++S G + E+V R+
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
F + K+G+G G V+KG + V ++ ++ E+ ++S + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
K G + + ++ E++ S LD L + PL I+ +GL YLH E
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEK 121
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGTLGYMAPEYVVRG 447
K IHRDIK +N+LL E K+ADFG+ + T I GT +MAPE + +
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 176
Query: 448 KLTEKADVYSFGVVVIEV 465
KAD++S G+ IE+
Sbjct: 177 AYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 36/206 (17%)
Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRLFYNTTQW-------VDHFFNEVNLISGINHK 325
LG G G V +KG+ G+ A+K L ++ V+H NE ++ I H
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKIL----SKAKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 326 NLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRY--KIILSTAEGLA 382
LV L G S +L LV E+VP L + P Y +++L L
Sbjct: 62 FLVNLYG-SFQDDSNLYLVMEYVPGGELFS-HLRKSGRFPEPVARFYAAQVVL----ALE 115
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
YLH I++RD+K N+LLD + KI DFG + T+ TL GT Y+APE
Sbjct: 116 YLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TY---TLCGTPEYLAPE 168
Query: 443 YVVRGKLTEKA-DVYSFGVVVIEVVC 467
++ K KA D ++ G+++ E++
Sbjct: 169 -IILSKGYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN-----EVNLISGINHKNLV 328
KLG+G VYK G VA+K++ + N E+ L+ + H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 329 KLLGCSITGPESLLVYEFVPN--QSLLDNLFVR---QDVEPLSWEVRYKIILSTAEGLAY 383
LL LV+EF+ + ++ + + D++ S+ +L T GL Y
Sbjct: 66 GLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIK--SY------MLMTLRGLEY 117
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
LH I+HRD+K +N+L+ + K+ADFGL R F ++ + T Y APE
Sbjct: 118 LHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPEL 173
Query: 444 VVRGKL-TEKADVYSFGVVVIEVVCRK 469
+ + D++S G + E++ R
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 36/226 (15%)
Query: 276 KLGQGGSGSVY------------KGTLPGGEA-----VAVKRLFYNTTQWV-DHFFNEVN 317
KLG+G G V+ K A VAVK L + + + F EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ----------DVEPLSW 367
++S ++ N+ +LLG P ++ E++ N L N F+++ + + LS+
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL--NQFLQKHVAETSGLACNSKSLSF 129
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDIT 426
+ A G+ YL L +HRD+ N L+ + +T KIADFG+ R L+ D
Sbjct: 130 STLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY 186
Query: 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV--VCRKR 470
+ + +MA E V+ GK T K+DV++FGV + E+ +CR++
Sbjct: 187 RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-16
Identities = 68/261 (26%), Positives = 125/261 (47%), Gaps = 24/261 (9%)
Query: 215 TSAVALLLVFSLVAF---FVR-RKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNY 270
T + LV +LVAF F+R R L+ +R + G ++ SK++ S T+ +
Sbjct: 633 TCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSI-TINDILSS 691
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLV 328
E N + +G G+ YKG ++ G VK + N+ +E+ + + H N+V
Sbjct: 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIV 746
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
KL+G + + L++E++ ++L + + LSWE R KI + A+ L +LH
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNL------SEVLRNLSWERRRKIAIGIAKALRFLHCRC 800
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK 448
++ ++ I++D + + L L D ++ Y+APE
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKD 854
Query: 449 LTEKADVYSFGVVVIEVVCRK 469
+TEK+D+Y FG+++IE++ K
Sbjct: 855 ITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKL 330
LGQG G VY G +AVK++ ++ T++ V+ E+ L+ + H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 331 LGCSITGPESLL--VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
GC E L E +P S+ D L + L+ V K EG++YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEGVSYLHSN- 125
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT----LAGTLGYMAPEYV 444
I+HRDIK +NIL D K+ DFG + +S T + GT +M+PE +
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASKRL--QTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 445 VRGKLTEKADVYSFGVVVIEVVCRK 469
KAD++S G V+E++ K
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 277 LGQGGSGSVYK--GTLPGGEAVAVKRLFYNTTQW----------VDHFFNEVNLI-SGIN 323
LG G G VYK G +A+K + + + + +EV +I +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSWEVRYKIILSTAEGLA 382
H N+V+ + +V + + L ++ +++ + + E + I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
YLH+E RI+HRD+ +NI+L E+ I DFGL + + S GT+ Y PE
Sbjct: 128 YLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV--VGTILYSCPE 183
Query: 443 YVVRGKLTEKADVYSFGVVVIEVV 466
V EKADV++FG ++ ++
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMC 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKL 330
LGQG G VY + G +A K++ ++ T++ V E+ L+ + H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 331 LGC-SITGPESLLVY-EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
GC ++L ++ E++P S+ D L + L+ V K EG++YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGMSYLHSN- 125
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT----LAGTLGYMAPEYV 444
I+HRDIK +NIL D K+ DFG + +S T + GT +M+PE +
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 445 VRGKLTEKADVYSFGVVVIEVVCRK 469
KADV+S G V+E++ K
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 274 SNKLGQGGSGSVYKGTL----PGGE-AVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNL 327
S+ L +G G ++ G L PG E V VK + + ++ V E L+ G++H+N+
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST---------- 377
+ +L I E V N L LF++Q E LST
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNL-KLFLQQ---CRLGEANNPQALSTQQLVHMAIQI 126
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL 436
A G++YLH K +IH+DI N ++DEE KI D L R LFP D + +
Sbjct: 127 ACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+MA E +V + + +DV+SFGV++ E++
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 65/202 (32%), Positives = 89/202 (44%), Gaps = 29/202 (14%)
Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGIN---HKN 326
LG+G G V YK T GE A+K L V+ E + N H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK--IILSTAEGLAYL 384
LV L C T V E+ L+ + + DV V Y ++L GL YL
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLM--MHIHTDVFSEPRAVFYAACVVL----GLQYL 117
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLGYMAPE 442
HE +I++RD+KL N+LLD E KIADFGL + E + +T GT ++APE
Sbjct: 118 HEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFLAPE 171
Query: 443 YVVRGKLTEKADVYSFGVVVIE 464
+ T D + GV++ E
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYE 193
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-16
Identities = 26/72 (36%), Positives = 43/72 (59%), Gaps = 3/72 (4%)
Query: 9 ARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFY 68
+ + +AA +G +VY +C DLS +DC C A +++ +C P + +GGR++Y
Sbjct: 38 SGKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRSCLATAVSELRRCCPNK---KGGRIWY 94
Query: 69 DGCYLRYDDYDF 80
D C+LRY+ Y F
Sbjct: 95 DSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-16
Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 18/171 (10%)
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLL-VYEFVPNQSLLDNLFVRQDVEPLSWEVR 370
F E L + + H N+V LL P L V+E+VP ++L + L L
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL---AADGALPAGET 81
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFP--EDI 425
+++L + LA H + I+HRD+K NI++ AK+ DFG+ L P D
Sbjct: 82 GRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138
Query: 426 THISATLA----GTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
+ T GT Y APE + RG+ +T +D+Y++G++ +E + +R+
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSDLYAWGLIFLECLTGQRV 188
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 7e-16
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 23/195 (11%)
Query: 296 VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
VAVK L + + + F EV ++S + N+++LLG + ++ E++ N L
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 355 NLFVRQ---------DVEP-------LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK 398
L D P +S+ + L A G+ YL S L +HRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 399 LSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYS 457
N L+ E T KIADFG+ R L+ D I + +MA E ++ GK T +DV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 458 FGVVVIEV--VCRKR 470
FGV + E+ +C+++
Sbjct: 226 FGVTLWEILMLCKEQ 240
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 18/199 (9%)
Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G VYK G A K + + + ++ + E+ +++ NH +VKLLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQD---VEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
+ ++ EF P ++ D + + D EP +++ I E L YLH ++
Sbjct: 79 YWDGKLWIMIEFCPGGAV-DAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHS---MK 130
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE 451
IIHRD+K N+LL + K+ADFG+ + + + GT +MAPE V+ + +
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR-RDSFIGTPYWMAPEVVMCETMKD 189
Query: 452 -----KADVYSFGVVVIEV 465
KAD++S G+ +IE+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA------VAVKRLFYNTTQWVDHFFN-EVNLISGINH 324
E LG+G G V+ G E V VK L + + F E+++ ++H
Sbjct: 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH 67
Query: 325 KNLVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVE------PLSWEVRYKIILST 377
KN+V+LLG C P ++ E+ L L + + PLS + + +
Sbjct: 68 KNVVRLLGLCREAEPH-YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL 436
A G+ +L S R +HRD+ N L+ + K++ L + ++ + + L L
Sbjct: 127 ALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PL 182
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
++APE V + K+DV+SFGV++ EV
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 61/207 (29%), Positives = 88/207 (42%), Gaps = 29/207 (14%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGC- 333
+G+G G VYK G+ VA+K + + + E N++ NH N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE-IKEEYNILRKYSNHPNIATFYGAF 72
Query: 334 -----SITGPESLLVYEFVPNQSLLD---NLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
+ LV E S+ D L R+ + L E I+ T GLAYLH
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGL--RKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMAPE 442
E ++IHRDIK NILL + K+ DFG+ + T GT +MAPE
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA----QLDSTLGRRNTFIGTPYWMAPE 183
Query: 443 YVV-----RGKLTEKADVYSFGVVVIE 464
+ ++DV+S G+ IE
Sbjct: 184 VIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHF-FNEVNLISGI---NH 324
+ E ++G+G G+VYK L G VA+K++ + + + E+ L+ + H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 325 KNLVKLLGCSITGPES------LLVYEFVPNQSLLDNLFVRQDVEP---------LSWEV 369
N+V+LL GP + LV+E V +Q L ++ + +P L +
Sbjct: 61 PNIVRLLDVC-HGPRTDRELKLTLVFEHV-DQDL--ATYLSKCPKPGLPPETIKDLMRQ- 115
Query: 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
+L G+ +LH RI+HRD+K NIL+ + KIADFGL R++ ++ S
Sbjct: 116 ----LLR---GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS 165
Query: 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
+ TL Y APE +++ D++S G + E+ R+
Sbjct: 166 VVV--TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 69/226 (30%), Positives = 102/226 (45%), Gaps = 50/226 (22%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHKNLV 328
+G+G G V+ K T G+ A+K L Q + H E ++++ + +V
Sbjct: 9 IGRGAFGEVWLVRDKDT---GQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIV 64
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
KL S E L LV E++P L+ NL +R+DV P R+ I AE + L
Sbjct: 65 KLY-YSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEET-ARFYI----AELVLALDSV 117
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGL------------------VRLFPEDIT--- 426
KL IHRDIK NIL+D + K+ADFGL LF +++
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 427 -------HISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIE 464
+ + GT Y+APE V+RG + D +S GV++ E
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 277 LGQGGSGSVYKGTLPGGEA--------VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
LG+G G V G + VAVK L + T+ + +E+ ++ I HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYK 372
++ LLG C+ GP ++V E+ +L + L R+ E LS++
Sbjct: 86 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
A G+ YL + + IHRD+ N+L+ E+ KIADFGL R DI HI
Sbjct: 145 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 197
Query: 433 AGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEV 465
T G +MAPE + T ++DV+SFGV++ E+
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
F ++G G G VYK + GE A+K + + E+ ++ H N+V
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
G + + + EF SL D V PLS + T +GL YLH + K
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA------GTLGYMAPEY 443
+HRDIK +NILL + K+ADFG+ I+AT+A GT +MAPE
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWMAPEV 177
Query: 444 VV---RGKLTEKADVYSFGVVVIEV 465
+G + D+++ G+ IE+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 4e-15
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVA---VKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKL 330
+++G G G V G G + A VK L + T F EV +NH N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNL-----FVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
LG I LLV EF P L + L V Q + +V ++ A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK---DVLQRMACEVASGLLWLH 117
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYV 444
+ IH D+ L N L + + KI D+GL + +PED A L ++APE V
Sbjct: 118 ---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 445 -VRG------KLTEKADVYSFGVVVIEV 465
+RG T+K++++S GV + E+
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 27/213 (12%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRL-FYNTTQWVDHF-FNEV 316
YE LEK +G+G G+V+K E VA+KR+ + + V E+
Sbjct: 1 KYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI 50
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL---LDNLFVRQDVEPLSWEVRYKI 373
L+ + HKN+V+L + + LV+E+ +Q L D+ D++P E+
Sbjct: 51 CLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSC--NGDIDP---EIVKSF 104
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
+ +GLA+ H ++HRD+K N+L+++ K+ADFGL R F + SA +
Sbjct: 105 MFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV 161
Query: 434 GTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEV 465
TL Y P+ + KL + D++S G + E+
Sbjct: 162 -TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 62/203 (30%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGI-NHKNLV 328
LG+G G V KGT E AVK L V+ E +++ H L
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY--KIILSTAEGLAYLHE 386
+L C T V E+V L+ ++ R Y +I+L GL +LHE
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHI-QRSGRFDEPRARFYAAEIVL----GLQFLHE 114
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMAPEYV 444
II+RD+KL N+LLD E KIADFG+ + + T +T GT Y+APE +
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEIL 168
Query: 445 VRGKLTEKADVYSFGVVVIEVVC 467
D ++ GV++ E++
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLA 191
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 59/212 (27%), Positives = 88/212 (41%), Gaps = 28/212 (13%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFN----E 315
YE L +G+G G V K GE VA+K+ + ++ + E
Sbjct: 3 YEVLGV----------VGEGAYGVVLKCRNKATGEIVAIKK--FKESEDDEDVKKTALRE 50
Query: 316 VNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP--LSWEVRYKI 373
V ++ + H+N+V L LV+E+V ++LL+ L + P L +
Sbjct: 51 VKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE-RTLLELL----EASPGGLPPDAVRSY 105
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
I + +AY H IIHRDIK NIL+ E K+ DFG R
Sbjct: 106 IWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV 162
Query: 434 GTLGYMAPEYVVRGKLTEKA-DVYSFGVVVIE 464
T Y APE +V K DV++ G ++ E
Sbjct: 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAE 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINH-K 325
N ++G G G VYK G +AVK++ + +++++ +
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
+VK G IT + + E + + LD L R P+ ++ K+ ++ + L YL
Sbjct: 75 YIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLK 131
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE--- 442
E K +IHRD+K SNILLD K+ DFG+ + + AG YMAPE
Sbjct: 132 E--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS--AGCAAYMAPERID 187
Query: 443 -------YVVRGKLTEKADVYSFGVVVIEVV 466
Y +R ADV+S G+ ++E+
Sbjct: 188 PPDPNPKYDIR------ADVWSLGISLVELA 212
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 9e-15
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDH---FFNEVNLISGINHKNLVKLLG 332
+G G G V G VA+K++ N + E+ L+ + H+N++ LL
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKIS-NVFDDLIDAKRILREIKLLRHLRHENIIGLL- 65
Query: 333 CSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI--ILSTAEGLA 382
I P S +V E + ++ L + +PL+ + ++Y + IL GL
Sbjct: 66 -DILRPPSPEDFNDVYIVTELM--ETDLHKVIKSP--QPLTDDHIQYFLYQILR---GLK 117
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG---TLGYM 439
YLH + +IHRD+K SNIL++ KI DFGL R D L T Y
Sbjct: 118 YLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF-LTEYVVTRWYR 173
Query: 440 APEYVVRGK-LTEKADVYSFGVVVIEVVCRK 469
APE ++ T+ D++S G + E++ RK
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 263 TLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQWVDHFFNEVNLI 319
T+ + TN + + +G G G V G+ VA+K++ ++T + E+ L+
Sbjct: 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLL 63
Query: 320 SGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYKIILST 377
+ H+N++ L I+ E + V E + L L + +E Y+I+
Sbjct: 64 KHLRHENIISLSDIFISPLEDIYFVTELLGTD--LHRLLTSRPLEKQFIQYFLYQIL--- 118
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTL 436
GL Y+H ++HRD+K SNIL++E KI DFGL R+ +T ++S T
Sbjct: 119 -RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS-----TR 169
Query: 437 GYMAPEYVVR-GKLTEKADVYSFGVVVIEVV 466
Y APE ++ K + D++S G + E++
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 23/205 (11%)
Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
K+G+G G VYKG G+ VA+K RL E++L+ + H N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 333 CSITGPESLLVYEFVPN--QSLLDNLFVRQDVEP-LSWEVRYKIILSTAEGLAYLHEESK 389
+ L++EF+ + LD+L Q ++ L Y+I+ +G+ + H
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCHSR-- 120
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI---THISATLAGTLGYMAPEYVVR 446
R++HRD+K N+L+D + K+ADFGL R F + TH TL Y APE V+
Sbjct: 121 -RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV----TLWYRAPE-VLL 174
Query: 447 G--KLTEKADVYSFGVVVIEVVCRK 469
G + + D++S G + E+ +K
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 14/195 (7%)
Query: 276 KLGQGGSGSVYKGTLPGGEA-VAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGC 333
++G+G G V+ G L VAVK F E ++ +H N+V+L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
+V E V L F+R + L + +++ + A G+ YL ESK I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLT--FLRTEGPRLKVKELIQMVENAAAGMEYL--ESK-HCI 116
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT----LGYMAPEYVVRGKL 449
HRD+ N L+ E+ KI+DFG+ R E+ + A+ G + + APE + G+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 450 TEKADVYSFGVVVIE 464
+ ++DV+SFG+++ E
Sbjct: 174 SSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 25/201 (12%)
Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G VYK L GE AVK + E+ ++ H N+V G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKIILSTAEGLAYLHEESKLRII 393
++ + + E+ SL D V PLS ++ Y + T +GLAYLH + K+
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHV---TGPLSELQIAY-VCRETLQGLAYLHSKGKM--- 128
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA------GTLGYMAPEYVV-- 445
HRDIK +NILL + K+ADFG+ I+AT+A GT +MAPE
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVA-------AKITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 446 -RGKLTEKADVYSFGVVVIEV 465
G + D+++ G+ IE+
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 276 KLGQGGSGSVYKGTL----PGGEA--VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G G V+ P + VAVK L + F E L++ + H+++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVR---------QDVEP---LSWEVRYKIILST 377
G + G ++V+E++ + L N F+R + L+ I
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDL--NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL 436
A G+ YL + +HRD+ N L+ E KI DFG+ R ++ D + +
Sbjct: 130 AAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
+M PE ++ K T ++DV+S GVV+ E+
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 53/187 (28%), Positives = 93/187 (49%), Gaps = 15/187 (8%)
Query: 296 VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL-- 352
VAVK L + + + F E+ ++S + N+++LL IT ++ E++ N L
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 353 ------LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406
+ DV +S+ + A G+ YL S L +HRD+ N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165
Query: 407 EFTAKIADFGLVR-LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
+T KIADFG+ R L+ D I + +M+ E ++ GK T +DV++FGV + E+
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 466 V--CRKR 470
+ C+++
Sbjct: 226 LTLCKEQ 232
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 30/214 (14%)
Query: 276 KLGQGGSGSVYKG----TLPG--GEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLV 328
+LG+ G VYKG T PG +AVA+K L + + F +E + S + H N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ---DV-------------EPLSWEVRYK 372
LLG +++ + + L + L +R DV EP +
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF---VH 128
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISAT 431
I+ A G+ +L S ++H+D+ N+L+ ++ KI+D GL R ++ D +
Sbjct: 129 IVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 432 LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
+ +M+PE ++ GK + +D++S+GVV+ EV
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 59/188 (31%), Positives = 96/188 (51%), Gaps = 23/188 (12%)
Query: 296 VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKNLVKLLG-CSITGPESLLVYEFVPNQSL 352
VAVK L + T+ + +E+ ++ I HKN++ LLG C+ GP ++V E+ +L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNL 108
Query: 353 LDNLFVRQ--------DV-----EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKL 399
+ L R+ D+ E ++++ A G+ YL + + IHRD+
Sbjct: 109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA 165
Query: 400 SNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVVRGKLTEKADVYS 457
N+L+ E KIADFGL R +I + T G L +MAPE + T ++DV+S
Sbjct: 166 RNVLVTENNVMKIADFGLARDV-NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 224
Query: 458 FGVVVIEV 465
FGV++ E+
Sbjct: 225 FGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 67/202 (33%), Positives = 101/202 (50%), Gaps = 21/202 (10%)
Query: 277 LGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWVDH---FFNEVNLISGI-NHKN 326
LG G G V + T G VAVK L T +E+ ++S + NH+N
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKML--KPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYKIILSTAEGLAYL 384
+V LLG C+I GP L++ E+ LL+ F+R+ E L+ E A+G+A+L
Sbjct: 101 IVNLLGACTIGGP-ILVITEYCCYGDLLN--FLRRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEY 443
SK IHRD+ N+LL KI DFGL R D ++ A + +MAPE
Sbjct: 158 --ASK-NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214
Query: 444 VVRGKLTEKADVYSFGVVVIEV 465
+ T ++DV+S+G+++ E+
Sbjct: 215 IFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 48/128 (37%), Positives = 69/128 (53%), Gaps = 10/128 (7%)
Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401
L+ ++V L +L+ R+ EVR I AE + L +L II+RDIKL N
Sbjct: 82 LILDYVNGGELFTHLYQREHFT--ESEVRVYI----AEIVLALDHLHQLGIIYRDIKLEN 135
Query: 402 ILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT--EKA-DVYSF 458
ILLD E + DFGL + F + + + GT+ YMAPE V+RG +KA D +S
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE-VIRGGSGGHDKAVDWWSL 194
Query: 459 GVVVIEVV 466
GV+ E++
Sbjct: 195 GVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 276 KLGQGGSGSVYKGTL----PGGEA--VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G G V+ P + VAVK L T F E L++ + H+++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQ---------DVEP------LSWEVRYKII 374
G G ++V+E++ + L N F+R D +P L I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDL--NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLA 433
A G+ YL + +HRD+ N L+ KI DFG+ R ++ D +
Sbjct: 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
+ +M PE ++ K T ++DV+SFGV++ E+
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 55/203 (27%), Positives = 83/203 (40%), Gaps = 28/203 (13%)
Query: 277 LGQGGSGSVYKGTL-PGGEAVAVKRL-----FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
LG GG G V + A+K + Q +H F+E ++ NH +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ--EHIFSEKEILEECNHPFIVKL 58
Query: 331 LGCSITGPESLLVY---EFVPNQSLLDNLFVRQDVEPLS-WEVRYKIILSTAEGLAYLHE 386
T + +Y E+ L L +D + R+ I YLH
Sbjct: 59 YR---TFKDKKYIYMLMEYCLGGELWTIL---RDRGLFDEYTARF-YIACVVLAFEYLHN 111
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGYMAPEYVV 445
II+RD+K N+LLD K+ DFG + L T T GT Y+APE ++
Sbjct: 112 RG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYVAPE-II 164
Query: 446 RGK-LTEKADVYSFGVVVIEVVC 467
K D +S G+++ E++
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLT 187
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKL 330
LG+G G VY G +AVK++ ++ T++ V+ E+ L+ + H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 331 LGCSITGPE----SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
GC + PE S+ V E++P S+ D L + L+ V + +G++YLH
Sbjct: 70 YGC-LRDPEEKKLSIFV-EYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT----LAGTLGYMAPE 442
I+HRDIK +NIL D K+ DFG + +S T + GT +M+PE
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRI--QTICMSGTGIKSVTGTPYWMSPE 179
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRK 469
+ KADV+S V+E++ K
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 39/113 (34%), Positives = 53/113 (46%), Gaps = 38/113 (33%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
KI +S + L YLH KL +IHRD+K SN+L++ K+ DFG IS
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFG-----------ISGY 153
Query: 432 L---------AGTLGYMAPE----------YVVRGKLTEKADVYSFGVVVIEV 465
L AG YMAPE Y V+ +DV+S G+ +IE+
Sbjct: 154 LVDSVAKTIDAGCKPYMAPERINPELNQKGYDVK------SDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 28/221 (12%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDH---FFNEVN 317
+T+ + + + + +G G G V G VA+K+L Q H + E+
Sbjct: 8 KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL-SRPFQSAIHAKRTYRELR 66
Query: 318 LISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-V 369
L+ ++H+N++ LL T SL LV + + L+N+ Q LS + +
Sbjct: 67 LLKHMDHENVIGLLDV-FTPASSLEDFQDVYLVTHLM--GADLNNIVKCQ---KLSDDHI 120
Query: 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
++ ++ GL Y+H IIHRD+K SNI ++E+ KI DFGL R +++T
Sbjct: 121 QF-LVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT--- 173
Query: 430 ATLAGTLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVVCRK 469
T Y APE ++ + D++S G ++ E++ K
Sbjct: 174 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 276 KLGQGGSGSVYKGT--LPGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGIN---HKNLV 328
++G+G G V+K GG VA+KR+ T + EV ++ + H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 329 KLLG-CSITGPES----LLVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYKIILSTAEGLA 382
+L C+++ + LV+E V +Q L ++ + EP + E ++ GL
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDL--TTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
+LH R++HRD+K NIL+ K+ADFGL R++ ++ TL Y APE
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPE 179
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478
+++ D++S G + E+ RK LF +S
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK--PLFRGSS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 59/210 (28%), Positives = 106/210 (50%), Gaps = 31/210 (14%)
Query: 275 NKLGQGGSGSVYKG----TLPGGEAVAVKRLFYNTTQWVDHF----FNEVNLISGINHKN 326
N++ +G G VY+ T GE VA+K+L + + F E+N++ + H N
Sbjct: 11 NRIEEGTYGVVYRARDKKT---GEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPN 65
Query: 327 LVKL----LGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
+V + +G ++ + +V E+V + +SL++ + +P ++L G
Sbjct: 66 IVTVKEVVVGSNLD--KIYMVMEYVEHDLKSLMETM-----KQPFLQSEVKCLMLQLLSG 118
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMA 440
+A+LH+ I+HRD+K SN+LL+ KI DFGL R + + + L TL Y A
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT-QLVVTLWYRA 174
Query: 441 PEYVVRGKL-TEKADVYSFGVVVIEVVCRK 469
PE ++ K + D++S G + E++ +K
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 14/196 (7%)
Query: 276 KLGQGGSGSVYKGTLPGGEA---VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLL 331
+LG G G V KG + VA+K L + V D E ++ +++ +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 332 GCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G + E+L LV E L L ++D +S V +++ + G+ YL ++
Sbjct: 62 G--VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVV--ELMHQVSMGMKYLEGKN-- 115
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYVVRGK 448
+HRD+ N+LL + AKI+DFGL + D ++ A AG L + APE + K
Sbjct: 116 -FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 449 LTEKADVYSFGVVVIE 464
+ ++DV+S+G+ + E
Sbjct: 175 FSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G VYK G A K + + + ++ + E+++++ +H N+VKLL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEESKLRII 393
++ EF ++ D + + + PL+ E + +++ T E L YLHE +II
Sbjct: 72 YYENNLWILIEFCAGGAV-DAVMLELE-RPLT-EPQIRVVCKQTLEALNYLHEN---KII 125
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE-- 451
HRD+K NIL + K+ADFG+ I + GT +MAPE V+ +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 452 ---KADVYSFGVVVIEV 465
KADV+S G+ +IE+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
LG G +G V+ + VAVK++ Q V H E+ +I ++H N+VK+ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVY--EV 70
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-----------EPLSWEVRYKIILSTAEGLAYL 384
GP + E V + + L+++++ Q+ PLS E + GL Y+
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYI 130
Query: 385 HEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITH---ISATLAGTLGYMA 440
H + ++HRD+K +N+ ++ E+ KI DFGL R+ +H +S L T Y +
Sbjct: 131 HSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKWYRS 186
Query: 441 PEYVVR-GKLTEKADVYSFGVVVIEVVCRK 469
P ++ T+ D+++ G + E++ K
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 267 ATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF-FNEVNLISGINH 324
AT+Y + KLG+G +VYKG + G+ VA+K + T + V E +L+ G+ H
Sbjct: 4 ATSYLN-LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 325 KNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
N+V LL I E+L V+E++ + L ++ + VR + GLAY
Sbjct: 63 ANIV-LLHDIIHTKETLTFVFEYM--HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAY 118
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
+H + I+HRD+K N+L+ K+ADFGL R S+ + TL Y P+
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDV 174
Query: 444 VVRG-KLTEKADVYSFGVVVIEVV 466
++ + D++ G + IE++
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 52/179 (29%), Positives = 93/179 (51%), Gaps = 10/179 (5%)
Query: 293 GEAVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVKLLG-CSITGPESL-LVYEFVPN 349
GE VAVK L + + E+ ++ + H+N+VK G C+ G + L+ EF+P+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409
SL + L ++ L +++Y + +G+ YL + +HRD+ N+L++ E
Sbjct: 93 GSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYLGSR---QYVHRDLAARNVLVESEHQ 147
Query: 410 AKIADFGLVRLFPEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
KI DFGL + D + + L + + APE +++ K +DV+SFGV + E++
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 59/197 (29%), Positives = 98/197 (49%), Gaps = 16/197 (8%)
Query: 276 KLGQGGSGSVYKG---TLPGGEAVAVKRLFY--NTTQWVDHFFNEVNLISGINHKNLVKL 330
+LG G G+V KG + VAVK L N D E N++ +++ +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 331 LGCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
+G I ES +LV E L N F++++ + +++ + G+ YL E +
Sbjct: 62 IG--ICEAESWMLVMELAELGPL--NKFLQKNKHVTEKNIT-ELVHQVSMGMKYLEETN- 115
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYVVRG 447
+HRD+ N+LL + AKI+DFGL + D + A G + + APE +
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 448 KLTEKADVYSFGVVVIE 464
K + K+DV+SFGV++ E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 14/202 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLV 328
F + KLG+G +VYKG GE VA+K + + + E++L+ + H+N+V
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 329 KLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
+L T + +LV+E++ + +D VR ++P + V+ +G+A+ HE
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNT--VKS-FTYQLLKGIAFCHE 118
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
R++HRD+K N+L+++ K+ADFGL R F + S + TL Y AP+ V+
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPD-VLL 173
Query: 447 GKLTEKA--DVYSFGVVVIEVV 466
G T D++S G ++ E++
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLGCS 334
LG G G+VYK L +AVK + + T + +E+ ++ + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
+ EF+ SL DV + V +I ++ +GL YL L+I+
Sbjct: 69 FVENRISICTEFMDGGSL--------DVYRKIPEHVLGRIAVAVVKGLTYLW---SLKIL 117
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
HRD+K SN+L++ K+ DFG+ + I+ T GT YMAPE + + +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 454 DVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVIL 487
DV+S G+ +E+ R +N S++ +L
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL 209
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 31/215 (14%)
Query: 277 LGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTT-QWVDHFFNEVNLISGI-NHKN 326
LG+G G V G + VAVK L + T + + +E+ ++ I HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDV-------------EPLSWEVRYK 372
++ LLG C+ GP +LV E+ +L + L R+ E L+++
Sbjct: 80 IINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
A G+ YL + + IHRD+ N+L+ E+ KIADFGL R +I + T
Sbjct: 139 CAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDV-HNIDYYKKTT 194
Query: 433 AGTL--GYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
G L +MAPE + T ++DV+SFGV++ E+
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 19/218 (8%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD-----HFFNEVNLISGINH 324
F K+G+G VY+ T L + VA+K++ + +D E++L+ +NH
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKV--QIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAY 383
N++K L I E +V E L + + ++ + +K + + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
+H R++HRDIK +N+ + K+ D GL R F T + +L GT YM+PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPER 177
Query: 444 VVRGKLTEKADVYSFGVVVIEVVCRK------RINLFT 475
+ K+D++S G ++ E+ + ++NLF+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 277 LGQGGSGSVYKGTLP----GGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
LG+G GSV + L + VAVK L ++ ++ F E + +H N++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 331 LGCSITG------PESLLVYEFVPNQSLLDNLFV-RQDVEP--LSWEVRYKIILSTAEGL 381
+G S+ P +++ F+ + L L + R EP L + + ++ A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGYMA 440
YL S IHRD+ N +L+E T +ADFGL + ++ D + ++A
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVCR 468
E + T +DV++FGV + E++ R
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-13
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 1/95 (1%)
Query: 98 FGGNNTVFGANAIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACEN 157
+ N+ F +N L+ +LS A + G + T +V+GLAQC ++ S C +
Sbjct: 12 YTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRS 71
Query: 158 CLENAVSRIAS-CTQKEEGRVLNAGCYLRYSTQRF 191
CL AVS + C K+ GR+ C+LRY + F
Sbjct: 72 CLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 56/218 (25%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V Y G+ VA+K+L F N T + E+ L+ +NHKN++ L
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTH-AKRAYRELVLMKLVNHKNIIGL 80
Query: 331 LGCSITGPESLLVYEFVPNQSLLD-------------NLF-VRQ---DVEPLSWEVRYKI 373
L F P +SL + NL V Q D E +S+ + Y++
Sbjct: 81 LNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLL-YQM 127
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
+ G+ +LH IIHRD+K SNI++ + T KI DFGL R T ++ +
Sbjct: 128 LC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMM 174
Query: 434 G----TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
T Y APE ++ E D++S G ++ E++
Sbjct: 175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 69/217 (31%), Positives = 107/217 (49%), Gaps = 30/217 (13%)
Query: 277 LGQGGSGSVYKGTLP-GGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
+G G G V+ T P G+ VA+K++ F N F E+ ++ H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVS-CKRVFRELKMLCFFKHDNVLSAL- 65
Query: 333 CSITGPESLLVYE--FVPN---QSLLDNLFVRQDVEPLSWE-VR---YKIILSTAEGLAY 383
I P + +E +V QS L + V +PLS + V+ Y+I+ GL Y
Sbjct: 66 -DILQPPHIDPFEEIYVVTELMQSDLHKIIVSP--QPLSSDHVKVFLYQIL----RGLKY 118
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPE 442
LH I+HRDIK N+L++ KI DFGL R+ P++ H++ + T Y APE
Sbjct: 119 LHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPE 174
Query: 443 YVVRGK-LTEKADVYSFGVVVIEVVCRKRINLFTQNS 478
++ + T D++S G + E++ R RI LF S
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGR-RI-LFQAQS 209
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 42/106 (39%), Positives = 54/106 (50%), Gaps = 25/106 (23%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
KI ++T + L YL EE L+IIHRD+K SNILLD K+ DFG IS
Sbjct: 111 KIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFG-----------ISGQ 157
Query: 432 L---------AGTLGYMAPEYV---VRGKLTEKADVYSFGVVVIEV 465
L AG YMAPE + R ++DV+S G+ + EV
Sbjct: 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 28/209 (13%)
Query: 271 FHESNKLGQGGSG---SVYKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINH 324
+ + +G G G + + L G VAVK+L F N T + E+ L+ +NH
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTH-AKRAYRELVLLKCVNH 79
Query: 325 KNLVKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
KN++ LL T +SL LV E + + +L + + D E +S+ + Y+++
Sbjct: 80 KNIISLLNV-FTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY-LLYQMLC-- 134
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
G+ +LH IIHRD+K SNI++ + T KI DFGL R + + T
Sbjct: 135 --GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRY 187
Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
Y APE ++ E D++S G ++ E+V
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 31/212 (14%)
Query: 277 LGQGGSGSVYKGTLPGGEA---VAVKRLFYNTTQWVDH--FFNEVNLISGIN-HKNLVKL 330
+G+G G V K + A+KR+ ++ DH F E+ ++ + H N++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINL 73
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQ----DVEP-----------LSWEVRYKIIL 375
LG L E+ P+ +LLD F+R+ + +P LS +
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG- 434
A G+ YL S+ + IHRD+ NIL+ E + AKIADFGL R ++ T+
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 185
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+ +MA E + T +DV+S+GV++ E+V
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 277 LGQGGSGSVYKGTLPGGEA---VAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
LG+G GSV +G L ++ VAVK ++ T ++ F +E + +H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 332 GCSITG------PESLLVYEFVPNQSLLDNL-FVRQDVEP--LSWEVRYKIILSTAEGLA 382
G + P +++ F+ + L L + R P L ++ K + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV-RLFPEDITHISATLAGTLGYMAP 441
YL S IHRD+ N +L+E +ADFGL +++ D + ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCR 468
E + T K+DV+SFGV + E+ R
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 70/217 (32%), Positives = 103/217 (47%), Gaps = 26/217 (11%)
Query: 276 KLGQGGSGSVYKGTLP-GGEAVAVK--RLFYNTTQWVDHFFNEVNLISGI---NHKNLVK 329
++G G G+VYK P G VA+K R+ N EV L+ + +H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 330 LL---GCSITGPES--LLVYEFVPNQSLLDNLFVRQDVEP--LSWEVRYKIILSTAEGLA 382
L+ S T E+ LV+E V +Q L L V P L E ++ GL
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL---DKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGTLGYMAP 441
+LH I+HRD+K NIL+ K+ADFGL R++ ++ T + TL Y AP
Sbjct: 123 FLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAP 176
Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478
E +++ D++S G + E+ RK LF NS
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFRRK--PLFCGNS 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGT 435
A GL +LH + II+RD+KL N++LD E KIADFG+ + +F T T GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR---TFCGT 164
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
Y+APE + + D ++FGV++ E++
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 46/130 (35%), Positives = 74/130 (56%), Gaps = 15/130 (11%)
Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRY---KIILSTAEGLAYLHEESKLRIIHRDIK 398
L+ ++V + +L+ R + EVR+ +IIL+ L +LH KL I++RDIK
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFS--EDEVRFYSGEIILA----LEHLH---KLGIVYRDIK 132
Query: 399 LSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL--TEKADVY 456
L NILLD E + DFGL + F + + + GT+ YMAPE ++RGK + D +
Sbjct: 133 LENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE-IIRGKGGHGKAVDWW 191
Query: 457 SFGVVVIEVV 466
S G+++ E++
Sbjct: 192 SLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHK 325
F K+G+G VY+ T L G VA+K++ + D E++L+ +NH
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARAD-CIKEIDLLKQLNHP 62
Query: 326 NLVKLLGCSITGPESLLVYEFVP--NQSLLDNLFVRQD---VEPLSWEVRYKIILSTAEG 380
N++K I E +V E + S + F +Q E W +Y + L +A
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW--KYFVQLCSA-- 118
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMA 440
L ++H R++HRDIK +N+ + K+ D GL R F T + +L GT YM+
Sbjct: 119 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMS 174
Query: 441 PEYVVRGKLTEKADVYSFGVVVIEV 465
PE + K+D++S G ++ E+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+G G GSV GE VA+K+L + + + + E+ L+ + H+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVE-----PLSWEVRYKIILSTAEGLAYLHEES 388
+ +F L +++ D++ PLS + ++ GL Y+H
Sbjct: 83 FTSAVSGDEFQDF-----YLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG 137
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG---TLGYMAPEYVV 445
IIHRD+K N+ ++E+ KI DFGL R H A + G T Y APE ++
Sbjct: 138 ---IIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEVIL 187
Query: 446 RG-KLTEKADVYSFGVVVIEVVCRK 469
+ D++S G ++ E++ K
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 28/225 (12%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHF----FNEVNLI 319
++ + F ++G+G G VYK GE VA+K++ + + + F E+ ++
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60
Query: 320 SGINHKNLVKLLGCSITGPESL----------LVYEFVPNQ--SLLDNLFVRQDVEPLSW 367
+NH+N+V L ++L LV+E++ + LL++ V S
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH-----FSE 115
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
+ + EGL Y H K +HRDIK SNILL+ + K+ADFGL RL+ + +
Sbjct: 116 DHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172
Query: 428 ISATLAGTLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVVCRKRI 471
TL Y PE ++ + DV+S G ++ E+ +K I
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 69/232 (29%), Positives = 104/232 (44%), Gaps = 55/232 (23%)
Query: 275 NKLGQGGSGSVYKG----TLPGGEAVAVKRLFYNTTQWVDHF---------FNEVNLISG 321
KLG+G G V+K T E VA+K++F D F F E+ +
Sbjct: 13 QKLGKGAYGIVWKAIDRRT---KEVVALKKIF-------DAFRNATDAQRTFREIMFLQE 62
Query: 322 I-NHKNLVKLLGC--SITGPESLLVYEF-------VPNQSLLDNLFVRQDVEPLSWEVRY 371
+ +H N+VKLL + + LV+E+ V ++L +DV RY
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANIL------EDVH-----KRY 111
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISA 430
I+ + L Y+H +IHRD+K SNILL+ + K+ADFGL R E + +
Sbjct: 112 -IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167
Query: 431 TLA---GTLGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVVCRKRINLFTQNS 478
L T Y APE ++ K D++S G ++ E++ K LF S
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK--PLFPGTS 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 36/89 (40%), Positives = 57/89 (64%), Gaps = 8/89 (8%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT--HISATLAGTLG 437
GL +LH++ II+RD+KL N+LLD++ KIADFG+ + E++ ++T GT
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK---ENMNGEGKASTFCGTPD 161
Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
Y+APE + K E D +SFGV++ E++
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 372 KIILSTAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
+ I A+ GL +LH+ RI++RD+K N+LLD+ +I+D GL I
Sbjct: 96 RAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKI 151
Query: 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
AGT GYMAPE + D ++ G + E++
Sbjct: 152 KGR-AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMI 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 271 FHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLV 328
F ++LG G G V K P G +A K + + + E+ ++ N +V
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
G + E + E + SL D V ++ + + E+ K+ ++ GLAYL E
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSL-DQ--VLKEAKRIPEEILGKVSIAVLRGLAYLRE-- 121
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK 448
K +I+HRD+K SNIL++ K+ DFG+ + I ++ + GT YM+PE +
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTH 178
Query: 449 LTEKADVYSFGVVVIEV 465
+ ++D++S G+ ++E+
Sbjct: 179 YSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 47/200 (23%), Positives = 91/200 (45%), Gaps = 39/200 (19%)
Query: 293 GEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350
G+ VA+K++ ++ E+ ++ H N++ + I P
Sbjct: 30 GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR--DI----------LRPPG 77
Query: 351 SLLDNLFVRQDV------------EPLSWE-VRYKI--ILSTAEGLAYLHEESKLRIIHR 395
+ +++V D+ +PL+ E +RY + +L GL Y+H + +IHR
Sbjct: 78 ADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLL---RGLKYIHSAN---VIHR 131
Query: 396 DIKLSNILLDEEFTAKIADFGLVRL---FPEDITHISATLAGTLGYMAPEYV-VRGKLTE 451
D+K SN+L++E+ +I DFG+ R P + + T Y APE + + T
Sbjct: 132 DLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTT 191
Query: 452 KADVYSFGVVVIEVVCRKRI 471
D++S G + E++ R+++
Sbjct: 192 AIDMWSVGCIFAEMLGRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 28/192 (14%)
Query: 269 NYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF----FNEVNLISGIN 323
+ + + K+GQG G V+K + VA+K++ + + F E+ ++ +
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLK 69
Query: 324 HKNLVKLLG-CSITG-------PESLLVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKI 373
H+N+V L+ C LV+EF + LL N V+ + E++ K+
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS----EIK-KV 124
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP---EDITHISA 430
+ GL Y+H +I+HRD+K +NIL+ ++ K+ADFGL R F +
Sbjct: 125 MKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 431 TLAGTLGYMAPE 442
TL Y PE
Sbjct: 182 NRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 277 LGQGGSGSVYKGTLP--GGEAVAVKRLFYNTTQWVDH--FFNEVNLISGI-NHKNLVKLL 331
+G+G G V + + G + A ++ DH F E+ ++ + +H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 332 GCSITGPESLLVYEFVPNQSLLDNL-----------FVRQ--DVEPLSWEVRYKIILSTA 378
G + E+ P +LLD L F ++ L+ + + A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLG 437
G+ YL E+ + IHRD+ N+L+ E +KIADFGL R E++ ++ T+ +
Sbjct: 130 TGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--GEEV-YVKKTMGRLPVR 183
Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+MA E + T K+DV+SFGV++ E+V
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 5e-12
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 277 LGQGGSGSVYKGTLP--GGEAVAVKRLFYNTTQWVDH--FFNEVNLISGI-NHKNLVKLL 331
+G+G G V K + G A + DH F E+ ++ + +H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 332 GCSITGPESLLVYEFVPNQSLLDNL-----------FVRQ--DVEPLSWEVRYKIILSTA 378
G L E+ P+ +LLD L F LS + A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLG 437
G+ YL ++ + IHRD+ NIL+ E + AKIADFGL R +++ ++ T+ +
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEV-YVKKTMGRLPVR 176
Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+MA E + T +DV+S+GV++ E+V
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 5e-12
Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 14/149 (9%)
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSW-EVRYKIILSTAEGL 381
++ N +KL T +L+ +++ + L D ++++ LS EV+ KII E L
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD--LLKKE-GKLSEAEVK-KIIRQLVEAL 122
Query: 382 AYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFPEDITHISATLAGTLGYMA 440
LH K IIH DIKL N+L D + + D+GL + I + GTL Y +
Sbjct: 123 NDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFS 174
Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
PE + D ++ GV+ E++ K
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 5/93 (5%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
KI ++ GL YL E K +I+HRD+K SNIL++ K+ DFG+ + I ++ +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANS 157
Query: 432 LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
GT YM+PE + T ++D++S G+ ++E
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 42/213 (19%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V Y L VA+K+L F N T + E+ L+ +NHKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGL 88
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
L T +SL +V E + + +L + + D E +S+ + Y+++ G+ +
Sbjct: 89 LNV-FTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-LLYQMLC----GIKH 141
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-------LFPEDITHISATLAGTL 436
LH IIHRD+K SNI++ + T KI DFGL R + P +T
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-------- 190
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
Y APE ++ E D++S G ++ E++
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 271 FHESNKLGQGGSGSVY--KGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKN 326
+ K+G+G G +Y K V +K + + + EV L++ + H N
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV-----EPLSWEVRYKIILSTAEGL 381
+V +V E+ L+ + ++ V + LSW V+ + GL
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GL 114
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHISATLAGTLGYMA 440
++H+ +I+HRDIK NI L + AK+ DFG+ R D ++ T GT Y++
Sbjct: 115 KHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLS 170
Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
PE K D++S G V+ E+ K
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 50/133 (37%), Positives = 74/133 (55%), Gaps = 20/133 (15%)
Query: 342 LVYEFVPNQSLLDNL-----FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRD 396
L+ +++ L +L F Q+V+ S E I+L+ L +LH KL II+RD
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGE----IVLA----LEHLH---KLGIIYRD 130
Query: 397 IKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT--EKA- 453
IKL NILLD + DFGL + F ED + + GT+ YMAP+ +VRG +KA
Sbjct: 131 IKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD-IVRGGDGGHDKAV 189
Query: 454 DVYSFGVVVIEVV 466
D +S GV++ E++
Sbjct: 190 DWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 6e-12
Identities = 65/205 (31%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 276 KLGQGGSGSVYKGTLPGG---EAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLL 331
++G G G V G + G V VK L + + Q F E + H NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 332 G-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVR--YKIILSTAEGLAYLHEES 388
G C+ P LLV EF P L L + E ++ + ++ A GL +LH
Sbjct: 62 GQCTEVTP-YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRL-FPEDITHISATLAGTLGYMAPEYV--V 445
K IH D+ L N LL + T KI D+GL + ED L L ++APE V V
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 446 RGKL-----TEKADVYSFGVVVIEV 465
G L T++++V+S GV + E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 7e-12
Identities = 36/91 (39%), Positives = 54/91 (59%), Gaps = 2/91 (2%)
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYM 439
LA H SK +IHRDIK +NILL K+ DFG +++ ++ + T GT Y+
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
APE R ++KAD++S GV++ E++ KR
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-12
Identities = 58/194 (29%), Positives = 89/194 (45%), Gaps = 21/194 (10%)
Query: 277 LGQGGSGSVYK-----GTLPG---GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
LG+GG G V++ G G V K + H E N++ + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS-TAEGLAYLHEE 387
L+ TG + L+ E++ LF+ + E + E LS + L +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSG----GELFMHLEREGIFMEDTACFYLSEISLALEHLH-- 117
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMAPEYVV 445
+ II+RD+K NILLD + K+ DFGL + + +TH T GT+ YMAPE ++
Sbjct: 118 -QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH---TFCGTIEYMAPEILM 173
Query: 446 RGKLTEKADVYSFG 459
R + D +S G
Sbjct: 174 RSGHGKAVDWWSLG 187
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNT--TQWVDHF-FNEV 316
YE L +G+G G V K G+ VA+K+ F + + V E+
Sbjct: 3 YENLGL----------VGEGSYGMVMKCKHKETGQIVAIKK-FLESEDDKMVKKIAMREI 51
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
++ + H+NLV L+ LV+EFV + ++LD+L + L K +
Sbjct: 52 RMLKQLRHENLVNLIEVFRRKKRLYLVFEFV-DHTVLDDL--EKYPNGLDESRVRKYLFQ 108
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP---EDITHISATLA 433
G+ + H + IIHRDIK NIL+ + K+ DFG R E T A
Sbjct: 109 ILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA--- 162
Query: 434 GTLGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVV 466
T Y APE +V +A D+++ G +V E++
Sbjct: 163 -TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEML 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 54/180 (30%), Positives = 83/180 (46%), Gaps = 20/180 (11%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLV---YEFVPNQSLLDNLFVRQD-VEPLSWEVR 370
E++++ I+H+ ++ L+ +V Y+ +LF D PL E
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC--------DLFTYVDRSGPLPLEQA 187
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV-RLFPEDITHIS 429
I E LAYLH IIHRD+K NI LDE A + DFG +L T
Sbjct: 188 ITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244
Query: 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF---TQNSCSILQTVI 486
+GTL +PE + K D++S G+V+ E+ K + LF ++S S L+++I
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV-KNVTLFGKQVKSSSSQLRSII 303
|
Length = 392 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 52/147 (35%), Positives = 76/147 (51%), Gaps = 13/147 (8%)
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
NH LV L C T V EFV L+ ++ RQ P Y +S A L
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM-QRQRKLPEEHARFYSAEISLA--LN 110
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMA 440
+LHE II+RD+KL N+LLD E K+ D+G+ + + P D T +T GT Y+A
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIA 164
Query: 441 PEYVVRGKLTE-KADVYSFGVVVIEVV 466
PE ++RG+ D ++ GV++ E++
Sbjct: 165 PE-ILRGEDYGFSVDWWALGVLMFEMM 190
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 36/87 (41%), Positives = 52/87 (59%), Gaps = 5/87 (5%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
GL LH+E RI++RD+K NILLD+ +I+D GL PE T I + GT+GYM
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYM 168
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVV 466
APE V + T D ++ G ++ E++
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
P W +Y I G+ LH+ IIHRDIK N+L+D+ K+ DFGL R
Sbjct: 95 PEDWAKQY--IAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSR---- 145
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
+ GT Y+APE ++ + +D +S G V+ E
Sbjct: 146 -NGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFE 185
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 13/148 (8%)
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGL 381
NH L +L C T V EFV L+ ++ R+ E + +I L
Sbjct: 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIT----SAL 109
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGYM 439
+LH++ II+RD+KL N+LLD E K+ADFG+ + E I + ++T GT Y+
Sbjct: 110 MFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYI 163
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVC 467
APE + D ++ GV++ E++C
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V Y L VA+K+L F N T + E+ L+ +NHKN++ L
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISL 81
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
L T +SL LV E + + +L + + D E +S+ + Y+++ G+ +
Sbjct: 82 LNV-FTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-LLYQMLC----GIKH 134
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
LH IIHRD+K SNI++ + T KI DFGL R + + T Y APE
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 189
Query: 444 VVRGKLTEKADVYSFGVVVIEVVCRK 469
++ E D++S G ++ E+V K
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 8/89 (8%)
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGY 438
L YLH +++RD+KL N++LD++ KI DFGL + E I+ T GT Y
Sbjct: 108 LGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEY 161
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
+APE + D + GVV+ E++C
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 68/225 (30%), Positives = 101/225 (44%), Gaps = 43/225 (19%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVN 317
YE +EK G+G G VYK E +A+K RL E++
Sbjct: 4 YEKVEKI----------GEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREIS 53
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD-NLFVRQDVEP-LSWEVR----- 370
L+ + H N+V+L + LV+E+ LD +L D P + R
Sbjct: 54 LLKEMQHGNIVRLQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIKTY 107
Query: 371 -YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVRLF--P-EDI 425
Y+I+ G+AY H R++HRD+K N+L+D A K+ADFGL R F P
Sbjct: 108 LYQIL----RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160
Query: 426 THISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRK 469
TH TL Y APE ++ + + D++S G + E+V +K
Sbjct: 161 THEVV----TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 52/197 (26%), Positives = 98/197 (49%), Gaps = 10/197 (5%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLV 328
F + ++LG G G V+K + P G +A K + + + E+ ++ N +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
G + E + E + SL D + + P ++ K+ ++ +GL YL E+
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP--EQILGKVSIAVIKGLTYLREKH 123
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK 448
K I+HRD+K SNIL++ K+ DFG+ + I ++ + GT YM+PE +
Sbjct: 124 K--IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTH 178
Query: 449 LTEKADVYSFGVVVIEV 465
+ ++D++S G+ ++E+
Sbjct: 179 YSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 276 KLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNLVKLLG 332
K+G+G G V+K G+ VA+K+ + V E+ ++ + H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
+ LV+E+ + ++L+ L ++ + + KII T + + + H K
Sbjct: 68 VFRRKRKLHLVFEYC-DHTVLNEL--EKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNC 121
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTLGYMAPEYVV-RGK 448
IHRD+K NIL+ ++ K+ DFG R+ +D T A T Y APE +V +
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA----TRWYRAPELLVGDTQ 177
Query: 449 LTEKADVYSFGVVVIEVVC 467
DV++ G V E++
Sbjct: 178 YGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 39/166 (23%), Positives = 80/166 (48%), Gaps = 8/166 (4%)
Query: 304 NTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV---YEFVPNQSLLDNLFVRQ 360
++ NE+ + +NH+N++K+ + + ++ Y+F + D F +
Sbjct: 202 AGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK 261
Query: 361 DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420
D PL + R I+ + Y+H++ ++IHRDIKL NI L+ + + DFG
Sbjct: 262 D-RPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316
Query: 421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
F ++ GT+ +PE + E D++S G+++++++
Sbjct: 317 FEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 57/165 (34%), Positives = 82/165 (49%), Gaps = 21/165 (12%)
Query: 308 WVD---HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
WV H F + + NH LV L C T V E+V L+ ++ RQ P
Sbjct: 41 WVQTEKHVFEQAS-----NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLP 94
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFP 422
Y +S A L YLHE II+RD+KL N+LLD E K+ D+G+ + L P
Sbjct: 95 EEHARFYSAEISLA--LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 149
Query: 423 EDITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVV 466
D T +T GT Y+APE ++RG+ D ++ GV++ E++
Sbjct: 150 GDTT---STFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMM 190
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 276 KLGQGGSGSVY---------KGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
+LG+G G+VY + L + + V L N T E L+S ++H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV---QANQEAQLLSKLDHPA 63
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSWEVRYKIILSTAEGLAYLH 385
+VK + ++ E+ + L L ++ + LS + + G+ Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
+ RI+HRD+K NI L KI DFG+ RL ++ T GT YM+PE +
Sbjct: 124 QR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGS-CDLATTFTGTPYYMSPEALK 178
Query: 446 RGKLTEKADVYSFGVVVIEVVC 467
K+D++S G ++ E+ C
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 38/101 (37%), Positives = 60/101 (59%), Gaps = 11/101 (10%)
Query: 371 YKIILSTAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI-- 425
Y+ AE GL +LH + II+RD+KL N++LD + KIADFG+ + E++
Sbjct: 96 YRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFG 149
Query: 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+ ++T GT Y+APE + K T D +SFGV++ E++
Sbjct: 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 9e-11
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 31/210 (14%)
Query: 277 LGQGGSGSVYKG----TLPGGEA----VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
LGQG ++KG GE V +K L + + + FF +++S ++HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY-LHEE 387
G + G ES++V E+V SL L +++ +SW+ L A+ LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWALHFL 116
Query: 388 SKLRIIHRDIKLSNILLDEEFTA--------KIADFGL-VRLFPEDITHISATLAGTLGY 438
+ H ++ N+LL E K++D G+ + + P++I L + +
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI------LLERIPW 170
Query: 439 MAPEYVVRGK-LTEKADVYSFGVVVIEVVC 467
+ PE + + L+ AD +SFG + E+
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGCS 334
+G G G VYKG + G+ A+K + T + E+N++ +H +N+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 335 IT-GPESL-----LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
I P + LV EF S+ D L L E I GL++LH+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQH- 130
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK 448
++IHRDIK N+LL E K+ DFG+ + T GT +MAPE + +
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACDE 187
Query: 449 LTE-----KADVYSFGVVVIEV 465
+ K+D++S G+ IE+
Sbjct: 188 NPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 35/89 (39%), Positives = 54/89 (60%), Gaps = 8/89 (8%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI--THISATLAGTLG 437
GL +LH + I++RD+KL NILLD + KIADFG+ + E++ + T GT
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPD 161
Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
Y+APE ++ K D +SFGV++ E++
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 48/222 (21%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
+ +G+G G V T P G VA+K++ F + T + E+ ++ H+N++ +L
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-FCQRTLREIKILRRFKHENIIGIL 69
Query: 332 GCSITGPESL-------LVYEFVP--------NQSLLDN---LFVRQDVEPLSWEVRYKI 373
I P S +V E + Q L ++ F+ Y+I
Sbjct: 70 --DIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL------------YQI 115
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
+ GL Y+H + ++HRD+K SN+LL+ KI DFGL R+ + H + L
Sbjct: 116 L----RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH-TGFLT 167
Query: 434 ---GTLGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVVCRKRI 471
T Y APE ++ K KA D++S G ++ E++ + +
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 45/160 (28%), Positives = 80/160 (50%), Gaps = 11/160 (6%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI 373
NE ++ ++H N+++ + ++V E+ P +L + ++++ L E
Sbjct: 48 NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAE--YIQKRCNSLLDE---DT 102
Query: 374 ILS--TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVRLFPEDITHISA 430
IL LA H +KL I+HRD+K NILLD+ KI DFG+ ++ +
Sbjct: 103 ILHFFVQILLALHHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--AY 159
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
T+ GT Y++PE +K+D+++ G V+ E+ KR
Sbjct: 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVK--RLFYNTTQWVDHFFNEV 316
+YE LEK +G+G G VYK G+ VA+K RL + E+
Sbjct: 2 AYEKLEK----------IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREI 51
Query: 317 NLISGINHKN-LVKLLGCSIT----GPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWE 368
+L+ ++ +V+LL G SL LV+E++ + + +D R PL +
Sbjct: 52 SLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMD-SNGRGPGRPLPAK 110
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVRLFPEDITH 427
+ +G+A+ H K ++HRD+K N+L+D++ KIAD GL R F +
Sbjct: 111 TIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS 167
Query: 428 ISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVV 466
+ + TL Y APE ++ + D++S G + E+
Sbjct: 168 YTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
A L YLHE+ I+HRD+K N+ L K+ D G+ R+ E+ +++TL GT
Sbjct: 112 AMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPY 167
Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
YM+PE K+DV++ G V E+ K
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF-FNEVN 317
SYE LEK LG+G +VYKG + G+ VA+K + + E +
Sbjct: 6 SYEKLEK----------LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREAS 55
Query: 318 LISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEP--LSWEVRYKII 374
L+ G+ H N+V LL I E+L LV+E+V +L D P L E +
Sbjct: 56 LLKGLKHANIV-LLHDIIHTKETLTLVFEYVHT-----DLCQYMDKHPGGLHPENVKLFL 109
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
GL+Y+H+ I+HRD+K N+L+ + K+ADFGL R +H +
Sbjct: 110 FQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVV 165
Query: 435 TLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVV 466
TL Y P+ ++ + + D++ G + +E++
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 271 FHESNKLGQGGSGSV----YKGTLPGGEAVAVKRLFYNTT---QWVDHFFNEVNLISGIN 323
F LG G G V +KGT GE A+K L + V H E +++ ++
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 324 HKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNL-----FVRQDVEPLSWEVRYKIILST 377
H +V ++ CS + + EFV L +L F + E+ +L+
Sbjct: 77 HPFIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL----VLA- 130
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
YLH + II+RD+K N+LLD + K+ DFG F + + + TL GT
Sbjct: 131 ---FEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFG----FAKKVPDRTFTLCGTPE 180
Query: 438 YMAPEYVVRGKLTEKA-DVYSFGVVVIEVV 466
Y+APE V++ K KA D ++ GV++ E +
Sbjct: 181 YLAPE-VIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 12/159 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
H NE ++ ++H +++L ++ E+VP L L +
Sbjct: 45 EQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL 104
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
I+ E YLH I++RD+K NILLD+E K+ DFG F + +
Sbjct: 105 FYASEIVCALE---YLHS---KEIVYRDLKPENILLDKEGHIKLTDFG----FAKKLRDR 154
Query: 429 SATLAGTLGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVV 466
+ TL GT Y+APE V++ K KA D ++ G+++ E++
Sbjct: 155 TWTLCGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 41/157 (26%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
F E + +H N+V+L G G ++V E++ N +L + F+R+ L
Sbjct: 53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL--DSFLRKHEGQLVAGQLM 110
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
++ A G+ YL E + +H+ + +L++ + KI+ F RL + I T
Sbjct: 111 GMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTT 165
Query: 432 LAG--TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
++G + + APE + + +DV+SFG+V+ EV+
Sbjct: 166 MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 4e-10
Identities = 51/182 (28%), Positives = 80/182 (43%), Gaps = 14/182 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
V H E ++ H L L T V E+V LF E + E
Sbjct: 39 VAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG----GELFFHLSRERVFSE 94
Query: 369 VRYKII-LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
R + L YLH +I++RD+KL N++LD++ KI DFGL + E IT
Sbjct: 95 DRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITD 148
Query: 428 ISA--TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
+ T GT Y+APE + D + GVV+ E++C R+ + Q+ + + +
Sbjct: 149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELI 207
Query: 486 IL 487
++
Sbjct: 208 LM 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 28/207 (13%)
Query: 277 LGQGGSGSVYK-GTLPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+G+G G V+K G AVK L ++ + ++ +N + +S +H N+VK G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS--DHPNVVKFYGM 83
Query: 334 -----SITGPESLLVYEFVPNQSLLD---NLFVRQD--VEPLSWEVRYKIILSTAEGLAY 383
G + LV E S+ D R + EP+ + ++ ++ GL +
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM----GLQH 139
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
LH + IHRD+K +NILL E K+ DFG V T GT +MAPE
Sbjct: 140 LHVN---KTIHRDVKGNNILLTTEGGVKLVDFG-VSAQLTSTRLRRNTSVGTPFWMAPEV 195
Query: 444 V-----VRGKLTEKADVYSFGVVVIEV 465
+ + + DV+S G+ IE+
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 25/227 (11%)
Query: 252 VNKSKLNFSYETLEKATNYFHES----NKLGQGGSGSVYKGTLPGGE--AVAVKRLFYNT 305
++K K + S + ++ +E LG G G V T + VA+KR +
Sbjct: 9 LHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSK 68
Query: 306 ---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV 362
+ VDH F+E +++ INH V L G LV EFV F+R++
Sbjct: 69 IIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT--FLRRNK 126
Query: 363 E-PLSWEVRY--KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
P Y +I+L YL L I++RD+K N+LLD++ K+ DFG +
Sbjct: 127 RFPNDVGCFYAAQIVLI----FEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179
Query: 420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+ + + TL GT Y+APE ++ + AD ++ G+ + E++
Sbjct: 180 V----VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 34/108 (31%), Positives = 59/108 (54%), Gaps = 4/108 (3%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
L YLH E +++RD+KL N++LD++ KI DFGL + +D + T GT Y+
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK-TFCGTPEYL 163
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVIL 487
APE + D + GVV+ E++C R+ + Q+ + + +++
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILM 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 35/109 (32%), Positives = 59/109 (54%), Gaps = 9/109 (8%)
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA--TLAGTLGY 438
L YLH +++RDIKL N++LD++ KI DFGL + E I+ + T GT Y
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEY 161
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVIL 487
+APE + D + GVV+ E++C R+ + Q+ + + +++
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILM 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG 321
E+L T+ + +G+G G VYK T ++A ++ + + E N++
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQS 74
Query: 322 I-NHKNLVKLLGC-----SITGPESLLVYEFVPNQS---LLDNLFVRQDV--EPLSWEVR 370
+ NH N+VK G + G + LV E S L+ L + E + +
Sbjct: 75 LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHIS 429
Y +L GL +LH RIIHRD+K +NILL E K+ DFG+ +L +
Sbjct: 135 YGALL----GLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR-- 185
Query: 430 ATLAGTLGYMAPEYVVRGKLTE-----KADVYSFGVVVIEV 465
T GT +MAPE + + + + DV+S G+ IE+
Sbjct: 186 NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
LV L C T LV E+V L+ ++ RQ P Y + A L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPEEHARFYAAEICIA--LNFLHE 114
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMAPEYV 444
II+RD+KL N+LLD + K+ D+G+ + L P D T +T GT Y+APE +
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPE-I 167
Query: 445 VRGK-LTEKADVYSFGVVVIEVVC-RKRINLFTQN 477
+RG+ D ++ GV++ E++ R ++ T N
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 39/105 (37%), Positives = 56/105 (53%), Gaps = 8/105 (7%)
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
PL+ E A G+ +L + + IHRD+ NILL E KI DFGL R +
Sbjct: 170 PLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 424 DITHI---SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
D ++ SA L L +MAPE + T ++DV+SFGV++ E+
Sbjct: 227 DPDYVRKGSARLP--LKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 30/213 (14%)
Query: 271 FHESNKLGQGGSGSV-YKGTLPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNL 327
+ + ++G G G+V G VA+K+L+ + + + + E+ L+ + H+N+
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 328 VKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
+ LL T SL LV F+ +L E LS + ++ +G
Sbjct: 77 IGLLDV-FTPDLSLDRFHDFYLVMPFMGT-----DLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG---TLG 437
L Y+H IIHRD+K N+ ++E+ KI DFGL R + + G T
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVTRW 180
Query: 438 YMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRK 469
Y APE ++ T+ D++S G ++ E++ K
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 39/106 (36%), Positives = 56/106 (52%), Gaps = 8/106 (7%)
Query: 363 EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422
EPL+ E A G+ +L + + IHRD+ NILL E KI DFGL R
Sbjct: 168 EPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 423 EDITHI---SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
+D ++ A L L +MAPE + T ++DV+SFGV++ E+
Sbjct: 225 KDPDYVRKGDARLP--LKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 270 YFHESNKLGQGGSGSV----YKGTLPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGI- 322
+ +LGQG G V T E VA+K++ ++ E+ L+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEE-ETVAIKKITNVFSKKILAKRALRELKLLRHFR 59
Query: 323 NHKNLVKLLGCSITGPES---LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK-IILSTA 378
HKN+ L I P + L +YE + L + +R PL+ + ++ I
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADL--HQIIRSGQ-PLT-DAHFQSFIYQIL 115
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG---T 435
GL Y+H + ++HRD+K N+L++ + KI DFGL R F E+ + + T
Sbjct: 116 CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 436 LGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVVCRK 469
Y APE ++ + KA DV+S G ++ E++ RK
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 9e-10
Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
++LG+G GSVYK P G +A+K RL + +++ + E++++ +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF-NQIIMELDILHKAVSPYIVDFY 65
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFV-RQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G + E++ SL D L+ E + +V +I + +GL +L EE
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--H 122
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV------ 444
IIHRD+K +N+L++ K+ DFG+ + ++ T G YMAPE +
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTNIGCQSYMAPERIKSGGPN 179
Query: 445 VRGKLTEKADVYSFGVVVIE 464
T ++DV+S G+ ++E
Sbjct: 180 QNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 36/87 (41%), Positives = 50/87 (57%), Gaps = 5/87 (5%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
GL LH E RI++RD+K NILLD+ +I+D GL PE T I + GT+GYM
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYM 168
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVV 466
APE V + T D + G ++ E++
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 48/143 (33%), Positives = 71/143 (49%), Gaps = 19/143 (13%)
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS----------TAEGLAY 383
SIT +S FV +SL D V ++ E YK +L+ A+G+ +
Sbjct: 140 SITSSQSSASSGFVEEKSLSD---VEEEEAE--QEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPE 442
L + + IHRD+ NILL E KI DFGL R +D ++ A L +MAPE
Sbjct: 195 L---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251
Query: 443 YVVRGKLTEKADVYSFGVVVIEV 465
+ T ++DV+SFGV++ E+
Sbjct: 252 TIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 31/101 (30%), Positives = 59/101 (58%), Gaps = 8/101 (7%)
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT-HIS 429
Y+I+L+ L E +++HRD+K +NI L K+ DFG + + + ++ ++
Sbjct: 176 YQIVLA-------LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
++ GT Y+APE R + ++KAD++S GV++ E++ R
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 34/91 (37%), Positives = 54/91 (59%), Gaps = 8/91 (8%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGT 435
A GL +LH + II+RD+KL N++LD E KIADFG+ + E++ + T GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGT 164
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
Y+APE + + D ++FGV++ E++
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 40/226 (17%)
Query: 277 LGQGGSGSVYKGTL----------PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
LGQG ++YKG L PG E V ++ + + FF +L+S ++HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
LVKL G + E+++V E+V L ++F+ ++ +S + + A L YL E
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPL--DVFLHREKNNVSLHWKLDVAKQLASALHYL-E 118
Query: 387 ESKLRIIHRDIKLSNILL-----DEEFT--AKIADFG-----LVRLFPEDITHISATLAG 434
+ KL +H ++ NIL+ +E + K++D G L R +
Sbjct: 119 DKKL--VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE---------- 166
Query: 435 TLGYMAPEYVVRG--KLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478
+ ++APE + G LT AD +SFG ++E+ L T +S
Sbjct: 167 RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL 436
+ GL +LH II+RD+KL N++LD E KIADFG+ + + +T + T GT
Sbjct: 111 SVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTP 165
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
Y+APE + + D +++GV++ E++
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 37/103 (35%), Positives = 58/103 (56%), Gaps = 14/103 (13%)
Query: 368 EVRY---KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
E+R+ +IIL GL ++H +++RD+K +NILLDE +I+D GL F +
Sbjct: 98 EMRFYAAEIIL----GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150
Query: 425 ITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVV 466
H S GT GYMAPE + +G AD +S G ++ +++
Sbjct: 151 KPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 34/87 (39%), Positives = 49/87 (56%), Gaps = 5/87 (5%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
GL L E RI++RD+K NILLD+ +I+D GL PE T + + GT+GYM
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYM 168
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVV 466
APE + K T D + G ++ E++
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 54/229 (23%), Positives = 94/229 (41%), Gaps = 53/229 (23%)
Query: 271 FHESNKLGQGGSGSVYKG---TLPGGEAVAVKRLFYNTTQWVDHF----FNEVNLISGIN 323
+ +G+G G VYK G+ A+K+ F + E+ L+ +
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK-FKGDKEQYTGISQSACREIALLRELK 60
Query: 324 HKNLVKLLGCSITGPESL--LVYEFV-------------PNQSLLDNLFVRQDVEPLSWE 368
H+N+V L+ + + L++++ + + V+ L W+
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS----LLWQ 116
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPED 424
IL G+ YLH ++HRD+K +NIL+ E KI D GL RLF
Sbjct: 117 -----IL---NGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 425 ITHISATLAG------TLGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVV 466
+ LA T+ Y APE ++ + KA D+++ G + E++
Sbjct: 166 L----KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 64/228 (28%), Positives = 97/228 (42%), Gaps = 44/228 (19%)
Query: 275 NKLGQGGSGSVYKG--TLPGGEAVAVKRLFYN--------TTQWVD----HF--FNEVNL 318
LG+G G V K TL G VA+K++ Q V HF E+ +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKI-VAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST- 377
++ I H+N++ L+ + G LV + + S L + D + E + K IL
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM--ASDLKKVV---DRKIRLTESQVKCILLQI 128
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG--- 434
GL LH K +HRD+ +NI ++ + KIADFGL R + S TL+
Sbjct: 129 LNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPP--YSDTLSKDET 183
Query: 435 ------------TLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRK 469
TL Y APE ++ K D++S G + E++ K
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 57/202 (28%), Positives = 87/202 (43%), Gaps = 19/202 (9%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGCS 334
+G G G VYKG + G+ A+K + T + E+N++ +H +N+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 335 ITGP------ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
I + LV EF S+ D L L + I GLA+LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICREILRGLAHLHAH- 140
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV--- 445
++IHRDIK N+LL E K+ DFG+ + T GT +MAPE +
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACDE 197
Query: 446 --RGKLTEKADVYSFGVVVIEV 465
++D++S G+ IE+
Sbjct: 198 NPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 32/88 (36%), Positives = 51/88 (57%), Gaps = 7/88 (7%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
GL ++H +++RD+K +NILLDE +I+D GL F + H S GT GYM
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162
Query: 440 APEYVVRGKLTE-KADVYSFGVVVIEVV 466
APE + +G + AD +S G ++ +++
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 32/88 (36%), Positives = 50/88 (56%), Gaps = 8/88 (9%)
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGY 438
L +LH +I+RD+KL NILLD E K+ADFG+ + E I + + T GT Y
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDY 162
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+APE + + D ++ GV++ E++
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMM 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 61/217 (28%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSW 367
V H E ++++ ++ +VKL S L L+ E++P ++ L +++D +
Sbjct: 45 VAHVRAERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMM-TLLMKKDT--FTE 100
Query: 368 EV-RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL--------V 418
E R+ I AE + + KL IHRDIK N+LLD + K++DFGL
Sbjct: 101 EETRFYI----AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156
Query: 419 RLFPEDITHISAT-------------------------LA----GTLGYMAPEYVVRGKL 449
F ++H + LA GT Y+APE ++
Sbjct: 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY 216
Query: 450 TEKADVYSFGVVVIEVV--------------CRKRIN 472
++ D +S GV++ E++ RK IN
Sbjct: 217 NKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIIN 253
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGT 435
A L YLH L II+RD+K NILLD + + DFGL + E I H ++T GT
Sbjct: 106 ASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGT 159
Query: 436 LGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVV 466
Y+APE V+R + ++ D + G V+ E++
Sbjct: 160 PEYLAPE-VLRKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 5/87 (5%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
GL LH E+ ++RD+K NILLD+ +I+D GL PE GT+GYM
Sbjct: 114 GLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRVGTVGYM 168
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVV 466
APE + + T D + G ++ E++
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 18/152 (11%)
Query: 275 NKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLG 332
+KLG+G +V+KG + VA+K + + EV+L+ + H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 333 CSITGPESLLVYEFVPN--QSLLD---NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
T LV+E++ + + LD NL +V+ +++ GL+Y H+
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQL--------LRGLSYCHKR 122
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
+I+HRD+K N+L++E+ K+ADFGL R
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
L ++H+ +I+HRDIK NI L ++ T K+ DFG+ R+ ++ T GT Y+
Sbjct: 113 ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELARTCIGTPYYL 168
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
+PE K+D+++ G V+ E+ K
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 6/91 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGY 438
GL +LH+ RII+RD+K N+LLD + +I+D GL V L +D + AGT G+
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGF 163
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
MAPE + + D ++ GV + E++ +
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 20/199 (10%)
Query: 275 NKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLG 332
KLG+G +V+KG E VA+K + + EV+L+ + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 333 CSITGPESLLVYEFVPN---QSLLD--NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
T LV+E++ Q + D N+ +V+ +++ GLAY H
Sbjct: 72 IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQI--------LRGLAYCH-- 121
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV-R 446
+ +++HRD+K N+L++E K+ADFGL R S + TL Y P+ ++
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGS 179
Query: 447 GKLTEKADVYSFGVVVIEV 465
+ + + D++ G + E+
Sbjct: 180 SEYSTQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 46/176 (26%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVD-HFFNEVN 317
+Y+ L+K LG+G +VYKG + G+ VA+K + + E +
Sbjct: 6 TYKKLDK----------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREAS 55
Query: 318 LISGINHKNLVKLLGCSITGPESL-LVYEFV-----------PNQSLLDN--LFVRQDVE 363
L+ + H N+V L I ++L LV+E++ + N LF+ Q
Sbjct: 56 LLKDLKHANIV-TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQ--- 111
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
+L GLAY H + R++HRD+K N+L+ E K+ADFGL R
Sbjct: 112 ----------LL---RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGY 438
L +LH+ I++RD+K NILLD + DFGL + L T+ T GT Y
Sbjct: 109 LEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN---TFCGTTEY 162
Query: 439 MAPEYVVRGK-LTEKADVYSFGVVVIEVVC 467
+APE ++ K T+ D +S GV+V E+ C
Sbjct: 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 30/98 (30%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 372 KIILSTAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
++I +A+ G+ +LH + I++RD+K N+LLD++ +++D GL + T
Sbjct: 96 RVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-- 150
Query: 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
AGT GYMAPE + + D ++ G + E+V
Sbjct: 151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMV 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 16/143 (11%)
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVE------PLSWEVRYKIILSTAEGLAYLH 385
G S G ++ + E P S +D E PL + + A+G+ +L
Sbjct: 172 GFSSQGSDTYV--EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA 229
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI---SATLAGTLGYMAPE 442
++ IHRD+ N+LL + AKI DFGL R D ++ +A L + +MAPE
Sbjct: 230 SKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP--VKWMAPE 284
Query: 443 YVVRGKLTEKADVYSFGVVVIEV 465
+ T ++DV+S+G+++ E+
Sbjct: 285 SIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGT 435
A + YLH L II+RD+K NILLD + + DFGL + + PE+ T +T GT
Sbjct: 106 ASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGT 159
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
Y+APE + + D + G V+ E++
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 13/160 (8%)
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVR 370
F+ E ++++ N +V+L C+ + L +V E++P L+ NL DV P W
Sbjct: 90 FWEERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLV-NLMSNYDV-PEKWAKF 146
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
Y TAE + L + +IHRD+K N+LLD+ K+ADFG E
Sbjct: 147 Y-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201
Query: 431 TLAGTLGYMAPEYVVR----GKLTEKADVYSFGVVVIEVV 466
T GT Y++PE + G + D +S GV + E++
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 42/225 (18%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
+T+ + + + +G G GSV G VAVK+L + + + E+ L
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL----------------LDNLFVRQDV 362
+ + H+N++ LL F P +SL L+N+ Q +
Sbjct: 70 LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 117
Query: 363 EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422
V++ +I GL Y+H IIHRD+K SN+ ++E+ KI DFGL R
Sbjct: 118 T--DDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD 171
Query: 423 EDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVV 466
+++T A T Y APE ++ + D++S G ++ E++
Sbjct: 172 DEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 212
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 50/159 (31%), Positives = 76/159 (47%), Gaps = 9/159 (5%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSW 367
V H E +++ +N +V L S PE L LV F+ L +L E
Sbjct: 37 VTHTLAERTVLAQVNCPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHL----QREGRFD 91
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
R + TAE L L K +I+RD+K NILLD + + DFGL +L +D
Sbjct: 92 LSRAR--FYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DD 148
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+ T GT Y+APE ++ T+ D ++ GV++ E++
Sbjct: 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 34/91 (37%), Positives = 46/91 (50%), Gaps = 5/91 (5%)
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT-HISATLAG 434
S + YLHE RIIHRDIK NI ++ + DFG FP DI + AG
Sbjct: 190 SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAG 245
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
T+ APE + R D++S G+V+ E+
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 20/163 (12%)
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
FF +++ ++HK++V L G + E+++V EFV L +LF+ + + L+ ++
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL--DLFMHRKSDVLTTPWKF 108
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILL-----DEEFTA--KIADFGLVRLFPED 424
K+ A L+YL ++ ++H ++ NILL D E K++D G+
Sbjct: 109 KVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI------P 159
Query: 425 ITHIS-ATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEV 465
IT +S + ++APE V K L+ AD +SFG + E+
Sbjct: 160 ITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 45/205 (21%), Positives = 75/205 (36%), Gaps = 29/205 (14%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+ K P VAVK++ ++ + + E+ + H N++ +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 335 ITGPESLLVYEFVPNQS---LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
I E +V + S LL F E L I+ L Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFP----EGLPELAIAFILKDVLNALDYIH---SKG 121
Query: 392 IIHRDIKLSNILLDEEFTAKIADF---------GLVRLFPEDITHISATLAGTLGYMAPE 442
IHR +K S+ILL + ++ G + D S L +++PE
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN---LPWLSPE 178
Query: 443 YVVRGKL---TEKADVYSFGVVVIE 464
V++ L EK+D+YS G+ E
Sbjct: 179 -VLQQNLQGYNEKSDIYSVGITACE 202
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGT 435
A L YLH L I++RD+K NILLD + + DFGL + E+I H ++T GT
Sbjct: 106 ASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGT 159
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
Y+APE + + D + G V+ E++
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 4/86 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
G+ ++HE+ R++HRDIK NI L + K+ DFG RL + + T GT Y+
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY-ACTYVGTPYYV 167
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEV 465
PE K+D++S G ++ E+
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 22/200 (11%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLL 331
+G G GSV Y L + VAVK+L + + + E+ L+ + H+N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 332 GC---SITGPESLLVYEFVPNQSLLD-NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
+ + VY V N D N V+ + LS E +I GL Y+H
Sbjct: 81 DVFTPATSIENFNEVY-LVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSA 137
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
IIHRD+K SN+ ++E+ +I DFGL R +++T A T Y APE ++
Sbjct: 138 G---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVA----TRWYRAPEIMLNW 190
Query: 448 -KLTEKADVYSFGVVVIEVV 466
+ D++S G ++ E++
Sbjct: 191 MHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 49/160 (30%), Positives = 71/160 (44%), Gaps = 14/160 (8%)
Query: 311 HFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEV 369
H E N L+ + H LV L T + V +FV L +L R+ P E
Sbjct: 41 HIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHL-QRERSFP---EP 96
Query: 370 RYKI-ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH- 427
R + A L YLH + I++RD+K NILLD + + DFGL + E I
Sbjct: 97 RARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQS 150
Query: 428 -ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+ T GT Y+APE + + D + G V+ E++
Sbjct: 151 DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 41/133 (30%), Positives = 64/133 (48%), Gaps = 19/133 (14%)
Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYLHEESKLRIIHRDIK 398
+V E++P L+ NL D+ P W Y TAE L +H + IHRD+K
Sbjct: 120 MVMEYMPGGDLV-NLMSNYDI-PEKWARFY-----TAEVVLALDAIH---SMGFIHRDVK 169
Query: 399 LSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYV----VRGKLTEKA 453
N+LLD+ K+ADFG +++ + T GT Y++PE + G +
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMDANGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGREC 228
Query: 454 DVYSFGVVVIEVV 466
D +S GV + E++
Sbjct: 229 DWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 46/200 (23%)
Query: 293 GEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES-------LL 342
E VA+K++ F N E+ L+ ++H+N++ + I P +
Sbjct: 30 NEKVAIKKIANAFDNRID-AKRTLREIKLLRHLDHENVIAIK--DIMPPPHREAFNDVYI 86
Query: 343 VYEFV---------PNQSLLDN---LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
VYE + +Q+L D+ F+ Q +L GL Y+H +
Sbjct: 87 VYELMDTDLHQIIRSSQTLSDDHCQYFLYQ-------------LL---RGLKYIHSAN-- 128
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR-GKL 449
++HRD+K SN+LL+ KI DFGL R E ++ + T Y APE ++ +
Sbjct: 129 -VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLLNCSEY 186
Query: 450 TEKADVYSFGVVVIEVVCRK 469
T DV+S G + E++ RK
Sbjct: 187 TTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 275 NKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLG 332
+KLG+G +VYKG + VA+K + + EV+L+ + H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 333 CSITGPESLLVYEFVPN---QSLLD--NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
T LV+E++ Q L D N +V+ +++ GL Y H
Sbjct: 72 IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQL--------LRGLNYCHRR 123
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI-THISATLAGTLGYMAPEYVV- 445
+++HRD+K N+L++E K+ADFGL R + I T + TL Y P+ ++
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLG 178
Query: 446 RGKLTEKADVYSFGVVVIEVV 466
+ + D++ G + E+
Sbjct: 179 STDYSTQIDMWGVGCIFYEMS 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS-ATLAGTL 436
A G+ +L ++ +HRD+ N+L+ E KI DFGL R D +IS + L
Sbjct: 249 ANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
+MAPE + T +DV+SFG+++ E+
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 4/118 (3%)
Query: 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
N S + NL E L+ A G+ +L ++ +HRD+ N+LL +
Sbjct: 218 NDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGK 274
Query: 409 TAKIADFGLVRLFPEDITHIS-ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
KI DFGL R D ++S + + +MAPE + T +DV+S+G+++ E+
Sbjct: 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 36/157 (22%), Positives = 61/157 (38%), Gaps = 17/157 (10%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV--KLLGC 333
L G + VY + V +K + + EV ++ + K L K+L
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LK--INPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
+ S L+ E++ ++L + +S E + I AE LA LH+ L +
Sbjct: 62 GESDGWSYLLMEWIEGETL----------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPE--DITHI 428
H D+ NIL+D+ I D+ P D+
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGPPAFDLAAA 148
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
AE + +H +L +HRDIK N+LLD ++ADFG +D T S+ GT
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD 168
Query: 438 YMAPEYVV-----RGKLTEKADVYSFGVVVIEVV 466
Y++PE + GK + D +S GV + E++
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 46/223 (20%)
Query: 276 KLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWV---DHFFNEVNLISGINHKNLVKLL 331
+G+GG G VY P VA+K++ + ++ F E + + + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 332 G-CSITGPESLLVYEFVPN------QSLLDNLFVRQDVEPLSWEVRYK--------IILS 376
CS + VY +P +SLL + V Q E LS E+ K I
Sbjct: 69 SICS----DGDPVYYTMPYIEGYTLKSLLKS--VWQK-ESLSKELAEKTSVGAFLSIFHK 121
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL-------------VRLFPE 423
+ Y+H + ++HRD+K NILL I D+G + +
Sbjct: 122 ICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 424 DITHISAT----LAGTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
+I + S T + GT YMAPE ++ +E D+Y+ GV++
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVIL 221
|
Length = 932 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 31/91 (34%), Positives = 52/91 (57%), Gaps = 8/91 (8%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI---SATLAG 434
A+G+++L ++ IHRD+ NILL KI DFGL R D ++ +A L
Sbjct: 224 AKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP- 279
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
+ +MAPE + T ++DV+S+G+++ E+
Sbjct: 280 -VKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 11/159 (6%)
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
F+ E ++++ N +V+L +V E++P L+ NL DV P W Y
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDV-PEKWARFY 147
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
TAE + L + IHRD+K N+LLD+ K+ADFG ++ T
Sbjct: 148 -----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202
Query: 432 LAGTLGYMAPEYVVR----GKLTEKADVYSFGVVVIEVV 466
GT Y++PE + G + D +S GV + E++
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
AE + + +L +HRDIK NIL+D ++ADFG ED T S+ GT
Sbjct: 109 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 168
Query: 438 YMAPEYVV-----RGKLTEKADVYSFGVVVIEVV 466
Y++PE + +GK + D +S GV + E++
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 21/143 (14%)
Query: 342 LVYEFVPNQSLLDNLFVRQDVEP----LSWEVRYKIILST-------AEGLAYLHEESKL 390
L Y F DNL++ + +P LS RY+ AE + +H ++
Sbjct: 66 LQYAFQDK----DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV----- 445
+HRDIK N+L+D K+ADFG + S GT Y+APE +
Sbjct: 122 GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGD 181
Query: 446 -RGKLTEKADVYSFGVVVIEVVC 467
+G + D +S GV+ E++
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMIY 204
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 41/211 (19%)
Query: 275 NKLGQGGSGSVYKG-TLPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGIN-HKNLVKL 330
K+G+G V K + G+ A+K + + + + V++ E+ + ++ H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRL 63
Query: 331 LGC---SITGPESL-LVYEFVPNQSLLD-NLF--VRQDVEPLSWEVRYK-IILSTAEGLA 382
+ TG L LV+E L+D NL+ ++ PL E R K + + L
Sbjct: 64 IEVLFDRKTG--RLALVFE------LMDMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLD 114
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL------FPEDITHISATLAGTL 436
++H I HRDIK NIL+ ++ K+ADFG R + E +IS T
Sbjct: 115 HMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE---YIS-----TR 162
Query: 437 GYMAPEYVVR-GKLTEKADVYSFGVVVIEVV 466
Y APE ++ G K D+++ G V E++
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 41/159 (25%), Positives = 68/159 (42%), Gaps = 40/159 (25%)
Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401
L+ EF+P ++ L +++D L+ E I T + +H+ L IHRDIK N
Sbjct: 78 LIMEFLPGGDMM-TLLMKKDT--LTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDN 131
Query: 402 ILLDEEFTAKIADFGLV----------------RLFPEDIT------------------H 427
+LLD + K++DFGL P D T
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
++ + GT Y+APE ++ + D +S GV++ E++
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 42/195 (21%), Positives = 89/195 (45%), Gaps = 19/195 (9%)
Query: 284 SVYKGTLPGGEAVAVKRL--FYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340
S+YKG + V ++ F+ + +D NE+ + I+ N++K+ G I +
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 341 L----LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRD 396
L L+ E+ L + L +D LS++ + + + +GL L++ + +++
Sbjct: 94 LPRLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKN 148
Query: 397 IKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV--VRGKLTEKAD 454
+ + L+ E + KI GL ++ ++ + Y + + + + + T K D
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKI----LSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDD 204
Query: 455 VYSFGVVVIEVVCRK 469
+YS GVV+ E+ K
Sbjct: 205 IYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 40/159 (25%)
Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401
L+ EF+P ++ L +++D LS E I T + +H+ L IHRDIK N
Sbjct: 78 LIMEFLPGGDMM-TLLMKKDT--LSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDN 131
Query: 402 ILLDEEFTAKIADFGLV--------RLFPEDITH-------------------------- 427
+LLD + K++DFGL F ++TH
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
++ + GT Y+APE ++ + D +S GV++ E++
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 40/166 (24%), Positives = 66/166 (39%), Gaps = 48/166 (28%)
Query: 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI 402
V +++P ++ +L +R + Y I + +H K+ IHRDIK NI
Sbjct: 79 VMDYIPGGDMM-SLLIRLGIFEEDLARFY--IAELTCAIESVH---KMGFIHRDIKPDNI 132
Query: 403 LLDEEFTAKIADFGLVRLF----------------------PEDITHISA---------- 430
L+D + K+ DFGL F E+ + I
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRR 192
Query: 431 ----------TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+L GT Y+APE ++R T+ D +S GV++ E++
Sbjct: 193 KRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 55/215 (25%)
Query: 299 KRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLF 357
K+ N Q V H E ++++ +++ +VKL S ++L V +++P ++ +L
Sbjct: 36 KKDVLNRNQ-VAHVKAERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMM-SLL 92
Query: 358 VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
+R +V P Y L+ A + K+ IHRDIK NIL+D + K+ DFGL
Sbjct: 93 IRMEVFPEVLARFYIAELTLA-----IESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGL 147
Query: 418 VRLF---------------------PEDI----------------------TH---ISAT 431
F P D+ H ++ +
Sbjct: 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHS 207
Query: 432 LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
L GT Y+APE ++R T+ D +S GV++ E++
Sbjct: 208 LVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 5/93 (5%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
AE + + +L +HRDIK N+LLD+ ++ADFG D T S GT
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD 168
Query: 438 YMAPEYVV-----RGKLTEKADVYSFGVVVIEV 465
Y++PE + +G+ + D +S GV + E+
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 50/206 (24%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 276 KLGQGGSGSVYKGTL---PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLL 331
++G G G V + G V VK L N +++ + F + + + H N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 332 GCSITGPESLLVYEFVPNQSLLDNL----FVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
G + LLV+E+ L L + R++ + L + ++ A G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMH-- 116
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYV-- 444
K +H D+ L N L + T K+ D+G+ + ED L ++APE V
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175
Query: 445 VRGKL-----TEKADVYSFGVVVIEV 465
G L T+ ++V++ GV + E+
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 9e-06
Identities = 54/217 (24%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGE---AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
+E K+G+G G VYK G+ A+K++ T E+ L+ + H N++
Sbjct: 4 YEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVI 61
Query: 329 KL--LGCSITGPESLLVYEFVPNQSLLDNLFVRQ---DVEP--LSWEVRYKIILSTAEGL 381
L + S + + L++++ + F R + +P L + ++ +G+
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 382 AYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPEDITHIS--ATLAGT 435
YLH ++HRD+K +NIL+ E KIAD G RLF + ++ + T
Sbjct: 122 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 436 LGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVVCRKRI 471
Y APE ++ + KA D+++ G + E++ + I
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 49/225 (21%)
Query: 277 LGQGGSGSVYKGTL---PGGEAVAVKRLFYNTTQWVDH---------------------- 311
LGQG ++Y G L GGE + + ++
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVE--PLSWEV 369
FF +L+S ++H +L + G + G E+++V EFV + L ++ +R++ P++W++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL--DVCLRKEKGRVPVAWKI 120
Query: 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD----EEFTA---KIADFGLVRLFP 422
L++A L+YL +++ ++H ++ NILL E T+ K++D G+
Sbjct: 121 TVAQQLASA--LSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV----- 170
Query: 423 EDITHIS-ATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEV 465
T +S + ++APE V G L+ AD +SFG ++E+
Sbjct: 171 -SFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 34/94 (36%), Positives = 46/94 (48%), Gaps = 7/94 (7%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL-FPEDITHISAT-LAGTLG 437
L Y+H + + HRD+K NIL + + KI DFGL R+ F + T I T T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 438 YMAPEYV--VRGKLTEKADVYSFGVVVIEVVCRK 469
Y APE K T D++S G + EV+ K
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 41/171 (23%), Positives = 67/171 (39%), Gaps = 52/171 (30%)
Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401
V +++P ++ +L +R + P Y AE + K+ IHRDIK N
Sbjct: 78 FVMDYIPGGDMM-SLLIRMGIFPEDLARFY-----IAELTCAVESVHKMGFIHRDIKPDN 131
Query: 402 ILLDEEFTAKIADFGLV---------------------------------------RLFP 422
IL+D + K+ DFGL RL P
Sbjct: 132 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKP 191
Query: 423 -------EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+ ++ +L GT Y+APE ++R T+ D +S GV++ E++
Sbjct: 192 LERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA---VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
+E K+G+G G VYK G+ A+K++ T E+ L+ + H N++
Sbjct: 4 YEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVI 61
Query: 329 KLLGCSITGPES--LLVYEFVPNQSLLDNLFVRQ---DVEP--LSWEVRYKIILSTAEGL 381
L ++ + L++++ + F R + +P L + ++ +G+
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 382 AYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPEDITHIS--ATLAGT 435
YLH ++HRD+K +NIL+ E KIAD G RLF + ++ + T
Sbjct: 122 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 436 LGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVVCRKRI 471
Y APE ++ + KA D+++ G + E++ + I
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 49/192 (25%), Positives = 82/192 (42%), Gaps = 18/192 (9%)
Query: 277 LGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
L G G V++ + P + V VK +Y ++ +E L+ ++H ++ LL +
Sbjct: 177 LTPGSEGCVFESSHPDYPQRVVVKAGWYASSV------HEARLLRRLSHPAVLALLDVRV 230
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
G + LV +P ++ + PL + + Y+H E IIHR
Sbjct: 231 VGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHR 284
Query: 396 DIKLSNILLDEEFTAKIADFG---LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
DIK N+L++ + DFG R H +AGT+ APE + T
Sbjct: 285 DIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG--IAGTVDTNAPEVLAGDPYTPS 342
Query: 453 ADVYSFGVVVIE 464
D++S G+V+ E
Sbjct: 343 VDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 35/114 (30%), Positives = 47/114 (41%), Gaps = 19/114 (16%)
Query: 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410
SL D L VR PL+ E + + L L LH ++K NILL +
Sbjct: 2 SLADILEVRG--RPLNEEEIWAVCLQCLGALRELHRQAKSG---------NILLTWDGLL 50
Query: 411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
K+ G V F +MAPE + TEKAD+YS G+ + E
Sbjct: 51 KL--DGSV-AFKTPEQSRPDPY-----FMAPEVIQGQSYTEKADIYSLGITLYE 96
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 41/173 (23%), Positives = 69/173 (39%), Gaps = 54/173 (31%)
Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEV-RYKIILSTAEGLAYLHEESKLRIIHRDIKLS 400
L+ EF+P L+ + ++ D S +V R+ + AE + + KL IHRDIK
Sbjct: 78 LIMEFLPGGDLM-TMLIKYDT--FSEDVTRFYM----AECVLAIEAVHKLGFIHRDIKPD 130
Query: 401 NILLDEEFTAKIADFGL-------------VRLFPED-------------ITHISATLA- 433
NIL+D K++DFGL +L + I+ T++
Sbjct: 131 NILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSS 190
Query: 434 -------------------GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
GT Y+APE ++ ++ D +S G ++ E +
Sbjct: 191 KDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 41/173 (23%), Positives = 73/173 (42%), Gaps = 26/173 (15%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN---QSLLDNLFVRQDVEPL 365
+ F E ++++ + +V + T +V E+V +LL N + L
Sbjct: 45 IQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN------IGAL 98
Query: 366 SWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
++ T L YLH I+HRD+K N+L+ K+ DFGL ++ +
Sbjct: 99 PVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155
Query: 426 T------HISA--------TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
T HI + GT Y+APE ++R + D ++ G+++ E
Sbjct: 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 22/53 (41%), Positives = 29/53 (54%), Gaps = 3/53 (5%)
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420
E+ K I A L YLH IIHRD+K N+L+ E K+ DFGL ++
Sbjct: 104 EMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 24/82 (29%), Positives = 38/82 (46%)
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
+H K I+HRDIK N+L+ K+ DFG R E T Y +PE
Sbjct: 113 IHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL 172
Query: 444 VVRGKLTEKADVYSFGVVVIEV 465
++ + D++S G ++ E+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 34/210 (16%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
N +G G G VY+ + E VA+K++ + Q+ + E+ ++ +NH N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNR---ELLIMKNLNHINIIFLKDY 127
Query: 334 SITGPESL----------LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
T E +V EF+P + + PL Y L A L
Sbjct: 128 YYT--ECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA--L 183
Query: 382 AYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLF---PEDITHISATLAGTLG 437
AY+H SK I HRD+K N+L+D T K+ DFG + +++I +
Sbjct: 184 AYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF----- 235
Query: 438 YMAPEYVVRG-KLTEKADVYSFGVVVIEVV 466
Y APE ++ T D++S G ++ E++
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 44/177 (24%), Positives = 67/177 (37%), Gaps = 48/177 (27%)
Query: 275 NKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTTQW--VDHFFNE----------VN 317
KLG+G G VYK +L +K+ T++ V+ + NE +
Sbjct: 138 KKLGEGAFGVVYKASLVNKQSKKEGKYVLKK----ATEYGAVEIWMNERVRRACPNSCAD 193
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ---DVEP-LSWEV---- 369
+ G K E LV+ + +L D + ++ +VEP L +V
Sbjct: 194 FVYGFLEPVSSK------KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 370 ----RYKIILSTA-----EGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFG 416
R I+ T L LH I+HRD+K NI+ E + KI D G
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLG 301
|
Length = 566 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.001
Identities = 65/236 (27%), Positives = 96/236 (40%), Gaps = 52/236 (22%)
Query: 271 FHESNKLGQGGSGSVY----KGTLPGGEAVAVKRLFYNTTQW---VDHFFNEVNLISGIN 323
F + LG+G G V+ KGT G+ A+K L V E +++ ++
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEV-RYKIILSTAE--- 379
H L L T LV ++ P L L RQ + LS EV R+ AE
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFR-LLQRQPGKCLSEEVARFYA----AEVLL 114
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL---------------------- 417
L YLH L I++RD+K NILL E ++DF L
Sbjct: 115 ALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 418 ------VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVV 466
F E+ + S + GT Y+APE V+ G A D ++ G+++ E++
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 47/195 (24%), Positives = 81/195 (41%), Gaps = 38/195 (19%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLL--VYEFVPNQSLLDNLFVRQDVEPLSWEVRYK 372
EVN++ + HKN+V+ + + L + EF L N+ Q + ++
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI---QKCYKMFGKIEEH 118
Query: 373 IILSTAE----GLAYLHE----ESKLRIIHRDIKLSNILLDEEF---------------- 408
I+ LAY H + R++HRD+K NI L
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178
Query: 409 -TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEV 465
AKI DFGL + I ++ + GT Y +PE ++ +K+D+++ G ++ E+
Sbjct: 179 PIAKIGDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
Query: 466 VCRK----RINLFTQ 476
K + N F+Q
Sbjct: 237 CSGKTPFHKANNFSQ 251
|
Length = 1021 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 492 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.98 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.98 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.83 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.32 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.17 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.11 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.0 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.99 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.9 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.78 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.77 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.63 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.63 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.6 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.43 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.37 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.35 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.3 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.24 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.21 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.19 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.16 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.12 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.03 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.0 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.9 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.9 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.87 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.78 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.73 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.72 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.49 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.44 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.44 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.43 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.32 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.2 | |
| PLN02236 | 344 | choline kinase | 97.18 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.16 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.08 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.06 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.98 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.85 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.67 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.3 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.18 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.97 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.93 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.92 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.82 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.8 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.76 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.52 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.44 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.33 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.31 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.13 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.0 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-50 Score=394.35 Aligned_cols=236 Identities=53% Similarity=0.803 Sum_probs=207.4
Q ss_pred CccccCHHHHHHHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeee
Q 011153 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334 (492)
Q Consensus 255 ~~~~~~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 334 (492)
....|++.++..+|++|...++||+|+||.||+|.++++..||||++.....+...+|.+|++++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 44568999999999999999999999999999999999999999988765543145599999999999999999999999
Q ss_pred ecCCc-ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEe
Q 011153 335 ITGPE-SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413 (492)
Q Consensus 335 ~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 413 (492)
.+.+. .+||||||++|+|.++|+..... +++|.++++|+.++|+||+|||+...++||||||||+|||+|+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99995 99999999999999999876554 89999999999999999999999988899999999999999999999999
Q ss_pred ecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--CCcHHHHHHhhhcC
Q 011153 414 DFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN--SCSILQTVILLTWN 491 (492)
Q Consensus 414 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~--~~~~~~~~~~~~~~ 491 (492)
|||+++..............||.+|+|||++..+..+.|+|||||||+|+||+||+++.+...+ ...+++|+|+.+-+
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 9999976554111111111799999999999999999999999999999999999999887652 23799999877543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=350.83 Aligned_cols=200 Identities=31% Similarity=0.486 Sum_probs=181.4
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.+|...+.||+|+|++||+|++. ++..||||.+... ..+..+.+..|+.+|++++|||||++++++..++..+||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 56888889999999999999864 5889999999766 66677888999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC------CcEEEeecCCcc
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE------FTAKIADFGLVR 419 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~------~~~kl~Dfgl~~ 419 (492)
||.+|+|.++++.++ .+++.+...++.||+.||++||+++ ||||||||+||||+.+ -.+||+|||+++
T Consensus 90 yC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999996543 5899999999999999999999998 9999999999999765 468999999999
Q ss_pred ccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.+.. .....+.+|++-|||||++..++|+.|+|+||+|++|||+++|+.||....
T Consensus 164 ~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 164 FLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 8764 334568899999999999999999999999999999999999999998543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=344.01 Aligned_cols=202 Identities=38% Similarity=0.517 Sum_probs=176.7
Q ss_pred ccCCcccccCcccEEEEEecCCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCC-cceeEEeecC
Q 011153 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-ESLLVYEFVP 348 (492)
Q Consensus 272 ~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~ 348 (492)
...+.||+|+||+||+|.+.....||||++.... ....+.|.+|+.+|.+++|||||+++|++.+.. ...+||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3455699999999999999866669999997643 222668999999999999999999999999988 7899999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-cEEEeecCCccccCCCCcc
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~~ 427 (492)
+|+|.++++.. ....+++..+++++.|||+||.|||+++. ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 99999999765 45679999999999999999999999863 99999999999999997 99999999998655432 2
Q ss_pred ccccccccccccchhhhc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVV--RGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
..+...||+.|||||++. ..+|+.|+|||||||+||||+||+.||.....
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 223468999999999999 66999999999999999999999999987664
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=330.80 Aligned_cols=202 Identities=29% Similarity=0.368 Sum_probs=180.8
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.++|++.++||+|+||+||.++. ++++.+|+|++++. .....+...+|..+|.+++||+||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46799999999999999999985 45888999999764 334567889999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
+||+.||.|..+|. +.+.+++....-++.+|+.||.|||+.+ ||||||||+|||+|++|+++|+||||++..-.
T Consensus 104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999984 3456888989999999999999999998 99999999999999999999999999985443
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.. ....+.+||+.|||||++.+..++..+|.||||+++|||++|++||...+
T Consensus 178 ~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 178 DG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred CC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 32 22345799999999999999999999999999999999999999998754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=324.45 Aligned_cols=196 Identities=30% Similarity=0.446 Sum_probs=176.4
Q ss_pred cccCCcccccCcccEEEEEec-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc-ceeEEeec
Q 011153 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE-SLLVYEFV 347 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~~ 347 (492)
++..+.||+|..|+|||+.++ +++.+|+|.+..+ ++...+++.+|++++++.+||+||+++|.|..+.. ..++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 445788999999999999875 6888999999655 44556789999999999999999999999999885 99999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
.+|||+..+.. .+.+++..+-+|+.+|++||.|||+ .+ ||||||||+||||+..|++||+|||.++.+-..
T Consensus 161 DgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 161 DGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999998843 3568999999999999999999996 55 999999999999999999999999999876544
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
...+.+||..|||||-+.+..|+.++||||||+.++|+.+|+.|+...
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 456789999999999999999999999999999999999999998875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=340.41 Aligned_cols=199 Identities=34% Similarity=0.513 Sum_probs=178.1
Q ss_pred cccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecC
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (492)
+.+...+.||+|-||.||.|.++....||+|.++... ...+.|.+|+++|++|+|+|||+++++|..+..++||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 3455678899999999999999988899999997653 335678999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 428 (492)
.|+|.++|.. .....+...+++.++.|||+||+||++++ +|||||.++||||+++..+||+||||++...++....
T Consensus 285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999999965 34566899999999999999999999998 9999999999999999999999999999777766655
Q ss_pred cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 011153 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRIN 472 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~ 472 (492)
.....-++.|.|||.+..+.|+.|||||||||+||||+|-.+.+
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~p 404 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVP 404 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCC
Confidence 55555688999999999999999999999999999999975554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=317.95 Aligned_cols=205 Identities=26% Similarity=0.391 Sum_probs=180.8
Q ss_pred cccccCCcccccCcccEEEEE-ecCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeee-eeecCCc-ceeE
Q 011153 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLG-CSITGPE-SLLV 343 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv 343 (492)
.+|++.++||+|.||+|||+. +.+|..+|.|.++.. +.+..+....|+.+|++|+|||||++++ .+.++.+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457889999999999999997 678999999998754 4566778999999999999999999999 5556666 7899
Q ss_pred EeecCCCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 344 YEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLR--IIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
||++..|+|.+.+..- +....+++..+++++.|++.||..+|+.- ++ |+||||||.||+|+.+|.+||+||||++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999988643 34567999999999999999999999843 33 99999999999999999999999999998
Q ss_pred cCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
+.... ......+|||.||+||.+.+.+|+.||||||+||+++||..-+.||-..
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 87654 3345789999999999999999999999999999999999999999754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=336.72 Aligned_cols=200 Identities=29% Similarity=0.439 Sum_probs=183.0
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
.+|...+.||+|+|.++|+++. ..|+.||+|++.+. .....+...+||++-++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5689999999999999999997 78999999999653 4556778999999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
|+|++++|..++. ..+++++.+++.++.||+.||.|||+++ |+|||||..|+|+++++++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999998884 4456999999999999999999999998 999999999999999999999999999887654
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ....+.+|||.|+|||++.+...+..+||||+|||+|-||.|++||...
T Consensus 172 ~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 172 G-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred c-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 2 2345789999999999999999999999999999999999999999865
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=323.09 Aligned_cols=210 Identities=28% Similarity=0.400 Sum_probs=176.7
Q ss_pred HhcccccCCcccccCcccEEEEE-ecCCCEEEEEEeccCChh-----h--HHHHHHHHHHHhccCcCceeeeeeeeecCC
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQ-----W--VDHFFNEVNLISGINHKNLVKLLGCSITGP 338 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~~~~~-----~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 338 (492)
..+.|.+.+.||+|+||.|-+|. ..+|+.||||++++.... . .....+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45668889999999999999997 467999999999754211 1 122469999999999999999999999999
Q ss_pred cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC---CcEEEeec
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADF 415 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Df 415 (492)
..||||||+++|+|.+.+... +.+.+..-..++.|++.|+.|||+.| |+||||||+|||++.+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999988543 34566667889999999999999998 9999999999999766 78999999
Q ss_pred CCccccCCCCccccccccccccccchhhhccCCC---CcchhHHHHHHHHHHHHhCCCCCCCCCCCCcHHHH
Q 011153 416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL---TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQT 484 (492)
Q Consensus 416 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDv~slGvll~elltg~~p~~~~~~~~~~~~~ 484 (492)
|+|+.... .....+.+|||.|.|||++.++.. ..++|+||+||+|+-+++|-+||.....+..+.+.
T Consensus 324 GlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ 393 (475)
T KOG0615|consen 324 GLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ 393 (475)
T ss_pred chhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH
Confidence 99998763 345668999999999999987543 34789999999999999999999986655434333
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=325.59 Aligned_cols=205 Identities=28% Similarity=0.403 Sum_probs=179.8
Q ss_pred cccccCCcccccCcccEEEEE-ecCCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecC--CcceeE
Q 011153 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLV 343 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 343 (492)
+.|+.+++||+|.||.||+++ ..+|+.||+|+++.+. ........+||.+|++|+||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457778899999999999998 5679999999997654 55567788999999999999999999998876 688999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
+|||+. +|.-++.. ..-.|+..++.-++.|++.||+|+|+++ |.|||||.+|||||++|.+||+|||||+++..
T Consensus 197 FeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999965 77666632 3445899999999999999999999998 99999999999999999999999999998887
Q ss_pred CCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
......+..+-|+.|.|||++.+ ..|+..+|+||.||||.||+.|++++....+-+
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve 327 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE 327 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH
Confidence 76665667778999999999987 469999999999999999999999988765543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=346.87 Aligned_cols=218 Identities=28% Similarity=0.457 Sum_probs=184.1
Q ss_pred HHHhcccccCCcccccCcccEEEEEec------CCCEEEEEEeccCChh-hHHHHHHHHHHHhccCcCceeeeeeeeecC
Q 011153 265 EKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITG 337 (492)
Q Consensus 265 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 337 (492)
+..+.+.+..+.||+|+||+||+|+.. +.+.||||.++..... ..++|.+|+++|..++|||||+|+|.|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344555677889999999999999853 3457999999887655 788999999999999999999999999999
Q ss_pred CcceeEEeecCCCCchhhhhccC-------C----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQ-------D----VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~-------~----~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~ 406 (492)
+..++|+|||..|+|.++|.... . ..+++..+.+.|+.|||.||+||-++. +|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence 99999999999999999996432 1 234899999999999999999999988 999999999999999
Q ss_pred CCcEEEeecCCcccc-CCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcHHHHH
Q 011153 407 EFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485 (492)
Q Consensus 407 ~~~~kl~Dfgl~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~~~~~~~~ 485 (492)
+..|||+||||++.. +.++.+......-+++|||||.|+.++|+.+||||||||+||||+|-.+-+.+...++++++.+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 999999999999844 4555554445566899999999999999999999999999999998655444444444444443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=302.92 Aligned_cols=199 Identities=29% Similarity=0.370 Sum_probs=181.2
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|+..+.||.|+||+|..++.+ +|..+|+|++.+.. -...+...+|..+|+.+.||+++++.+.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45778999999999999999865 58899999997653 345667889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++|.|.+++ ++.+++++...+-++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||+++.....
T Consensus 124 eyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999 44566899999999999999999999998 999999999999999999999999999977654
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
..+.+|||.|+|||.+....++..+|.|||||++|||+.|.+||...+.
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 3478999999999999999999999999999999999999999987765
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=302.05 Aligned_cols=204 Identities=24% Similarity=0.354 Sum_probs=175.4
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
+.|+.+.++|+|+||.|||.+.+ +|+.||||++.+.. +...+-.++|+++|++++|||+|.|+++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46788889999999999999965 59999999996543 3334557899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|++..-|.+ |. .....++.+.+.+++.|++.|+.|+|+++ +|||||||+||||+.++.+||+|||+|+.+..+
T Consensus 82 ~~dhTvL~e-Le--~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHE-LE--RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHH-HH--hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 997754543 32 23345888999999999999999999998 999999999999999999999999999988642
Q ss_pred ccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
+..-+..+.|..|.|||.+.+ .+|+..+||||+||++.||++|.+.|....+-+
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD 209 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID 209 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH
Confidence 233456678999999999887 789999999999999999999999887765544
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=291.03 Aligned_cols=203 Identities=28% Similarity=0.396 Sum_probs=175.3
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChh--hHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.+|...++||+|.||.||+|+. .+|+.||||+++..... ......+|++.|++++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4577788999999999999984 57999999999765322 24467899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
||+ .+|...+. .+...++...+..++.++++||+|||++. |+||||||.|+||+++|.+||+|||+++.+....
T Consensus 82 fm~-tdLe~vIk--d~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIK--DKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhc--ccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 996 58888874 34567899999999999999999999999 9999999999999999999999999999887654
Q ss_pred ccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
... +..+-|..|.|||.+.+ ..|+..+||||.|||+.||+-|.+.+.-..+-
T Consensus 156 ~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi 208 (318)
T KOG0659|consen 156 RIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI 208 (318)
T ss_pred ccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH
Confidence 332 23367999999999987 56999999999999999999998777655443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=320.86 Aligned_cols=200 Identities=31% Similarity=0.487 Sum_probs=182.9
Q ss_pred hcccccCCcccccCcccEEEEE-ecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
...|...++||+|+.|.||.+. ..+++.||||++........+.+++|+.+|+..+|+|||++++.+..++++++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 4567888999999999999997 457889999999887777778899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
|++|+|.+.+ ....+++.++..|.++++.||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999887 3334899999999999999999999998 99999999999999999999999999988766544
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
...+++|||.|||||++....|+.|+||||||+|++||+-|++|+.+.
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE 472 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE 472 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC
Confidence 345789999999999999999999999999999999999999999863
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=308.71 Aligned_cols=196 Identities=37% Similarity=0.515 Sum_probs=163.6
Q ss_pred cccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhc--cCcCceeeeeeeeecCC----ccee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG--INHKNLVKLLGCSITGP----ESLL 342 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~l 342 (492)
...+..++||+|.||.||||.+.+ +.||||++.. +..+.|.+|-++.+. ++|+||+++++.-...+ +.+|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhccC-ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 335567889999999999999874 9999999954 345577777777654 58999999999877655 7899
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc------CCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE------SKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~------~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 416 (492)
|+||.+.|+|.++| +...++|....+|+..+++||+|||+. .+++|+|||||++||||.+|++..|+|||
T Consensus 286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999 345689999999999999999999975 36899999999999999999999999999
Q ss_pred CccccCCCCcc-ccccccccccccchhhhccCC-CC-----cchhHHHHHHHHHHHHhCCCCC
Q 011153 417 LVRLFPEDITH-ISATLAGTLGYMAPEYVVRGK-LT-----EKADVYSFGVVVIEVVCRKRIN 472 (492)
Q Consensus 417 l~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDv~slGvll~elltg~~p~ 472 (492)
|+..+...... .....+||.+|||||++.+.. +. .+.||||+|.+||||+++-.-+
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 99887644322 222468999999999987643 22 3689999999999999986544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=334.34 Aligned_cols=215 Identities=27% Similarity=0.439 Sum_probs=183.0
Q ss_pred cCHHHHHHHhcc---------cccCCcccccCcccEEEEEecC----CCEEEEEEeccC-ChhhHHHHHHHHHHHhccCc
Q 011153 259 FSYETLEKATNY---------FHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINH 324 (492)
Q Consensus 259 ~~~~~l~~~~~~---------~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h 324 (492)
++||+...+-+. ..+.++||.|.||.|++|+++- ...||||.++.. .+.....|+.|+.+|.+++|
T Consensus 610 ~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH 689 (996)
T KOG0196|consen 610 HTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 689 (996)
T ss_pred ccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC
Confidence 456655444433 4567899999999999998752 346999999876 44567789999999999999
Q ss_pred CceeeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 011153 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL 404 (492)
Q Consensus 325 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill 404 (492)
|||++|.|+........+|+|||++|+|+.+|.. +.+.+++.++..++++|+.||.||.+.+ +|||||.++||||
T Consensus 690 PNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILV 764 (996)
T KOG0196|consen 690 PNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILV 764 (996)
T ss_pred CcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheee
Confidence 9999999999999999999999999999999954 3356999999999999999999999988 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCccccccccc--cccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 011153 405 DEEFTAKIADFGLVRLFPEDITHISATLAG--TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNS 478 (492)
Q Consensus 405 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~~~~ 478 (492)
+.+..+|++||||++.+.++.....++..| +++|.|||.|...+++..||||||||++||.++ |++|.+...+.
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ 841 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 841 (996)
T ss_pred ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH
Confidence 999999999999999887665333333323 679999999999999999999999999999775 88998765543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=314.55 Aligned_cols=213 Identities=23% Similarity=0.318 Sum_probs=183.4
Q ss_pred HhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
..++|+.+++||+|+||.||.++. .+|+.+|+|++++. ....++....|-.+|...++|+||+|+..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 346799999999999999999985 56999999999875 34556778899999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
||||+|||++..+|. +...+++......+.+++.|++-||+.| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999984 4456889999999999999999999998 9999999999999999999999999985321
Q ss_pred C-----------------------CCcc-----------------------ccccccccccccchhhhccCCCCcchhHH
Q 011153 423 E-----------------------DITH-----------------------ISATLAGTLGYMAPEYVVRGKLTEKADVY 456 (492)
Q Consensus 423 ~-----------------------~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~ 456 (492)
. +... .....+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 0000 01134699999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCC---cHHHHH
Q 011153 457 SFGVVVIEVVCRKRINLFTQNSC---SILQTV 485 (492)
Q Consensus 457 slGvll~elltg~~p~~~~~~~~---~~~~~~ 485 (492)
|||||++|||.|-+||......+ .++.|-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr 404 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWR 404 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999999999999877665 455543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=318.06 Aligned_cols=198 Identities=29% Similarity=0.422 Sum_probs=178.0
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+. ..+..+.+.+|++++++++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56788899999999999999854 6788999998654 34456779999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+.+ +|..++.. .+.++++.+..++.+++.||.|||++. |.|||+||+|||++.++.+|++|||+++.....
T Consensus 82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 9977 99999844 345899999999999999999999998 999999999999999999999999999976653
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
+...+.+.|||-|||||+..+++|+..+|+||+|||+||+++|++||-.
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 3455677899999999999999999999999999999999999999853
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=314.23 Aligned_cols=205 Identities=25% Similarity=0.362 Sum_probs=179.6
Q ss_pred HHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcc
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES 340 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 340 (492)
+...+|..++.||+|+|++|++++. ..++.+|||++.+. .+.-.+...+|-.+|.+| .||.|++|+..|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3456788899999999999999985 56899999998543 233345567888999999 899999999999999999
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
|+|+||.++|+|.+++. +.+.+++.....++.+|+.||+|||+.| ||||||||+|||+|.||++||+|||.|+.
T Consensus 150 YFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999994 4567899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCcc----------cc--ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 421 FPEDITH----------IS--ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 421 ~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
++..... .+ ...+||..|.+||++.++..+..+|+|+||||||+|+.|++||-..+
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 7543221 12 35789999999999999999999999999999999999999997654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=316.62 Aligned_cols=190 Identities=31% Similarity=0.476 Sum_probs=169.0
Q ss_pred ccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCC
Q 011153 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQS 351 (492)
Q Consensus 272 ~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 351 (492)
..++-||.|+.|.||+|++. ++.||||+++.-. ..+|+.|++|+||||+.+.|+|.....++||||||+.|-
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 44778999999999999987 6889999874322 357889999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccccc
Q 011153 352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431 (492)
Q Consensus 352 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 431 (492)
|.++|. ....++...+..+..+||.||.|||.+. |||||||+-||||+.+..+||+|||-++..++..+. -.
T Consensus 199 L~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk--MS 270 (904)
T KOG4721|consen 199 LYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK--MS 270 (904)
T ss_pred HHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhh--hh
Confidence 999994 3455788999999999999999999998 999999999999999999999999999877654222 25
Q ss_pred ccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 432 LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 432 ~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
.+||..|||||+|.+.+.+.|+|||||||+|||||||+.|+...+.
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds 316 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS 316 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch
Confidence 6899999999999999999999999999999999999999876443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=316.12 Aligned_cols=211 Identities=30% Similarity=0.478 Sum_probs=179.3
Q ss_pred CHHHHHHHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC
Q 011153 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG 337 (492)
Q Consensus 260 ~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 337 (492)
+.++++...+.+.+.+.||+|.||+||+|.+- ..||||++... +.+..+.|++|+.++++-+|.||+-+.|++..+
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34556666677788999999999999999975 35999999765 456788999999999999999999999999887
Q ss_pred CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCC
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl 417 (492)
+. .||+.++++.+|..+++..+ ..|+..+.+.|+.||++||.|||.++ |||||||+.||++.+++.|||+||||
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred ce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence 77 99999999999999997655 45899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCC-ccccccccccccccchhhhcc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 418 VRLFPEDI-THISATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 418 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
+..-..-. ........|...|||||+++. .+|+..+||||||+++|||++|..|+. .++.+
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~d 599 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRD 599 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChh
Confidence 86332111 111224567889999999975 468999999999999999999999998 44333
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=309.55 Aligned_cols=208 Identities=30% Similarity=0.448 Sum_probs=180.7
Q ss_pred HhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCCh-hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
+.....+.++||+|-||.|.......+.+||||+++.... .....|.+|+++|.+++||||++++|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 3445667899999999999999999889999999987654 445889999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc-CCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PED 424 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~-~~~ 424 (492)
||++|+|.+++....... .......+|+.||+.||+||.+.. +|||||.++|+|++.++++||+|||+++-+ ..+
T Consensus 616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999997653332 466677889999999999999987 999999999999999999999999999844 444
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHH--HhCCCCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV--VCRKRINLFTQNS 478 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~el--ltg~~p~~~~~~~ 478 (492)
..+.....+-+++|||||.+..++++.+||||+||+.+||+ ++.++|+....++
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e 747 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE 747 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence 44444466678999999999999999999999999999996 4678888765443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=301.53 Aligned_cols=202 Identities=32% Similarity=0.463 Sum_probs=172.5
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC--cceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP--ESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 345 (492)
.++...+.||+|+||.||++... +|...|||.+...+....+.+.+|+.+|.+++|||||+++|...... ...+.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 44677889999999999999865 48999999987664444777999999999999999999999755444 5889999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-CCcEEEeecCCccccCC-
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFPE- 423 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~~- 423 (492)
|+++|+|.+++..... .+++..+.++..||++||+|||+++ |||+||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999854432 6999999999999999999999998 999999999999999 79999999999987663
Q ss_pred -CCccccccccccccccchhhhccCC-CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 -DITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 -~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
..........||+.|||||++..+. ...++|||||||+++||+||++|+...
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 2222233578999999999998643 335999999999999999999998863
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=308.04 Aligned_cols=205 Identities=28% Similarity=0.380 Sum_probs=179.0
Q ss_pred HhcccccCCcccccCcccEEEEE-ecCCCEEEEEEeccCChhhHHH-HHHHHHHHhccC-cCceeeeeeeeecCC-ccee
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDH-FFNEVNLISGIN-HKNLVKLLGCSITGP-ESLL 342 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~~~~~~~~~-~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 342 (492)
..++|...++||.|.||.||+|+ ...++.||||+++..-..+.+- -+||+..|++|. |||||+|.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 45778899999999999999998 5578999999998765554433 469999999998 999999999999888 8999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
|||||+ .+|.+.+..+ ...+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+.+.
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999995 5888887554 678999999999999999999999999 9999999999999999999999999999776
Q ss_pred CCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
+..+ .+..+.|..|+|||++.. +-|+.+.|||++|||++||.+-++.|....+-+
T Consensus 162 SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D 217 (538)
T KOG0661|consen 162 SKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID 217 (538)
T ss_pred cCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH
Confidence 5443 345678999999998764 679999999999999999999999987765544
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=287.75 Aligned_cols=204 Identities=27% Similarity=0.395 Sum_probs=174.2
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChh--hHHHHHHHHHHHhccCcCceeeeeeeeecC--CcceeE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLV 343 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 343 (492)
+.|+..++|++|.||.||+|+.. +++.||+|+++.+... .--.-++||.+|.+++|||||.+..+.+.. +..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45778899999999999999964 6889999999765322 223568999999999999999999987743 468999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||++. +|..++... .+++...+..-++.|+++|++|||.++ |+|||||++|+|+++.|.+||+|||||+.+++
T Consensus 156 Me~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999964 888877543 357889999999999999999999999 99999999999999999999999999999887
Q ss_pred CCccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
.... .+..+-|..|.|||++.+. .|+...|+||+|||+.||+++++.|.-..+-+
T Consensus 230 p~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d 285 (419)
T KOG0663|consen 230 PLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID 285 (419)
T ss_pred Cccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH
Confidence 6433 3456779999999999875 58999999999999999999999987765543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=307.51 Aligned_cols=204 Identities=26% Similarity=0.398 Sum_probs=178.0
Q ss_pred HHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC----Ch-hhHHHHHHHHHHHhccC-cCceeeeeeeeecCC
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN----TT-QWVDHFFNEVNLISGIN-HKNLVKLLGCSITGP 338 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 338 (492)
....+|...+.||+|.||+|+.+.. .++..||+|.+... .. ...+.+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456789999999999999999974 56899999976543 12 23456678999999998 999999999999999
Q ss_pred cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-CcEEEeecCC
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGL 417 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgl 417 (492)
..++||||+.+|+|.+++.. .+++.+.....++.|++.|++|+|+++ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999954 455788999999999999999999998 9999999999999999 9999999999
Q ss_pred ccccCCCCccccccccccccccchhhhccCC-CC-cchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 418 VRLFPEDITHISATLAGTLGYMAPEYVVRGK-LT-EKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 418 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+.... .......+.+||+.|+|||++.+.. |+ .++||||+||+|+-|++|+.||....
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 98774 2223455789999999999999877 86 67999999999999999999999843
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=312.15 Aligned_cols=205 Identities=28% Similarity=0.370 Sum_probs=180.3
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcce
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 341 (492)
..++|...++||+|.||+|+++..+ +++.+|||.+++. ..+.++..+.|.+++... +||.|++|+.+|++.++++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3467889999999999999999975 5788999999876 456678888999988777 5999999999999999999
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
.||||+.||++..+. ....+++....-++..|+.||.|||+++ ||+||||.+|||+|.+|.+||+||||++.-
T Consensus 446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999954333 4456899999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
-.. .....+.+|||.|||||++.++.|+..+|.|||||+||||+.|+.||..+++++
T Consensus 519 m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee 575 (694)
T KOG0694|consen 519 MGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE 575 (694)
T ss_pred CCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 321 223457899999999999999999999999999999999999999999877664
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.79 Aligned_cols=204 Identities=33% Similarity=0.490 Sum_probs=175.5
Q ss_pred hcccccCCcccccCcccEEEEEecC--CC----EEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG--GE----AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~--~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (492)
....+..+.||+|.||.||.|...+ +. .||||.+.+. +.+...+|.+|..+|+.++|||||+++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3445667889999999999998643 33 4899999765 566778899999999999999999999999999999
Q ss_pred eeEEeecCCCCchhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 011153 341 LLVYEFVPNQSLLDNLFVRQD----VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 416 (492)
++++|||++|+|..+|...+. ...++...++.++.|||+|+.||++++ +|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999965421 456899999999999999999999998 9999999999999999999999999
Q ss_pred Ccc-ccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 417 LVR-LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 417 l~~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
||+ ++..++........-+.+|||||.+.++.|+.|+|||||||+||||+|...++-.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~ 906 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP 906 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC
Confidence 999 4444444444333457899999999999999999999999999999997755443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=294.25 Aligned_cols=207 Identities=29% Similarity=0.370 Sum_probs=179.3
Q ss_pred hcccccCCcccccCcccEEEEE-ecCCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
...|+..++||.|.-++||+|+ .+.++.||||++..+. ....+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4568899999999999999998 5778999999997653 3346889999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
||.+||+.+.+...-.. .+++..+..|+.++++||.|||++| .||||||+.||||+++|.|||+|||....+-+..
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999988654333 3899999999999999999999998 9999999999999999999999999876443322
Q ss_pred cc---ccccccccccccchhhhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 426 TH---ISATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 426 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
.+ ...+.+||+.|||||+++. ..|+.|+|||||||..+||.+|.-||....+-
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm 238 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM 238 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH
Confidence 11 1156789999999999765 45899999999999999999999999876543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=309.10 Aligned_cols=202 Identities=25% Similarity=0.323 Sum_probs=174.2
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|+..+.||+|+||+||++... +++.||||++.... ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888999999999999999854 58899999996532 233456888999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999998853 346899999999999999999999988 999999999999999999999999998754321
Q ss_pred Cc----------------------------------cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCC
Q 011153 425 IT----------------------------------HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470 (492)
Q Consensus 425 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~ 470 (492)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 00123579999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 011153 471 INLFTQ 476 (492)
Q Consensus 471 p~~~~~ 476 (492)
||....
T Consensus 235 Pf~~~~ 240 (363)
T cd05628 235 PFCSET 240 (363)
T ss_pred CCCCCC
Confidence 996543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=287.38 Aligned_cols=212 Identities=27% Similarity=0.401 Sum_probs=175.9
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChh--hHHHHHHHHHHHhccCcCc-eeeeeeeeecCC-----
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGINHKN-LVKLLGCSITGP----- 338 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 338 (492)
...|+..++||+|+||+||+|+. .+|+.||+|+++.+..+ .-....+|+.++++++|+| |+.|.+++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34566678899999999999985 56899999999766442 3456789999999999999 999999998877
Q ss_pred -cceeEEeecCCCCchhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 011153 339 -ESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (492)
Q Consensus 339 -~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 416 (492)
..++|+||+. .+|..++...... ..++...+..++.||+.||+|||+++ |+||||||+||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 7889999994 5888888544322 45777899999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcHHHHH
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~~~~~~~~~~ 485 (492)
+|+.+..+... .++.++|..|.|||++.+. .|+...||||+|||+.||++++..|.-..+. +.+..+
T Consensus 166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql~~I 233 (323)
T KOG0594|consen 166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQLFRI 233 (323)
T ss_pred hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHHHHH
Confidence 99976543322 3466789999999999886 6999999999999999999988877665442 334333
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=310.90 Aligned_cols=200 Identities=31% Similarity=0.418 Sum_probs=169.9
Q ss_pred ccccCCcccccCcccEEEEEecC--C--CE-EEEEEecc---CChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 270 YFHESNKLGQGGSGSVYKGTLPG--G--EA-VAVKRLFY---NTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~~--~--~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
+....++||+|+||.||+|.+.. + .. ||||..+. .......+|++|+++|++++|||||+++|++.....++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34456899999999999998643 2 23 89999875 34667889999999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+|||++++|+|.++|.... ..++..++++++.+.|+||+|||+++ +|||||.++|+|++.+..+||+||||++.-
T Consensus 238 ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 9999999999999995433 26899999999999999999999998 999999999999999999999999998754
Q ss_pred CCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
.. .........-+..|+|||.+..+.|+.++|||||||++||+++ |..|+...
T Consensus 313 ~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~ 366 (474)
T KOG0194|consen 313 SQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM 366 (474)
T ss_pred cc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC
Confidence 31 1111112235789999999999999999999999999999999 67776543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=302.90 Aligned_cols=207 Identities=29% Similarity=0.403 Sum_probs=171.4
Q ss_pred HhcccccCCcccccCcccEEEEEe------cCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCC
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGP 338 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 338 (492)
..++|++.++||+|+||.||++.. .++..||||++.... ....+.+.+|+.++..+ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 456789999999999999999974 235679999987543 33456789999999999 8999999999887644
Q ss_pred -cceeEEeecCCCCchhhhhccCC--------------------------------------------------------
Q 011153 339 -ESLLVYEFVPNQSLLDNLFVRQD-------------------------------------------------------- 361 (492)
Q Consensus 339 -~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 361 (492)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999988854221
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc-ccccccccc
Q 011153 362 ---VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI-SATLAGTLG 437 (492)
Q Consensus 362 ---~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~ 437 (492)
..++++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......... .....+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 135888999999999999999999988 9999999999999999999999999998654332211 123446788
Q ss_pred ccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 011153 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQ 476 (492)
Q Consensus 438 y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~~ 476 (492)
|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999999999999997 888886543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=309.06 Aligned_cols=201 Identities=26% Similarity=0.347 Sum_probs=172.6
Q ss_pred ccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.|+..++||+|+||+||+++. .+++.||||++... .....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578899999999999999985 46889999999653 23445678999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999988853 235788889999999999999999988 9999999999999999999999999976431100
Q ss_pred c----------------------------------------------cccccccccccccchhhhccCCCCcchhHHHHH
Q 011153 426 T----------------------------------------------HISATLAGTLGYMAPEYVVRGKLTEKADVYSFG 459 (492)
Q Consensus 426 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG 459 (492)
. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001235699999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 011153 460 VVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 460 vll~elltg~~p~~~~~ 476 (492)
|++|||++|+.||....
T Consensus 236 ~il~elltG~~Pf~~~~ 252 (381)
T cd05626 236 VILFEMLVGQPPFLAPT 252 (381)
T ss_pred hHHHHHHhCCCCCcCCC
Confidence 99999999999997644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=292.63 Aligned_cols=200 Identities=27% Similarity=0.319 Sum_probs=173.3
Q ss_pred cccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
|+..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.+++.++|+||+++++++.+++..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999985 578999999986432 22344678999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+.+.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999988775432 335899999999999999999999988 99999999999999999999999999986543221
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 234568999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=295.89 Aligned_cols=197 Identities=23% Similarity=0.315 Sum_probs=173.4
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|+..++||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788999999999999999865 68899999986432 234566889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++... ..+++.....++.||+.||+|||+++ ++||||||+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999988532 45888999999999999999999988 999999999999999999999999999865432
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ....|++.|+|||++.+..++.++||||||++++||++|+.||...
T Consensus 155 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 155 T----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred c----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 2356899999999999888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=306.84 Aligned_cols=201 Identities=24% Similarity=0.338 Sum_probs=173.7
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|+..++||+|+||+||+++.. +++.||||++... .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999999999999864 6889999999653 2334556889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999988542 35899999999999999999999998 999999999999999999999999998754321
Q ss_pred Ccc-------------------------------------ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh
Q 011153 425 ITH-------------------------------------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467 (492)
Q Consensus 425 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt 467 (492)
... ......||+.|+|||++....++.++|||||||+++||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 011153 468 RKRINLFT 475 (492)
Q Consensus 468 g~~p~~~~ 475 (492)
|+.||...
T Consensus 235 G~~Pf~~~ 242 (364)
T cd05599 235 GYPPFCSD 242 (364)
T ss_pred CCCCCCCC
Confidence 99998653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=306.12 Aligned_cols=203 Identities=22% Similarity=0.243 Sum_probs=174.1
Q ss_pred HHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
...++|+..++||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34567999999999999999999865 5788999998642 2233456789999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999998843 24788899999999999999999988 999999999999999999999999999876
Q ss_pred CCCCccccccccccccccchhhhccC----CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVRG----KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
............||+.|||||++... .++.++|||||||++|||++|+.||...
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 44322223356799999999998754 3788999999999999999999999654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.10 Aligned_cols=202 Identities=24% Similarity=0.338 Sum_probs=172.5
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.++||+|+||+||++.. .+++.||||++... .....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999985 46889999998643 2334567889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999998843 345888999999999999999999998 999999999999999999999999998633210
Q ss_pred Cc------------c----------------------------------ccccccccccccchhhhccCCCCcchhHHHH
Q 011153 425 IT------------H----------------------------------ISATLAGTLGYMAPEYVVRGKLTEKADVYSF 458 (492)
Q Consensus 425 ~~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~sl 458 (492)
.. . ......||+.|+|||++....++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0 0012468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 011153 459 GVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 459 Gvll~elltg~~p~~~~~ 476 (492)
||+++||++|+.||....
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (377)
T cd05629 235 GAIMFECLIGWPPFCSEN 252 (377)
T ss_pred chhhhhhhcCCCCCCCCC
Confidence 999999999999986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=301.72 Aligned_cols=197 Identities=28% Similarity=0.360 Sum_probs=173.0
Q ss_pred cccccCCcccccCcccEEEEEecC--CCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPG--GEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~--~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
++|+..+.||+|+||.||++...+ +..||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 458889999999999999998543 368999998643 233456788999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999988533 45889999999999999999999988 99999999999999999999999999986543
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 2 12457899999999999888999999999999999999999999754
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.82 Aligned_cols=201 Identities=25% Similarity=0.339 Sum_probs=172.1
Q ss_pred ccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
+|+..++||+|+||+||+++. .+++.+|+|++.... ....+.+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578899999999999999986 468899999986532 3345678899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999988532 45788889999999999999999988 9999999999999999999999999975321000
Q ss_pred ----------------------------------------------ccccccccccccccchhhhccCCCCcchhHHHHH
Q 011153 426 ----------------------------------------------THISATLAGTLGYMAPEYVVRGKLTEKADVYSFG 459 (492)
Q Consensus 426 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slG 459 (492)
........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001134689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 011153 460 VVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 460 vll~elltg~~p~~~~~ 476 (492)
|++|||++|+.||....
T Consensus 236 vil~elltG~~Pf~~~~ 252 (382)
T cd05625 236 VILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHHhCCCCCCCCC
Confidence 99999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=300.38 Aligned_cols=197 Identities=26% Similarity=0.360 Sum_probs=174.0
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999865 5889999998653 2234567889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999988853 345788889999999999999999988 999999999999999999999999999866443
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ....||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 2 2357899999999999999999999999999999999999998643
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=271.96 Aligned_cols=204 Identities=30% Similarity=0.387 Sum_probs=179.9
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
-++|++++.||+|.||.||.|+. .++-.||+|++.+. ..+...++.+|+++-..|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 35689999999999999999985 45778999999654 233456789999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
+||.++|+|...|... ....+++.....++.|+|.||.|+|... +|||||||+|+|++.++.+||+|||-+...+.
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 9999999999998643 3455788888899999999999999987 99999999999999999999999998865432
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
....+.+||..|.+||+..+...+..+|+|++|++.+|++.|.+||.....+
T Consensus 177 ---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~ 228 (281)
T KOG0580|consen 177 ---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS 228 (281)
T ss_pred ---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH
Confidence 2335789999999999999999999999999999999999999999987644
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=306.65 Aligned_cols=201 Identities=24% Similarity=0.332 Sum_probs=171.9
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
+|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5888999999999999999854 58899999986432 2335668899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++++|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999998843 345788888999999999999999988 9999999999999999999999999975321000
Q ss_pred ------------------------------------------ccccccccccccccchhhhccCCCCcchhHHHHHHHHH
Q 011153 426 ------------------------------------------THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVI 463 (492)
Q Consensus 426 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ 463 (492)
........||+.|||||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00011346899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCC
Q 011153 464 EVVCRKRINLFTQ 476 (492)
Q Consensus 464 elltg~~p~~~~~ 476 (492)
||++|+.||....
T Consensus 236 ell~G~~Pf~~~~ 248 (376)
T cd05598 236 EMLVGQPPFLADT 248 (376)
T ss_pred ehhhCCCCCCCCC
Confidence 9999999997544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=287.27 Aligned_cols=195 Identities=32% Similarity=0.455 Sum_probs=164.0
Q ss_pred HHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhc--cCcCceeeeeeeeecCC----c
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG--INHKNLVKLLGCSITGP----E 339 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~ 339 (492)
...+.....+.||+|.||+||+|.+. |+.||||++...+ .+.+.+|.++.+. |+|+||+.+++.-..+. +
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 44566788899999999999999998 8899999996443 3467788888765 59999999999876554 5
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCeEecCCCCCCeeeCCCCcEEEee
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-----ESKLRIIHRDIKLSNILLDEEFTAKIAD 414 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~-----~~~~~ivH~Dlk~~Nill~~~~~~kl~D 414 (492)
++||++|.+.|||.++|.. ..++.+..+++++.+|.||++||- +|+|.|.|||||+.||||..++.+.|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 7899999999999999943 568999999999999999999995 4789999999999999999999999999
Q ss_pred cCCccccCCCCcc---ccccccccccccchhhhccCC----CC--cchhHHHHHHHHHHHHhC
Q 011153 415 FGLVRLFPEDITH---ISATLAGTLGYMAPEYVVRGK----LT--EKADVYSFGVVVIEVVCR 468 (492)
Q Consensus 415 fgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~~--~~sDv~slGvll~elltg 468 (492)
+|||.....+... ..+..+||.+|||||++.... |. ..+||||||.++||+..+
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR 422 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 9999877655332 234678999999999986543 22 359999999999998764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=300.69 Aligned_cols=196 Identities=29% Similarity=0.359 Sum_probs=174.0
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
+|++.++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++..++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5888999999999999999975 58899999987542 2345678899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 82 YVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999998843 345889999999999999999999988 99999999999999999999999999976543
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence 223457899999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=297.63 Aligned_cols=194 Identities=27% Similarity=0.307 Sum_probs=168.4
Q ss_pred CcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCC
Q 011153 275 NKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (492)
+.||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 46889999998753 2334566789999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccc
Q 011153 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430 (492)
Q Consensus 351 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 430 (492)
+|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~ 153 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccc
Confidence 99888743 345889999999999999999999998 9999999999999999999999999987532221 1223
Q ss_pred cccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 431 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
...||+.|+|||++.+..++.++|||||||+++||++|+.||...
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 457899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=296.08 Aligned_cols=194 Identities=27% Similarity=0.313 Sum_probs=168.1
Q ss_pred CcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCC
Q 011153 275 NKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (492)
+.||+|+||.||++.. .+++.||+|++... .......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999986 46899999998753 2334566788999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccc
Q 011153 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430 (492)
Q Consensus 351 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 430 (492)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 153 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccc
Confidence 99887743 345889999999999999999999988 99999999999999999999999999875322211 122
Q ss_pred cccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 431 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
...||+.|+|||++.++.++.++|||||||++|||++|+.||...
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 456899999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=286.12 Aligned_cols=204 Identities=25% Similarity=0.375 Sum_probs=166.9
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc-----ceeE
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE-----SLLV 343 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv 343 (492)
.|...+++|.|+||.||+|.+. +++.||||+...+.+ .--+|+++|+.++|||||+|+.+|..... ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4677889999999999999965 578999999865533 22479999999999999999998874332 3489
Q ss_pred EeecCCCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-CcEEEeecCCcccc
Q 011153 344 YEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLF 421 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgl~~~~ 421 (492)
+||||. +|.+.+... .....++...+.-++.||.+||+|||+.+ |+||||||+|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999975 777776421 22345777778889999999999999987 9999999999999976 99999999999988
Q ss_pred CCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcHHH
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQ 483 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~~~~~~~~ 483 (492)
...... .....|..|+|||.+.+ ..|+.+.||||.||++.||+-|++.|...+..+++++
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~e 237 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVE 237 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHH
Confidence 765444 34567899999999987 5699999999999999999999999988655444443
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=302.52 Aligned_cols=206 Identities=21% Similarity=0.235 Sum_probs=175.6
Q ss_pred HHHHHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC
Q 011153 263 TLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP 338 (492)
Q Consensus 263 ~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 338 (492)
.+....++|++.+.||+|+||.||++... +++.+|+|++... .....+.+.+|+.+++.++||||+++++.+.+++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34455678999999999999999999865 5788999998542 2233456789999999999999999999999999
Q ss_pred cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCc
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~ 418 (492)
..++||||+++++|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999988743 24788888999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccchhhhccC----CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVRG----KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
+..............||+.|||||++... .++.++|||||||++|||++|+.||...
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 87654332233456799999999998653 3788999999999999999999999653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=300.60 Aligned_cols=211 Identities=27% Similarity=0.355 Sum_probs=182.7
Q ss_pred ccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
-|+.++.||.|+.|.|-.|++ .+|+..|||++.+. .......+.+|+-+|+.+.||||++++++|.+...+|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 377889999999999999985 57999999998654 22334568899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++|.|.+++.. .+++.+.+..+++.||+.|+.|+|..+ |+||||||+|+|+|..+++||+|||+|.+...
T Consensus 93 yv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-- 164 (786)
T KOG0588|consen 93 YVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP-- 164 (786)
T ss_pred ecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC--
Confidence 9999999999954 355888999999999999999999988 99999999999999999999999999986543
Q ss_pred ccccccccccccccchhhhccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCcHHHHHHhhh
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLT-EKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVILLT 489 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~slGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 489 (492)
+....+.+|+|.|.+||++++.+|. .++||||.||||+.||+|+.||+ +++-..|+..+-+..
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-DdNir~LLlKV~~G~ 228 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-DDNIRVLLLKVQRGV 228 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-CccHHHHHHHHHcCc
Confidence 2345577999999999999999985 68999999999999999999998 233336776665543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=295.82 Aligned_cols=194 Identities=28% Similarity=0.329 Sum_probs=168.7
Q ss_pred CcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCC
Q 011153 275 NKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (492)
++||+|+||.||++.. .+++.||+|++... .......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 46889999999753 2344567889999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccc
Q 011153 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430 (492)
Q Consensus 351 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 430 (492)
+|.+.+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 153 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMK 153 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccc
Confidence 99887743 345889999999999999999999988 99999999999999999999999999875432211 123
Q ss_pred cccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 431 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence 457899999999999889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=293.47 Aligned_cols=191 Identities=25% Similarity=0.285 Sum_probs=167.4
Q ss_pred ccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCCc
Q 011153 277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (492)
Q Consensus 277 iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 352 (492)
||+|+||.||++... +++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999865 5789999998643 334456788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccccc
Q 011153 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432 (492)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 432 (492)
.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 153 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF 153 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence 988853 345889999999999999999999988 9999999999999999999999999987543322 122345
Q ss_pred cccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 433 ~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.||+.|+|||++.+..++.++|||||||+++||++|+.||..
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 789999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=282.46 Aligned_cols=207 Identities=25% Similarity=0.410 Sum_probs=176.0
Q ss_pred HHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEec--cCChhhHHHHHHHHHHHhccCcCceeeeeeeeec-----C
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT-----G 337 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 337 (492)
....+|...+.||+|+||.|.++.. .+|+.||||++. ....-..++..+|+++|+.++|+||+.+++++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 4456677788999999999999985 468999999997 3455667788999999999999999999998876 3
Q ss_pred CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCC
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl 417 (492)
...|+|+|+| +.+|.+.+. .+..++......+++||++||.|+|+.+ |+||||||+|+|++.+..+||+|||+
T Consensus 99 ~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 3578999999 668888873 3344899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCC-Cccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 418 VRLFPED-ITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 418 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
|+..... .....+..+.|..|.|||++.. ..|+...||||.|||+.||++|++.|...+.-+
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~ 235 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH 235 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH
Confidence 9977543 1122345678999999998865 679999999999999999999999998766543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=291.30 Aligned_cols=202 Identities=28% Similarity=0.409 Sum_probs=179.1
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
..|...++||+|.||.||+|... .++.||+|++..+ .....+.+.+|+.+|.+++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 44677789999999999999864 6888999999765 455678899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+.+|++.+.+. ....+++..+.-++.+++.||.|||.++ .+|||||+.|||+..+|.+||+|||++..+.....
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999883 3334477777888999999999999998 99999999999999999999999999987766544
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
.. .+.+||+.|||||++....|+.|+||||||++.+||.+|.+|+.-.++
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 43 678999999999999988999999999999999999999999876544
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=302.99 Aligned_cols=202 Identities=22% Similarity=0.244 Sum_probs=172.7
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
..++|+..++||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467889999999999999999864 6889999998642 22334557889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
||||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999988743 24778888899999999999999988 9999999999999999999999999998664
Q ss_pred CCCccccccccccccccchhhhccC----CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRG----KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
...........||+.|+|||++... .++.++|||||||++|||++|+.||...
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 4322223355789999999998653 4788999999999999999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=285.70 Aligned_cols=205 Identities=27% Similarity=0.362 Sum_probs=168.7
Q ss_pred HHHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCCh--------------hhHHHHHHHHHHHhccCcCceee
Q 011153 265 EKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT--------------QWVDHFFNEVNLISGINHKNLVK 329 (492)
Q Consensus 265 ~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~ 329 (492)
.+.-+.|++.+.||+|.||.|-++.. .+++.||||++.+... .-.+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34457799999999999999999985 4689999999854311 11347889999999999999999
Q ss_pred eeeeeec--CCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC
Q 011153 330 LLGCSIT--GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE 407 (492)
Q Consensus 330 l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~ 407 (492)
|+.+.-+ .+..|||+||+..|.+... ......++..+.++++.++..||+|||.++ ||||||||+|+||+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9998765 4578999999998877542 233334999999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCccccCCCCc----cccccccccccccchhhhccCC---C-CcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 408 FTAKIADFGLVRLFPEDIT----HISATLAGTLGYMAPEYVVRGK---L-TEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 408 ~~~kl~Dfgl~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~---~-~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
|++||+|||.+..+..... ......+|||.|||||...++. + +.+.||||+||.||.|+.|+.||...
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 9999999999986632211 1122478999999999988743 3 45789999999999999999999754
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=295.52 Aligned_cols=201 Identities=23% Similarity=0.266 Sum_probs=172.6
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.+.||+|+||+||++... +++.||+|++... .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888999999999999999864 5889999998642 2234556889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999988432 345888999999999999999999988 999999999999999999999999998765543
Q ss_pred Cccccccccccccccchhhhcc-----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVR-----GKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.........||+.|||||++.. +.++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 3322334568999999999863 4578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=287.97 Aligned_cols=203 Identities=28% Similarity=0.401 Sum_probs=169.3
Q ss_pred hcccccCCcccccCcccEEEEEecC-----------------CCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG-----------------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVK 329 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 329 (492)
.++|+..++||+|+||.||++...+ +..||+|.+.... ......+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3568889999999999999997532 3369999987643 344567999999999999999999
Q ss_pred eeeeeecCCcceeEEeecCCCCchhhhhccC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 011153 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQ----------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393 (492)
Q Consensus 330 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iv 393 (492)
+++++.+.+..++||||+++++|.+++.... ....+++..+++++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999998875321 1134788899999999999999999988 99
Q ss_pred ecCCCCCCeeeCCCCcEEEeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhC--CC
Q 011153 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCR--KR 470 (492)
Q Consensus 394 H~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg--~~ 470 (492)
||||||+|||+++++.+||+|||+++....... .......++..|||||++..+.++.++||||||+++|||+++ ..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999986543322 122234567899999999989999999999999999999974 44
Q ss_pred CCC
Q 011153 471 INL 473 (492)
Q Consensus 471 p~~ 473 (492)
|+.
T Consensus 241 p~~ 243 (304)
T cd05096 241 PYG 243 (304)
T ss_pred CCC
Confidence 554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=289.09 Aligned_cols=202 Identities=22% Similarity=0.287 Sum_probs=173.3
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
++|++.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999975 57889999986542 3345678899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|++++.+..... ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999876654432 2345889999999999999999999988 9999999999999999999999999998765433
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
........|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 322334568999999999998899999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=299.94 Aligned_cols=202 Identities=25% Similarity=0.326 Sum_probs=176.9
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.+.||+|+||+||++... +++.||||++.... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999865 68999999986532 244567889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999988543 56889999999999999999999988 999999999999999999999999999865443
Q ss_pred C----------------------------ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 425 I----------------------------THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 425 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 112234568999999999999999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=301.03 Aligned_cols=202 Identities=25% Similarity=0.330 Sum_probs=173.7
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|+..+.||+|+||+||++... +++.||||++... .......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 35788999999999999999864 6889999998643 2334567888999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999998843 345889999999999999999999988 999999999999999999999999998754321
Q ss_pred Cc----------------------------------cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCC
Q 011153 425 IT----------------------------------HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470 (492)
Q Consensus 425 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~ 470 (492)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 00113468999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 011153 471 INLFTQ 476 (492)
Q Consensus 471 p~~~~~ 476 (492)
||....
T Consensus 235 Pf~~~~ 240 (360)
T cd05627 235 PFCSET 240 (360)
T ss_pred CCCCCC
Confidence 986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=295.09 Aligned_cols=200 Identities=27% Similarity=0.352 Sum_probs=171.1
Q ss_pred ccccCCcccccCcccEEEEEe----cCCCEEEEEEeccC----ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcc
Q 011153 270 YFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYN----TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES 340 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~----~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 340 (492)
+|++.++||+|+||.||+++. .+++.||+|++... .....+.+.+|+.++..+ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 35789999998643 223345678899999999 599999999999999999
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999888543 35889999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 421 FPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
+............||+.|||||++.+. .++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 544333333356789999999998765 4788999999999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=294.54 Aligned_cols=205 Identities=23% Similarity=0.343 Sum_probs=183.3
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc-ceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE-SLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 344 (492)
++|...++||+|+||.++..+.+ ++..+++|++... +....+....|+.++++++|||||.+.+.|++++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56788999999999999999754 5778999998654 34445578899999999999999999999999998 89999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
+|++||+|.+.+...+ ...++++++..++.||+.|+.|||++. |+|||||+.||+++.+..+||+|||+++....+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999986654 567999999999999999999999887 999999999999999999999999999988776
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
.. ...+.+||+.||+||++.+.+|+.|+|||||||+++||++-+++|...+..
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~ 212 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS 212 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH
Confidence 52 345789999999999999999999999999999999999999999876544
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=295.69 Aligned_cols=201 Identities=24% Similarity=0.245 Sum_probs=172.9
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999865 5788999998642 2233456788999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999988542 245788999999999999999999988 999999999999999999999999999866544
Q ss_pred Cccccccccccccccchhhhcc-----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVR-----GKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.........||+.|+|||++.. +.++.++||||||+++|||++|+.||..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 3322334568999999998865 5678899999999999999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=291.04 Aligned_cols=199 Identities=25% Similarity=0.385 Sum_probs=174.5
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.++|++.+.||+|+||.||+++.. ++..+|+|.+... .....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467899999999999999999865 6788999988765 33445679999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 99999999988532 35789999999999999999999853 39999999999999999999999999987654322
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2345689999999999988999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=282.72 Aligned_cols=199 Identities=26% Similarity=0.395 Sum_probs=179.2
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
.+|++.+.||+|.||+|-++.. ..|+.||||.++++ +.+..-.+.+|+++|..|+||||++++.+|+..+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4577888999999999999974 78999999988764 4556667889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||..+|.|.+++.. .+.+++.....++.||..|+.|+|.+. ++|||||.+|||+|.++++||+||||+..+.+.
T Consensus 133 EYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999954 345899999999999999999999988 999999999999999999999999999877654
Q ss_pred CccccccccccccccchhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
...++.+|++.|.+||++.+.+| .+.+|-|||||+||-|+-|.-||+..
T Consensus 207 --kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~ 256 (668)
T KOG0611|consen 207 --KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR 256 (668)
T ss_pred --cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc
Confidence 34567899999999999998887 47899999999999999999998653
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=294.17 Aligned_cols=202 Identities=24% Similarity=0.263 Sum_probs=172.2
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.++||+|+||.||+++.. +++.+|+|++... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999865 4778999998542 2233445788999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999998542 235889999999999999999999988 999999999999999999999999998765443
Q ss_pred Cccccccccccccccchhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.........||+.|+|||++. .+.++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 332233457899999999986 346789999999999999999999998653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=281.70 Aligned_cols=203 Identities=22% Similarity=0.322 Sum_probs=171.1
Q ss_pred hcccccCCcccccCcccEEEEEec----CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ......+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888999999999999999753 35689999987653 3445678999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999888542 346899999999999999999999988 9999999999999999999999999876543
Q ss_pred CCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
...........++..|+|||.+....++.++||||||+++||+++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 222111112335678999999999999999999999999999875 99888643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=304.28 Aligned_cols=202 Identities=22% Similarity=0.329 Sum_probs=176.2
Q ss_pred ccccCCcccccCcccEEEEEec-C-CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-G-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
.|...+.||+|+||.||++... + ++.|++|.+..........+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888999999999999999753 3 6788999876666555667888999999999999999999999999999999999
Q ss_pred CCCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 348 PNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 348 ~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
++|+|.+++... ....++++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887543 23456899999999999999999999988 99999999999999999999999999987654322
Q ss_pred -cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 427 -HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 427 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.......||+.|+|||++.+..++.++|||||||+++||++|+.||..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~ 273 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 123355789999999999999999999999999999999999999864
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=285.76 Aligned_cols=201 Identities=25% Similarity=0.346 Sum_probs=170.3
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
++|+..++||+|+||.||++... +++.||+|+++... ......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999864 68899999986543 23345678999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 975 888877432 335788999999999999999999988 99999999999999999999999999876543221
Q ss_pred cccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1224467899999998865 568999999999999999999999986543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=286.78 Aligned_cols=202 Identities=26% Similarity=0.368 Sum_probs=170.5
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.++|++.++||+|+||.||+++.. +++.||||++..... .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467899999999999999999965 688999999865432 233467889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|++ ++|.+.+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 677776643 2345888999999999999999999988 9999999999999999999999999987543322
Q ss_pred ccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.......+++.|+|||++.+ ..++.++|||||||+++||++|+.||....
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 12234567899999998865 457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=291.55 Aligned_cols=194 Identities=27% Similarity=0.368 Sum_probs=166.6
Q ss_pred CcccccCcccEEEEEe----cCCCEEEEEEeccC----ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 275 NKLGQGGSGSVYKGTL----PGGEAVAVKRLFYN----TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~----~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
++||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 35788999998653 223345678899999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+.+.. ...+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 999999888743 345788888999999999999999988 9999999999999999999999999987543222
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~ 203 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence 1223456899999999998888999999999999999999999998653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=289.51 Aligned_cols=194 Identities=28% Similarity=0.341 Sum_probs=164.8
Q ss_pred CcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhc-cCcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISG-INHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
++||+|+||.||++... +++.||+|.++... ....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 57889999987532 2334456667777765 4899999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 999888743 235889999999999999999999988 9999999999999999999999999997543322 223
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 3557899999999999889999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=290.37 Aligned_cols=200 Identities=27% Similarity=0.297 Sum_probs=170.2
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEE
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 344 (492)
+|+..+.||+|+||.||++... +++.||||.+.... ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999865 57899999987542 23344567788888777 6899999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++|+|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999998887432 45889999999999999999999988 999999999999999999999999998754322
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
. .......||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 155 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred C-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 1 12234578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=296.25 Aligned_cols=201 Identities=24% Similarity=0.282 Sum_probs=174.2
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.++||+|+||+||++... +++.||+|+++... .+..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999864 68899999997542 234566889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999988543 245899999999999999999999988 999999999999999999999999999876544
Q ss_pred Cccccccccccccccchhhhc------cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVV------RGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.........||+.|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 211 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence 333333457899999999986 45678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=294.51 Aligned_cols=205 Identities=29% Similarity=0.391 Sum_probs=171.5
Q ss_pred hcccccCCcccccCcccEEEEEe------cCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPE 339 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 339 (492)
.++|+..++||+|+||.||+++. .++..||||+++... ....+.+.+|+.++..+ +||||+++++++.+++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45688899999999999999963 235689999986543 33456788999999999 89999999999999999
Q ss_pred ceeEEeecCCCCchhhhhccCC----------------------------------------------------------
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQD---------------------------------------------------------- 361 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 361 (492)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999988854221
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 362 --------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 362 --------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
...+++..+++++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 125789999999999999999999988 999999999999999999999999999865433221
Q ss_pred c-cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 428 I-SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 428 ~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 1 122345678999999999999999999999999999998 77777543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=290.50 Aligned_cols=197 Identities=29% Similarity=0.370 Sum_probs=167.6
Q ss_pred cccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHH---hccCcCceeeeeeeeecCCcceeE
Q 011153 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLI---SGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
|++.++||+|+||.||++... +++.||||+++... ....+.+.+|++++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999864 68899999996532 23345666676654 567899999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++++|...+. ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999987763 245899999999999999999999988 99999999999999999999999999875332
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.. .......|++.|||||.+.+..++.++||||||+++|||++|+.||...
T Consensus 154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 21 1223467899999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=292.79 Aligned_cols=194 Identities=27% Similarity=0.313 Sum_probs=167.3
Q ss_pred CcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCC
Q 011153 275 NKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (492)
+.||+|+||.||++.. .+++.||+|++... .......+.+|++++..++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 46889999998653 2334566788999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 351 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
+|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TM 153 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cc
Confidence 99887743 3458999999999999999999997 56 99999999999999999999999999875332211 12
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 2456899999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=289.69 Aligned_cols=199 Identities=27% Similarity=0.302 Sum_probs=169.6
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcC-ceeeeeeeeecCCcceeEE
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHK-NLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 344 (492)
+|+..+.||+|+||.||++... +++.||||++... .....+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999865 5778999998753 233456788899999999765 5888999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999888743 245789999999999999999999988 999999999999999999999999998743221
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 155 G-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred C-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 1 1223456899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=294.80 Aligned_cols=207 Identities=29% Similarity=0.408 Sum_probs=172.6
Q ss_pred HhcccccCCcccccCcccEEEEEec------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCC
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGP 338 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 338 (492)
..++|++.++||+|+||.||++... ++..||||++.... ....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3457889999999999999998742 34579999997543 33456788999999999 8999999999999999
Q ss_pred cceeEEeecCCCCchhhhhccC----------------------------------------------------------
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQ---------------------------------------------------------- 360 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 360 (492)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999998875321
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc-ccc
Q 011153 361 ---------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH-ISA 430 (492)
Q Consensus 361 ---------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~ 430 (492)
...++++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++........ ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 1135788999999999999999999988 999999999999999999999999999765433211 112
Q ss_pred cccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 011153 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQ 476 (492)
Q Consensus 431 ~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~~ 476 (492)
...+++.|||||++.+..++.++||||||+++|||++ |+.||....
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 2345678999999999999999999999999999997 999986543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=296.31 Aligned_cols=193 Identities=23% Similarity=0.256 Sum_probs=167.2
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
.+|++.++||+|+||.||++.. .+++.||+|... ...+.+|++++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 5699999999999999999986 468899999653 235679999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
. ++|..++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 5 678777643 235789999999999999999999988 999999999999999999999999999754332222
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
......||+.|+|||++....++.++|||||||++|||++|+.|+..
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 23345799999999999999999999999999999999999988754
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=297.29 Aligned_cols=212 Identities=28% Similarity=0.396 Sum_probs=182.3
Q ss_pred ccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCC------cce
Q 011153 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ESL 341 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 341 (492)
.+...+.||+|+||.||+|+. ..|+.||||.++... ....+...+|+++|++++|||||+++++-.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 356678899999999999994 579999999987643 344667889999999999999999999766543 567
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee--CCCC--cEEEeecCC
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL--DEEF--TAKIADFGL 417 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill--~~~~--~~kl~Dfgl 417 (492)
+|||||.+|||...+....+...+++..++.++.++..||.|||+++ |+||||||.||++ ..+| .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999988888888999999999999999999999998 9999999999998 3434 469999999
Q ss_pred ccccCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcHHHHHH
Q 011153 418 VRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVI 486 (492)
Q Consensus 418 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~~~~~~~~~~~ 486 (492)
|+.++++. ......||+.|.+||++.. +.|+..+|.|||||++||.+||..||.......+.-+-+|
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~ 238 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMW 238 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhh
Confidence 99877654 4567899999999999985 8899999999999999999999999988766544434444
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=289.48 Aligned_cols=195 Identities=27% Similarity=0.329 Sum_probs=167.2
Q ss_pred CcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
++||+|+||.||+++.. +++.||+|++... .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 5789999998653 233455677899988866 899999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|...+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT 153 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence 9998887432 35888999999999999999999988 99999999999999999999999999875432221 22
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 34568999999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=280.82 Aligned_cols=195 Identities=24% Similarity=0.322 Sum_probs=168.4
Q ss_pred ccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCCc
Q 011153 277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (492)
Q Consensus 277 iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 352 (492)
||+|+||+||++... +++.+|+|++.... ....+.+..|+++++.++||||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999864 68899999986432 22345678899999999999999999999999999999999999999
Q ss_pred hhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccccc
Q 011153 353 LDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431 (492)
Q Consensus 353 ~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 431 (492)
.+.+... .....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+..... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 8877543 23456899999999999999999999988 99999999999999999999999999976544322 1234
Q ss_pred ccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 432 LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 432 ~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 56899999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=282.00 Aligned_cols=191 Identities=21% Similarity=0.295 Sum_probs=164.8
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccCCh---hhHHHHHHHHHHHhccCcCceeeeeeeeec----CCcceeEEee
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT---QWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPESLLVYEF 346 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 346 (492)
...|++|++|.||+|.. +|+.||||++..... ...+.+.+|+.+|++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46799999999999998 588999999875433 235678899999999999999999999876 3467899999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
+++|+|.+++.. ...+++....+++.|++.||.|||+. + ++||||||+|||+++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999999854 24588999999999999999999984 5 7899999999999999999999999988654322
Q ss_pred ccccccccccccccchhhhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....+++.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 23457889999999876 68999999999999999999999999754
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=290.15 Aligned_cols=193 Identities=26% Similarity=0.328 Sum_probs=166.3
Q ss_pred CcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
+.||+|+||.||++... +++.+|+|+++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 5789999998753 334456678899988776 899999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT 153 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence 999887743 345889999999999999999999988 99999999999999999999999999875322211 12
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
....||+.|+|||++.+..++.++||||||++++||++|+.||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 345789999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=287.80 Aligned_cols=193 Identities=25% Similarity=0.318 Sum_probs=167.1
Q ss_pred CcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
++||+|+||+||++... +++.+|+|+++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 5788999999754 233456688999999888 699999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|...+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTT 153 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cce
Confidence 999887743 245899999999999999999999988 9999999999999999999999999987532221 112
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 345789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=289.28 Aligned_cols=193 Identities=26% Similarity=0.330 Sum_probs=167.1
Q ss_pred CcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
++||+|+||.||++... +++.||+|+++.. .....+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 6889999999753 233456688999999888 799999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|.+++.. ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT 153 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence 999887743 245899999999999999999999988 9999999999999999999999999987432211 122
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 345789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=287.80 Aligned_cols=194 Identities=29% Similarity=0.372 Sum_probs=166.6
Q ss_pred CcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
++||+|+||.||++... +++.||||++... .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 5789999998653 233456678888888876 799999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT 153 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence 9998877432 45889999999999999999999988 9999999999999999999999999987532221 122
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 3456899999999999889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=289.20 Aligned_cols=199 Identities=25% Similarity=0.367 Sum_probs=166.4
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC-----cce
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-----ESL 341 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 341 (492)
+|++.++||+|+||.||++... +++.||||++... .......+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999864 6899999998643 2233456889999999999999999999886433 468
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+||||++ ++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 688887743 345899999999999999999999998 999999999999999999999999999754
Q ss_pred CCCCcc--ccccccccccccchhhhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 422 PEDITH--ISATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 422 ~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
...... ......||+.|+|||++.. ..++.++|||||||+++||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 322211 1224578999999999865 67899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=287.90 Aligned_cols=198 Identities=27% Similarity=0.322 Sum_probs=169.1
Q ss_pred cccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccC-cCceeeeeeeeecCCcceeEEe
Q 011153 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 345 (492)
|+..+.||+|+||+||++... +++.||+|++... .....+.+..|..++..+. |++|+++.+++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 677889999999999999864 6889999998753 2234456788999988885 5778889999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 82 y~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 82 YVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999888743 345899999999999999999999988 9999999999999999999999999987543221
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ......||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 1 123456899999999999889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=287.38 Aligned_cols=200 Identities=24% Similarity=0.395 Sum_probs=174.0
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.++|++.++||+|+||.||++... ++..+|+|.+... .....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467899999999999999999865 5788999988754 33445678999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +++|+||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 9999999998843 235788999999999999999999742 39999999999999999999999999987553321
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.....|++.|+|||++.+..++.++|||||||++|||++|+.|+...
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 22346889999999999888999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=276.37 Aligned_cols=202 Identities=31% Similarity=0.439 Sum_probs=175.1
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
.++|++.++||+|+||.||+|...++..|++|.+..... ..+.+.+|+.+++.++|+||+++++.+.+.+..++++||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 356888999999999999999988888999998865432 3568899999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999988543 3345889999999999999999999987 999999999999999999999999999876543322
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
......++..|+|||.+..+.++.++||||||+++|||++ |+.|+..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 2223345778999999988889999999999999999998 8888754
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=291.72 Aligned_cols=207 Identities=25% Similarity=0.332 Sum_probs=173.1
Q ss_pred HHhcccccCCcccccCcccEEEEEec------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccC-cCceeeeeeeeecC
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGIN-HKNLVKLLGCSITG 337 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 337 (492)
...++|.+.++||+|+||.||+|+.. .+..||||++.... ....+.+.+|+++++++. ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 44667889999999999999999753 13469999997543 334567999999999996 99999999999999
Q ss_pred CcceeEEeecCCCCchhhhhccCC--------------------------------------------------------
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQD-------------------------------------------------------- 361 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 361 (492)
+..++||||+++|+|.+++.....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999988754210
Q ss_pred -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 011153 362 -------------------------------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL 404 (492)
Q Consensus 362 -------------------------------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill 404 (492)
...+++..+.+++.||+.||+|||+.+ ++||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 134788889999999999999999988 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 405 DEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 405 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 99999999999999865433221 1223456788999999998899999999999999999997 88887653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=301.60 Aligned_cols=210 Identities=25% Similarity=0.313 Sum_probs=177.6
Q ss_pred HHHHHHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC
Q 011153 262 ETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP 338 (492)
Q Consensus 262 ~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 338 (492)
.+.....++|.+.++||+|+||+||++.. .+++.||||++... +......+.+|+..+..++|+||+++.+.+....
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 34445567899999999999999999985 57899999998654 3445567889999999999999999988765432
Q ss_pred --------cceeEEeecCCCCchhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc
Q 011153 339 --------ESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409 (492)
Q Consensus 339 --------~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~ 409 (492)
..++||||+++|+|.+.+.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 2579999999999999886432 3456899999999999999999999987 999999999999999999
Q ss_pred EEEeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 410 AKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 410 ~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
+||+|||+++.+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~ 247 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999986643321 223356789999999999999999999999999999999999999864
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=280.45 Aligned_cols=200 Identities=28% Similarity=0.323 Sum_probs=172.8
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.|+..++||+|+||+||++... +++.||+|++.... ......+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3778899999999999999864 68899999986532 2223457889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++++|.+.+... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999998877543 2345899999999999999999999988 9999999999999999999999999988654322
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. .....|++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 1 12346899999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=285.04 Aligned_cols=194 Identities=27% Similarity=0.346 Sum_probs=165.2
Q ss_pred CcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhc-cCcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISG-INHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
+.||+|+||+||+++.. +++.||||+++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 57899999987542 2334556778888876 4999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 999988843 245889999999999999999999988 99999999999999999999999999875322211 12
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 3456899999999999889999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=288.86 Aligned_cols=194 Identities=27% Similarity=0.328 Sum_probs=164.5
Q ss_pred CcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHH-HHhccCcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
++||+|+||+||++.. .+++.+|+|++... .......+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 46889999998653 2233445566655 56789999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|...+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTT 153 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCc
Confidence 999887743 345889999999999999999999988 9999999999999999999999999987532221 122
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 3457899999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=280.82 Aligned_cols=201 Identities=28% Similarity=0.414 Sum_probs=165.9
Q ss_pred cccccCCcccccCcccEEEEEec--CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcc---CcCceeeeeeeee-----c
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP--GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGI---NHKNLVKLLGCSI-----T 336 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 336 (492)
++|++.+.||+|+||.||+++.. +++.||+|+++... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 46789999886532 22334566777776665 6999999999885 2
Q ss_pred CCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 011153 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (492)
Q Consensus 337 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 416 (492)
....++|+||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 446789999996 58888775432 345899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+++..... .......|++.|+|||.+....++.++||||||+++|||++|++||....
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 99865433 22234568999999999988899999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=287.68 Aligned_cols=194 Identities=27% Similarity=0.328 Sum_probs=164.1
Q ss_pred CcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHH-HHhccCcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
++||+|+||+||++... +++.||+|++.... ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999864 68899999986532 223344555555 56889999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT 153 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence 999888743 345889999999999999999999988 9999999999999999999999999987532221 122
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 3456899999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=274.65 Aligned_cols=201 Identities=29% Similarity=0.381 Sum_probs=172.1
Q ss_pred cccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecC
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (492)
++|+..+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4577889999999999999998888889999886433 224678899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 428 (492)
+++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999998875432 35889999999999999999999988 9999999999999999999999999987654332222
Q ss_pred cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
.....++..|+|||.+....++.++||||||+++|||++ |+.|+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~ 205 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 223345678999999988889999999999999999999 88887543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=286.60 Aligned_cols=194 Identities=26% Similarity=0.300 Sum_probs=162.8
Q ss_pred CcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHH-HHhccCcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
+.||+|+||+||+++.. +++.+|+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 57789999986432 222334444544 56889999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|.+.+.. ...+.......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~ 153 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TT 153 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cc
Confidence 999988843 234778888899999999999999988 99999999999999999999999999875432211 22
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence 3457899999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=288.65 Aligned_cols=195 Identities=28% Similarity=0.413 Sum_probs=164.4
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
+|+..++||+|+||.||+++.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3556789999999999999864 68999999986543 334567899999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++++|.+.. ..++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 999986532 2456778899999999999999988 99999999999999999999999999986643321
Q ss_pred ccccccccccccchhhhcc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVR-----GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
......||..|+|||.+.. ...+.++|||||||++|||++|+.||...
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 1224578999999998743 22346899999999999999999998743
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=286.45 Aligned_cols=194 Identities=27% Similarity=0.318 Sum_probs=163.5
Q ss_pred CcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHH-HHhccCcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
++||+|+||.||+++.. +++.||+|++.... ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 68899999986432 223344555554 67889999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 999887743 345788889999999999999999988 9999999999999999999999999987532221 122
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 3456899999999999889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=284.63 Aligned_cols=194 Identities=28% Similarity=0.319 Sum_probs=165.3
Q ss_pred CcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
++||+|+||.||+++.. +++.||+|.++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999865 58899999987542 23345667788887654 899999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence 999888743 245788999999999999999999988 9999999999999999999999999987432211 122
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....||+.|+|||++.+..++.++||||||++++||++|+.||...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 3457899999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=273.67 Aligned_cols=201 Identities=28% Similarity=0.389 Sum_probs=172.3
Q ss_pred cccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecC
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (492)
.+|+..+.||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 45778899999999999999887777899998865432 34678999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 428 (492)
+++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999999885432 36899999999999999999999988 9999999999999999999999999988654432222
Q ss_pred cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
.....++..|++||.+....++.++||||||+++|||++ |+.|+...
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 223345678999999988889999999999999999999 88887643
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=283.21 Aligned_cols=200 Identities=28% Similarity=0.436 Sum_probs=168.7
Q ss_pred cccccCCcccccCcccEEEEEec-CCC----EEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGE----AVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
.+|+..+.||+|+||.||+|++. +++ .||+|+++... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45889999999999999999853 333 48999986543 34566789999999999999999999998764 5789
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
|+||+++|+|.+++... ...+++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999988543 345889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCcccc-ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 423 EDITHIS-ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 423 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
....... .....+..|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 4332211 12234678999999999999999999999999999998 8888764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=277.27 Aligned_cols=199 Identities=36% Similarity=0.538 Sum_probs=166.1
Q ss_pred cCCcccccCcccEEEEEec-----CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 273 ESNKLGQGGSGSVYKGTLP-----GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 273 ~~~~iG~G~fG~Vy~~~~~-----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
..+.||.|.||.||+|.+. .+..|+||.+... ..+..+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999876 2557999999654 334578899999999999999999999999988889999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC-C
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED-I 425 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~ 425 (492)
+++|+|.+++... ....+++..+.+|+.||++||+|||+.+ ++|+||+++||++++++.+||+|||++...... .
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999665 3456899999999999999999999988 999999999999999999999999999876322 1
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
............|+|||.+....++.++||||||+++|||++ |+.|+...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 222234456789999999999999999999999999999999 56776543
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=290.30 Aligned_cols=200 Identities=27% Similarity=0.377 Sum_probs=169.4
Q ss_pred ccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC-----cce
Q 011153 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-----ESL 341 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 341 (492)
+|+..++||+|+||.||++.. .+++.||||++... .....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 377889999999999999986 46899999998643 2334567889999999999999999999998776 789
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+|+||+. ++|.+.+. ....+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57777663 2346899999999999999999999988 999999999999999999999999999865
Q ss_pred CCCCccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
............+++.|+|||.+.+. .++.++|||||||+++||++|+.||....
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 44333333345678999999998764 47899999999999999999999987544
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=307.54 Aligned_cols=203 Identities=23% Similarity=0.328 Sum_probs=173.5
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.++||+|+||.||+|... +++.||+|++... .....+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999865 5889999998653 2334567999999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 011153 345 EFVPNQSLLDNLFVRQ--------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~--------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 416 (492)
||+++++|.+++.... .....++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999998885321 1234667888999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCc-----------------cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 417 LVRLFPEDIT-----------------HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 417 l~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
+++....... .......||+.|||||.+.+..++.++|||||||+++||++|+.||..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9986521110 011134689999999999999999999999999999999999999865
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=288.22 Aligned_cols=194 Identities=31% Similarity=0.326 Sum_probs=167.9
Q ss_pred CcccccCcccEEEEEe----cCCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecC
Q 011153 275 NKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~----~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (492)
+.||+|+||.||++.. .+++.+|+|++.... ......+.+|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 357899999997542 2234567789999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 428 (492)
+++|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~ 154 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K 154 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-c
Confidence 9999988843 345899999999999999999999988 99999999999999999999999999876543321 2
Q ss_pred cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.....|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 23457899999999998888999999999999999999999998653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=273.84 Aligned_cols=203 Identities=29% Similarity=0.404 Sum_probs=174.0
Q ss_pred HhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
..++|+..+.||+|++|.||++...+++.||+|.++.... ..+.+.+|++++++++||||+++++++...+..++|+||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 3456888999999999999999987788899999865432 356788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999885432 346899999999999999999999988 99999999999999999999999999987653322
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
........+..|+|||.+....++.++||||||++++||++ |+.|+..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 207 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 11112223468999999988899999999999999999999 8888754
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=283.21 Aligned_cols=194 Identities=28% Similarity=0.335 Sum_probs=166.5
Q ss_pred CcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
+.||+|+||+||++... +++.||||+++.. .......+.+|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 5789999998754 233456678899998887 799999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|...+.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT 153 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence 999887743 345899999999999999999999988 99999999999999999999999999874322211 12
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 2456899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=296.05 Aligned_cols=202 Identities=30% Similarity=0.449 Sum_probs=172.5
Q ss_pred cccCCcccccCcccEEEEEe-cCCC----EEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 271 FHESNKLGQGGSGSVYKGTL-PGGE----AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~-~~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
.+..++||+|+||+||||.+ ++|+ +||||++... ..+...++++|+-+|.+++||||++|+++|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34578999999999999974 5554 6899998654 4556788999999999999999999999998776 88999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
+||+.|+|.+++... ...+.....+.|..||++||.|||++. ++||||.++||||.+-..+||.|||+++.+..+
T Consensus 777 q~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999998653 345788899999999999999999887 999999999999999999999999999988766
Q ss_pred Cccccc-cccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 011153 425 ITHISA-TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNS 478 (492)
Q Consensus 425 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~~~~ 478 (492)
...... ...-.+.|||-|.+....|+.++|||||||.+||++| |.+|.......
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~ 907 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE 907 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH
Confidence 544433 2234689999999999999999999999999999997 66776654433
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=284.57 Aligned_cols=205 Identities=25% Similarity=0.334 Sum_probs=182.3
Q ss_pred HHhcccccCCcccccCcccEEEEEecC-CCEEEEEEeccCCh---hhHHHHHHHHHHHhccC-cCceeeeeeeeecCCcc
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTT---QWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPES 340 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 340 (492)
.....|+..+.||+|.||.||+++.+. |+.+|+|.+.+... ...+...+|+.+|+++. |||||.+.+.+++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345668889999999999999999764 99999999966533 34568899999999998 99999999999999999
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC----CCcEEEeecC
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE----EFTAKIADFG 416 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~----~~~~kl~Dfg 416 (492)
++|||++.+|.|.+.+... .+++.....++.||+.+++|||+.+ |+||||||+|+|+.. ++.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999998655 3999999999999999999999988 999999999999953 3579999999
Q ss_pred CccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
++..... .......+||+.|+|||++....++..+||||+||++|.|++|..||....+.+
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~ 245 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE 245 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH
Confidence 9998766 344567899999999999999999999999999999999999999998876554
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=272.23 Aligned_cols=200 Identities=29% Similarity=0.394 Sum_probs=170.6
Q ss_pred ccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCC
Q 011153 270 YFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
+|++.+.||+|+||.||++...++..+|+|.+..... ....+.+|+++++.++||||+++++++.+.+..++|+||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4778899999999999999987777899998864332 245688999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++...+......
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 99999885432 36899999999999999999999988 99999999999999999999999999876543322222
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
....++..|+|||.+....++.++||||||+++|||++ |+.|+...
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 22234568999999998999999999999999999999 77777543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=291.92 Aligned_cols=210 Identities=25% Similarity=0.394 Sum_probs=177.4
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEec----cCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc--ce
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLF----YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE--SL 341 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~----~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~ 341 (492)
+..+..++||+|+|-+||||.+. +|.+||=-.++ ..++...++|..|+.+|+.|+||||++++.+|.+... ..
T Consensus 40 Ry~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred ceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 34456778999999999999875 46666532222 1345567899999999999999999999999998776 66
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-CCcEEEeecCCccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRL 420 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgl~~~ 420 (492)
+|+|.|..|+|..++.. .+.++.+.+..|++||++||.|||++. |||||||||-.||+|+. .|.|||+|+|||..
T Consensus 120 ~iTEL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHH
Confidence 99999999999999854 345788899999999999999999986 89999999999999975 58999999999987
Q ss_pred cCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcHHHHHH
Q 011153 421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVI 486 (492)
Q Consensus 421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~~~~~~~~~ 486 (492)
..... ...+.|||.|||||++. ..|+..+||||||+.++||+|+..|.....+...+...|-
T Consensus 196 ~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~ 257 (632)
T KOG0584|consen 196 LRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT 257 (632)
T ss_pred hhccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH
Confidence 65442 33579999999999765 8899999999999999999999999999888776666553
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=272.73 Aligned_cols=193 Identities=24% Similarity=0.299 Sum_probs=165.7
Q ss_pred ccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCCc
Q 011153 277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (492)
Q Consensus 277 iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 352 (492)
||+|+||.||++... +++.+|+|++.... ......+..|++++++++||||+++.+.+.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 68999999986432 12234556799999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccccc
Q 011153 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432 (492)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 432 (492)
.+.+.... ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~ 154 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQR 154 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eecc
Confidence 88775432 345889999999999999999999988 99999999999999999999999999876644321 2234
Q ss_pred cccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 433 ~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.|++.|+|||++.+..++.++|||||||++|||++|+.|+...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 6889999999999888999999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=318.59 Aligned_cols=204 Identities=26% Similarity=0.392 Sum_probs=168.6
Q ss_pred HhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
....+...++||+|+||.||+|+. .++..||||++...... ...|++.+++++|||||++++++.+++..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 345577888999999999999986 57899999998644322 2356889999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++|+|.+++. .++|..+.+++.||++||+|||+...++|+||||||+||+++.++.+++. |+........
T Consensus 764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 999999999883 38899999999999999999996655669999999999999999988875 6655433221
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-CcHHHHHH
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS-CSILQTVI 486 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~-~~~~~~~~ 486 (492)
....+++.|||||++....++.++|||||||++|||++|+.|+...... ..+++|++
T Consensus 836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~ 893 (968)
T PLN00113 836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR 893 (968)
T ss_pred ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHH
Confidence 1236789999999999999999999999999999999999998543222 25555554
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=271.55 Aligned_cols=207 Identities=26% Similarity=0.279 Sum_probs=177.8
Q ss_pred cccccCCcccccCcccEEEEEecC-CCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
+.|+..+.||.|.-|+||++++.+ +..+|+|++.+.. .+...+...|-++|+.++||.++.|+..++.+...+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 446778899999999999999865 5889999997653 334456677999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
|||+||+|...++ ++....+++..+.-++.+++.||+|||-.| ||.|||||+||||.++|++-|+||.|+......
T Consensus 157 eyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999988775 456677999999999999999999999988 999999999999999999999999997532100
Q ss_pred ----------------------------------C---------------------ccccccccccccccchhhhccCCC
Q 011153 425 ----------------------------------I---------------------THISATLAGTLGYMAPEYVVRGKL 449 (492)
Q Consensus 425 ----------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 449 (492)
. ...+...+||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 001123469999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 450 TEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 450 ~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
+..+|.|+|||+||||+.|+.||.-..+.+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~ 342 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE 342 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchh
Confidence 999999999999999999999999887766
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=273.36 Aligned_cols=204 Identities=31% Similarity=0.442 Sum_probs=178.6
Q ss_pred HhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+..+|+..++||+|+||.||+|...+++.+++|.+..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44568889999999999999999888999999999877665677899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++... ....+++..+.+++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999998643 3356899999999999999999999988 99999999999999999999999999986654322
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
. .....++..|++||.+..+.++.++||||||++++||++ |+.|+...
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~ 208 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence 2 123345778999999988899999999999999999999 78887543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=274.82 Aligned_cols=203 Identities=30% Similarity=0.474 Sum_probs=172.0
Q ss_pred cccccCCcccccCcccEEEEEecC------CCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
++|+..+.||+|+||.||+|.... ...|++|.+.... ......+.+|++++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357889999999999999998643 2579999986543 344567899999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC
Q 011153 342 LVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~ 408 (492)
+++||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999998864321 145889999999999999999999988 99999999999999999
Q ss_pred cEEEeecCCccccCCCC-ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 409 TAKIADFGLVRLFPEDI-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 409 ~~kl~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
.+||+|||+++...... ........+++.|+|||.+..+.++.++||||||+++|||++ |..||..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG 229 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999997653322 122233456789999999998999999999999999999998 8888754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=274.97 Aligned_cols=203 Identities=28% Similarity=0.426 Sum_probs=173.5
Q ss_pred cccccCCcccccCcccEEEEEecC------CCEEEEEEeccCChh-hHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
+.|.+.+.||+|+||.||++...+ ++.||||.+...... ..+.+.+|+++++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457788999999999999998633 468999998765443 4678999999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcE
Q 011153 342 LVYEFVPNQSLLDNLFVRQ-----------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ 410 (492)
+||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999886432 2345789999999999999999999988 9999999999999999999
Q ss_pred EEeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 411 KIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 411 kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
||+|||+++....... .......+++.|+|||++..+.++.++||||||+++|||++ |+.|+..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~ 227 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG 227 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 9999999875433221 12223446789999999999999999999999999999999 9988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=270.39 Aligned_cols=201 Identities=31% Similarity=0.440 Sum_probs=172.0
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
..|...++||+|+||.||++... .++.|++|.+..+. .....+.+|+++++.++||||+++++++..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778899999999999999865 57889999986543 33567899999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999988543 2345899999999999999999999987 999999999999999999999999999866543322
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
.......++.|+|||.+....++.++||||||++++||++ |..|+..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 208 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 2222334678999999988999999999999999999998 8888754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=274.61 Aligned_cols=199 Identities=27% Similarity=0.317 Sum_probs=172.0
Q ss_pred cccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
|+..++||+|+||+||++.. .+++.+|+|.+.... ......+.+|+++++.++|+||+++.+.+.+++..++|+||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678899999999999986 468899999986532 22345578899999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+.+.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999988775432 345899999999999999999999988 99999999999999999999999999876543221
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.....|++.|+|||.+.+..++.++|+||||++++||++|+.||...
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 22456899999999999889999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=274.07 Aligned_cols=205 Identities=29% Similarity=0.416 Sum_probs=171.1
Q ss_pred HhcccccCCcccccCcccEEEEEec------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (492)
..++|+..+.||+|+||.||+|... .+..||+|++.... ......+.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998753 24679999886432 3345678899999999999999999999999999
Q ss_pred ceeEEeecCCCCchhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEE
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQD-------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl 412 (492)
.++|+||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999998854321 234678899999999999999999987 999999999999999999999
Q ss_pred eecCCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 413 ADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 413 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
+|||+++........ ......+++.|+|||.+..+.++.++||||||++++||++ |+.|+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~ 224 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 224 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 999998755432221 1122345788999999998899999999999999999999 6777654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=273.62 Aligned_cols=203 Identities=27% Similarity=0.429 Sum_probs=170.7
Q ss_pred cccccCCcccccCcccEEEEEe-----cCCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
..|+..++||+|+||.||+|.. .++..+++|.+... ..+....+.+|+++++.++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3577789999999999999974 24578999998743 33445678899999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC
Q 011153 343 VYEFVPNQSLLDNLFVRQD--------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~ 408 (492)
||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999998853221 235788999999999999999999988 99999999999999999
Q ss_pred cEEEeecCCccccCCCC-ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 409 TAKIADFGLVRLFPEDI-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 409 ~~kl~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
.+||+|||+++...... ........++..|+|||.+....++.++||||||++++||++ |..||..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 99999999997654322 112223445778999999988889999999999999999999 8877754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=282.48 Aligned_cols=205 Identities=28% Similarity=0.397 Sum_probs=170.2
Q ss_pred HhcccccCCcccccCcccEEEEEec------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CcCceeeeeeeeecC-
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG- 337 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 337 (492)
+.++|++.++||+|+||.||++... +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3457899999999999999999642 24689999987543 33456788999999999 899999999987654
Q ss_pred CcceeEEeecCCCCchhhhhccCC--------------------------------------------------------
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQD-------------------------------------------------------- 361 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 361 (492)
...++++||+++++|.+.+.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 567899999999999988753221
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc-cccccccccc
Q 011153 362 --VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI-SATLAGTLGY 438 (492)
Q Consensus 362 --~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y 438 (492)
..++++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+....... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 136899999999999999999999988 9999999999999999999999999998664332211 2234567789
Q ss_pred cchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 439 ~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
+|||++.+..++.++|||||||+++||++ |+.|+..
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999999999998 9888864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=288.35 Aligned_cols=201 Identities=25% Similarity=0.322 Sum_probs=172.1
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccC-c-----CceeeeeeeeecCCcce
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-H-----KNLVKLLGCSITGPESL 341 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~ 341 (492)
-+|++.+.||+|.||.|.++.. .+++.||||+++.. .....+-..|+.+|..|+ | -|+|+++++|...+..+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 3789999999999999999985 56999999999654 344566778999999986 4 48999999999999999
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC--CcEEEeecCCcc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE--FTAKIADFGLVR 419 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~Dfgl~~ 419 (492)
||+|.+ ..+|.+++... +...++...+..|+.||+.||..||+.+ |||.||||+||||.+- ..+||+|||.+.
T Consensus 265 iVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 999998 56899988544 4556999999999999999999999988 9999999999999643 479999999998
Q ss_pred ccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
....... +..-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|...++.+
T Consensus 340 ~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 340 FESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred ccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 6554322 4566889999999999999999999999999999999977776655443
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=270.67 Aligned_cols=200 Identities=30% Similarity=0.430 Sum_probs=172.3
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC-----hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-----TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
++|+..+.||+|++|.||++.. .+++.+++|.+.... ....+.+.+|++++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999986 468899999886432 2234578899999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
|+||+++++|.+.+... ..+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999887432 45788999999999999999999988 9999999999999999999999999987654
Q ss_pred CCCcccc--ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 423 EDITHIS--ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 423 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
....... ....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 3221111 234578899999999988899999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=262.43 Aligned_cols=201 Identities=24% Similarity=0.367 Sum_probs=174.1
Q ss_pred hcccccCCcccccCcccEEEEE-ecCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++.|++.+.||+|.|+.|++.. .++|+.+|+|.+... +....+++.+|+++-+.|+||||++|.+...+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4567788899999999999986 467899998887543 3446788999999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC---CCCcEEEeecCCcccc
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLF 421 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgl~~~~ 421 (492)
|+|.+++|..-+..+ ..+++...-..+.||+++|.|+|.++ |||||+||.|+|+- ...-+||+|||++..+
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999997666443 34677888899999999999999998 99999999999994 3456999999999877
Q ss_pred CCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
++ .......+|||+|||||++.+.+|+..+|||+-||+|+-|+.|.+||...+
T Consensus 164 ~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~ 216 (355)
T KOG0033|consen 164 ND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 216 (355)
T ss_pred CC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc
Confidence 72 333446789999999999999999999999999999999999999998743
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=273.30 Aligned_cols=204 Identities=26% Similarity=0.400 Sum_probs=173.7
Q ss_pred hcccccCCcccccCcccEEEEEec------CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
.++|.+.+.||+|+||.||++... ++..+++|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 356888999999999999999742 24568999987766666778999999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEE
Q 011153 342 LVYEFVPNQSLLDNLFVRQ----------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK 411 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~k 411 (492)
+|+||+++++|.+++.... ....+++..++.++.|++.+|+|||+.+ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999998885332 2235899999999999999999999988 99999999999999999999
Q ss_pred EeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 412 IADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 412 l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
|+|||+++....... .......+++.|+|||.+....++.++||||||++++||++ |+.|+..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~ 225 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999976543221 11223345778999999988899999999999999999998 8888754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=274.07 Aligned_cols=199 Identities=27% Similarity=0.335 Sum_probs=171.8
Q ss_pred cccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
|+..++||+|+||.||++... +++.+|+|.+.... ......+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667889999999999999864 68899999986532 22345677899999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+.+.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999998875432 345889999999999999999999987 99999999999999999999999999876543221
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 12346899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=275.56 Aligned_cols=205 Identities=25% Similarity=0.302 Sum_probs=180.7
Q ss_pred HHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
...+.|+.-++||+|+||.|+-.+. .+|+.+|.|++.+. ........++|-.+|.+++.+.||.+-..+++.+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 3456688889999999999999875 46888999988543 2333445678999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+|+..|.||+|.-+|+.... ..+++...+-.+.+|+.||++||+.. ||.|||||+|||+|+.|+++|+|+|||..+
T Consensus 262 lVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999999976655 45999999999999999999999988 999999999999999999999999999987
Q ss_pred CCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
++.... ...+||.+|||||++.++.|+...|.|||||+||||+-|+.||-...
T Consensus 338 ~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 338 PEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred CCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 765443 34489999999999999999999999999999999999999997644
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=286.90 Aligned_cols=203 Identities=31% Similarity=0.461 Sum_probs=178.4
Q ss_pred HHHHHHhcccccCCcccccCcccEEEEEecC-CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcc
Q 011153 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (492)
Q Consensus 262 ~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (492)
+.++-...+....++||-|.||.||.|.++. .-.||||.++++..+ .++|+.|+.+|+.++|||+|+|+|+|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4445455667788999999999999999865 457999999776544 78999999999999999999999999999999
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
|||+|||..|+|.++|.... ...++...++.++.||..||+||..++ +|||||.++|+|+.++..+||+||||+++
T Consensus 339 YIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999996543 345788889999999999999999988 99999999999999999999999999999
Q ss_pred cCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCC
Q 011153 421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469 (492)
Q Consensus 421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~ 469 (492)
...+.........-++.|.|||.+.-..++.|+|||+|||+||||.|-.
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYG 463 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYG 463 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcC
Confidence 8777655444444578999999999999999999999999999999854
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=269.58 Aligned_cols=201 Identities=30% Similarity=0.427 Sum_probs=170.3
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
..+|++.++||+|+||.||+|+..+...||+|++..... ..+.+.+|+++++.++||||+++++.+. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 356889999999999999999987777899999875332 3457899999999999999999999774 45679999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999988543 2345789999999999999999999988 999999999999999999999999999866543322
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
......++..|+|||.+....++.++||||||++++||++ |+.|+..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~ 206 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 2223456778999999988899999999999999999999 7767654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=291.29 Aligned_cols=201 Identities=24% Similarity=0.349 Sum_probs=163.2
Q ss_pred HhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecC--------
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-------- 337 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 337 (492)
...+|+..++||+|+||.||+|.. .+++.||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 346799999999999999999986 468899999885432 2345799999999999999999876432
Q ss_pred CcceeEEeecCCCCchhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-cEEEeec
Q 011153 338 PESLLVYEFVPNQSLLDNLFV-RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADF 415 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Df 415 (492)
...++||||+++ +|.+.+.. ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999975 66655532 234456899999999999999999999988 99999999999998664 7999999
Q ss_pred CCccccCCCCccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 416 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
|+++.+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|++||.....
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 276 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99986643322 2245679999999988764 689999999999999999999999876443
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=286.85 Aligned_cols=196 Identities=33% Similarity=0.505 Sum_probs=170.3
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCCh---hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT---QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
..|..++.||.|+||.||.++. .+.+.||||++..... +-++.++.|++.|++++|||+|.+.||+..+...||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3467788899999999999985 4678899999976543 44667899999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
|||- ||-.+.+... .+++.+..+..|..+.+.||+|||+++ .||||||+.|||+++.|.|||+|||.+.+..+
T Consensus 106 EYCl-GSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 106 EYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HHHh-ccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 9995 4666666433 345888889999999999999999998 99999999999999999999999999876543
Q ss_pred Cccccccccccccccchhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.+..+|||.|||||+|. .+.|+.|+|||||||...||.-+|+|.+..
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM 228 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 228 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc
Confidence 34678999999999985 478999999999999999999999997653
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=265.76 Aligned_cols=195 Identities=30% Similarity=0.439 Sum_probs=167.3
Q ss_pred CcccccCcccEEEEEecCCCEEEEEEeccCCh-hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCCch
Q 011153 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLL 353 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (492)
++||+|+||.||+|...+++.+|+|.+..... .....+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46999999999999988889999999876543 33457889999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccccccc
Q 011153 354 DNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433 (492)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 433 (492)
+++... ...+++..+..++.|++.+|.|||+.+ ++|+||||+||++++++.+||+|||++...............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 887432 345789999999999999999999988 999999999999999999999999998754433222222234
Q ss_pred ccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 434 gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
+++.|+|||++..+.++.++||||||+++|||++ |..||..
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~ 197 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC
Confidence 4678999999988899999999999999999999 8888754
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=273.54 Aligned_cols=204 Identities=26% Similarity=0.381 Sum_probs=174.3
Q ss_pred cccccCCcccccCcccEEEEEec------CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
++|...+.||+|+||.||++... ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45778899999999999999742 345689999877666666789999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc
Q 011153 343 VYEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~ 409 (492)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ ++||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999885432 1245899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 410 AKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 410 ~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
++|+|||++........ .......++..|+|||.+....++.++||||||++++||++ |+.|+...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999976543321 12234456789999999999999999999999999999999 88887543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=294.55 Aligned_cols=207 Identities=25% Similarity=0.341 Sum_probs=173.8
Q ss_pred HhcccccCCcccccCcccEEEEEecCC-CEEEEEEeccCChhhHHHHHHHHHHHhccC-cCceeeeeee-eec------C
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPGG-EAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGC-SIT------G 337 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~ 337 (492)
...+.++.+.|.+|||+.||.+....+ ..+|+|++...++...+...+||++|++|+ |||||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345577888999999999999997765 999999998888888999999999999996 9999999993 321 1
Q ss_pred CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCC
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl 417 (492)
-+.+|.||||++|+|.+++..+.... |++.++++|+.|+++|+++||... +||||||||.+||||+.+++.||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 24579999999999999996554444 999999999999999999999985 8999999999999999999999999999
Q ss_pred ccccCCCC--ccc------cccccccccccchhhh---ccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 418 VRLFPEDI--THI------SATLAGTLGYMAPEYV---VRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 418 ~~~~~~~~--~~~------~~~~~gt~~y~aPE~~---~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
+.-.-... ... .-...-|+.|+|||++ .+.+.++|+|||+|||+||-|+-...||+..
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 86221111 100 0022358999999987 4567899999999999999999999999865
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=269.16 Aligned_cols=203 Identities=31% Similarity=0.453 Sum_probs=173.6
Q ss_pred HhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
..+.|++.++||+|+||.||++...+++.+|+|.+..... ..+.+.+|+.+++.++||||+++++++ ..+..++++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 3467888999999999999999988899999999875443 346788999999999999999999976 45678999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999987543 3346899999999999999999999987 99999999999999999999999999986653322
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
.......++..|+|||++....++.++||||||++++||++ |+.|+...
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 22223445778999999988889999999999999999999 89888643
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=269.27 Aligned_cols=202 Identities=26% Similarity=0.402 Sum_probs=171.8
Q ss_pred hcccccCCcccccCcccEEEEEecC----CCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
.++|+..+.||+|+||.||+|.+.. ...|+||.+.... ......|.+|+.++++++||||+++++++.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3568889999999999999998642 3579999886543 3445678999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
||||+++++|.+++... ...+++..+++++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999988543 236899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 423 EDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 423 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
..... ......+++.|+|||.+....++.++||||||++++||++ |..|+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 22221 1112334678999999998899999999999999999998 8888743
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=267.70 Aligned_cols=201 Identities=31% Similarity=0.450 Sum_probs=171.2
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
.++|++.++||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|||++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 456888999999999999999988888899999875433 2457899999999999999999999875 45689999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999988543 2345899999999999999999999988 999999999999999999999999999866543322
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
......++..|+|||.+....++.++||||||++++||++ |+.|+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 206 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 2223345678999999988899999999999999999999 7777754
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=274.61 Aligned_cols=201 Identities=28% Similarity=0.438 Sum_probs=175.9
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
..+|+..+.||+|+||.||++.. .+++.+++|.+........+.+.+|+.+++.++||||+++++.+..+...++|+||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35688889999999999999985 46889999999776666667889999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998732 34789999999999999999999988 99999999999999999999999999876543321
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
. .....+++.|+|||.+.+..++.++||||||++++||++|+.||....
T Consensus 172 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred c-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 223467899999999988889999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=258.79 Aligned_cols=201 Identities=26% Similarity=0.396 Sum_probs=172.8
Q ss_pred HhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC--------hhhHHHHHHHHHHHhcc-CcCceeeeeeeeec
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--------TQWVDHFFNEVNLISGI-NHKNLVKLLGCSIT 336 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 336 (492)
.-+.|...+.||.|..+.|-+... .+++++|+|++.... ....+.-.+|+.+|+++ .||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 345678889999999999988764 568899999885321 12344567899999998 79999999999999
Q ss_pred CCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 011153 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (492)
Q Consensus 337 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 416 (492)
+...++|+|.|+.|.|.++|. ..-.++++...+|+.|+.+|+.|||..+ ||||||||+|||++++.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 999999999999999999993 3456899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCccccccccccccccchhhhcc------CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVR------GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
++..+... ......+|||+|+|||.+.- ..|+..+|+|+.||+++.|+.|-+||.+-
T Consensus 169 Fa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR 231 (411)
T KOG0599|consen 169 FACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR 231 (411)
T ss_pred eeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH
Confidence 99877553 34457899999999998743 34788999999999999999999999763
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=270.36 Aligned_cols=201 Identities=28% Similarity=0.412 Sum_probs=167.3
Q ss_pred cccccCCcccccCcccEEEEEec-CCC----EEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGE----AVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
.+|+..+.||+|+||+||+|... +++ .+++|.+.... .....++..|+..++.++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 45778899999999999999863 444 47888775443 234567888899999999999999999875 456789
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999988543 345899999999999999999999988 9999999999999999999999999998654
Q ss_pred CCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 423 EDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 423 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
..... ......++..|+|||.+..+.++.++||||||+++|||++ |+.|+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 33221 2224456789999999998999999999999999999998 88887543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=282.73 Aligned_cols=206 Identities=29% Similarity=0.431 Sum_probs=178.3
Q ss_pred hcccccCCcccccCcccEEEEEecC---CC--EEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG---GE--AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~---~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
.+.....++||+|-||.||+|...+ |+ .||||..+.+ ..+..+.|+.|..+|++++|||||+|+|+|.+ ...+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 3445567889999999999998532 33 5899988774 55668899999999999999999999999965 4678
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+|||+.+-|.|..+|..+ ...++...+..++.||..+|+|||+.. +|||||.++|||+.+.--+||+||||++.+
T Consensus 467 ivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 999999999999999654 345889999999999999999999987 999999999999999999999999999998
Q ss_pred CCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSC 479 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~~~~~ 479 (492)
.++.........-++.|||||.+.-.+|+..||||.|||.+|||++ |.+||....+++
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD 600 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD 600 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence 8876666666667899999999999999999999999999999876 778887655544
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=269.96 Aligned_cols=200 Identities=29% Similarity=0.398 Sum_probs=172.4
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
..+|++.+.||+|+||.||+|+. .+++.+|+|++..........+.+|+.++++++||||+++++.+..++..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35688899999999999999986 56889999999766555566788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++........
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999988743 245789999999999999999999987 99999999999999999999999999986543221
Q ss_pred cccccccccccccchhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
......+++.|+|||.+. ...++.++||||||++++||++|+.|+..
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~ 211 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 112346788999999874 34578899999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=266.68 Aligned_cols=202 Identities=26% Similarity=0.400 Sum_probs=175.7
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+|+..+.||+|++|.||++... +++.|++|.+... .....+.+.+|+++++.++||||+++++++.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3677889999999999999864 6889999998643 344567789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999988643 2356899999999999999999999987 99999999999999999999999999886654322
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
......+++.|+|||++.+..++.++|+||||++++||++|+.|+....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1234467889999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=270.86 Aligned_cols=192 Identities=26% Similarity=0.377 Sum_probs=168.7
Q ss_pred ccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
+|+..++||+|+||.||++.. .+++.||+|.+... .....+.+.+|++++++++||||+++++.+..++..++|+||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577789999999999999985 56889999998654 3444567899999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++++|.... .+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999986432 3678889999999999999999988 9999999999999999999999999987654322
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.....++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 2245688999999999988999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=275.14 Aligned_cols=197 Identities=25% Similarity=0.377 Sum_probs=171.7
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
++|++.++||+|+||.||++... ++..+++|.+... .......+.+|++++++++||||+++++++.+++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 35888999999999999999864 5788999988654 334456788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
+++++|.+++... ..+++..+..++.|++.||.|||+. + ++|+||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999988533 4588999999999999999999974 5 9999999999999999999999999987543321
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.....+++.|+|||.+.+..++.++||||||++++||++|+.|+..
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 2345688999999999888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=276.02 Aligned_cols=202 Identities=24% Similarity=0.347 Sum_probs=169.8
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
++|...++||+|+||.||+++.. +++.||+|++.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999865 57889999987543 22344678899999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++ +|.+.+... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 777766432 335788999999999999999999988 99999999999999999999999999875433222
Q ss_pred cccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
. .....+++.|+|||.+.+ ..++.++||||||++++||++|+.||.....
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 210 (309)
T cd07872 160 T-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210 (309)
T ss_pred c-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 1 223457899999998865 4688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=276.56 Aligned_cols=197 Identities=24% Similarity=0.401 Sum_probs=160.3
Q ss_pred CCcccccCcccEEEEEec---CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeec--CCcceeEEeecC
Q 011153 274 SNKLGQGGSGSVYKGTLP---GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPESLLVYEFVP 348 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 348 (492)
.++||+|+||+||+++.. +++.+|+|.+.... ....+.+|++++++++||||+++++++.. +...++++||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 568999999999999854 46789999986442 23457789999999999999999998864 345689999986
Q ss_pred CCCchhhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee----CCCCcEEEeecCCc
Q 011153 349 NQSLLDNLFVR------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLV 418 (492)
Q Consensus 349 ~gsL~~~l~~~------~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~Dfgl~ 418 (492)
++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4776665322 12235889999999999999999999988 9999999999999 45679999999999
Q ss_pred cccCCCCcc--ccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 419 RLFPEDITH--ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 419 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+........ ......+|+.|+|||++.+. .++.++||||+||+++||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876543222 12345789999999998774 58899999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=282.23 Aligned_cols=198 Identities=29% Similarity=0.376 Sum_probs=167.3
Q ss_pred HhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC-----
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----- 338 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 338 (492)
..++|+..+.||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357799999999999999999986 45889999998643 3344567889999999999999999999886543
Q ss_pred -cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCC
Q 011153 339 -ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (492)
Q Consensus 339 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl 417 (492)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999975 5555542 23788889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 418 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
++...... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 97543321 123456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=268.05 Aligned_cols=199 Identities=31% Similarity=0.447 Sum_probs=178.0
Q ss_pred cccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCC
Q 011153 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
|.+.++||+|+||.|||+.++ .|+.+|||++..++ ..+++..|+.+|++.+.|++|+++|.+.....+++|||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 677889999999999999864 69999999986543 468899999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
|+..+.+..+ .+++++..+..++...++||+|||... -||||||+.|||++.+|.+||+|||.+..+.+... ..
T Consensus 113 GSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KR 186 (502)
T KOG0574|consen 113 GSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KR 186 (502)
T ss_pred CcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-hh
Confidence 9999988544 456999999999999999999999876 79999999999999999999999999987665433 23
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
+++.|||-|||||++..-.|+.++||||||+...||.-|++|+..-++
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP 234 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP 234 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc
Confidence 478899999999999999999999999999999999999999875443
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=269.60 Aligned_cols=201 Identities=28% Similarity=0.401 Sum_probs=173.4
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
.++|+..++||+|+||.||++.. .+++.+|+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 34677888999999999999986 46889999998766555566788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999998743 345889999999999999999999988 99999999999999999999999999876543221
Q ss_pred cccccccccccccchhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
......|++.|+|||.+. .+.++.++|||||||++|||++|+.|+...
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence 122456889999999874 456889999999999999999999997543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=267.83 Aligned_cols=202 Identities=24% Similarity=0.377 Sum_probs=173.9
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.++||+|+||.||+++.. +++.||||.+... .......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888999999999999999864 6889999987542 3344567889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 345 EFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
||+++++|.+++.... ....++...+..++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988775322 2345788999999999999999999988 99999999999999999999999999886654
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.|+..
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~ 208 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 322 12234678899999999888899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=270.35 Aligned_cols=199 Identities=29% Similarity=0.411 Sum_probs=171.3
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecC
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (492)
.|++.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++.+..++..++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3677889999999999999875 477889999876666667789999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 428 (492)
+++|...+.. ...++++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ .
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 9999887643 2346899999999999999999999988 99999999999999999999999999875533221 2
Q ss_pred cccccccccccchhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 429 SATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.....+++.|+|||++. ...++.++|||||||++|||++|++|+..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 210 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence 23456889999999874 34577899999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=264.79 Aligned_cols=195 Identities=26% Similarity=0.413 Sum_probs=164.7
Q ss_pred CcccccCcccEEEEEec-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCCc
Q 011153 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 352 (492)
+.||+|+||.||+++.. +++.+|+|.+... ..+....+.+|++++++++||||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999864 6889999987654 334556799999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc-ccc
Q 011153 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI-SAT 431 (492)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~ 431 (492)
.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......... ...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 998843 2345889999999999999999999988 9999999999999999999999999987543321111 111
Q ss_pred ccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 432 LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 432 ~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
...+..|+|||.+..+.++.++||||||++++||++ |..|+..
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 223567999999998999999999999999999998 7777653
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=266.81 Aligned_cols=203 Identities=33% Similarity=0.456 Sum_probs=175.0
Q ss_pred HhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
..++|++.++||+|+||.||++..++++.++||.+..... ..+.+.+|+.++++++||||+++++++......++|+||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 4567899999999999999999988888999999875433 346789999999999999999999999988999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++... ....+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999988543 2345899999999999999999999988 99999999999999999999999999886654322
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
........+..|+|||.+.+..++.++||||||++++||++ |+.|+..
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 207 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 22223334678999999998889999999999999999999 8888754
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=263.08 Aligned_cols=202 Identities=24% Similarity=0.401 Sum_probs=171.0
Q ss_pred cccccCCcccccCcccEEEEEec---C--CCEEEEEEeccCCh--hhHHHHHHHHHHHhccCcCceeeeeeeeec-CCcc
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP---G--GEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSIT-GPES 340 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~---~--~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 340 (492)
..|+....||+|.||.||++.-. + .+.+|||+++.+.. .......+|+.++++++||||+.|..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 45888999999999999999532 2 23789999975422 234567899999999999999999999988 7788
Q ss_pred eeEEeecCCCCchhhhhc--cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC----CcEEEee
Q 011153 341 LLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE----FTAKIAD 414 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~D 414 (492)
++++||.+. +|...++. ..+...++...+.+|+.||+.|+.|||++. |+||||||.||||..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999965 77776643 334467899999999999999999999999 9999999999999877 8999999
Q ss_pred cCCccccCCCCccc--cccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 415 FGLVRLFPEDITHI--SATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 415 fgl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
||+++++.....+. ...++-|+.|.|||++.+. .|++..|||+.|||+.||++-++.|.-
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 99999987765443 3467789999999999875 589999999999999999999988864
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=287.00 Aligned_cols=195 Identities=25% Similarity=0.351 Sum_probs=167.3
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
...|.+.+.||+|+||.||++... .++.||||... ...+.+|+++|++++|+||+++++++..++..++|+|+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 456889999999999999999875 47889999642 23467899999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+. ++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 6887777432 346899999999999999999999988 99999999999999999999999999986543322
Q ss_pred c-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 427 H-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 427 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
. ......||+.|+|||++.+..++.++|||||||+||||++|..|+..
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 1 22245799999999999999999999999999999999999876543
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=253.62 Aligned_cols=208 Identities=25% Similarity=0.307 Sum_probs=177.6
Q ss_pred HHhcccccCCcccccCcccEEEEE-ecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC-----c
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-----E 339 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 339 (492)
...++|++.++||+|||+-||.++ +.+++.+|+|++.-.+.+..+..++|++.-++++||||++++++...+. .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 456789999999999999999998 6778999999998777778889999999999999999999999876544 3
Q ss_pred ceeEEeecCCCCchhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCc
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~ 418 (492)
.|++++|...|+|.+.+.... ++..+++.+++.|+.+|++||++||+.. +++.||||||.|||+++.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999999987654 4458999999999999999999999986 68999999999999999999999999998
Q ss_pred cccCCCCccc--------cccccccccccchhhhcc---CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 419 RLFPEDITHI--------SATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 419 ~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
....-..... -.....|..|.|||.+.- ...+.++|||||||+||+|+.|..||..
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 7543211110 012346899999998743 4467899999999999999999999975
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=282.44 Aligned_cols=208 Identities=27% Similarity=0.371 Sum_probs=172.8
Q ss_pred HHHHhcccccCCcccccCcccEEEEEec------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccC-cCceeeeeeeee
Q 011153 264 LEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGIN-HKNLVKLLGCSI 335 (492)
Q Consensus 264 l~~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 335 (492)
.+...++|.+.++||+|+||.||++++. .++.||+|+++... ....+.+.+|+++|.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3344556888899999999999999853 34579999997543 333457889999999997 999999999999
Q ss_pred cCCcceeEEeecCCCCchhhhhccCC------------------------------------------------------
Q 011153 336 TGPESLLVYEFVPNQSLLDNLFVRQD------------------------------------------------------ 361 (492)
Q Consensus 336 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 361 (492)
..+..++|+||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999998864321
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 011153 362 -----------------------------------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLS 400 (492)
Q Consensus 362 -----------------------------------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~ 400 (492)
...+++..++.++.||+.||+|||+.+ ++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 124678888999999999999999987 999999999
Q ss_pred CeeeCCCCcEEEeecCCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 401 NILLDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 401 Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
|||+++++.+||+|||+++........ ......+++.|||||.+....++.++||||||+++|||++ |+.|+..
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999865332211 1123456789999999998889999999999999999998 8888754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=282.42 Aligned_cols=192 Identities=28% Similarity=0.325 Sum_probs=160.7
Q ss_pred ccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcc---CcCceeeeeeeeecCCcceeEEeecCC
Q 011153 277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGI---NHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 277 iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
||+|+||+||+++.. +++.||||++.... ......+..|..++... +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999864 68899999986432 22334455677776655 799999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~ 153 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TT 153 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Cc
Confidence 999888743 345889999999999999999999988 99999999999999999999999999875432221 22
Q ss_pred ccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....||+.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 345789999999998764 4789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=267.40 Aligned_cols=200 Identities=30% Similarity=0.407 Sum_probs=169.0
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC-----ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC--Ccc
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PES 340 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 340 (492)
++|++.++||+|+||.||++... ++..|+||.+... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 56888999999999999999864 5889999988532 123456788999999999999999999988764 456
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++++||+++++|.+++... ..+++....+++.|++.+|+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 7999999999999887532 34788889999999999999999988 99999999999999999999999999875
Q ss_pred cCCCCcc--ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 421 FPEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 421 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 5322111 12234578899999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=269.30 Aligned_cols=203 Identities=26% Similarity=0.374 Sum_probs=172.4
Q ss_pred cccccCCcccccCcccEEEEEec------CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
+++...++||+|+||.||++... ++..+++|.+........+.+.+|+++++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45777899999999999999642 355789999877666667789999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcE
Q 011153 343 VYEFVPNQSLLDNLFVRQD------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ 410 (492)
++||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999998854321 135889999999999999999999988 9999999999999999999
Q ss_pred EEeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 411 KIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 411 kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
||+|||++........ .......+++.|+|||.+....++.++||||||+++|||++ |++|+..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999875533221 11223345788999999998999999999999999999998 8888744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=269.56 Aligned_cols=201 Identities=26% Similarity=0.426 Sum_probs=170.5
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+|+..+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3778899999999999999864 68899999986542 23346788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
++ ++|.+++........+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 688887755444467899999999999999999999988 99999999999999999999999999876543221
Q ss_pred cccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
......+++.|+|||.+.+. .++.++||||||++++||++|+.|+...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 12234568899999988654 5788999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=263.24 Aligned_cols=205 Identities=26% Similarity=0.312 Sum_probs=179.5
Q ss_pred HhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
..++|..+++||+|.||+|...+- ..++.+|+|+++++ ..+.+..-+.|-++|+..+||.+..|...|+..+.++.
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 346788899999999999999984 46899999999865 44556677889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
||||..+|.|.-+|.. ...+++....-.-..|+.||.|||+++ ||.||||.+|.|+|.||++||+||||++.--
T Consensus 246 VMeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 9999999999888843 345777877888899999999999988 9999999999999999999999999997421
Q ss_pred CCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
.......+.+|||.|+|||++.+..|...+|.|.+||++|||++|+.||-..+.+
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~ 374 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE 374 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence 1223345789999999999999999999999999999999999999999876554
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=267.18 Aligned_cols=198 Identities=28% Similarity=0.353 Sum_probs=160.3
Q ss_pred CcccccCcccEEEEEecC---CCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCC
Q 011153 275 NKLGQGGSGSVYKGTLPG---GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (492)
+.||+|+||.||+|...+ ...+++|.+.... ......+.+|+++++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997543 3468888876443 334567889999999999999999999999999999999999999
Q ss_pred CchhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc-c
Q 011153 351 SLLDNLFVRQD--VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT-H 427 (492)
Q Consensus 351 sL~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-~ 427 (492)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99998865432 234567888999999999999999988 99999999999999999999999999865432211 1
Q ss_pred ccccccccccccchhhhcc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVR-------GKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
......+++.|+|||++.. ..++.++||||||+++|||++ |+.|+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 1123345778999998743 356789999999999999999 66666543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=268.43 Aligned_cols=204 Identities=26% Similarity=0.371 Sum_probs=173.1
Q ss_pred hcccccCCcccccCcccEEEEEecC-----CCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeec-CCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT-GPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~-----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 340 (492)
.++|+..++||+|+||.||+|...+ +..|++|++... .....+.+.+|+.+++.++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999998765 678999988654 33446678899999999999999999998776 5678
Q ss_pred eeEEeecCCCCchhhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDV-----EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 415 (492)
++++||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999988554322 56899999999999999999999987 999999999999999999999999
Q ss_pred CCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 416 GLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 416 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
|+++.+...... ......++..|+|||++....++.++||||||+++||+++ |+.|+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 222 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc
Confidence 999865433222 1223445778999999988889999999999999999999 8888754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=271.07 Aligned_cols=197 Identities=28% Similarity=0.389 Sum_probs=173.6
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|+..+.||+|+||.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999865 58899999986432 334567889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+|||+++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999888543 46889999999999999999999988 999999999999999999999999999866543
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.....+++.|+|||.+.....+.++||||||++++||++|+.|+...
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 22346789999999998888899999999999999999999998653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=268.52 Aligned_cols=200 Identities=31% Similarity=0.453 Sum_probs=168.8
Q ss_pred cccccCCcccccCcccEEEEEe-----cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeec--CCcce
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPESL 341 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 341 (492)
++|++.+.||+|+||.||++.. .++..|++|++........+.+.+|+++++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678899999999999999974 2578899999987766667789999999999999999999998754 34678
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+|+||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999988532 235899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCccc--cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 011153 422 PEDITHI--SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINL 473 (492)
Q Consensus 422 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~ 473 (492)
....... .....++..|+|||.+.+..++.++||||||++++||++|..++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 4432211 112223456999999988899999999999999999999876643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=284.32 Aligned_cols=197 Identities=26% Similarity=0.328 Sum_probs=168.9
Q ss_pred hcccccCCcccccCcccEEEEEec---CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP---GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
..+|++.+.||+|+||.||++... .+..|++|.+... ....+|+++++.++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 456999999999999999999753 3568999987543 23568999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
|++. ++|.+++ .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9995 6787777 23356899999999999999999999988 999999999999999999999999999765443
Q ss_pred Ccc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 425 ITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 425 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
... ......||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 222 2224578999999999998999999999999999999999999986543
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=265.17 Aligned_cols=200 Identities=32% Similarity=0.457 Sum_probs=169.8
Q ss_pred cccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecC
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (492)
++|++.++||+|++|.||++...++..+++|.+.... ...+.+.+|+++++.++|||++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5588889999999999999998777789999886543 23467889999999999999999998874 556889999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 428 (492)
+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999988543 2345889999999999999999999987 9999999999999999999999999997664432222
Q ss_pred cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
.....++..|+|||.+....++.++||||||++++||++ |+.|+..
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 206 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 223345778999999988899999999999999999999 7888754
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=265.62 Aligned_cols=201 Identities=26% Similarity=0.400 Sum_probs=167.0
Q ss_pred cccCCcccccCcccEEEEEecC----CCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc-----
Q 011153 271 FHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE----- 339 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 339 (492)
|.+.+.||+|+||.||+|.... +..||+|+++.. .....+.+.+|++.++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4678899999999999998642 367999998754 23445678999999999999999999998876554
Q ss_pred -ceeEEeecCCCCchhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 011153 340 -SLLVYEFVPNQSLLDNLFVRQ---DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (492)
Q Consensus 340 -~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 415 (492)
.++++||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999998885432 2346899999999999999999999988 999999999999999999999999
Q ss_pred CCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 416 GLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 416 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
|+++........ .......+..|+|||.+....++.++||||||++++||++ |..|+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~ 218 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 999865433221 1122334678999999988889999999999999999999 7777654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=272.84 Aligned_cols=204 Identities=25% Similarity=0.392 Sum_probs=179.2
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.-|...+.||+|.|..|-.+++ -+|..||||++.+.. .-....++.|++.|+.++|||||+|+.+..+...+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577788899999999999974 579999999997653 3345578899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee-CCCCcEEEeecCCccccCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL-DEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill-~~~~~~kl~Dfgl~~~~~~~ 424 (492)
+=.+|+|.+++....+ .+.++...+++.||+.|+.|+|+.+ +|||||||+||.+ ..-|.+||.|||++..+...
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999965543 4888899999999999999999988 9999999999876 56789999999999766543
Q ss_pred CccccccccccccccchhhhccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLT-EKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
...++.+|++.|-|||++.+..|+ +.+||||||||||.|++|+.||...++++
T Consensus 173 --~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE 226 (864)
T KOG4717|consen 173 --KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE 226 (864)
T ss_pred --chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence 344578999999999999999987 57999999999999999999999888776
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.13 Aligned_cols=209 Identities=24% Similarity=0.353 Sum_probs=171.6
Q ss_pred HHHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC--Cc
Q 011153 265 EKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PE 339 (492)
Q Consensus 265 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 339 (492)
+...++|++.++||+|+||+||++... +++.+|+|.+... .......+..|+.+++.++|||||++++++.+. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344578999999999999999999864 5778999988643 334456789999999999999999999988643 45
Q ss_pred ceeEEeecCCCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCC----CCeEecCCCCCCeeeCCC-------
Q 011153 340 SLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESK----LRIIHRDIKLSNILLDEE------- 407 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~----~~ivH~Dlk~~Nill~~~------- 407 (492)
.+|||||+++++|.++|... .....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 78999999999999988542 233569999999999999999999998531 349999999999999642
Q ss_pred ----------CcEEEeecCCccccCCCCccccccccccccccchhhhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 408 ----------FTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 408 ----------~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
..+||+|||++..+.... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 358999999998654322 2234578999999999864 45889999999999999999999998653
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=271.41 Aligned_cols=200 Identities=29% Similarity=0.440 Sum_probs=175.9
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
..+|+..+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36688899999999999999985 57899999999766555567788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++.. ..+++..+..++.|++.+|.|||+.+ ++||||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999988732 34788999999999999999999987 99999999999999999999999999876543322
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. .....+++.|+|||.+.+..++.++|+||||++++||++|+.||...
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~ 218 (297)
T cd06656 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (297)
T ss_pred C-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 22346788999999999888999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=267.61 Aligned_cols=201 Identities=29% Similarity=0.463 Sum_probs=168.1
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCC----EEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGE----AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
.++|+..++||+|+||+||+|+. .+++ .||+|.+... .....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35688899999999999999984 3444 4899998654 33445678899999999999999999998875 4578
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999888532 345899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCccc-cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 422 PEDITHI-SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 422 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 5332211 112334678999999998999999999999999999998 8888754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=269.76 Aligned_cols=202 Identities=26% Similarity=0.401 Sum_probs=168.8
Q ss_pred ccccCCcccccCcccEEEEEecC------CCEEEEEEeccCCh-hhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 270 YFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
.|+..+.||+|+||.||+|...+ ++.||||++..... ...+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46678899999999999998632 46899999975533 335678899999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc
Q 011153 343 VYEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~ 409 (492)
++||+++++|.+++.... ....+++..+.+++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999998875321 1245888999999999999999999988 999999999999999999
Q ss_pred EEEeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 410 AKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 410 ~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
+||+|||+++....... .......+++.|+|||.+..+.++.++||||||+++|||++ |..|+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 229 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999886543221 11223345789999999988899999999999999999998 6666643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=260.03 Aligned_cols=204 Identities=27% Similarity=0.351 Sum_probs=174.2
Q ss_pred CHHHHHHHhcccccCCcccccCcccEEEEE-ecCCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecC
Q 011153 260 SYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG 337 (492)
Q Consensus 260 ~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 337 (492)
+++++.+.+ .+.||+|+|+.|--.. +.++.++|||++.+.......+..+|++++... .|+||++|+++|+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 467777666 4679999999998876 678999999999888777788899999999988 599999999999999
Q ss_pred CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC---cEEEee
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIAD 414 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~D 414 (492)
.+.|||+|-|.+|+|..+++.+ ..+++....+++.+|+.||.+||.++ |.||||||+|||..+.. -+||+|
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeec
Confidence 9999999999999999999654 45889999999999999999999998 99999999999996543 589999
Q ss_pred cCCccccC--CCC----ccccccccccccccchhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 415 FGLVRLFP--EDI----THISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 415 fgl~~~~~--~~~----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
|.|..-+. .+- ++...+++|+..|||||+.. ...|+.+.|.||||||||-|++|-+||.-
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 99876332 221 22233678999999999863 23578899999999999999999999964
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=267.02 Aligned_cols=206 Identities=30% Similarity=0.372 Sum_probs=171.0
Q ss_pred HhcccccCCcccccCcccEEEEEecC------CCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (492)
.+++|.+.+.||+|+||.||++...+ +..|++|.+.... ......+.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678899999999999999998653 5678999886543 3344578999999999999999999999999999
Q ss_pred ceeEEeecCCCCchhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC---cEEE
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQD----VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKI 412 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~kl 412 (492)
.++||||+++++|.+++..... ...+++..+++++.||+.||+|||+.+ ++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999998865432 235899999999999999999999988 99999999999998654 6999
Q ss_pred eecCCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 413 ADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 413 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
+|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~ 225 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999865332211 1112234568999999999999999999999999999997 88887643
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=273.08 Aligned_cols=197 Identities=24% Similarity=0.399 Sum_probs=159.8
Q ss_pred CCcccccCcccEEEEEec---CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeec--CCcceeEEeecC
Q 011153 274 SNKLGQGGSGSVYKGTLP---GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPESLLVYEFVP 348 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 348 (492)
..+||+|+||+||+++.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 468999999999999864 35689999886543 23467899999999999999999998854 456789999986
Q ss_pred CCCchhhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee----CCCCcEEEeecCCc
Q 011153 349 NQSLLDNLFVR------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLV 418 (492)
Q Consensus 349 ~gsL~~~l~~~------~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~Dfgl~ 418 (492)
+ +|.+.+... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 666665321 12345889999999999999999999988 9999999999999 56679999999999
Q ss_pred cccCCCCcc--ccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 419 RLFPEDITH--ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 419 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+........ ......+|+.|+|||++.+ ..++.++||||||+++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 876543322 1224568999999999876 457899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=279.65 Aligned_cols=199 Identities=26% Similarity=0.355 Sum_probs=168.1
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC-----
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----- 338 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 338 (492)
..++|+..+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3567999999999999999999854 5889999998653 2344567889999999999999999999876433
Q ss_pred -cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCC
Q 011153 339 -ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (492)
Q Consensus 339 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl 417 (492)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 46899999965 6666552 23788899999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 418 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
++...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 98654322 1234568999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=265.56 Aligned_cols=198 Identities=28% Similarity=0.336 Sum_probs=162.8
Q ss_pred CcccccCcccEEEEEecC---CCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCC
Q 011153 275 NKLGQGGSGSVYKGTLPG---GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (492)
+.||+|+||.||+|...+ +..+++|+++... ......+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 4579999887553 233457889999999999999999999999999999999999999
Q ss_pred CchhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc-
Q 011153 351 SLLDNLFVRQD--VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH- 427 (492)
Q Consensus 351 sL~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~- 427 (492)
+|.+++..... ....++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99998864332 234677888899999999999999988 999999999999999999999999998754332211
Q ss_pred ccccccccccccchhhhccC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRG-------KLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
......++..|+|||++... .++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 12234567899999988542 35789999999999999996 99888653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=269.58 Aligned_cols=200 Identities=28% Similarity=0.383 Sum_probs=173.0
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
+.|++.++||+|+||.||+|+.. +++.+++|.+........+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999865 58899999998777777788999999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++++|...+... ...+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence 999998776432 245899999999999999999999987 99999999999999999999999999875433221
Q ss_pred ccccccccccccchhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
......+++.|+|||++. ...++.++||||||+++|||++|+.|+..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 122446788999999884 34567899999999999999999999854
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=270.20 Aligned_cols=202 Identities=27% Similarity=0.371 Sum_probs=167.8
Q ss_pred cccccCCcccccCcccEEEEEecC-CC--EEEEEEeccC-ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPG-GE--AVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 343 (492)
++|++.++||+|+||.||++...+ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468889999999999999998753 33 4788888643 344456789999999999 799999999999999999999
Q ss_pred EeecCCCCchhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcE
Q 011153 344 YEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ 410 (492)
+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999885432 1235889999999999999999999988 9999999999999999999
Q ss_pred EEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 411 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
||+|||++........ ......+..|+|||.+....++.++||||||++++||++ |+.||...
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~ 222 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM 222 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999864322111 111223567999999988899999999999999999998 88887543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=271.26 Aligned_cols=199 Identities=28% Similarity=0.455 Sum_probs=175.5
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
.+|+..+.||.|++|.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4588899999999999999985 568999999997665556678899999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 99999987732 35899999999999999999999988 999999999999999999999999998765443221
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~ 218 (296)
T cd06655 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (296)
T ss_pred -CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22346788999999998888999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=263.70 Aligned_cols=200 Identities=32% Similarity=0.459 Sum_probs=175.6
Q ss_pred hcccccCCcccccCcccEEEEEecC-CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
.++|+..++||+|+||.||++...+ ++.+++|.+..... .+.+.+|++++++++||||+++++++.++...++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678889999999999999999764 78999999865433 67899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 80 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 9999999988432 346899999999999999999999988 99999999999999999999999999886654321
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+...
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 223345788999999998889999999999999999999999998653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=267.60 Aligned_cols=204 Identities=31% Similarity=0.450 Sum_probs=172.7
Q ss_pred hcccccCCcccccCcccEEEEEecC------CCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (492)
.++|++.+.||+|+||.||++...+ +..|++|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578889999999999999998642 3679999986543 34456788999999999999999999999999999
Q ss_pred eeEEeecCCCCchhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEe
Q 011153 341 LLVYEFVPNQSLLDNLFVRQD-------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 413 (492)
++|+||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999998864322 234788999999999999999999988 9999999999999999999999
Q ss_pred ecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 414 DFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 414 Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
|||+++....... .......++..|+|||.+..+.++.++||||||+++|||++ |+.|+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 224 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG 224 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc
Confidence 9999875543321 12233456789999999988889999999999999999998 8888754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=264.66 Aligned_cols=190 Identities=25% Similarity=0.346 Sum_probs=159.4
Q ss_pred CcccccCcccEEEEEecC-------------CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 275 NKLGQGGSGSVYKGTLPG-------------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
+.||+|+||.||+|.... ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2258999887665666678899999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc-------EEEee
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT-------AKIAD 414 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~-------~kl~D 414 (492)
+|+||+++++|..++.. ....+++..+++++.||+.||+|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999887643 2345899999999999999999999988 999999999999987664 89999
Q ss_pred cCCccccCCCCccccccccccccccchhhhc-cCCCCcchhHHHHHHHHHHHH-hCCCCCCC
Q 011153 415 FGLVRLFPEDITHISATLAGTLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVV-CRKRINLF 474 (492)
Q Consensus 415 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvll~ell-tg~~p~~~ 474 (492)
||++...... ....++..|+|||.+. ...++.++||||||+++|||+ +|+.|+..
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9998654322 1335678999999886 466889999999999999998 57776643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=268.25 Aligned_cols=202 Identities=30% Similarity=0.365 Sum_probs=168.9
Q ss_pred ccccCCcccccCcccEEEEEec------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
+|++.+.||+|+||.||+|... ....+++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3677899999999999999753 23568898886543 3445678999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 011153 343 VYEFVPNQSLLDNLFVRQ---------------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~N 401 (492)
++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999998875321 1245889999999999999999999988 9999999999
Q ss_pred eeeCCCCcEEEeecCCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 402 ILLDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 402 ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |+.|+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999765332221 1123345678999999988889999999999999999999 8888753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=280.00 Aligned_cols=199 Identities=27% Similarity=0.367 Sum_probs=167.9
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC-----
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----- 338 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 338 (492)
..++|+..+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999854 5889999998654 3334567889999999999999999999886443
Q ss_pred -cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCC
Q 011153 339 -ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (492)
Q Consensus 339 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl 417 (492)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 46899999965 5655552 23788899999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 418 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
++...... ......+|+.|+|||++.+..++.++||||||++++||++|+.||....
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 98654322 1234568999999999998899999999999999999999999987543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=277.21 Aligned_cols=198 Identities=27% Similarity=0.385 Sum_probs=167.0
Q ss_pred HHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecC-----
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG----- 337 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 337 (492)
...++|+..+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4457799999999999999999985 467899999986542 23345678999999999999999999987643
Q ss_pred -CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 011153 338 -PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (492)
Q Consensus 338 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 416 (492)
...++++|++ +++|.+.+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3457899987 778877662 245899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
+++...... ....+|+.|+|||++.+ ..++.++||||||++++||++|+.||...
T Consensus 164 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 164 LARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred cceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 998654322 23468999999999876 56889999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=269.77 Aligned_cols=199 Identities=26% Similarity=0.384 Sum_probs=171.0
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
+|+..+.||+|+||.||++... +++.+|+|.+... .......+.+|++++++++||||+++++.+...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5788899999999999999875 6889999988654 3344567899999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
++++|.+++........+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999988875543345789999999999999999999974 5 9999999999999999999999999987653322
Q ss_pred cccccccccccccchhhhccCC------CCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGK------LTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.....+++.|+|||.+.... ++.++|+||||+++|||++|+.||..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 22345788999999885543 47899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=269.55 Aligned_cols=205 Identities=28% Similarity=0.432 Sum_probs=170.0
Q ss_pred HHhcccccCCcccccCcccEEEEEec------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCC
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP 338 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 338 (492)
...++|++.++||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34678999999999999999999743 24579999886443 233456889999999999999999999999999
Q ss_pred cceeEEeecCCCCchhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEE
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQD-------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK 411 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~k 411 (492)
..++||||+++|+|.+++..... ....++..+..++.|++.||.|||+++ ++||||||+|||+++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 99999999999999999854321 234577888999999999999999988 99999999999999999999
Q ss_pred EeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 011153 412 IADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINL 473 (492)
Q Consensus 412 l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~ 473 (492)
|+|||+++....... .......++..|+|||.+..+.++.++||||||++++||++ |+.|+.
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~ 223 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 223 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999886543221 11122345678999999998899999999999999999999 676764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=270.26 Aligned_cols=203 Identities=28% Similarity=0.417 Sum_probs=168.5
Q ss_pred hcccccCCcccccCcccEEEEEecC---------------CCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG---------------GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLL 331 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~---------------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~ 331 (492)
.++|++.++||+|+||.||++...+ ...||+|.++.. .....+.+.+|++++++++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4578899999999999999987532 224899998754 334456799999999999999999999
Q ss_pred eeeecCCcceeEEeecCCCCchhhhhccC---------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 011153 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQ---------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI 402 (492)
Q Consensus 332 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Ni 402 (492)
+++...+..++||||+++++|.+++.... ....+++..+++++.|++.||+|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999885432 1134788999999999999999999988 99999999999
Q ss_pred eeCCCCcEEEeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhC--CCCCC
Q 011153 403 LLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCR--KRINL 473 (492)
Q Consensus 403 ll~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg--~~p~~ 473 (492)
++++++.+||+|||++........ .......+++.|+|||.+..+.++.++||||||++++||+++ ..|+.
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 999999999999999876543221 112233457789999999989999999999999999999984 44544
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=270.32 Aligned_cols=204 Identities=28% Similarity=0.387 Sum_probs=172.4
Q ss_pred HhcccccCCcccccCcccEEEEEec------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCC
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGP 338 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 338 (492)
..++|...+.||+|+||.||++... .+..||+|+++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3457899999999999999999742 34579999887543 34456789999999999 7999999999999999
Q ss_pred cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCc
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~ 418 (492)
..++|+||+++++|.+++.... ...+++.++..++.||+.||+|||+.+ ++|+||||+|||++.++.++|+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999885432 234899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 419 RLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 419 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
+........ ......++..|+|||.+..+.++.++||||||+++|||++ |+.|+..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~ 246 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence 865443221 1122345778999999999999999999999999999998 8888754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=264.21 Aligned_cols=195 Identities=31% Similarity=0.494 Sum_probs=168.2
Q ss_pred CcccccCcccEEEEEecC--CC--EEEEEEeccCCh-hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLPG--GE--AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~--~~--~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
++||+|++|.||++.+.+ ++ .||||.+..... ...+.+.+|++++++++||||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 32 689999977655 667789999999999999999999999988 888999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc-
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI- 428 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~- 428 (492)
++|.+.+..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999998865433 56899999999999999999999988 9999999999999999999999999998765432211
Q ss_pred -cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 429 -SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 429 -~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
.....++..|+|||.+....++.++||||||++++||++ |+.|+..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 113456789999999998899999999999999999999 9999753
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=265.59 Aligned_cols=207 Identities=29% Similarity=0.369 Sum_probs=173.4
Q ss_pred HHHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 265 EKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 265 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
+.+++.+.....||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 445666767789999999999999854 5778999998777666677899999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-CCcEEEeecCCccccC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFP 422 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~ 422 (492)
+||+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999998864322211278888899999999999999987 999999999999976 6799999999987654
Q ss_pred CCCccccccccccccccchhhhccCC--CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGK--LTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.... ......+++.|+|||++.... ++.++||||||+++|||++|+.|+...
T Consensus 161 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 161 GINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred cCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 3221 122345789999999986644 788999999999999999999998643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=262.62 Aligned_cols=193 Identities=24% Similarity=0.389 Sum_probs=161.4
Q ss_pred cccccCcccEEEEEec---CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCC
Q 011153 276 KLGQGGSGSVYKGTLP---GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQS 351 (492)
Q Consensus 276 ~iG~G~fG~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 351 (492)
.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999753 34579999987653 334567999999999999999999999875 457899999999999
Q ss_pred chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc--
Q 011153 352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS-- 429 (492)
Q Consensus 352 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-- 429 (492)
|.+++... ...+++..+++++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99887532 346899999999999999999999988 99999999999999999999999999986544322111
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
....+++.|+|||.+..+.++.++||||||+++|||++ |+.|+..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 201 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKK 201 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCc
Confidence 12223578999999988889999999999999999996 8888754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=266.51 Aligned_cols=198 Identities=35% Similarity=0.495 Sum_probs=172.1
Q ss_pred cccCCcccccCcccEEEEEecC-CCEEEEEEeccCChhhHH--HHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVD--HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
|+..+.||+|+||+||++.... ++.+|+|.+......... ...+|+.++++++||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678899999999999999764 568999999876544332 3466999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++++|.+++. ....+++..+..++.||++||.+||+.+ ++|+||||+||++++++.++|+|||.+...... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NE 153 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST-TS
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence 9999999886 3345799999999999999999999998 999999999999999999999999998764222 22
Q ss_pred ccccccccccccchhhhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
......+++.|+|||.+. ...++.++||||+|++++||++|+.|+...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 233567899999999988 788999999999999999999999998876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=268.52 Aligned_cols=202 Identities=27% Similarity=0.368 Sum_probs=175.2
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
.++|++.+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++.+.++...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888999999999999999864 6889999999877666778899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999887432 345899999999999999999999998 99999999999999999999999999875543222
Q ss_pred cccccccccccccchhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
......+++.|+|||.+. ...++.++||||||+++|||++|+.|+...
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 122456889999999875 345778999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=265.05 Aligned_cols=199 Identities=30% Similarity=0.442 Sum_probs=171.7
Q ss_pred ccccCCcccccCcccEEEEEecCCCEEEEEEeccCC------hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 270 YFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT------TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
+|+..+.||+|+||+||+|...+++.+|+|.+.... ......+.+|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 367789999999999999998889999999886432 22345688999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
+||+++++|.+++... ..+++..+..++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999988432 35788999999999999999999988 99999999999999999999999999875432
Q ss_pred CC-----ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 424 DI-----THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 424 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.. ........++..|+|||.+.+..++.++||||||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 11 1112234688999999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=264.77 Aligned_cols=202 Identities=26% Similarity=0.392 Sum_probs=170.5
Q ss_pred cccccCCcccccCcccEEEEEec-C---CCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-G---GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.+|++.+.||+|+||.||+|... + +..+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788999999999999999853 2 3369999886543 33456789999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999988533 345899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCccccc--cccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 424 DITHISA--TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
....... ...++..|+|||.+..+.++.++|+||||++++|+++ |+.|+...
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~ 213 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence 3322111 1223568999999998899999999999999999887 99887543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=263.48 Aligned_cols=202 Identities=25% Similarity=0.386 Sum_probs=175.2
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|+..+.||+|+||.||++... +++.+++|.++.. .....+.+.+|++++++++|+||+++++.+.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 56888999999999999999976 7899999988632 2334667899999999999999999999999999999999
Q ss_pred eecCCCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 345 EFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 345 e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
||+++++|.+++... .....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999887542 23455899999999999999999999988 99999999999999999999999999876543
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.... .....+++.|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 3221 2234578899999999888899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=268.12 Aligned_cols=203 Identities=28% Similarity=0.374 Sum_probs=170.6
Q ss_pred HHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecC------
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG------ 337 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 337 (492)
.+++.|+..+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677888999999999999999864 57889999986543 3345788999999998 799999999998753
Q ss_pred CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCC
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl 417 (492)
...++|+||+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 3478999999999999988542 3345889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccchhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 418 VRLFPEDITHISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 418 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
+........ ......|++.|+|||++. ...++.++||||||+++|||++|+.|+..
T Consensus 158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 876543222 223456899999999986 34578899999999999999999999853
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=264.60 Aligned_cols=200 Identities=27% Similarity=0.397 Sum_probs=164.4
Q ss_pred ccCCcccccCcccEEEEEecCC-C--EEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC------Ccc
Q 011153 272 HESNKLGQGGSGSVYKGTLPGG-E--AVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------PES 340 (492)
Q Consensus 272 ~~~~~iG~G~fG~Vy~~~~~~~-~--~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 340 (492)
.+.++||+|+||.||+|+..+. . .+|+|.++.. .....+.+.+|+++++.++||||+++++.+... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4678899999999999987543 2 5899988653 344567889999999999999999999987532 246
Q ss_pred eeEEeecCCCCchhhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCC
Q 011153 341 LLVYEFVPNQSLLDNLFVR---QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl 417 (492)
++++||+++++|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999998877432 22345899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 418 VRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 418 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
++........ ......+++.|++||.+....++.++||||||+++|||++ |+.|+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 217 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9866433221 1123345778999999998899999999999999999999 7777753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=284.76 Aligned_cols=198 Identities=31% Similarity=0.420 Sum_probs=173.8
Q ss_pred cccccCcccEEEEEecC-CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCCchh
Q 011153 276 KLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354 (492)
Q Consensus 276 ~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 354 (492)
+||+|.||+||.|++.+ ...+|||.+.....+..+-+.+|+.+-+.++|+|||+++|.+.+++..-+.||.+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999765 55799999988888888899999999999999999999999999998889999999999999
Q ss_pred hhhccCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC-CCCcEEEeecCCccccCCCCcccccc
Q 011153 355 NLFVRQDVEPL--SWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITHISAT 431 (492)
Q Consensus 355 ~l~~~~~~~~~--~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~ 431 (492)
.|. .+.+++ ++.+.-....||++||.|||++. |||||||-+||||+ -.|.+||+|||-++.+..- .+...+
T Consensus 662 LLr--skWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TET 735 (1226)
T KOG4279|consen 662 LLR--SKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTET 735 (1226)
T ss_pred HHH--hccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-Cccccc
Confidence 883 455666 67788888999999999999998 99999999999996 4689999999999876543 234456
Q ss_pred ccccccccchhhhccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 432 LAGTLGYMAPEYVVRGK--LTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 432 ~~gt~~y~aPE~~~~~~--~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
.-||..|||||++..++ |+..+|||||||.+.||.||++||-...+..
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq 785 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ 785 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh
Confidence 77999999999998765 7889999999999999999999997655443
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=267.08 Aligned_cols=204 Identities=29% Similarity=0.428 Sum_probs=171.6
Q ss_pred hcccccCCcccccCcccEEEEEecC-----------------CCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG-----------------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVK 329 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 329 (492)
..+|++.++||+|+||.||++...+ +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578899999999999999987542 2458999987653 345678899999999999999999
Q ss_pred eeeeeecCCcceeEEeecCCCCchhhhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 011153 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQ--------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401 (492)
Q Consensus 330 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~N 401 (492)
+++++..++..++++|++++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999885432 1236899999999999999999999988 9999999999
Q ss_pred eeeCCCCcEEEeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh--CCCCCCC
Q 011153 402 ILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC--RKRINLF 474 (492)
Q Consensus 402 ill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt--g~~p~~~ 474 (492)
|++++++.++|+|||+++....... .......+++.|+|||.+..+.++.++||||||+++|||++ +..|+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999876543321 12224456789999999988899999999999999999998 5555543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=271.02 Aligned_cols=204 Identities=28% Similarity=0.363 Sum_probs=170.0
Q ss_pred hcccccCCcccccCcccEEEEEec--------CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecC
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG 337 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 337 (492)
.++|.+.+.||+|+||.||++... +...+|+|.+... .......+.+|+++++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 356899999999999999999742 2346999998754 234456788999999999 799999999999999
Q ss_pred CcceeEEeecCCCCchhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL 404 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill 404 (492)
+..++|+||+++++|.+++..... ...+++..+++++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999865322 235889999999999999999999987 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCccc-cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 405 DEEFTAKIADFGLVRLFPEDITHI-SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 405 ~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
+.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~ 245 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 999999999999987654321111 112234568999999998899999999999999999998 7777643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=269.07 Aligned_cols=199 Identities=30% Similarity=0.437 Sum_probs=163.4
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcc---CcCceeeeeeeeecC-----C
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGI---NHKNLVKLLGCSITG-----P 338 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 338 (492)
+|++.+.||+|+||+||++... +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999865 68899999986532 22233456777776655 799999999987643 3
Q ss_pred cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCc
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~ 418 (492)
..++|+||+++ +|.+++... ....+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 46899999974 787777433 2345899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
+....... .....+++.|+|||++.+..++.++|||||||+++||++|++||...
T Consensus 156 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 156 RIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred ccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 86643221 22346789999999999889999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=264.07 Aligned_cols=203 Identities=27% Similarity=0.428 Sum_probs=171.0
Q ss_pred hcccccCCcccccCcccEEEEEecC-CC---EEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG-GE---AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~---~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
.++|+..+.||+|+||.||++.... ++ .+++|.+... .....+.+.+|++++++++||||+++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3567888999999999999998652 33 6899988654 34446678999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999988843 2346899999999999999999999988 9999999999999999999999999987654
Q ss_pred CCCccccc--cccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 423 EDITHISA--TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 423 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
........ ....++.|+|||++..+.++.++||||||+++|||++ |+.|+...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 33222111 1223467999999988889999999999999999998 99998543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=264.66 Aligned_cols=202 Identities=29% Similarity=0.428 Sum_probs=172.4
Q ss_pred HhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
..++|+..++||+|+||.||++...++..+++|.+.... ...+.+.+|+++++.++|+||+++.+.+.+ ...++++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 356788999999999999999998778889999886543 335678999999999999999999999877 778999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999988543 3345788999999999999999999987 99999999999999999999999999876644322
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
.......++..|+|||++..+.++.++|+||||++++||++ |+.|+..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 206 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence 22223345678999999988889999999999999999999 8888754
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=262.01 Aligned_cols=201 Identities=23% Similarity=0.358 Sum_probs=175.2
Q ss_pred ccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+|+..+.||+|+||.||.++. .+++.+++|++... +....+.+.+|++++++++|+||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478899999999999999985 46889999988654 345566788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+.+.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999885432 456899999999999999999999988 99999999999999999999999999986644332
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
......+++.|+|||.+.+..++.++||||||+++|||++|+.|+...
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence 223456899999999998888899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=270.76 Aligned_cols=206 Identities=29% Similarity=0.377 Sum_probs=172.7
Q ss_pred HHhcccccCCcccccCcccEEEEEecC------CCEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecC
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG 337 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 337 (492)
...++|+..+.||+|+||.||++...+ ...+|+|.+... ..+....+.+|++++.++ +||||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 345668889999999999999998542 357999998754 334456788999999999 899999999999999
Q ss_pred CcceeEEeecCCCCchhhhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 011153 338 PESLLVYEFVPNQSLLDNLFVR-------------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL 404 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill 404 (492)
+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999988542 23456899999999999999999999987 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCccc-cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 405 DEEFTAKIADFGLVRLFPEDITHI-SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 405 ~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+..
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 999999999999998665432211 122335678999999988899999999999999999998 8777653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=266.22 Aligned_cols=199 Identities=31% Similarity=0.412 Sum_probs=174.6
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
++|+..+.||.|++|.||++... +++.+++|++.... ......+.+|+++++.++||||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35778899999999999999865 68899999986543 44556788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++... .+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999888432 6899999999999999999999988 99999999999999999999999999987654322
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
......+++.|+|||.+.+..++.++||||||+++|||++|+.|+...
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 222446788999999999888999999999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=264.91 Aligned_cols=201 Identities=27% Similarity=0.443 Sum_probs=169.0
Q ss_pred cccccCCcccccCcccEEEEEecC-C---CEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPG-G---EAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
..|++.+.||+|+||.||+|.... + ..|+||.+... .....+.|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 347788999999999999998653 3 36999998754 344567899999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
+||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999887433 345899999999999999999999988 99999999999999999999999999876543
Q ss_pred CCccc--ccccc--ccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 424 DITHI--SATLA--GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 424 ~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
..... ..... .+..|+|||.+....++.++||||||++++||++ |+.|+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~ 214 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence 22111 11111 2457999999998999999999999999999986 8888754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=266.95 Aligned_cols=198 Identities=32% Similarity=0.444 Sum_probs=166.1
Q ss_pred ccccCCcccccCcccEEEEEe-----cCCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCC--cce
Q 011153 270 YFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP--ESL 341 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~ 341 (492)
+|+..+.||+|+||+||++.. .+++.||+|.+.... ......+.+|+++++.++||||+++++++...+ ..+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 348889999999999988642 357789999987543 334567889999999999999999999877543 578
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+||||+++++|.+++.. ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 85 lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999988843 24899999999999999999999988 999999999999999999999999999866
Q ss_pred CCCCcc--ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 422 PEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 422 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
...... ......++..|+|||.+....++.++||||||++++||++|+.|+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 433221 11123356679999999888899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=263.87 Aligned_cols=202 Identities=30% Similarity=0.402 Sum_probs=176.2
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
.++|+..+.||+|+||.||++... +++.+++|.+........+.+.+|+++++.++||||+++++.+......+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357888999999999999999864 5788999999876666678899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999887432 245889999999999999999999988 99999999999999999999999999876543221
Q ss_pred cccccccccccccchhhhccC---CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRG---KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
......++..|+|||.+... .++.++||||||+++|||++|+.|+...
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 12245678899999998776 7899999999999999999999998653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=265.27 Aligned_cols=202 Identities=25% Similarity=0.378 Sum_probs=174.1
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|+..+.||+|+||.||++.. .+++.++||.+... .......+.+|+.+++.++||||+++++++.+++..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577889999999999999985 57899999987643 2334567889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 345 EFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 345 e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
||+++++|.+++... .....+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999887532 23456899999999999999999999988 99999999999999999999999999876644
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.... .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+..
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence 3221 2234678899999999888899999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=261.58 Aligned_cols=192 Identities=27% Similarity=0.390 Sum_probs=162.1
Q ss_pred cccccCcccEEEEEe---cCCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCC
Q 011153 276 KLGQGGSGSVYKGTL---PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (492)
Q Consensus 276 ~iG~G~fG~Vy~~~~---~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (492)
.||+|+||.||+|.+ .++..+|+|++.... ....+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 357789999986443 344667899999999999999999999875 45678999999999
Q ss_pred CchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc-
Q 011153 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS- 429 (492)
Q Consensus 351 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~- 429 (492)
+|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99998843 235889999999999999999999988 99999999999999999999999999986644332211
Q ss_pred -ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 430 -ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 430 -~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
....+++.|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 201 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 12234678999999988889999999999999999998 8888864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=271.25 Aligned_cols=197 Identities=30% Similarity=0.459 Sum_probs=171.2
Q ss_pred cccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCC
Q 011153 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
|+....||+|+||.||++... +++.|++|++........+.+.+|+.++..++||||+++++++..++..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 344557999999999999864 6889999998765555567788999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|.+.+.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........ ..
T Consensus 103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 174 (297)
T cd06659 103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KR 174 (297)
T ss_pred CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cc
Confidence 999887632 35889999999999999999999988 99999999999999999999999999875544322 12
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....+++.|+|||++.+..++.++||||||++++||++|+.|+...
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 220 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2456889999999999889999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=270.40 Aligned_cols=201 Identities=29% Similarity=0.398 Sum_probs=167.3
Q ss_pred cccccCCcccccCcccEEEEEec-CCC--EEEEEEeccC-ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGE--AVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 343 (492)
++|++.+.||+|+||.||++... ++. .+++|.+... .......+.+|++++.++ +||||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46788899999999999999864 344 4688877643 334456788999999999 899999999999999999999
Q ss_pred EeecCCCCchhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcE
Q 011153 344 YEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ 410 (492)
+||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999886432 1235889999999999999999999988 9999999999999999999
Q ss_pred EEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 411 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
||+|||++....... .......+..|+|||.+....++.++||||||++++||++ |..||..
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 226 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 226 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc
Confidence 999999986432111 1112234668999999988889999999999999999998 8888753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=263.90 Aligned_cols=201 Identities=29% Similarity=0.411 Sum_probs=169.4
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-----hhhHHHHHHHHHHHhccCcCceeeeeeeeecC--Ccc
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-----TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PES 340 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 340 (492)
.+|+..+.||+|+||.||++... ++..+++|++.... .+....+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999864 58899999886432 23345688999999999999999999988753 466
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++++||+++++|.+.+... ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999888432 34788999999999999999999987 99999999999999999999999999876
Q ss_pred cCCCCcc--ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 421 FPEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 421 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 5332111 112345788999999998888999999999999999999999998643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=269.45 Aligned_cols=203 Identities=27% Similarity=0.372 Sum_probs=170.5
Q ss_pred hcccccCCcccccCcccEEEEEec--------CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecC
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG 337 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 337 (492)
..+|.+.+.||+|+||.||+++.. ++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456888999999999999999731 2447999988654 234467789999999999 899999999999999
Q ss_pred CcceeEEeecCCCCchhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL 404 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill 404 (492)
...++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999998865321 235788999999999999999999988 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCccc-cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 011153 405 DEEFTAKIADFGLVRLFPEDITHI-SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINL 473 (492)
Q Consensus 405 ~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~ 473 (492)
++++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..|+.
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 999999999999998664432221 223345678999999988889999999999999999998 666664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=274.26 Aligned_cols=204 Identities=28% Similarity=0.360 Sum_probs=168.0
Q ss_pred hcccccCCcccccCcccEEEEEe------cCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CcCceeeeeeeeecC-C
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG-P 338 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 338 (492)
.++|++.++||+|+||.||++.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45789999999999999999973 346789999997543 33456788999999999 689999999987654 4
Q ss_pred cceeEEeecCCCCchhhhhccCC---------------------------------------------------------
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQD--------------------------------------------------------- 361 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 361 (492)
..++|+||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999988754211
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc-cccccc
Q 011153 362 -------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH-ISATLA 433 (492)
Q Consensus 362 -------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~ 433 (492)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124788899999999999999999988 999999999999999999999999998765332211 111234
Q ss_pred ccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 434 gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
+++.|+|||.+....++.++||||||+++|||++ |..|+..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 284 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 5678999999988899999999999999999997 8888754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=262.30 Aligned_cols=198 Identities=30% Similarity=0.417 Sum_probs=172.4
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-----hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-----TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
+|+..+.||+|++|+||+|... +++.|++|.+.... .+..+.+.+|+.+++.++||||+++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999976 78999999886533 33556789999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
+||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999988843 245889999999999999999999988 99999999999999999999999999876543
Q ss_pred CCccccccccccccccchhhhccCC-CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.. ......+++.|++||.+.... ++.++|+||||++++||++|+.||...
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 32 123456788999999987776 899999999999999999999998654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=238.53 Aligned_cols=208 Identities=26% Similarity=0.382 Sum_probs=174.0
Q ss_pred ccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+|...++||+|.||+|||++. ++++.||+|+++.++ +..-....+|+-++++++|+|||++++....+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 456678999999999999985 468889999987543 33345678999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+. .+|..++. .-.+.++.+...+++.|+++||.++|+++ +.||||||+|.||+.+|..|++|||+++.+..+..
T Consensus 83 cd-qdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 94 46766653 23456899999999999999999999998 99999999999999999999999999998876543
Q ss_pred cccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcHHHH
Q 011153 427 HISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQT 484 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~~~~~~~~~ 484 (492)
..+ ..+-|..|.+|.++.+. .|+...|+||-||++.|+..-.+|.....+.++.+..
T Consensus 157 cys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkr 214 (292)
T KOG0662|consen 157 CYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214 (292)
T ss_pred eee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHH
Confidence 333 34568999999999875 4889999999999999999988887665544444433
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=270.63 Aligned_cols=197 Identities=31% Similarity=0.485 Sum_probs=171.6
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecC
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (492)
.|.....||+|+||.||++... ++..||||++........+.+.+|+.+++.++||||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444677999999999999864 688999999876665666778999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 428 (492)
+++|.+++.. ..+++..+..++.||+.||+|||+.+ ++||||||+||++++++.++|+|||++........ .
T Consensus 103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 174 (292)
T cd06658 103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K 174 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence 9999887732 34789999999999999999999988 99999999999999999999999999875543322 1
Q ss_pred cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.....+++.|+|||.+.+..++.++||||||++++||++|+.|+..
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 220 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2345688999999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=262.52 Aligned_cols=204 Identities=32% Similarity=0.428 Sum_probs=176.3
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
++|++.+.||.|+||+||++... ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+..+...++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36888999999999999999854 67889999986543 33567889999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+.+........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999998865433356899999999999999999999988 99999999999999999999999999876654322
Q ss_pred c---ccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 H---ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ......++..|+|||.+... .++.++|+||||++++||++|+.|+...
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 2 12344688999999998877 7899999999999999999999998653
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=263.62 Aligned_cols=199 Identities=32% Similarity=0.485 Sum_probs=170.3
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh---------hhHHHHHHHHHHHhccCcCceeeeeeeeecCCc
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT---------QWVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (492)
+|...+.||+|++|.||+|... +++.+++|.+..... +..+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999864 578999998864322 123568899999999999999999999999999
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
.++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999988843 245788999999999999999999988 9999999999999999999999999988
Q ss_pred ccCCCCcc-----ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 420 LFPEDITH-----ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 420 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
........ ......+++.|+|||.+.+..++.++||||||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 66532111 11234578899999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=261.38 Aligned_cols=200 Identities=29% Similarity=0.415 Sum_probs=171.1
Q ss_pred cccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecC
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (492)
.+|+..+.||+|+||.||++...++..+++|.+..... ....+.+|++++++++||||+++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35777899999999999999887788999998865432 24578899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 428 (492)
+++|.+++... ...++++.+..++.|++.+|+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999887432 245789999999999999999999988 9999999999999999999999999987654432222
Q ss_pred cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
.....++.+|+|||.+..+.++.++||||||+++|||++ |+.|+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 204 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 223345678999999988899999999999999999998 8888754
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=266.59 Aligned_cols=199 Identities=27% Similarity=0.454 Sum_probs=168.4
Q ss_pred cccccCCcccccCcccEEEEEe-----cCCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecC--Ccc
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PES 340 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 340 (492)
+.|++.+.||+|+||.||++.. .++..||+|.++... ......+.+|+++++.++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999974 357789999987543 44456799999999999999999999988775 567
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999987432 235899999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCcc--ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 011153 421 FPEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRIN 472 (492)
Q Consensus 421 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~ 472 (492)
+...... ......++..|+|||.+.+..++.++||||||++++||++++.|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 6433221 112345677899999998889999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=262.35 Aligned_cols=200 Identities=22% Similarity=0.317 Sum_probs=173.5
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
+|++.++||+|+||.||++... +++.+++|.++.. .....+.+.+|+.+++.++||||+++++.+.+++..++|+||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4678899999999999999864 6889999998643 3445677889999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++++|.+.+... ....++...++.++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998877432 3445789999999999999999999988 99999999999999999999999999876543321
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
......+++.|+|||++....++.++|+||||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 202 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC
Confidence 22245688899999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=268.97 Aligned_cols=200 Identities=25% Similarity=0.353 Sum_probs=168.9
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
++|+..++||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.++||||+++++++..+...++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888999999999999999865 57899999986543 33345678999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
++ ++|.+.+... ...+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 5888777443 335789999999999999999999988 99999999999999999999999999875443221
Q ss_pred cccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. .....+++.|+|||.+.+ ..++.++||||||++++||++|+.||...
T Consensus 160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 160 T-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred c-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 123456889999998865 45788999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=269.78 Aligned_cols=203 Identities=26% Similarity=0.305 Sum_probs=173.9
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh---hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT---QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|+..+.||+|+||.||++... +++.+|+|.+..... ...+.+.+|+++++.++||||+++++.+.++...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999865 488999999876432 24567889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999998753 23456899999999999999999999988 999999999999999999999999998754322
Q ss_pred Ccc----------------------------ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITH----------------------------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
... ......|+..|+|||++.+..++.++||||||+++|||++|+.|+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 110 111346788999999999888999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=265.41 Aligned_cols=201 Identities=24% Similarity=0.360 Sum_probs=170.4
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999875 58899999886432 2234567899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|++++.|...+. ....+++..+..++.|++.+|+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999988876653 2335899999999999999999999987 9999999999999999999999999998664432
Q ss_pred ccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1223456789999999876 557899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=261.51 Aligned_cols=194 Identities=30% Similarity=0.423 Sum_probs=159.1
Q ss_pred CcccccCcccEEEEEec----CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeee-cCCcceeEEeecC
Q 011153 275 NKLGQGGSGSVYKGTLP----GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSI-TGPESLLVYEFVP 348 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 348 (492)
+.||+|+||.||+|... +...+|+|++... .....+.+.+|+.+++.++||||+++++++. .++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2357999988543 3445678889999999999999999999776 4556789999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc-
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH- 427 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~- 427 (492)
+++|.+++... ....++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999988532 234677888999999999999999987 999999999999999999999999998755432111
Q ss_pred --ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 011153 428 --ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINL 473 (492)
Q Consensus 428 --~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~ 473 (492)
......++..|+|||.+....++.++||||||+++|||++|+.|+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 203 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCC
Confidence 1113345678999999988899999999999999999999765543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=264.38 Aligned_cols=202 Identities=25% Similarity=0.343 Sum_probs=171.3
Q ss_pred cccccCCcccccCcccEEEEEec------CCCEEEEEEeccCChh-hHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
.+|+..+.||+|+||.||+++.. +.+.+++|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999853 2457999988655443 5678999999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhccCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 011153 342 LVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 415 (492)
+||||+++++|.+++...... ..+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999988654422 26899999999999999999999988 999999999999999999999999
Q ss_pred CCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 011153 416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINL 473 (492)
Q Consensus 416 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~ 473 (492)
|++...............++..|+|||.+.+..++.++||||||++++||++ |..|+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~ 220 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY 220 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 9987543322222223456788999999988889999999999999999999 666664
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=263.61 Aligned_cols=201 Identities=28% Similarity=0.444 Sum_probs=169.5
Q ss_pred cccccCCcccccCcccEEEEEecC-CC----EEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPG-GE----AVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
.+|+..+.||+|+||.||+|...+ ++ .+++|.+.... ......+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567888999999999999998642 33 58999886554 3445678999999999999999999999887 78899
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
|+||+++++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999988543 334899999999999999999999987 9999999999999999999999999998665
Q ss_pred CCCcccc-ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 423 EDITHIS-ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 423 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
....... ....++..|+|||.+....++.++|+||||++++||++ |+.|+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 215 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 3322211 12223568999999988899999999999999999999 99988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=267.36 Aligned_cols=204 Identities=26% Similarity=0.385 Sum_probs=169.3
Q ss_pred hcccccCCcccccCcccEEEEEec-----------------CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-----------------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVK 329 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-----------------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 329 (492)
.++|++.++||+|+||.||++... +...+|+|++... .....+.+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356899999999999999998532 2346899998754 3344568999999999999999999
Q ss_pred eeeeeecCCcceeEEeecCCCCchhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 011153 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQD--------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401 (492)
Q Consensus 330 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~N 401 (492)
+++++..++..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999988854321 234778899999999999999999988 9999999999
Q ss_pred eeeCCCCcEEEeecCCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh--CCCCCCC
Q 011153 402 ILLDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC--RKRINLF 474 (492)
Q Consensus 402 ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt--g~~p~~~ 474 (492)
||+++++.++|+|||+++.+...... ......+++.|++||....+.++.++||||||+++|||++ |..|+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999998765432211 1122344678999999888899999999999999999998 5566643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=270.60 Aligned_cols=199 Identities=21% Similarity=0.255 Sum_probs=164.9
Q ss_pred cCCccccc--CcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 273 ESNKLGQG--GSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 273 ~~~~iG~G--~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
+.++||+| +|++||++.. .+++.||+|++... .....+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 6889999986 57899999998654 2334556788999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999885432 234889999999999999999999988 999999999999999999999999865433211100
Q ss_pred ------ccccccccccccchhhhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 428 ------ISATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 428 ------~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
......++..|+|||++.. ..++.++|||||||+++||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0112346778999999876 45889999999999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=269.26 Aligned_cols=204 Identities=28% Similarity=0.369 Sum_probs=169.8
Q ss_pred hcccccCCcccccCcccEEEEEec--------CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecC
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG 337 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 337 (492)
..+|.+.++||+|+||.||+++.. ....+|+|.++.. .......+.+|+++++.+ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 456888999999999999999742 2456899988754 334466788999999999 699999999999999
Q ss_pred CcceeEEeecCCCCchhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL 404 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill 404 (492)
...++|+||+++++|.+++.... ....+++..+.+++.||+.||.|||+.+ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999886432 1245899999999999999999999988 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 405 DEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 405 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
++++.+||+|||+++........ ......+++.|||||.+.++.++.++||||||+++|||++ |+.|+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999865432211 1112234568999999998899999999999999999999 7777643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=263.79 Aligned_cols=202 Identities=26% Similarity=0.361 Sum_probs=169.5
Q ss_pred cccccCCcccccCcccEEEEEecC----CCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
++|...++||+|+||.||+|...+ ...|+||...... .+..+.+.+|+.+++.++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999998643 2468999887654 4556789999999999999999999998865 567899
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999988543 235899999999999999999999988 99999999999999999999999999986654
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQ 476 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~~ 476 (492)
..........++..|+|||.+....++.++||||||++++||++ |+.||....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 42222223334578999999988889999999999999999996 999885543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=266.47 Aligned_cols=201 Identities=25% Similarity=0.362 Sum_probs=168.8
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
++|+..+.||+|++|.||++... +++.||||.+..... .....+.+|++++++++||||+++++++.+++..++|+||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888999999999999999865 688999999865432 2234577899999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++ +|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 975 8888775332 36889999999999999999999988 99999999999999999999999999875432211
Q ss_pred cccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1122346789999998865 457899999999999999999999986544
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=261.61 Aligned_cols=195 Identities=29% Similarity=0.410 Sum_probs=162.1
Q ss_pred CcccccCcccEEEEEecC-CC--EEEEEEeccC-ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLPG-GE--AVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
+.||+|+||.||++.+.+ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999998754 43 4688888643 344556788999999999 899999999999999999999999999
Q ss_pred CCchhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 011153 350 QSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (492)
Q Consensus 350 gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 416 (492)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999885432 1235789999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
++....... .......+..|+|||++....++.++||||||++++||++ |+.||..
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 214 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 986322111 1111223567999999988889999999999999999997 8888743
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=260.20 Aligned_cols=197 Identities=29% Similarity=0.488 Sum_probs=171.6
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
.++|+..+.||+|+||.||++... ++.|++|.+..... ..+++.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356788999999999999999875 78899999976544 5678999999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999885432 236899999999999999999999988 99999999999999999999999999986633221
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
....+..|+|||.+..+.++.++||||||++++||++ |+.|+..
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 202 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 2234668999999988899999999999999999998 8887654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=265.67 Aligned_cols=203 Identities=32% Similarity=0.455 Sum_probs=170.9
Q ss_pred hcccccCCcccccCcccEEEEEec------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (492)
.++|+..+.||+|+||.||++... ++..+|+|++.... ....+.+.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999853 46789999987543 34456789999999999999999999999999999
Q ss_pred eeEEeecCCCCchhhhhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 011153 341 LLVYEFVPNQSLLDNLFVRQ-------------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~N 401 (492)
++|+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999885321 1234788999999999999999999988 9999999999
Q ss_pred eeeCCCCcEEEeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 011153 402 ILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINL 473 (492)
Q Consensus 402 ill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~ 473 (492)
|++++++.++|+|||++........ ........++.|+|||.+....++.++||||||+++|||++ |..|+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999875533221 11222344678999999988899999999999999999998 777764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=262.07 Aligned_cols=200 Identities=28% Similarity=0.403 Sum_probs=169.4
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC-----ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC--Ccc
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PES 340 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 340 (492)
.+|++.+.||+|+||.||++... +++.+++|.+... ..+....+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999864 5889999987532 233456788999999999999999999998764 357
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++++||+++++|.+.+... ..+++....+++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999888432 34788999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCc--cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 421 FPEDIT--HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 421 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
...... .......++..|+|||.+.+..++.++|+||||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 532111 111234678999999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=264.59 Aligned_cols=190 Identities=25% Similarity=0.329 Sum_probs=157.9
Q ss_pred cccccCcccEEEEEecC-------------------------CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeee
Q 011153 276 KLGQGGSGSVYKGTLPG-------------------------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330 (492)
Q Consensus 276 ~iG~G~fG~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l 330 (492)
+||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 12488998876655556788999999999999999999
Q ss_pred eeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC--
Q 011153 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-- 408 (492)
Q Consensus 331 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-- 408 (492)
++++.++...++||||+++++|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999888743 2345789999999999999999999987 99999999999997643
Q ss_pred -----cEEEeecCCccccCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHH-hCCCCCCCC
Q 011153 409 -----TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVV-CRKRINLFT 475 (492)
Q Consensus 409 -----~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~ell-tg~~p~~~~ 475 (492)
.+|++|||++....... ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+...
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred cCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 38999999876432221 2346788999998865 56899999999999999995 688887543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=262.04 Aligned_cols=196 Identities=22% Similarity=0.320 Sum_probs=157.6
Q ss_pred CcccccCcccEEEEEecCC---CEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCC
Q 011153 275 NKLGQGGSGSVYKGTLPGG---EAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (492)
+.||+|+||.||++...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 345677665443 345678999999999999999999999999999999999999999
Q ss_pred CchhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC-Cccc
Q 011153 351 SLLDNLFVRQD-VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED-ITHI 428 (492)
Q Consensus 351 sL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~ 428 (492)
+|.+++..... ....++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99998865322 345677788899999999999999987 999999999999999999999999998643221 1112
Q ss_pred cccccccccccchhhhcc-------CCCCcchhHHHHHHHHHHHHhC-CCCCC
Q 011153 429 SATLAGTLGYMAPEYVVR-------GKLTEKADVYSFGVVVIEVVCR-KRINL 473 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~slGvll~elltg-~~p~~ 473 (492)
.....++..|+|||++.. ..++.++||||||+++|||+++ +.|+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 210 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence 234567889999998743 2457899999999999999975 44553
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=258.17 Aligned_cols=195 Identities=31% Similarity=0.479 Sum_probs=166.8
Q ss_pred CcccccCcccEEEEEecCCCEEEEEEeccCChh-hHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCCch
Q 011153 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLL 353 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (492)
++||+|+||.||++...+++.|++|.+...... ....+.+|++++++++||||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765433 5678999999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc-ccc
Q 011153 354 DNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS-ATL 432 (492)
Q Consensus 354 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-~~~ 432 (492)
+++... ...+++..+..++.+++.+|+|||+++ ++||||+|+||+++.++.+||+|||++........... ...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 888442 335789999999999999999999988 99999999999999999999999999876543222111 122
Q ss_pred cccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 433 ~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
..+..|+|||.+..+.++.++|+||||++++||++ |..|+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 34567999999988899999999999999999999 7777644
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=265.71 Aligned_cols=197 Identities=30% Similarity=0.457 Sum_probs=170.8
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4666788999999999999864 57789999886443 344567899999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++++|.+++. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999988773 245889999999999999999999987 99999999999999999999999999876544321
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
......++..|+|||.+.+..++.++||||||++++||++|+.|+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 12234578899999999988899999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=261.26 Aligned_cols=200 Identities=34% Similarity=0.480 Sum_probs=174.0
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+|+..+.||+|+||.||++... +++.|++|.+..... ...+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 688999999876544 3677899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999998853 234788999999999999999999988 99999999999999999999999999987654433
Q ss_pred cccc---cccccccccchhhhccCC---CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISA---TLAGTLGYMAPEYVVRGK---LTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~---~~~gt~~y~aPE~~~~~~---~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.... ...+++.|+|||++.... .+.++||||||++++||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 2221 356788999999988766 889999999999999999999998643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=266.55 Aligned_cols=200 Identities=31% Similarity=0.428 Sum_probs=172.7
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
++|++.++||+|+||+||++... +++.+|+|++.... ....+.+.+|+++++.++||||+++++.+...+..++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45778899999999999999854 68889999886543 34467789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++.. .+.+++.....++.+++.+|.|||+.. +++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999887743 346899999999999999999999742 39999999999999999999999999986543221
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.....++..|+|||++.++.++.++||||||++++||++|+.||....
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 124568999999999988899999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=259.74 Aligned_cols=198 Identities=33% Similarity=0.486 Sum_probs=170.9
Q ss_pred CcccccCcccEEEEEecC----CCEEEEEEeccCChh-hHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
++||+|+||.||++.... +..+++|.+...... ..+.+.+|+++++.++|+||+++++++.+....++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998754 778999999765433 367889999999999999999999999999999999999999
Q ss_pred CCchhhhhccCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 350 QSLLDNLFVRQD------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 350 gsL~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
++|.+++..... ...+++..+..++.|++.||+|||+++ ++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865421 367899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 424 DIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 424 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
... .......+++.|+|||.+....++.++||||||++++||++ |+.|+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 321 11224457889999999988889999999999999999999 58887654
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=275.30 Aligned_cols=193 Identities=27% Similarity=0.373 Sum_probs=164.7
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
...|++.+.||+|+||.||++... +++.||+|..... ....|+.++++++||||+++++++.+....++|+|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 456999999999999999999865 5678999975332 235699999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+. ++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 139 ~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 139 YS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred cC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 95 578777743 3346899999999999999999999988 9999999999999999999999999987533221
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
......||+.|+|||++.+..++.++|||||||++|||+++..|+..
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 12245689999999999999999999999999999999997776543
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=260.63 Aligned_cols=189 Identities=28% Similarity=0.389 Sum_probs=159.1
Q ss_pred CcccccCcccEEEEEecCCC-----------EEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 275 NKLGQGGSGSVYKGTLPGGE-----------AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999875433 5788877654433 6788999999999999999999999988 788999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-------cEEEeecC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-------TAKIADFG 416 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-------~~kl~Dfg 416 (492)
+||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999885432 26889999999999999999999987 99999999999999887 79999999
Q ss_pred CccccCCCCccccccccccccccchhhhccC--CCCcchhHHHHHHHHHHHHhC-CCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRG--KLTEKADVYSFGVVVIEVVCR-KRINLFT 475 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvll~elltg-~~p~~~~ 475 (492)
++...... ....++..|+|||++... .++.++||||||+++|||++| ..|+...
T Consensus 154 ~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 154 IPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred cccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 98765431 223466789999998776 789999999999999999995 5555443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.17 Aligned_cols=208 Identities=25% Similarity=0.253 Sum_probs=181.9
Q ss_pred HHHHHHHhcccccCCcccccCcccEEEEEec-CCCEEEEEEecc---CChhhHHHHHHHHHHHhccCcCceeeeeeeeec
Q 011153 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFY---NTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336 (492)
Q Consensus 261 ~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 336 (492)
...+....++|++.++||+|+||.|..++.. +++.+|+|++.+ -......-|..|-.+|..-+.+-|+++...|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3344555678999999999999999999865 578899999975 234445668888999999999999999999999
Q ss_pred CCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 011153 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (492)
Q Consensus 337 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 416 (492)
+..+|+|||||+||+|..++.. ...+++.-...++..|+-||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999998843 336888888899999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCccccccccccccccchhhhcc-----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVR-----GKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.+-.+..+..-.+...+|||.|++||++.. +.|++..|.||+||++|||+.|..||-.
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 998887666666678899999999999852 6789999999999999999999999854
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=259.11 Aligned_cols=201 Identities=25% Similarity=0.328 Sum_probs=171.4
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC-CcceeEEe
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-PESLLVYE 345 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 345 (492)
.|++.+.||+|++|.||++... +++.+++|++... .....+.+.+|++++++++|+|++++++.+... ...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3778899999999999999864 5788999998653 234456788999999999999999999987644 45789999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++++|.+++... ....+++.++..++.+++.+|++||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999888542 3346899999999999999999999988 9999999999999999999999999998664332
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ......+++.|+|||.+.+..++.++||||||++++||++|+.|+...
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 2 223456789999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=268.10 Aligned_cols=200 Identities=22% Similarity=0.313 Sum_probs=170.3
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|+..+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999864 57899999986543 234557889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999988432 45889999999999999999999987 999999999999999999999999998642111
Q ss_pred Cc--------------cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 425 IT--------------HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 425 ~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.. .......++..|+|||.+....++.++|+||||+++|||++|+.|+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~ 218 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 00 011124578899999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=266.41 Aligned_cols=202 Identities=26% Similarity=0.345 Sum_probs=168.2
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCCh-hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
+++|...+.||+|+||.||++.. .+++.+++|++..... .....+.+|+.+++.++|+||+++.+++.++...++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46789999999999999999986 4688999999865432 233467889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+. ++|.+.+... ...+++..+..++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 84 YMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred ccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 996 6776665432 235778888999999999999999988 9999999999999999999999999987543322
Q ss_pred ccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
. ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 158 Q-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred C-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 1 12234568899999988754 57889999999999999999999987543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=262.05 Aligned_cols=200 Identities=29% Similarity=0.429 Sum_probs=171.4
Q ss_pred ccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC------hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT------TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
+|+..+.||+|++|.||++.. .+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999985 568899999986432 2235678999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-cEEEeecCCcccc
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLF 421 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~ 421 (492)
|+||+++++|.+++.. ..++++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998853 245889999999999999999999998 99999999999998775 6999999998766
Q ss_pred CCCCcc---ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 422 PEDITH---ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 422 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
...... ......++..|+|||.+.+..++.++||||+|++++||++|+.|+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 543211 112346788999999998888999999999999999999999998643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=265.55 Aligned_cols=200 Identities=26% Similarity=0.390 Sum_probs=168.0
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+|+..++||+|+||.||++... +|+.+++|++.... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999864 68899999986532 22345678899999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
++ ++|.+.+... ...+++..+..++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 5777766432 345899999999999999999999988 99999999999999999999999999986543322
Q ss_pred cccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
. .....+++.|+|||.+.+. .++.++||||||++++||++|+.|+....
T Consensus 155 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~ 204 (284)
T cd07839 155 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 204 (284)
T ss_pred C-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC
Confidence 1 1234568899999988764 46899999999999999999999975443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=264.47 Aligned_cols=199 Identities=28% Similarity=0.428 Sum_probs=171.3
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+|++.+.||+|+||.||++... +++.|++|++.... ....+.+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999864 68899999987653 33456789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+ +++|.+.+.... ..+++..+..++.||+.+|+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999998875433 56899999999999999999999988 99999999999999999999999999987654432
Q ss_pred cccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.......++..|+|||.+.+. .++.++||||+|++++||++|++|+..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 223345688999999988654 468899999999999999999776644
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=259.73 Aligned_cols=201 Identities=30% Similarity=0.435 Sum_probs=177.4
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
++|+..+.||+|++|.||+++.. +++.|++|++..... ...+.+.+|++.+.+++|+||+++++++..+...++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 35788899999999999999876 589999999876644 4567899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
+++++|.+++... ..+++..+..++.|++++|+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999988543 568999999999999999999999 87 9999999999999999999999999988665433
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.. .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+....
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 22 123457889999999998889999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=265.60 Aligned_cols=200 Identities=30% Similarity=0.444 Sum_probs=174.7
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
..+|+..+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36788899999999999999985 46788999998765555567789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999988742 34788999999999999999999988 99999999999999999999999999875543322
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
......+++.|++||.+..+.++.++||||||+++||+++|+.||...
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 122346788999999998888999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=258.15 Aligned_cols=195 Identities=29% Similarity=0.441 Sum_probs=166.2
Q ss_pred cccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeee-cCCcceeEEeec
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI-TGPESLLVYEFV 347 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 347 (492)
.+|+..+.||+|+||.||++... +..+++|.+.... ..+.+.+|+.++++++|+|++++++++. +++..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46788899999999999999765 7789999886443 3467899999999999999999999765 456789999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999885432 345889999999999999999999988 9999999999999999999999999987543322
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
.....+..|+|||++....++.++||||||++++||++ |+.|+..
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 12344678999999988889999999999999999998 8888753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=261.88 Aligned_cols=198 Identities=29% Similarity=0.447 Sum_probs=172.5
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
..|+..++||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34677889999999999999865 58899999987543 44567789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999988732 35788999999999999999999987 99999999999999999999999999976543321
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
......++..|+|||.+.+..++.++|+||||++++||++|+.|+..
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12234578899999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=269.75 Aligned_cols=204 Identities=27% Similarity=0.359 Sum_probs=169.4
Q ss_pred hcccccCCcccccCcccEEEEEec--------CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecC
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG 337 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 337 (492)
..+|++.+.||+|+||.||++... ....||+|.+... .....+.+.+|+++++++ +||||+++++++..+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 346888999999999999999742 1236899988654 234467899999999999 899999999999999
Q ss_pred CcceeEEeecCCCCchhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL 404 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill 404 (492)
+..++++||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999886432 2245889999999999999999999988 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCccc-cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 405 DEEFTAKIADFGLVRLFPEDITHI-SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 405 ~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
+.++.+||+|||+++......... .....++..|+|||.+....++.++||||||+++|||++ |+.|+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999998654322111 112234568999999999999999999999999999999 7777643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=278.57 Aligned_cols=198 Identities=28% Similarity=0.454 Sum_probs=171.6
Q ss_pred cccCCcccccCcccEEEEEec--CCC--EEEEEEeccCChh-hHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 271 FHESNKLGQGGSGSVYKGTLP--GGE--AVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~--~~~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
....++||+|.||.|++|.+. +|+ .||||.++..... ....|++|+.+|.+|+|||+++|+|+..+ ....||+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 345678999999999999875 354 5899999876544 67889999999999999999999999887 77889999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
+.+.|+|.+.|.. .....|-...+..++.|||.||.||.+++ +|||||.++|+|+-..-.+||+||||.+.+....
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999976 55667888999999999999999999988 9999999999999999999999999999876543
Q ss_pred cc--ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 011153 426 TH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINL 473 (492)
Q Consensus 426 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~ 473 (492)
.. ......-+..|.|||.+....|+.++|||+|||.||||+|+..-.+
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW 316 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPW 316 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCC
Confidence 32 2223445789999999999999999999999999999999765443
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=284.16 Aligned_cols=203 Identities=23% Similarity=0.276 Sum_probs=163.4
Q ss_pred HHHHHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccC------cCceeeeeeeee
Q 011153 263 TLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN------HKNLVKLLGCSI 335 (492)
Q Consensus 263 ~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~ 335 (492)
++...+++|++.++||+|+||+||++... .++.||||+++... ...+.+..|+.++..++ |++++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 33445688999999999999999999864 57889999986432 22344556777766664 456889998887
Q ss_pred cC-CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCCeeeCCCC-----
Q 011153 336 TG-PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEF----- 408 (492)
Q Consensus 336 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~----- 408 (492)
.. ...++|||++ +++|.+++.. ...+++..+..++.||+.||+|||++ + ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 65 4678899887 6788887743 24689999999999999999999974 6 99999999999998765
Q ss_pred -----------cEEEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 409 -----------TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 409 -----------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
.+||+|||++..... ......||+.|||||++.+..++.++|||||||++|||++|+.||....+
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 499999998764322 22356789999999999999999999999999999999999999976543
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=265.48 Aligned_cols=200 Identities=26% Similarity=0.374 Sum_probs=169.5
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
++|+..++||+|+||.||++... +++.+|+|++.... ....+.+.+|+++++.++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35788899999999999999975 58899999886532 2234568899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++++|.+.... ...+++..+..++.||+.+|+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999888776532 234899999999999999999999987 9999999999999999999999999987654432
Q ss_pred ccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.......++..|+|||++.+ ..++.++||||||++++||++|++|+...
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 22233457889999998865 45788999999999999999999888643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=257.03 Aligned_cols=194 Identities=31% Similarity=0.447 Sum_probs=162.7
Q ss_pred CcccccCcccEEEEEec--C--CCEEEEEEeccCCh-hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLP--G--GEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~--~--~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
++||+|+||.||+|... + +..+|+|.+..... ...+.+.+|+.+++.++||||+++++++. .+..++|+||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999743 2 26899999876543 34567899999999999999999999875 5567999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|.+++.... .+++..+..++.|++.+|+|||+.+ ++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999885432 6899999999999999999999988 99999999999999999999999999986644332211
Q ss_pred c--cccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 430 A--TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 430 ~--~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
. ...++..|+|||.+....++.++||||||+++|||++ |+.|+...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 1 2223568999999988899999999999999999998 88887653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=260.37 Aligned_cols=199 Identities=29% Similarity=0.428 Sum_probs=169.0
Q ss_pred ccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCCh----------hhHHHHHHHHHHHhccCcCceeeeeeeeecCC
Q 011153 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT----------QWVDHFFNEVNLISGINHKNLVKLLGCSITGP 338 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 338 (492)
+|...+.||+|+||.||+|.. .+++.+|+|.++.... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999985 4688999998854211 12346788999999999999999999999999
Q ss_pred cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCc
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~ 418 (492)
..++|+||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999988433 46889999999999999999999987 999999999999999999999999998
Q ss_pred cccCCCCccc-cccccccccccchhhhccCC--CCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 419 RLFPEDITHI-SATLAGTLGYMAPEYVVRGK--LTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 419 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
+......... .....++..|+|||.+.... ++.++|+||||+++||+++|+.|+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 7654322111 22446789999999987654 78999999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=264.63 Aligned_cols=212 Identities=26% Similarity=0.324 Sum_probs=174.3
Q ss_pred cCHHHHHHHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeee-
Q 011153 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSI- 335 (492)
Q Consensus 259 ~~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~- 335 (492)
+.++.+..+.++|++.+.||+|+||.||++... +++.+++|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344556677889999999999999999999864 57889999875432 2245678899999999 6999999999874
Q ss_pred ----cCCcceeEEeecCCCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcE
Q 011153 336 ----TGPESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (492)
Q Consensus 336 ----~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ 410 (492)
.++..++||||+++++|.+.+... .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345679999999999998877532 23356889999999999999999999987 9999999999999999999
Q ss_pred EEeecCCccccCCCCccccccccccccccchhhhcc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR-----GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 411 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
||+|||++........ ......|++.|+|||++.. ..++.++||||||+++|||++|+.|+...
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999876543221 2234468999999998753 45788999999999999999999997643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=285.88 Aligned_cols=202 Identities=20% Similarity=0.308 Sum_probs=161.3
Q ss_pred hcccccCCcccccCcccEEEEEecC--CCEEEEE------------------EeccCChhhHHHHHHHHHHHhccCcCce
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG--GEAVAVK------------------RLFYNTTQWVDHFFNEVNLISGINHKNL 327 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~h~ni 327 (492)
.++|++.++||+|+||+||++.... +...++| ++. ........+.+|+++|+.++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence 4679999999999999999986532 2222222 111 122345568899999999999999
Q ss_pred eeeeeeeecCCcceeEEeecCCCCchhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC
Q 011153 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD--VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD 405 (492)
Q Consensus 328 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~ 405 (492)
+++++++.+.+..++|+|++. ++|.+++..... ...........++.||+.||+|||+++ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999985 566666543211 122345667789999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 406 EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 406 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.++.+||+|||+++.+............||+.|+|||++.+..++.++|||||||++|||++|+.++..
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence 999999999999987755433333356789999999999999999999999999999999999876554
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=265.21 Aligned_cols=200 Identities=30% Similarity=0.463 Sum_probs=166.0
Q ss_pred cccccCCcccccCcccEEEEEec-CCC----EEEEEEeccCCh-hhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGE----AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
++|+..+.||+|+||.||++... ++. .+|+|.+..... .....+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45778899999999999999853 344 478898865432 3345788999999999999999999988654 5679
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999987543 335789999999999999999999988 9999999999999999999999999998664
Q ss_pred CCCccc-cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 423 EDITHI-SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 423 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
...... .....++..|+|||.+....++.++||||||+++|||++ |+.|+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 332211 122345678999999988899999999999999999998 8888754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=262.18 Aligned_cols=200 Identities=29% Similarity=0.348 Sum_probs=169.6
Q ss_pred ccccCCcccccCcccEEEEEe----cCCCEEEEEEeccCC----hhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcc
Q 011153 270 YFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNT----TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES 340 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 340 (492)
+|++.+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367789999999999999985 368899999986532 23346678899999999 699999999999999999
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999988542 45788999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCccccccccccccccchhhhccC--CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 421 FPEDITHISATLAGTLGYMAPEYVVRG--KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.............++..|+|||.+... .++.++||||||++++||++|+.|+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 654332222345688999999998753 4678999999999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=301.78 Aligned_cols=208 Identities=32% Similarity=0.408 Sum_probs=176.2
Q ss_pred HHHhcccccCCcccccCcccEEEEE-ecCCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 265 ~~~~~~~~~~~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
...+-++.....||.|.||.||.+. .++|+..|+|.++... ........+|+.++..++|||+|+++|+-.+.+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3445667888999999999999998 4678899999886543 334556789999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
|.||||++|+|.+.+.. ....++.....+..|++.|++|||++| ||||||||.||+++.+|.+|++|||.|..+
T Consensus 1311 IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 99999999999998843 333556666677899999999999999 999999999999999999999999999877
Q ss_pred CCCC---ccccccccccccccchhhhccCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 422 PEDI---THISATLAGTLGYMAPEYVVRGK---LTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 422 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
.... +.......||+-|||||++.+.. ...+.||||+||+++||+||++|+...+++
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence 6543 22234678999999999997643 456799999999999999999999876543
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=273.11 Aligned_cols=199 Identities=28% Similarity=0.374 Sum_probs=176.2
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
...|.+.+.||+|.|++|..++. .++..||||.+.+.. ....+.+.+|+++|+.++|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 46688999999999999999985 468999999987653 334566899999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||..+|.+.+++..... ........+..|+.++++|||++. |+|||||++||||+.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~- 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY- 207 (596)
T ss_pred EeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc-
Confidence 99999999999954433 444778888999999999999998 99999999999999999999999999987763
Q ss_pred CccccccccccccccchhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.....+.+|++.|.|||++.+..+ .+++|+||+|++||-|++|..||+.
T Consensus 208 -~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 208 -GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred -cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 345567899999999999988776 5789999999999999999999984
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=264.37 Aligned_cols=200 Identities=27% Similarity=0.332 Sum_probs=171.6
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
++|+..++||+|+||.||++... +++.|++|+++.. .....+.+.+|+++++.++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999865 5789999988653 33345678999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|++++.+..... ....+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999866655442 2344899999999999999999999988 9999999999999999999999999998765543
Q ss_pred ccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
........++..|+|||++... .++.++||||||+++|||++|+.|+..
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3233345678899999999887 789999999999999999999988864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=258.96 Aligned_cols=200 Identities=25% Similarity=0.402 Sum_probs=169.9
Q ss_pred ccccCCcccccCcccEEEEEecC--CCEEEEEEeccC----------ChhhHHHHHHHHHHHhc-cCcCceeeeeeeeec
Q 011153 270 YFHESNKLGQGGSGSVYKGTLPG--GEAVAVKRLFYN----------TTQWVDHFFNEVNLISG-INHKNLVKLLGCSIT 336 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~~--~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 336 (492)
.|++.+.||+|+||.||++.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778899999999999999754 678999987532 22334567889998865 799999999999999
Q ss_pred CCcceeEEeecCCCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCcEEEee
Q 011153 337 GPESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIAD 414 (492)
Q Consensus 337 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~D 414 (492)
++..++|+||+++++|.+.+... .....+++..++.++.|++.+|.|||+ .+ ++|+||+|+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999998887432 334568999999999999999999996 45 99999999999999999999999
Q ss_pred cCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 415 FGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 415 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
||++....... ......++..|++||.+..+.++.++||||||+++|||++|+.|+..
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~ 215 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence 99998654432 22345688999999999988899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=260.25 Aligned_cols=199 Identities=30% Similarity=0.344 Sum_probs=175.0
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
+|+..+.||+|+||.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999875 58899999986532 2456789999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++++|.+.+... ..+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999888432 46889999999999999999999988 9999999999999999999999999987654432
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
......++..|+|||.+....++.++|+||||++++||++|+.|+....
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 2234567889999999988889999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=260.70 Aligned_cols=196 Identities=30% Similarity=0.474 Sum_probs=171.8
Q ss_pred cccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCC
Q 011153 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
|...++||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++..++..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 45567899999999999985 46889999998766555567789999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|.+++.. ..+++..+..++.|++.+|+|||+.+ ++||||+|+||+++.++.++|+|||++......... .
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~ 172 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-R 172 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-c
Confidence 999988743 35889999999999999999999988 999999999999999999999999988755443221 2
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
....|++.|+|||.+.+..++.++||||||++++||++|+.|+..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 234688999999999888899999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=260.54 Aligned_cols=202 Identities=27% Similarity=0.429 Sum_probs=171.5
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
+|+..++||+|++|.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++.+.+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999975 688999999876533 23456788999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++ +|.+++........+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 88887755444456899999999999999999999988 99999999999999999999999999875543221
Q ss_pred ccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
......+++.|++||.+.+. .++.++||||||+++|||++|+.|+....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11234568899999987654 56889999999999999999999987654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=256.57 Aligned_cols=200 Identities=22% Similarity=0.344 Sum_probs=172.8
Q ss_pred ccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+|+..++||+|+||.||++.. .+++.+++|++... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999985 46889999998643 334456789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+.+... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999887542 2335789999999999999999999988 99999999999999999999999999976544321
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
......+++.|+|||.+.++.++.++|+||||++++||++|+.|+..
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence 12234578899999999888999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=255.23 Aligned_cols=200 Identities=35% Similarity=0.517 Sum_probs=169.6
Q ss_pred cccCCcccccCcccEEEEEecC-----CCEEEEEEeccCChh-hHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 271 FHESNKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
+++.+.||+|+||.||++...+ +..||+|++...... ..+.+.+|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999998653 378999999765433 5678999999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++..... ..+++..+..++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999998854322 22899999999999999999999988 999999999999999999999999999866544
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
.........+++.|+|||.+....++.++||||||++++||++ |+.|+..
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 2222212336789999999988889999999999999999999 6666543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=260.49 Aligned_cols=198 Identities=28% Similarity=0.402 Sum_probs=173.5
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
+|+..+.||+|++|.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++.+..+...++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777889999999999999875 68899999987653 345567899999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
++++|.+++.... ..+++..+.+++.|++.+|+|||+ .+ ++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999885432 568899999999999999999999 77 99999999999999999999999999875533221
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ...++..|+|||.+.+..++.++||||||++++||++|+.|+...
T Consensus 157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1 256788999999998889999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=265.59 Aligned_cols=203 Identities=23% Similarity=0.389 Sum_probs=168.8
Q ss_pred ccccCCcccccCcccEEEEEec---CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecC--Ccce
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP---GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESL 341 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 341 (492)
+|++.++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3778889999999999999864 47899999997633 34456788999999999999999999999988 7789
Q ss_pred eEEeecCCCCchhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC----CCcEEEeec
Q 011153 342 LVYEFVPNQSLLDNLFVRQ--DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE----EFTAKIADF 415 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~----~~~~kl~Df 415 (492)
+|+||+++ +|.+.+.... ....+++..+..++.||+.||.|||+.+ ++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6666553222 2236889999999999999999999988 999999999999999 899999999
Q ss_pred CCccccCCCCc--cccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 416 GLVRLFPEDIT--HISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 416 gl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
|++........ .......+++.|+|||.+.+. .++.++||||||++++||++|+.|+....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99986644322 112245678899999988764 57899999999999999999999987544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=263.07 Aligned_cols=211 Identities=29% Similarity=0.337 Sum_probs=174.2
Q ss_pred CHHHHHHHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecC
Q 011153 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG 337 (492)
Q Consensus 260 ~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 337 (492)
...++..+.++|+..+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3455566788899999999999999999986 468899999886432 2345677899999998 899999999998754
Q ss_pred C-----cceeEEeecCCCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEE
Q 011153 338 P-----ESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK 411 (492)
Q Consensus 338 ~-----~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~k 411 (492)
+ ..++|+||+++++|.+++... .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 3 578999999999999877532 23456899999999999999999999987 99999999999999999999
Q ss_pred EeecCCccccCCCCccccccccccccccchhhhccCC-----CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 412 IADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK-----LTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 412 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
|+|||++......... .....++..|+|||.+.... ++.++||||||+++|||++|+.|+...
T Consensus 169 l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 169 LVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred Eeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 9999998765432211 22346788999999876433 678999999999999999999998643
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=262.89 Aligned_cols=198 Identities=28% Similarity=0.370 Sum_probs=167.7
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChh-----hHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQ-----WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
+|+..+.||+|+||.||+|... +++.|+||++...... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677889999999999999864 6889999999754322 345577899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899998885432 36899999999999999999999998 99999999999999999999999999986654
Q ss_pred CCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.... .....+++.|+|||.+.+ ..++.++||||||++++||++|.+|+..
T Consensus 155 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 155 PNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred CCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 3221 123346788999998855 4678999999999999999999766643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=260.20 Aligned_cols=188 Identities=25% Similarity=0.373 Sum_probs=159.0
Q ss_pred CcccccCcccEEEEEecC--------CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 275 NKLGQGGSGSVYKGTLPG--------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+.||+|+||.||+|.... ...+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997532 234888888665556667889999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc--------EEEeecCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT--------AKIADFGLV 418 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~--------~kl~Dfgl~ 418 (492)
+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999885432 35889999999999999999999988 999999999999987765 699999988
Q ss_pred cccCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRIN 472 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~ 472 (492)
...... ....+++.|+|||++.+ ..++.++||||||+++|||++|..++
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~ 205 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP 205 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 654321 23457889999999876 45789999999999999999996544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=260.20 Aligned_cols=203 Identities=29% Similarity=0.462 Sum_probs=176.7
Q ss_pred HHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
..++.|+..+.||+|++|.||++..+ +++.+++|++..... ..+.+.+|+++++.++|+||+++++.+...+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34566888899999999999999876 688999999976544 4667889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999986533 46899999999999999999999987 999999999999999999999999998755433
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.. ......++..|++||.+.+..++.++||||||+++|||++|+.|+...
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~ 219 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE 219 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 21 122345788999999998888999999999999999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=260.17 Aligned_cols=200 Identities=26% Similarity=0.360 Sum_probs=165.2
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHH-HhccCcCceeeeeeeeecCCcceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNL-ISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
++|++.+.||+|+||.||++... +++.||+|++.... .+....+..|+.. ++.++||||+++++++..++..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999865 68999999987542 2333455666665 666799999999999999999999999
Q ss_pred ecCCCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 346 FVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 346 ~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|++ ++|.+.+... .....+++..+..++.||+.||+|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6787776432 2345789999999999999999999986 6 99999999999999999999999999886543
Q ss_pred CCccccccccccccccchhhhcc----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVR----GKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
... .....++..|+|||.+.. ..++.++|+||||+++|||++|+.|+..
T Consensus 157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 157 SVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ccc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 221 123467889999998754 4568899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=259.83 Aligned_cols=197 Identities=34% Similarity=0.464 Sum_probs=165.0
Q ss_pred CcccccCcccEEEEEecC-------CCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 275 NKLGQGGSGSVYKGTLPG-------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+.||+|+||.||+|+..+ ++.+++|.+.... ......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998642 2578999886543 34466789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-----cEEEeecCC
Q 011153 347 VPNQSLLDNLFVRQ----DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-----TAKIADFGL 417 (492)
Q Consensus 347 ~~~gsL~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-----~~kl~Dfgl 417 (492)
+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999886432 2345789999999999999999999987 99999999999999877 899999999
Q ss_pred ccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 418 VRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 418 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
++....... .......++..|+|||.+.++.++.++||||||+++|||++ |+.|+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~ 216 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc
Confidence 875533221 11123345678999999999999999999999999999998 8888754
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=258.62 Aligned_cols=198 Identities=29% Similarity=0.486 Sum_probs=170.7
Q ss_pred ccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC-ChhhHHHHHHHHHHHhccC---cCceeeeeeeeecCCcceeEE
Q 011153 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGIN---HKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 344 (492)
.|+..+.||+|+||.||+|.. .+++.+++|.+... .......+.+|+.++++++ |||++++++++..++..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999986 56889999998654 3344567889999999986 999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++.. ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988733 26889999999999999999999988 999999999999999999999999999876544
Q ss_pred CccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
... .....|+..|+|||.+..+ .++.++|+||||+++|||++|+.|+...
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 155 SSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred ccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 322 2344688999999988654 4688999999999999999999998543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=259.00 Aligned_cols=193 Identities=24% Similarity=0.292 Sum_probs=166.3
Q ss_pred ccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCCc
Q 011153 277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (492)
Q Consensus 277 iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 352 (492)
||+|+||+||++... +++.+++|.+.... ....+.+.+|+++++.++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68899999986532 22345677899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccccc
Q 011153 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432 (492)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 432 (492)
.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR 154 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence 988864432 46899999999999999999999988 9999999999999999999999999987654321 12234
Q ss_pred cccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 433 ~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.++..|+|||.+.++.++.++||||||++++||++|+.||...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 5788999999998888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=260.85 Aligned_cols=209 Identities=27% Similarity=0.372 Sum_probs=173.1
Q ss_pred CHHHHHHHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeeec-
Q 011153 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSIT- 336 (492)
Q Consensus 260 ~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 336 (492)
++..+..+...|+..+.||+|+||.||++.. .+++.+|+|.+..... ....+..|+.+++++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4555566778899999999999999999986 4688999998865433 345688899999998 79999999998863
Q ss_pred -----CCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEE
Q 011153 337 -----GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK 411 (492)
Q Consensus 337 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~k 411 (492)
....+++|||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 346789999999999998875432 345788889999999999999999988 99999999999999999999
Q ss_pred EeecCCccccCCCCccccccccccccccchhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 412 IADFGLVRLFPEDITHISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 412 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
|+|||++........ ......+++.|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~ 228 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence 999999875533221 122456889999999876 34578899999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=252.01 Aligned_cols=199 Identities=33% Similarity=0.467 Sum_probs=176.3
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecC
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (492)
.|+..+.||+|++|.||++... +++.+++|++........+.+.+|+++++.++||||+++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999975 688999999977665567789999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 428 (492)
+++|.+++.... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999998875432 46899999999999999999999987 99999999999999999999999999886654432
Q ss_pred cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.....++..|++||.+....++.++||||||++++||++|+.|+...
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23456788999999998888999999999999999999999998654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=254.40 Aligned_cols=194 Identities=30% Similarity=0.473 Sum_probs=164.9
Q ss_pred cccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecC
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (492)
++|++.+.||+|+||.||++.. +++.+|+|.+.... ..+.+.+|+.+++.++||||+++++++.. +..++|+||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence 4578899999999999999975 57789999986543 24578899999999999999999998865 45799999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 428 (492)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999885432 345789999999999999999999987 9999999999999999999999999987543221
Q ss_pred cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
.....+..|+|||.+..+.++.++|+||||++++||++ |+.|+..
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 200 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK 200 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 12234578999999988899999999999999999998 8887754
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=257.17 Aligned_cols=198 Identities=29% Similarity=0.437 Sum_probs=171.3
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+-|+..++||+|+||.||+|.. .+++.+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3467788999999999999986 468899999886443 34456788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++.. ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999988732 35889999999999999999999988 99999999999999999999999999876543321
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
......++..|+|||.+....++.++|+||||++++||++|+.|+..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 12234678899999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=254.99 Aligned_cols=192 Identities=26% Similarity=0.316 Sum_probs=168.1
Q ss_pred ccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCCc
Q 011153 277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (492)
Q Consensus 277 iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 352 (492)
||.|++|.||+++.. +++.+++|++.... ....+.+.+|+.+++.++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 48899999986532 23456789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccccc
Q 011153 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432 (492)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 432 (492)
.+++... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 9988442 34889999999999999999999988 9999999999999999999999999998665432 12234
Q ss_pred cccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 433 ~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.+++.|++||.+....++.++|+||||+++|||++|+.|+....
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 67889999999988889999999999999999999999987654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-33 Score=275.25 Aligned_cols=203 Identities=24% Similarity=0.347 Sum_probs=175.7
Q ss_pred cccccCCcccccCcccEEEEEecCCC-EEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~-~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
+.|++...||.|+||.||++..++.. .-|-|.+...+.+..+.|+-||++|...+||+||+|++.|..++.+++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 44667788999999999999876544 45778887788888999999999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
.||-....+..- ...+++.++.-+.+|++.||.|||++. |||||||+.|||+.-+|.++|+|||.+...... ..
T Consensus 112 ~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~q 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQ 185 (1187)
T ss_pred CCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-Hh
Confidence 999998777543 346899999999999999999999998 999999999999999999999999997644322 12
Q ss_pred ccccccccccccchhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
......|||.|||||+.+ +.+|+.++|||||||.|.||.-+.+|......
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp 240 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP 240 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence 234678999999999874 57899999999999999999999999766543
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=254.37 Aligned_cols=200 Identities=24% Similarity=0.362 Sum_probs=172.0
Q ss_pred ccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+|+..+.||+|+||.||++.. .+++.+++|.+... .....+.+.+|++++++++||||+++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999986 46888999998654 334467789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-CcEEEeecCCccccCCCC
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~~ 425 (492)
+++++|.+++... ....+++..+.+++.+++.+|+|||+++ ++|+||+|+||+++++ ..+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999988543 2345889999999999999999999988 9999999999999855 468999999998665432
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. .....++..|+|||.+....++.++||||||+++|||++|+.|+...
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 157 K--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred c--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 1 22356788999999998888899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=261.62 Aligned_cols=195 Identities=34% Similarity=0.510 Sum_probs=166.4
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
..|+..+.||+|+||.||++... +++.|++|++... ..+..+.+.+|+++++.++||||+++.+++.+++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999864 6889999988643 2334567889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||++ ++|.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 5666665332 345899999999999999999999988 999999999999999999999999998754332
Q ss_pred Cccccccccccccccchhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
....+++.|+|||++. .+.++.++||||||+++|||++|+.|+..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 2345788999999874 45688999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=260.30 Aligned_cols=201 Identities=31% Similarity=0.475 Sum_probs=169.2
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+|+..+.||+|++|.||+++.. +++.|+||++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999864 68899999886542 23345788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+. ++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 6888777543 2346899999999999999999999987 99999999999999999999999999876543321
Q ss_pred cccccccccccccchhhhccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
. .....+++.|+|||.+.+.. ++.++||||||++++||++|+.||....
T Consensus 156 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 156 T-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred c-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 1 22335688999999876644 5889999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=258.59 Aligned_cols=201 Identities=29% Similarity=0.368 Sum_probs=171.5
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecC--CcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 344 (492)
++|+..++||.|++|.||++... +++.+|+|.+.... ......+.+|+++++.++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35788899999999999999974 57889999987543 34456789999999999999999999988654 3678999
Q ss_pred eecCCCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 345 EFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 345 e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
||+++++|.+++... .....++...+..++.||+.+|.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998876532 23456889999999999999999999988 99999999999999999999999999875433
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.|+...
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 221 2345688999999999899999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=257.46 Aligned_cols=191 Identities=25% Similarity=0.273 Sum_probs=157.8
Q ss_pred cccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHH---hccCcCceeeeeeeeecCCcceeEEeecC
Q 011153 276 KLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLI---SGINHKNLVKLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 276 ~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (492)
+||+|+||.||++... +++.+|+|.+.... ......+.+|..++ ...+||||+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 58899999886532 12223344554433 34479999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 428 (492)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+|||+++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 9999888743 245899999999999999999999988 99999999999999999999999999875543221
Q ss_pred cccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 429 SATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....|++.|+|||.+.+ ..++.++||||||++++||++|+.||...
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 153 -HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred -cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 23468999999998864 45789999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=259.89 Aligned_cols=201 Identities=27% Similarity=0.422 Sum_probs=168.7
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecC--CcceeE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLV 343 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 343 (492)
++|+..+.||+|+||.||+|... +++.+++|.++... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 45788899999999999999975 58899999986543 22334577899999999999999999998877 789999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
+||++ ++|.+.+.... ..+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 48888775432 36899999999999999999999988 99999999999999999999999999986654
Q ss_pred CCccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.... .....+++.|+|||.+.+. .++.++|+||||++++||++|+.|+....
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 159 PLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred Cccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3221 1234568899999988654 46889999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=260.61 Aligned_cols=193 Identities=31% Similarity=0.473 Sum_probs=169.0
Q ss_pred CCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCCc
Q 011153 274 SNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 352 (492)
..+||+|+||.||++.. .+++.||||++..........+.+|+.+++.++|+||+++++.+..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 46799999999999986 46889999998765555667799999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccccc
Q 011153 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432 (492)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 432 (492)
.+++.. ..+++..+..++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++........ .....
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 887632 34789999999999999999999988 99999999999999999999999999875543321 12335
Q ss_pred cccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 433 ~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.+++.|++||.+....++.++|+||||++++||++|+.|+..
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~ 218 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 678999999999888899999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=258.71 Aligned_cols=201 Identities=29% Similarity=0.440 Sum_probs=170.5
Q ss_pred cccccCCcccccCcccEEEEEec-----CCCEEEEEEeccCChh-hHHHHHHHHHHHhccCcCceeeeeeeeec--CCcc
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-----GGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSIT--GPES 340 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 340 (492)
+.|+..+.||+|+||.||++... +++.+|||.+...... ..+.+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677889999999999999853 3678999999765443 56789999999999999999999999877 5578
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++|+||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999885432 25899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCcc--ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 421 FPEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 421 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
....... ......++..|++||.+....++.++||||||++++||++|+.|+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 214 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence 6532211 11123445679999999888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=254.18 Aligned_cols=201 Identities=25% Similarity=0.405 Sum_probs=164.2
Q ss_pred cccCCcccccCcccEEEEEec----CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC------
Q 011153 271 FHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ 338 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 338 (492)
|.+.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556789999999999999753 3678999998654 3344667889999999999999999999886543
Q ss_pred cceeEEeecCCCCchhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQ---DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 415 (492)
..++++||+++++|.+++.... +...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999988764322 2235788999999999999999999988 999999999999999999999999
Q ss_pred CCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 416 GLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 416 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
|+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.|+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~ 218 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC
Confidence 998865432211 1223345678999999988889999999999999999999 7777653
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=257.52 Aligned_cols=204 Identities=31% Similarity=0.395 Sum_probs=172.0
Q ss_pred HHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCC-----
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGP----- 338 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----- 338 (492)
.++++|+..+.||+|++|.||++... +++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45688999999999999999999975 578899998875543 346789999999999 7999999999997654
Q ss_pred -cceeEEeecCCCCchhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 011153 339 -ESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (492)
Q Consensus 339 -~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 416 (492)
..++||||+++++|.+.+.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 3789999999999998875422 2456899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCccccccccccccccchhhhcc-----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVR-----GKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
++........ ......+++.|+|||.+.. ..++.++||||||++++||++|+.|+..
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 9876543222 1224568899999998753 3467899999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=258.17 Aligned_cols=200 Identities=28% Similarity=0.400 Sum_probs=169.3
Q ss_pred cccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecC--CcceeEEe
Q 011153 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLVYE 345 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 345 (492)
|++.++||+|++|.||++... +++.+++|++.... ......+.+|+++++.++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999865 58899999997653 34456788999999999999999999999888 78999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++ +|.+.+... ...+++..++.++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9974 887777433 246899999999999999999999987 9999999999999999999999999998765543
Q ss_pred ccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
........++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 222234456789999997765 457899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=255.53 Aligned_cols=191 Identities=26% Similarity=0.284 Sum_probs=158.4
Q ss_pred cccccCcccEEEEEec-CCCEEEEEEeccCCh---hhHHHHHHHHH---HHhccCcCceeeeeeeeecCCcceeEEeecC
Q 011153 276 KLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT---QWVDHFFNEVN---LISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 276 ~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (492)
.||+|+||.||++... +++.||+|.+..... .....+..|.. +++...||||+++++.+.+.+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 588999998865321 11222334433 4455689999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 428 (492)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++..+.....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 9999887743 346899999999999999999999988 99999999999999999999999999875543221
Q ss_pred cccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 429 SATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....|+..|+|||.+.++ .++.++||||+|++++||++|+.||...
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 234689999999998754 5889999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=265.65 Aligned_cols=198 Identities=27% Similarity=0.374 Sum_probs=167.9
Q ss_pred HhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC-----
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----- 338 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 338 (492)
..++|+..+.||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457799999999999999999985 46889999998643 3344567788999999999999999999886443
Q ss_pred -cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCC
Q 011153 339 -ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (492)
Q Consensus 339 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl 417 (492)
..++|+||+. ++|.+.+.. .++...+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 4689999996 477776632 2788899999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 418 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
++....... .....+++.|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 165 ARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred ceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 986544321 22345788999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=258.29 Aligned_cols=203 Identities=21% Similarity=0.217 Sum_probs=153.2
Q ss_pred hcccccCCcccccCcccEEEEEecC----CCEEEEEEeccCChhhH-----------HHHHHHHHHHhccCcCceeeeee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNTTQWV-----------DHFFNEVNLISGINHKNLVKLLG 332 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~ 332 (492)
.++|++.++||+|+||.||+|...+ +..+++|+......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4679999999999999999998654 34566665433222111 11223444566779999999999
Q ss_pred eeecCCc----ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC
Q 011153 333 CSITGPE----SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408 (492)
Q Consensus 333 ~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~ 408 (492)
++..... .++++|++.. ++.+.+.. ....++..+..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 7765442 3567776633 45444422 223567888999999999999999987 99999999999999999
Q ss_pred cEEEeecCCccccCCCCcc------ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 409 TAKIADFGLVRLFPEDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 409 ~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
.++|+|||+++.+...... ......||+.|+|||++.+..++.++|||||||+++||++|+.||.....
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999866432111 11234689999999999999999999999999999999999999976533
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=261.43 Aligned_cols=215 Identities=30% Similarity=0.380 Sum_probs=177.0
Q ss_pred HHhcccccCCcccccCcccEEEEE-ecCCCEEEEEEeccCC-------hhhHHHHHHHHHHHhccCcCceeeeeeeee-c
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-------TQWVDHFFNEVNLISGINHKNLVKLLGCSI-T 336 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~ 336 (492)
...++|-.+++||+|+|+.|||+. +...+.||||+-..+. ....+...+|.++-+.|+||.||++++++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 345667788999999999999998 5568899999764331 223455778999999999999999999987 5
Q ss_pred CCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCcEEEe
Q 011153 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIA 413 (492)
Q Consensus 337 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~ 413 (492)
.+..+-|+||+++.+|.-+|.. ...+++.....|+.||+.||.||.+.. +||||-||||.|||+-+ -|.+||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cccceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence 5567899999999999988843 345889999999999999999999874 89999999999999954 4789999
Q ss_pred ecCCccccCCCCcc------ccccccccccccchhhhccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcHHH
Q 011153 414 DFGLVRLFPEDITH------ISATLAGTLGYMAPEYVVRG----KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQ 483 (492)
Q Consensus 414 Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~slGvll~elltg~~p~~~~~~~~~~~~ 483 (492)
||||+++..++... .....+||..|++||.+.-+ ..+.|+||||.|||+|+.+-|++||.+.....++++
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 99999988654322 12245799999999987543 467899999999999999999999999776666665
Q ss_pred H
Q 011153 484 T 484 (492)
Q Consensus 484 ~ 484 (492)
+
T Consensus 696 e 696 (775)
T KOG1151|consen 696 E 696 (775)
T ss_pred h
Confidence 4
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=257.40 Aligned_cols=202 Identities=25% Similarity=0.393 Sum_probs=167.1
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
++|+..+.||+|++|.||+|... +++.|++|++.... ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999865 68899999886542 2334578899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-CCcEEEeecCCccccCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFPED 424 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~ 424 (492)
|++ ++|.+.+... ....+++..+..++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 5777766432 2334678888999999999999999987 999999999999985 567999999999765432
Q ss_pred CccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.. ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 157 VR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred cc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 12234568899999988664 57899999999999999999999986543
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=258.16 Aligned_cols=202 Identities=25% Similarity=0.363 Sum_probs=167.1
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccC-cCceeeeeeeeecCCc-----
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPE----- 339 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 339 (492)
++|+..+.||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888999999999999999864 68899999886543 223457889999999995 6999999999887665
Q ss_pred ceeEEeecCCCCchhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-CCcEEEeecC
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQD--VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFG 416 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg 416 (492)
.++||||+++ +|.+++..... ...+++..+..++.||+.||.|||+.+ ++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78887754322 356899999999999999999999988 999999999999998 8999999999
Q ss_pred CccccCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
+++.+...... .....+++.|+|||.+.+ ..++.++||||||++++||++|+.||...
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 98865433221 123356788999998865 45789999999999999999999988653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-33 Score=260.02 Aligned_cols=204 Identities=27% Similarity=0.308 Sum_probs=173.4
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 343 (492)
.+|..+.+||+|+||.|.++..+ +.+.+|||+++++ ..+..+--+.|-++|... +-|.++++..++++-+.+|.|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 45777899999999999999865 4667999999765 233345556788888777 678999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+.+|+|..+++.- +.+.+....-.+.+|+-||-+||+++ ||.||||..|||+|.+|.+||+|||+++.---
T Consensus 429 MEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999998888543 34666778889999999999999998 99999999999999999999999999973211
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
+ .....+.+|||.|+|||++..++|+..+|.|||||+|+||+.|++||...++++
T Consensus 503 ~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e 557 (683)
T KOG0696|consen 503 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 557 (683)
T ss_pred C-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 1 222347899999999999999999999999999999999999999998876654
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=259.10 Aligned_cols=204 Identities=29% Similarity=0.439 Sum_probs=168.8
Q ss_pred HHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCC----
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP---- 338 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 338 (492)
...++|++.+.||+|+||.||+|... +++.|++|+++... ......+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567899999999999999999975 58899999986543 233456788999999999999999999887655
Q ss_pred ------cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEE
Q 011153 339 ------ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412 (492)
Q Consensus 339 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl 412 (492)
..++|+||+++ ++...+.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 68899999976 66665533 2346899999999999999999999988 999999999999999999999
Q ss_pred eecCCccccCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 413 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
+|||++...............++..|+|||.+.+ ..++.++||||||++++||++|++|+...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999998665433222223356788999998865 35788999999999999999999888643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=264.65 Aligned_cols=199 Identities=25% Similarity=0.423 Sum_probs=165.7
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC-----cc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-----ES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 340 (492)
.++|++.++||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46799999999999999999985 46889999998643 3334567889999999999999999999876443 46
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++|+||+++ +|.+.+. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999964 7766652 245899999999999999999999988 99999999999999999999999999876
Q ss_pred cCCCCcc--ccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 421 FPEDITH--ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 421 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
....... ......+++.|+|||.+.+ ..++.++||||||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 5432221 1123467899999998765 5688999999999999999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=256.59 Aligned_cols=199 Identities=30% Similarity=0.462 Sum_probs=167.5
Q ss_pred cccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
|+..+.||+|++|.||++... +|..|++|++.... ......+.+|+++++.++|||++++++++.+++..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999864 68999999986543 233457889999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
+ ++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 68888774432 245899999999999999999999987 999999999999999999999999998755432211
Q ss_pred ccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.....+++.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1233568899999987664 5788999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=252.39 Aligned_cols=202 Identities=25% Similarity=0.393 Sum_probs=171.5
Q ss_pred ccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeec--CCcceeEE
Q 011153 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPESLLVY 344 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 344 (492)
+|++.+.||.|+||.||++.. .+++.+++|++... .....+.+.+|+++++.++||||+++++++.. +...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999985 46789999998643 33445678899999999999999999997764 34568999
Q ss_pred eecCCCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCeEecCCCCCCeeeCCCCcEEEeecCCc
Q 011153 345 EFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLH-----EESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (492)
Q Consensus 345 e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH-----~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~ 418 (492)
||+++++|.+++... .....+++..++.++.||+.||+||| +.+ ++|+||+|+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999988543 23457899999999999999999999 555 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
......... .....+++.|+|||.+....++.++|+||||++++||++|+.|+...
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 876543321 22346889999999998888999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=253.26 Aligned_cols=192 Identities=27% Similarity=0.346 Sum_probs=166.5
Q ss_pred ccccCcccEEEEEec-CCCEEEEEEeccCCh---hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCCc
Q 011153 277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT---QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (492)
Q Consensus 277 iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 352 (492)
||+|+||.||++... +++.+++|.+..... ...+.+.+|++++++++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999865433 4566788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc------
Q 011153 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT------ 426 (492)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~------ 426 (492)
.+++... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9888543 26899999999999999999999988 99999999999999999999999999875433211
Q ss_pred -cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 427 -HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 427 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.......++..|++||.......+.++||||||++++||++|+.|+..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 203 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 112234578899999999888899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=250.44 Aligned_cols=193 Identities=25% Similarity=0.288 Sum_probs=160.4
Q ss_pred HhcccccCCcc--cccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCccee
Q 011153 267 ATNYFHESNKL--GQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 267 ~~~~~~~~~~i--G~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 342 (492)
..++|++.+.+ |+|+||.||++.. .++..+++|.+........ |+.....+ +||||+++++.+...+..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34566666666 9999999999985 4678899998864322111 22222222 79999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-cEEEeecCCcccc
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLF 421 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~ 421 (492)
||||+++++|.+++... ..+++..+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 99999999999988433 36899999999999999999999988 99999999999999988 9999999998765
Q ss_pred CCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.... ...++..|+|||++.+..++.++||||||++++||++|+.|+...
T Consensus 161 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 161 GTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred CCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 4322 235788999999999889999999999999999999999998744
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=252.76 Aligned_cols=200 Identities=24% Similarity=0.371 Sum_probs=171.5
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+|+..+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|+++++.++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999865 57889999986532 23456788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-cEEEeecCCccccCCCC
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDI 425 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~ 425 (492)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988543 2345799999999999999999999988 99999999999998885 56999999987665432
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
. ......|++.|+|||.+....++.++|+||||++++||++|+.|+..
T Consensus 157 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 204 (257)
T cd08225 157 E-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204 (257)
T ss_pred c-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2 22234688999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=258.23 Aligned_cols=193 Identities=34% Similarity=0.518 Sum_probs=165.2
Q ss_pred cccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
|+..+.||+|+||.||+++. .++..+|+|++... ..+....+.+|+++++.++|||++++++++.++...++|+||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 67788999999999999986 46889999998643 233456788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
++ |+|.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 97 4776666432 345899999999999999999999988 999999999999999999999999998754332
Q ss_pred cccccccccccccchhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
....+++.|+|||.+. .+.++.++||||||++++||++|+.|+..
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 2345788999999874 45688999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=259.47 Aligned_cols=201 Identities=30% Similarity=0.430 Sum_probs=166.8
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhccCcCceeeeeeeeecC--Cccee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLL 342 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 342 (492)
.++|+..++||+|+||.||++... +++.||+|+++.... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999864 689999999865432 2234567899999999999999999998765 45789
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
|+||+++ +|.+.+... ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999964 787776432 256899999999999999999999998 9999999999999999999999999998665
Q ss_pred CCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 160 LPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred CccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 43211 122345788999998865 45789999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=263.60 Aligned_cols=197 Identities=26% Similarity=0.377 Sum_probs=170.7
Q ss_pred CCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCC
Q 011153 274 SNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (492)
.++||.|.||+||-|+. ++|+.||||++.+. ..+...++.+|+.+|+++.||.||.+...|++.++.++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 47899999999999985 57999999998653 2334478899999999999999999999999999999999999 55
Q ss_pred CchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC---CcEEEeecCCccccCCCCcc
Q 011153 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 351 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Dfgl~~~~~~~~~~ 427 (492)
+..+.+.... .+.+++.....++.||+.||.|||.++ |+|.||||+|||+.+. -++||+|||+++++.+..
T Consensus 648 DMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 648 DMLEMILSSE-KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred hHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 6666665443 456888888889999999999999998 9999999999999643 489999999999987753
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
....++|||.|+|||++.++.|+..-|+||.|||+|--++|..||..+.+
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd 771 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED 771 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence 33468999999999999999999999999999999999999999976544
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=248.96 Aligned_cols=201 Identities=31% Similarity=0.392 Sum_probs=175.6
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecC--CcceeEE
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLVY 344 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 344 (492)
+|...+.||+|++|.||+|... +++.|++|++.... ....+.+.+|+.++++++||||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677889999999999999976 68899999987654 25567899999999999999999999999988 7889999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++.... .+++..+..++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999885432 7899999999999999999999987 999999999999999999999999998876554
Q ss_pred Ccc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 425 ITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 425 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
... ......++..|++||.+.....+.++||||||++++||++|+.|+....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 321 1234567889999999988889999999999999999999999986644
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=250.31 Aligned_cols=189 Identities=26% Similarity=0.297 Sum_probs=159.8
Q ss_pred CcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHH-HhccCcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNL-ISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
+.||+|+||.||++... +++.||+|.+.... ......+..|..+ ....+|||++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999864 58899999986542 2222344555554 4456899999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.... .
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 999998843 245788999999999999999999988 99999999999999999999999999875433 1
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
....+++.|++||.+.+..++.++||||||++++||++|+.|+..
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 195 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC
Confidence 234578899999999888889999999999999999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=254.48 Aligned_cols=202 Identities=24% Similarity=0.350 Sum_probs=174.5
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccC-cCceeeeeeeeecCCcceeE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 343 (492)
++|...+.||+|+||.||++... +++.|++|++... .....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36788899999999999999865 6899999998653 2334567889999999998 99999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
||++++++|.+.+.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999998843 236899999999999999999999988 99999999999999999999999999886644
Q ss_pred CCc-------------------cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 424 DIT-------------------HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 424 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
... .......++..|+|||.+....++.++||||||++++|+++|+.|+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 321 11223457889999999988889999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=232.59 Aligned_cols=215 Identities=26% Similarity=0.346 Sum_probs=173.3
Q ss_pred HHHHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC-ChhhHHHHHHHHHHHhc-cCcCceeeeeeeeecCCcc
Q 011153 264 LEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISG-INHKNLVKLLGCSITGPES 340 (492)
Q Consensus 264 l~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~ 340 (492)
++...+.......||+|++|.|-+-++ ++|...|+|++... ..+..++.++|+.+..+ ...|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 444445556677899999999999874 68999999999754 34556678889987544 5899999999999999999
Q ss_pred eeEEeecCCCCchhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 341 LLVYEFVPNQSLLDNLFV-RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
++.||.| ..||..+... -.+...+++..+-+|+..+.+||.|||++- .+||||+||+||||+.+|++|++|||++.
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999 4566554321 245677899999999999999999999964 69999999999999999999999999998
Q ss_pred ccCCCCccccccccccccccchhhhcc----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcHHH
Q 011153 420 LFPEDITHISATLAGTLGYMAPEYVVR----GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQ 483 (492)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~slGvll~elltg~~p~~~~~~~~~~~~ 483 (492)
.+.+.... +.-.|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|.......=++|.
T Consensus 198 ~L~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLk 263 (282)
T KOG0984|consen 198 YLVDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLK 263 (282)
T ss_pred eehhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHH
Confidence 77554322 12457789999998854 3688999999999999999999999887654433333
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=247.84 Aligned_cols=198 Identities=29% Similarity=0.474 Sum_probs=174.1
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+|+..+.||+|++|.||+++.. +++.+++|.+..... ...+.+.+|++++++++|||++++++++.++...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 578999999976543 4567899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999888433 56899999999999999999999988 99999999999999999999999999987654432
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
. .....++..|+|||......++.++||||+|++++||++|+.|+..
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 2 2345678899999998888889999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=248.32 Aligned_cols=202 Identities=24% Similarity=0.388 Sum_probs=176.7
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+|+..+.||+|+||.||++... +++.+++|++..... ...+.+.+|+++++.++|||++++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999865 688999999875432 5566789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 347 VPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 347 ~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
+++++|.+.+.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999998885532 2467899999999999999999999987 9999999999999999999999999998665443
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.......+++.|+|||......++.++|+||+|++++||++|+.|+...
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 2233456888999999998888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=255.44 Aligned_cols=199 Identities=29% Similarity=0.362 Sum_probs=168.4
Q ss_pred ccccCCcccccCcccEEEEEe----cCCCEEEEEEeccCC----hhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcc
Q 011153 270 YFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNT----TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES 340 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 340 (492)
+|+..+.||+|++|.||+++. .+++.+|||.++... ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999874 356789999986432 23345688999999999 699999999999999999
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++||||+++++|.+.+.. ...+++..+..++.|++++|.|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999888743 245889999999999999999999987 99999999999999999999999999876
Q ss_pred cCCCCccccccccccccccchhhhccCC--CCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 421 FPEDITHISATLAGTLGYMAPEYVVRGK--LTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.............++..|++||.+.+.. .+.++||||||++++||++|+.|+..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 5443322223456789999999987655 78899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=257.18 Aligned_cols=202 Identities=26% Similarity=0.391 Sum_probs=165.3
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc-----
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE----- 339 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 339 (492)
-++|+..++||+|+||.||++... +++.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 356889999999999999999864 68899999886432 2233456789999999999999999998876543
Q ss_pred ---ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 011153 340 ---SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (492)
Q Consensus 340 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 416 (492)
.++|+||+.+ +|.+.+.. ....+++..+..++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 4899999964 77776633 2235899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCcc---ccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 417 LVRLFPEDITH---ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 417 l~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
++......... ......++..|+|||.+.+. .++.++||||||++++||++|+.|+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 99866433221 11234578899999987664 4788999999999999999999888654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=255.21 Aligned_cols=199 Identities=28% Similarity=0.370 Sum_probs=163.8
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccC-cCceeeeeeeeecCCcceeEEee
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+|+..++||+|+||.||++... +++.+|+|++.... ......+.+|+.++.++. ||||+++++++..+...++++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556778999999999999864 58899999986543 344567889999999996 99999999999999999999999
Q ss_pred cCCCCchhhhhc--cCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 347 VPNQSLLDNLFV--RQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 347 ~~~gsL~~~l~~--~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
++. ++.+.... ......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 55443211 12235689999999999999999999975 5 99999999999999999999999999876543
Q ss_pred CCccccccccccccccchhhhccC---CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRG---KLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.... ....+++.|+|||.+... .++.++||||||+++|||++|+.||..
T Consensus 161 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 161 SIAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred CCcc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 3221 233578899999998776 688999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=262.02 Aligned_cols=201 Identities=29% Similarity=0.425 Sum_probs=167.0
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCC--cc
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGP--ES 340 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~--~~ 340 (492)
..++|+..+.||+|+||.||+|... +++.+++|++... .......+.+|+.+++++ +||||+++++++...+ ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999865 5788999988542 233445678899999999 9999999999886543 57
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++|+||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 89999997 588877633 26789999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCc----cccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 421 FPEDIT----HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 421 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
...... .......+++.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 543322 12234568899999998765 45788999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=260.04 Aligned_cols=203 Identities=24% Similarity=0.361 Sum_probs=170.4
Q ss_pred HhcccccCCcccccCcccEEEEEecCCCEEEEEEecc--CChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeE
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFY--NTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 343 (492)
....|++.++||.||.+.||++...+.+.+|+|++.. .+.+...-|.+|+.+|.+| .|.+||+|++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3455888999999999999999988888899887754 3566678899999999999 599999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
||+= .-+|...|..... ....| .+..+..||+.++.++|+++ |||-||||.|+|+-. |.+||+|||+|..+..
T Consensus 439 mE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 9975 5688888854333 22334 67778899999999999998 999999999998854 5899999999998877
Q ss_pred CCcccc-ccccccccccchhhhccCC-----------CCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 424 DITHIS-ATLAGTLGYMAPEYVVRGK-----------LTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 424 ~~~~~~-~~~~gt~~y~aPE~~~~~~-----------~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+.+... ..-+||+.||+||.+.... .+.++||||||||||+|+-|+.||....
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 665543 3678999999999985422 5678999999999999999999997543
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=249.73 Aligned_cols=200 Identities=28% Similarity=0.414 Sum_probs=173.9
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+|++.++||+|+||.||++... +++.+++|.+... .......+.+|+++++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999754 6789999998653 234456788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 347 VPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 347 ~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999998875432 2356899999999999999999999988 9999999999999999999999999998765442
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.....+++.|++||.+.+..++.++|+||||++++||++|+.|+...
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 204 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22345788999999999888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=240.20 Aligned_cols=201 Identities=26% Similarity=0.406 Sum_probs=165.8
Q ss_pred cccCCcccccCcccEEEEEec-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEEeec
Q 011153 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
.+....||.|..|.|++.+.. .|..+|||.+... +.+..++++..+.++..- +.|+||+-+|+|..+...++-||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 344667999999999999865 5889999999765 455667788888876555 5899999999999999999999998
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
. ..++.++. +..+++++..+-++...+.+||.||.+++ +|+|||+||+|||+|+.|++||+|||++..+-+...+
T Consensus 174 s-~C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 174 S-TCAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred H-HHHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 3 33444442 23456888888899999999999999876 6999999999999999999999999999766554332
Q ss_pred ccccccccccccchhhhcc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
+..+|-+.|||||-+.- ..|+.++|||||||.|+||.||+.|+.....+
T Consensus 249 --trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td 300 (391)
T KOG0983|consen 249 --TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD 300 (391)
T ss_pred --ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc
Confidence 34578899999998854 46888999999999999999999999875443
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=264.09 Aligned_cols=204 Identities=25% Similarity=0.347 Sum_probs=174.1
Q ss_pred ccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
-|..++.||-|+||+|.++.. ++...+|+|.|++.+ ...+...+.|-.+|.+.+.+-||+|+..|.+.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 377788999999999999974 456679999997654 3445667889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc----
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---- 421 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~---- 421 (492)
|++||++..+|-. .+.|.++....++.++..|+++.|..| +|||||||+|||||.+|.+||+||||+.-+
T Consensus 710 YIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999988843 345778888888999999999999877 999999999999999999999999998532
Q ss_pred -----CCCCcc--------------------------------ccccccccccccchhhhccCCCCcchhHHHHHHHHHH
Q 011153 422 -----PEDITH--------------------------------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464 (492)
Q Consensus 422 -----~~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~e 464 (492)
.+.... .....+||+.|+|||++....++...|.||.||||+|
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 110000 0113479999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCC
Q 011153 465 VVCRKRINLFTQNSC 479 (492)
Q Consensus 465 lltg~~p~~~~~~~~ 479 (492)
|+.|+.||......+
T Consensus 864 m~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGE 878 (1034)
T ss_pred HhhCCCCccCCCCCc
Confidence 999999999877665
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=259.68 Aligned_cols=203 Identities=26% Similarity=0.386 Sum_probs=168.8
Q ss_pred HHHHHHHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecC
Q 011153 261 YETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG 337 (492)
Q Consensus 261 ~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 337 (492)
..++...+++|.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 445666789999999999999999999985 568899999986542 23345688999999999999999999987643
Q ss_pred ------CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEE
Q 011153 338 ------PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK 411 (492)
Q Consensus 338 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~k 411 (492)
...+++++++ +++|.+.+.. ..+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 2356787776 7788776632 34899999999999999999999988 99999999999999999999
Q ss_pred EeecCCccccCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 412 IADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 412 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
|+|||++...... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||...
T Consensus 161 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 161 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred Eeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999998754332 123467889999998866 56888999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=251.07 Aligned_cols=196 Identities=24% Similarity=0.321 Sum_probs=162.0
Q ss_pred cccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccC-cCceeeeeeeeecC--CcceeEEe
Q 011153 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGIN-HKNLVKLLGCSITG--PESLLVYE 345 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 345 (492)
|+..++||+|+||.||++... +++.+|+|+++... ........+|+.++.++. ||||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999854 68899999987542 222234567899998885 99999999999987 88899999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|++ ++|.+.+... ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 5777776432 246899999999999999999999988 999999999999999 999999999998664332
Q ss_pred ccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.. ....+++.|+|||.+.. +.++.++|||||||+++||++|+.||...
T Consensus 154 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~ 202 (282)
T cd07831 154 PY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT 202 (282)
T ss_pred Cc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence 21 23457889999997654 55788999999999999999999998653
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=260.98 Aligned_cols=201 Identities=23% Similarity=0.387 Sum_probs=167.7
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeec----CCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 340 (492)
.++|++.+.||+|+||.||++... +++.|++|++.... ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 467889999999999999999854 68999999987542 2345677889999999999999999998763 3457
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++|+||+. ++|.+.+.. ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999995 588877743 344899999999999999999999988 99999999999999999999999999876
Q ss_pred cCCCCcc---ccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 421 FPEDITH---ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 421 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 5432221 1124468899999998765 46889999999999999999999998543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=260.10 Aligned_cols=199 Identities=26% Similarity=0.384 Sum_probs=166.8
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC-----c
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-----E 339 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 339 (492)
.++|.+.+.||+|+||+||+++. .+++.||||.+... .......+.+|+.+++.++||||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45788999999999999999985 46889999998653 2333556788999999999999999999886543 4
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
.++|+||+. ++|.+.+. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 689999996 67877763 2346899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 420 LFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
...... .......++..|+|||.+.. ..++.++||||||++++||++|+.||..
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 654332 12234457889999998865 4688999999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=255.54 Aligned_cols=199 Identities=19% Similarity=0.192 Sum_probs=162.3
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCC
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQS 351 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 351 (492)
.+.+|.|+++.|+++.. +++.||||++... .....+.+.+|+++++.++||||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 44455555555555544 6889999998754 34556789999999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc-----
Q 011153 352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT----- 426 (492)
Q Consensus 352 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----- 426 (492)
|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999885432 235888999999999999999999988 99999999999999999999999998865432111
Q ss_pred -cccccccccccccchhhhccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 427 -HISATLAGTLGYMAPEYVVRG--KLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 427 -~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
.......++..|+|||.+... .++.++||||||+++|||++|+.||....+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~ 215 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA 215 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 111234567889999998763 578899999999999999999999976543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=258.20 Aligned_cols=199 Identities=26% Similarity=0.416 Sum_probs=167.4
Q ss_pred HHHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc--
Q 011153 265 EKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE-- 339 (492)
Q Consensus 265 ~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 339 (492)
....++|++.+.||+|+||.||++.. .++..||||++... .....+.+.+|+.+++.++||||+++++++..+..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34567899999999999999999985 46889999998543 23334568899999999999999999998876543
Q ss_pred ----ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 011153 340 ----SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (492)
Q Consensus 340 ----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 415 (492)
.++|+||+ +++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 48999998 678877763 245899999999999999999999988 999999999999999999999999
Q ss_pred CCccccCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 416 GLVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 416 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
|++....... ....+++.|+|||.+.+ ..++.++|+||||++++||++|+.||...
T Consensus 163 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 163 GLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9987654321 23456889999999876 45888999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=253.38 Aligned_cols=198 Identities=27% Similarity=0.405 Sum_probs=163.5
Q ss_pred cccccCCcccccCcccEEEEEecC-CCEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 345 (492)
++|+..+.||+|+||.||++...+ ++.||||.++... ......+.+|+.++.+. .||||+++++++.++...+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 557889999999999999999764 8899999987543 23345667788777666 59999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
|++ ++|.+.+... ...+++..+..++.||+.||+|||+. + ++||||+|+||++++++.+||+|||++..+...
T Consensus 95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 985 4666655332 23689999999999999999999974 5 999999999999999999999999998765433
Q ss_pred CccccccccccccccchhhhccCC----CCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGK----LTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
... ....+++.|+|||.+.... ++.++||||||+++|||++|+.|+..
T Consensus 169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 169 KAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred Ccc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 221 2335788999999986553 78899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=259.21 Aligned_cols=199 Identities=27% Similarity=0.389 Sum_probs=170.3
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCC-----cce
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-----ESL 341 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 341 (492)
+|++.+.||+|++|.||+++.. +++.++||++.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999965 48899999987643 445667899999999999999999999988775 789
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+|+||++ ++|.+.+.. ...+++..+..++.||+.||+|||+.+ ++|+||||.|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 478777743 236899999999999999999999988 999999999999999999999999999866
Q ss_pred CCCCc--cccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 422 PEDIT--HISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 422 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
..... .......+++.|+|||.+.+. .++.++|+||||++++||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 54321 112334578899999999887 7899999999999999999999998644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=250.74 Aligned_cols=199 Identities=29% Similarity=0.442 Sum_probs=169.3
Q ss_pred cccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999865 688999999865432 34567889999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++ +|.+.+... ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 75 887776442 256899999999999999999999988 99999999999999999999999999886655431
Q ss_pred ccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
......++..|+|||.+.+. .++.++|+||||++++||++|+.||....
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 12234577899999998776 78899999999999999999998886543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=257.29 Aligned_cols=195 Identities=27% Similarity=0.426 Sum_probs=163.1
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC------
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ 338 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 338 (492)
.++|...+.||+|+||.||+|.. .+++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46788999999999999999986 46899999998653 2233456889999999999999999999887543
Q ss_pred cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCc
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~ 418 (492)
..++|+||+.. +|...+ ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 35899999864 565443 235889999999999999999999988 999999999999999999999999998
Q ss_pred cccCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
+..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 754322 123456889999999876 46889999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=276.76 Aligned_cols=209 Identities=27% Similarity=0.374 Sum_probs=174.6
Q ss_pred HHHHHhcccccCCcccccCcccEEEEEec----C----CCEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CcCceeeeee
Q 011153 263 TLEKATNYFHESNKLGQGGSGSVYKGTLP----G----GEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLG 332 (492)
Q Consensus 263 ~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~----~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~ 332 (492)
.++...++..+.+.||+|.||.|++|... . ...||||+++... ....+.+..|+++|+.+ +||||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 44555566677779999999999999743 1 3469999997653 35677899999999999 6999999999
Q ss_pred eeecCCcceeEEeecCCCCchhhhhccC-------C----C--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 011153 333 CSITGPESLLVYEFVPNQSLLDNLFVRQ-------D----V--EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKL 399 (492)
Q Consensus 333 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~----~--~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~ 399 (492)
+|.+....++|+||++.|+|.++|...+ . . ..++...++.++.||+.||+||++.. +|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999996554 0 0 23889999999999999999999987 99999999
Q ss_pred CCeeeCCCCcEEEeecCCccccCCCCcccccccc--ccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 400 SNILLDEEFTAKIADFGLVRLFPEDITHISATLA--GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 400 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
+|||+.++..+||+|||+++.............. -+..|||||.+....|+.|+|||||||+||||+|...++-.
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 9999999999999999999965544333322222 36679999999999999999999999999999997765443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=279.38 Aligned_cols=196 Identities=31% Similarity=0.471 Sum_probs=155.4
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC-------
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------- 337 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 337 (492)
-.++|++.+.||+||||.|||++.+ ||+.+|||++... +........+|+.+|.+|+|||||+++..|.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4466899999999999999999964 8999999999765 344456788999999999999999998653210
Q ss_pred --------------------------------------------------------------------------------
Q 011153 338 -------------------------------------------------------------------------------- 337 (492)
Q Consensus 338 -------------------------------------------------------------------------------- 337 (492)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 011153 338 --------------------------------PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385 (492)
Q Consensus 338 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH 385 (492)
..+||-||||+...|.+.+....-.. .....++++.+|++||+|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence 11356777777766665553221111 35678899999999999999
Q ss_pred hcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC------C-----------CCccccccccccccccchhhhccC-
Q 011153 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP------E-----------DITHISATLAGTLGYMAPEYVVRG- 447 (492)
Q Consensus 386 ~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~~~~- 447 (492)
+.+ ||||||||.||+++++..|||+|||++.... + ......+..+||--|+|||++.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 998 9999999999999999999999999998621 0 011123456899999999998764
Q ss_pred --CCCcchhHHHHHHHHHHHHh
Q 011153 448 --KLTEKADVYSFGVVVIEVVC 467 (492)
Q Consensus 448 --~~~~~sDv~slGvll~ellt 467 (492)
.|+.|+|+|||||||+||+-
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc
Confidence 49999999999999999973
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=256.44 Aligned_cols=201 Identities=25% Similarity=0.314 Sum_probs=164.8
Q ss_pred cccc-cCCcccccCcccEEEEEec-CCCEEEEEEeccCChhh--------------HHHHHHHHHHHhccCcCceeeeee
Q 011153 269 NYFH-ESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQW--------------VDHFFNEVNLISGINHKNLVKLLG 332 (492)
Q Consensus 269 ~~~~-~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~ 332 (492)
++|. ..+.||+|+||+||++... +++.||||++....... ...+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3444 4577999999999999864 68899999986542211 124778999999999999999999
Q ss_pred eeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEE
Q 011153 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412 (492)
Q Consensus 333 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl 412 (492)
++..++..++||||++ ++|.+.+.. ...+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999996 688887743 345889999999999999999999988 999999999999999999999
Q ss_pred eecCCccccCCCC-------------ccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 413 ADFGLVRLFPEDI-------------THISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 413 ~Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+|||++....... ........+++.|+|||.+.+. .++.++||||||++++||++|+.|+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999987654110 1111123467889999998764 46889999999999999999999986543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=251.46 Aligned_cols=194 Identities=35% Similarity=0.510 Sum_probs=164.3
Q ss_pred cccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
|...++||+|+||+||+|+.. +++.|++|++... .....+.+.+|+++++.++|||++++++++.+....++|+||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566778999999999999864 6889999998643 223446788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+. ++|.+.+.. ...++++..+..++.||+.+|.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 567666643 2345899999999999999999999988 99999999999999999999999999864322
Q ss_pred cccccccccccccchhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.....++..|+|||++. .+.++.++||||||+++|||++|++|+...
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 12346788999999874 456888999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=255.48 Aligned_cols=199 Identities=27% Similarity=0.414 Sum_probs=167.2
Q ss_pred HHHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeec-CCcc
Q 011153 265 EKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT-GPES 340 (492)
Q Consensus 265 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 340 (492)
...+++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|+++++.++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 456788999999999999999999854 7889999988543 23345678899999999999999999998875 5577
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++|+||+ +++|.+.+. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 567877663 235788888899999999999999988 99999999999999999999999999875
Q ss_pred cCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 421 FPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 421 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
..... ....+++.|+|||.+.+ ..++.++||||||++++||++|+.||...
T Consensus 158 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 158 QDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred cCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 43221 23456889999998766 56899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=254.08 Aligned_cols=201 Identities=29% Similarity=0.436 Sum_probs=164.2
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh--hhHHHHHHHHHHHhccCcCceeeeeeeeecCC------
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ 338 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 338 (492)
.++|++.++||+|+||.||++... +++.+++|++..... .....+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467999999999999999999864 688999998864422 22346788999999999999999999876544
Q ss_pred --cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 011153 339 --ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (492)
Q Consensus 339 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 416 (492)
..++|+||+.. +|.+.+.. ....+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999965 56665533 2346899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCcc----------ccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 417 LVRLFPEDITH----------ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 417 l~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
+++........ ......+++.|+|||.+.+. .++.++||||||++++||++|++|+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 99765432211 11234568889999987654 578999999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=248.34 Aligned_cols=198 Identities=29% Similarity=0.425 Sum_probs=164.1
Q ss_pred cccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhcc---CcCceeeeeeeeecCCc-----
Q 011153 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGI---NHKNLVKLLGCSITGPE----- 339 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 339 (492)
|++.+.||+|+||.||+++.. +++.+|+|++.... ......+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999976 48899999997432 22234566787776655 69999999999988776
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
.++++||+++ +|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999974 7887774322 235899999999999999999999988 9999999999999999999999999987
Q ss_pred ccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.+..... .....++..|+|||.+....++.++|+||||++++||++|++|+...
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 7643321 12334688999999999889999999999999999999998887643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=252.38 Aligned_cols=195 Identities=32% Similarity=0.503 Sum_probs=165.2
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
+.|+..+.||+|+||.||+|+.. +++.+++|.+... .....+.+.+|+++++.++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34677788999999999999864 5788999988642 3344567889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+. ++|.+.+... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 5777666432 245889999999999999999999987 999999999999999999999999998765432
Q ss_pred Cccccccccccccccchhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
....+++.|+|||.+. .+.++.++||||||+++|||++|+.|+..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 2345788999999874 35678899999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=248.64 Aligned_cols=199 Identities=32% Similarity=0.472 Sum_probs=169.6
Q ss_pred cccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
|+..+.||+|++|.||+++.. +++.+++|++.... ....+.+.+|+.+++.++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999865 58999999987653 334567889999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
+ ++|.+++.... ..+++..+..++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 7 58988885432 45899999999999999999999988 999999999999999999999999998866443221
Q ss_pred ccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.....++..|+|||.+... .++.++||||||++++||++|+.|+....
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 155 -YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred -cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 2233457789999998776 78999999999999999999988886543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=257.79 Aligned_cols=199 Identities=26% Similarity=0.425 Sum_probs=165.0
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecC---------
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--------- 337 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 337 (492)
..+|...+.||+|+||.||++.. .+++.|++|++........+.+.+|+++++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36789999999999999999986 46889999998776666677889999999999999999999876544
Q ss_pred -----CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC-CCCcEE
Q 011153 338 -----PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAK 411 (492)
Q Consensus 338 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~k 411 (492)
...++|+||++ ++|.+.+. ...+++..+..++.||+.||.|||+.+ ++||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 24689999997 57877663 235889999999999999999999988 99999999999997 456789
Q ss_pred EeecCCccccCCCCccc--cccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 412 IADFGLVRLFPEDITHI--SATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 412 l~Dfgl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
|+|||++.......... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 221 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999997654322111 122357889999998754 5578899999999999999999999954
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=254.04 Aligned_cols=199 Identities=23% Similarity=0.283 Sum_probs=162.2
Q ss_pred Cccccc--CcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQG--GSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G--~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
+.||+| +||+||++.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 8999999986 47899999998653 234457788999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc-
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI- 428 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~- 428 (492)
++|.+++.... ...+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99998875432 235889999999999999999999987 9999999999999999999999998654322111000
Q ss_pred -----cccccccccccchhhhccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 429 -----SATLAGTLGYMAPEYVVRG--KLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 429 -----~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
.....++..|+|||++.+. .++.++||||||++++||++|+.|+.....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 215 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLR 215 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcCh
Confidence 0112345679999998764 478999999999999999999999876543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=243.31 Aligned_cols=211 Identities=24% Similarity=0.326 Sum_probs=177.1
Q ss_pred HHHHHhcccccCCcccccCcccEEEEEec------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeee
Q 011153 263 TLEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSI 335 (492)
Q Consensus 263 ~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 335 (492)
++.....+++...++.+|.||.||.|.+. +.+.|.+|.++... +-....++.|.-++..+.|||+.++.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 44445566888889999999999999654 34567888776553 345667899999999999999999999887
Q ss_pred c-CCcceeEEeecCCCCchhhhh-----ccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc
Q 011153 336 T-GPESLLVYEFVPNQSLLDNLF-----VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409 (492)
Q Consensus 336 ~-~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~ 409 (492)
+ ....++++.++.-|+|..+|. .....+.++..++..++.|++.||+|||+++ +||.||.++|++||+..+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence 5 456789999999999999997 3444567888899999999999999999998 999999999999999999
Q ss_pred EEEeecCCcc-ccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 011153 410 AKIADFGLVR-LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQ 476 (492)
Q Consensus 410 ~kl~Dfgl~~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~~ 476 (492)
+||+|=.+++ .++.++.........+..||+||.+.+..|+..+|||||||+||||+| |+.|...-+
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID 503 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID 503 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC
Confidence 9999999998 445566666666777899999999999999999999999999999998 555655443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=258.60 Aligned_cols=202 Identities=23% Similarity=0.287 Sum_probs=177.3
Q ss_pred ccccCCcccccCcccEEEEEecCCC-EEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 270 YFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~~~~-~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
+++....||-|+||.|=.+...+.. .+|+|.+++. +....+....|-.+|.+.+.|.||+++-.|.+....|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3455667999999999999876444 3788877543 44556778899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
-|-+|.|...+. +.+.++..+...++..+++|++|||+++ ||.|||||+|.+++.+|-+||.|||+|+.+...
T Consensus 501 aClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g- 573 (732)
T KOG0614|consen 501 ACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG- 573 (732)
T ss_pred hhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence 999999999984 4456788888889999999999999998 999999999999999999999999999988664
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
....+.+|||.|.|||++.+...+..+|.|||||+++||++|++||...++-.
T Consensus 574 -~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk 626 (732)
T KOG0614|consen 574 -RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK 626 (732)
T ss_pred -CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH
Confidence 34467899999999999999999999999999999999999999999876543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=248.05 Aligned_cols=198 Identities=29% Similarity=0.392 Sum_probs=166.2
Q ss_pred cccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh-hhHHHHHHHHHHHhccC-cCceeeeeeeeecCCcceeEEeec
Q 011153 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-QWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
|++.+.||+|++|+||+|+.. +++.|+||++..... .......+|+..+++++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999975 478899999865432 22334567999999998 999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
+++|.+.+.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 788988775433 346899999999999999999999988 99999999999999999999999999876543221
Q ss_pred ccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.....++..|+|||.+.. ..++.++|+||||++++||++|+.|+...
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 123457889999998754 45789999999999999999999888544
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=241.38 Aligned_cols=193 Identities=32% Similarity=0.392 Sum_probs=167.4
Q ss_pred ccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCCc
Q 011153 277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (492)
Q Consensus 277 iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 352 (492)
||+|+||.||++... +++.+++|.+.... ......+.+|+++++.++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999865 58899999986543 23456789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccccc
Q 011153 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432 (492)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 432 (492)
.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTF 153 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCC
Confidence 9988433 35899999999999999999999987 99999999999999999999999999876544321 12345
Q ss_pred cccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 433 ~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.++..|++||...+...+.++|+||||++++||++|+.|+....
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 67889999999988888999999999999999999999986543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=243.53 Aligned_cols=200 Identities=29% Similarity=0.395 Sum_probs=162.3
Q ss_pred cccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC-hhhHHHHHHHHHH-HhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-TQWVDHFFNEVNL-ISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
.+.+..||.|+||+|+|-.+ +.|+.+|||+++... ....++++.|.+. ++.-+.||||+++|.+..++..++-||+|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 34466799999999999975 579999999998654 3566788889886 45558999999999999999999999999
Q ss_pred CCCCchhhhhc--cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 348 PNQSLLDNLFV--RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 348 ~~gsL~~~l~~--~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
. .||..+... ......+++..+-.|......||.||.+.. .|||||+||+|||++..|.+||+|||++..+.+..
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 4 466443311 112345788888888889999999998764 59999999999999999999999999997665433
Q ss_pred ccccccccccccccchhhhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. .+.-+|-..|||||-+.. ..|+.+|||||||+.|+|+.||+.|..-.
T Consensus 223 A--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w 272 (361)
T KOG1006|consen 223 A--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW 272 (361)
T ss_pred H--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence 2 234578889999999854 34889999999999999999999997543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=236.74 Aligned_cols=200 Identities=25% Similarity=0.315 Sum_probs=172.9
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCccee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 342 (492)
-++|..+++||+|+|.+|..+++. +.+.+|+|+++++ ..+..+....|-.++.+. +||.+|.+..+|+++..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467899999999999999999865 5778999988754 344455666777777665 79999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
|.||+++|+|.-++++. ..++++........|.-||.|||+.| ||.||||..|||+|..|.+||+|+|+++.--
T Consensus 329 vieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999997776443 34788888889999999999999998 9999999999999999999999999998432
Q ss_pred CCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.+ .....+.+|||.|.|||++.+..|.-.+|.|+|||+++||+.|+.||..
T Consensus 403 ~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 403 GP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 22 2223478999999999999999999999999999999999999999985
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=252.17 Aligned_cols=199 Identities=28% Similarity=0.391 Sum_probs=162.1
Q ss_pred ccccCCcccccCcccEEEEEec-C--CCEEEEEEeccC--ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecC----Cc
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-G--GEAVAVKRLFYN--TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG----PE 339 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~--~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 339 (492)
+|+..+.||+|+||.||++... . +..+|+|++... .....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999864 3 678999988643 223356788999999999 599999999875432 34
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
.++++|++. ++|.+.+.. ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888885 688877732 345899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCcc---ccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 420 LFPEDITH---ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 420 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.+...... ......|++.|+|||.+.+ ..++.++||||||++++||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 65432211 1123468899999998765 46889999999999999999999988653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=242.82 Aligned_cols=200 Identities=25% Similarity=0.342 Sum_probs=165.2
Q ss_pred ccccCCcccccCcccEEEEEecC-CCEEEEEEeccC-----ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 270 YFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
+|.+.++||+|+||.||++.... +..+++|.++.. .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998643 444556655431 222344577899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 344 YEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
+||+++++|.+.+... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999998887542 23456899999999999999999999988 999999999999975 569999999987654
Q ss_pred CCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.... ......+++.|+|||.+....++.++|+||||+++|||++|+.|+..
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3322 22244578899999998888889999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=258.89 Aligned_cols=203 Identities=23% Similarity=0.282 Sum_probs=153.5
Q ss_pred hcccccCCcccccCcccEEEEEe-----------------cCCCEEEEEEeccCChhhHHH--------------HHHHH
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-----------------PGGEAVAVKRLFYNTTQWVDH--------------FFNEV 316 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~E~ 316 (492)
.++|++.++||+|+||+||+|.. .+++.||||++........+. ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56799999999999999999964 235679999987544332333 34467
Q ss_pred HHHhccCcCce-----eeeeeeeec--------CCcceeEEeecCCCCchhhhhccC---------------------CC
Q 011153 317 NLISGINHKNL-----VKLLGCSIT--------GPESLLVYEFVPNQSLLDNLFVRQ---------------------DV 362 (492)
Q Consensus 317 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~ 362 (492)
.++.+++|.++ +++++++.. .+..+|||||+++++|.++++... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766654 677777653 356799999999999999886421 11
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccccccccccccchh
Q 011153 363 EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442 (492)
Q Consensus 363 ~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE 442 (492)
..+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++...............+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 23567889999999999999999987 999999999999999999999999999755432221111223478999999
Q ss_pred hhccCCC----------------------CcchhHHHHHHHHHHHHhCCC-CCC
Q 011153 443 YVVRGKL----------------------TEKADVYSFGVVVIEVVCRKR-INL 473 (492)
Q Consensus 443 ~~~~~~~----------------------~~~sDv~slGvll~elltg~~-p~~ 473 (492)
.+..... ..+.||||+||+++||+++.. |+.
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 8754321 134799999999999999986 443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-31 Score=239.82 Aligned_cols=202 Identities=26% Similarity=0.389 Sum_probs=169.5
Q ss_pred cccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC-----ccee
Q 011153 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-----ESLL 342 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 342 (492)
.+..+.||-|+||.||..+++ +|+.||+|++..- +-...+.+.+|+++|..++|.|++..+++..... +.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 344678999999999999975 7999999998543 2234567899999999999999999998876544 5678
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
++|.|. .+|...+. ....++.+.+.-+++||++||.|||+.+ |.||||||.|.|+++|..+||+|||+++.-.
T Consensus 135 ~TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 999884 57777764 3456888888899999999999999998 9999999999999999999999999999776
Q ss_pred CCCccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
.+.....+..+-|..|.|||++++. .|+...||||.|||+.||+.++-.|....+-+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq 265 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE 265 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH
Confidence 6555555566678999999999875 68999999999999999999998887765543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-30 Score=253.78 Aligned_cols=198 Identities=26% Similarity=0.409 Sum_probs=167.5
Q ss_pred HHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc---
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE--- 339 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 339 (492)
...++|+..+.||+|++|.||++... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34677999999999999999999875 5789999988643 23344667889999999999999999998876654
Q ss_pred ---ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 011153 340 ---SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (492)
Q Consensus 340 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 416 (492)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 78999998 5688887732 45899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
++...... .....++..|+|||.+.. ..++.++||||||++++||++|+.||...
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 98765432 223457889999998865 36788999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=269.46 Aligned_cols=145 Identities=27% Similarity=0.341 Sum_probs=129.9
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|.+.++||+|+||.||++... +++.||||+++.. .......+.+|+.++..++||||+++++.+......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56889999999999999999865 6889999998653 2334567889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998843 235788999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=261.28 Aligned_cols=213 Identities=28% Similarity=0.380 Sum_probs=181.6
Q ss_pred cCHHHHHHHhcccccCCcccccCcccEEEEE-ecCCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeee-
Q 011153 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSI- 335 (492)
Q Consensus 259 ~~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~- 335 (492)
..++.+...+..|++.+.||.|.+|.||+++ ..+++..|+|++..... ..++...|.++++.. .|||++.++|++.
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 4556666778889999999999999999998 46788999998865433 345677788888887 7999999999886
Q ss_pred ----cCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEE
Q 011153 336 ----TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK 411 (492)
Q Consensus 336 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~k 411 (492)
.++.++||||||.+||..++..... ...+.|+.+..|++.++.||.+||.+. ++|||||-.|||++.++.+|
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 3568899999999999999886554 778999999999999999999999988 99999999999999999999
Q ss_pred EeecCCccccCCCCccccccccccccccchhhhcc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 412 IADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR-----GKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 412 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
|.|||++..+...... ..+..||+.|||||++.. ..|+.++|+||||++..||--|.+|+....+
T Consensus 164 LvDFGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP 233 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP 233 (953)
T ss_pred Eeeeeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence 9999999876554333 346789999999999854 3477899999999999999999999876544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=230.24 Aligned_cols=199 Identities=34% Similarity=0.473 Sum_probs=172.4
Q ss_pred cccCCcccccCcccEEEEEecC-CCEEEEEEeccCChh-hHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecC
Q 011153 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (492)
|...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999765 889999999766554 67789999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 428 (492)
+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999998854322 1789999999999999999999987 9999999999999999999999999998765543112
Q ss_pred cccccccccccchhhh-ccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 429 SATLAGTLGYMAPEYV-VRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~-~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.....++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2345677899999998 667788899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=236.52 Aligned_cols=179 Identities=21% Similarity=0.173 Sum_probs=152.3
Q ss_pred cCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCCchhhhhc
Q 011153 280 GGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV 358 (492)
Q Consensus 280 G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 358 (492)
|.+|.||++... +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++++|.+.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999864 68899999986543 233455556666799999999999999999999999999999988854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccccccccccc
Q 011153 359 RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY 438 (492)
Q Consensus 359 ~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y 438 (492)
. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++|||++....... ....++..|
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y 148 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY 148 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence 3 34899999999999999999999988 9999999999999999999999999876554321 223456789
Q ss_pred cchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 011153 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINL 473 (492)
Q Consensus 439 ~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~ 473 (492)
+|||.+..+.++.++||||+|++++||++|+.|+.
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 99999888889999999999999999999997754
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-31 Score=234.08 Aligned_cols=204 Identities=26% Similarity=0.405 Sum_probs=164.9
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC--------
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-------- 337 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 337 (492)
..|+...+||+|.||.||+++. ++++.||+|+...+ ....-...++|+++|..++|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3455677899999999999985 45788999876433 222345678999999999999999999988632
Q ss_pred CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCC
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl 417 (492)
...++|+++++. +|.-.|.. ....++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 246899999964 66666632 2345889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCcc---ccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 418 VRLFPEDITH---ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 418 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
++.++..... ..+..+-|..|.+||.+.+ ..++++.|||.-||++.||++|.+.+....+.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq 235 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ 235 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH
Confidence 9876533221 1234556999999999887 56899999999999999999999988765443
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=232.82 Aligned_cols=199 Identities=25% Similarity=0.308 Sum_probs=165.5
Q ss_pred HhcccccC-CcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHH-HhccCcCceeeeeeeeec----CCc
Q 011153 267 ATNYFHES-NKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNL-ISGINHKNLVKLLGCSIT----GPE 339 (492)
Q Consensus 267 ~~~~~~~~-~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~----~~~ 339 (492)
.+++|.+. ++||-|-.|.|..... .+++.+|+|++... ....+|+++ +..-.|||||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34556554 6799999999998875 56889999988543 345678886 445589999999998763 456
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC---CCCcEEEeecC
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFG 416 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfg 416 (492)
+.+|||.|+||.|.+.+..+.. ..+++.+...|+.||..|+.|||+.+ |.||||||+|+|.. .|..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 7899999999999999866543 46999999999999999999999998 99999999999995 45679999999
Q ss_pred CccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+|+..... ....+.+-||.|.|||++...+|+...|+||+||++|-|++|-+||-...
T Consensus 210 FAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h 267 (400)
T KOG0604|consen 210 FAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_pred cccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC
Confidence 99865432 23346778999999999999999999999999999999999999986543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=220.43 Aligned_cols=202 Identities=20% Similarity=0.354 Sum_probs=167.9
Q ss_pred hcccccCCcccccCcccEEEEE-ecCCCEEEEEEeccCChhhHHHHHHHHHHHhccC-cCceeeeeeeeecCC--cceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGP--ESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv 343 (492)
.++|++.+++|+|.+++||.|. ..+.++++||+++.-. .+.+.+|+.+|..+. ||||++|++...+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4668889999999999999998 5678899999996433 457889999999996 999999999987654 45799
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-CcEEEeecCCccccC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFP 422 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgl~~~~~ 422 (492)
+||+.+.+..... ..++...+...+.+++.||.|+|+.| |.|||+||.|++||.. -.++|+|+|||.++.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999887776544 34667778899999999999999998 9999999999999865 579999999999876
Q ss_pred CCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC-cHHH
Q 011153 423 EDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC-SILQ 483 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~~~~-~~~~ 483 (492)
..... +..+.+..|--||.+.+ +.|+..-|+|||||+|.+|+..|.||....++. +++.
T Consensus 185 p~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVk 245 (338)
T KOG0668|consen 185 PGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVK 245 (338)
T ss_pred CCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHH
Confidence 54322 23455778899999876 568889999999999999999999998865543 4443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=249.37 Aligned_cols=197 Identities=25% Similarity=0.341 Sum_probs=165.5
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 345 (492)
++.|+....+|.|+|+.|-.... .+++..++|++.+... .-.+|+.++... +||||+++.+.+.++...++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 55677788899999999998874 5688899999865522 234567665555 89999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee-CCCCcEEEeecCCccccCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL-DEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill-~~~~~~kl~Dfgl~~~~~~~ 424 (492)
.+.++-|.+.+.... .+. ..+..|+.+|+.++.|||++| +|||||||+|||+ ++.++++|+|||.++....+
T Consensus 397 ~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999998877764322 222 677789999999999999988 9999999999999 69999999999999876554
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
..+.+-|..|.|||++....++..+|+||||++||||++|+.|+.....+.
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ 520 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI 520 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH
Confidence 234466889999999999999999999999999999999999998866553
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=256.48 Aligned_cols=199 Identities=23% Similarity=0.292 Sum_probs=142.7
Q ss_pred HhcccccCCcccccCcccEEEEEec-C----CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeee------ee
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-G----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC------SI 335 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 335 (492)
..++|+..++||+|+||.||+|++. + +..||||++...... +....| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4567999999999999999999865 4 689999988643221 111111 1222222333322222 24
Q ss_pred cCCcceeEEeecCCCCchhhhhccCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 011153 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-----------------EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK 398 (492)
Q Consensus 336 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk 398 (492)
.+...++|+||+++++|.+++...... .......+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999998887543210 11123446679999999999999988 9999999
Q ss_pred CCCeeeCC-CCcEEEeecCCccccCCCCccccccccccccccchhhhccC----------------------CCCcchhH
Q 011153 399 LSNILLDE-EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG----------------------KLTEKADV 455 (492)
Q Consensus 399 ~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDv 455 (492)
|+|||+++ ++.+||+|||+++.+............+++.|||||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 58999999999986654433344456789999999965422 23346799
Q ss_pred HHHHHHHHHHHhCCCCC
Q 011153 456 YSFGVVVIEVVCRKRIN 472 (492)
Q Consensus 456 ~slGvll~elltg~~p~ 472 (492)
|||||+||||+++..++
T Consensus 363 wSlGviL~el~~~~~~~ 379 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRS 379 (566)
T ss_pred HHHHHHHHHHHhCcCCC
Confidence 99999999999976654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=225.86 Aligned_cols=186 Identities=32% Similarity=0.425 Sum_probs=163.9
Q ss_pred CcccEEEEEec-CCCEEEEEEeccCChhh-HHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCCchhhhhc
Q 011153 281 GSGSVYKGTLP-GGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV 358 (492)
Q Consensus 281 ~fG~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 358 (492)
+||.||++... +++.+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999997665444 67899999999999999999999999999999999999999999988844
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccccccccccc
Q 011153 359 RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY 438 (492)
Q Consensus 359 ~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y 438 (492)
.. .+++..+..++.+++.++.|||+.+ ++|+||+|+||++++++.++|+|||++....... ......++..|
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 32 2889999999999999999999987 9999999999999999999999999998765432 22345678899
Q ss_pred cchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 439 ~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
++||.+....++.++||||||++++||++|+.|+..
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999888899999999999999999999999866
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-29 Score=252.25 Aligned_cols=200 Identities=31% Similarity=0.413 Sum_probs=162.6
Q ss_pred cccCCcccccCccc-EEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEEeecC
Q 011153 271 FHESNKLGQGGSGS-VYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 271 ~~~~~~iG~G~fG~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (492)
|...+++|.|+.|+ ||+|... ++.||||++-.+. ..-..+|+..|+.- +|||||++++.-.+....|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 44556789999877 7999886 7899999985433 33457899999888 6999999999999999999999999
Q ss_pred CCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---C--CcEEEeecCCccccC
Q 011153 349 NQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---E--FTAKIADFGLVRLFP 422 (492)
Q Consensus 349 ~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~--~~~kl~Dfgl~~~~~ 422 (492)
..+|.+++... ...........+.++.|+++||++||+.+ ||||||||+||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56899988653 11111121445678899999999999987 999999999999975 3 578999999999887
Q ss_pred CCCcccc--ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCC
Q 011153 423 EDITHIS--ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCR-KRINLFTQNS 478 (492)
Q Consensus 423 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg-~~p~~~~~~~ 478 (492)
.+..... ....||-+|+|||++....-+..+||||+||+++..++| +.||....+.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 6654433 367799999999999998888899999999999999998 8888765443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=230.55 Aligned_cols=204 Identities=24% Similarity=0.296 Sum_probs=171.1
Q ss_pred HHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccC--cC----ceeeeeeeeecCC
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN--HK----NLVKLLGCSITGP 338 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--h~----niv~l~~~~~~~~ 338 (492)
..+++|.+..++|+|.||.|-..... .+..||||+++.-. ...+..+-|+++|.++. .| -+|++.++|.-.+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 34788999999999999999998754 46889999886433 33455677999999993 23 2888999999999
Q ss_pred cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC------------
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE------------ 406 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~------------ 406 (492)
..++|+|.+ |.|+.+++. .++..+++...+..|+.|+++++++||+.. ++|-||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk-~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLK-ENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred ceEEEEecc-ChhHHHHhc-cCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 999999998 668888884 345678999999999999999999999988 999999999999842
Q ss_pred --------CCcEEEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 407 --------EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 407 --------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
+..+||+|||.|....... ..++.|..|.|||++++-.++.++||||+||||.|+.+|...|.-..+.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 2358999999998654432 3567899999999999999999999999999999999999999877655
Q ss_pred C
Q 011153 479 C 479 (492)
Q Consensus 479 ~ 479 (492)
+
T Consensus 316 E 316 (415)
T KOG0671|consen 316 E 316 (415)
T ss_pred H
Confidence 4
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=236.26 Aligned_cols=195 Identities=24% Similarity=0.375 Sum_probs=163.5
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh---hh-----HHHHHHHHHHHhccC---cCceeeeeeeeec
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT---QW-----VDHFFNEVNLISGIN---HKNLVKLLGCSIT 336 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~---~~-----~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 336 (492)
..|...+.+|+|+||.|+.+..+ +...|+||.+.++.- .+ .-..-.|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 34788899999999999999875 456789998865421 11 113456999999997 9999999999999
Q ss_pred CCcceeEEeec-CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 011153 337 GPESLLVYEFV-PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (492)
Q Consensus 337 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 415 (492)
++..||+||-. ++-+|.+++.. ...+++.....|..||+.|+++||+++ |||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999976 45567777733 345888999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCccccccccccccccchhhhccCCCC-cchhHHHHHHHHHHHHhCCCCC
Q 011153 416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT-EKADVYSFGVVVIEVVCRKRIN 472 (492)
Q Consensus 416 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~slGvll~elltg~~p~ 472 (492)
|.+...... .....+||..|.|||++.+.+|- ..-|||++||+||.++-.+.|+
T Consensus 715 gsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 998765543 23467899999999999988875 4589999999999999888876
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=216.63 Aligned_cols=195 Identities=28% Similarity=0.390 Sum_probs=163.0
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC------
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ 338 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 338 (492)
..+|.....+|.|.- .|-.+.. -.++.||+|++... .....++..+|..++..++|+||++++.++....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777788888887 4544443 35889999988543 3344567789999999999999999999987544
Q ss_pred cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCc
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~ 418 (492)
+.|+|||+| ..+|.+.++ ..++.+++..|..|++.|++|||+.+ |+||||||+||++..+..+||.|||++
T Consensus 95 e~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 568999999 568887775 34788899999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
+.-..+ -..+..+.|..|.|||++.+..+...+||||+||++.||++|+-.|..
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 854433 344567789999999999998899999999999999999999988764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-25 Score=200.81 Aligned_cols=183 Identities=38% Similarity=0.608 Sum_probs=158.7
Q ss_pred ccccCcccEEEEEecC-CCEEEEEEeccCChh-hHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCCchh
Q 011153 277 LGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354 (492)
Q Consensus 277 iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 354 (492)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 889999999765443 45679999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-CCcEEEeecCCccccCCCCcccccccc
Q 011153 355 NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFPEDITHISATLA 433 (492)
Q Consensus 355 ~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 433 (492)
++.... ..+++..+..++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 885432 45889999999999999999999987 999999999999999 89999999999986654321 122345
Q ss_pred ccccccchhhhccC-CCCcchhHHHHHHHHHHH
Q 011153 434 GTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEV 465 (492)
Q Consensus 434 gt~~y~aPE~~~~~-~~~~~sDv~slGvll~el 465 (492)
+...|++||..... ..+.++|+|++|++++||
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 68899999998777 788999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=215.92 Aligned_cols=206 Identities=27% Similarity=0.422 Sum_probs=169.7
Q ss_pred HHHHHhcccccCCcccccCcccEEEEEec----CCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecC
Q 011153 263 TLEKATNYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG 337 (492)
Q Consensus 263 ~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 337 (492)
.+....+.|...++||+|.|++||++.+. ..+.||+|.+...+.. ....+|+++|..+ .+.||+++.+++..+
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34455677899999999999999999854 3678999998655433 4688999999999 699999999999999
Q ss_pred CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-CCcEEEeecC
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFG 416 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg 416 (492)
+...+|+||++.-...+++. .++...+...++.++.||+++|.+| ||||||||+|+|.+. .+.-.|.|||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred CeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 99999999999988877762 3667888999999999999999998 999999999999975 4678999999
Q ss_pred CccccCCCC-------------------------------------------ccccccccccccccchhhhcc-CCCCcc
Q 011153 417 LVRLFPEDI-------------------------------------------THISATLAGTLGYMAPEYVVR-GKLTEK 452 (492)
Q Consensus 417 l~~~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 452 (492)
|+....... .......+||+||.|||++.. +..+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 987211000 000113469999999999876 557889
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 453 ADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 453 sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
+||||-|||++-+++++.||.-..++-
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~ 285 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDA 285 (418)
T ss_pred cceeeccceeehhhccccccccCcccc
Confidence 999999999999999999998766554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-26 Score=229.63 Aligned_cols=203 Identities=29% Similarity=0.399 Sum_probs=177.1
Q ss_pred HhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
+.++|+...++|.|.||.|||++. ..++..|+|+++........-...|+-+++..+|||||.++|.+...+.+++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 456788899999999999999985 5689999999998887778888999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+.+|+|.+..+. .+++++.++..+.+..++||+|||+.+ =+|||||-.|||+++.+.+|+.|||.+..+....
T Consensus 93 ycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 9999999987743 456889999999999999999999988 7999999999999999999999999987554322
Q ss_pred ccccccccccccccchhhh---ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYV---VRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
. ......||+.|||||+. ..+.|..++|||++|+...|+---++|.....
T Consensus 167 ~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh 219 (829)
T KOG0576|consen 167 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH 219 (829)
T ss_pred h-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc
Confidence 1 23356899999999986 45678999999999999999988777755433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=214.17 Aligned_cols=167 Identities=20% Similarity=0.162 Sum_probs=129.7
Q ss_pred HHHhcccccCCcccccCcccEEEEEec--CCCEEEEEEeccC-----ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC
Q 011153 265 EKATNYFHESNKLGQGGSGSVYKGTLP--GGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG 337 (492)
Q Consensus 265 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~--~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 337 (492)
......|...++||+|+||+||++... +++.+|||++... .....+.|.+|+++|++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345677999999999999999999864 5777899987533 22335668999999999999999853322 2
Q ss_pred CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCCeeeCCCCcEEEeecC
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDI-KLSNILLDEEFTAKIADFG 416 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~Dfg 416 (492)
...++||||+++++|.. + ... . ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~---~~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-A---RPH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHH-h---Ccc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 46799999999999863 2 111 1 1467889999999999988 999999 9999999999999999999
Q ss_pred CccccCCCCcc-------ccccccccccccchhhhccC
Q 011153 417 LVRLFPEDITH-------ISATLAGTLGYMAPEYVVRG 447 (492)
Q Consensus 417 l~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 447 (492)
+++.+...... ......+++.|+|||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99876543211 11355688899999988543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=200.03 Aligned_cols=195 Identities=21% Similarity=0.326 Sum_probs=153.6
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeee-eecCCcceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGC-SITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~e 345 (492)
+.|.+.+.||+|.||.+-+++++ ....+++|-+...-. -...|.+|..-=-.| .|.||+.-++. |++.+..+.++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 45778899999999999999865 577899998765432 246788887654444 68999987764 566677779999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee--CCCCcEEEeecCCccccCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill--~~~~~~kl~Dfgl~~~~~~ 423 (492)
|.|.|+|.+.+.. ..+.+....+++.|+++||.|+|+++ +||||||.+|||| .+..++||+|||+.+..+.
T Consensus 103 ~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999887632 34677788899999999999999998 9999999999999 3456899999999875433
Q ss_pred CCccccccccccccccchhhhccC-----CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRG-----KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.. ....-+..|.+||..... ...+.+|+|.|||+++.+++|+.|+.-.
T Consensus 176 tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 176 TV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred ee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 21 122335678999987542 2467899999999999999999999843
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-25 Score=216.34 Aligned_cols=213 Identities=20% Similarity=0.193 Sum_probs=179.0
Q ss_pred cCHHHHHHHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccC------cCceeeee
Q 011153 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN------HKNLVKLL 331 (492)
Q Consensus 259 ~~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~ 331 (492)
+.+...+....+|.+....|+|-|++|.++... -|+.||||++..+. -..+.=+.|+++|++|. -.|.++|+
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 344445566778888888999999999999865 47899999997543 33455578999999994 35899999
Q ss_pred eeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-CcE
Q 011153 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTA 410 (492)
Q Consensus 332 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~ 410 (492)
-.|...+.++||+|-+ ..+|.++|..-.....+....+..++.|+.-||..|...+ |+|.||||.|||+++. ..+
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence 9999999999999987 5688999877666677888999999999999999999887 9999999999999865 568
Q ss_pred EEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 411 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
||||||.|....+..- +...-+..|.|||++.+-+|+...|+||.||.||||.||+-.|....+.+
T Consensus 577 KLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ 642 (752)
T KOG0670|consen 577 KLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ 642 (752)
T ss_pred eeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH
Confidence 9999999987765432 23455778999999999999999999999999999999999998776653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=202.14 Aligned_cols=203 Identities=22% Similarity=0.234 Sum_probs=165.6
Q ss_pred ccccCCcccccCcccEEEEEecCC--CEEEEEEeccCChhhHHHHHHHHHHHhccCc----Cceeeeeeee-ecCCccee
Q 011153 270 YFHESNKLGQGGSGSVYKGTLPGG--EAVAVKRLFYNTTQWVDHFFNEVNLISGINH----KNLVKLLGCS-ITGPESLL 342 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 342 (492)
+|.+.++||+|+||.||++...+. ..+|+|............+..|+.++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996553 4788887765433323367889999888863 5888999888 47778899
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-----CcEEEeecCC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-----FTAKIADFGL 417 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-----~~~kl~Dfgl 417 (492)
||+.+ +.+|.++..... ...++..+.++++.|++.+|++||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 789988764433 567999999999999999999999998 9999999999999754 4699999999
Q ss_pred cc--ccCCCCc-----c-c-cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 418 VR--LFPEDIT-----H-I-SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 418 ~~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
++ .+..... . . .....||..|.++....+.+.+.+.|+||++.++.|++.|..|+.....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 98 4322221 1 1 1234599999999999999999999999999999999999999866443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.5e-23 Score=197.86 Aligned_cols=133 Identities=27% Similarity=0.385 Sum_probs=109.9
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccC-----c---Cceeeeeeeeec--
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-----H---KNLVKLLGCSIT-- 336 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 336 (492)
..+|.+.++||-|.|++||++.+ ++.+.||+|+.+. .....+..+.||++|++++ | ..||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 36788999999999999999985 4677899998853 3344667889999999883 3 369999999874
Q ss_pred --CCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC
Q 011153 337 --GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD 405 (492)
Q Consensus 337 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~ 405 (492)
+...+||+|++ |-+|..++... ..+.++...+.+|+.||+.||.|||... +|||.||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 44779999999 66787777543 3445899999999999999999999975 799999999999994
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-23 Score=181.30 Aligned_cols=202 Identities=20% Similarity=0.242 Sum_probs=167.9
Q ss_pred hcccccCCcccccCcccEEEEE-ecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCc-CceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 345 (492)
...|...++||.|+||.+|.|. ..+|++||||.-..... ..++..|.++.+.+++ ..|..+..+..+.....+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4678999999999999999997 67899999997643322 3467789999999976 567778888888889999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCcEEEeecCCccccC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLVRLFP 422 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgl~~~~~ 422 (492)
.+ +.||++.+.--. ..++..+.+-++-|++.-++|+|.++ +|||||||+|+|..- -.++.++||||++.+.
T Consensus 92 LL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 88 789988774322 34889999999999999999999998 999999999999953 4578999999999876
Q ss_pred CCCcc------ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 423 EDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 423 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
+..+. ......||.+|.+-....+...+.+.|+-|+|.+|..+--|..||.....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 54322 23356799999998888888889999999999999999999999986443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=185.77 Aligned_cols=200 Identities=21% Similarity=0.266 Sum_probs=168.4
Q ss_pred cccccCCcccccCcccEEEEE-ecCCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEEee
Q 011153 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
-.|+++++||+|.||.++.|+ +-+++.||||.-... ....++..|.+..+.| ..++|...+.+..++..-.||+|+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 468999999999999999998 568999999964322 2234677788888877 578999999998999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-----CcEEEeecCCcccc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-----FTAKIADFGLVRLF 421 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-----~~~kl~Dfgl~~~~ 421 (492)
+ +.||++++.-- ...++.+++..++.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 78998877332 345899999999999999999999998 9999999999999643 35899999999987
Q ss_pred CCCCcc------ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 422 PEDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 422 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
-+..+. ......||.+||+--...+.+.+.+.|+-|||-|+...|-|..||.-..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 655432 2335679999999999999999999999999999999999999997643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-23 Score=226.02 Aligned_cols=148 Identities=18% Similarity=0.180 Sum_probs=113.4
Q ss_pred hccCc-Cceeeeeeee-------ecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 011153 320 SGINH-KNLVKLLGCS-------ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391 (492)
Q Consensus 320 ~~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ 391 (492)
+.++| +||+++++++ .+....++++|++ +++|.+++.. ....+++..++.++.||++||+|||+++
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 34456 6888888877 2334567888887 5699998853 2345899999999999999999999988
Q ss_pred eEecCCCCCCeeeCC-------------------CCcEEEeecCCccccCCCC---------------cccccccccccc
Q 011153 392 IIHRDIKLSNILLDE-------------------EFTAKIADFGLVRLFPEDI---------------THISATLAGTLG 437 (492)
Q Consensus 392 ivH~Dlk~~Nill~~-------------------~~~~kl~Dfgl~~~~~~~~---------------~~~~~~~~gt~~ 437 (492)
|+||||||+||||+. ++.+||+|||+++...... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999965 4456666666665321100 000112357889
Q ss_pred ccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 011153 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINL 473 (492)
Q Consensus 438 y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~ 473 (492)
|||||++.+..++.++|||||||+||||++|..|+.
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 999999999999999999999999999999988765
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6e-21 Score=187.23 Aligned_cols=201 Identities=34% Similarity=0.476 Sum_probs=168.8
Q ss_pred cccCCcccccCcccEEEEEecCCCEEEEEEeccCChh---hHHHHHHHHHHHhccCcC-ceeeeeeeeecCCcceeEEee
Q 011153 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ---WVDHFFNEVNLISGINHK-NLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 346 (492)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999877 78899988655332 477899999999999988 799999999777778999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-cEEEeecCCccccCCCC
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDI 425 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~ 425 (492)
+.++++.+.+........+.......++.|++.++.|+|+.+ ++||||||+||+++..+ .+++.|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999855532211136888999999999999999999998 99999999999999988 79999999998655433
Q ss_pred cc-----ccccccccccccchhhhcc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 426 TH-----ISATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 426 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.. ......++..|++||.+.. ...+...|+||+|++++++++|..|+....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 2346789999999999987 578889999999999999999999965544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-22 Score=183.47 Aligned_cols=172 Identities=10% Similarity=0.097 Sum_probs=134.0
Q ss_pred HHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChh---hHHH------HHHHHHHHhccCcCceeeeeeeeec
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ---WVDH------FFNEVNLISGINHKNLVKLLGCSIT 336 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~---~~~~------~~~E~~~l~~l~h~niv~l~~~~~~ 336 (492)
...++|+..+++|.|+||.||.... ++..+|||.++..... .... +.+|++.+.++.||+|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3468899999999999999999655 5778999999754322 2222 6789999999999999999988664
Q ss_pred C--------CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC
Q 011153 337 G--------PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408 (492)
Q Consensus 337 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~ 408 (492)
. ...++||||++|.+|.+.. .++. ....+++.+|..+|+.+ ++||||||+||++++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 3578999999999997763 1222 34568999999999998 99999999999999988
Q ss_pred cEEEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHH
Q 011153 409 TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466 (492)
Q Consensus 409 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ell 466 (492)
++|+|||.......+... ..+.....+..++|+|+||+.+.-+.
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987655332111 11345556778999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=177.23 Aligned_cols=139 Identities=17% Similarity=0.145 Sum_probs=108.0
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccCChh--h-------H-----------------HHHHHHHHHHhccCcCce
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ--W-------V-----------------DHFFNEVNLISGINHKNL 327 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni 327 (492)
...||+|+||.||+|...+|+.||||+++..... . . .....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999999654211 0 0 122359999999988776
Q ss_pred eeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEecCCCCCCeeeCC
Q 011153 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL-HEESKLRIIHRDIKLSNILLDE 406 (492)
Q Consensus 328 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yL-H~~~~~~ivH~Dlk~~Nill~~ 406 (492)
....... ....++||||++++++..... ....++......++.|++.+|.|+ |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4433222 223489999999877754432 224688999999999999999999 6877 99999999999998
Q ss_pred CCcEEEeecCCcccc
Q 011153 407 EFTAKIADFGLVRLF 421 (492)
Q Consensus 407 ~~~~kl~Dfgl~~~~ 421 (492)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=171.59 Aligned_cols=141 Identities=18% Similarity=0.183 Sum_probs=111.3
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccCChh--------------------------hHHHHHHHHHHHhccCcCce
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ--------------------------WVDHFFNEVNLISGINHKNL 327 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 327 (492)
...||+|+||.||+|...+|+.||||+++..... ....+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998754211 01224578999999999987
Q ss_pred eeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCC
Q 011153 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDE 406 (492)
Q Consensus 328 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nill~~ 406 (492)
.....+... ..++||||++++++..... ....++.....+++.|++.++.++|+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544443332 3589999999886544322 12346788899999999999999999 87 99999999999999
Q ss_pred CCcEEEeecCCccccCC
Q 011153 407 EFTAKIADFGLVRLFPE 423 (492)
Q Consensus 407 ~~~~kl~Dfgl~~~~~~ 423 (492)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.1e-22 Score=176.94 Aligned_cols=196 Identities=22% Similarity=0.327 Sum_probs=155.2
Q ss_pred cCCcccccCcccEEEEEecCCCEEEEEEecc--CChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCC
Q 011153 273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLFY--NTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (492)
Q Consensus 273 ~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (492)
...+|.+...|+.|+|+++.+ .++.|++.. -+....+.|..|.-.|+.+.||||.++++.|...+.+.++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 355788999999999999854 456676643 24445567899999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEe--ecCCccccCCCCccc
Q 011153 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA--DFGLVRLFPEDITHI 428 (492)
Q Consensus 351 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~--Dfgl~~~~~~~~~~~ 428 (492)
+|.+.|+.... -..+..+..+++.+|++||+|||+.. +-|.---|.++.++||++.+++|+ |--++. . .
T Consensus 273 slynvlhe~t~-vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf--q-e---- 343 (448)
T KOG0195|consen 273 SLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--Q-E---- 343 (448)
T ss_pred HHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee--e-c----
Confidence 99999976543 34677888999999999999999986 223344799999999999998886 222211 0 0
Q ss_pred cccccccccccchhhhccCCCC---cchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 429 SATLAGTLGYMAPEYVVRGKLT---EKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~~~~~---~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
....-.|.||+||.+...+-+ ..+|+|||+++||||-|++.||....+-+
T Consensus 344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme 396 (448)
T KOG0195|consen 344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME 396 (448)
T ss_pred -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh
Confidence 112336899999999876543 46899999999999999999998766544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.4e-20 Score=165.33 Aligned_cols=189 Identities=13% Similarity=0.045 Sum_probs=141.5
Q ss_pred ccCCcccccCcccEEEEEecCCCEEEEEEeccCChh----hHHHHHHHHHHHhccC-cCceeeeeeeeecCCcceeEEee
Q 011153 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ----WVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 272 ~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
.+...|++|+||+|+.+.. .+.+++.+.+.....- ....+.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997665 5777887777544321 1225789999999995 5889999885 456999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDI-KLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
+++.+|.+.+. . ....++.|++.+|.++|+++ |+|||| ||.|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99988865331 0 11356789999999999998 999999 7999999999999999999998554322
Q ss_pred cc----c--------cccccccccccchhhhcc-CCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 426 TH----I--------SATLAGTLGYMAPEYVVR-GKLT-EKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 426 ~~----~--------~~~~~gt~~y~aPE~~~~-~~~~-~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
.. . ......++.+++|+-..- ...+ ...+.++.|..++.++|++.++..+.++
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 10 0 001225777888875322 2334 5678999999999999999999887665
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=153.25 Aligned_cols=100 Identities=35% Similarity=0.656 Sum_probs=73.6
Q ss_pred ceeec---CCCCCCCchhHHHHHHHHHHHHHHHhhcC--CceeeeeecccCCCceEEEEEeecCCCChhhHHHHHHHHHH
Q 011153 90 RTVCG---SKDFGGNNTVFGANAIELVRNLSVQAVKN--DGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVS 164 (492)
Q Consensus 90 ~~~~~---~~~~~~~~~~f~~~~~~l~~~l~~~a~~~--~~~~~~~~~~~~~~~~vy~l~qC~~dl~~~~C~~Cl~~~~~ 164 (492)
|..|+ ..+++.+.+.|..+++.||+.|+..|+.. .+|++++.+ .++++||||+||++||++++|..||+.++.
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~--~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~ 78 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAG--SGPDTVYGLAQCRGDLSPSDCRACLADAVA 78 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE----ST---EEEEEEE-TTS-HHHHHHHHHHHHC
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecC--CCCCeEEEEEEcCCCCChhhhHHHHHHHHH
Confidence 35677 23332344559999999999999998864 689999864 678899999999999999999999999999
Q ss_pred hhhhc-cCCCCceeeCCccccccccccc
Q 011153 165 RIASC-TQKEEGRVLNAGCYLRYSTQRF 191 (492)
Q Consensus 165 ~~~~c-~~~~~g~v~~~~C~~ry~~~~f 191 (492)
+++.| ..+.+|++++++|++||++++|
T Consensus 79 ~~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 79 NISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp CHHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHHHhCCCCceEEEECCCEEEEEECCCC
Confidence 99985 4589999999999999999987
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-20 Score=167.06 Aligned_cols=108 Identities=31% Similarity=0.306 Sum_probs=93.5
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
|+|.+++... ...+++..++.++.||+.||+|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 6788887532 346999999999999999999999875 999999999999999 99988654422
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
..|++.|||||++.+..++.++|||||||++|||++|+.|+....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 257899999999999999999999999999999999999986543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-19 Score=162.25 Aligned_cols=137 Identities=16% Similarity=0.195 Sum_probs=106.4
Q ss_pred cccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhcc-----CcCceeeeeeeeecCC---cce-
Q 011153 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-----NHKNLVKLLGCSITGP---ESL- 341 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~- 341 (492)
....+.||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+ +||||++++|++.++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 3233444 69988765555567899999999999 6799999999998874 223
Q ss_pred eEEee--cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeEecCCCCCCeeeCC----CCcEEEee
Q 011153 342 LVYEF--VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL-AYLHEESKLRIIHRDIKLSNILLDE----EFTAKIAD 414 (492)
Q Consensus 342 lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l-~yLH~~~~~~ivH~Dlk~~Nill~~----~~~~kl~D 414 (492)
+|+|| .++++|.+++... .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 5579999999432 24544 35678888888 9999998 999999999999974 34899999
Q ss_pred cCCc
Q 011153 415 FGLV 418 (492)
Q Consensus 415 fgl~ 418 (492)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5443
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.8e-20 Score=148.34 Aligned_cols=76 Identities=39% Similarity=0.888 Sum_probs=60.8
Q ss_pred CCcccchhcc---ccEEEeeCCCCCceEEEEecCCCCChhhhHHHHHHHHHHHHhhCCCCCCcccEEEEccceEEEEccC
Q 011153 2 DIVTPLIARQ---RYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDY 78 (492)
Q Consensus 2 ~~l~~~~~~~---~~~~~~~g~~~~~vygl~~C~~d~~~~~C~~Cl~~a~~~~~~~c~~~~~~~~~~~~~~~C~~ry~~~ 78 (492)
+.|++.++.. +|+++..|.++++|||++||++|+++++|..||+.|+..+..+|+++ +||+|+++.|+||||++
T Consensus 28 ~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~---~g~~v~~~~C~lRY~~~ 104 (106)
T PF01657_consen 28 SSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGS---RGGRVWYDSCFLRYENY 104 (106)
T ss_dssp HHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSB---SSEEEEESSEEEEEESS
T ss_pred HHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCC---ceEEEECCCEEEEEECC
Confidence 3456665543 89999888899999999999999999999999999999999999987 99999999999999999
Q ss_pred CC
Q 011153 79 DF 80 (492)
Q Consensus 79 ~f 80 (492)
+|
T Consensus 105 ~F 106 (106)
T PF01657_consen 105 PF 106 (106)
T ss_dssp --
T ss_pred CC
Confidence 98
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-19 Score=190.40 Aligned_cols=200 Identities=24% Similarity=0.323 Sum_probs=158.1
Q ss_pred ccCCcccccCcccEEEEEec-CCCEEEEEEec----c-CChh-hHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 272 HESNKLGQGGSGSVYKGTLP-GGEAVAVKRLF----Y-NTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 272 ~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~----~-~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
...+++|.|++|.|+..... ..+..+.|... . .... ....+..|..+-..+.|||++..+....+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999988777643 33334444332 1 1111 1122566777778899999999988888887777779
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||++. +|...+... ..+....+.-++.|++.|+.|+|+.| |.|||||++|+++..++.+||+|||.+..+..+
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 998887432 35777888899999999999999998 999999999999999999999999999766433
Q ss_pred Cc---cccccccccccccchhhhccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 425 IT---HISATLAGTLGYMAPEYVVRGKLTEK-ADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 425 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
.. .......|+..|+|||.+...+|.+. .||||.|+++..|++|+.||......
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 22 44557889999999999999999875 89999999999999999999765433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-19 Score=181.81 Aligned_cols=186 Identities=28% Similarity=0.247 Sum_probs=154.0
Q ss_pred cccccCcccEEEEE----ecCCCEEEEEEeccCChh--hHHHHHHHHHHHhccC-cCceeeeeeeeecCCcceeEEeecC
Q 011153 276 KLGQGGSGSVYKGT----LPGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 276 ~iG~G~fG~Vy~~~----~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 348 (492)
++|+|.||.|+... .+.+..+|+|.+++.... .......|..++...+ ||.+|++...++.+...+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999764 234677899988654321 1225566888888886 9999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 428 (492)
+|.|...+.. ...++..........++-+++++|+.+ ++|||+|++||+++.+|.+++.|||+++..-+...
T Consensus 81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 9999887743 334566666777788999999999988 99999999999999999999999999986543321
Q ss_pred cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.+||..|||||++. .....+|.||||++.+||++|-.||..
T Consensus 153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28899999999887 567789999999999999999999977
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.8e-18 Score=157.47 Aligned_cols=147 Identities=18% Similarity=0.136 Sum_probs=112.5
Q ss_pred HhcccccCCcccccCcccEEEEE--ecCCCEEEEEEeccCChh------------------------hHHHHHHHHHHHh
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGT--LPGGEAVAVKRLFYNTTQ------------------------WVDHFFNEVNLIS 320 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~ 320 (492)
-...|++.+.||+|+||.||+|. ..+|+.||+|+++..... ....+.+|+..+.
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 33457888999999999999998 568999999998643210 1123568999999
Q ss_pred ccCcCc--eeeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 011153 321 GINHKN--LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK 398 (492)
Q Consensus 321 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk 398 (492)
++.+.. +.++++. ...++||||+++.+|...... ...+.......++.||+.+|.+||+.+ +++|+|||
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dik 176 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLS 176 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCC
Confidence 997533 3444432 345899999999888665422 223556667889999999999999875 49999999
Q ss_pred CCCeeeCCCCcEEEeecCCccccCC
Q 011153 399 LSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 399 ~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|+||+++ ++.++|+|||++.....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccCC
Confidence 9999999 88999999999875443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.1e-18 Score=153.52 Aligned_cols=145 Identities=21% Similarity=0.201 Sum_probs=112.1
Q ss_pred HHHHHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChh----------------------hHHHHHHHHHHHh
Q 011153 263 TLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ----------------------WVDHFFNEVNLIS 320 (492)
Q Consensus 263 ~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~E~~~l~ 320 (492)
++......|...+.||+|+||.||++...+|+.||||++...... ....+.+|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 333444447778999999999999999888999999987543210 1123567888999
Q ss_pred ccCcCc--eeeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 011153 321 GINHKN--LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK 398 (492)
Q Consensus 321 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk 398 (492)
.+.|++ +.+.++ ....++||||+++++|.+.... .....++.+++.++.++|+.+ ++|||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 988774 444443 3456899999999988764310 234578899999999999987 9999999
Q ss_pred CCCeeeCCCCcEEEeecCCccccCC
Q 011153 399 LSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 399 ~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|+||++++++.++|+|||++.....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999865544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.9e-18 Score=155.94 Aligned_cols=135 Identities=18% Similarity=0.248 Sum_probs=113.2
Q ss_pred CcccccCcccEEEEEecCCCEEEEEEeccCCh---h-----hHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT---Q-----WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~---~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
+.||+|++|.||+|.. .+..+++|+...... + ....+.+|++++..+.|++|.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 577899997654321 1 124578899999999999988887777778889999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+++++|.+.+... .+ .+..++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++|+|||++...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999887432 12 77889999999999999988 99999999999999 789999999998753
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3e-18 Score=183.09 Aligned_cols=200 Identities=22% Similarity=0.208 Sum_probs=158.1
Q ss_pred HHHHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccC---cCceeeeeeeeecCCcc
Q 011153 264 LEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN---HKNLVKLLGCSITGPES 340 (492)
Q Consensus 264 l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~ 340 (492)
.+.....|.+.+.||+|+||+||+|...+|+.||+|+=+....- +|.-=.+++.+|+ -+-|..+..+..-.+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 34445668889999999999999999888999999976554332 1111122333333 24455666666778888
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-------CCcEEEe
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-------EFTAKIA 413 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-------~~~~kl~ 413 (492)
+||+||.+.|+|.+++. ..+.++|.....++.|+++-++.||..+ |||+||||+|+||.. .-.++|+
T Consensus 770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 99999999999999984 5567899999999999999999999998 999999999999942 3468999
Q ss_pred ecCCccccCC-CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 011153 414 DFGLVRLFPE-DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRIN 472 (492)
Q Consensus 414 Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~ 472 (492)
|||.+-...- .........++|-.+-.+|+..+.+++...|.|.|+-+++-||.|+..-
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q 903 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME 903 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH
Confidence 9998853221 1122344667899999999999999999999999999999999999876
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-17 Score=152.47 Aligned_cols=131 Identities=19% Similarity=0.284 Sum_probs=106.6
Q ss_pred cccccCcccEEEEEecCCCEEEEEEeccCCh--------hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT--------QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 276 ~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
.||+|+||.||+|.. ++..+++|....... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 467899998653221 11356788999999999887666555666777789999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
++++|.+.+.... ..++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999988763211 078999999999999988 99999999999999 889999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.9e-18 Score=176.13 Aligned_cols=141 Identities=20% Similarity=0.281 Sum_probs=113.8
Q ss_pred HHhcccccCCcccccCcccEEEEEecCCCEEEEEE-eccC-------ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKR-LFYN-------TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG 337 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~-l~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 337 (492)
.....|...++||+|+||+||++.+.+.. +++|+ .... .....+.+.+|++++..++|++++....++.+.
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 33445567889999999999999876544 33333 2211 111235688999999999999999888888887
Q ss_pred CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCC
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl 417 (492)
...++||||+++++|.+.+. ....++.+++.+|.+||+.+ ++||||||+|||+ +++.++|+|||+
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcc
Confidence 88899999999999988773 35678999999999999988 9999999999999 678999999999
Q ss_pred ccccC
Q 011153 418 VRLFP 422 (492)
Q Consensus 418 ~~~~~ 422 (492)
++...
T Consensus 474 a~~~~ 478 (535)
T PRK09605 474 GKYSD 478 (535)
T ss_pred cccCC
Confidence 98643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.4e-18 Score=158.96 Aligned_cols=199 Identities=21% Similarity=0.267 Sum_probs=131.2
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCc----------Cceeeeeeee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINH----------KNLVKLLGCS 334 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~ 334 (492)
..+...+.||.|+++.||.+++. +++.+|||+.... .....+++.+|.-....+.+ -.++.-++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 34566788999999999999976 4889999988543 23346677777766655322 1222222221
Q ss_pred e---------cCC--------cceeEEeecCCCCchhhhh---ccCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 011153 335 I---------TGP--------ESLLVYEFVPNQSLLDNLF---VRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRII 393 (492)
Q Consensus 335 ~---------~~~--------~~~lv~e~~~~gsL~~~l~---~~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iv 393 (492)
. ... +.+++|+-+ .++|.+.+. ..... ..+....++.+..|+++.+++||+.| ++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 1 111 235666766 567766643 22222 23445566777799999999999998 99
Q ss_pred ecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccccccccccccchhhhccC--------CCCcchhHHHHHHHHHHH
Q 011153 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG--------KLTEKADVYSFGVVVIEV 465 (492)
Q Consensus 394 H~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDv~slGvll~el 465 (492)
|+||+|+|++++.+|.+.|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.|
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999999887655443221 2345789999976442 468899999999999999
Q ss_pred HhCCCCCCCC
Q 011153 466 VCRKRINLFT 475 (492)
Q Consensus 466 ltg~~p~~~~ 475 (492)
++++.||...
T Consensus 244 WC~~lPf~~~ 253 (288)
T PF14531_consen 244 WCGRLPFGLS 253 (288)
T ss_dssp HHSS-STCCC
T ss_pred HHccCCCCCC
Confidence 9999999854
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.4e-18 Score=165.04 Aligned_cols=188 Identities=27% Similarity=0.341 Sum_probs=135.2
Q ss_pred CCcccccCcccEEEEEecC----CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeee-------eeec-----C
Q 011153 274 SNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-------CSIT-----G 337 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-------~~~~-----~ 337 (492)
.+..++.+++.++...... .+.+..+....++........+++-.+....|-+..-+.+ .+.. .
T Consensus 249 ~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~ 328 (516)
T KOG1033|consen 249 SKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKK 328 (516)
T ss_pred cccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccccc
Confidence 3445555555555544322 2233444333333233334445555555554433333322 1111 1
Q ss_pred CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCC
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl 417 (492)
..+++.|+++...+|.+++..+......++...+.++.|++.++.| ++ .+|+|+||.||+...+.++||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 2468999999999999999877777888999999999999999999 55 99999999999999999999999999
Q ss_pred ccccCCCC-----ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh
Q 011153 418 VRLFPEDI-----THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467 (492)
Q Consensus 418 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt 467 (492)
........ ....+.-.||..||+||.+.+..|+.|+||||||+||+|++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87654443 112335579999999999999999999999999999999998
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.7e-17 Score=171.96 Aligned_cols=196 Identities=23% Similarity=0.235 Sum_probs=149.2
Q ss_pred ccccCCcccccCcccEEEEEecCCCEEEEEEeccCCh-hhHHHHHHHHHH--HhccCcCceeeeeeeeecCCcceeEEee
Q 011153 270 YFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT-QWVDHFFNEVNL--ISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
++...+.||.+.|=+|.+++.++|. |+||++.+..+ -..+.|.++++- ...++|||.+++.-+-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4666889999999999999998887 99999866542 233444443333 5566999999999888888888999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc--CCC
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF--PED 424 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~--~~~ 424 (492)
+. .+|.+.+. ....+...+..-|+.|++.||.-+|..+ |+|||||.+||||+.-..+.|+||...+.. +++
T Consensus 103 vk-hnLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VK-HNLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hh-hhhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 84 47777763 2334566667778999999999999998 999999999999999999999999877632 333
Q ss_pred Cccc----cccccccccccchhhhccC----------C-CCcchhHHHHHHHHHHHHhC-CCCCC
Q 011153 425 ITHI----SATLAGTLGYMAPEYVVRG----------K-LTEKADVYSFGVVVIEVVCR-KRINL 473 (492)
Q Consensus 425 ~~~~----~~~~~gt~~y~aPE~~~~~----------~-~~~~sDv~slGvll~elltg-~~p~~ 473 (492)
.+.. ..+...-..|+|||-+... . .+++-||||+||++.||++- ++||.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 2221 1233344589999987541 1 56788999999999999987 44553
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.4e-16 Score=133.48 Aligned_cols=135 Identities=24% Similarity=0.188 Sum_probs=114.5
Q ss_pred cCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCc--CceeeeeeeeecCCcceeEEeecCCC
Q 011153 273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH--KNLVKLLGCSITGPESLLVYEFVPNQ 350 (492)
Q Consensus 273 ~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 350 (492)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| +++++++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999865 7899998865443 4678899999999976 58999999888888899999999887
Q ss_pred CchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 351 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
.+... +......++.+++++|++||.....+++|+|++|+||++++++.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 5566778899999999999986545699999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.8e-16 Score=158.98 Aligned_cols=163 Identities=32% Similarity=0.508 Sum_probs=131.7
Q ss_pred HhccCcCceeeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 011153 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK 398 (492)
Q Consensus 319 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk 398 (492)
|+.+.|.|+.+++|.+.+++..++|.+|++.|+|.+.+.. ....+++.....++.+|+.||+|||+.. -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4678999999999999999999999999999999999965 3445889999999999999999999864 23999999
Q ss_pred CCCeeeCCCCcEEEeecCCccccCCCC-ccccccccccccccchhhhccCC-------CCcchhHHHHHHHHHHHHhCCC
Q 011153 399 LSNILLDEEFTAKIADFGLVRLFPEDI-THISATLAGTLGYMAPEYVVRGK-------LTEKADVYSFGVVVIEVVCRKR 470 (492)
Q Consensus 399 ~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDv~slGvll~elltg~~ 470 (492)
++|+++|....+||+|||+........ ........-..-|.|||.+.... .+.+.||||||++++||++++.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999987664311 11111222356899999987631 4667999999999999999999
Q ss_pred CCCCCCCCC---cHHHHH
Q 011153 471 INLFTQNSC---SILQTV 485 (492)
Q Consensus 471 p~~~~~~~~---~~~~~~ 485 (492)
||....... .++.++
T Consensus 157 ~~~~~~~~~~~~eii~~~ 174 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRV 174 (484)
T ss_pred ccccccccCChHHHHHHH
Confidence 998744433 355443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.5e-16 Score=140.34 Aligned_cols=138 Identities=21% Similarity=0.193 Sum_probs=98.0
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccCChh--hHHH----------------------HHHHHHHHhccCcCc--e
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ--WVDH----------------------FFNEVNLISGINHKN--L 327 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 327 (492)
.+.||+|+||+||++...+++.||||++...... .... ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5679999999999999888999999988653221 1111 134555555554332 3
Q ss_pred eeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCC
Q 011153 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDE 406 (492)
Q Consensus 328 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nill~~ 406 (492)
.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|+ .+ ++|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444432 346899999998654322111100 11 5577899999999999998 76 99999999999999
Q ss_pred CCcEEEeecCCccccCC
Q 011153 407 EFTAKIADFGLVRLFPE 423 (492)
Q Consensus 407 ~~~~kl~Dfgl~~~~~~ 423 (492)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 89999999999875433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=4e-15 Score=139.46 Aligned_cols=136 Identities=21% Similarity=0.263 Sum_probs=104.4
Q ss_pred CCccc-ccCcccEEEEEecCCCEEEEEEeccCC-------------hhhHHHHHHHHHHHhccCcCce--eeeeeeeecC
Q 011153 274 SNKLG-QGGSGSVYKGTLPGGEAVAVKRLFYNT-------------TQWVDHFFNEVNLISGINHKNL--VKLLGCSITG 337 (492)
Q Consensus 274 ~~~iG-~G~fG~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 337 (492)
...|| .|+.|+||+.... +..++||.+.... ......+.+|++++..++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45787 8999999999876 6778998875321 1223567889999999998875 6677664433
Q ss_pred Cc----ceeEEeecCC-CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEE
Q 011153 338 PE----SLLVYEFVPN-QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412 (492)
Q Consensus 338 ~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl 412 (492)
.. .++|+|++++ .+|.+.+.. .+++.. .+.+|+.+|.+||+.+ |+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 22 2599999997 688877632 234443 3578999999999998 999999999999999999999
Q ss_pred eecCCcccc
Q 011153 413 ADFGLVRLF 421 (492)
Q Consensus 413 ~Dfgl~~~~ 421 (492)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.3e-15 Score=160.27 Aligned_cols=168 Identities=21% Similarity=0.330 Sum_probs=120.5
Q ss_pred hcccccCCcccccCcccEEEEEecC-CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
...|+.++.|..|+||.||..++.. .+.+|+|+- +++- +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccc-ccch-----hhhc--cccccCCccee------------------
Confidence 3568889999999999999998764 567888432 2110 1100 22223344433
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
|+=...+ +..++++. +++.+++|||+.+ |+|||+||+|.||..-|.+|+.|||+.+.......
T Consensus 136 ---gDc~tll---k~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLL---KNIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhc---ccCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 2222222 12222332 2267899999987 99999999999999999999999999875432211
Q ss_pred c-------------c-cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 427 H-------------I-SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 427 ~-------------~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
. . ...++||+.|.|||++..+.|...+|.|++|+|++|.+-|+.||+-+..+
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe 264 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 264 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH
Confidence 1 1 12468999999999999999999999999999999999999999887544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.8e-15 Score=140.60 Aligned_cols=144 Identities=29% Similarity=0.364 Sum_probs=106.7
Q ss_pred CcCceeeeeeeeec---------------------------CCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHH
Q 011153 323 NHKNLVKLLGCSIT---------------------------GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL 375 (492)
Q Consensus 323 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~ 375 (492)
+|||||++.++|.+ +..+|+||.-.+ .+|.+++..+ ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHHH
Confidence 69999999987754 224578887764 4777777433 345566777899
Q ss_pred HHHHHHHHHhhcCCCCeEecCCCCCCeee--CCCC--cEEEeecCCccccCCC---Ccccc--ccccccccccchhhhcc
Q 011153 376 STAEGLAYLHEESKLRIIHRDIKLSNILL--DEEF--TAKIADFGLVRLFPED---ITHIS--ATLAGTLGYMAPEYVVR 446 (492)
Q Consensus 376 ~i~~~l~yLH~~~~~~ivH~Dlk~~Nill--~~~~--~~kl~Dfgl~~~~~~~---~~~~~--~~~~gt~~y~aPE~~~~ 446 (492)
|+++|+.|||+++ |.|||+|++|||| |+|. .+.|+|||.+-.-... .+..+ -...|.-.-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 9999999999999 4454 5678999987532210 11111 13457788999997654
Q ss_pred C--CC----CcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 447 G--KL----TEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 447 ~--~~----~~~sDv~slGvll~elltg~~p~~~ 474 (492)
. +. -.|+|.|+.|-+.||+++...||-.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 2 22 2589999999999999999999854
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=7.5e-14 Score=142.15 Aligned_cols=142 Identities=20% Similarity=0.195 Sum_probs=99.9
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccCChhhHH----------------------------------------HHH
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD----------------------------------------HFF 313 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~----------------------------------------~~~ 313 (492)
.+.||.|++|+||+|++.+|+.||||+.+....+... .|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3679999999999999999999999998654211100 134
Q ss_pred HHHHHHhcc----C-cCceeeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHH-HHHHHhhc
Q 011153 314 NEVNLISGI----N-HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE-GLAYLHEE 387 (492)
Q Consensus 314 ~E~~~l~~l----~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~-~l~yLH~~ 387 (492)
+|++.+.++ + +++|.-..-+....+..+|||||+++.+|.+........ .+ ..+++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--LD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--CC---HHHHHHHHHHHHHHHHHhC
Confidence 455555444 2 333322222223345679999999999998876432111 22 3456666665 46788988
Q ss_pred CCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 388 ~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
+ ++|+|+||.||+++++++++++|||++..+..
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7 99999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.4e-15 Score=156.65 Aligned_cols=208 Identities=25% Similarity=0.316 Sum_probs=163.3
Q ss_pred hcccccCCcccccCcccEEEEEecC--CCEEEEEEeccCC--hhhHHHHHHHHHHHhccC-cCceeeeeeeeecCCccee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG--GEAVAVKRLFYNT--TQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 342 (492)
...|...+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3456778889999999998887543 4456777665443 333444556777777776 9999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEecCCCCCCeeeCCCC-cEEEeecCCccc
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH-EESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRL 420 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH-~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~ 420 (492)
+.++..++++.+.+.. ......+....-....|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||++..
T Consensus 99 ~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999887731 12213445556678899999999999 777 99999999999999999 999999999987
Q ss_pred cCC--CCccccccccc-cccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 421 FPE--DITHISATLAG-TLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 421 ~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
+.. ..........| ++.|+|||...+. -..+..|+||.|+++.-+++|..|+......+
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 655 22223335677 9999999988774 45678999999999999999999998865543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.2e-12 Score=114.63 Aligned_cols=131 Identities=20% Similarity=0.163 Sum_probs=97.1
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCcee-eeeeeeecCCcceeEEeecCCCCc
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV-KLLGCSITGPESLLVYEFVPNQSL 352 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL 352 (492)
.+.|+.|.++.||+.+.. ++.+++|....... ....+.+|+..++.+.+.+++ +++.. .....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence 356889999999999876 77899998755432 223467899999988665554 34443 23456899999999887
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES--KLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
.... . ....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5420 0 11245678999999999876 23469999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=9.7e-13 Score=135.58 Aligned_cols=144 Identities=17% Similarity=0.186 Sum_probs=90.4
Q ss_pred cccccCCcccccCcccEEEEEecC-CCEEEEEEeccCChh----------------------------------hHHH--
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQ----------------------------------WVDH-- 311 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~----------------------------------~~~~-- 311 (492)
..|+. +.||.|++|+||++++.+ |+.||||+.+..-.+ ..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34655 789999999999999887 999999999754211 1112
Q ss_pred ----HHHHHHHHhcc----CcCceeeeeeeeec-CCcceeEEeecCCCCchhhhhccCCC---CCCCHHHHHHHHHHHHH
Q 011153 312 ----FFNEVNLISGI----NHKNLVKLLGCSIT-GPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAE 379 (492)
Q Consensus 312 ----~~~E~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~i~~~i~~ 379 (492)
+.+|+..+.++ .+.+.+.+-..+.+ ....+|||||++|+++.+.-...... ..+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 23333333333 13222322222222 45667999999999997642111111 01222222222233
Q ss_pred HHHHHhhcCCCCeEecCCCCCCeeeCCCC----cEEEeecCCccccCC
Q 011153 380 GLAYLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFGLVRLFPE 423 (492)
Q Consensus 380 ~l~yLH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfgl~~~~~~ 423 (492)
++..| ++|+|+||.||+++.++ ++++.|||+...++.
T Consensus 276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34455 99999999999999888 999999999987654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.1e-11 Score=125.96 Aligned_cols=167 Identities=17% Similarity=0.167 Sum_probs=126.7
Q ss_pred ecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHH
Q 011153 290 LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEV 369 (492)
Q Consensus 290 ~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~ 369 (492)
..++.+|.|...+.......+...+-++.|+.++||||++++..++.++..|||+|-+. .|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 45688899998877666556677888999999999999999999999999999999873 45555532 22455
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccccccccccccchhhhccCCC
Q 011153 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449 (492)
Q Consensus 370 ~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 449 (492)
..-.+.||+.||.+||+.+ .++|++|.-..|+|+..|..||.+|.++........ .......-..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 5667899999999999665 499999999999999999999999998764432221 111111223466676543222
Q ss_pred CcchhHHHHHHHHHHHHhCC
Q 011153 450 TEKADVYSFGVVVIEVVCRK 469 (492)
Q Consensus 450 ~~~sDv~slGvll~elltg~ 469 (492)
-..|.|-||++++|++.|.
T Consensus 182 -~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -cchhhhhHHHHHHHHhCcc
Confidence 3469999999999999993
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.3e-10 Score=104.42 Aligned_cols=138 Identities=12% Similarity=0.068 Sum_probs=98.3
Q ss_pred CCcccccCcccEEEEEecC-------CCEEEEEEeccCC----------------------hhhHHHH----HHHHHHHh
Q 011153 274 SNKLGQGGSGSVYKGTLPG-------GEAVAVKRLFYNT----------------------TQWVDHF----FNEVNLIS 320 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~-------~~~vavK~l~~~~----------------------~~~~~~~----~~E~~~l~ 320 (492)
...||.|.-+.||.|...+ +..+|||+.+... ....+.+ .+|.+.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999997543 4789999875321 0112223 37999998
Q ss_pred ccCc--CceeeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEecCC
Q 011153 321 GINH--KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL-HEESKLRIIHRDI 397 (492)
Q Consensus 321 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yL-H~~~~~~ivH~Dl 397 (492)
++.. -++.+++++ ...++||||+.+..+..... +...++......+..+++.+|..| |+.+ +||+||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 8853 455566653 57789999997754422111 112244556677889999999999 7877 999999
Q ss_pred CCCCeeeCCCCcEEEeecCCccccC
Q 011153 398 KLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 398 k~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
++.|||++ ++.+.|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999876443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.1e-10 Score=108.30 Aligned_cols=142 Identities=23% Similarity=0.275 Sum_probs=109.7
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccCCh-hhHHHHHHHHHHHhccCc--CceeeeeeeeecCC---cceeEEeec
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINH--KNLVKLLGCSITGP---ESLLVYEFV 347 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~ 347 (492)
.+.|+.|..+.||++...+|+.+++|....... .....+.+|+++++.+.+ .++.+++.+..... ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 356899999999999887778899998765432 234578899999999865 34566777665542 568999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES--------------------------------------- 388 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~--------------------------------------- 388 (492)
++.++.+.+.. ..++......++.++++.|..||+..
T Consensus 83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99888765421 34677778888888888888888531
Q ss_pred --------------CCCeEecCCCCCCeeeCC--CCcEEEeecCCcc
Q 011153 389 --------------KLRIIHRDIKLSNILLDE--EFTAKIADFGLVR 419 (492)
Q Consensus 389 --------------~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgl~~ 419 (492)
...++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 246799999999999998 6678999999765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.4e-11 Score=124.15 Aligned_cols=200 Identities=24% Similarity=0.281 Sum_probs=155.5
Q ss_pred cccccCCcccc--cCcccEEEEEe---cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcc
Q 011153 269 NYFHESNKLGQ--GGSGSVYKGTL---PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES 340 (492)
Q Consensus 269 ~~~~~~~~iG~--G~fG~Vy~~~~---~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 340 (492)
..|...+.+|. |.+|.||++.. .++..+|+|+-+.. .+.....-.+|+.....+ .|+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34667788999 99999999986 35788999985433 223333445677777777 599999999999999999
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeEecCCCCCCeeeCCC-CcEEEeec
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE----GLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADF 415 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~----~l~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Df 415 (492)
++-+|++. .+|.++.+.. ...++...+.....+... ||..+|+.. ++|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999885 6777666433 233556667777777777 999999988 9999999999999999 89999999
Q ss_pred CCccccCCCCcc----ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 416 GLVRLFPEDITH----ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 416 gl~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
|+...+.+..-. ......|...|++||. .++.++..+|+|++|.+++|-.++-..+...
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 999877654311 1223357788999995 5677899999999999999999888776543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.2e-10 Score=98.36 Aligned_cols=132 Identities=20% Similarity=0.281 Sum_probs=100.9
Q ss_pred CcccccCcccEEEEEecCCCEEEEEEe-ccC--Chh-----hHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 275 NKLGQGGSGSVYKGTLPGGEAVAVKRL-FYN--TTQ-----WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~~~~vavK~l-~~~--~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
..+.+|+-+.++.+.+. |..+++|.= .+. .++ ..++..+|++++.+++--.|.-..=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999999765 334555532 211 111 234567899999998766666666677788899999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+++..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||+++.+. +.++||||+...
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999998887432 2456777888889999998 99999999999998775 999999998753
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.3e-10 Score=95.69 Aligned_cols=144 Identities=23% Similarity=0.248 Sum_probs=105.9
Q ss_pred cCCcccccCcccEEEEEecCCCEEEEEE-eccC-------ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 273 ESNKLGQGGSGSVYKGTLPGGEAVAVKR-LFYN-------TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 273 ~~~~iG~G~fG~Vy~~~~~~~~~vavK~-l~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
....|-||+-+.|+++.++ |+...||. +.+. ..-..++..+|+++|.++.--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678899999999999887 55555553 2221 1112346788999999887666665555677888889999
Q ss_pred eecCC-CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC---cEEEeecCCccc
Q 011153 345 EFVPN-QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIADFGLVRL 420 (492)
Q Consensus 345 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~Dfgl~~~ 420 (492)
||+++ .++.+++...-... ...+....++..|-+.+.-||.++ |||+||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 35677775443332 333344678889999999999998 99999999999996554 458999999864
Q ss_pred c
Q 011153 421 F 421 (492)
Q Consensus 421 ~ 421 (492)
.
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1e-10 Score=109.05 Aligned_cols=153 Identities=22% Similarity=0.270 Sum_probs=115.8
Q ss_pred HHhccCcCceeeeeeeeecC-----CcceeEEeecCCCCchhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 011153 318 LISGINHKNLVKLLGCSITG-----PESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391 (492)
Q Consensus 318 ~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ 391 (492)
-|-++.|.|||++..++.+. .+..++.|||+.|+|.++|.+.+ ....+......+++.||+.||.|||+.. ++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 35566799999999988653 35679999999999999997543 3456788888999999999999999975 88
Q ss_pred eEecCCCCCCeeeCCCCcEEEeecCCccccCC---CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhC
Q 011153 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPE---DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCR 468 (492)
Q Consensus 392 ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg 468 (492)
|+|+++.-+-|++..++.+|+.--.-...... ..........+-++|.+||+=.....+..+|||+||+..+||.-+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999999999852211110000 000011122356799999976666677889999999999999888
Q ss_pred CCC
Q 011153 469 KRI 471 (492)
Q Consensus 469 ~~p 471 (492)
.--
T Consensus 279 Eiq 281 (458)
T KOG1266|consen 279 EIQ 281 (458)
T ss_pred eec
Confidence 754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.2e-10 Score=115.59 Aligned_cols=197 Identities=21% Similarity=0.222 Sum_probs=148.4
Q ss_pred hcccccCCcccccCcccEEEEEe--cCCCEEEEEEeccCChhhHHH--HHHHHHHHhcc-CcCceeeeeeeeecCCccee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL--PGGEAVAVKRLFYNTTQWVDH--FFNEVNLISGI-NHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~--~~~~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 342 (492)
..+|.....||.|.|+.|++... .++..+++|.+.........+ -..|+.+...+ .|.+++.+...|......++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 45688889999999999998764 357788999886653332222 24566666666 69999999998988889999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-CcEEEeecCCcccc
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLF 421 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgl~~~~ 421 (492)
-.||++++++..... ...-++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+..+
T Consensus 344 p~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence 999999998866552 2233667778899999999999999877 9999999999999886 78899999998642
Q ss_pred CCCCcccccccccccccc--chhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYM--APEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.... ......-+++ +|+......+..+.|++|||.-+.|.+++......
T Consensus 418 ~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~ 468 (524)
T KOG0601|consen 418 AFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES 468 (524)
T ss_pred ceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcc
Confidence 2111 1112223444 45555567788999999999999999988865443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.7e-09 Score=103.95 Aligned_cols=170 Identities=21% Similarity=0.310 Sum_probs=130.8
Q ss_pred ccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeee----cCCcceeEEeecCC-CCchhhh
Q 011153 283 GSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI----TGPESLLVYEFVPN-QSLLDNL 356 (492)
Q Consensus 283 G~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~~l 356 (492)
.+.||+.. .||..+++|+++............-++.++++.|+|||++.+++. .+..+++||+|.|+ ++|.+..
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 56889874 589999999996554444444456688999999999999999887 34567899999986 5676665
Q ss_pred hccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 357 FVRQ------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 357 ~~~~------------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
+... .....+++.++.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 4322 1234678999999999999999999998 888999999999999999999998887655444
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINL 473 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~ 473 (492)
... -+.. -.+-|.=.||.+++.|.||.....
T Consensus 447 ~~~---------------~le~---~Qq~D~~~lG~ll~aLAt~~~ns~ 477 (655)
T KOG3741|consen 447 PTE---------------PLES---QQQNDLRDLGLLLLALATGTENSN 477 (655)
T ss_pred CCc---------------chhH---HhhhhHHHHHHHHHHHhhcccccc
Confidence 311 1111 235788889999999999976533
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=7.2e-09 Score=92.78 Aligned_cols=126 Identities=25% Similarity=0.264 Sum_probs=81.6
Q ss_pred cEEEEEecCCCEEEEEEeccCC-------------h-------------hhHHHHHHHHHHHhccCcC--ceeeeeeeee
Q 011153 284 SVYKGTLPGGEAVAVKRLFYNT-------------T-------------QWVDHFFNEVNLISGINHK--NLVKLLGCSI 335 (492)
Q Consensus 284 ~Vy~~~~~~~~~vavK~l~~~~-------------~-------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 335 (492)
.||.|...+|..+|||..+... . .......+|.+.|.++..- ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899999889999999875321 0 0122467899999999765 45566544
Q ss_pred cCCcceeEEeecC--CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCeEecCCCCCCeeeCCCCcEEE
Q 011153 336 TGPESLLVYEFVP--NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY-LHEESKLRIIHRDIKLSNILLDEEFTAKI 412 (492)
Q Consensus 336 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~y-LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 412 (492)
....|||||++ +..+..+.... ++.+....++.+++..+.. +|+.+ ++|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 35689999998 54454332111 1123345667777776665 46777 9999999999999988 9999
Q ss_pred eecCCccccC
Q 011153 413 ADFGLVRLFP 422 (492)
Q Consensus 413 ~Dfgl~~~~~ 422 (492)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.2e-08 Score=96.83 Aligned_cols=141 Identities=15% Similarity=0.099 Sum_probs=98.5
Q ss_pred CcccccCcccEEEEEecCCCEEEEEEeccCChh-hHH----------HHHHHHHHHhccCcCc--eeeeeeeeec-----
Q 011153 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ-WVD----------HFFNEVNLISGINHKN--LVKLLGCSIT----- 336 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~-~~~----------~~~~E~~~l~~l~h~n--iv~l~~~~~~----- 336 (492)
+.+-+-....|.+..+ +|+.+.||+....... ..+ .+.+|.+.+..+...+ ..+++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444455777666 4678999977433211 111 3778988887774333 3344444433
Q ss_pred CCcceeEEeecCCC-CchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-------CC
Q 011153 337 GPESLLVYEFVPNQ-SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-------EF 408 (492)
Q Consensus 337 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-------~~ 408 (492)
....++|+|++++. +|.+++.... ..+.+......++.+++..+.-||+.| |+|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23467999999986 7887763221 233456677789999999999999998 999999999999975 46
Q ss_pred cEEEeecCCccc
Q 011153 409 TAKIADFGLVRL 420 (492)
Q Consensus 409 ~~kl~Dfgl~~~ 420 (492)
.+.|+||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=4.7e-10 Score=119.08 Aligned_cols=206 Identities=20% Similarity=0.198 Sum_probs=146.7
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
..+.+.+.+-+-.|.++.++...-. .|...++|..... .....+....+-.++-...||-++.....+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3445667778888999999877532 2433344433211 11122233333334444466778877766777888999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
+++|..+++|...++... ..+.+-....+..+..+++|||... +.|+|++|.|+|+..++..++.||+......
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999988875433 3444445566777888999999876 8999999999999999999999998543221
Q ss_pred CC-----C---------------------c----cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 011153 423 ED-----I---------------------T----HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRIN 472 (492)
Q Consensus 423 ~~-----~---------------------~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~ 472 (492)
.. . . .......+|+.|.+||...+......+|.|+.|+.++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0 0 0011346899999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 011153 473 LFTQNS 478 (492)
Q Consensus 473 ~~~~~~ 478 (492)
......
T Consensus 1036 na~tpq 1041 (1205)
T KOG0606|consen 1036 NAETPQ 1041 (1205)
T ss_pred CCcchh
Confidence 875544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=7.6e-08 Score=88.77 Aligned_cols=134 Identities=22% Similarity=0.186 Sum_probs=96.0
Q ss_pred cccCCcccccCcccEEEEEecCCCEEEEEEeccCCh------------------h----hHHHHHHHHHHHhccCcC--c
Q 011153 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT------------------Q----WVDHFFNEVNLISGINHK--N 326 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~------------------~----~~~~~~~E~~~l~~l~h~--n 326 (492)
..++++||.|.-+.||.|..++|.++|||.-+.... . ......+|.+.|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999999999999995432110 0 122357899999988655 5
Q ss_pred eeeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC
Q 011153 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406 (492)
Q Consensus 327 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~ 406 (492)
+.+.++ .+.-.+|||++++-.|...- ++.+..-.++..|++-+.-+-..| |||+|+++=||++++
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 666654 35668999999986664422 122223344444555555444556 999999999999999
Q ss_pred CCcEEEeecCCcc
Q 011153 407 EFTAKIADFGLVR 419 (492)
Q Consensus 407 ~~~~kl~Dfgl~~ 419 (492)
||.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999997654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=8.8e-08 Score=92.80 Aligned_cols=193 Identities=14% Similarity=0.156 Sum_probs=128.1
Q ss_pred ccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeee------ecCCc-ceeE
Q 011153 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCS------ITGPE-SLLV 343 (492)
Q Consensus 272 ~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~------~~~~~-~~lv 343 (492)
..+..||+|+-+.+|-.--- ...+-|+++........+. +..|... .||-+..-+.+= -.... .-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh--hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 34678999999999854211 1134566665544322222 2233333 566443312111 11222 3466
Q ss_pred EeecCCCCchhhh----hccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 344 YEFVPNQSLLDNL----FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 344 ~e~~~~gsL~~~l----~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
|..+++.---..+ .+++.....+|..+++.++.++.+.+-||+.| .+-+|+.++|+|+++++.+.|.|=....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 6666553221122 23455677999999999999999999999998 8999999999999999999999765433
Q ss_pred ccCCCCccccccccccccccchhhhc-----cCCCCcchhHHHHHHHHHHHHhC-CCCCCC
Q 011153 420 LFPEDITHISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCR-KRINLF 474 (492)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvll~elltg-~~p~~~ 474 (492)
+- .........+|...|.+||.-. +-.-+..+|-|.|||++++++.| +.|+.-
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 32 2223334567899999999754 22346789999999999999988 888764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.4e-07 Score=95.29 Aligned_cols=143 Identities=17% Similarity=0.208 Sum_probs=93.5
Q ss_pred CcccccCcccEEEEEecCCCEEEEEEeccCChhh------------------------------HHH----------HHH
Q 011153 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQW------------------------------VDH----------FFN 314 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~------------------------------~~~----------~~~ 314 (492)
+-|+.++-|+||+|++.+|+.||||+.+.+-.+. .++ +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5789999999999999999999999886542111 111 233
Q ss_pred HHHHHhcc-----CcCceeeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 011153 315 EVNLISGI-----NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389 (492)
Q Consensus 315 E~~~l~~l-----~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~ 389 (492)
|..-+.++ +.|++.=..=++.-.+...|+|||++|-.+.+...... ...+...+.....++. +..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f--~~q~~~dg- 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAF--LRQLLRDG- 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHH--HHHHHhcC-
Confidence 44433333 23333222223344567899999999988887753322 2345433333333322 22222234
Q ss_pred CCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 390 ~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
++|.|.+|.||+++.++++.+.|||+...+++.
T Consensus 286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred --ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999998766543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.8e-07 Score=81.04 Aligned_cols=139 Identities=22% Similarity=0.160 Sum_probs=100.3
Q ss_pred ccccCcccEEEEEecCCCEEEEEEeccC-C-----hhhHHHHHHHHHHHhccCcC--ceeeeeeeeecCC----cceeEE
Q 011153 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYN-T-----TQWVDHFFNEVNLISGINHK--NLVKLLGCSITGP----ESLLVY 344 (492)
Q Consensus 277 iG~G~fG~Vy~~~~~~~~~vavK~l~~~-~-----~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~ 344 (492)
-|+||-+.|++-.+.+ +.+-+|+-... . +-....|.+|+..|..+... .+.+.+....... ..+||+
T Consensus 26 ~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 4678888999977664 46888976411 1 22456899999999888532 2444442222211 347999
Q ss_pred eecCC-CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc--EEEeecCCccc
Q 011153 345 EFVPN-QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT--AKIADFGLVRL 420 (492)
Q Consensus 345 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~Dfgl~~~ 420 (492)
|-+++ .+|.+++... ...+.+......++.+++..++-||+.+ +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 5677766332 2335677778899999999999999998 999999999999986666 99999987653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.6e-07 Score=84.76 Aligned_cols=106 Identities=23% Similarity=0.238 Sum_probs=80.3
Q ss_pred HHHHHHHHHHhccCcC--ceeeeeeeeecCC----cceeEEeecCCC-CchhhhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 011153 310 DHFFNEVNLISGINHK--NLVKLLGCSITGP----ESLLVYEFVPNQ-SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382 (492)
Q Consensus 310 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 382 (492)
....+|...+..+... ...+.+++..... ..++|+|++++. +|.+++..... .+......++.+++..++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence 4577888877777432 3445555555422 347999999884 78887743222 556677889999999999
Q ss_pred HHhhcCCCCeEecCCCCCCeeeCCCC---cEEEeecCCcccc
Q 011153 383 YLHEESKLRIIHRDIKLSNILLDEEF---TAKIADFGLVRLF 421 (492)
Q Consensus 383 yLH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~Dfgl~~~~ 421 (492)
-||+.+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999998 99999999999998887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.3e-06 Score=78.47 Aligned_cols=139 Identities=14% Similarity=0.161 Sum_probs=83.9
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCc--eeeeeeeeecCCcceeEEeecCCCC
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN--LVKLLGCSITGPESLLVYEFVPNQS 351 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs 351 (492)
-..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 6 ~~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 6 WTQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred heeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 357899999999983 24567788776433 2345688999998886443 4566777767777789999999863
Q ss_pred -chhhh---------------------hccCCCCCCCHHHHHHHH-H----------HHHH-HHHHHhhc-CCCCeEecC
Q 011153 352 -LLDNL---------------------FVRQDVEPLSWEVRYKII-L----------STAE-GLAYLHEE-SKLRIIHRD 396 (492)
Q Consensus 352 -L~~~l---------------------~~~~~~~~~~~~~~~~i~-~----------~i~~-~l~yLH~~-~~~~ivH~D 396 (492)
+...+ +.- .............+ . .+.. ...+|... ....++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~-~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHST-KCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCC-CCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 21111 100 00011111111000 0 0001 11222211 234578999
Q ss_pred CCCCCeeeCCCCcEEEeecCCcc
Q 011153 397 IKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 397 lk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.2e-06 Score=77.41 Aligned_cols=153 Identities=20% Similarity=0.183 Sum_probs=96.5
Q ss_pred cCHHHHHHHhcccccCCcc---cccCcccEEEEEecCCCEEEEEEeccCChhhHH------------------------H
Q 011153 259 FSYETLEKATNYFHESNKL---GQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD------------------------H 311 (492)
Q Consensus 259 ~~~~~l~~~~~~~~~~~~i---G~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~------------------------~ 311 (492)
.+.+.+....++..+.+.. ..|.-+.||+|...++..+|||+++.......+ .
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 4566666666666665554 466777799999888999999998654321111 1
Q ss_pred HHHHHHHHhccC--cCceeeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cC
Q 011153 312 FFNEVNLISGIN--HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ES 388 (492)
Q Consensus 312 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~-~~ 388 (492)
...|..-|.++. +-.+.+.+.+ ....|||||+....+---. -+..++..+....+..++++.+.-|-. .+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~---LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~ 187 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPR---LKDVPLELEEAEGLYEDVVEYMRRLYKEAG 187 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCC---cccCCcCchhHHHHHHHHHHHHHHHHHhcC
Confidence 233444444442 2222222222 2446999999654211100 011223333566677788888888876 44
Q ss_pred CCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 389 ~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
+||+||+.=|||+. ++.+.|+|++-+....
T Consensus 188 ---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 ---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred ---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 8899999999876544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.7e-06 Score=75.53 Aligned_cols=137 Identities=15% Similarity=0.108 Sum_probs=85.7
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHH---------HHHHHHHhccCc---Cceeeeeeee-
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHF---------FNEVNLISGINH---KNLVKLLGCS- 334 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~h---~niv~l~~~~- 334 (492)
.++|...+++-......|.+-..+ |+.+.+|..+.......+.| .+++..+.+++. .....++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 455666666666555555554444 68889998866543322222 233333333322 2222222222
Q ss_pred ----ecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcE
Q 011153 335 ----ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (492)
Q Consensus 335 ----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ 410 (492)
.-....+++|||++|..|.+... ++. .+...+.+.|.-||+.| +.|+|.+|.|+++++++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence 22334568999999988866431 222 24456778899999998 99999999999998654 9
Q ss_pred EEeecCCccc
Q 011153 411 KIADFGLVRL 420 (492)
Q Consensus 411 kl~Dfgl~~~ 420 (492)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.30 E-value=7.5e-06 Score=77.27 Aligned_cols=140 Identities=17% Similarity=0.148 Sum_probs=85.3
Q ss_pred cccccCc-ccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccC-cCceeeeeeeeecCCcceeEEeecCCCCch
Q 011153 276 KLGQGGS-GSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFVPNQSLL 353 (492)
Q Consensus 276 ~iG~G~f-G~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (492)
.|-.|.. ..||+.... +..+.||+..... ...+.+|+++++.+. +--+.+++++...++..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 788998765 4678888775432 345678888888873 444667777777667789999999998776
Q ss_pred hhhh-------------------ccCC-CCCCCH--HHHHHHHHH--------------------HHHHHHHHhh----c
Q 011153 354 DNLF-------------------VRQD-VEPLSW--EVRYKIILS--------------------TAEGLAYLHE----E 387 (492)
Q Consensus 354 ~~l~-------------------~~~~-~~~~~~--~~~~~i~~~--------------------i~~~l~yLH~----~ 387 (492)
.... .... ..++.. ...+..... +...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 0000 001110 000000000 1111122211 1
Q ss_pred CCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 388 ~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
..+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 23569999999999999998778999999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.5e-07 Score=95.73 Aligned_cols=191 Identities=18% Similarity=0.101 Sum_probs=133.8
Q ss_pred HHHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCc-eeeeeeeeecCCcceeE
Q 011153 265 EKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN-LVKLLGCSITGPESLLV 343 (492)
Q Consensus 265 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 343 (492)
+..+..+...+-+++|++++++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..++..+++
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 3334444445567899999999987543344445544222 34456889999999999 77777777778888899
Q ss_pred EeecCCC-CchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 344 YEFVPNQ-SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 344 ~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
++++..+ +-.... ......+...+...+.+.-.+++++||+.. =+|+| ||+..+ ...|..||+....+.
T Consensus 313 ~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 313 MRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred hhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccC
Confidence 9999776 221111 011112333444556666778999999864 48888 777665 678999999887665
Q ss_pred CCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRIN 472 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~ 472 (492)
... ...+..+++.|+|||+...+.+..+.|+|++++-..++--|-+|-
T Consensus 383 ~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 383 RTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 543 234567899999999999999999999999998777777666654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.21 E-value=8.7e-06 Score=75.94 Aligned_cols=143 Identities=20% Similarity=0.198 Sum_probs=83.2
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcC--ceeeeeeeeec---CCcceeEEeecC
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK--NLVKLLGCSIT---GPESLLVYEFVP 348 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~ 348 (492)
.+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3568899999999999887 68999987544 4456777888888887533 24556653322 224579999999
Q ss_pred CCCchh----------------hh---hcc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHhh
Q 011153 349 NQSLLD----------------NL---FVR-QDVEPLSWEV---------RYKI------------ILSTAE-GLAYLHE 386 (492)
Q Consensus 349 ~gsL~~----------------~l---~~~-~~~~~~~~~~---------~~~i------------~~~i~~-~l~yLH~ 386 (492)
+..+.. .+ +.. ....++.... .... ...+.. .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987766 00 011 0111111110 0000 111222 2333332
Q ss_pred ----cCCCCeEecCCCCCCeeeC-CCCcEEEeecCCcc
Q 011153 387 ----ESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVR 419 (492)
Q Consensus 387 ----~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgl~~ 419 (492)
.....++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1345699999999999999 66677899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.19 E-value=9.1e-06 Score=73.08 Aligned_cols=105 Identities=25% Similarity=0.198 Sum_probs=82.3
Q ss_pred HHHHHHHhccCc-CceeeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 011153 313 FNEVNLISGINH-KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391 (492)
Q Consensus 313 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ 391 (492)
..|.-+|+.+++ +++.+++|+| ..++|.||.+.+++......-......+|..+.+|+.++++.+++|++...-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 6999999998 45789999987766422100012234689999999999999999999865444
Q ss_pred eEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 392 ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+...|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 777899999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=4.1e-07 Score=93.57 Aligned_cols=99 Identities=26% Similarity=0.433 Sum_probs=76.9
Q ss_pred HHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC--------ccccccccccccccchhhhc
Q 011153 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI--------THISATLAGTLGYMAPEYVV 445 (492)
Q Consensus 374 ~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~ 445 (492)
+.+++.||.|+|.. ..+||++|.|++|.++.++..||..|+.+....... .....-......|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 44556999999975 469999999999999999999999999876443311 11111233467899999999
Q ss_pred cCCCCcchhHHHHHHHHHHHH-hCCCCCCC
Q 011153 446 RGKLTEKADVYSFGVVVIEVV-CRKRINLF 474 (492)
Q Consensus 446 ~~~~~~~sDv~slGvll~ell-tg~~p~~~ 474 (492)
....+.++|+||+|++++-+. .|+..+..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a 212 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAA 212 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhc
Confidence 988899999999999999999 45544443
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.6e-05 Score=81.85 Aligned_cols=142 Identities=17% Similarity=0.180 Sum_probs=90.6
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccCChhh-------------------------------HH------HHHHHH
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQW-------------------------------VD------HFFNEV 316 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~-------------------------------~~------~~~~E~ 316 (492)
.+.|+.-+.|+||++++++|+.||||+-+..-++. .+ .|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 35799999999999999999999999875431110 11 133344
Q ss_pred HHHh----ccCcCc------eeeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 011153 317 NLIS----GINHKN------LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386 (492)
Q Consensus 317 ~~l~----~l~h~n------iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~ 386 (492)
+-.. .++|-+ |.+++ +.-.....|+||||+|..+.+.-.-.+. .++...+..-+.+...-+-+-|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~qIf~~- 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQIFKT- 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHHHHhc-
Confidence 3222 233444 22222 2234578999999999888776543322 2444444444444332222222
Q ss_pred cCCCCeEecCCCCCCeeeCC----CCcEEEeecCCccccCCC
Q 011153 387 ESKLRIIHRDIKLSNILLDE----EFTAKIADFGLVRLFPED 424 (492)
Q Consensus 387 ~~~~~ivH~Dlk~~Nill~~----~~~~kl~Dfgl~~~~~~~ 424 (492)
| ++|.|-+|.||+++. ++.+.+-|||+...++..
T Consensus 321 -G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 321 -G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred -C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 3 999999999999984 678999999998766543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.03 E-value=7.7e-05 Score=82.76 Aligned_cols=79 Identities=11% Similarity=0.236 Sum_probs=56.8
Q ss_pred CCcccccCcccEEEEEecCC---CEEEEEEeccCC-hhhHHHHHHHHHHHhccC-cCce--eeeeeeeecC---CcceeE
Q 011153 274 SNKLGQGGSGSVYKGTLPGG---EAVAVKRLFYNT-TQWVDHFFNEVNLISGIN-HKNL--VKLLGCSITG---PESLLV 343 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 343 (492)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|.++|+.+. |+++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56788999999999876654 357777654322 123356889999999995 6664 7777777654 467899
Q ss_pred EeecCCCCc
Q 011153 344 YEFVPNQSL 352 (492)
Q Consensus 344 ~e~~~~gsL 352 (492)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.0001 Score=66.61 Aligned_cols=130 Identities=20% Similarity=0.236 Sum_probs=88.5
Q ss_pred ccCCcccccCcccEEEEEecCCCEEEEEEeccCC----------------hhhHHHHHHHHHHHhccC------cCceee
Q 011153 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT----------------TQWVDHFFNEVNLISGIN------HKNLVK 329 (492)
Q Consensus 272 ~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~ 329 (492)
.....||+|+.-.||. +++.....||++.... ....++..+|+.-...+. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 3456799999998884 5556667888886554 122455666766555444 889999
Q ss_pred eeeeeecCCcceeEEeecCC------CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 011153 330 LLGCSITGPESLLVYEFVPN------QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL 403 (492)
Q Consensus 330 l~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nil 403 (492)
++|+.+++...-+|+|.+.+ .+|.+++. ...++. ...+.+.+ -..||-+++ |+.+||+|+||+
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~~---f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALDE---FKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHHH---HHHHHHHcC---CeecCCCcccEE
Confidence 99999999999999998743 33555552 223444 34444443 445666666 999999999999
Q ss_pred eCCC--C--cEEEee
Q 011153 404 LDEE--F--TAKIAD 414 (492)
Q Consensus 404 l~~~--~--~~kl~D 414 (492)
+..+ + .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 9532 2 466665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00024 Score=69.06 Aligned_cols=78 Identities=9% Similarity=-0.036 Sum_probs=56.0
Q ss_pred ccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCc---Cceeeeeeeeec---CCcceeEEe
Q 011153 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH---KNLVKLLGCSIT---GPESLLVYE 345 (492)
Q Consensus 272 ~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e 345 (492)
...+.||.|..+.||+....+++ +.+|..+... ....+..|.+.|+.+.. -.+.++++.+.. .+..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-PMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-EEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 34567999999999998776654 6667643211 23578889999888742 367778877654 356899999
Q ss_pred ecCCCCc
Q 011153 346 FVPNQSL 352 (492)
Q Consensus 346 ~~~~gsL 352 (492)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00013 Score=68.45 Aligned_cols=74 Identities=15% Similarity=0.300 Sum_probs=45.0
Q ss_pred CcccccCcc-cEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcC---ceeeeeeeeecC---CcceeEEeec
Q 011153 275 NKLGQGGSG-SVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK---NLVKLLGCSITG---PESLLVYEFV 347 (492)
Q Consensus 275 ~~iG~G~fG-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~ 347 (492)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|.+++..+... .+.+.++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456766665 58875 235677765432 2245788899988777532 233444433322 2347899999
Q ss_pred CCCCchh
Q 011153 348 PNQSLLD 354 (492)
Q Consensus 348 ~~gsL~~ 354 (492)
+|.++.+
T Consensus 77 ~G~~l~~ 83 (235)
T cd05155 77 EGETATA 83 (235)
T ss_pred cCCCCCc
Confidence 9977743
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00016 Score=67.64 Aligned_cols=140 Identities=21% Similarity=0.225 Sum_probs=80.8
Q ss_pred CcccccCcccEEEEEecC--CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCce-eeeeeeeecCCcceeEEeecCCCC
Q 011153 275 NKLGQGGSGSVYKGTLPG--GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVYEFVPNQS 351 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 351 (492)
+.|..|-...+|+....+ ++.+++|........ .....+|+.+++.+...++ .++++... ..+++||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457778888999988764 678889977543222 1223478888888854333 34443322 248999999877
Q ss_pred chhh-------h----------hccCCC--------CCC-CHHHHHHHHH----------------------HH---HHH
Q 011153 352 LLDN-------L----------FVRQDV--------EPL-SWEVRYKIIL----------------------ST---AEG 380 (492)
Q Consensus 352 L~~~-------l----------~~~~~~--------~~~-~~~~~~~i~~----------------------~i---~~~ 380 (492)
+... + +..... ... .++.+..+.. .+ +..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 0 010000 011 1222222211 11 111
Q ss_pred HH-HHhhc-CCCCeEecCCCCCCeeeCC-CCcEEEeecCCcc
Q 011153 381 LA-YLHEE-SKLRIIHRDIKLSNILLDE-EFTAKIADFGLVR 419 (492)
Q Consensus 381 l~-yLH~~-~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgl~~ 419 (492)
|. .+... ....++|+|+.+.|||+++ +..+.|+||..+.
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 11 11111 2346999999999999998 5789999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00023 Score=63.90 Aligned_cols=125 Identities=28% Similarity=0.431 Sum_probs=88.8
Q ss_pred cccccCCcccccCc-ccEEEEEecCCCEEEEEEecc---CCh------------------hhHHHHHHHHHHHhccC---
Q 011153 269 NYFHESNKLGQGGS-GSVYKGTLPGGEAVAVKRLFY---NTT------------------QWVDHFFNEVNLISGIN--- 323 (492)
Q Consensus 269 ~~~~~~~~iG~G~f-G~Vy~~~~~~~~~vavK~l~~---~~~------------------~~~~~~~~E~~~l~~l~--- 323 (492)
..++..+.||.|.- |.||++++. |+.+|+|.++. ... ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 999999987 66999999321 100 11235788999877764
Q ss_pred cCce--eeeeeeeecC------------------CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 011153 324 HKNL--VKLLGCSITG------------------PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383 (492)
Q Consensus 324 h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~y 383 (492)
+.++ |+.+|+..-. ....||-||.+... .+. .+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 5566 8888876321 11246777765432 122 2346677788889
Q ss_pred HhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCc
Q 011153 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (492)
Q Consensus 384 LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~ 418 (492)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99988 999999999976 5689999854
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00026 Score=61.59 Aligned_cols=130 Identities=17% Similarity=0.163 Sum_probs=86.4
Q ss_pred ccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCC
Q 011153 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQS 351 (492)
Q Consensus 272 ~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 351 (492)
+..+.|++|.+|.||++.+. |..+|+|+-+.+++ ...+..|+++|..+.-.++.+=+-.+ +..++.|||+.|.+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcc
Confidence 44677999999999999987 45788887655443 46788999999888766655433222 23345599999988
Q ss_pred chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC-CCCeeeCCCCcEEEeecCCccc
Q 011153 352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK-LSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 352 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk-~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
|.+.... .+..++ ..+++.---|...| |-|+.|. |..++|-.+..+.|+||.-|..
T Consensus 99 L~~~~~~------~~rk~l----~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIG------GDRKHL----LRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhc------ccHHHH----HHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8765411 122333 33444433344444 8999887 4444444445999999998874
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00028 Score=67.02 Aligned_cols=139 Identities=15% Similarity=0.119 Sum_probs=78.5
Q ss_pred cccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCce-eeeeeeeecCCcceeEEeecCCCCchh
Q 011153 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVYEFVPNQSLLD 354 (492)
Q Consensus 276 ~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~ 354 (492)
.+..|-.+.+|+... +++.+++|..........-...+|.++++.+....+ .+++... ...+|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 355678889998873 466788887654332221235678888888854333 3333332 2479999999876642
Q ss_pred h-----------------hhccC-CCCCCCHHHH-HHHHHHH---------HHHHHHHhhc-----CCCCeEecCCCCCC
Q 011153 355 N-----------------LFVRQ-DVEPLSWEVR-YKIILST---------AEGLAYLHEE-----SKLRIIHRDIKLSN 401 (492)
Q Consensus 355 ~-----------------l~~~~-~~~~~~~~~~-~~i~~~i---------~~~l~yLH~~-----~~~~ivH~Dlk~~N 401 (492)
. ++... ...+++.... .....++ ..-+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 1112222211 1111111 1112222111 12458999999999
Q ss_pred eeeCCCCcEEEeecCCccc
Q 011153 402 ILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 402 ill~~~~~~kl~Dfgl~~~ 420 (492)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0016 Score=63.36 Aligned_cols=143 Identities=15% Similarity=0.157 Sum_probs=84.3
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCc--eeeeeee------eecCCcceeEEe
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN--LVKLLGC------SITGPESLLVYE 345 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e 345 (492)
.+.|..|....+|+....+ ..+++|+.... .......|++++..+.+.+ +.+++.. ...++..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778888999987654 46888887542 2345667777777774332 4444432 123445689999
Q ss_pred ecCCCCchh----hh----------hcc-CC-------CCCCCHHHHH----------HHHHHHHHHHHHHhh----cCC
Q 011153 346 FVPNQSLLD----NL----------FVR-QD-------VEPLSWEVRY----------KIILSTAEGLAYLHE----ESK 389 (492)
Q Consensus 346 ~~~~gsL~~----~l----------~~~-~~-------~~~~~~~~~~----------~i~~~i~~~l~yLH~----~~~ 389 (492)
|++|..+.. .. +.. .. .....|.... .....+...+.++.+ ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877632 01 000 00 0111222111 011112334444443 112
Q ss_pred CCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 390 ~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
..++|+|+.|.|||++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4599999999999999987788999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0026 Score=63.91 Aligned_cols=76 Identities=16% Similarity=0.156 Sum_probs=54.0
Q ss_pred CCcccccCcccEEEEEecCC-CEEEEEEeccC-----C--hhhHHHHHHHHHHHhccC---cCceeeeeeeeecCCccee
Q 011153 274 SNKLGQGGSGSVYKGTLPGG-EAVAVKRLFYN-----T--TQWVDHFFNEVNLISGIN---HKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~-~~vavK~l~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 342 (492)
.+.||.|.+..||+....+| +.++||.-... . +-..+++..|.+.|..+. ..++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35689999999999998877 48999985311 1 123456777888887762 2456667765 4466789
Q ss_pred EEeecCCCC
Q 011153 343 VYEFVPNQS 351 (492)
Q Consensus 343 v~e~~~~gs 351 (492)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0028 Score=62.32 Aligned_cols=142 Identities=16% Similarity=0.173 Sum_probs=75.2
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccC-----cCceeeee-e--eeecCCcceeEEe
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-----HKNLVKLL-G--CSITGPESLLVYE 345 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e 345 (492)
.+.|..|....+|+....+| .+++|+...... +....|+.++..|. -|.+++-. | +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 34566777789999876655 688888752222 23334445554442 23333211 0 1123455789999
Q ss_pred ecCCCCchhh----h----------hcc-CC-------CCCCCH-HHHHH------------HHHH-HHHHHHHHhhc--
Q 011153 346 FVPNQSLLDN----L----------FVR-QD-------VEPLSW-EVRYK------------IILS-TAEGLAYLHEE-- 387 (492)
Q Consensus 346 ~~~~gsL~~~----l----------~~~-~~-------~~~~~~-~~~~~------------i~~~-i~~~l~yLH~~-- 387 (492)
|++|..+... . +.. .. ...+.| ..... .+.+ +...++.+.+.
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 9998754210 1 110 00 001111 11111 1111 11122333211
Q ss_pred --CCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 388 --SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 388 --~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
-..+++|+|++|.|||++.+...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23469999999999999977556899999875
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.001 Score=64.80 Aligned_cols=141 Identities=23% Similarity=0.302 Sum_probs=82.5
Q ss_pred CcccccCcccEEEEEecC-------CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCce-eeeeeeeecCCcceeEEee
Q 011153 275 NKLGQGGSGSVYKGTLPG-------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 346 (492)
+.+..|-...+|+....+ ++.+++|+...... ......+|.+++..+....+ .++++.+. ..+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 345567677899988665 57888998755432 23345678888877743333 34454443 2368999
Q ss_pred cCCCCchhhh-----------------hccCCC--------CCCCHHHHHH--------------------------HHH
Q 011153 347 VPNQSLLDNL-----------------FVRQDV--------EPLSWEVRYK--------------------------IIL 375 (492)
Q Consensus 347 ~~~gsL~~~l-----------------~~~~~~--------~~~~~~~~~~--------------------------i~~ 375 (492)
++|..+.... +..... .+.-+..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9887764311 110000 0001111111 111
Q ss_pred HHHHHHHHHhh------cCCCCeEecCCCCCCeeeCCC----CcEEEeecCCccc
Q 011153 376 STAEGLAYLHE------ESKLRIIHRDIKLSNILLDEE----FTAKIADFGLVRL 420 (492)
Q Consensus 376 ~i~~~l~yLH~------~~~~~ivH~Dlk~~Nill~~~----~~~kl~Dfgl~~~ 420 (492)
.+..-+..|.. .....++|+|+.+.|||++++ +.+.++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 234579999999999999885 8899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0058 Score=59.76 Aligned_cols=143 Identities=16% Similarity=0.185 Sum_probs=80.4
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCc--eeeeeee------eecCCcceeEEe
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN--LVKLLGC------SITGPESLLVYE 345 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e 345 (492)
.+.++.|....+|+....++ .+++|+.+.... .+....|++++..|.... +.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45577777789999876555 577887654321 234455666666663222 3344331 112345689999
Q ss_pred ecCCCCchhh--------------hhccCCC---------CCCCHHHHHH------------HHHHHHHHHHHHhh----
Q 011153 346 FVPNQSLLDN--------------LFVRQDV---------EPLSWEVRYK------------IILSTAEGLAYLHE---- 386 (492)
Q Consensus 346 ~~~~gsL~~~--------------l~~~~~~---------~~~~~~~~~~------------i~~~i~~~l~yLH~---- 386 (492)
|++|..+... ++..... ..-.|..... ....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9988654211 1110000 0011211110 01123334555542
Q ss_pred cCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 387 ~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
.....++|+|+++.||++++++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123569999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.004 Score=59.80 Aligned_cols=31 Identities=23% Similarity=0.483 Sum_probs=25.8
Q ss_pred CCeEecCCCCCCeeeCCCCc-EEEeecCCccc
Q 011153 390 LRIIHRDIKLSNILLDEEFT-AKIADFGLVRL 420 (492)
Q Consensus 390 ~~ivH~Dlk~~Nill~~~~~-~kl~Dfgl~~~ 420 (492)
+.++|+|+++.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0034 Score=62.37 Aligned_cols=141 Identities=19% Similarity=0.288 Sum_probs=82.3
Q ss_pred CcccccCcccEEEEEecC-----CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCcee-eeeeeeecCCcceeEEeecC
Q 011153 275 NKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV-KLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~ 348 (492)
+.|-.|-...+|+....+ ++.+++|..........+ -.+|..+++.+...++. ++++.+..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345557778899987542 367889987655433333 36788888888544443 445554322 5899998
Q ss_pred CCCchhh-----------------hhccC-C--CCCCCHHHHHHHHHHH-----------------HHHHHHH----hh-
Q 011153 349 NQSLLDN-----------------LFVRQ-D--VEPLSWEVRYKIILST-----------------AEGLAYL----HE- 386 (492)
Q Consensus 349 ~gsL~~~-----------------l~~~~-~--~~~~~~~~~~~i~~~i-----------------~~~l~yL----H~- 386 (492)
+.+|... +|... . .....+.++.++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776421 11111 0 1112233333332221 1111122 21
Q ss_pred cCCCCeEecCCCCCCeeeCC-CCcEEEeecCCccc
Q 011153 387 ESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRL 420 (492)
Q Consensus 387 ~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgl~~~ 420 (492)
.....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346899999999999976 57899999998764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0014 Score=72.12 Aligned_cols=157 Identities=21% Similarity=0.198 Sum_probs=113.6
Q ss_pred HHHHHHHHHHhccCcCceeeeeeeeecCCcc----eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 011153 310 DHFFNEVNLISGINHKNLVKLLGCSITGPES----LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385 (492)
Q Consensus 310 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH 385 (492)
....-|...+.++.|+|++.++.+..+.... .+..|+++.-++...+ +.....+..+.+.+..++.+||+|+|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHH
Confidence 3345577778889999999999987755433 2455677777776666 34456788899999999999999999
Q ss_pred hcCCCCeEecCCCCC---CeeeCCCCcEEEe--ecCCccccCCCCccccccccccccccchhhhccCCCC--cchhHHHH
Q 011153 386 EESKLRIIHRDIKLS---NILLDEEFTAKIA--DFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT--EKADVYSF 458 (492)
Q Consensus 386 ~~~~~~ivH~Dlk~~---Nill~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~sDv~sl 458 (492)
+.. ..|.-+..+ +..++.++.+.++ ||+..+.+.+..... ...-+..+.+||........ ...|+|.+
T Consensus 304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHH
Confidence 985 555555555 5555666777777 998887665543322 22345567788876655544 34799999
Q ss_pred HHHHHHHHhCCCCCCC
Q 011153 459 GVVVIEVVCRKRINLF 474 (492)
Q Consensus 459 Gvll~elltg~~p~~~ 474 (492)
|.++..+..|..+...
T Consensus 379 gll~~~~~~~~~i~~~ 394 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEK 394 (1351)
T ss_pred HHHHhhhhhcCccccc
Confidence 9999999999987654
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0087 Score=58.05 Aligned_cols=140 Identities=14% Similarity=0.148 Sum_probs=78.9
Q ss_pred cCcccEEEEEecCCCEEEEEEec-cCChhhHHHHHHHHHHHhccCc--CceeeeeeeeecCC--cceeEEeecCCCCchh
Q 011153 280 GGSGSVYKGTLPGGEAVAVKRLF-YNTTQWVDHFFNEVNLISGINH--KNLVKLLGCSITGP--ESLLVYEFVPNQSLLD 354 (492)
Q Consensus 280 G~fG~Vy~~~~~~~~~vavK~l~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~~gsL~~ 354 (492)
|.--.+|..... ++.+++++-. ...........+|.++|+.+.- --+...++.|.++. ..+.||+|+++..+.+
T Consensus 36 G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~ 114 (321)
T COG3173 36 GWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWS 114 (321)
T ss_pred CcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccC
Confidence 333344444443 6777777221 1233445667788888877743 33445566666665 6689999998844332
Q ss_pred hhhccCC---------------------------C--CCCCHHHHHHHHHH--------------HHHHHHHHhhc----
Q 011153 355 NLFVRQD---------------------------V--EPLSWEVRYKIILS--------------TAEGLAYLHEE---- 387 (492)
Q Consensus 355 ~l~~~~~---------------------------~--~~~~~~~~~~i~~~--------------i~~~l~yLH~~---- 387 (492)
.+..... . ......++.++..+ ...-..+|+++
T Consensus 115 ~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~ 194 (321)
T COG3173 115 ALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPW 194 (321)
T ss_pred cCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCc
Confidence 2210000 0 00000111111111 11223344433
Q ss_pred -CCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 388 -SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 388 -~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
+.+.++|+|+++.|++++.+..+-|.||+++..
T Consensus 195 ~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 195 AGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 246799999999999999988899999999864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0011 Score=63.14 Aligned_cols=133 Identities=17% Similarity=0.180 Sum_probs=92.6
Q ss_pred cccCCcccccCcccEEEEEecCCCEEEEEEeccC------------------Chhh----HHHHHHHHHHHhccC-cCc-
Q 011153 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN------------------TTQW----VDHFFNEVNLISGIN-HKN- 326 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~------------------~~~~----~~~~~~E~~~l~~l~-h~n- 326 (492)
+..++.||-|.-+.||.+...+|++.++|.-+.. +..| .-...+|...|+.|. |..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 5678999999999999999999999988843211 0111 112456788888774 322
Q ss_pred eeeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC
Q 011153 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406 (492)
Q Consensus 327 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~ 406 (492)
+.+.+ +.+.-++|||++.+-.|...-+. .+..+ +...+..-+.-|..+| +||+|..-=||++++
T Consensus 174 VPkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 174 VPKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCcc----cccceeeHHHhhcccceeeeeec------CChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEec
Confidence 33344 34566899999998888654321 22233 3334444556677777 999999999999999
Q ss_pred CCcEEEeecCCcc
Q 011153 407 EFTAKIADFGLVR 419 (492)
Q Consensus 407 ~~~~kl~Dfgl~~ 419 (492)
+..++++||--..
T Consensus 238 d~~i~vIDFPQmv 250 (465)
T KOG2268|consen 238 DDKIVVIDFPQMV 250 (465)
T ss_pred CCCEEEeechHhh
Confidence 9999999997543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0056 Score=58.86 Aligned_cols=141 Identities=20% Similarity=0.199 Sum_probs=72.2
Q ss_pred cCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhcc---CcCceeeeeeeeecCCcceeEEeecCC
Q 011153 273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI---NHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 273 ~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
..+.|+.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.| .--.+.+.+++....+..+||+||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 35668889999999887 5678899998752 2234577788777777 345577888888877888999999987
Q ss_pred CCc--------hh---hhhc-cC------------------CCCCCCHHHHH-----HHHH--------------HHHHH
Q 011153 350 QSL--------LD---NLFV-RQ------------------DVEPLSWEVRY-----KIIL--------------STAEG 380 (492)
Q Consensus 350 gsL--------~~---~l~~-~~------------------~~~~~~~~~~~-----~i~~--------------~i~~~ 380 (492)
+.. .. .++. .. +.-.-+|.... .-.. ++.+.
T Consensus 97 ~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~ 176 (288)
T PF03881_consen 97 GSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVER 176 (288)
T ss_dssp ----CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHH
Confidence 611 00 1122 10 00112332222 1111 11111
Q ss_pred HH-HHhhc-CCCCeEecCCCCCCeeeCCCCcEEEeecCC
Q 011153 381 LA-YLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (492)
Q Consensus 381 l~-yLH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl 417 (492)
+. .|+.. -.|.++|+||-+.|++.+.++.+.|.|-..
T Consensus 177 ~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa~ 215 (288)
T PF03881_consen 177 LPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPAC 215 (288)
T ss_dssp HHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S---
T ss_pred HHHHhcCCCCCceeeEcCccccceeecCCCCceeecccc
Confidence 11 12211 247899999999999999999899988764
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.00034 Score=78.39 Aligned_cols=162 Identities=9% Similarity=-0.020 Sum_probs=115.4
Q ss_pred HHHHHHHHHHhccCcCceeeeeeeee--cCCcceeEEeecCCCCchhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhh
Q 011153 310 DHFFNEVNLISGINHKNLVKLLGCSI--TGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHE 386 (492)
Q Consensus 310 ~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~yLH~ 386 (492)
+....|...+++..|+++.....=.. +..+.+.+++++..|.+.+.+-... +..+++..-......+...+..-+|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 34455666667778999876655333 3446689999999999998885433 33444444444444443555555554
Q ss_pred cC--CCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHH
Q 011153 387 ES--KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464 (492)
Q Consensus 387 ~~--~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~e 464 (492)
.. .--.+|+++|+-|.+|..+.++|+.++|+.++..... .......+++-|+.|+....-.++.++|+|..|+.+++
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchH-hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 32 2346899999999999999999999999998443332 22335567889999998888889999999999999998
Q ss_pred HHhCCCCC
Q 011153 465 VVCRKRIN 472 (492)
Q Consensus 465 lltg~~p~ 472 (492)
.-.|..++
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 87776554
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.021 Score=55.92 Aligned_cols=32 Identities=22% Similarity=0.385 Sum_probs=28.3
Q ss_pred CCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 389 ~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
..+++|+|+.+.|||++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34699999999999999999999999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.033 Score=55.00 Aligned_cols=141 Identities=20% Similarity=0.230 Sum_probs=78.8
Q ss_pred CcccccCcccEEEEEecC----CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCcee-eeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV-KLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~ 349 (492)
+.|..|-...+|+....+ +..|++|+....... .-.-.+|..+++.+..-++. ++++++.. . +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcC
Confidence 345557778899887543 237889987654432 22235788888888655543 45555422 1 58999977
Q ss_pred CCchhh-------h----------hccC-C--CCCCCHHHHHHHHHHH-------------------------HHHHHHH
Q 011153 350 QSLLDN-------L----------FVRQ-D--VEPLSWEVRYKIILST-------------------------AEGLAYL 384 (492)
Q Consensus 350 gsL~~~-------l----------~~~~-~--~~~~~~~~~~~i~~~i-------------------------~~~l~yL 384 (492)
..|... + |... . ..+--|..+.++..++ +..+..+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 665321 1 1111 0 0111233322222111 1111111
Q ss_pred h-h-cCCCCeEecCCCCCCeeeCC-CCcEEEeecCCccc
Q 011153 385 H-E-ESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRL 420 (492)
Q Consensus 385 H-~-~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgl~~~ 420 (492)
. . ....-++|.|+.+.|||+++ ++.++++||..+..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 1 11234799999999999974 57899999998763
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.012 Score=53.99 Aligned_cols=30 Identities=30% Similarity=0.504 Sum_probs=21.4
Q ss_pred CCeEecCCCCCCeee-CCCCcEEEeecCCcc
Q 011153 390 LRIIHRDIKLSNILL-DEEFTAKIADFGLVR 419 (492)
Q Consensus 390 ~~ivH~Dlk~~Nill-~~~~~~kl~Dfgl~~ 419 (492)
..++|+|+.|.|||+ +.++.++++||..+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 358899999999999 889999999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.073 Score=52.55 Aligned_cols=72 Identities=15% Similarity=0.115 Sum_probs=46.7
Q ss_pred cccccCcccEEEEEecCC-CEEEEEEecc-------CChhhHHHHHHHHHHHhccC--cC-ceeeeeeeeecCCcceeEE
Q 011153 276 KLGQGGSGSVYKGTLPGG-EAVAVKRLFY-------NTTQWVDHFFNEVNLISGIN--HK-NLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 276 ~iG~G~fG~Vy~~~~~~~-~~vavK~l~~-------~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 344 (492)
.||.|...-||++..+++ +.|+||.-.. .-+-..++...|.+.|+... -| .+.+++. .++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 479999999999998754 6899997531 11223345556777776652 24 3444543 3556667999
Q ss_pred eecCC
Q 011153 345 EFVPN 349 (492)
Q Consensus 345 e~~~~ 349 (492)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99865
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.12 Score=50.66 Aligned_cols=136 Identities=20% Similarity=0.292 Sum_probs=78.9
Q ss_pred CcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCc---Cc---eeeeee----eeecCCcceeEEeecCCC
Q 011153 281 GSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH---KN---LVKLLG----CSITGPESLLVYEFVPNQ 350 (492)
Q Consensus 281 ~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~n---iv~l~~----~~~~~~~~~lv~e~~~~g 350 (492)
.-..+|+....+|+. ++|..+.. ....+...|+..|..+.- += |..+=| ....+...+.+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 456789988887776 88877665 234556667777766631 11 121111 112223667899999998
Q ss_pred Cchh-hh--------------hc--------c-CCCCCCCHHH-------------HHHHHHHHHHHHHHHhhcC----C
Q 011153 351 SLLD-NL--------------FV--------R-QDVEPLSWEV-------------RYKIILSTAEGLAYLHEES----K 389 (492)
Q Consensus 351 sL~~-~l--------------~~--------~-~~~~~~~~~~-------------~~~i~~~i~~~l~yLH~~~----~ 389 (492)
.+.. .. +. + .......|.. -.....++...+..+.+.- .
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8873 11 00 0 0011233320 0012233344444444331 1
Q ss_pred ---CCeEecCCCCCCeeeCCCCc-EEEeecCCcc
Q 011153 390 ---LRIIHRDIKLSNILLDEEFT-AKIADFGLVR 419 (492)
Q Consensus 390 ---~~ivH~Dlk~~Nill~~~~~-~kl~Dfgl~~ 419 (492)
..+||+|+.|.||+++.+.. +.++||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 22999999999999999885 8899999765
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.12 Score=52.06 Aligned_cols=73 Identities=10% Similarity=0.128 Sum_probs=49.2
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccC----Ch---hhHHHHHHHHHHHhccC---cCceeeeeeeeecCCcceeE
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN----TT---QWVDHFFNEVNLISGIN---HKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~----~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 343 (492)
.+.||.|....||+.... ++.++||+-... .. -...+-..|.+.|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 557899999999998864 557889976411 11 12334445566665553 347777887766 557889
Q ss_pred EeecCC
Q 011153 344 YEFVPN 349 (492)
Q Consensus 344 ~e~~~~ 349 (492)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.1 Score=50.88 Aligned_cols=29 Identities=28% Similarity=0.407 Sum_probs=25.3
Q ss_pred CCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 390 ~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 56999999999999987 578999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.05 Score=53.16 Aligned_cols=139 Identities=17% Similarity=0.155 Sum_probs=91.2
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccC-----Ch--------------------hhHH-HHHHHHHHHhccCcCce
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN-----TT--------------------QWVD-HFFNEVNLISGINHKNL 327 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~-----~~--------------------~~~~-~~~~E~~~l~~l~h~ni 327 (492)
-..|..|.-..||.+.-.+|..+|||+++.. +. ..++ ....|++-|.++....|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4467889999999999999999999987532 10 1111 13456666666654333
Q ss_pred eeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC
Q 011153 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE 407 (492)
Q Consensus 328 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~ 407 (492)
....-+. -..-.|||+|+....-. .-.-+...++...+..+-.+++.-|.-|-+.. ++||.||.-=|+|+- +
T Consensus 229 P~PePIl--Lk~hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 229 PCPEPIL--LKNHVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCCcee--eecceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-C
Confidence 2111111 12336899998532211 11123345777778888888888888887765 599999999998874 5
Q ss_pred CcEEEeecCCccc
Q 011153 408 FTAKIADFGLVRL 420 (492)
Q Consensus 408 ~~~kl~Dfgl~~~ 420 (492)
|.+.|+|.+-+..
T Consensus 301 G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 GKLYIIDVSQSVE 313 (520)
T ss_pred CEEEEEEcccccc
Confidence 6899999887653
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.19 Score=49.57 Aligned_cols=94 Identities=11% Similarity=-0.009 Sum_probs=51.9
Q ss_pred ccCHHHHHHHhcccccC---C-cccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcC--ceeeee
Q 011153 258 NFSYETLEKATNYFHES---N-KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK--NLVKLL 331 (492)
Q Consensus 258 ~~~~~~l~~~~~~~~~~---~-~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~ 331 (492)
.++.+.+..+-..+... + ..=.+.-..||+....++..+++|..+... ........|++.+..+... .++...
T Consensus 10 ~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~ 88 (325)
T PRK11768 10 TLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPL 88 (325)
T ss_pred CCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCc
Confidence 44555555554444221 1 111234567999988888889999875332 2344566777777666321 122211
Q ss_pred ---e--eeecCCcceeEEeecCCCCc
Q 011153 332 ---G--CSITGPESLLVYEFVPNQSL 352 (492)
Q Consensus 332 ---~--~~~~~~~~~lv~e~~~~gsL 352 (492)
| ....++..+.++++++|...
T Consensus 89 ~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 89 AFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 1 12224456789999987654
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.066 Score=53.05 Aligned_cols=61 Identities=16% Similarity=0.171 Sum_probs=38.5
Q ss_pred cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD 405 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~ 405 (492)
...|+=+|+++-++..++.. ...+++...+++.-.+.++.-+--.. .++|.|++|.||++.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~----~~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW----KSQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhc----ccChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence 33566677778777766632 22344455566665566654333222 299999999999994
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.078 Score=53.00 Aligned_cols=74 Identities=14% Similarity=0.041 Sum_probs=48.4
Q ss_pred CCcccccCcccEEEEEecC-CCEEEEEEecc---CC---hhhHHHHHHHHHHHhccC--cC-ceeeeeeeeecCCcceeE
Q 011153 274 SNKLGQGGSGSVYKGTLPG-GEAVAVKRLFY---NT---TQWVDHFFNEVNLISGIN--HK-NLVKLLGCSITGPESLLV 343 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~---~~---~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv 343 (492)
.+.||.|.-.-||++...+ ++.|+||.-.. .. +-..++...|.+.|+... -| .+.+++. .++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 4578999999999999753 57899996421 11 223455666777777652 34 3445554 355566788
Q ss_pred EeecCC
Q 011153 344 YEFVPN 349 (492)
Q Consensus 344 ~e~~~~ 349 (492)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888854
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.38 Score=44.16 Aligned_cols=76 Identities=18% Similarity=0.277 Sum_probs=50.9
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhcc---CcCceeeeeeeeecCCcceeEEeecCCC
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI---NHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (492)
.+.+.-|.--..|... .+...+.||+- ..+....|..|+.-|..+ +--++.+.+....+....++|+||++-+
T Consensus 21 r~~v~gG~inea~~v~-dg~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 21 REEVSGGDINEAWRLR-DGTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred ccccCCccccceeEee-cCCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 3444444434444333 23567888864 334456677777766555 4466888888888999999999999987
Q ss_pred Cch
Q 011153 351 SLL 353 (492)
Q Consensus 351 sL~ 353 (492)
.+.
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 775
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.069 Score=48.54 Aligned_cols=115 Identities=17% Similarity=0.166 Sum_probs=69.3
Q ss_pred CcccEEEEEecCCCEEEEEEeccCChh-hHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCCchhhhhcc
Q 011153 281 GSGSVYKGTLPGGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVR 359 (492)
Q Consensus 281 ~fG~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~ 359 (492)
+-.+.-++.-+-| ...+|++..-.-. ...-|..+.+++.++. .|+++..= ..-..-++.|.|-....
T Consensus 74 gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------- 141 (308)
T PF07387_consen 74 GNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------- 141 (308)
T ss_pred CceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------
Confidence 3444444443323 3455655433222 2345677878877764 56666621 22234488888733111
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCC
Q 011153 360 QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (492)
Q Consensus 360 ~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl 417 (492)
. ...++.-=+..|.-.|+.+ ...+|+|-.|+||+-|..|.+||.|-+.
T Consensus 142 -----~----~~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 -----N----FSNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred -----c----hhHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 0 0122222256788889654 5699999999999999999999999875
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.29 Score=55.83 Aligned_cols=141 Identities=16% Similarity=0.206 Sum_probs=76.7
Q ss_pred CcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhcc-------CcCceeeeee-----eeec-CC--c
Q 011153 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-------NHKNLVKLLG-----CSIT-GP--E 339 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-------~h~niv~l~~-----~~~~-~~--~ 339 (492)
+.|+ |..-.+|+....+++.+++|+.+..... .....|...|..| .-|.+++-.+ .... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3453 4567889988888889999998754322 2333344454433 2334443321 1111 12 3
Q ss_pred ceeEEeecCCCCchhhh-------h----------c------c-CCCCCCCHHH-----------------HHHHHHHHH
Q 011153 340 SLLVYEFVPNQSLLDNL-------F----------V------R-QDVEPLSWEV-----------------RYKIILSTA 378 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l-------~----------~------~-~~~~~~~~~~-----------------~~~i~~~i~ 378 (492)
.+.+++|++|..+.+.. . . . .....+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 46789999997775410 0 0 0 0011222321 112222333
Q ss_pred HHHH-----HHhhcCCCCeEecCCCCCCeeeCCCC--cEE-EeecCCcc
Q 011153 379 EGLA-----YLHEESKLRIIHRDIKLSNILLDEEF--TAK-IADFGLVR 419 (492)
Q Consensus 379 ~~l~-----yLH~~~~~~ivH~Dlk~~Nill~~~~--~~k-l~Dfgl~~ 419 (492)
.... .+.+ -...+||+|+.+.|||++.+. ++. |+|||-+.
T Consensus 188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 2222 1222 234599999999999999875 555 99999765
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.17 Score=50.96 Aligned_cols=74 Identities=22% Similarity=0.279 Sum_probs=44.5
Q ss_pred CcccccCcccEEEEEecCC--CE-----EEEEEeccCChhhHHHHHHHHHHHhccCcCcee-eeeeeeecCCcceeEEee
Q 011153 275 NKLGQGGSGSVYKGTLPGG--EA-----VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV-KLLGCSITGPESLLVYEF 346 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~~--~~-----vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~ 346 (492)
+.|..|-...+|+....++ .. |.++...... +..-.-.+|+++++.+...++. ++++.+. ..+++||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence 4555688889999876543 22 4444322211 1112235688999999665554 4555443 2699999
Q ss_pred cCCCCch
Q 011153 347 VPNQSLL 353 (492)
Q Consensus 347 ~~~gsL~ 353 (492)
+++.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 492 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-45 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-45 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-37 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-36 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-20 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-20 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-20 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-20 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-20 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-20 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-20 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-05 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 9e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-05 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 341 bits (876), Expect = e-115
Identities = 100/234 (42%), Positives = 141/234 (60%), Gaps = 4/234 (1%)
Query: 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDH-FFNEVN 317
FS L+ A++ F N LG+GG G VYKG L G VAVKRL TQ + F EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSWEVRYKIILS 376
+IS H+NL++L G +T E LLVY ++ N S+ L + PL W R +I L
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
+A GLAYLH+ +IIHRD+K +NILLDEEF A + DFGL +L TH++ + GT+
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVILLTW 490
G++APEY+ GK +EK DV+ +GV+++E++ +R + + V+LL W
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND--DDVMLLDW 251
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-105
Identities = 98/223 (43%), Positives = 133/223 (59%), Gaps = 16/223 (7%)
Query: 259 FSYETLEKATNYFHE------SNKLGQGGSGSVYKGTLPGGEAVAVKRL----FYNTTQW 308
FS+ L+ TN F E NK+G+GG G VYKG + VAVK+L T +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEEL 73
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
F E+ +++ H+NLV+LLG S G + LVY ++PN SLLD L PLSW
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITH 427
+R KI A G+ +LHE IHRDIK +NILLDE FTAKI+DFGL R + T
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
+++ + GT YMAPE +RG++T K+D+YSFGVV++E++
Sbjct: 191 MTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLP 232
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 314 bits (808), Expect = e-105
Identities = 95/225 (42%), Positives = 130/225 (57%), Gaps = 6/225 (2%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD 310
V LE+ATN F +G G G VYKG L G VA+KR ++Q ++
Sbjct: 21 LVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE 80
Query: 311 HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSWEV 369
F E+ +S H +LV L+G E +L+Y+++ N +L +L+ +SWE
Sbjct: 81 EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHI 428
R +I + A GL YLH + IIHRD+K NILLDE F KI DFG+ + E D TH+
Sbjct: 141 RLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197
Query: 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRIN 472
S + GTLGY+ PEY ++G+LTEK+DVYSFGVV+ EV+C R I
Sbjct: 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 240 bits (613), Expect = 9e-76
Identities = 70/234 (29%), Positives = 97/234 (41%), Gaps = 25/234 (10%)
Query: 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ-WVDHFF 313
S ++ E L + +G G V+K E VAVK Q W
Sbjct: 10 SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW--QNE 66
Query: 314 NEVNLISGINHKNLVKLLGCSITGP----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEV 369
EV + G+ H+N+++ +G G + L+ F SL D L +SW
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNE 122
Query: 370 RYKIILSTAEGLAYLHEE-------SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422
I + A GLAYLHE+ K I HRDIK N+LL TA IADFGL F
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 423 EDITHISAT-LAGTLGYMAPEYV-----VRGKLTEKADVYSFGVVVIEVVCRKR 470
+ GT YMAPE + + + D+Y+ G+V+ E+ R
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 3e-62
Identities = 62/248 (25%), Positives = 99/248 (39%), Gaps = 35/248 (14%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
+ + + +G+G G+VYKG+L VAVK + +F NE
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEK 56
Query: 317 N--LISGINHKNLVKLLGCSITGPES-----LLVYEFVPNQSLLDNLFVRQDVEPLSWEV 369
N + + H N+ + + LLV E+ PN SL L + W
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVS 112
Query: 370 RYKIILSTAEGLAYLHEE------SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-- 421
++ S GLAYLH E K I HRD+ N+L+ + T I+DFGL
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 422 -----PEDITHISATLAGTLGYMAPEY-------VVRGKLTEKADVYSFGVVVIEVVCRK 469
P + + + + GT+ YMAPE ++ D+Y+ G++ E+ R
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 470 RINLFTQN 477
++
Sbjct: 233 TDLFPGES 240
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 3e-61
Identities = 69/199 (34%), Positives = 106/199 (53%), Gaps = 9/199 (4%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLG 332
K+G G G+V++ G VAVK L + V+ F EV ++ + H N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
P +V E++ SL L E L R + A+G+ YLH I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPI 160
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGTLGYMAPEYVVRGKL-T 450
+HR++K N+L+D+++T K+ DFGL RL + T +S+ AGT +MAPE V+R +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPE-VLRDEPSN 217
Query: 451 EKADVYSFGVVVIEVVCRK 469
EK+DVYSFGV++ E+ +
Sbjct: 218 EKSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-57
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G+G G V K + VA+K++ + F E+ +S +NH N+VKL
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKL 66
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G P L V E+ SL + L + + + L ++G+AYLH
Sbjct: 67 YGAC-LNPVCL-VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 391 RIIHRDIKLSNILLDEEFT-AKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
+IHRD+K N+LL T KI DFG DI G+ +MAPE V G
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPE-VFEGSN 179
Query: 450 -TEKADVYSFGVVVIEVVCRKR 470
+EK DV+S+G+++ EV+ R++
Sbjct: 180 YSEKCDVFSWGIILWEVITRRK 201
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 4e-56
Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 26/212 (12%)
Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVKRLFY-------NTTQWVDHFFNEVNLISGINHKN 326
++G+GG G V+KG L VA+K L + F EV ++S +NH N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
+VKL G P +V EFVP L L P+ W V+ +++L A G+ Y+
Sbjct: 85 IVKLYGLMHNPP--RMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 387 ESKLRIIHRDIKLSNILLDE-----EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
+ I+HRD++ NI L AK+ADFGL + ++ L G +MAP
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS----GLLGNFQWMAP 195
Query: 442 EYVVRGKL---TEKADVYSFGVVVIEVVCRKR 470
E + + TEKAD YSF +++ ++ +
Sbjct: 196 E-TIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 5e-55
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G GG G VY+ G+ VAVK + +Q +++ E L + + H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G + P LV EF L L ++ + ++ + A G+ YLH+E+ +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 391 RIIHRDIKLSNILLDEEF--------TAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
IIHRD+K SNIL+ ++ KI DFGL R + + AG +MAPE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPE 184
Query: 443 YVVRGKL-TEKADVYSFGVVVIEVVCRK 469
V+R + ++ +DV+S+GV++ E++ +
Sbjct: 185 -VIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 7e-55
Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLG 332
KL + SG ++KG G + VK L +T+ F E + +H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 333 CSITGPESLL--VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
+ P + ++P SL + L + K L A G+A+LH L
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK-- 448
I + ++++DE+ TA+I+ + F ++APE ++ K
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSFQSP------GRMYAPAWVAPE-ALQKKPE 185
Query: 449 --LTEKADVYSFGVVVIEVVCRK 469
AD++SF V++ E+V R+
Sbjct: 186 DTNRRSADMWSFAVLLWELVTRE 208
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-54
Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 30/219 (13%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNE--VNLISGINHKNLVKLLG 332
+G+G G V++G+ GE VAVK ++ +F E + + H+N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 333 CSITGPES----LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE- 387
+T S L+ + SL D L + L +I+LS A GLA+LH E
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 388 ----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMA 440
K I HRD+K NIL+ + IAD GL + + + GT YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 441 PEYVVRGKL-------TEKADVYSFGVVVIEVVCRKRIN 472
PE V+ + ++ D+++FG+V+ EV R N
Sbjct: 186 PE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-54
Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 19/210 (9%)
Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
LG+G G K T GE + +K L + F EV ++ + H N++K +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
+ E++ +L ++ W R A G+AYLH + II
Sbjct: 76 LYKDKRLNFITEYIKGGTLRG--IIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNII 130
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA-------------TLAGTLGYMA 440
HRD+ N L+ E +ADFGL RL ++ T T+ G +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
PE + EK DV+SFG+V+ E++ R
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 1e-53
Identities = 68/219 (31%), Positives = 98/219 (44%), Gaps = 30/219 (13%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNE--VNLISGINHKNLVKLLG 332
++G+G G V+ G GE VAVK F T +F E + + H+N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 333 CSITGPES----LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE- 387
I G S L+ ++ N SL D +++ L + K+ S+ GL +LH E
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYD--YLKS--TTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 388 ----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI---SATLAGTLGYMA 440
K I HRD+K NIL+ + T IAD GL F D + T GT YM
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 441 PEYVVRGKL-------TEKADVYSFGVVVIEVVCRKRIN 472
PE V+ L AD+YSFG+++ EV R
Sbjct: 215 PE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 5e-53
Identities = 66/219 (30%), Positives = 100/219 (45%), Gaps = 30/219 (13%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNE--VNLISGINHKNLVKLLG 332
+G+G G V++G GE VAVK ++ +F E + + H+N++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 333 CSI----TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE- 387
T + LV ++ + SL D L + ++ E K+ LSTA GLA+LH E
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 388 ----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTLGYMA 440
K I HRD+K NIL+ + T IAD GL + I GT YMA
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 441 PEYVVRGKL-------TEKADVYSFGVVVIEVVCRKRIN 472
PE V+ + ++AD+Y+ G+V E+ R I
Sbjct: 220 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 6e-51
Identities = 68/202 (33%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
++G G G+VYKG G VAVK L T Q + F NEV ++ H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
S T P+ +V ++ SL + + I TA G+ YLH +S I
Sbjct: 88 YS-TAPQLAIVTQWCEGSSLYH--HLHASETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGTLGYMAPEYVVRGKL-- 449
IHRD+K +NI L E+ T KI DFGL L+G++ +MAPE V+R +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSN 200
Query: 450 --TEKADVYSFGVVVIEVVCRK 469
+ ++DVY+FG+V+ E++ +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-48
Identities = 48/211 (22%), Positives = 85/211 (40%), Gaps = 25/211 (11%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
+G+G G VY G G VA++ + + + F EV H+N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
++ P ++ ++L VR L +I +G+ YLH + I
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYS--VVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---I 151
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRL----FPEDITHISATLAGTLGYMAPEYVVRGK 448
+H+D+K N+ D I DFGL + G L ++APE ++R
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE-IIRQL 209
Query: 449 L----------TEKADVYSFGVVVIEVVCRK 469
++ +DV++ G + E+ R+
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-40
Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 270 YFHESNKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKN 326
+ ++G+G +VYKG VA + T F E ++ G+ H N
Sbjct: 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86
Query: 327 LVKLLGC---SITGPESLLVY-EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
+V+ ++ G + +++ E + + +L + + + +V +GL
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKT---YLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
+LH + IIHRD+K NI + + KI D GL L + GT +MAP
Sbjct: 144 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAP 199
Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCRK 469
E + K E DVY+FG+ ++E+ +
Sbjct: 200 E-MYEEKYDESVDVYAFGMCMLEMATSE 226
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 276 KLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLG- 332
++G+G G V+ G L VAVK F E ++ +H N+V+L+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
C+ P +V E V L F+R + L + +++ A G+ YL +
Sbjct: 181 CTQKQP-IYIVMELVQGGDFLT--FLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CC 234
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY--MAPEYVVRGKLT 450
IHRD+ N L+ E+ KI+DFG+ R + + + ++ + APE + G+ +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGV-YAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 451 EKADVYSFGVVVIEVV 466
++DV+SFG+++ E
Sbjct: 294 SESDVWSFGILLWETF 309
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 275 NKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
++LG+G GSV G VAVK+L ++ F E+ ++ ++ +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
G G +SL LV E++P+ L D F+++ L +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYL--G 144
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVV 445
S+ R +HRD+ NIL++ E KIADFGL +L P D + G + APE +
Sbjct: 145 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 446 RGKLTEKADVYSFGVVVIEVV 466
+ ++DV+SFGVV+ E+
Sbjct: 204 DNIFSRQSDVWSFGVVLYELF 224
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 14/201 (6%)
Query: 275 NKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G GSV GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
G C G +L L+ E++P SL D ++++ E + + +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYL--G 131
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVV 445
+K R IHRD+ NIL++ E KI DFGL ++ P+D G + APE +
Sbjct: 132 TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 446 RGKLTEKADVYSFGVVVIEVV 466
K + +DV+SFGVV+ E+
Sbjct: 191 ESKFSVASDVWSFGVVLYELF 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 65/201 (32%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 275 NKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G GSV GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
G C G +L L+ E++P SL D ++++ E + + +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYL--G 162
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVV 445
+K R IHRD+ NIL++ E KI DFGL ++ P+D + G + APE +
Sbjct: 163 TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 446 RGKLTEKADVYSFGVVVIEVV 466
K + +DV+SFGVV+ E+
Sbjct: 222 ESKFSVASDVWSFGVVLYELF 242
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-39
Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
LG+G G VY G L +A+K + +++ E+ L + HKN+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 336 TGPESLLVYEFVPNQSLLDNLFVR----QDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
+ E VP SL L + +D E + EGL YLH+ +
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT---IG-FYTKQILEGLKYLHDN---Q 142
Query: 392 IIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL- 449
I+HRDIK N+L++ KI+DFG + I + T GTL YMAPE ++
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPE-IIDKGPR 200
Query: 450 --TEKADVYSFGVVVIE 464
+ AD++S G +IE
Sbjct: 201 GYGKAADIWSLGCTIIE 217
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 269 NYFHESNKLGQGGSGSVYKGTLPG-----GEAVAVKRL--FYNTTQWVDHFFNEVNLISG 321
+ LG+G G V GE VAVK L D E+ ++
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRN 79
Query: 322 INHKNLVKLLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
+ H+N+VK G C+ G + L+ EF+P+ SL + ++ ++ ++ + + K + +
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE--YLPKNKNKINLKQQLKYAVQICK 137
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--G 437
G+ YL S+ + +HRD+ N+L++ E KI DFGL + D + +
Sbjct: 138 GMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194
Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+ APE +++ K +DV+SFGV + E++
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELL 223
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-38
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGE----AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKN 326
H +G+G G VY G A+K L T Q V+ F E L+ G+NH N
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
++ L+G ++ ++ + LL F+R + + L A G+ YL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQ--FIRSPQRNPTVKDLISFGLQVARGMEYL- 140
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTL--GYMAPE 442
+ + +HRD+ N +LDE FT K+ADFGL R + + + L + A E
Sbjct: 141 -AEQ-KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 443 YVVRGKLTEKADVYSFGVVVIEVV 466
+ + T K+DV+SFGV++ E++
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELL 222
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-38
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEA---VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLV 328
LG G G+VYKG G + VA+K L T+ +E +++ +++ ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
+LLG L+ + +P LLD +VR+ + + + + A+G+ YL E
Sbjct: 81 RLLGI-CLTSTVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL--ED 135
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT---LGYMAPEYVV 445
+ R++HRD+ N+L+ KI DFGL +L + A G + +MA E ++
Sbjct: 136 R-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESIL 192
Query: 446 RGKLTEKADVYSFGVVVIEVV 466
T ++DV+S+GV V E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 275 NKLGQGGSGSVYKGTLPG-----GEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
LG+G G V GE VAVK L Q + E++++ + H++++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 329 KLLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
K G C G SL LV E+VP SL D ++ + L+ + + EG+AYLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLF--AQQICEGMAYLHA 152
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYV 444
IHRD+ N+LLD + KI DFGL + PE + G + APE +
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 445 VRGKLTEKADVYSFGVVVIEVV 466
K +DV+SFGV + E++
Sbjct: 210 KEYKFYYASDVWSFGVTLYELL 231
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 54/196 (27%), Positives = 99/196 (50%), Gaps = 14/196 (7%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-C 333
+LG G G V G G VA+K + + D F E ++ ++H+ LV+L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
+ P ++ E++ N LL+ ++R+ + ++ E + YL ESK + +
Sbjct: 89 TKQRP-IFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAMEYL--ESK-QFL 142
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL---GYMAPEYVVRGKLT 450
HRD+ N L++++ K++DFGL R +D S G+ + PE ++ K +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS---VGSKFPVRWSPPEVLMYSKFS 199
Query: 451 EKADVYSFGVVVIEVV 466
K+D+++FGV++ E+
Sbjct: 200 SKSDIWAFGVLMWEIY 215
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 63/195 (32%), Positives = 96/195 (49%), Gaps = 14/195 (7%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-CS 334
+LG G G V G G VAVK + + D FF E + ++H LVK G CS
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
P +V E++ N LL+ ++R + L ++ EG+A+L ES + IH
Sbjct: 74 KEYP-IYIVTEYISNGCLLN--YLRSHGKGLEPSQLLEMCYDVCEGMAFL--ESH-QFIH 127
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL---GYMAPEYVVRGKLTE 451
RD+ N L+D + K++DFG+ R +D S GT + APE K +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS---VGTKFPVKWSAPEVFHYFKYSS 184
Query: 452 KADVYSFGVVVIEVV 466
K+DV++FG+++ EV
Sbjct: 185 KSDVWAFGILMWEVF 199
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 65/194 (33%), Positives = 100/194 (51%), Gaps = 8/194 (4%)
Query: 275 NKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+KLG G G VY+G VAVK L +T + V+ F E ++ I H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
P ++ EF+ +LLD ++R+ + + +S V + + + YL E K
Sbjct: 285 CTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL--EKK-NF 339
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
IHR++ N L+ E K+ADFGL RL D A + + APE + K + K
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 453 ADVYSFGVVVIEVV 466
+DV++FGV++ E+
Sbjct: 400 SDVWAFGVLLWEIA 413
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-37
Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 14/196 (7%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-C 333
++G G G V+ G + VA+K + + F E ++ ++H LV+L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
P LV EF+ + L D ++R + E + L EG+AYL E +I
Sbjct: 73 LEQAP-ICLVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYL--EEA-CVI 126
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL---GYMAPEYVVRGKLT 450
HRD+ N L+ E K++DFG+ R +D S GT + +PE + +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS---TGTKFPVKWASPEVFSFSRYS 183
Query: 451 EKADVYSFGVVVIEVV 466
K+DV+SFGV++ EV
Sbjct: 184 SKSDVWSFGVLMWEVF 199
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-37
Identities = 54/235 (22%), Positives = 94/235 (40%), Gaps = 19/235 (8%)
Query: 237 QKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEA 295
+ +R + + + KL + ++ ++G+G G V++ G
Sbjct: 26 KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ 85
Query: 296 VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDN 355
AVK++ + E+ +G++ +V L G GP + E + SL
Sbjct: 86 CAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQL 140
Query: 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIAD 414
+ + + L + + EGL YLH RI+H D+K N+LL + A + D
Sbjct: 141 I---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCD 194
Query: 415 FG----LVRLFPEDITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIE 464
FG L + GT +MAPE VV GK K D++S +++
Sbjct: 195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKVDIWSSCCMMLH 248
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-37
Identities = 50/235 (21%), Positives = 93/235 (39%), Gaps = 24/235 (10%)
Query: 254 KSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHF 312
+ L F + ++ KLG+GG V L G A+KR+ + Q +
Sbjct: 14 RENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEA 73
Query: 313 FNEVNLISGINHKNLVKLLGCSITGPES----LLVYEFVPNQSLLDNLFVR-QDVEPLS- 366
E ++ NH N+++L+ + + L+ F +L + + L+
Sbjct: 74 QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133
Query: 367 WEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426
++ ++L GL +H HRD+K +NILL +E + D G + +
Sbjct: 134 DQIL-WLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189
Query: 427 HIS--------ATLAGTLGYMAPEYVVRGK----LTEKADVYSFGVVVIEVVCRK 469
A T+ Y APE + + + E+ DV+S G V+ ++ +
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 48/218 (22%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKR--LFYNTTQWVDHFFNEVNLISGINHKNL- 327
+ ++G GGS V++ + A+K L Q +D + NE+ ++ + +
Sbjct: 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 328 -VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKI--ILSTAEGLAY 383
++L IT +V E N L L + + + WE + +L +
Sbjct: 118 IIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLE---AVHT 170
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA-TLAGTLGYMAPE 442
+H+ I+H D+K +N L+ + K+ DFG+ D T + + G + YM PE
Sbjct: 171 IHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 443 -----------YVVRGKLTEKADVYSFGVVVIEVVCRK 469
+ K++ K+DV+S G ++ + K
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 3e-36
Identities = 61/193 (31%), Positives = 98/193 (50%), Gaps = 8/193 (4%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV- 330
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
++ +V E++ SLLD F++ + L + A G+AY+ E +
Sbjct: 331 VSEEPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYV--ERM-NYV 385
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
HRD++ +NIL+ E K+ADFGL RL ++ + + APE + G+ T K+
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 454 DVYSFGVVVIEVV 466
DV+SFG+++ E+
Sbjct: 446 DVWSFGILLTELT 458
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 51/238 (21%), Positives = 99/238 (41%), Gaps = 26/238 (10%)
Query: 249 QVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKR--LFYNTT 306
V+ N ++++ + ++G GGS V++ + A+K L
Sbjct: 8 SSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN 67
Query: 307 QWVDHFFNEVNLISGINHKNL--VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
Q +D + NE+ ++ + + ++L IT +V E N L L + +
Sbjct: 68 QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKS 123
Query: 365 LS-WEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
+ WE + + E + +H+ I+H D+K +N L+ + K+ DFG+
Sbjct: 124 IDPWERKS-YWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQP 178
Query: 424 DITHISA-TLAGTLGYMAPE-----------YVVRGKLTEKADVYSFGVVVIEVVCRK 469
D T + + GT+ YM PE + K++ K+DV+S G ++ + K
Sbjct: 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 276 KLGQGGSGSVYKGTLPGGEA---VAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKL 330
+LG G G+V KG + VAVK L D E N++ +++ +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 331 LG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
+G C +LV E L +++Q+ + + +++ + G+ YL E
Sbjct: 84 IGIC--EAESWMLVMEMAELGPLNK--YLQQN-RHVKDKNIIELVHQVSMGMKYL--EES 136
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVVRG 447
+HRD+ N+LL + AKI+DFGL + D + A G + APE +
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 448 KLTEKADVYSFGVVVIEVV 466
K + K+DV+SFGV++ E
Sbjct: 196 KFSSKSDVWSFGVLMWEAF 214
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-36
Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 14/196 (7%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V+ G G VAVK L + D F E NL+ + H+ LV+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
+T ++ E++ N SL+D F++ L+ + AEG+A++ E + I
Sbjct: 77 VTQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI--EER-NYI 131
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL---GYMAPEYVVRGKLT 450
HRD++ +NIL+ + + KIADFGL RL ++ G + APE + G T
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR---EGAKFPIKWTAPEAINYGTFT 188
Query: 451 EKADVYSFGVVVIEVV 466
K+DV+SFG+++ E+V
Sbjct: 189 IKSDVWSFGILLTEIV 204
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 12/197 (6%)
Query: 276 KLGQGGSGSVYKGTLPGGE---AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLL 331
+LG G GSV +G + VA+K L T + E ++ +++ +V+L+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
G +LV E L F+ E + +++ + G+ YL E K
Sbjct: 77 GV-CQAEALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYL--EEK-N 130
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVVRGKL 449
+HRD+ N+LL AKI+DFGL + D ++ +A AG + APE + K
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 450 TEKADVYSFGVVVIEVV 466
+ ++DV+S+GV + E +
Sbjct: 191 SSRSDVWSYGVTMWEAL 207
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 46/224 (20%), Positives = 94/224 (41%), Gaps = 14/224 (6%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN--TTQ 307
V+ N ++++EK + K+G+G G G +K + + +++
Sbjct: 10 GVDLGTENLYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSW 367
+ EV +++ + H N+V+ +V ++ L Q
Sbjct: 66 EREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDL-FKRINAQKGVLFQE 124
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
+ + L ++H+ +I+HRDIK NI L ++ T ++ DFG+ R+
Sbjct: 125 DQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VE 180
Query: 428 ISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKR 470
++ GT Y++PE + K K+D+++ G V+ E+ K
Sbjct: 181 LARACIGTPYYLSPE-ICENKPYNNKSDIWALGCVLYELCTLKH 223
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 49/216 (22%), Positives = 92/216 (42%), Gaps = 26/216 (12%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKR--LFYNTTQWVDHFFNEVNLISGINHKNL- 327
+ ++G GGS V++ + A+K L Q +D + NE+ ++ + +
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 328 -VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKIILSTAEGLAYLH 385
++L IT +V E N L L + + + WE + + E + +H
Sbjct: 71 IIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKS-YWKNMLEAVHTIH 125
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA-TLAGTLGYMAPE-- 442
+ I+H D+K +N L+ + K+ DFG+ D T + + GT+ YM PE
Sbjct: 126 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 443 ---------YVVRGKLTEKADVYSFGVVVIEVVCRK 469
+ K++ K+DV+S G ++ + K
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-36
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEA---VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLV 328
LG G G+VYKG G + VA+K L T+ +E +++ +++ ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
+LLG L+ + +P LLD +VR+ + + + + A+G+ YL E
Sbjct: 81 RLLGI-CLTSTVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL--ED 135
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT---LGYMAPEYVV 445
+ R++HRD+ N+L+ KI DFGL +L + A G + +MA E ++
Sbjct: 136 R-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESIL 192
Query: 446 RGKLTEKADVYSFGVVVIEVV 466
T ++DV+S+GV V E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 61/193 (31%), Positives = 98/193 (50%), Gaps = 8/193 (4%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV- 247
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
++ +V E++ SLLD F++ + L + A G+AY+ E +
Sbjct: 248 VSEEPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYV--ERM-NYV 302
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
HRD++ +NIL+ E K+ADFGL RL ++ + + APE + G+ T K+
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 454 DVYSFGVVVIEVV 466
DV+SFG+++ E+
Sbjct: 363 DVWSFGILLTELT 375
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 275 NKLGQGGSGSVYKGTLPGGE----AVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
+G+G G VY GTL + AVK L + + F E ++ +H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVL 89
Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
LLG C + L+V ++ + L + F+R + + + L A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL--A 145
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL--GYMAPEYV 444
SK + +HRD+ N +LDE+FT K+ADFGL R ++ ++ + L +MA E +
Sbjct: 146 SK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 445 VRGKLTEKADVYSFGVVVIEVV 466
K T K+DV+SFGV++ E++
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELM 226
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEA---VAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
LG G G+V+KG G V +K + + Q + + I ++H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
+LLG G LV +++P SLLD VRQ L ++ + A+G+ YL E
Sbjct: 79 RLLGL-CPGSSLQLVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMYYL--EE 133
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT-LGYMAPEYVVRG 447
++HR++ N+LL ++ADFG+ L P D + + A T + +MA E + G
Sbjct: 134 H-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 448 KLTEKADVYSFGVVVIEVV 466
K T ++DV+S+GV V E++
Sbjct: 193 KYTHQSDVWSYGVTVWELM 211
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 66/196 (33%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 275 NKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+KLG G G VY+G VAVK L +T + V+ F E ++ I H NLV+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
P ++ EF+ +LLD ++R+ + + +S V + + + YL E K
Sbjct: 78 CTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL--EKK-NF 132
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY--MAPEYVVRGKLT 450
IHRD+ N L+ E K+ADFGL RL D +A APE + K +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFS 190
Query: 451 EKADVYSFGVVVIEVV 466
K+DV++FGV++ E+
Sbjct: 191 IKSDVWAFGVLLWEIA 206
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-35
Identities = 66/201 (32%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 276 KLGQGGSGSVYKGTL--PGGEA--VAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLV 328
KLG G G V +G P G+ VAVK L + + +D F EVN + ++H+NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
+L G P +V E P SLLD +R+ + + AEG+ YL E
Sbjct: 85 RLYGVV--LTPPMKMVTELAPLGSLLD--RLRKHQGHFLLGTLSRYAVQVAEGMGYL--E 138
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY--MAPEYVV 445
SK R IHRD+ N+LL KI DFGL+R P++ H + + APE +
Sbjct: 139 SK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 446 RGKLTEKADVYSFGVVVIEVV 466
+ +D + FGV + E+
Sbjct: 198 TRTFSHASDTWMFGVTLWEMF 218
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 276 KLGQGGSGSVYKGTL--PGGEA---VAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLV 328
+G G G VYKG L G+ VA+K L T Q VD F E ++ +H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNII 109
Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
+L G S P +++ E++ N +L F+R+ S ++ A G+ YL
Sbjct: 110 RLEGVISKYKP-MMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKYL--A 164
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY--MAPEYVV 445
+ +HRD+ NIL++ K++DFGL R+ +D T G + APE +
Sbjct: 165 NM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 446 RGKLTEKADVYSFGVVVIEVV 466
K T +DV+SFG+V+ EV+
Sbjct: 224 YRKFTSASDVWSFGIVMWEVM 244
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 275 NKLGQGGSGSVYKGTL--PGGE--AVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLV 328
+G G SG V G L PG VA+K L T Q D F +E +++ +H N++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNII 113
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
+L G G +++V E++ N SL F+R + ++ G+ YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYL--SD 169
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY--MAPEYVVR 446
+HRD+ N+L+D K++DFGL R+ +D T G + APE +
Sbjct: 170 L-GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 447 GKLTEKADVYSFGVVVIEVV 466
+ +DV+SFGVV+ EV+
Sbjct: 229 RTFSSASDVWSFGVVMWEVL 248
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 31/231 (13%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF-YNTTQWVD 310
++S N + + LGQG + +V++G G+ A+K + + VD
Sbjct: 3 SQSTSNHLWLLSDI----------LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD 52
Query: 311 HFFNEVNLISGINHKNLVKLLGC--SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
E ++ +NHKN+VKL T +L+ EF P SL L + L
Sbjct: 53 VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPED 424
++ G+ +L + I+HR+IK NI+ D + K+ DFG R +D
Sbjct: 113 EFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169
Query: 425 ITHISATLAGTLGYMAPEYVVRGKL--------TEKADVYSFGVVVIEVVC 467
+L GT Y+ P+ R L D++S GV
Sbjct: 170 --EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 275 NKLGQGGSGSVYKGTLPGGE----AVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNL 327
LG+G GSV +G L + VAVK + + + + F +E + +H N+
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEE-FLSEAACMKDFSHPNV 98
Query: 328 VKLLG-CSITGPES----LLVYEFVPNQSLLDNLFVRQ-----DVEPLSWEVRYKIILST 377
++LLG C + +++ F+ L ++ + + + K ++
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHT--YLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
A G+ YL ++ +HRD+ N +L ++ T +ADFGL + I G +
Sbjct: 157 ALGMEYL--SNR-NFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYRQGRIA 209
Query: 438 -----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
++A E + T K+DV++FGV + E+
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 31/214 (14%)
Query: 275 NKLGQGGSGSVYKGTLPGGE----AVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNLV 328
LG+G GSV + L + VAVK L + D F E + +H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 329 KLLG-CSITGPES-----LLVYEFVPNQSLLDNLFVR-----QDVEPLSWEVRYKIILST 377
KL+G + + +++ F+ + L F+ ++ L + + ++
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHA--FLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
A G+ YL S+ IHRD+ N +L E+ T +ADFGL R I G
Sbjct: 147 ACGMEYL--SSR-NFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQGCAS 199
Query: 438 -----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
++A E + T +DV++FGV + E++
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 53/217 (24%), Positives = 88/217 (40%), Gaps = 33/217 (15%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
+LG+G G V+ VAVK L T F E L++ + H+++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST---------- 377
K G C P ++V+E++ + L L + + + +
Sbjct: 81 KFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 378 ---AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
A G+ YL + +HRD+ N L+ KI DFG+ R D+ G
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVG 192
Query: 435 TLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+M PE ++ K T ++DV+SFGV++ E+
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-35
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
K+G+G +G V G VAVK + Q + FNEV ++ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
+V++ + G E ++ EF+ +L D + + E ++ + + + LAYLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE---QIAT-VCEAVLQALAYLHA 159
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMAPEY 443
+ +IHRDIK +ILL + K++DFG F I+ +L GT +MAPE
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGTPYWMAPEV 212
Query: 444 VVRGKLTEKADVYSFGVVVIE 464
+ R + D++S G++VIE
Sbjct: 213 ISRSLYATEVDIWSLGIMVIE 233
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-35
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
+ K+GQG SG+VY + G+ VA++++ + NE+ ++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
+V L + G E +V E++ SL D + E ++ + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG---QIAA-VCRECLQALEFLHS 134
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMAPEY 443
++IHRDIK NILL + + K+ DFG F IT + T+ GT +MAPE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
V R K D++S G++ IE++
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMI 210
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 61/192 (31%), Positives = 94/192 (48%), Gaps = 6/192 (3%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
KLG G G V+ T VAVK + + V+ F E N++ + H LVKL
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV- 251
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
+T ++ EF+ SLLD L + AEG+A++ E + IH
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFI--EQR-NYIH 307
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
RD++ +NIL+ KIADFGL R+ ++ + + APE + G T K+D
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 455 VYSFGVVVIEVV 466
V+SFG++++E+V
Sbjct: 368 VWSFGILLMEIV 379
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-35
Identities = 72/238 (30%), Positives = 108/238 (45%), Gaps = 27/238 (11%)
Query: 232 RRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-L 290
+ + R+QL L + ++ LEK LG+G GSVYK
Sbjct: 2 LETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEK----------LGEGSYGSVYKAIHK 51
Query: 291 PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350
G+ VA+K++ + E++++ + ++VK G + +V E+
Sbjct: 52 ETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG 109
Query: 351 SLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409
S+ D + +R L+ E IL ST +GL YLH R IHRDIK NILL+ E
Sbjct: 110 SVSDIIRLRNK--TLT-EDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGH 163
Query: 410 AKIADFGLVRLFPEDITHISA---TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
AK+ADFG +T A T+ GT +MAPE + AD++S G+ IE
Sbjct: 164 AKLADFG----VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 275 NKLGQGGSGSVYKGTLPGGE----AVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
+G+G G VY GTL + AVK L + + F E ++ +H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVL 153
Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
LLG C + L+V ++ + L + F+R + + + L A+G+ +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL--A 209
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG-----YMAPE 442
SK + +HRD+ N +LDE+FT K+ADFGL R + + T +MA E
Sbjct: 210 SK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD--SVHNKTGAKLPVKWMALE 266
Query: 443 YVVRGKLTEKADVYSFGVVVIEVV 466
+ K T K+DV+SFGV++ E++
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELM 290
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-35
Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 276 KLGQGGSGSVYKGTLPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLL 331
+LG G GSV +G + VA+K L T + E ++ +++ +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
G +LV E L F+ E + +++ + G+ YL E K
Sbjct: 403 GV-CQAEALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYL--EEK-N 456
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY--MAPEYVVRGKL 449
+HR++ N+LL AKI+DFGL + D ++ +A AG APE + K
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 450 TEKADVYSFGVVVIEVV 466
+ ++DV+S+GV + E +
Sbjct: 517 SSRSDVWSYGVTMWEAL 533
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 58/231 (25%), Positives = 92/231 (39%), Gaps = 31/231 (13%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF-YNTTQWVD 310
++S N + + LGQG + +V++G G+ A+K + + VD
Sbjct: 3 SQSTSNHLWLLSDI----------LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD 52
Query: 311 HFFNEVNLISGINHKNLVKLLGC--SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
E ++ +NHKN+VKL T +L+ EF P SL L + L
Sbjct: 53 VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPED 424
++ G+ +L E I+HR+IK NI+ D + K+ DFG R +D
Sbjct: 113 EFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169
Query: 425 ITHISATLAGTLGYMAPEYVVRGKL--------TEKADVYSFGVVVIEVVC 467
+L GT Y+ P+ R L D++S GV
Sbjct: 170 --EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 18/196 (9%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-C 333
+G+G G V G G + VAVK + + T F E ++++ + H NLV+LLG
Sbjct: 27 QTIGKGEFGDVMLGDYRGNK-VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
+V E++ SL+D ++R L + K L E + YL E
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN-NF 138
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY--MAPEYVVRGKLT 450
+HRD+ N+L+ E+ AK++DFGL + + + S G L APE + K +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK----EAS--STQDTGKLPVKWTAPEALREKKFS 192
Query: 451 EKADVYSFGVVVIEVV 466
K+DV+SFG+++ E+
Sbjct: 193 TKSDVWSFGILLWEIY 208
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 275 NKLGQGGSGSVYKGTL--PGGE--AVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLV 328
+G G G V G L P + +VA+K L T Q D F E +++ +H N++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNII 109
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
+L G ++V E++ N SL F+R+ + ++ A G+ YL S
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---S 164
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY--MAPEYVVR 446
+ +HRD+ NIL++ K++DFGL R+ +D T G + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 447 GKLTEKADVYSFGVVVIEVV 466
K T +DV+S+G+V+ EV+
Sbjct: 225 RKFTSASDVWSYGIVLWEVM 244
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNL 327
+LGQG G VY+G G VA+K + + F NE +++ N ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ---------DVEPLSWEVRYKIILSTA 378
V+LLG G +L++ E + L ++R + P S ++ A
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKS--YLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY 438
+G+AYL + + +HRD+ N ++ E+FT KI DFG+ R DI G G
Sbjct: 149 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGL 201
Query: 439 -----MAPEYVVRGKLTEKADVYSFGVVVIEVV 466
M+PE + G T +DV+SFGVV+ E+
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 20/197 (10%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-C 333
+G+G G V G G + VAVK + + T F E ++++ + H NLV+LLG
Sbjct: 199 QTIGKGEFGDVMLGDYRGNK-VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
+V E++ SL+D ++R L + K L E + YL E
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN-NF 310
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT---LGYMAPEYVVRGKL 449
+HRD+ N+L+ E+ AK++DFGL + S+T + + APE + K
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 363
Query: 450 TEKADVYSFGVVVIEVV 466
+ K+DV+SFG+++ E+
Sbjct: 364 STKSDVWSFGILLWEIY 380
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 42/229 (18%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
F E LGQG G V K A+K++ + + + +EV L++ +NH+ +V+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 330 LLGC----------SITGPESLLVY---EFVPNQSLLDNLFVRQDV---EPLSWEVRYKI 373
+ ++ E+ N +L D L +++ W + +I
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD-LIHSENLNQQRDEYWRLFRQI 125
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA--- 430
+ E L+Y+H + IIHRD+K NI +DE KI DFGL + + +
Sbjct: 126 L----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 431 ----------TLAGTLGYMAPEYVVRGKLT--EKADVYSFGVVVIEVVC 467
+ GT Y+A E V+ G EK D+YS G++ E++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 276 KLGQGGSGSVYKGTLPGGEA----VAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLVKL 330
LG+G G VY+G + VAVK + T + F +E ++ ++H ++VKL
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 331 LG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
+G + ++ E P L ++ ++ L L + +AYL ES
Sbjct: 79 IGII--EEEPTWIIMELYPYGELGH--YLERNKNSLKVLTLVLYSLQICKAMAYL--ESI 132
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL---GYMAPEYVVR 446
+HRDI + NIL+ K+ DFGL R ++ + + + T +M+PE +
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA---SVTRLPIKWMSPESINF 188
Query: 447 GKLTEKADVYSFGVVVIEVV 466
+ T +DV+ F V + E++
Sbjct: 189 RRFTTASDVWMFAVCMWEIL 208
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 30/223 (13%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLV 328
F LG+GG G V++ A+KR+ + + EV ++ + H +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 329 KLLGCSITGPE---------SLLVY---EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
+ + + +Y + ++L D + R +E V I L
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-----------PEDI 425
AE + +LH + ++HRD+K SNI + K+ DFGLV P
Sbjct: 127 IAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 426 THISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVC 467
GT YM+PE + G + K D++S G+++ E++
Sbjct: 184 YARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY 225
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 32/216 (14%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
+LG+G G V+ VAVK L + F E L++ + H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNL------------FVRQDVEPLSWEVRYKIIL 375
+ G C+ P L+V+E++ + L L PL +
Sbjct: 107 RFFGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
A G+ YL + L +HRD+ N L+ + KI DFG+ R DI G
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGG 218
Query: 436 LG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+M PE ++ K T ++DV+SFGVV+ E+
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-34
Identities = 57/198 (28%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 276 KLGQGGSGSVYKGTL--PGGE--AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKL 330
+G+G G V++G P AVA+K T+ + F E + +H ++VKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
+G IT ++ E L F++ L + LAYL ESK
Sbjct: 82 IGV-ITENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYL--ESK- 135
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVVRGK 448
R +HRDI N+L+ K+ DFGL R + G L +MAPE + +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRR 193
Query: 449 LTEKADVYSFGVVVIEVV 466
T +DV+ FGV + E++
Sbjct: 194 FTSASDVWMFGVCMWEIL 211
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 54/238 (22%), Positives = 91/238 (38%), Gaps = 16/238 (6%)
Query: 239 RRERKQLGALQVAVNKSKLNFSYETLEKATNY---FHESNKLGQGGSGSVYKGT-LPGGE 294
+ + + + + +++ + Y+ + + F ++LG G G V+K G
Sbjct: 24 HQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGR 83
Query: 295 AVAVK--RLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPNQS 351
AVK + + EV + H V+L G L E S
Sbjct: 84 LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPS 142
Query: 352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK 411
L + L + + T LA+LH + ++H D+K +NI L K
Sbjct: 143 LQQHC--EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCK 197
Query: 412 IADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
+ DFGL+ G YMAPE +++G ADV+S G+ ++EV C
Sbjct: 198 LGDFGLLVEL--GTAGAGEVQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNM 252
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-34
Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
F E +G GG G V+K G+ +KR+ YN + EV ++ ++H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVH 68
Query: 330 LLGC-------------SITGPESLLVY---EFVPNQSLLDNLFVRQDV---EPLSWEVR 370
GC + + ++ ++ EF +L + R+ + L+
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL--- 125
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
++ +G+ Y+H + ++I+RD+K SNI L + KI DFGLV D
Sbjct: 126 -ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--T 179
Query: 431 TLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKR 470
GTL YM+PE + + ++ D+Y+ G+++ E++
Sbjct: 180 RSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 8e-34
Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 40/225 (17%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNL 327
LG+G G V K T + VAVK L N + + +E N++ +NH ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST---------- 377
+KL G LL+ E+ SL L + V P S+
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 378 -----------AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426
++G+ YL +++HRD+ NIL+ E KI+DFGL R D+
Sbjct: 149 MGDLISFAWQISQGMQYL--AEM-KLVHRDLAARNILVAEGRKMKISDFGLSR----DVY 201
Query: 427 HISATLAGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+ + + G +MA E + T ++DV+SFGV++ E+V
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-34
Identities = 65/215 (30%), Positives = 88/215 (40%), Gaps = 34/215 (15%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRL--FYNTTQWVDHFFNEVNLISGINHKN 326
LG G G VY+G + G VAVK L + +D F E +IS NH+N
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 94
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQ------DVEPLSWEVRYKIILSTAE 379
+V+ +G + P ++ E + L F+R+ L+ + A
Sbjct: 95 IVRCIGVSLQSLP-RFILMELMAGGDLKS--FLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLAGTL 436
G YL E IHRDI N LL AKI DFG+ R DI S G
Sbjct: 152 GCQYL--EEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGC 204
Query: 437 GY-----MAPEYVVRGKLTEKADVYSFGVVVIEVV 466
M PE + G T K D +SFGV++ E+
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 63/216 (29%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
LG G G V + T G VAVK L + +E+ ++S + H+N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILST-------- 377
+V LLG G L++ E+ LL+ L + +E ST
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 378 --AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
A+G+A+L SK IHRD+ N+LL AKI DFGL R DI + S +
Sbjct: 172 QVAQGMAFL--ASK-NCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIVKG 224
Query: 436 LG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+MAPE + T ++DV+S+G+++ E+
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 34/219 (15%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
LG+G G V + G + VAVK L T +E+ ++ I +H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST-------- 377
+V LLG C+ G +++ EF +L L +++ +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 378 -----AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
A+G+ +L S+ + IHRD+ NILL E+ KI DFGL R DI +
Sbjct: 153 YSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYV 205
Query: 433 AGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+MAPE + T ++DV+SFGV++ E+
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 67/221 (30%), Positives = 99/221 (44%), Gaps = 37/221 (16%)
Query: 275 NKLGQGGSGSVYKGTLPGGEA------VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
LG G G V + T G VAVK L + + +E+ ++S + NH N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNL------FVRQDVEPLSWEVRYKIILST-- 377
+V LLG C+I GP +L++ E+ LL+ L F+ P E +
Sbjct: 89 IVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 378 -------AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
A+G+A+L SK IHRD+ NILL KI DFGL R DI + S
Sbjct: 148 LSFSYQVAKGMAFL--ASK-NCIHRDLAARNILLTHGRITKICDFGLAR----DIKNDSN 200
Query: 431 TLAGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+ +MAPE + T ++DV+S+G+ + E+
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLV 328
F + K+G+G G V+KG + VA+K + + ++ E+ ++S + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
K G + + ++ E++ S LD L E ++ I+ +GL YLH E
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET---QIAT-ILREILKGLDYLHSE- 138
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMAPEYVV 445
+ IHRDIK +N+LL E K+ADFG +T T GT +MAPE +
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFG----VAGQLTDTQIKRNTFVGTPFWMAPEVIK 192
Query: 446 RGKLTEKADVYSFGVVVIE 464
+ KAD++S G+ IE
Sbjct: 193 QSAYDSKADIWSLGITAIE 211
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNL 327
+LG+ G VYKG L G AVA+K L + F +E L + + H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 328 VKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--------- 377
V LLG + P +++ + + L + L +R + + + S
Sbjct: 75 VCLLGVVTKDQP-LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 378 ----AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
A G+ YL S ++H+D+ N+L+ ++ KI+D GL R ++
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKL 186
Query: 434 GTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+MAPE ++ GK + +D++S+GVV+ EV
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 63/215 (29%), Positives = 87/215 (40%), Gaps = 34/215 (15%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRL--FYNTTQWVDHFFNEVNLISGINHKN 326
LG G G VY+G + G VAVK L + +D F E +IS NH+N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 135
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQ------DVEPLSWEVRYKIILSTAE 379
+V+ +G + P ++ E + L F+R+ L+ + A
Sbjct: 136 IVRCIGVSLQSLP-RFILLELMAGGDLKS--FLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLAGTL 436
G YL + IHRDI N LL AKI DFG+ R DI G
Sbjct: 193 GCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGC 245
Query: 437 GY-----MAPEYVVRGKLTEKADVYSFGVVVIEVV 466
M PE + G T K D +SFGV++ E+
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 35/220 (15%)
Query: 275 NKLGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NH 324
LG+G G V G + VAVK L + T+ + +E+ ++ I H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-------------FVRQDVEPLSWEVRY 371
KN++ LLG ++ E+ +L + L R E ++++
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
A G+ YL S+ + IHRD+ N+L+ E KIADFGL R DI +I
Sbjct: 161 SCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYY 213
Query: 432 LAGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
T G +MAPE + T ++DV+SFGV++ E+
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-33
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 15/219 (6%)
Query: 258 NFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN---TTQWVDHFF 313
+ Y TL F K+G+G VY+ L G VA+K++ +
Sbjct: 25 DMGYNTLAN----FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI 80
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYK 372
E++L+ +NH N++K I E +V E L + ++ + +K
Sbjct: 81 KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
+ L ++H R++HRDIK +N+ + K+ D GL R F T +L
Sbjct: 141 YFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-SL 196
Query: 433 AGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKR 470
GT YM+PE + K+D++S G ++ E+ +
Sbjct: 197 VGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQS 234
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVK 329
F + LG G G++ + VAVKR+ + D EV L+ + H N+++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIR 82
Query: 330 LLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
C+ + + E + L ++D L E ++ T GLA+LH
Sbjct: 83 YF-CTEKDRQFQYIAIELCA--ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHS-- 136
Query: 389 KLRIIHRDIKLSNILLDE-----EFTAKIADFGLVRLFPEDITHIS--ATLAGTLGYMAP 441
L I+HRD+K NIL+ + A I+DFGL + S + + GT G++AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 442 EYV---VRGKLTEKADVYSFGVVVIEVVCR 468
E + + T D++S G V V+
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-33
Identities = 62/202 (30%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+G G + V P E VA+KR+ +D E+ +S +H N+V
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 334 SITGPESLLVYEFVPNQSLLD-----NLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEE 387
+ E LV + + S+LD L E IL EGL YLH+
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILREVLEGLEYLHKN 140
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFG----LVRLFPEDITHISATLAGTLGYMAPEY 443
+ IHRD+K NILL E+ + +IADFG L + T GT +MAPE
Sbjct: 141 GQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 444 VVRGKL-TEKADVYSFGVVVIE 464
+ + + KAD++SFG+ IE
Sbjct: 198 MEQVRGYDFKADIWSFGITAIE 219
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-33
Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLVKLL-- 331
+LG GG G V + GE VA+K+ + + + + E+ ++ +NH N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 332 ----GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
LL E+ L L ++ L ++ + L YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139
Query: 388 SKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
RIIHRD+K NI+L + KI D G + + + GTL Y+APE +
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQYLAPE-L 194
Query: 445 VRGKL-TEKADVYSFGVVVIEVVC 467
+ K T D +SFG + E +
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECIT 218
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-33
Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+ +LG G G VYK G A K + + + ++ + E+ +++ +H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEES 388
LLG + ++ EF P ++ + + L+ E + +++ E L +LH +
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDA--IMLELDRGLT-EPQIQVVCRQMLEALNFLHSK- 136
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMAPEYVV 445
RIIHRD+K N+L+ E ++ADFG + GT +MAPE V+
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 446 RGKLTE-----KADVYSFGVVVIE 464
+ + KAD++S G+ +IE
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIE 214
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLF---YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
LG+GG ++ + E A K + + E+++ + H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLR 391
+V E +SLL+ R+ + EP E RY + G YLH + R
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEP---EARY-YLRQIVLGCQYLH---RNR 161
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL-T 450
+IHRD+KL N+ L+E+ KI DFGL D L GT Y+APE V+ K +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPE-VLSKKGHS 219
Query: 451 EKADVYSFGVVVIEVVC 467
+ DV+S G ++ ++
Sbjct: 220 FEVDVWSIGCIMYTLLV 236
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 35/220 (15%)
Query: 275 NKLGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NH 324
LG+G G V G + VAVK L + T+ + +E+ ++ I H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNL---------FVRQDVEPLSWEVRYKIIL 375
KN++ LLG ++ E+ +L + L + ++ K ++
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 376 S----TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
S A G+ YL SK + IHRD+ N+L+ E+ KIADFGL R DI HI
Sbjct: 195 SCAYQVARGMEYL--ASK-KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 247
Query: 432 LAGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
T G +MAPE + T ++DV+SFGV++ E+
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 44/204 (21%), Positives = 79/204 (38%), Gaps = 19/204 (9%)
Query: 275 NKLGQGGS--GSVYKGT-LPGGEAVAVKR--LFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+G+G +V P GE V V+R L + + V E+++ NH N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEES 388
I E +V F+ S D L ++ ++ E+ IL + L Y+H
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMN-ELAIAYILQGVLKALDYIHHMG 148
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED------ITHISATLAGTLGYMAPE 442
+HR +K S+IL+ + ++ + L +++PE
Sbjct: 149 Y---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
Query: 443 YVVRGKL--TEKADVYSFGVVVIE 464
+ + K+D+YS G+ E
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACE 229
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-32
Identities = 57/199 (28%), Positives = 86/199 (43%), Gaps = 17/199 (8%)
Query: 276 KLGQGGSGSVYKGTL--PGGEA--VAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVK 329
+G+G G V++G P A VA+K T+ F E + +H ++VK
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVK 455
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
L+G IT ++ E L F++ L + LAYL ESK
Sbjct: 456 LIGV-ITENPVWIIMELCTLGELRS--FLQVRKFSLDLASLILYAYQLSTALAYL--ESK 510
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVVRG 447
R +HRDI N+L+ K+ DFGL R + G L +MAPE +
Sbjct: 511 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFR 567
Query: 448 KLTEKADVYSFGVVVIEVV 466
+ T +DV+ FGV + E++
Sbjct: 568 RFTSASDVWMFGVCMWEIL 586
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 67/274 (24%), Positives = 109/274 (39%), Gaps = 48/274 (17%)
Query: 234 KLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHE--------SNKLGQGGSGSV 285
K ++ R QL +QV + F + E + E LG G G V
Sbjct: 2 KYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKV 61
Query: 286 YKGTLPGGEA------VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKNLVKLLGCSITG 337
T G VAVK L + +E+ +++ + +H+N+V LLG
Sbjct: 62 MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121
Query: 338 PESLLVYEFVPNQSLLDNL----------FVRQDVEPLSWEVRYKIILST---------- 377
L++E+ LL+ L + + + E +L+
Sbjct: 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
A+G+ +L E K +HRD+ N+L+ KI DFGL R DI S +
Sbjct: 182 AKGMEFL--EFK-SCVHRDLAARNVLVTHGKVVKICDFGLAR----DIMSDSNYVVRGNA 234
Query: 438 -----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+MAPE + G T K+DV+S+G+++ E+
Sbjct: 235 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 35/220 (15%)
Query: 275 NKLGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NH 324
LG+G G V G + VAVK L + T+ + +E+ ++ I H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-------------FVRQDVEPLSWEVRY 371
KN++ LLG ++ E+ +L + L R E ++++
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
A G+ YL S+ + IHRD+ N+L+ E KIADFGL R DI +I
Sbjct: 207 SCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYY 259
Query: 432 LAGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
T G +MAPE + T ++DV+SFGV++ E+
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 48/215 (22%), Positives = 85/215 (39%), Gaps = 41/215 (19%)
Query: 276 KLGQGGSGSVYKGTL--PGGEA------VAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
LGQG ++KG G V +K L + + FF +++S ++HK+L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
V G + G E++LV EFV SL +++++ ++ + ++ A + +L E
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDT--YLKKNKNCINILWKLEVAKQLAAAMHFL--E 130
Query: 388 SKLRIIHRDIKLSNILLDEEFT--------AKIADFGLVRLFPEDITHISATLAGTLGY- 438
+IH ++ NILL E K++D G+
Sbjct: 131 EN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------------DIL 177
Query: 439 ------MAPEYVVRGKL-TEKADVYSFGVVVIEVV 466
+ PE + K D +SFG + E+
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 17/198 (8%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLF---YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
LG+GG ++ + E A K + + E+++ + H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 333 CSITGPESL-LVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKL 390
+ + +V E +SLL+ R+ + EP E RY + G YLH +
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELHKRRKALTEP---EARY-YLRQIVLGCQYLH---RN 134
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL- 449
R+IHRD+KL N+ L+E+ KI DFGL D L GT Y+APE V+ K
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPE-VLSKKGH 192
Query: 450 TEKADVYSFGVVVIEVVC 467
+ + DV+S G ++ ++
Sbjct: 193 SFEVDVWSIGCIMYTLLV 210
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 35/216 (16%)
Query: 275 NKLGQGGSGSVYKGTLPGGEA---VAVKRL--FYNTTQWVDHFFNEVNLISGI-NHKNLV 328
+ +G+G G V K + A+KR+ + + D F E+ ++ + +H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNII 89
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST----------- 377
LLG L E+ P+ +LLD L + +E ST
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 378 --AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
A G+ YL S+ + IHRD+ NIL+ E + AKIADFGL R + T
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 199
Query: 436 LG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+G +MA E + T +DV+S+GV++ E+V
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-32
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 11/204 (5%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLG 332
+G G G K G+ + K L Y T +EVNL+ + H N+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 333 CSITGPESLL--VYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLHE--E 387
I + L V E+ L + ++ + L E +++ L H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
++HRD+K +N+ LD + K+ DFGL R+ D T + T GT YM+PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKTFVGTPYYMSPE-QMNR 190
Query: 448 KL-TEKADVYSFGVVVIEVVCRKR 470
EK+D++S G ++ E+
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMP 214
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-32
Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 16/198 (8%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLG 332
LG+G VY+ + G VA+K + V NEV + + H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKIILSTAEGLAYLHEESKLR 391
LV E N + L R +P S E R+ + G+ YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRV--KPFSENEARH-FMHQIITGMLYLH---SHG 132
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVRGKL- 449
I+HRD+ LSN+LL KIADFGL +L H TL GT Y++PE +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH--YTLCGTPNYISPE-IATRSAH 189
Query: 450 TEKADVYSFGVVVIEVVC 467
++DV+S G + ++
Sbjct: 190 GLESDVWSLGCMFYTLLI 207
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 42/226 (18%)
Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRL--FYNTTQWVDHFFNEVNLISGINHKN 326
+G+G G V++ PG VAVK L + D F E L++ ++ N
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPN 111
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--------- 377
+VKLLG G L++E++ L + L S +
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 378 ------------AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
A G+AYL S+ + +HRD+ N L+ E KIADFGL R +I
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NI 224
Query: 426 THISATLAGTLGY-----MAPEYVVRGKLTEKADVYSFGVVVIEVV 466
A M PE + + T ++DV+++GVV+ E+
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 53/241 (21%), Positives = 95/241 (39%), Gaps = 34/241 (14%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLF---------- 302
N LN + +K N + L QG + + A+K+
Sbjct: 15 NLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDF 73
Query: 303 -------YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLD 354
+ D F NE+ +I+ I ++ + G IT + + ++YE++ N S+L
Sbjct: 74 TKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG-IITNYDEVYIIYEYMENDSILK 132
Query: 355 NL-----FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409
+ + +V II S +Y+H ++ I HRD+K SNIL+D+
Sbjct: 133 FDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGR 190
Query: 410 AKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT---EKADVYSFGVVVIEVV 466
K++DFG + GT +M PE + + K D++S G+ + +
Sbjct: 191 VKLSDFGESEYMVDKKIK---GSRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMF 246
Query: 467 C 467
Sbjct: 247 Y 247
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-31
Identities = 56/234 (23%), Positives = 108/234 (46%), Gaps = 18/234 (7%)
Query: 238 KRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAV 296
K+ E +L Q ++ L + E + F + ++LG G G V+K + P G +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61
Query: 297 AVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDN 355
A K + + + E+ ++ N +V G + E + E + SL
Sbjct: 62 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ- 120
Query: 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415
V + + ++ K+ ++ +GL YL E+ +I+HRD+K SNIL++ K+ DF
Sbjct: 121 --VLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDF 176
Query: 416 G----LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
G L+ ++ + GT YM+PE + + ++D++S G+ ++E+
Sbjct: 177 GVSGQLID-------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 60/248 (24%), Positives = 99/248 (39%), Gaps = 26/248 (10%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN 304
G+L A + + +F +T+E L +GG VY+ + G A+KRL N
Sbjct: 5 GSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN 64
Query: 305 TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES-------LLVYEFVPNQSLLDNL 356
+ EV + + H N+V+ + G E L+ + L++ L
Sbjct: 65 EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL 124
Query: 357 FVRQDVEPLS-WEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415
+ PLS V KI T + ++H K IIHRD+K+ N+LL + T K+ DF
Sbjct: 125 KKMESRGPLSCDTVL-KIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDF 182
Query: 416 GLVRLFPEDITHIS-----------ATLAGTLGYMAPE--YVVRGK-LTEKADVYSFGVV 461
G + T T Y PE + + EK D+++ G +
Sbjct: 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242
Query: 462 VIEVVCRK 469
+ + R+
Sbjct: 243 LYLLCFRQ 250
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 32/208 (15%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFF---NEVNLISGINHKN 326
F + ++G G G+VY + E VA+K++ Y+ Q + + EV + + H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLH 385
++ GC + + LV E+ S D L V + +PL EV + +GLAYLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHK--KPLQ-EVEIAAVTHGALQGLAYLH 171
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA------GTLGYM 439
+IHRD+K NILL E K+ DFG ++ +A GT +M
Sbjct: 172 SH---NMIHRDVKAGNILLSEPGLVKLGDFG-----------SASIMAPANSFVGTPYWM 217
Query: 440 APEYVVRGKLTE---KADVYSFGVVVIE 464
APE ++ + K DV+S G+ IE
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIE 245
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 59/198 (29%), Positives = 86/198 (43%), Gaps = 15/198 (7%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKL 330
LG+G G+VY +A+K LF EV + S + H N+++L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G L+ E+ P ++ L Q + + I A L+Y H
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH---SK 128
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL- 449
R+IHRDIK N+LL KIADFG P L GTL Y+ PE ++ G++
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---DLCGTLDYLPPE-MIEGRMH 184
Query: 450 TEKADVYSFGVVVIEVVC 467
EK D++S GV+ E +
Sbjct: 185 DEKVDLWSLGVLCYEFLV 202
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-31
Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 16/196 (8%)
Query: 276 KLGQGGSGSVYKGT---LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
KLG GG +VY L VA+K + + + F EV+ S ++H+N+V
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
++ LV E++ +L + + + PLS + +G+ + H+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHDM-- 130
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED-ITHISATLAGTLGYMAPEYVVRGK 448
RI+HRDIK NIL+D T KI DFG+ + E +T + L GT+ Y +PE
Sbjct: 131 -RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEA 188
Query: 449 LTEKADVYSFGVVVIE 464
E D+YS G+V+ E
Sbjct: 189 TDECTDIYSIGIVLYE 204
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 60/229 (26%), Positives = 93/229 (40%), Gaps = 37/229 (16%)
Query: 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVN-LISGINHKNL 327
N LG G SG+V G VAVKR+ + D E+ L +H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNV 71
Query: 328 VKLLGCSITGPESL-LVYEFVPNQSLLD----NLFVRQDVEPLSWEVRYKIILSTAEGLA 382
++ CS T L + E N +L D ++++ ++ A G+A
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 383 YLHEESKLRIIHRDIKLSNILLD-------------EEFTAKIADFGLVRLFPEDITHIS 429
+LH L+IIHRD+K NIL+ E I+DFGL + +
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 430 ATL---AGTLGYMAPE-------YVVRGKLTEKADVYSFGVVVIEVVCR 468
L +GT G+ APE + +LT D++S G V ++ +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 41/263 (15%), Positives = 77/263 (29%), Gaps = 30/263 (11%)
Query: 231 VRRKLLQKRRER-KQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT 289
+ KLL + K + + + + LG+G VY+ T
Sbjct: 26 LIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEAT 85
Query: 290 LPG------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343
+ +K + + +K + S+LV
Sbjct: 86 QGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145
Query: 344 YEFVPNQSLLD--NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401
E +LL+ NL+ + + + + + +H IIH DIK N
Sbjct: 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDN 202
Query: 402 ILL-----------DEEFTAKIADFGL---VRLFPEDITHISATLAGTLGYMAPEYVVRG 447
+L D + D G ++LFP+ T G+ E ++
Sbjct: 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT--AKCETSGFQCVE-MLSN 259
Query: 448 KL-TEKADVYSFGVVVIEVVCRK 469
K + D + V ++
Sbjct: 260 KPWNYQIDYFGVAATVYCMLFGT 282
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-30
Identities = 48/225 (21%), Positives = 79/225 (35%), Gaps = 35/225 (15%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKR--LFYNTTQWVDHFFNEVNLISGI-NHKN 326
FHE K+G G GSV+K G A+KR + + EV + + H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
+V+ L+ E+ SL D + + + ++L GL Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 386 EESKLRIIHRDIKLSNILLDEE-------------------FTAKIADFGLVRLFPEDIT 426
++H DIK SNI + KI D G V
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--- 186
Query: 427 HISATLAGTLGYMAPEYVVRGKL--TEKADVYSFGVVVIEVVCRK 469
G ++A E V++ KAD+++ + V+ +
Sbjct: 187 --PQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 5e-30
Identities = 48/203 (23%), Positives = 79/203 (38%), Gaps = 23/203 (11%)
Query: 276 KLGQGGSGSVYKG--TLPGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLL- 331
+ GG G +Y G V +K L ++ + E ++ + H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 332 ----GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
P +V E+V QSL + + L +L L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKR---SKG--QKLPVAEAIAYLLEILPALSYLHSI 201
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
+++ D+K NI+L EE K+ D G V I GT G+ APE +VR
Sbjct: 202 ---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR----INSFGYLY-GTPGFQAPE-IVRT 251
Query: 448 KLTEKADVYSFGVVVIEVVCRKR 470
T D+Y+ G + +
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLP 274
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 21/199 (10%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVK 329
LG+G G+VY K +A+K LF + E+ + S + H N+++
Sbjct: 22 LGKGKFGNVYLAREKQN---KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
+ L+ EF P L L Q + + A+ L Y H +
Sbjct: 79 MYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCH---E 132
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
++IHRDIK N+L+ + KIADFG P T+ GTL Y+ PE ++ GK
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR---TMCGTLDYLPPE-MIEGKT 188
Query: 450 -TEKADVYSFGVVVIEVVC 467
EK D++ GV+ E +
Sbjct: 189 HDEKVDLWCAGVLCYEFLV 207
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 276 KLGQGGSGSVYKGT---LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
LG GG V+ VAVK L + F E + +NH +V
Sbjct: 19 ILGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 330 LL--GCSITGPESL--LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
+ G + T L +V E+V +L D + P++ + ++I + L + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH 133
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT--LAGTLGYMAPEY 443
+ IIHRD+K +NI++ K+ DFG+ R + ++ T + GT Y++PE
Sbjct: 134 Q---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
+ ++DVYS G V+ EV+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVL 213
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 35/233 (15%)
Query: 253 NKSKLNFSYE-TLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWV 309
+ KL S E + + ++G+G GSV K P G+ +AVKR+ +
Sbjct: 5 SSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ 64
Query: 310 DHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL--FVRQDVEPLS 366
+++ ++ + +V+ G + + E + + S + +
Sbjct: 65 KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIP 123
Query: 367 WEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426
E+ KI L+T + L +L L+IIHRDIK SNILLD K+ DFG
Sbjct: 124 EEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFG---------- 171
Query: 427 HISATL---------AGTLGYMAPEYVVRGKLTE-----KADVYSFGVVVIEV 465
IS L AG YMAPE + + ++DV+S G+ + E+
Sbjct: 172 -ISGQLVDSIAKTRDAGCRPYMAPE-RIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 60/229 (26%), Positives = 93/229 (40%), Gaps = 27/229 (11%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDH 311
+S L F +G G G VYKG + G+ A+K + + +
Sbjct: 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE- 66
Query: 312 FFNEVNLISGI-NHKNLVKLLGCSITGPESL------LVYEFVPNQSLLDNLFVRQDVEP 364
E+N++ +H+N+ G I LV EF S+ D L
Sbjct: 67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNT 125
Query: 365 LS-WEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
L + Y I GL++LH+ ++IHRDIK N+LL E K+ DFG+
Sbjct: 126 LKEEWIAY-ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA---- 177
Query: 424 DITHISA---TLAGTLGYMAPEYVVRGKLTE-----KADVYSFGVVVIE 464
+ T GT +MAPE + + + K+D++S G+ IE
Sbjct: 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-29
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 33/221 (14%)
Query: 263 TLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHFFNEVN-LI 319
++E + +LG+G G V K +P G+ +AVKR+ +Q +++ +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTA 378
++ V G + + E + + SL V + + ++ KI +S
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL------ 432
+ L +LH SKL +IHRD+K SN+L++ K+ DFG IS L
Sbjct: 120 KALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFG-----------ISGYLVDDVAK 166
Query: 433 ---AGTLGYMAPEYVVRGKLTE-----KADVYSFGVVVIEV 465
AG YMAPE + +L + K+D++S G+ +IE+
Sbjct: 167 DIDAGCKPYMAPE-RINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-29
Identities = 45/196 (22%), Positives = 76/196 (38%), Gaps = 16/196 (8%)
Query: 276 KLGQGGSGSVYKGT---LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
+G+GG G VY+ VA+K + + + E + ++V
Sbjct: 41 LVGRGGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
+ + + + L L + PL+ I+ L H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED-ITHISATLAGTLGYMAPEYVVRGK 448
HRD+K NIL+ + A + DFG+ ++ +T + T+ GTL YMAPE
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESH 211
Query: 449 LTEKADVYSFGVVVIE 464
T +AD+Y+ V+ E
Sbjct: 212 ATYRADIYALTCVLYE 227
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 34/236 (14%), Positives = 72/236 (30%), Gaps = 53/236 (22%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFY----------------------------NTTQ 307
LGQ + + T GE+ V ++ +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGC--SITGPESLLVYEFV--PNQSLLDNLFVRQDV- 362
F +L+ K ++++ + +Y + Q+ + L
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 363 EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422
+ L R ++ L LA LH ++H ++ +I+LD+ + F +
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 423 EDITHISATLAGTLGYMAPEYVV-----------RGKLTEKADVYSFGVVVIEVVC 467
+ + G+ PE R +T D ++ G+V+ + C
Sbjct: 258 AR-----VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 24/230 (10%), Positives = 56/230 (24%), Gaps = 46/230 (20%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLF---YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
L G V+ + E A+K N+ ++ + + ++ +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 333 C--------------------------SITGPESLLVYEFV-----PNQSLLDNLFVRQD 361
LL+ S LD ++V +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR- 188
Query: 362 VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
+ + A L ++H N+ + + + D +
Sbjct: 189 -GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 422 PEDITHISATLAGTLGYMAPEYVVRGKL--TEKADVYSFGVVVIEVVCRK 469
+ + Y E++ T + + G+ + V C
Sbjct: 245 GT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 56/238 (23%), Positives = 100/238 (42%), Gaps = 34/238 (14%)
Query: 246 GALQVAVNKS-KLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFY 303
G+ + ++ L + + N ++G G G V+K G +AVK++
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 304 NTT-QWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD 361
+ + +++ ++ + +V+ G IT + + E + ++
Sbjct: 61 SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEK--LKKRM 117
Query: 362 VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
P+ + K+ ++ + L YL K +IHRD+K SNILLDE K+ DFG
Sbjct: 118 QGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFG----- 170
Query: 422 PEDITHISATL---------AGTLGYMAPEYVVRGKLTE-----KADVYSFGVVVIEV 465
IS L AG YMAPE + T+ +ADV+S G+ ++E+
Sbjct: 171 ------ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 60/231 (25%), Positives = 90/231 (38%), Gaps = 15/231 (6%)
Query: 237 QKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEA 295
++ Q + + F + + KLG G G V
Sbjct: 5 HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64
Query: 296 VAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLL 353
A+K + +T EV ++ ++H N++KL LV E L
Sbjct: 65 RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF 124
Query: 354 DNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTA 410
D + R + II G+ YLH+ I+HRD+K N+LL +++
Sbjct: 125 DEIIHR---MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALI 178
Query: 411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
KI DFGL +F GT Y+APE V+R K EK DV+S GV+
Sbjct: 179 KIVDFGLSAVFENQ--KKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVI 226
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 55/205 (26%), Positives = 86/205 (41%), Gaps = 22/205 (10%)
Query: 268 TNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHK 325
+ F KLG G G V+ G +K + + +Q ++ E+ ++ ++H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAE 379
N++K+ +V E LL+ + V + +++
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERI-----VSAQARGKALSEGYVAELMKQMMN 135
Query: 380 GLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
LAY H ++H+D+K NIL KI DFGL LF D S AGT
Sbjct: 136 ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTA 190
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVV 461
YMAPE V + +T K D++S GVV
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVV 214
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 60/260 (23%), Positives = 87/260 (33%), Gaps = 55/260 (21%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK-----RLFYNTT 306
+ L F +L + +H +GQG G V A+K ++
Sbjct: 10 GRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINP 69
Query: 307 QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS 366
+ V+ EV L+ ++H N+ +L LV E LLD L V D
Sbjct: 70 KDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGK 129
Query: 367 WEVRY-------------------------------------KIILSTAEGLAYLHEESK 389
+ I+ L YLH
Sbjct: 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---N 186
Query: 390 LRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFP---EDITHISATLAGTLGYMAPEYV 444
I HRDIK N L ++ F K+ DFGL + F + T AGT ++APE V
Sbjct: 187 QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-V 245
Query: 445 VRGKL---TEKADVYSFGVV 461
+ K D +S GV+
Sbjct: 246 LNTTNESYGPKCDAWSAGVL 265
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-27
Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 38/230 (16%)
Query: 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL------------ 301
+ + + K + + KLG G G V G A+K +
Sbjct: 22 NPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSD 81
Query: 302 -FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ 360
N ++ + +NE++L+ ++H N++KL LV EF L + + R
Sbjct: 82 DNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH 141
Query: 361 DVEPLSWEVRY------KIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAK 411
++ I+ G+ YLH+ I+HRDIK NILL + K
Sbjct: 142 ---------KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK 189
Query: 412 IADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
I DFGL F +D + GT Y+APE V++ K EK DV+S GV+
Sbjct: 190 IVDFGLSSFFSKD--YKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVI 236
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-27
Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL--FYNTTQWV 309
+ + N ++ ++ LG+G G V K + AVK + +
Sbjct: 8 SSGRENLYFQ--GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 310 DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEV 369
EV L+ ++H N++KL +V E L D + R+
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--------- 116
Query: 370 RY------KIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRL 420
R+ +II G+ Y+H+ I+HRD+K NILL +++ KI DFGL
Sbjct: 117 RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
F ++ GT Y+APE V+RG EK DV+S GV+
Sbjct: 174 FQQN--TKMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVI 211
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-27
Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 16/223 (7%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL--- 301
G++ ++ + F + ++ + LG+G G V G+ AVK +
Sbjct: 3 GSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 62
Query: 302 FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD 361
+ EV L+ ++H N++KL LV E L D + R
Sbjct: 63 QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR-- 120
Query: 362 VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLV 418
+ S +II G+ Y+H+ +I+HRD+K N+LL ++ +I DFGL
Sbjct: 121 -KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176
Query: 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
F GT Y+APE V+ G EK DV+S GV+
Sbjct: 177 THFEAS--KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVI 216
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 30/232 (12%), Positives = 66/232 (28%), Gaps = 42/232 (18%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFY----------------------------NTTQ 307
LGQ + + T GE+ V ++ +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGC--SITGPESLLVYEFV--PNQSLLDNLFVRQDV- 362
F +L+ K ++++ + +Y + Q+ + L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 363 EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422
+ L R ++ L LA LH ++H ++ +I+LD+ + F +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 423 EDITHISATLAGTLGYMAPEYV-----VRGKLTEKADVYSFGVVVIEVVCRK 469
A + +T D ++ G+ + + C
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 59/198 (29%), Positives = 87/198 (43%), Gaps = 27/198 (13%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
LG+G G V K + AVK + + EV L+ ++H N++KL
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEGLAYLHE 386
+V E L D + R+ R+ +II G+ Y+H+
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMHK 139
Query: 387 ESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
I+HRD+K NILL +++ KI DFGL F ++ GT Y+APE
Sbjct: 140 ---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPE- 193
Query: 444 VVRGKLTEKADVYSFGVV 461
V+RG EK DV+S GV+
Sbjct: 194 VLRGTYDEKCDVWSAGVI 211
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 45/196 (22%), Positives = 80/196 (40%), Gaps = 25/196 (12%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+G+G G V A K++ + VD F E+ ++ ++H N+++L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEGLAYLHEES 388
+ LV E L + + ++ + +I+ +AY H+
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKR---------VFRESDAARIMKDVLSAVAYCHK-- 124
Query: 389 KLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
L + HRD+K N L + K+ DFGL F + T GT Y++P+ V+
Sbjct: 125 -LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSPQ-VL 180
Query: 446 RGKLTEKADVYSFGVV 461
G + D +S GV+
Sbjct: 181 EGLYGPECDEWSAGVM 196
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK-----RLFYNTTQWVDH---FFNEVNL 318
+ + S LG G G V + VA++ + + + D E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILST 377
+ +NH ++K+ + +V E + L D + + + E Y+++
Sbjct: 194 LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML--- 249
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAG 434
+ YLHE IIHRD+K N+LL +E+ KI DFG ++ E + TL G
Sbjct: 250 -LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCG 303
Query: 435 TLGYMAPE---YVVRGKLTEKADVYSFGVVV 462
T Y+APE V D +S GV++
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 52/197 (26%), Positives = 80/197 (40%), Gaps = 25/197 (12%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
LG G V+ G+ A+K + + NE+ ++ I H+N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEGLAYLHEES 388
+ LV + V L D + R Y +I + YLHE
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERG---------VYTEKDASLVIQQVLSAVKYLHE-- 124
Query: 389 KLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
I+HRD+K N+L +E I DFGL ++ I T GT GY+APE +
Sbjct: 125 -NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS---TACGTPGYVAPEVLA 180
Query: 446 RGKLTEKADVYSFGVVV 462
+ ++ D +S GV+
Sbjct: 181 QKPYSKAVDCWSIGVIT 197
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 52/261 (19%), Positives = 88/261 (33%), Gaps = 36/261 (13%)
Query: 227 VAFFVRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVY 286
V F + K+ A+ + +L EK KL G +
Sbjct: 21 VVFEAKNKVDDC----------NYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 70
Query: 287 KGTLPGGEAVAVKRLFYNTTQWVDH------------FFNEVNLISGINHKNLVKLLGCS 334
L + + + ++ + + KN V L S
Sbjct: 71 NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
+ + ++L D + R +E V I + AE + +LH + ++H
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMH 187
Query: 395 RDIKLSNILLDEEFTAKIADFGLVR-----------LFPEDITHISATLAGTLGYMAPEY 443
RD+K SNI + K+ DFGLV L P GT YM+PE
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
Query: 444 VVRGKLTEKADVYSFGVVVIE 464
+ + K D++S G+++ E
Sbjct: 248 IHGNNYSHKVDIFSLGLILFE 268
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 59/199 (29%), Positives = 88/199 (44%), Gaps = 20/199 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGC 333
+G+G V + G VA+K + + F EV ++ +NH N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKI--ILSTAEGLAYLHEESKL 390
T L+ E+ + D L + E E R K I+S + Y H +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEK---EARSKFRQIVS---AVQYCH---QK 133
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
RI+HRD+K N+LLD + KIADFG F G Y APE + +GK
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPE-LFQGKKY 190
Query: 451 E--KADVYSFGVVVIEVVC 467
+ + DV+S GV++ +V
Sbjct: 191 DGPEVDVWSLGVILYTLVS 209
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 47/196 (23%), Positives = 78/196 (39%), Gaps = 14/196 (7%)
Query: 276 KLGQGGSGSVYKGTLPG-GEAVAVK-----RLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+G+G V + G+ AVK + + + E ++ + H ++V+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEES 388
LL + +V+EF+ L + R S V + E L Y H+
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 148
Query: 389 KLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
IIHRD+K +LL + K+ FG+ E ++ GT +MAPE V
Sbjct: 149 -NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES-GLVAGGRVGTPHFMAPEVVK 206
Query: 446 RGKLTEKADVYSFGVV 461
R + DV+ GV+
Sbjct: 207 REPYGKPVDVWGCGVI 222
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 51/208 (24%), Positives = 80/208 (38%), Gaps = 38/208 (18%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVK-----RLFYNTTQWVDH---FFNEVNLISGINHKN 326
LG G G V + VA+K + + + D E+ ++ +NH
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEG 380
++K+ + +V E + L D + + R
Sbjct: 77 IIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLA 126
Query: 381 LAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
+ YLHE IIHRD+K N+LL +E+ KI DFG ++ E + TL GT
Sbjct: 127 VQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPT 181
Query: 438 YMAPEYVVRGKL----TEKADVYSFGVV 461
Y+APE V+ D +S GV+
Sbjct: 182 YLAPE-VLVSVGTAGYNRAVDCWSLGVI 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 39/210 (18%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVK----RLFYNTTQWV-----DHFFNEVNLISGIN-H 324
LG+G S V + P + AVK + + + EV+++ ++ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTA 378
N+++L T LV++ + L D L + KI+ +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALL 134
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY 438
E + LH+ L I+HRD+K NILLD++ K+ DFG + GT Y
Sbjct: 135 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSY 189
Query: 439 MAPEYVVRGKL-------TEKADVYSFGVV 461
+APE ++ + ++ D++S GV+
Sbjct: 190 LAPE-IIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 24/217 (11%)
Query: 250 VAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW 308
V + +N Y ++ LG G G V+K G +A K + +
Sbjct: 78 VTAKQGAVNSFYT--------VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
+ NE+++++ ++H NL++L + + +LV E+V L D + + +
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDR-IIDESYNLTELD 188
Query: 369 VRY--KIILSTAEGLAYLHEESKLRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFPED 424
K I EG+ ++H ++ I+H D+K NIL + KI DFGL R +
Sbjct: 189 TILFMKQIC---EGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242
Query: 425 ITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGV 460
GT ++APE VV ++ D++S GV
Sbjct: 243 --EKLKVNFGTPEFLAPE-VVNYDFVSFPTDMWSVGV 276
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 22/196 (11%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVK-----RLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G V + G A K +L + + E + + H N+V+
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVR 69
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
L LV++ V L +++ R E S I E +AY H
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS--- 123
Query: 390 LRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
I+HR++K N+LL + K+ADFGL + AGT GY++PE V++
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPE-VLK 180
Query: 447 GKL-TEKADVYSFGVV 461
++ D+++ GV+
Sbjct: 181 KDPYSKPVDIWACGVI 196
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 26/196 (13%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG+G + VY+ + A+K L T E+ ++ ++H N++KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEGLAYLHEES 388
T E LV E V L D + + Y + E +AYLHE
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKG---------YYSERDAADAVKQILEAVAYLHE-- 166
Query: 389 KLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
I+HRD+K N+L + KIADFGL ++ + T+ GT GY APE +
Sbjct: 167 -NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGTPGYCAPEILR 223
Query: 446 RGKLTEKADVYSFGVV 461
+ D++S G++
Sbjct: 224 GCAYGPEVDMWSVGII 239
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 28/182 (15%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL-------FYNTTQWVDHFFNEVNLISGINHKN 326
KLG G +VYKG G VA+K + +T E++L+ + H+N
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA------IREISLMKELKHEN 64
Query: 327 LVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
+V+L I L LV+EF+ N + +D+ V L + +GLA+
Sbjct: 65 IVRLYDV-IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI---THISATLAGTLGYMA 440
HE +I+HRD+K N+L+++ K+ DFGL R F + + TL Y A
Sbjct: 124 CHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV----TLWYRA 176
Query: 441 PE 442
P+
Sbjct: 177 PD 178
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 46/209 (22%), Positives = 86/209 (41%), Gaps = 38/209 (18%)
Query: 276 KLGQGGSGSVYKGTLPG-GEAVAVKRL--------FYNTTQWVDHFFNEVNLISGI-NHK 325
+G+G S V + G AVK + + + E +++ + H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAE 379
+++ L+ + LV++ + L D L + V I+ S E
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK---------VALSEKETRSIMRSLLE 211
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
+++LH I+HRD+K NILLD+ +++DFG L GT GY+
Sbjct: 212 AVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGYL 266
Query: 440 APEYVVRGKL-------TEKADVYSFGVV 461
APE +++ + ++ D+++ GV+
Sbjct: 267 APE-ILKCSMDETHPGYGKEVDLWACGVI 294
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 44/193 (22%), Positives = 82/193 (42%), Gaps = 15/193 (7%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
+LG+G V + + G+ A + + + E + + H N+V+L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
L+++ V L +++ R E S I E + + H+ + +
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQ---MGV 131
Query: 393 IHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
+HR++K N+LL + K+ADFGL + AGT GY++PE V+R
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPGYLSPE-VLRKDP 189
Query: 450 -TEKADVYSFGVV 461
+ D+++ GV+
Sbjct: 190 YGKPVDLWACGVI 202
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 29/217 (13%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN-----EVNL---ISG 321
+ ++G G G+VYK G VA+K + EV L +
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 322 INHKNLVKLL----GCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKII 374
H N+V+L+ + LV+E V ++ LD L E ++
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA----PPPGLPAETIKDLM 126
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF--PEDITHISATL 432
GL +LH I+HRD+K NIL+ T K+ADFGL R++ +T +
Sbjct: 127 RQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP----V 179
Query: 433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
TL Y APE +++ D++S G + E+ RK
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 53/202 (26%), Positives = 85/202 (42%), Gaps = 14/202 (6%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDH--FFNEVNLISG 321
+Y+ +LG G G V++ G K F NT +D NE+++++
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK--FINTPYPLDKYTVKNEISIMNQ 104
Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
++H L+ L E +L+ EF+ L D + +S + EGL
Sbjct: 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGL 162
Query: 382 AYLHEESKLRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
++HE I+H DIK NI+ + + KI DFGL D I T +
Sbjct: 163 KHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFA 217
Query: 440 APEYVVRGKLTEKADVYSFGVV 461
APE V R + D+++ GV+
Sbjct: 218 APEIVDREPVGFYTDMWAIGVL 239
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 54/208 (25%), Positives = 85/208 (40%), Gaps = 31/208 (14%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRL------FYNTTQWVDHFFNEVNLISGINHK--NL 327
LG GG GSVY G + VA+K + + EV L+ ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 328 VKLLGCSITGPESLLVYEFV-PNQSLLDNLFVRQDV-EPLSWEVRYK---IILSTAEGLA 382
++LL +L+ E P Q L D + R + E R ++ E +
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE---LARSFFWQVL----EAVR 163
Query: 383 YLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
+ H ++HRDIK NIL+D K+ DFG L + + GT Y P
Sbjct: 164 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRVYSPP 217
Query: 442 EYVVRGKLTE--KADVYSFGVVVIEVVC 467
E +R A V+S G+++ ++VC
Sbjct: 218 E-WIRYHRYHGRSAAVWSLGILLYDMVC 244
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 49/193 (25%), Positives = 80/193 (41%), Gaps = 16/193 (8%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNLVKLLG 332
+LG+G V + G A K + D E + + H N+V+L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
LV++ V L +++ R E S I E +AY H I
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS---NGI 149
Query: 393 IHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
+HR++K N+LL + K+ADFGL + AGT GY++PE V++
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPE-VLKKDP 206
Query: 450 -TEKADVYSFGVV 461
++ D+++ GV+
Sbjct: 207 YSKPVDIWACGVI 219
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-23
Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVK---RLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
LG G G V G G VAVK R + V E+ + H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI--ILSTAEGLAYLHEESKL 390
T + +V E+V L D + VE + E R ILS + Y H +
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEM--EARRLFQQILS---AVDYCH---RH 130
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
++HRD+K N+LLD AKIADFGL + + T G+ Y APE V+ G+L
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPE-VISGRLY 187
Query: 451 E--KADVYSFGVVVIEVVC 467
+ D++S GV++ ++C
Sbjct: 188 AGPEVDIWSCGVILYALLC 206
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 7e-23
Identities = 53/206 (25%), Positives = 82/206 (39%), Gaps = 27/206 (13%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVK--------RLFYNTTQWVDHFFNEVNLISGINHKNL 327
LG G G V+ + V VK + + E+ ++S + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 328 VKLLGCSITGPESLLVYEF-VPNQSLLDNLFVRQDV-EPLSWEVRYKI--ILSTAEGLAY 383
+K+L LV E L + + EP Y ++S + Y
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP---LASYIFRQLVS---AVGY 145
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
L IIHRDIK NI++ E+FT K+ DFG + T GT+ Y APE
Sbjct: 146 LR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTIEYCAPE- 199
Query: 444 VVRGKLTE--KADVYSFGVVVIEVVC 467
V+ G + +++S GV + +V
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-23
Identities = 47/200 (23%), Positives = 81/200 (40%), Gaps = 12/200 (6%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN 323
+ +++ +LG G G V++ T G A K + + E+ +S +
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 212
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
H LV L E +++YEF+ L + + + +S + + + +GL +
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCH 270
Query: 384 LHEESKLRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
+HE +H D+K NI+ K+ DFGL GT + AP
Sbjct: 271 MHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAP 325
Query: 442 EYVVRGK-LTEKADVYSFGV 460
E V GK + D++S GV
Sbjct: 326 E-VAEGKPVGYYTDMWSVGV 344
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 46/216 (21%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRL--------FYNTTQWVDHFFNEVNLISGINHKN 326
K+G+G G VYK G VA+KR+ +T E++L+ ++H N
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA------IREISLLKELHHPN 80
Query: 327 LVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
+V L+ I L LV+EF+ + +LD L + G+A+
Sbjct: 81 IVSLIDV-IHSERCLTLVFEFMEKDLKKVLDENKT-----GLQDSQIKIYLYQLLRGVAH 134
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTLGYMA 440
H+ RI+HRD+K N+L++ + K+ADFGL R F TH TL Y A
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRA 187
Query: 441 PE-------YVVRGKLTEKADVYSFGVVVIEVVCRK 469
P+ Y + D++S G + E++ K
Sbjct: 188 PDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 25/180 (13%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN-----EVNLISGINHKNLV 328
+ LG+G +VYK + VA+K++ N E+ L+ ++H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 329 KLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
LL ++ LV++F+ + ++ + + L+ +L T +GL YLH
Sbjct: 76 GLLDA-FGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLH 129
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTLGYMAPE 442
+ I+HRD+K +N+LLDE K+ADFGL + F TH T Y APE
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV----TRWYRAPE 182
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 44/224 (19%), Positives = 82/224 (36%), Gaps = 26/224 (11%)
Query: 252 VNKSKLNFSYETLEKATNYFHE-----SNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT 305
+ S L ++ E + LG G +G V + G+ A+K L
Sbjct: 7 HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL---- 62
Query: 306 TQWVDHFFNEVN-LISGINHKNLVKLLG----CSITGPESLLVYEFVPNQSLLDNLFVRQ 360
EV+ ++V +L L++ E + L + +
Sbjct: 63 -YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI-QER 120
Query: 361 DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGL 417
+ + +I+ + +LH I HRD+K N+L +++ K+ DFG
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177
Query: 418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
+ ++ T T Y+APE + K + D++S GV+
Sbjct: 178 AKETTQNALQ---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 3e-22
Identities = 56/179 (31%), Positives = 81/179 (45%), Gaps = 27/179 (15%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFN-----EVNLISGINHKNLVK 329
K+G+G G VYK GE A+K++ D E++++ + H N+VK
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVK 64
Query: 330 LLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
L I + L LV+E + + LLD L +L G+AY H+
Sbjct: 65 LYDV-IHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHD 118
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTLGYMAPE 442
R++HRD+K N+L++ E KIADFGL R F TH TL Y AP+
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPD 170
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 47/204 (23%), Positives = 83/204 (40%), Gaps = 27/204 (13%)
Query: 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKN 326
+ + LG+G K +A AVK + + + + E+ + H N
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPN 67
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEG 380
+VKL + LV E + L + + ++ + I+
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK---------HFSETEASYIMRKLVSA 118
Query: 381 LAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
++++H+ + ++HRD+K N+L ++ KI DFG RL P D T TL
Sbjct: 119 VSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPCFTLH 174
Query: 438 YMAPEYVVRGKLTEKADVYSFGVV 461
Y APE + + E D++S GV+
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVI 198
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 25/211 (11%)
Query: 265 EKATNYFHESNKLGQGGSGSVY----KGTLPGGEAVAVK----RLFYNTTQWVDH--FFN 314
+K +++ +LG G V K T G A K R + + V
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKST---GLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
EV+++ + H N++ L + +L+ E V L D L + E LS E I
Sbjct: 65 EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLSEEEATSFI 121
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPEDITHISA 430
+G+ YLH +I H D+K NI+L K+ DFGL +
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFK 176
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
+ GT ++APE V L +AD++S GV+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-22
Identities = 54/223 (24%), Positives = 89/223 (39%), Gaps = 52/223 (23%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVK-----RLFYNTTQW---------------------V 309
+G+G G V A+K +L +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 310 DHFFNEVNLISGINHKNLVKLLGCSITGPESL---LVYEFVPNQSLLDNLFVRQDVEPLS 366
+ + E+ ++ ++H N+VKL+ + P +V+E V +++ PLS
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPVME--VPTLK--PLS 135
Query: 367 WEV--RY--KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422
+ Y +I G+ YLH +IIHRDIK SN+L+ E+ KIADFG+ F
Sbjct: 136 EDQARFYFQDLIK----GIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF- 187
Query: 423 EDITHISATLAGTLGYMAPEYVVRGKLTE----KADVYSFGVV 461
+ + + GT +MAPE + DV++ GV
Sbjct: 188 KGSDALLSNTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVT 229
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 50/208 (24%), Positives = 80/208 (38%), Gaps = 36/208 (17%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCS 334
LG+G V L + AVK + F EV ++ H+N+++L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEGLAYLHEES 388
LV+E + S+L ++ R+ + ++ A L +LH
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRR---------HFNELEASVVVQDVASALDFLHN-- 129
Query: 389 KLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISA------TLAGTLGYM 439
I HRD+K NIL ++ KI DF L + T G+ YM
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 440 APEYVVRGKLT------EKADVYSFGVV 461
APE VV ++ D++S GV+
Sbjct: 189 APE-VVEAFSEEASIYDKRCDLWSLGVI 215
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 6e-22
Identities = 61/199 (30%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVK---RLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
LG G G V G G VAVK R + V E+ + H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI--ILSTAEGLAYLHEESKL 390
T + +V E+V L D + ++ E R ILS G+ Y H +
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEK--ESRRLFQQILS---GVDYCH---RH 135
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
++HRD+K N+LLD AKIADFGL + + T G+ Y APE V+ G+L
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPE-VISGRLY 192
Query: 451 E--KADVYSFGVVVIEVVC 467
+ D++S GV++ ++C
Sbjct: 193 AGPEVDIWSSGVILYALLC 211
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 6e-22
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 39/221 (17%)
Query: 271 FHESNKLGQGGSGSVYKG--TLPGGEAVAVKRL--------FYNTTQWVDHFFNEVNL-- 318
+ ++G+G G V+K GG VA+KR+ +T EV +
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST------IREVAVLR 66
Query: 319 -ISGINHKNLVKLL----GCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVR 370
+ H N+V+L L LV+E V + LD + + E
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETI 122
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF--PEDITHI 428
++ GL +LH R++HRD+K NIL+ K+ADFGL R++ +T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS- 178
Query: 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
+ TL Y APE +++ D++S G + E+ RK
Sbjct: 179 ---VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 33/186 (17%)
Query: 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRL-------FYNTTQWVDHFFNEVNLISGI 322
+ + +KLG+G +VYKG VA+K + T EV+L+ +
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA------IREVSLLKDL 57
Query: 323 NHKNLVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
H N+V L I +SL LV+E++ + LD+ ++ +
Sbjct: 58 KHANIVTLHDI-IHTEKSLTLVFEYLDKDLKQYLDDCGN-----IINMHNVKLFLFQLLR 111
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTL 436
GLAY H + +++HRD+K N+L++E K+ADFGL R + + TL
Sbjct: 112 GLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV----TL 164
Query: 437 GYMAPE 442
Y P+
Sbjct: 165 WYRPPD 170
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 8e-22
Identities = 46/183 (25%), Positives = 78/183 (42%), Gaps = 34/183 (18%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL--------FYNTTQWVDHFFNEVNLISGINHK 325
K+G+G G+V+K E VA+KR+ ++ E+ L+ + HK
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA------LREICLLKELKHK 61
Query: 326 NLVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
N+V+L + + L LV+EF + D+ L E+ + +GL
Sbjct: 62 NIVRLHDV-LHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLG 115
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTLGYM 439
+ H ++HRD+K N+L++ K+A+FGL R F + TL Y
Sbjct: 116 FCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV----TLWYR 168
Query: 440 APE 442
P+
Sbjct: 169 PPD 171
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 9e-22
Identities = 61/195 (31%), Positives = 93/195 (47%), Gaps = 22/195 (11%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN---EVNLISGINHKNLVKLLG 332
LG+G G V EAVAVK + + + VD N E+ + +NH+N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKI--ILSTAEGLAYLHEESK 389
G L E+ L D + + + + +++ G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMA---GVVYLH---G 123
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEYVVRGK 448
+ I HRDIK N+LLDE KI+DFGL +F + + + GTL Y+APE +++ +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRR 182
Query: 449 L--TEKADVYSFGVV 461
E DV+S G+V
Sbjct: 183 EFHAEPVDVWSCGIV 197
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 61/224 (27%), Positives = 86/224 (38%), Gaps = 43/224 (19%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL--------FYNTTQWVDH 311
YE L +G+G G V K G VA+K+
Sbjct: 27 YENLGL----------VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA----- 71
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEV 369
E+ L+ + H+NLV LL LV+EFV + L+ L ++V
Sbjct: 72 -MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN-----GLDYQV 125
Query: 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDIT 426
K + G+ + H IIHRDIK NIL+ + K+ DFG R E
Sbjct: 126 VQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182
Query: 427 HISATLAGTLGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVVCRK 469
AT Y APE +V KA DV++ G +V E+ +
Sbjct: 183 DEVATRW----YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 51/237 (21%), Positives = 86/237 (36%), Gaps = 31/237 (13%)
Query: 237 QKRRERKQLGALQVAVNK-SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE 294
LG + N Y K +LG+G V + G+
Sbjct: 5 HHHSSGVDLGTENLYFQSMENFNNFYILTSK---------ELGRGKFAVVRQCISKSTGQ 55
Query: 295 AVAVK--RLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGCSITGPESLLVYEFVPNQS 351
A K + +E+ ++ ++ L E +L+ E+
Sbjct: 56 EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE 115
Query: 352 LLDNLFVRQDVEPLS-WEVRY--KIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---D 405
+ + + E +S +V K IL EG+ YLH+ I+H D+K NILL
Sbjct: 116 IFSLC-LPELAEMVSENDVIRLIKQIL---EGVYYLHQ---NNIVHLDLKPQNILLSSIY 168
Query: 406 EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVV 461
KI DFG+ R + GT Y+APE ++ +T D+++ G++
Sbjct: 169 PLGDIKIVDFGMSRKIGHA--CELREIMGTPEYLAPE-ILNYDPITTATDMWNIGII 222
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 1e-21
Identities = 57/183 (31%), Positives = 85/183 (46%), Gaps = 33/183 (18%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL--------FYNTTQWVDHFFNEVNLISGINHK 325
K+G+G G VYK GE VA+K++ +T E++L+ +NH
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA------IREISLLKELNHP 62
Query: 326 NLVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
N+VKLL I L LV+EF+ + +D + + + + +GLA
Sbjct: 63 NIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLA 117
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTLGYM 439
+ H R++HRD+K N+L++ E K+ADFGL R F TH TL Y
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYR 170
Query: 440 APE 442
APE
Sbjct: 171 APE 173
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 48/202 (23%), Positives = 79/202 (39%), Gaps = 20/202 (9%)
Query: 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVN-LISGINHKN 326
+Y S LG G +G V + E A+K L Q EV +
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPH 116
Query: 327 LVKLLGC---SITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
+V+++ G + L +V E + L + + + + +I+ S E +
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 383 YLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
YLH + I HRD+K N+L K+ DFG + + T T Y+
Sbjct: 176 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYV 230
Query: 440 APEYVVRGKLTEKADVYSFGVV 461
APE + K + D++S GV+
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVI 252
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 61/195 (31%), Positives = 93/195 (47%), Gaps = 22/195 (11%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN---EVNLISGINHKNLVKLLG 332
LG+G G V EAVAVK + + + VD N E+ + +NH+N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKI--ILSTAEGLAYLHEESK 389
G L E+ L D + + + + +++ G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMA---GVVYLH---G 123
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEYVVRGK 448
+ I HRDIK N+LLDE KI+DFGL +F + + + GTL Y+APE +++ +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRR 182
Query: 449 L--TEKADVYSFGVV 461
E DV+S G+V
Sbjct: 183 EFHAEPVDVWSCGIV 197
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 52/237 (21%), Positives = 97/237 (40%), Gaps = 48/237 (20%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN---- 314
+ E K + F GQG G+V G G +VA+K++ + F N
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQ 68
Query: 315 EVNLISGINHKNLVKLLGCSITGPES-------LLVYEFVP---NQSLLDNLFVRQDVEP 364
+ ++ ++H N+V+L T E +V E+VP ++ + + P
Sbjct: 69 IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPP 128
Query: 365 LSWEVRYKI--ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLF 421
+ ++ + ++ + LH S + + HRDIK N+L++E T K+ DFG +
Sbjct: 129 I--LIKVFLFQLI---RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 422 PEDITHIS--ATLAGTLGYMAPE-------YVVRGKLTEKADVYSFGVVVIEVVCRK 469
+++ + Y APE Y T D++S G + E++ +
Sbjct: 183 SPSEPNVAYICSRY----YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 19/208 (9%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK------RLFYNTTQWVDHFFNEVN 317
+K +++ +LG G V K G A K + EV+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
++ + H N++ L + +L+ E V L D L + E LS E I
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQI 124
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPEDITHISATLA 433
+G+ YLH +I H D+K NI+L K+ DFGL + +
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIF 179
Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVV 461
GT ++APE V L +AD++S GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 19/197 (9%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVK----RLFYNTTQWVDH--FFNEVNLISGINHKNLV 328
+LG G V K G+ A K R ++ + V EVN++ I H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
L + +L+ E V L D L + E L+ + + + +G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHS-- 126
Query: 389 KLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
RI H D+K NI+L K+ DFG+ + GT ++APE V
Sbjct: 127 -KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEIV 183
Query: 445 VRGKLTEKADVYSFGVV 461
L +AD++S GV+
Sbjct: 184 NYEPLGLEADMWSIGVI 200
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 33/210 (15%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYN-TTQWVD-----HFFNEVN----LISGINHK 325
LG+GG G+V+ G L VA+K + N W EV + +G H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 326 NLVKLLGCSITGPESLLVYEF-VPNQSLLDNLFVRQDV-EPLSWEVRYK---IILSTAEG 380
+++LL T +LV E +P Q L D + + + E R ++
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG---PSRCFFGQVV----AA 151
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
+ + H ++HRDIK NIL+D AK+ DFG L ++ GT Y
Sbjct: 152 IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT---DFDGTRVYS 205
Query: 440 APEYVVRGKLTE--KADVYSFGVVVIEVVC 467
PE + A V+S G+++ ++VC
Sbjct: 206 PPE-WISRHQYHALPATVWSLGILLYDMVC 234
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 20/199 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVK---RLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
LG+G G V T + VA+K R + E++ + + H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI--ILSTAEGLAYLHEESKL 390
T + ++V E+ + L D + ++ + E R I+ + Y H +
Sbjct: 77 VITTPTDIVMVIEYAGGE-LFDYIVEKKRMTE--DEGRRFFQQIIC---AIEYCH---RH 127
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
+I+HRD+K N+LLD+ KIADFGL + + + T G+ Y APE V+ GKL
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPE-VINGKLY 184
Query: 451 E--KADVYSFGVVVIEVVC 467
+ DV+S G+V+ ++
Sbjct: 185 AGPEVDVWSCGIVLYVMLV 203
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-21
Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 26/226 (11%)
Query: 256 KLNFSYETLEKAT-NYFHESNKLGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQ 307
L + + + ++F + LG+GG G V+ K T G+ A K+L +
Sbjct: 171 FLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRK 227
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLS 366
E +++ ++ + +V L T L LV + + +++ + P
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLAYAFET-KTDLCLVMTIMNGGDIRYHIYNVDEDNPGF 286
Query: 367 WEVRYK-----IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
E R I+ GL +LH+ II+RD+K N+LLD++ +I+D GL
Sbjct: 287 QEPRAIFYTAQIVS----GLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339
Query: 422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
T AGT G+MAPE ++ + D ++ GV + E++
Sbjct: 340 KAGQTKTK-GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 6e-21
Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 35/220 (15%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKG----TLPGGEAVAVKRL-FYNTTQWVDHF-FN 314
YE + K +G+G G V+K T G+ VA+K+ +
Sbjct: 5 YEKIGK----------IGEGSYGVVFKCRNRDT---GQIVAIKKFLESEDDPVIKKIALR 51
Query: 315 EVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI 373
E+ ++ + H NLV LL L LV+E+ + ++L + + + + I
Sbjct: 52 EIRMLKQLKHPNLVNLLEV-FRRKRRLHLVFEYC-DHTVLH--ELDRYQRGVPEHLVKSI 107
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF--PEDI-THISA 430
T + + + H K IHRD+K NIL+ + K+ DFG RL P D A
Sbjct: 108 TWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA 164
Query: 431 TLAGTLGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVVCRK 469
T Y +PE +V DV++ G V E++
Sbjct: 165 ----TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 6e-21
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 276 KLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLVKLLGC 333
+G G G VY+ L GE VA+K++ + F N E+ ++ ++H N+V+L
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYF 115
Query: 334 SITGPESL------LVYEFVP---NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
+ E LV ++VP + +Q + + V+ + LAY+
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI--YVKL-YMYQLFRSLAYI 172
Query: 385 HEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHIS--ATLAGTLGYMAP 441
H I HRDIK N+LLD + K+ DFG + ++S + Y AP
Sbjct: 173 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----YRAP 225
Query: 442 EYVVRGKL-TEKADVYSFGVVVIEVVCRK 469
E + T DV+S G V+ E++ +
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-21
Identities = 38/206 (18%), Positives = 72/206 (34%), Gaps = 25/206 (12%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGI 322
++ + + LG+G G V++ + K F E+++++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK--FVKVKGTDQVLVKKEISILNIA 58
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILS 376
H+N++ L + E ++++EF+ + + + +
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTS--------AFELNEREIVSYVHQ 110
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFPEDITHISATLAG 434
E L +LH I H DI+ NI+ T KI +FG R L
Sbjct: 111 VCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFT 165
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGV 460
Y APE ++ D++S G
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGT 191
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 8e-21
Identities = 43/226 (19%), Positives = 85/226 (37%), Gaps = 33/226 (14%)
Query: 252 VNKSKLNFSYETLEKATNYFHE----SNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTT 306
+ ++ + L + + F + +G G + AVK + + +
Sbjct: 1 MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII--DKS 58
Query: 307 QWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPL 365
+ E+ L+ H N++ L G +V E + LLD + ++
Sbjct: 59 K--RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK----- 111
Query: 366 SWEVRY------KIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADF 415
+ ++ + + + YLH ++HRD+K SNIL + +I DF
Sbjct: 112 ----FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDF 164
Query: 416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
G + + + T T ++APE + R D++S GV+
Sbjct: 165 GFAKQLRAE-NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVL 209
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 56/222 (25%), Positives = 85/222 (38%), Gaps = 47/222 (21%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL------FYNTTQWVDHFFNEVN 317
E +Y+ +LG G V K G A K + + EV+
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-------------FVRQDVEP 364
++ I H N++ L + +L+ E V L D L F++Q
Sbjct: 67 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ---- 122
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRL 420
IL G+ YLH L+I H D+K NI+L + KI DFGL
Sbjct: 123 ---------IL---NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 421 FPEDITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVV 461
+ GT ++APE +V + L +AD++S GV+
Sbjct: 168 IDFGNEF--KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVI 206
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 50/203 (24%), Positives = 82/203 (40%), Gaps = 31/203 (15%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVK----RLFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
LG+G G V + AVK + + E+ L+ + HKN+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 332 GCSITGPES----LLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYK---IILSTAEGLA 382
+ E +V E+ Q +LD++ ++ + +I +GL
Sbjct: 73 --DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV---CQAHGYFCQLI----DGLE 123
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAP 441
YLH I+H+DIK N+LL T KI+ G+ P T G+ + P
Sbjct: 124 YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 442 EYVVRGKLT---EKADVYSFGVV 461
E + G T K D++S GV
Sbjct: 181 E-IANGLDTFSGFKVDIWSAGVT 202
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 50/194 (25%), Positives = 83/194 (42%), Gaps = 36/194 (18%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL--------FYNTTQWVDHFFNEVNLISG 321
+ + K+GQG G V+K G+ VA+K++ F T E+ ++
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA------LREIKILQL 72
Query: 322 INHKNLVKLLG-------CSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRY 371
+ H+N+V L+ S+ LV++F + LL N+ V +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIK 127
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
+++ GL Y+H +I+HRD+K +N+L+ + K+ADFGL R F
Sbjct: 128 RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 432 LAG---TLGYMAPE 442
TL Y PE
Sbjct: 185 YTNRVVTLWYRPPE 198
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 53/188 (28%), Positives = 76/188 (40%), Gaps = 40/188 (21%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL--------FYNTTQWVDHFFNEVNLISGINHK 325
KLG+G G VYK E VA+KR+ T EV+L+ + H+
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA------IREVSLLKELQHR 93
Query: 326 NLVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
N+++L I L L++E+ N + +D +S V + G+
Sbjct: 94 NIIELKSV-IHHNHRLHLIFEYAENDLKKYMDKN------PDVSMRVIKSFLYQLINGVN 146
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTA-----KIADFGLVRLF---PEDITHISATLAG 434
+ H R +HRD+K N+LL + KI DFGL R F TH
Sbjct: 147 FCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII---- 199
Query: 435 TLGYMAPE 442
TL Y PE
Sbjct: 200 TLWYRPPE 207
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 31/223 (13%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFN--EVNLI 319
+T E+ + +G G G V++ L + VA+K++ D F E+ ++
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL------QDKRFKNRELQIM 86
Query: 320 SGINHKNLVKLLGCSITGPESL------LVYEFVP---NQSLLDNLFVRQDVEPLSWEVR 370
+ H N+V L + + LV E+VP ++ ++Q + L ++
Sbjct: 87 RIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML--LIK 144
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHIS 429
+ LAY+H + I HRDIK N+LLD K+ DFG ++ ++S
Sbjct: 145 L-YMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200
Query: 430 --ATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRK 469
+ Y APE + T D++S G V+ E++ +
Sbjct: 201 YICSRY----YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 25/224 (11%)
Query: 256 KLNFSYETLEKAT-NYFHESNKLGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQ 307
L + + + T N F + LG+GG G V + T G+ A K+L +
Sbjct: 170 FLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRK 226
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLS 366
NE ++ +N + +V L T ++L LV + L ++ +
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLTLMNGGDLKFHI--YHMGQAGF 283
Query: 367 WEVRYKIILSTAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
E R AE GL LH E RI++RD+K NILLD+ +I+D GL PE
Sbjct: 284 PEARAVFY--AAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
T GT+GYMAPE V + T D ++ G ++ E++
Sbjct: 339 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 6e-20
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKN--- 326
+G+GG G VY T G+ A+K L Q NE ++S ++ +
Sbjct: 197 IGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 327 LVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLA 382
+V + T P+ L + + + L +L + V + Y AE GL
Sbjct: 254 IVCMSYAFHT-PDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFY-----AAEIILGLE 306
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
++H +++RD+K +NILLDE +I+D GL F + H GT GYMAPE
Sbjct: 307 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPE 360
Query: 443 YVVRGKL-TEKADVYSFGVVVIEVVC 467
+ +G AD +S G ++ +++
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLR 386
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 54/172 (31%), Positives = 77/172 (44%), Gaps = 25/172 (14%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDV---EP 364
V + F E+ ++ G+ H LV L E + +V + + L +L +Q+V E
Sbjct: 59 VRNVFKELQIMQGLEHPFLVNLWYSFQD-EEDMFMVVDLLLGGDLRYHL--QQNVHFKEE 115
Query: 365 LSWEVRYKIILSTAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
V+ I E L YL RIIHRD+K NILLDE I DF + +
Sbjct: 116 ---TVKLFI----CELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165
Query: 422 PEDITHISATLAGTLGYMAPEYVVRGKL---TEKADVYSFGVVVIEVVCRKR 470
P + T+AGT YMAPE K + D +S GV E++ +R
Sbjct: 166 PRETQI--TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 52/194 (26%), Positives = 80/194 (41%), Gaps = 23/194 (11%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLGCS 334
+G G G E VAVK + +D + E+ + H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVK--YIERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKI--ILSTAEGLAYLHEESKLR 391
+T ++ E+ L + + E E R+ +LS G++Y H ++
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSED---EARFFFQQLLS---GVSYCH---SMQ 136
Query: 392 IIHRDIKLSNILLDEEFTA--KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
I HRD+KL N LLD KI DFG + + GT Y+APE V+ +
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPE-VLLRQE 193
Query: 450 TE--KADVYSFGVV 461
+ ADV+S GV
Sbjct: 194 YDGKIADVWSCGVT 207
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 33/210 (15%)
Query: 254 KSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKG---TLPGGEAVAVKRL----FYNTT 306
K KL+ E +E Y E K+G+G G VYK + A+K++ +
Sbjct: 8 KVKLSSERERVEDLFEY--EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA 65
Query: 307 QWVDHFFNEVNLISGINHKNLVKLLG-CSITGPESL-LVYEFVPN--QSLLDNLFVRQDV 362
E+ L+ + H N++ L + L++++ + ++ +
Sbjct: 66 C------REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 119
Query: 363 E---PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA----KIADF 415
+ L + ++ +G+ YLH ++HRD+K +NIL+ E KIAD
Sbjct: 120 KKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 176
Query: 416 GLVRLF---PEDITHISATLAGTLGYMAPE 442
G RLF + + + + T Y APE
Sbjct: 177 GFARLFNSPLKPLADLDPVVV-TFWYRAPE 205
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 33/207 (15%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHKNLV 328
LG+G +V T A+K L + V + E +++S ++H V
Sbjct: 38 LGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPFFV 93
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEV-R-YKIILSTAE---GLA 382
KL E L + N LL + + + R Y TAE L
Sbjct: 94 KLYFTFQD-DEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFY-----TAEIVSALE 144
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA-TLAGTLGYMAP 441
YLH IIHRD+K NILL+E+ +I DFG ++ + A + GT Y++P
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 442 EYVVRGKLTEKA-DVYSFGVVVIEVVC 467
E ++ K K+ D+++ G ++ ++V
Sbjct: 202 E-LLTEKSACKSSDLWALGCIIYQLVA 227
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 30/208 (14%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVK 329
+G+G G V K + A+K L F E +++ + K +
Sbjct: 82 IGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 330 LLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYLH 385
L + +L LV ++ LL L +D P Y AE + +H
Sbjct: 139 LH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY-----LAEMVIAIDSVH 192
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
+L +HRDIK NIL+D ++ADFG ED T S+ GT Y++PE ++
Sbjct: 193 ---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE-IL 248
Query: 446 RGKLTEK------ADVYSFGVVVIEVVC 467
+ K D +S GV + E++
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 59/207 (28%), Positives = 84/207 (40%), Gaps = 34/207 (16%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
LG+G G V K T G A+K L V H E ++ H L
Sbjct: 156 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 330 LLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS---TAE---GLA 382
L T + L V E+ LF LS E + + AE L
Sbjct: 213 LKYSFQT-HDRLCFVMEYANG----GELFFH-----LSRERVFSEDRARFYGAEIVSALD 262
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMA 440
YLH S+ +++RD+KL N++LD++ KI DFGL + + T GT Y+A
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK---TFCGTPEYLA 317
Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVC 467
PE + D + GVV+ E++C
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMC 344
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 7e-18
Identities = 22/192 (11%), Positives = 46/192 (23%), Gaps = 44/192 (22%)
Query: 276 KLGQGGSGSVYKGT---LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
G ++ L VA+ + + + +S I+ + +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
+L T L+V E++ SL + S + + S A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHRAG- 149
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
+ S + + + +A M
Sbjct: 150 --VALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA------- 179
Query: 450 TEKADVYSFGVV 461
+ D+ G
Sbjct: 180 NPQDDIRGIGAS 191
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 59/207 (28%), Positives = 82/207 (39%), Gaps = 35/207 (16%)
Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
LG+G G V K T G A+K L V H E ++ H L
Sbjct: 13 LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 330 LLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS---TAE---GLA 382
L T + L V E+ LF LS E + + AE L
Sbjct: 70 LKYAFQT-HDRLCFVMEYANG----GELFFH-----LSRERVFTEERARFYGAEIVSALE 119
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMA 440
YLH +++RDIKL N++LD++ KI DFGL + + T GT Y+A
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK---TFCGTPEYLA 173
Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVC 467
PE + D + GVV+ E++C
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMC 200
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 30/234 (12%)
Query: 253 NKSKLNFSYETLEKATNYFHESNK------LGQGGSGSVYKGT-LPGGEAVAVKRL---F 302
+KSK++ + ++E + F + +G G G V VA+K+L F
Sbjct: 40 SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 99
Query: 303 YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLLDN 355
N T + E+ L+ +NHKN++ LL T ++L LV E + + L
Sbjct: 100 QNQTH-AKRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELM--DANLCQ 155
Query: 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415
+ ++ +++ + Y ++ G+ +LH IIHRD+K SNI++ + T KI DF
Sbjct: 156 V-IQMELDHE--RMSY-LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 208
Query: 416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
GL R + T Y APE ++ E D++S G ++ E+V K
Sbjct: 209 GLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 3e-17
Identities = 61/205 (29%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
LG+G G V KGT E AVK L V+ E L L
Sbjct: 349 LGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
+L C T + L V E+V L+ ++ + V Y AE GL +L
Sbjct: 406 QLHSCFQT-MDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFY-----AAEIAIGLFFL 458
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMAPE 442
II+RD+KL N++LD E KIADFG+ + ++ T T GT Y+APE
Sbjct: 459 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK---TFCGTPDYIAPE 512
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVC 467
+ + D ++FGV++ E++
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLA 537
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 32/204 (15%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHKNLV 328
LG G G V K + G A+K L Q ++H NE ++ +N LV
Sbjct: 49 LGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFPFLV 104
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
KL +L +V E+V + +L + + S E + A+ YL
Sbjct: 105 KLEFSFKD-NSNLYMVMEYVAGGEMFSHL---RRIGRFS-EPHARFY--AAQIVLTFEYL 157
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
H L +I+RD+K N+L+D++ ++ DFG + + T TL GT +APE +
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW---TLCGTPEALAPE-I 209
Query: 445 VRGKLTEKA-DVYSFGVVVIEVVC 467
+ K KA D ++ GV++ E+
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 51/209 (24%), Positives = 77/209 (36%), Gaps = 30/209 (14%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
+G+G V K T G+ A+K + V F E +++ + + + +
Sbjct: 69 IGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 330 LLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYLH 385
L + L LV E+ LL L + P Y AE + +H
Sbjct: 126 LH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY-----LAEIVMAIDSVH 179
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
+L +HRDIK NILLD ++ADFG D T S GT Y++PE +
Sbjct: 180 ---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 446 RGKLTEKADVY-------SFGVVVIEVVC 467
Y + GV E+
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 32/208 (15%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
+G G G+V G VA+K+L F + + E+ L+ + H+N++ LL
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF-AKRAYRELRLLKHMRHENVIGLLD 91
Query: 333 CSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI--ILSTAEGLA 382
T E+L LV F+ + L L + L + +++ + +L GL
Sbjct: 92 V-FTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE---KLGEDRIQFLVYQMLK---GLR 142
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
Y+H IIHRD+K N+ ++E+ KI DFGL R ++T T Y APE
Sbjct: 143 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----YRAPE 195
Query: 443 YVV-RGKLTEKADVYSFGVVVIEVVCRK 469
++ + T+ D++S G ++ E++ K
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 7e-17
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 38/207 (18%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHKNLV 328
LG G G V+ + G A+K L Q V+H +E ++S + H ++
Sbjct: 14 LGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTHPFII 69
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS---TAE---GL 381
++ G + + ++ +++ L F L R+ ++ AE L
Sbjct: 70 RMWGTFQD-AQQIFMIMDYIEGGEL----FSL-----LRKSQRFPNPVAKFYAAEVCLAL 119
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
YLH II+RD+K NILLD+ KI DFG + P D+T+ TL GT Y+AP
Sbjct: 120 EYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTY---TLCGTPDYIAP 172
Query: 442 EYVVRGKLTEKA-DVYSFGVVVIEVVC 467
E VV K K+ D +SFG+++ E++
Sbjct: 173 E-VVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 8e-17
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGIN 323
+ +G G GSV GE VA+K+L F + + E+ L+ +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF-AKRAYRELLLLKHMQ 81
Query: 324 HKNLVKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI-- 373
H+N++ LL T SL LV F+ Q+ L + + S E ++Y +
Sbjct: 82 HENVIGLLDV-FTPASSLRNFYDFYLVMPFM--QTDLQKI-MGL---KFSEEKIQYLVYQ 134
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
+L GL Y+H ++HRD+K N+ ++E+ KI DFGL R ++T T
Sbjct: 135 MLK---GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW 188
Query: 434 GTLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVVCRK 469
Y APE ++ + D++S G ++ E++ K
Sbjct: 189 ----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 63/244 (25%), Positives = 104/244 (42%), Gaps = 38/244 (15%)
Query: 240 RERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAV 298
R ++ V + S + L++ + +G G G V VA+
Sbjct: 4 RSKRDNNFYSVEIGDST----FTVLKR----YQNLKPIGSGAQGIVCAAYDAILERNVAI 55
Query: 299 KRL---FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVP 348
K+L F N T + E+ L+ +NHKN++ LL T +SL +V E +
Sbjct: 56 KKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGLLNV-FTPQKSLEEFQDVYIVMELM- 112
Query: 349 NQSLLDNLFVRQDVEPLSWE-VRYKI--ILSTAEGLAYLHEESKLRIIHRDIKLSNILLD 405
+ L + ++ L E + Y + +L G+ +LH IIHRD+K SNI++
Sbjct: 113 -DANLCQV-IQM---ELDHERMSYLLYQMLC---GIKHLHSAG---IIHRDLKPSNIVVK 161
Query: 406 EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
+ T KI DFGL R + T Y APE ++ E D++S G ++ E+
Sbjct: 162 SDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 466 VCRK 469
+
Sbjct: 220 IKGG 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 58/240 (24%), Positives = 94/240 (39%), Gaps = 45/240 (18%)
Query: 260 SYETLEKATNYFHESNK------LGQGGSGSVYKGTLPGGEAVAVKRLF--YNTTQWVDH 311
+ + + G G+V G G VA+KR+F + + V+
Sbjct: 7 EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI 66
Query: 312 FFN---------EVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLLDN 355
+ E+ L++ +H N++ L I LV E + ++ L
Sbjct: 67 LSDSFLCKRVLREIRLLNHFHHPNILGLR--DIFVHFEEPAMHKLYLVTELM--RTDLAQ 122
Query: 356 LFVRQDVEPLSWE-VRYKI--ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412
+ + +S + ++Y + IL GL LHE ++HRD+ NILL + I
Sbjct: 123 V-IHDQRIVISPQHIQYFMYHILL---GLHVLHEAG---VVHRDLHPGNILLADNNDITI 175
Query: 413 ADFGLVRLFPED--ITHISATLAGTLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVVCRK 469
DF L R D TH Y APE V+ T+ D++S G V+ E+ RK
Sbjct: 176 CDFNLAREDTADANKTHYVTHRW----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 41/212 (19%)
Query: 277 LGQGGSGSVY-------KGTLPGGEAVAVK-----RLFYNTTQWVDHFFNEVNLISGINH 324
LG+GG G V+ T G+ A+K + N H E N++ + H
Sbjct: 25 LGKGGYGKVFQVRKVTGANT---GKIFAMKVLKKAMIVRNAKD-TAHTKAERNILEEVKH 80
Query: 325 KNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS---TAE- 379
+V L+ T L L+ E++ LF++ L E + + AE
Sbjct: 81 PFIVDLIYAFQT-GGKLYLILEYLSG----GELFMQ-----LEREGIFMEDTACFYLAEI 130
Query: 380 --GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL--VRLFPEDITHISATLAGT 435
L +LH+ II+RD+K NI+L+ + K+ DFGL + +TH T GT
Sbjct: 131 SMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH---TFCGT 184
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
+ YMAPE ++R D +S G ++ +++
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLT 216
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 30/205 (14%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
+G+G V K T A++ + N + +D E + NH LV
Sbjct: 60 IGRGSYAKVLLVRLKKT---DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
L C T L V E+V L+ ++ RQ P Y +AE L YL
Sbjct: 117 GLHSCFQT-ESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFY-----SAEISLALNYL 169
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMAPE 442
HE II+RD+KL N+LLD E K+ D+G+ + L P D T T GT Y+APE
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS---TFCGTPNYIAPE 223
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVC 467
+ D ++ GV++ E++
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMA 248
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 32/206 (15%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
+G+G V K T A+K + N + +D E + NH LV
Sbjct: 17 IGRGSYAKVLLVRLKKT---DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
L C T L V E+V L+ ++ RQ P Y +AE L YL
Sbjct: 74 GLHSCFQT-ESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFY-----SAEISLALNYL 126
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMAPE 442
HE II+RD+KL N+LLD E K+ D+G+ + L P D T T GT Y+APE
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS---TFCGTPNYIAPE 180
Query: 443 YVVRGKLTEKA-DVYSFGVVVIEVVC 467
++RG+ + D ++ GV++ E++
Sbjct: 181 -ILRGEDYGFSVDWWALGVLMFEMMA 205
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 61/205 (29%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
LG+G G V KGT E AVK L V+ E L L
Sbjct: 28 LGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
+L C T + L V E+V L+ ++ + V Y AE GL +L
Sbjct: 85 QLHSCFQT-MDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFY-----AAEIAIGLFFL 137
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMAPE 442
II+RD+KL N++LD E KIADFG+ + ++ T T GT Y+APE
Sbjct: 138 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK---TFCGTPDYIAPE 191
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVC 467
+ + D ++FGV++ E++
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLA 216
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 3e-16
Identities = 41/96 (42%), Positives = 55/96 (57%), Gaps = 11/96 (11%)
Query: 377 TAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL--VRLFPEDITHISAT 431
AE L +LH L II+RD+K NILLDEE K+ DFGL + E + +
Sbjct: 132 LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---S 185
Query: 432 LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
GT+ YMAPE V R T+ AD +SFGV++ E++
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 48/255 (18%), Positives = 97/255 (38%), Gaps = 66/255 (25%)
Query: 264 LEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN-EVNLISG 321
LE ++ + LG G G V + + G+ A+K++ + + N E++++
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKV 56
Query: 322 INHKNLVKLLGCSITGPESL--------------------------------------LV 343
++H N++KL+ T + ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 344 YEFVP---NQSLLDNLFVRQDVEPLSWEVRYKI--ILSTAEGLAYLHEESKLRIIHRDIK 398
E+VP ++ L + + + + I + + ++H L I HRDIK
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMN--LISIYIYQLF---RAVGFIH---SLGICHRDIK 168
Query: 399 LSNILLDEE-FTAKIADFGLVRLFPEDITHIS--ATLAGTLGYMAPEYVVRGKL-TEKAD 454
N+L++ + T K+ DFG + ++ + Y APE ++ T D
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF----YRAPELMLGATEYTPSID 224
Query: 455 VYSFGVVVIEVVCRK 469
++S G V E++ K
Sbjct: 225 LWSIGCVFGELILGK 239
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 33/208 (15%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHKNLV 328
+G+G G V K T + A+K L + F+ E ++++ N +V
Sbjct: 77 IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSD-SAFFWEERDIMAFANSPWVV 132
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
+L L +V E++P L+ NL DV P W Y TAE L +
Sbjct: 133 QLFYAFQD-DRYLYMVMEYMPGGDLV-NLMSNYDV-PEKWARFY-----TAEVVLALDAI 184
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
H + IHRD+K N+LLD+ K+ADFG ++ T GT Y++PE V
Sbjct: 185 H---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE-V 240
Query: 445 VRGKLTEKA-----DVYSFGVVVIEVVC 467
++ + + D +S GV + E++
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLV 268
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 30/205 (14%)
Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
LG+G G V +K T + A+K L V+ E L H L
Sbjct: 25 LGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
+ T E+L V E++ L+ ++ LS Y AE GL +L
Sbjct: 82 HMFCTFQT-KENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFY-----AAEIILGLQFL 134
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMAPE 442
H I++RD+KL NILLD++ KIADFG+ + + + T+ T GT Y+APE
Sbjct: 135 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN---TFCGTPDYIAPE 188
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVC 467
++ K D +SFGV++ E++
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLI 213
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 9e-16
Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 12/94 (12%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
A+G+ +L S+ + IHRD+ NILL E+ KI DFGL R DI +
Sbjct: 203 AKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGDA 255
Query: 438 -----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
+MAPE + T ++DV+SFGV++ E+
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 32/152 (21%), Positives = 56/152 (36%), Gaps = 19/152 (12%)
Query: 275 NKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
LG+G G V + G VAVK L T +E+ ++ I +H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
+V LLG C+ G +++ EF +L L R + + +G +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
+ + I D+K + ++ + F
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 65/205 (31%), Positives = 90/205 (43%), Gaps = 30/205 (14%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
LG+G G V K T G+ AVK L V+ E L NH L
Sbjct: 31 LGKGSFGKVMLARVKET---GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
+L C T P+ L V EFV L+ ++ Q E R + AE L +L
Sbjct: 88 QLFCCFQT-PDRLFFVMEFVNGGDLMFHI---QKSRRFD-EARARFY--AAEIISALMFL 140
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGL--VRLFPEDITHISATLAGTLGYMAPE 442
H+ II+RD+KL N+LLD E K+ADFG+ + T T GT Y+APE
Sbjct: 141 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA---TFCGTPDYIAPE 194
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVC 467
+ D ++ GV++ E++C
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLC 219
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 38/97 (39%), Positives = 53/97 (54%), Gaps = 10/97 (10%)
Query: 377 TAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
E L +LH+ L II+RDIKL NILLD + DFGL + F D T +
Sbjct: 165 VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221
Query: 434 GTLGYMAPEYVVRGKL---TEKADVYSFGVVVIEVVC 467
GT+ YMAP+ +VRG + D +S GV++ E++
Sbjct: 222 GTIEYMAPD-IVRGGDSGHDKAVDWWSLGVLMYELLT 257
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 56/207 (27%), Positives = 82/207 (39%), Gaps = 34/207 (16%)
Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
+G+G G V K AVK L + H +E N L+ + H LV
Sbjct: 46 IGKGSFGKVLLARHKAE---EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK-----IILSTAEGLA 382
L T + L V +++ L +L Q E R + I L
Sbjct: 103 GLHFSFQT-ADKLYFVLDYINGGELFYHL---QRERCFL-EPRARFYAAEIAS----ALG 153
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMA 440
YLH L I++RD+K NILLD + + DFGL + + T T GT Y+A
Sbjct: 154 YLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS---TFCGTPEYLA 207
Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVC 467
PE + + D + G V+ E++
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLY 234
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINH 324
+ + +G+G G V VA+K++ F + T E+ ++ H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLREIKILLRFRH 84
Query: 325 KNLVKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI--I 374
+N++ + I ++ +V + + ++ L L Q LS + + Y + I
Sbjct: 85 ENIIGIN--DIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQ---HLSNDHICYFLYQI 137
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
L GL Y+H + ++HRD+K SN+LL+ KI DFGL R+ D H + L
Sbjct: 138 LR---GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH-TGFLTE 190
Query: 435 ---TLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRK 469
T Y APE ++ K T+ D++S G ++ E++ +
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 47/193 (24%), Positives = 84/193 (43%), Gaps = 32/193 (16%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVD--HFFNEVNLISGINHKNLVK 329
+G+G G VY + VA+K++ F + D E+ +++ + +++
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI---DCKRILREITILNRLKSDYIIR 89
Query: 330 LLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI--ILSTAE 379
L + P+ L +V E S L LF L+ E ++ + +L
Sbjct: 90 LY--DLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPI--FLTEEHIKTILYNLLL--- 140
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
G ++HE IIHRD+K +N LL+++ + K+ DFGL R + E T+I L
Sbjct: 141 GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 439 MAPEYVVRGKLTE 451
++ +LT
Sbjct: 198 GPHNKNLKKQLTS 210
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 56/222 (25%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
+ + + LG GG+G V+ + VA+K++ Q V H E+ +I ++H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV-----------EPLSWE-VRYKI- 373
+VK+ I GP + + V + + L+++++ Q+ PL E R +
Sbjct: 70 IVKVF--EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY 127
Query: 374 -ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDITHISAT 431
+L GL Y+H + ++HRD+K +N+ ++ E KI DFGL R+ +H
Sbjct: 128 QLLR---GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH-KGH 180
Query: 432 LAG---TLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRK 469
L+ T Y +P ++ T+ D+++ G + E++ K
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 42/198 (21%), Positives = 76/198 (38%), Gaps = 40/198 (20%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD--HFFNEVNLISGINHKNLVKLLG 332
+G G G V + VA+K++ +D E+ +++ +NH ++VK+L
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL- 118
Query: 333 CSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI--ILSTAEGLA 382
I P+ + +V E S LF L+ ++ + +L G+
Sbjct: 119 -DIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPV--YLTELHIKTLLYNLLV---GVK 170
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP- 441
Y+H I+HRD+K +N L++++ + K+ DFGL R S
Sbjct: 171 YVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 442 --------------EYVV 445
+VV
Sbjct: 228 VTFPHTKNLKRQLTGHVV 245
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 38/238 (15%)
Query: 253 NKSKLNFSYETLEKATNYFHESNK------LGQGGSGSVYKGT-LPGGEAVAVKRL---F 302
+ S+ ++ E + + +G G GSV G VAVK+L F
Sbjct: 7 HHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 66
Query: 303 YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLLDN 355
+ + E+ L+ + H+N++ LL T SL LV + + L+N
Sbjct: 67 QSIIH-AKRTYRELRLLKHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM--GADLNN 122
Query: 356 LFVRQDVEPLSWE-VRYKI--ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412
+ Q L+ + V++ I IL GL Y+H IIHRD+K SN+ ++E+ KI
Sbjct: 123 IVKCQ---KLTDDHVQFLIYQILR---GLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 173
Query: 413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRK 469
DFGL R +++T AT Y APE ++ + D++S G ++ E++ +
Sbjct: 174 LDFGLARHTADEMTGYVATRW----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 41/233 (17%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL--FYNTTQWVDHFFNEVNL 318
+ ++ F + LG+G G V T P GE VA+K++ F E+ +
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF-ALRTLREIKI 62
Query: 319 ISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VR 370
+ H+N++ + +I P+S ++ E + Q+ L + Q LS + ++
Sbjct: 63 LKHFKHENIITIF--NIQRPDSFENFNEVYIIQELM--QTDLHRVISTQ---MLSDDHIQ 115
Query: 371 YKI--ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
Y I L + LH + +IHRD+K SN+L++ K+ DFGL R+ E
Sbjct: 116 YFIYQTLR---AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD- 168
Query: 429 SATLAGTLGYMAPEYVV------------RGKLTEKADVYSFGVVVIEVVCRK 469
++ G M E+V K + DV+S G ++ E+ R+
Sbjct: 169 NSEPTGQQSGM-VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 50/210 (23%), Positives = 96/210 (45%), Gaps = 36/210 (17%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDH--FFNEVNLISGI-NHKNLVKL 330
KLG+G V++ + E V VK L + V E+ ++ + N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITL 96
Query: 331 LGCSITGPES---LLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKI--ILSTAEGLAYL 384
+ P S LV+E V N +Q + L+ +++R+ + IL + L Y
Sbjct: 97 ADI-VKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEIL---KALDYC 146
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVRLF--PEDITHISATLAGTLGYMAP 441
H S I+HRD+K N+++D E ++ D+GL + ++ A+ + P
Sbjct: 147 H--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY----FKGP 199
Query: 442 EYVVRGKLTEKA-DVYSFGVVVIEVVCRKR 470
E +V ++ + + D++S G ++ ++ RK
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 44/202 (21%), Positives = 71/202 (35%), Gaps = 41/202 (20%)
Query: 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVN-LISGINHKN 326
+Y S LG G +G V + E A+K L Q EV +
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPH 72
Query: 327 LVKLLGC---SITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
+V+++ G + L +V E + L + + + + +I+ S E +
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 383 YLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
YLH + I HRD+K N+L K+ DFG
Sbjct: 132 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------- 166
Query: 440 APEYVVRGKLTEKADVYSFGVV 461
A E K + D++S GV+
Sbjct: 167 AKE-TTGEKYDKSCDMWSLGVI 187
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 52/191 (27%), Positives = 89/191 (46%), Gaps = 30/191 (15%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVD--HFFNEVNLISGIN-HKNL 327
KLG+G G V+K GE VAVK++ F N+T D F E+ +++ ++ H+N+
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST---DAQRTFREIMILTELSGHENI 71
Query: 328 VKLLGCSITGPESL----LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI--ILSTAEG 380
V LL ++ ++ LV++++ ++ L + L +Y + ++
Sbjct: 72 VNLL--NVLRADNDRDVYLVFDYM--ETDLHAVIRAN---ILEPVHKQYVVYQLIK---V 121
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMA 440
+ YLH ++HRD+K SNILL+ E K+ADFGL R F +
Sbjct: 122 IKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 441 PEYVVRGKLTE 451
+ LT+
Sbjct: 179 NFDDDQPILTD 189
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 33/225 (14%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN----------- 323
KLG G +V+ + VA+K + + + +E+ L+ +N
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 324 HKNLVKLLGC-SITGPESL---LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
+++KLL + GP + +V+E V ++LL L + + + +I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLA-LIKKYEHRGIPLIYVKQISKQLLL 142
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEE------FTAKIADFGLVRLFPEDITHISATLA 433
GL Y+H + IIH DIK N+L++ KIAD G + E T
Sbjct: 143 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT----NSI 196
Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478
T Y +PE ++ AD++S ++ E++ LF +
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF--LFEPDE 239
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.6 bits (164), Expect = 2e-12
Identities = 31/202 (15%), Positives = 53/202 (26%), Gaps = 54/202 (26%)
Query: 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD--------HFFNEVNL 318
T K+G+G G V++ VA+K + V+ E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 319 ---------ISGINHKNLVKLLGCSI---TGPESL------------------------- 341
+ + L + P L
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 342 --LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKL 399
+V EF L+ + + S I+ LA LR HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190
Query: 400 SNILLDEEFTAKIADFGLVRLF 421
N+LL + K+ +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSS 212
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 59/261 (22%), Positives = 93/261 (35%), Gaps = 73/261 (27%)
Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI--------NHKN 326
KLG G +V+ + G + VA+K + + + + +E+ L+ + N +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 327 LVKLLGC-SITGPESL---LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
+V+LL I+G +V+E V LL ++ + + L KII +GL
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFE-VLGHHLLK-WIIKSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 383 YLHEESKLRIIHRDIKLSNILL-------------------------------------- 404
YLH +K RIIH DIK NILL
Sbjct: 161 YLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 405 -----------DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
E+ KIAD G + T T Y + E ++ A
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTED----IQTRQYRSLEVLIGSGYNTPA 274
Query: 454 DVYSFGVVVIEVVCRKRINLF 474
D++S + E+ LF
Sbjct: 275 DIWSTACMAFELATGDY--LF 293
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 52/235 (22%), Positives = 88/235 (37%), Gaps = 65/235 (27%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFF 313
+ + YE L+ +G+G G V K + VA+K R N ++
Sbjct: 95 VAYRYEVLKV----------IGKGSFGQVVKAYDHKVHQHVALKMVR---NEKRFHRQAA 141
Query: 314 NEVNLISGINHK------NLVKLLG--------CSITGPESLLVYEFVPNQSLLDNLFVR 359
E+ ++ + + N++ +L C S+ +YE + N F
Sbjct: 142 EEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYEL-----IKKNKFQ- 195
Query: 360 QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA--KIADFGL 417
S + K S + L LH K RIIH D+K NILL ++ + K+ DFG
Sbjct: 196 ----GFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG- 247
Query: 418 VRLFPEDITHISATLAG--------TLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
S+ + Y APE ++ + D++S G ++ E
Sbjct: 248 -----------SSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAE 291
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 51/227 (22%), Positives = 84/227 (37%), Gaps = 53/227 (23%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISG 321
EK + + + +G+G G V K E VA+K + N +++ EV L+
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK---NKKAFLNQAQIEVRLLEL 106
Query: 322 INH------KNLVKLLG--------CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSW 367
+N +V L C + S +Y+ L + F +S
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDL-----LRNTNFR-----GVSL 156
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA--KIADFGLVRLFPEDI 425
+ K L +L +L IIH D+K NILL + KI DFG
Sbjct: 157 NLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG--------- 206
Query: 426 THISATLAG--------TLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
S+ G + Y +PE ++ D++S G +++E
Sbjct: 207 ---SSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 27/198 (13%), Positives = 60/198 (30%), Gaps = 43/198 (21%)
Query: 275 NKLGQGGSGSVYKGT---------LPGGEAVAVK-----------RLFYNTTQWVDHFFN 314
+ + G +Y+ P + ++K + F+
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 315 EVNLISGINHKNLVKLLGCSITGPE-SLLVYEFV-PNQSLLDNLFVRQDVEPLSWEVRYK 372
L + +G + + LV + + L + LS +
Sbjct: 108 WKKL-YSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRS---LQSALDVSPKHVLSERSVLQ 163
Query: 373 I---ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI--ADFGLVRLFPEDITH 427
+ +L E +LHE +H ++ NI +D E +++ A +G + H
Sbjct: 164 VACRLLDALE---FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
Query: 428 I------SATLAGTLGYM 439
+ + G L ++
Sbjct: 218 VAYVEGSRSPHEGDLEFI 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 2e-07
Identities = 62/406 (15%), Positives = 112/406 (27%), Gaps = 114/406 (28%)
Query: 76 DDYDFFNESLSSQDRTVCGSKD--------FGGNNTVFGA---NAIELVRNLSVQAVKND 124
+Y F + ++ R +N VF + ++ L QA+
Sbjct: 89 INYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR-QALLEL 147
Query: 125 GFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRV--LNAGC 182
NV + G+ G + + V K + ++ LN
Sbjct: 148 R--------PAKNVLIDGVLGS-----G---KTWVALDVCLSYKVQCKMDFKIFWLNLKN 191
Query: 183 YLRYST-----QRFYNNSGPDPVPGNGGDNKLAVILATSAVALLLVFSLVAFFVRRKLLQ 237
T Q+ DP + D+ + L ++ L RR L
Sbjct: 192 CNSPETVLEMLQKLLYQI--DPNWTSRSDHSSNIKLRIHSIQAEL---------RRLLKS 240
Query: 238 KRRERKQLGALQVA--VNKSK----LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLP 291
K E L V V +K N S + L T + ++ L
Sbjct: 241 KPYEN----CLLVLLNVQNAKAWNAFNLSCKIL-LTTRFKQVTDFLS------------- 282
Query: 292 GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQS 351
A + + + S + L+K L C P+ L P +
Sbjct: 283 ---AATTTHISLDHHSMT---LTPDEVKS-L----LLKYLDCR---PQDL------PREV 322
Query: 352 LLDNLFV------RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD 405
L N +W+ +K +++ + II + N+L
Sbjct: 323 LTTNPRRLSIIAESIRDGLATWD-NWK----------HVNCDKLTTIIESSL---NVLEP 368
Query: 406 EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE 451
E+ +FP HI L + + + V + +
Sbjct: 369 AEYRKMFDRLS---VFPPS-AHIPTILLSLIWFDVIKSDVMVVVNK 410
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 43/186 (23%), Positives = 68/186 (36%), Gaps = 39/186 (20%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGC 333
K+G G G + G L E VA+K E + + + ++
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 334 SITGPESLLVYEFV-PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA--------YL 384
G + +V E + P+ L++LF D L T +A Y+
Sbjct: 74 GPCGKYNAMVLELLGPS---LEDLFDLCD---------RTFSLKTVLMIAIQLISRMEYV 121
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAK-----IADFGLVRLF--PEDITHI----SATLA 433
H ++ +I+RD+K N L+ I DF L + + PE HI +L
Sbjct: 122 HSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178
Query: 434 GTLGYM 439
GT YM
Sbjct: 179 GTARYM 184
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 32/190 (16%), Positives = 60/190 (31%), Gaps = 29/190 (15%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDH--FFNEVN----LISGINHKNLVK 329
+GQGG G +Y + E+V + D+ F E+ + ++
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQ----DVEPLSWEVRYKIILSTAEGLA--- 382
G + D++ + + T L+
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRI 161
Query: 383 -----YLHEESKLRIIHRDIKLSNILLDEEFTAKI--ADFGLVRLFPEDITHI------S 429
Y+HE +H DIK SN+LL+ + ++ D+GL + + H
Sbjct: 162 LDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPK 218
Query: 430 ATLAGTLGYM 439
GT+ +
Sbjct: 219 RCHDGTIEFT 228
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 40/182 (21%), Positives = 75/182 (41%), Gaps = 31/182 (17%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGC 333
++G+G G +++GT L + VA+K + +E + + +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 334 SITGPESLLVYEFV-PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE----GLAYLHEES 388
G ++LV + + P+ L++L S K + A+ + +HE+S
Sbjct: 75 GQEGLHNVLVIDLLGPS---LEDLLDLCG-RKFS----VKTVAMAAKQMLARVQSIHEKS 126
Query: 389 KLRIIHRDIKLSNILLDEEFTAK-----IADFGLVRLF--PEDITHI----SATLAGTLG 437
+++RDIK N L+ + + DFG+V+ + P HI L+GT
Sbjct: 127 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 438 YM 439
YM
Sbjct: 184 YM 185
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 44/178 (24%), Positives = 72/178 (40%), Gaps = 25/178 (14%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNL---ISGINHKNLVKLL 331
K+G G G +Y GT + GE VA+K T E + + G + +
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG--IPTIR 71
Query: 332 GCSITGPESLLVYEFV-PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
C G +++V E + P+ L++LF + S + + + Y+H ++
Sbjct: 72 WCGAEGDYNVMVMELLGPS---LEDLFNFCSRK-FSLKTVLLLADQMISRIEYIHSKN-- 125
Query: 391 RIIHRDIKLSNILL---DEEFTAKIADFGLVRLF--PEDITHI----SATLAGTLGYM 439
IHRD+K N L+ + I DFGL + + HI + L GT Y
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 43/176 (24%), Positives = 70/176 (39%), Gaps = 21/176 (11%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV-KLLGC 333
K+G G G +Y GT + E VA+K T E + + + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWF 71
Query: 334 SITGPESLLVYEFV-PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
+ G ++LV + + P+ L++LF LS + + + ++H +S
Sbjct: 72 GVEGDYNVLVMDLLGPS---LEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS---F 124
Query: 393 IHRDIKLSNILLDEEFTAK---IADFGLVRLF--PEDITHI----SATLAGTLGYM 439
+HRDIK N L+ A I DFGL + + HI + L GT Y
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 18/67 (26%), Positives = 30/67 (44%), Gaps = 11/67 (16%)
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKI--ADFGLVRLFPEDITHI------SATL 432
L Y+HE +H DIK +N+LL + ++ AD+GL + + H
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220
Query: 433 AGTLGYM 439
GT+ +
Sbjct: 221 NGTIEFT 227
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 48/234 (20%), Positives = 74/234 (31%), Gaps = 73/234 (31%)
Query: 276 KLGQGGSGSVYKG--TLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHK------ 325
LG+G G V + G VA+K R N ++ + E+N++ I K
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIR---NVGKYREAARLEINVLKKIKEKDKENKF 82
Query: 326 NLVKLLG--------CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
V + C +EF L +N F P +
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELLGKNTFEF-----LKENNFQ-----PYPLPHVRHMAYQL 132
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA-------------------KIADFGLV 418
L +LH + ++ H D+K NIL ++ADFG
Sbjct: 133 CHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-- 187
Query: 419 RLFPEDITHISATLAG--------TLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
SAT T Y PE ++ + DV+S G ++ E
Sbjct: 188 ----------SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 50/234 (21%), Positives = 85/234 (36%), Gaps = 73/234 (31%)
Query: 276 KLGQGGSGSVYKG--TLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHK------ 325
LG+G G V + GG VAVK + N ++ + +E+ ++ +N
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVK---NVDRYCEAARSEIQVLEHLNTTDPNSTF 77
Query: 326 NLVKLLG--------CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
V++L C + L Y+F + +N F+ P + K+
Sbjct: 78 RCVQMLEWFEHHGHICIVFELLGLSTYDF-----IKENGFL-----PFRLDHIRKMAYQI 127
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA-------------------KIADFGLV 418
+ + +LH ++ H D+K NIL + K+ DFG
Sbjct: 128 CKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-- 182
Query: 419 RLFPEDITHISATLAG--------TLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
SAT T Y APE ++ ++ DV+S G ++IE
Sbjct: 183 ----------SATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 50/226 (22%), Positives = 77/226 (34%), Gaps = 53/226 (23%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINH-----KNL 327
K+G G G V + + AVK R N ++ E +++ I + N+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVR---NIKKYTRSAKIEADILKKIQNDDINNNNI 98
Query: 328 VKLLG--------CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
VK G C I P +YE + N + E + +
Sbjct: 99 VKYHGKFMYYDHMCLIFEPLGPSLYEI-----ITRNNYN-----GFHIEDIKLYCIEILK 148
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI----------- 428
L YL K+ + H D+K NILLD+ + K + I
Sbjct: 149 ALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 429 --SATLAG--------TLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
AT T Y APE ++ +D++SFG V+ E
Sbjct: 206 FGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 492 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.98 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.85 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.81 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.09 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.04 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.66 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.56 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.47 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.36 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.34 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.3 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.16 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.99 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.92 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.83 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.76 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.49 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.42 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.33 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.21 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.21 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.2 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.14 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.06 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.78 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.63 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.31 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.92 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 90.85 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 89.95 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 89.72 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 88.33 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.24 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.37 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.05 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=385.17 Aligned_cols=204 Identities=26% Similarity=0.400 Sum_probs=179.4
Q ss_pred cccccCCcccccCcccEEEEEec------CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
++|.+.++||+|+||+||+|++. ++..||||+++..+.+..++|.+|+++|++++|||||+++|++.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56788899999999999999863 367899999988777778899999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhcc----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEE
Q 011153 343 VYEFVPNQSLLDNLFVR----------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~----------~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl 412 (492)
||||+++|+|.++|... .....++|..+++++.||++||+|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999653 23457999999999999999999999988 999999999999999999999
Q ss_pred eecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 413 ADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 413 ~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
+|||+++....... .......||+.|||||++.++.++.++|||||||+||||+| |+.||...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~ 234 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999986654332 22334578999999999999999999999999999999999 89998654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=384.66 Aligned_cols=204 Identities=26% Similarity=0.381 Sum_probs=173.5
Q ss_pred cccccCCcccccCcccEEEEEec------CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
++|...++||+|+||+||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|++.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45777889999999999999864 467899999988777778899999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcE
Q 011153 343 VYEFVPNQSLLDNLFVRQD------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ 410 (492)
||||+++|+|.+++..... ..+++|.++++++.||++||+|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999865432 356999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCccccCCCC-ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 411 KIADFGLVRLFPEDI-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 411 kl~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
||+|||+++...... ........||+.|||||++.+..++.++|||||||+||||+| |+.||...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~ 264 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 264 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC
Confidence 999999998664432 223345679999999999999999999999999999999999 89998654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=380.50 Aligned_cols=204 Identities=26% Similarity=0.388 Sum_probs=176.3
Q ss_pred cccccCCcccccCcccEEEEEec------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
..++..++||+|+||+||+|++. +++.||||+++... ....++|.+|+.+|++++|||||+++|++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34566789999999999999863 46789999997543 344678999999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC
Q 011153 342 LVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~ 408 (492)
|||||+++|+|.++|..... ...++|..+++++.||++||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999965321 246899999999999999999999988 99999999999999999
Q ss_pred cEEEeecCCccccCCCC-ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 409 TAKIADFGLVRLFPEDI-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 409 ~~kl~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
.+||+|||+++...... ........||+.|||||++.++.++.++|||||||+||||+| |+.||...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence 99999999998664332 223345679999999999999999999999999999999999 78888653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=376.85 Aligned_cols=202 Identities=32% Similarity=0.466 Sum_probs=170.0
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.++++..++||+|+||+||+|++.+ .||||+++.. +.+..+.|.+|+++|++++|||||++++++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4567788999999999999998753 6999998643 44556789999999999999999999998754 57899999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++|+|.+++... ...+++..+++|+.||++||+|||+++ ||||||||+||||++++.+||+|||+++......
T Consensus 112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999998643 346999999999999999999999987 9999999999999999999999999998765432
Q ss_pred -ccccccccccccccchhhhcc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 426 -THISATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 426 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
........||+.|||||++.. ++++.++|||||||+||||+||+.||....+
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence 223346789999999999864 4689999999999999999999999975443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=382.68 Aligned_cols=200 Identities=30% Similarity=0.475 Sum_probs=181.1
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
...|+..++||+|+||+||+++.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 356899999999999999999864 6999999999776666667789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.+.....
T Consensus 153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999998853 34899999999999999999999998 99999999999999999999999999987755432
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||...
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 273 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 273 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 234678999999999999999999999999999999999999999653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=382.76 Aligned_cols=203 Identities=20% Similarity=0.331 Sum_probs=175.1
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
.++|++.++||+|+||+||+++. .+|+.||||++... .....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 36799999999999999999986 56899999999754 3445678999999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++|+|.+++... +...+++..++.++.||+.||+|||+++ ||||||||+||||++++.+||+|||+++.+...
T Consensus 103 Ey~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999998543 3455789999999999999999999998 999999999999999999999999999876432
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 228 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 1 2234568999999999999999999999999999999999999999654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=375.97 Aligned_cols=201 Identities=22% Similarity=0.313 Sum_probs=180.7
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.++||+|+||+||+++. .+++.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5699999999999999999985 56899999999653 2344678999999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++|+|.+++... +.+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999998543 45899999999999999999999998 999999999999999999999999999977543
Q ss_pred C-ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 I-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. .....+.+||+.|||||++.+..++.++||||+||+||||++|+.||...
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2 23344678999999999999999999999999999999999999999654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=384.37 Aligned_cols=200 Identities=30% Similarity=0.477 Sum_probs=181.5
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
.+.|+..++||+|+||+||+|+. .+|+.||||++........+.+.+|+.+|+.++|||||++++++.+++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 46799999999999999999986 46899999999876666677899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.+.....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999998843 34899999999999999999999998 99999999999999999999999999987754432
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||...
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 350 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 350 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 234678999999999999999999999999999999999999999653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=367.78 Aligned_cols=198 Identities=28% Similarity=0.369 Sum_probs=170.7
Q ss_pred cccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeec----CCcceeE
Q 011153 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPESLLV 343 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 343 (492)
|+..++||+|+||+||+|... ++..||+|++... .....+.|.+|+++|++++|||||++++++.+ ++..+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 466778999999999999864 6889999999643 34456789999999999999999999999865 3457899
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC-CCCcEEEeecCCccccC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFP 422 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgl~~~~~ 422 (492)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ ++||||||||+||||+ .++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999998543 45899999999999999999999975 5699999999999997 47999999999998644
Q ss_pred CCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.. ...+.+||+.|||||++. +.++.++|||||||+||||+||+.||....
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~ 233 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred CC---ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 32 234678999999999875 579999999999999999999999996543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=371.77 Aligned_cols=200 Identities=24% Similarity=0.286 Sum_probs=173.2
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
.+.|+..++||+|+||+||+++. .+|+.||||+++.... ..+|+.+|+.++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 35688889999999999999986 4689999999975432 24799999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-cEEEeecCCccccCCCC
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDI 425 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~ 425 (492)
+++|+|.+++... +.+++..+..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+++.+..+.
T Consensus 132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999543 45899999999999999999999998 99999999999999987 69999999998775432
Q ss_pred cc----ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 426 TH----ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 426 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
.. .....+||+.|||||++.+..++.++|||||||++|||++|+.||......
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~ 262 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG 262 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH
Confidence 11 123467999999999999999999999999999999999999999765443
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=369.84 Aligned_cols=200 Identities=31% Similarity=0.304 Sum_probs=169.7
Q ss_pred cccccCCcccccCcccEEEEEec----CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
++|++.++||+|+||+||+++.. .++.||||+++... ......+.+|+++|++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999752 46789999996542 2234468899999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999998543 45899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.... ...+.+||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 178 ~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 178 DHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp ---C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 3322 234578999999999999999999999999999999999999999754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=374.32 Aligned_cols=219 Identities=27% Similarity=0.339 Sum_probs=185.6
Q ss_pred ccCHHHHHHHhcccccCCcccccCcccEEEEEecC------CCEEEEEEeccCC-hhhHHHHHHHHHHHhccCc-Cceee
Q 011153 258 NFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINH-KNLVK 329 (492)
Q Consensus 258 ~~~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h-~niv~ 329 (492)
.+....++...++|++.++||+|+||+||+|.+.. ++.||||++.... ....+.|.+|+++|.+++| ||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 34555666677899999999999999999998542 3579999997653 3446779999999999965 89999
Q ss_pred eeeeeecC-CcceeEEeecCCCCchhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 011153 330 LLGCSITG-PESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395 (492)
Q Consensus 330 l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~ 395 (492)
++|+|.+. +..++|||||++|+|.++|..... ...+++..++.++.||++||+|||+++ ||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecC
Confidence 99998764 568999999999999999965321 345899999999999999999999998 9999
Q ss_pred CCCCCCeeeCCCCcEEEeecCCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 011153 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINL 473 (492)
Q Consensus 396 Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~ 473 (492)
||||+|||+++++.+||+|||+++....+... ......||+.|||||++.++.++.++|||||||+||||+| |+.||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876544332 2345678999999999999999999999999999999998 899987
Q ss_pred CCCCCC
Q 011153 474 FTQNSC 479 (492)
Q Consensus 474 ~~~~~~ 479 (492)
.....+
T Consensus 290 ~~~~~~ 295 (353)
T 4ase_A 290 GVKIDE 295 (353)
T ss_dssp TCCCSH
T ss_pred CCCHHH
Confidence 654443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=357.86 Aligned_cols=198 Identities=26% Similarity=0.428 Sum_probs=162.1
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.+.||+|+||+||+++. .+++.||||++... .....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999986 46899999999654 2334567999999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+ +|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 68999888543 45899999999999999999999998 999999999999999999999999999866543
Q ss_pred CccccccccccccccchhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ...+..||+.|||||++.+..+ +.++||||+||++|||++|+.||...
T Consensus 166 ~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 166 N--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 2 2345689999999999988876 57999999999999999999999653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=363.26 Aligned_cols=200 Identities=31% Similarity=0.383 Sum_probs=163.3
Q ss_pred cccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC----cceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----ESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 344 (492)
+++.+.++||+|+||+||+|++. |+.||||++...... ...+..|+..+.+++|||||++++++.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 45778899999999999999984 889999999654322 222345666677899999999999998764 468999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-----~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
||+++|+|.+++.. ..++|+.+++++.|+++||+|||++ ..++||||||||+||||++++.+||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999954 3589999999999999999999986 23459999999999999999999999999998
Q ss_pred ccCCCCcc---ccccccccccccchhhhccC------CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 420 LFPEDITH---ISATLAGTLGYMAPEYVVRG------KLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 420 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
........ ......||+.|||||++.+. .++.++|||||||+||||+||++|+..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 76543322 12346799999999998764 367899999999999999999887654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=358.45 Aligned_cols=196 Identities=26% Similarity=0.425 Sum_probs=161.8
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc-------
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE------- 339 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------- 339 (492)
++|++.+.||+|+||+||+++. .+++.||||+++... ....+.+.+|+++|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4588999999999999999986 468999999997544 3445679999999999999999999999876543
Q ss_pred -----ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEee
Q 011153 340 -----SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD 414 (492)
Q Consensus 340 -----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 414 (492)
.++||||+++|+|.+++.........++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 5899999999999999976655556778889999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCcc-----------ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh
Q 011153 415 FGLVRLFPEDITH-----------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467 (492)
Q Consensus 415 fgl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt 467 (492)
||+++........ ..+..+||+.|||||++.+..++.++|||||||++|||++
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~ 225 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc
Confidence 9999876543211 1234579999999999999999999999999999999996
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=349.59 Aligned_cols=205 Identities=24% Similarity=0.371 Sum_probs=173.9
Q ss_pred HHHHHhcccccCCcccccCcccEEEEEec----CCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecC
Q 011153 263 TLEKATNYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG 337 (492)
Q Consensus 263 ~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 337 (492)
.+....++|++.++||+|+||+||+++.+ .++.||||++..... ..++.+|+++|+.+ +||||+++++++.+.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 33445678999999999999999999753 467899999865432 45678999999988 699999999999999
Q ss_pred CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-CcEEEeecC
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFG 416 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfg 416 (492)
+..++||||+++++|.+++ ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TEEEEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CEEEEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 9999999999999999988 24899999999999999999999998 9999999999999876 799999999
Q ss_pred CccccCCCCcc---------------------------ccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhC
Q 011153 417 LVRLFPEDITH---------------------------ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCR 468 (492)
Q Consensus 417 l~~~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg 468 (492)
+|+...+.... ...+.+||+.|||||++.+. .++.++||||+||+++||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 99865432211 12245799999999999875 489999999999999999999
Q ss_pred CCCCCCCCCC
Q 011153 469 KRINLFTQNS 478 (492)
Q Consensus 469 ~~p~~~~~~~ 478 (492)
+.||....++
T Consensus 244 ~~Pf~~~~~~ 253 (361)
T 4f9c_A 244 RYPFYKASDD 253 (361)
T ss_dssp CSSSSCCSSH
T ss_pred CCCCCCCCCH
Confidence 9999765443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=352.57 Aligned_cols=201 Identities=23% Similarity=0.368 Sum_probs=172.2
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeec------CCc
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT------GPE 339 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 339 (492)
++|++.++||+|+||+||+++. .+|+.||||+++.. .....+.+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999986 57999999999654 33445678999999999999999999998764 357
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
.||||||++ |+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++
T Consensus 134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 799999996 679888843 456999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCC---ccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 420 LFPEDI---THISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 420 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.+.... .....+.+||+.|||||++.+. .++.++||||+||+++||++|+.||....
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence 764322 2223467899999999998875 46899999999999999999999997543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=362.75 Aligned_cols=201 Identities=24% Similarity=0.253 Sum_probs=173.4
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHH---HHHHHHHhccCcCceeeeeeeeecCCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHF---FNEVNLISGINHKNLVKLLGCSITGPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (492)
.++|++.++||+|+||+||+++.. +|+.||||++.+.. ....... .+++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 356999999999999999999864 68999999996431 1222223 3456777888999999999999999999
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+++.
T Consensus 268 ylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999999543 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 421 FPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 421 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
+.... ..+.+||+.|||||++.. ..|+.++|||||||+||||++|+.||.....
T Consensus 342 ~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~ 396 (689)
T 3v5w_A 342 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396 (689)
T ss_dssp CSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred cCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 65543 235689999999999975 5799999999999999999999999976443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=359.39 Aligned_cols=201 Identities=22% Similarity=0.294 Sum_probs=180.9
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
.++|++.+.||+|+||+||++.. .+|+.||+|++........+.+.+|+++|+.++|||||++++++.+++..+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36799999999999999999986 46899999999877666677899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC--CcEEEeecCCccccCCC
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE--FTAKIADFGLVRLFPED 424 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~Dfgl~~~~~~~ 424 (492)
+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999998843 3346899999999999999999999998 9999999999999854 89999999999987554
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. .....+||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~ 359 (573)
T 3uto_A 311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 359 (573)
T ss_dssp S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 3 234568999999999999999999999999999999999999999654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=340.42 Aligned_cols=212 Identities=23% Similarity=0.254 Sum_probs=183.5
Q ss_pred CHHHHHHHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeee
Q 011153 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSI 335 (492)
Q Consensus 260 ~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 335 (492)
.+.++....++|++.++||+|+||+||+++.. +++.||||++.... ....+.+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34455566788999999999999999999976 47889999996532 222345889999999999999999999999
Q ss_pred cCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 011153 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (492)
Q Consensus 336 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 415 (492)
+++..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999998542 345899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCccccccccccccccchhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 416 GLVRLFPEDITHISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 416 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
|+++..............||+.|+|||++. .+.++.++|||||||++|||++|+.||....
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 285 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence 999876655444444568999999999987 5678999999999999999999999997543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=321.66 Aligned_cols=216 Identities=42% Similarity=0.687 Sum_probs=189.3
Q ss_pred cCHHHHHHHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC
Q 011153 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP 338 (492)
Q Consensus 259 ~~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 338 (492)
+.+.++...+++|+..+.||+|+||.||++...+++.||||++........+.+.+|+++++.++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34445556788999999999999999999998889999999998777677788999999999999999999999999999
Q ss_pred cceeEEeecCCCCchhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCC
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl 417 (492)
..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999886543 2346899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCC-ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 418 VRLFPEDI-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 418 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
++...... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 98654322 2223345689999999999999999999999999999999999999876443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=320.98 Aligned_cols=218 Identities=44% Similarity=0.699 Sum_probs=191.8
Q ss_pred ccccCHHHHHHHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCCh-hhHHHHHHHHHHHhccCcCceeeeeeee
Q 011153 256 KLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCS 334 (492)
Q Consensus 256 ~~~~~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~ 334 (492)
...+++.++....++|+..++||+|+||.||++...+++.||||++..... .....+.+|+++++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 346889999999999999999999999999999988899999999976432 2233689999999999999999999999
Q ss_pred ecCCcceeEEeecCCCCchhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEe
Q 011153 335 ITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413 (492)
Q Consensus 335 ~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 413 (492)
.+.+..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+...++|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999986543 34569999999999999999999999822239999999999999999999999
Q ss_pred ecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 011153 414 DFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINL 473 (492)
Q Consensus 414 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~ 473 (492)
|||+++..............||+.|+|||.+....++.++||||||++++||++|+.||.
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 999998776554444555679999999999999999999999999999999999999996
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=312.58 Aligned_cols=200 Identities=28% Similarity=0.439 Sum_probs=180.0
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
.++|+..++||+|+||+||++.. .+++.||||++........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999985 56899999999776666677899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999988542 4899999999999999999999998 99999999999999999999999999987654432
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 172 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 219 (297)
T 3fxz_A 172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (297)
T ss_dssp C-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred c-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2 33567999999999999999999999999999999999999998654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.25 Aligned_cols=211 Identities=29% Similarity=0.422 Sum_probs=185.5
Q ss_pred cccCHHHHHHHhcc----------cccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcC
Q 011153 257 LNFSYETLEKATNY----------FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK 325 (492)
Q Consensus 257 ~~~~~~~l~~~~~~----------~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ 325 (492)
..++++++..+++. |+..++||+|+||.||+++.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34677777776653 667789999999999999975 7999999999877666678899999999999999
Q ss_pred ceeeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC
Q 011153 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD 405 (492)
Q Consensus 326 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~ 405 (492)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 999999999999999999999999999998732 35899999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 406 EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 406 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~ 244 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999987654332 223567999999999999999999999999999999999999998653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=311.95 Aligned_cols=203 Identities=29% Similarity=0.447 Sum_probs=179.3
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
.++|+..++||+|+||+||++... +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 356888999999999999999864 6889999999777777788999999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999998643 345899999999999999999999998 99999999999999999999999999987644322
Q ss_pred cc-------------cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HI-------------SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|..|+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 11 11457899999999999999999999999999999999999998653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=328.05 Aligned_cols=212 Identities=22% Similarity=0.230 Sum_probs=183.3
Q ss_pred CHHHHHHHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeee
Q 011153 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSI 335 (492)
Q Consensus 260 ~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 335 (492)
.+++.....++|+..++||+|+||+||+++.. +++.||||++.... ....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34445556788999999999999999999974 68999999996532 233456889999999999999999999999
Q ss_pred cCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 011153 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (492)
Q Consensus 336 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 415 (492)
+.+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 9999999999999999999986432 35899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCccccccccccccccchhhhc-------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 416 GLVRLFPEDITHISATLAGTLGYMAPEYVV-------RGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 416 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
|+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 999877654433334568999999999987 3568999999999999999999999997543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.01 Aligned_cols=207 Identities=21% Similarity=0.236 Sum_probs=180.0
Q ss_pred HHHHHHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecC
Q 011153 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITG 337 (492)
Q Consensus 262 ~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 337 (492)
..+....++|++.++||+|+||+||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344455688999999999999999999865 58899999986521 22334588999999999999999999999999
Q ss_pred CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCC
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl 417 (492)
+..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999998853 24889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccchhhhccCC----CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 418 VRLFPEDITHISATLAGTLGYMAPEYVVRGK----LTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 418 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
++..............||+.|+|||++.... ++.++|||||||++|||++|+.||...
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 9877654433344678999999999998765 788999999999999999999999754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=317.40 Aligned_cols=201 Identities=27% Similarity=0.307 Sum_probs=177.4
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.++|+..+.||+|+||+||+++.. +++.||||+++.. .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367899999999999999999865 6899999999654 234466788999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999888543 35899999999999999999999998 99999999999999999999999999985433
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 158 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 208 (337)
T 1o6l_A 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence 22 2234567999999999999999999999999999999999999998653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=314.30 Aligned_cols=200 Identities=26% Similarity=0.369 Sum_probs=177.8
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
.++|++.+.||+|+||.||++.. .+++.||||++... .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45799999999999999999986 57999999999654 3445677899999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999988554 34899999999999999999999998 999999999999999999999999999866543
Q ss_pred CccccccccccccccchhhhccCCCC-cchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLT-EKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ......||+.|+|||++.+..+. .++||||||++++||++|+.||...
T Consensus 168 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 168 G--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp C--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 2 23456799999999999888775 7899999999999999999998653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=310.88 Aligned_cols=202 Identities=28% Similarity=0.412 Sum_probs=172.9
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999854 6889999998543 334467889999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999988543 35899999999999999999999998 99999999999999999999999999987655
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
..........||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 215 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 4433344567999999999999999999999999999999999999999654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=316.84 Aligned_cols=205 Identities=27% Similarity=0.365 Sum_probs=177.1
Q ss_pred hcccccCCcccccCcccEEEEEec--------CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecC
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG 337 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 337 (492)
.++|++.+.||+|+||.||+++.. ++..||||+++.. .....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467899999999999999999852 3457999999765 334567899999999999 899999999999999
Q ss_pred CcceeEEeecCCCCchhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL 404 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill 404 (492)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999865432 245899999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 405 DEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 405 ~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999986654322 12234457889999999999999999999999999999999 88888653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=318.47 Aligned_cols=204 Identities=16% Similarity=0.192 Sum_probs=174.3
Q ss_pred HHhcccccCCcccccCcccEEEEE------ecCCCEEEEEEeccCChhhHHHHHHHHHHHhccC---cCceeeeeeeeec
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGT------LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN---HKNLVKLLGCSIT 336 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 336 (492)
...++|.+.++||+|+||+||+|. ..+++.||||++.... ...+.+|++++..++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345779999999999999999994 4568899999997654 345677777777775 9999999999999
Q ss_pred CCcceeEEeecCCCCchhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC--------
Q 011153 337 GPESLLVYEFVPNQSLLDNLFVRQ--DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-------- 406 (492)
Q Consensus 337 ~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-------- 406 (492)
.+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 999999999999999999986432 3456999999999999999999999988 999999999999998
Q ss_pred ---CCcEEEeecCCccccCC-CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 407 ---EFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 407 ---~~~~kl~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
++.+||+|||+++.... ..........||+.|||||++.+..++.++||||||+++|||++|+.||...
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 89999999999975532 2222334567999999999999999999999999999999999999998643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=310.82 Aligned_cols=198 Identities=27% Similarity=0.371 Sum_probs=176.6
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.++|++.+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357899999999999999999864 68999999996542 23456788999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999988543 45899999999999999999999988 99999999999999999999999999986544
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 206 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 206 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 2 23467999999999999999999999999999999999999998653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=311.17 Aligned_cols=207 Identities=32% Similarity=0.480 Sum_probs=171.3
Q ss_pred HHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
...++|++.++||+|+||+||+++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3456799999999999999999987 47889999987543 44567899999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++++|.+++........+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999999999865443345899999999999999999999875 4599999999999999999999999999975543
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~ 242 (309)
T 3p86_A 192 TF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred cc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 32 1223457899999999999999999999999999999999999998654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=304.34 Aligned_cols=218 Identities=44% Similarity=0.694 Sum_probs=189.9
Q ss_pred ccccCHHHHHHHhcccccC------CcccccCcccEEEEEecCCCEEEEEEeccC----ChhhHHHHHHHHHHHhccCcC
Q 011153 256 KLNFSYETLEKATNYFHES------NKLGQGGSGSVYKGTLPGGEAVAVKRLFYN----TTQWVDHFFNEVNLISGINHK 325 (492)
Q Consensus 256 ~~~~~~~~l~~~~~~~~~~------~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~h~ 325 (492)
...+++.++..++++|... ++||+|+||.||+|.. +++.||||++... .....+.+.+|+.+++.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3568999999999999877 8999999999999987 5789999998643 234567899999999999999
Q ss_pred ceeeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC
Q 011153 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD 405 (492)
Q Consensus 326 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~ 405 (492)
||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||+|||+.+ ++||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999999876555567999999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 406 EEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 406 ~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
.++.+||+|||+++........ ......||+.|+|||.+. +.++.++||||||+++|||++|+.|+......
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 9999999999999866543222 223457899999999775 45899999999999999999999999765443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=318.81 Aligned_cols=202 Identities=28% Similarity=0.359 Sum_probs=173.0
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcce
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 341 (492)
..++|++.++||+|+||+||+++.. +++.||||+++.. .....+.+.+|.+++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3467999999999999999999864 6899999999754 234456788999999988 7999999999999999999
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999988543 35899999999999999999999998 999999999999999999999999999854
Q ss_pred CCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 175 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 227 (353)
T 3txo_A 175 ICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227 (353)
T ss_dssp CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence 3222 2234567999999999999889999999999999999999999999654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=312.82 Aligned_cols=200 Identities=27% Similarity=0.352 Sum_probs=177.2
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChh------hHHHHHHHHHHHhccCcCceeeeeeeeecCCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQ------WVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (492)
.++|++.+.||+|+||.||++... +|+.||+|.+...... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999865 6899999999754321 356789999999999999999999999999999
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC----cEEEeecC
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFG 416 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfg 416 (492)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999998843 346899999999999999999999998 99999999999998876 79999999
Q ss_pred CccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
+++...... ......||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 165 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~ 221 (361)
T 2yab_A 165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (361)
T ss_dssp SCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 998765432 223567999999999999889999999999999999999999999654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=320.70 Aligned_cols=201 Identities=25% Similarity=0.320 Sum_probs=174.7
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCccee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 342 (492)
.++|++.++||+|+||+||+++.. +++.||||+++.. .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999865 5778999999754 233345688899999887 89999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999888543 35899999999999999999999998 9999999999999999999999999998533
Q ss_pred CCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 205 ~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 205 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred cCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 221 2234568999999999999999999999999999999999999999643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=309.76 Aligned_cols=202 Identities=24% Similarity=0.418 Sum_probs=173.9
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc------
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE------ 339 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 339 (492)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 456899999999999999999975 78999999997543 3456789999999999999999999999865543
Q ss_pred ---------------------------------------------------ceeEEeecCCCCchhhhhccCCCCCCCHH
Q 011153 340 ---------------------------------------------------SLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368 (492)
Q Consensus 340 ---------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~ 368 (492)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 68999999999999999776666667888
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc-----------ccccccccccc
Q 011153 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT-----------HISATLAGTLG 437 (492)
Q Consensus 369 ~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-----------~~~~~~~gt~~ 437 (492)
.++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999998 99999999999999999999999999987655421 11234568999
Q ss_pred ccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 011153 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRIN 472 (492)
Q Consensus 438 y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~ 472 (492)
|+|||.+.+..++.++||||||++++||++|..|+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 99999999999999999999999999999998775
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=315.79 Aligned_cols=201 Identities=27% Similarity=0.354 Sum_probs=176.7
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+++|+.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367899999999999999999865 5889999998653 233456788999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999998853 345899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccccccccccccccchhhhcc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 168 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 168 ET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp TC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred CC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence 32 2345679999999999864 458999999999999999999999997543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=305.25 Aligned_cols=206 Identities=26% Similarity=0.380 Sum_probs=175.7
Q ss_pred HhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
..++|++.++||+|+||+||+++..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 357799999999999999999999889999999996543 233567889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++ +|.+.+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99984 77777643 3345899999999999999999999998 999999999999999999999999999876543
Q ss_pred Cccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
... .....+|+.|+|||++.+ ..++.++||||||++++||++|+.||....+.+
T Consensus 173 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 227 (311)
T 3niz_A 173 VRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT
T ss_pred ccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 222 234578999999999876 568999999999999999999999998765544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=313.41 Aligned_cols=203 Identities=26% Similarity=0.326 Sum_probs=176.8
Q ss_pred HHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcc
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES 340 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 340 (492)
...++|++.++||+|+||.||+++.. +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999975 68899999997542 33456788899999877 999999999999999999
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999988543 35899999999999999999999998 99999999999999999999999999985
Q ss_pred cCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (345)
T 1xjd_A 168 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221 (345)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence 43222 1234568999999999999999999999999999999999999998653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=301.45 Aligned_cols=202 Identities=28% Similarity=0.402 Sum_probs=178.2
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
.++|+..+.||+|+||.||++...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 357889999999999999999988888999999976543 2467899999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999998854 3345899999999999999999999998 999999999999999999999999999876544333
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
......+|+.|+|||.+....++.++||||||++++||++ |+.||...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 3334567889999999999999999999999999999999 88887643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=308.79 Aligned_cols=205 Identities=29% Similarity=0.404 Sum_probs=175.6
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.++|++.++||+|+||+||++... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999865 78999999986543 2334678899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999884 3345899999999999999999999998 9999999999999999999999999998654322
Q ss_pred -ccccccccccccccchhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 426 -THISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 426 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
........||+.|+|||++.+..+ +.++||||||++++||++|+.||......
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 214 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 222335679999999999988776 77899999999999999999999765543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=308.58 Aligned_cols=203 Identities=27% Similarity=0.433 Sum_probs=173.1
Q ss_pred hcccccCCcccccCcccEEEEEec----CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
.++|++.++||+|+||.||+|... .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356888999999999999999874 3445999999765 44456789999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999988432 346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccc--cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 423 EDITHI--SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 423 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
...... .....+|+.|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 433221 223346788999999998999999999999999999999 99988543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=306.41 Aligned_cols=205 Identities=27% Similarity=0.373 Sum_probs=177.9
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCC--cceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP--ESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 343 (492)
.++|++.++||+|+||+||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 367999999999999999999865 58999999997543 344677889999999999999999999988665 66899
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee----CCCCcEEEeecCCcc
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVR 419 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~Dfgl~~ 419 (492)
|||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555556999999999999999999999998 9999999999999 788889999999998
Q ss_pred ccCCCCccccccccccccccchhhhc--------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 420 LFPEDITHISATLAGTLGYMAPEYVV--------RGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
....... .....||+.|+|||++. ...++.++||||||+++|||++|+.||.....
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 228 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 7654432 23456899999999986 57789999999999999999999999975443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=312.55 Aligned_cols=199 Identities=26% Similarity=0.326 Sum_probs=176.0
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 343 (492)
++|+..+.||+|+||.||+++.. +++.||||++... .....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56899999999999999999965 5889999999754 334456788999999887 899999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999988543 35899999999999999999999998 99999999999999999999999999985432
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 163 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 163 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 22 223456899999999999999999999999999999999999999965
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=312.21 Aligned_cols=198 Identities=24% Similarity=0.309 Sum_probs=177.2
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.++|+..+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367999999999999999999865 68999999986542 23456788999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999988643 35899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 241 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence 3 23457899999999999999999999999999999999999998653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=315.84 Aligned_cols=218 Identities=28% Similarity=0.349 Sum_probs=184.0
Q ss_pred cccCHHHHHHHhcccccCCcccccCcccEEEEEe------cCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CcCcee
Q 011153 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLV 328 (492)
Q Consensus 257 ~~~~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv 328 (492)
..+....++...++|++.++||+|+||.||++++ .+++.||||++... .....+.+.+|++++.++ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 3456667777789999999999999999999973 24578999999764 334457799999999999 799999
Q ss_pred eeeeeeecCCc-ceeEEeecCCCCchhhhhccCC----------------------------------------------
Q 011153 329 KLLGCSITGPE-SLLVYEFVPNQSLLDNLFVRQD---------------------------------------------- 361 (492)
Q Consensus 329 ~l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------- 361 (492)
++++++.+.+. .++||||+++|+|.+++.....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 99999887654 8899999999999999865432
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 362 -----------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 362 -----------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 122899999999999999999999998 999999999999999999999999999866443
Q ss_pred Cc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 011153 425 IT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQN 477 (492)
Q Consensus 425 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~~~ 477 (492)
.. .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 301 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence 22 22335668899999999999999999999999999999998 9999876543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=314.29 Aligned_cols=203 Identities=26% Similarity=0.396 Sum_probs=164.5
Q ss_pred hcccccCCcccccCcccEEEEEec----CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
..+|++.++||+|+||.||+|+.. ++..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357889999999999999999864 5678999999765 34456789999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999853 3346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCcccc--ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 423 EDITHIS--ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 423 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
....... ....+++.|+|||++....++.++||||||+++|||++ |+.|+...
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 4332211 12235778999999999999999999999999999998 99998543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=309.54 Aligned_cols=201 Identities=26% Similarity=0.357 Sum_probs=167.0
Q ss_pred hcccccCCcccccCcccEEEEEe----cCCCEEEEEEeccCC----hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNT----TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (492)
.++|++.++||+|+||.||+++. .+++.||+|+++... ......+.+|+.+++.++||||+++++++.+++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999986 468999999997542 2345568899999999999999999999999999
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999988543 35889999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 170 ESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 543322 1223567899999999999999999999999999999999999998653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.63 Aligned_cols=201 Identities=23% Similarity=0.343 Sum_probs=176.7
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
..++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567999999999999999999864 6899999999654 334567789999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC---CcEEEeecCCccc
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRL 420 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Dfgl~~~ 420 (492)
|||+++++|.+.+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999988843 346899999999999999999999998 9999999999999865 4599999999987
Q ss_pred cCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 233 (362)
T 2bdw_A 181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233 (362)
T ss_dssp CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 65432 223467999999999999989999999999999999999999998653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=305.28 Aligned_cols=200 Identities=28% Similarity=0.328 Sum_probs=176.5
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh------hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT------QWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (492)
.++|+..+.||+|+||.||++... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456899999999999999999865 689999999865432 1356799999999999999999999999999999
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC----cEEEeecC
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFG 416 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfg 416 (492)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999998843 356899999999999999999999998 99999999999999887 89999999
Q ss_pred CccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
+++...... ......||+.|+|||++....++.++||||||++++||++|+.||...
T Consensus 164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 220 (326)
T 2y0a_A 164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220 (326)
T ss_dssp TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 998765332 223457899999999999899999999999999999999999998653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=301.01 Aligned_cols=211 Identities=25% Similarity=0.379 Sum_probs=177.3
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
++|+..++||+|+||+||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999864 68899999997543 3345778899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++ +|.+.+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9975 55555533 2345899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccccchhhhccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcHHHHHH
Q 011153 426 THISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVI 486 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvll~elltg~~p~~~~~~~~~~~~~~~ 486 (492)
. ......+|+.|+|||++.+.. ++.++||||||++++||++|+.|+....+....+..+.
T Consensus 156 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~ 216 (292)
T 3o0g_A 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred c-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 2 223457899999999987765 79999999999999999999999765544444444443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=312.26 Aligned_cols=202 Identities=27% Similarity=0.283 Sum_probs=176.9
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcce
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 341 (492)
..++|+..++||+|+||+||+++.. +++.||||+++.. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3467999999999999999999975 4788999999754 233456788999999988 8999999999999999999
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999988543 35899999999999999999999998 999999999999999999999999999854
Q ss_pred CCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 172 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 3222 2234567999999999999999999999999999999999999998654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=311.45 Aligned_cols=203 Identities=23% Similarity=0.290 Sum_probs=176.1
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC-----hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-----TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
.++|++.+.||+|+||+||++.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35689999999999999999986 468999999985421 224577999999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc---EEEeecCC
Q 011153 342 LVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT---AKIADFGL 417 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfgl 417 (492)
+||||+++++|.+.+.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775432 3445899999999999999999999998 999999999999986654 99999999
Q ss_pred ccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 418 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
++....... ......||+.|+|||++....++.++||||||+++|||++|+.||..
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence 987654322 23345799999999999999999999999999999999999999865
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=305.63 Aligned_cols=201 Identities=20% Similarity=0.249 Sum_probs=177.0
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
.++|++.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467899999999999999999865 57889999987543 3456788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC--CCcEEEeecCCccccCCC
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE--EFTAKIADFGLVRLFPED 424 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~ 424 (492)
+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999998843 2346899999999999999999999998 999999999999987 789999999999876543
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred C--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 2 2234578999999999988889999999999999999999999997643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=298.15 Aligned_cols=202 Identities=28% Similarity=0.384 Sum_probs=178.6
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
.++|++.+.||+|+||.||++...++..||+|++..... ..+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 467899999999999999999988888999999976543 3467899999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999988543 235899999999999999999999998 999999999999999999999999999876655433
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
......+|+.|+|||.+....++.++||||||++++||++ |+.|+...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 3344556788999999998899999999999999999999 99888643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=311.09 Aligned_cols=201 Identities=24% Similarity=0.303 Sum_probs=178.4
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
.++|++.+.||+|+||.||++... +++.||+|++..........+.+|+++|+.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999864 6889999999877666667899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC--CCcEEEeecCCccccCCC
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE--EFTAKIADFGLVRLFPED 424 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~ 424 (492)
+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999988843 2345899999999999999999999998 999999999999974 578999999999876543
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 253 (387)
T 1kob_A 205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253 (387)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence 22 23457899999999999999999999999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=308.32 Aligned_cols=200 Identities=33% Similarity=0.415 Sum_probs=171.0
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc----ceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE----SLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv 343 (492)
.++|++.++||+|+||+||+|+.. ++.||||++..... ....+.+|+.++++++||||+++++++.+... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467999999999999999999876 78999999965433 34456679999999999999999999987554 5899
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc----------CCCCeEecCCCCCCeeeCCCCcEEEe
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE----------SKLRIIHRDIKLSNILLDEEFTAKIA 413 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~----------~~~~ivH~Dlk~~Nill~~~~~~kl~ 413 (492)
|||+++++|.+++.. ..+++..+..++.||+.||+|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 999999999999854 3489999999999999999999998 6 9999999999999999999999
Q ss_pred ecCCccccCCCCcc-ccccccccccccchhhhccC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 414 DFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRG-----KLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 414 Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
|||+++........ ......||+.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 99999876543322 22345789999999998763 45678999999999999999999987643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=322.85 Aligned_cols=205 Identities=29% Similarity=0.419 Sum_probs=177.8
Q ss_pred HHHHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 264 LEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 264 l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
++...++|+..++||+|+||+||+|...++..||||+++... ...+.|.+|+++|++++||||+++++++. .+..++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 344567889999999999999999999888899999997654 34678999999999999999999999886 6678999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 261 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 99999999999985432 234788999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
..........+|+.|+|||++..+.++.++||||||+++|||++ |+.|+..
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 32222233456789999999999999999999999999999999 9998864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=315.16 Aligned_cols=204 Identities=25% Similarity=0.384 Sum_probs=176.0
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
..++|+..+.||+|+||.||+|... +++.||||+++... ....+.|.+|+++|++++||||+++++++.+.+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3567889999999999999999975 78999999987543 344567899999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999988543 235889999999999999999999998 999999999999999999999999999865443
Q ss_pred Ccccc-ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 425 ITHIS-ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 425 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
..... ....+++.|+|||.+..+.++.++||||||+++|||++ |+.|+...
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~ 319 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22111 12345788999999999999999999999999999998 88887643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=310.02 Aligned_cols=198 Identities=25% Similarity=0.316 Sum_probs=170.0
Q ss_pred ccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCC
Q 011153 272 HESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350 (492)
Q Consensus 272 ~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 350 (492)
...+.||+|+||.||++.. .+++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3467899999999999986 468999999998776666788999999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee--CCCCcEEEeecCCccccCCCCccc
Q 011153 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 351 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill--~~~~~~kl~Dfgl~~~~~~~~~~~ 428 (492)
+|.+.+... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.......
T Consensus 172 ~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 172 ELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 999888542 235899999999999999999999998 9999999999999 6778999999999987654322
Q ss_pred cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.....||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 234568999999999988899999999999999999999999997543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.71 Aligned_cols=204 Identities=31% Similarity=0.434 Sum_probs=179.1
Q ss_pred HhcccccCCcccccCcccEEEEEecC-CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
...+|++.++||+|+||.||+|.... +..||||+++.... ..+.|.+|+.+|++++||||+++++++.+.+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 35668889999999999999999764 78999999976543 36789999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999986532 345899999999999999999999998 9999999999999999999999999998775543
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
........+++.|+|||.+..+.++.++||||||+++|||++ |+.|+...
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 333334456789999999999999999999999999999999 88887653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=300.12 Aligned_cols=199 Identities=27% Similarity=0.389 Sum_probs=167.5
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCCh--------------------------hhHHHHHHHHHHHh
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT--------------------------QWVDHFFNEVNLIS 320 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~ 320 (492)
.++|++.+.||+|+||.||++.. .+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36789999999999999999986 4688999999865421 12356889999999
Q ss_pred ccCcCceeeeeeeeec--CCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 011153 321 GINHKNLVKLLGCSIT--GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK 398 (492)
Q Consensus 321 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk 398 (492)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++..+..++.||+.||+|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999986 55789999999999998765 2346899999999999999999999998 9999999
Q ss_pred CCCeeeCCCCcEEEeecCCccccCCCCccccccccccccccchhhhccCC---CCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 399 LSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK---LTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 399 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
|+|||++.++.+||+|||+++....... ......||+.|+|||.+.... .+.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987654322 223457899999999987655 37789999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=299.88 Aligned_cols=203 Identities=24% Similarity=0.374 Sum_probs=175.8
Q ss_pred HhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
..++|+..+.||+|+||.||++...++..||||++...... .+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 45678999999999999999999988889999999765433 46789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 9999999988542 245899999999999999999999998 99999999999999999999999999987654433
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
.......+|+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 33334556889999999999999999999999999999998 99888643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=308.23 Aligned_cols=202 Identities=25% Similarity=0.393 Sum_probs=168.9
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcc---
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES--- 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 340 (492)
.++|++.++||+|+||.||+++. .+++.||||++... .......+.+|++++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999996 56889999999764 334456789999999999999999999998876655
Q ss_pred -eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 341 -LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 341 -~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
++||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 9999999999999988543 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCcc--ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 420 LFPEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 420 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 222 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 66543221 223456899999999999999999999999999999999999998654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=320.00 Aligned_cols=205 Identities=23% Similarity=0.342 Sum_probs=180.5
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.++|+..++||+|+||+||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367889999999999999999975 68999999996542 23456788999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 344 YEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
|||+++|+|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999886543 2456999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 341 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp TTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 43322 234589999999999999999999999999999999999999997654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=304.70 Aligned_cols=203 Identities=19% Similarity=0.233 Sum_probs=176.6
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.++|++.+.||+|+||.||++.. .+++.||||++..... .+.+.+|+++++.+ +||||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36789999999999999999985 5788999999865432 34688999999999 99999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc-----EEEeecCCccc
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT-----AKIADFGLVRL 420 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~Dfgl~~~ 420 (492)
|+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999988643 346899999999999999999999998 999999999999998887 99999999987
Q ss_pred cCCCCcc------ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 421 FPEDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 421 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~ 223 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD 223 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc
Confidence 6443221 123567999999999999999999999999999999999999999875443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=316.60 Aligned_cols=202 Identities=21% Similarity=0.302 Sum_probs=175.9
Q ss_pred HHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
...++|++.++||+|+||.||++.. .+++.+|+|++.... ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3457799999999999999999985 468899999987543 3445678999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC---CCCcEEEeecCCcc
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVR 419 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgl~~ 419 (492)
||||+++|+|.+.+... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 88 v~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999888643 45899999999999999999999998 99999999999998 56789999999998
Q ss_pred ccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~ 215 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 7654332 22356799999999999999999999999999999999999999854
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=299.87 Aligned_cols=200 Identities=29% Similarity=0.418 Sum_probs=170.4
Q ss_pred cccccCCcccccCcccEEEEEecCCCEEEEEEeccCCh--hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
++|+..+.||+|+||+||+++..+++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46889999999999999999988899999999965432 2346788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++ +|.+.+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 975 888877432 345899999999999999999999998 99999999999999999999999999986643322
Q ss_pred cccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
......+|+.|+|||++.+. .++.++||||||++++||++|+.||...
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 22345689999999998764 5899999999999999999999998654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=300.27 Aligned_cols=204 Identities=28% Similarity=0.422 Sum_probs=162.1
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.++|+..++||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457889999999999999999864 68999999997553 3345678899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 346 FVPNQSLLDNLFVRQ---DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
|++ ++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58988875432 2345899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 160 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 160 IPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp SCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 43222 234578999999999876 468999999999999999999999987543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=302.57 Aligned_cols=202 Identities=30% Similarity=0.458 Sum_probs=172.1
Q ss_pred hcccccCCcccccCcccEEEEEe-----cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeec--CCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 340 (492)
.++|++.++||+|+||+||+++. .+++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46789999999999999999984 3578999999988777777889999999999999999999998865 3568
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 99999999999999985432 34899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCc--cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 421 FPEDIT--HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 421 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
...... .......+++.|+|||.+.+..++.++||||||+++|||++|..|+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 654322 122234577889999999999999999999999999999999988754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=305.95 Aligned_cols=198 Identities=24% Similarity=0.361 Sum_probs=173.6
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.+.||+|+||.||++.. .+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5789999999999999999996 578999999986432 233457899999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+ +|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 78888887543 35899999999999999999999998 999999999999999999999999999866543
Q ss_pred CccccccccccccccchhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...
T Consensus 162 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 162 N--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp B--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred c--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 2 2235579999999999987776 68999999999999999999998653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=323.01 Aligned_cols=203 Identities=27% Similarity=0.333 Sum_probs=179.4
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.++|+..++||+|+||.||+++.. +++.||||++... .......+.+|+++|+.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999864 6899999999653 223456788999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++|+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999886433 345899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 339 ~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 339 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp TCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred Ccc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 322 234579999999999999899999999999999999999999997654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=312.01 Aligned_cols=201 Identities=25% Similarity=0.295 Sum_probs=167.1
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHH-HhccCcCceeeeeeeeecCCccee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNL-ISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
.++|+..++||+|+||+||+++.. +++.||||++.... ......+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999865 57889999997543 2334556777776 577899999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999988543 35889999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 242 (373)
T 2r5t_A 191 EHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242 (373)
T ss_dssp CCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 322 2234568999999999999999999999999999999999999998653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=308.70 Aligned_cols=208 Identities=19% Similarity=0.227 Sum_probs=179.0
Q ss_pred hcccccCCccccc--CcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 268 TNYFHESNKLGQG--GSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 268 ~~~~~~~~~iG~G--~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
.++|++.++||+| +||.||+++.. +++.||||++... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 5679999999999 99999999965 6899999999754 34456778899999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999988653 2345899999999999999999999998 9999999999999999999999999986442
Q ss_pred CCC------ccccccccccccccchhhhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 423 EDI------THISATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 423 ~~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 244 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 244 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 211 111223478999999999987 679999999999999999999999997654443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=322.39 Aligned_cols=201 Identities=27% Similarity=0.308 Sum_probs=166.7
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.++|++.++||+|+||.||++.. .+++.||||++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35789999999999999999985 46899999999753 334456788999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
|||+++++|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999888543 358999999999999999999998 77 9999999999999999999999999998643
Q ss_pred CCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 301 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 301 KDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 322 2234567999999999999999999999999999999999999999654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=306.10 Aligned_cols=207 Identities=29% Similarity=0.414 Sum_probs=177.7
Q ss_pred HHhcccccCCcccccCcccEEEEEec------CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP 338 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 338 (492)
...++|++.+.||+|+||.||+++.. +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 44678999999999999999999874 3478999999765 3445677999999999999999999999999999
Q ss_pred cceeEEeecCCCCchhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQD---------------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDI 397 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl 397 (492)
..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 99999999999999999865321 256899999999999999999999998 999999
Q ss_pred CCCCeeeCCCCcEEEeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 398 KLSNILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 398 k~~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
||+|||++.++.+||+|||+++....... .......+|+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999986543221 12234567899999999999999999999999999999999 88888643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=305.81 Aligned_cols=209 Identities=26% Similarity=0.375 Sum_probs=176.5
Q ss_pred HHhcccccCCcccccCcccEEEEEe------cCCCEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecC
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG 337 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 337 (492)
...++|+..+.||+|+||.||++.. .++..||||++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3467899999999999999999985 23557999999754 334457899999999999 899999999999999
Q ss_pred CcceeEEeecCCCCchhhhhccCCC--------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQDV--------------------EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDI 397 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl 397 (492)
+..++||||+++++|.+++...... ..+++..++.++.||+.||+|||+.+ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 9999999999999999998654321 34899999999999999999999998 999999
Q ss_pred CCCCeeeCCCCcEEEeecCCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 398 KLSNILLDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 398 k~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
||+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999999866543322 2234567889999999999999999999999999999998 99898765
Q ss_pred CC
Q 011153 476 QN 477 (492)
Q Consensus 476 ~~ 477 (492)
..
T Consensus 279 ~~ 280 (344)
T 1rjb_A 279 PV 280 (344)
T ss_dssp CC
T ss_pred Cc
Confidence 43
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=307.28 Aligned_cols=201 Identities=27% Similarity=0.405 Sum_probs=161.3
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
..++|++.+.||+|+||.||+++.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567999999999999999999975 57899999997543 34568899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCcEEEeecCCccccC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLVRLFP 422 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgl~~~~~ 422 (492)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999998843 345899999999999999999999998 999999999999975 8899999999998654
Q ss_pred CCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 255 (349)
T 2w4o_A 203 HQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC
T ss_pred ccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 332 22345789999999999999999999999999999999999999865443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=300.70 Aligned_cols=206 Identities=29% Similarity=0.356 Sum_probs=177.9
Q ss_pred HhcccccCCcccccCcccEEEEEe------cCCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (492)
..++|.+.+.||+|+||.||++.. .+++.||||++... .....+.+.+|+++++.++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 356789999999999999999985 23578999999764 34556789999999999999999999999999999
Q ss_pred ceeEEeecCCCCchhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQD---------------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK 398 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk 398 (492)
.++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999865433 234899999999999999999999998 9999999
Q ss_pred CCCeeeCCCCcEEEeecCCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 399 LSNILLDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 399 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
|+|||+++++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||++++||++ |+.|+...
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999866543322 1224456889999999999999999999999999999999 88888654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=310.49 Aligned_cols=205 Identities=29% Similarity=0.356 Sum_probs=174.9
Q ss_pred hcccccCCcccccCcccEEEEEec------CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (492)
.++|++.++||+|+||+||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467899999999999999999843 3568999999654 445566789999999999999999999999999999
Q ss_pred eeEEeecCCCCchhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC---cEEEe
Q 011153 341 LLVYEFVPNQSLLDNLFVRQ----DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIA 413 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~ 413 (492)
++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999986543 2346899999999999999999999998 99999999999999554 59999
Q ss_pred ecCCccccCCC-CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 414 DFGLVRLFPED-ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 414 Dfgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
|||+++..... .........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~ 290 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999754321 1122234567899999999999999999999999999999998 88888643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=307.59 Aligned_cols=205 Identities=28% Similarity=0.359 Sum_probs=177.5
Q ss_pred HhcccccCCcccccCcccEEEEEec--------CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeec
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSIT 336 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 336 (492)
..++|.+.++||+|+||.||+++.. .+..||||++... .....+.+.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4567999999999999999999852 2347999999765 344567899999999999 99999999999999
Q ss_pred CCcceeEEeecCCCCchhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 011153 337 GPESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL 403 (492)
Q Consensus 337 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nil 403 (492)
++..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999865432 246999999999999999999999998 999999999999
Q ss_pred eCCCCcEEEeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 404 LDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 404 l~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||++++||++ |+.|+..
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999986654322 22234567889999999999999999999999999999999 8888864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=313.68 Aligned_cols=198 Identities=28% Similarity=0.433 Sum_probs=171.9
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC-cceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-ESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 346 (492)
.++|+..++||+|+||.||+|... ++.||||+++... ..+.|.+|+++|++++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467888999999999999999876 6799999997654 4578999999999999999999999987665 78999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 99999999996543 234789999999999999999999998 9999999999999999999999999998543321
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQ 476 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~~ 476 (492)
....+++.|+|||.+....++.++||||||+++|||++ |+.|+....
T Consensus 344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 22356889999999999999999999999999999998 999987543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=314.40 Aligned_cols=199 Identities=27% Similarity=0.400 Sum_probs=176.1
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56889999999999999999865 78999999996542 234567899999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999998843 346899999999999999999999998 999999999999999999999999999876543
Q ss_pred CccccccccccccccchhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...
T Consensus 170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 219 (476)
T 2y94_A 170 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219 (476)
T ss_dssp C--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence 2 2335679999999999988776 68999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=318.14 Aligned_cols=203 Identities=30% Similarity=0.426 Sum_probs=170.5
Q ss_pred HHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
...++|+..++||+|+||.||+|...++..||||+++.... ..+.|.+|+++|++++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 44567889999999999999999998888899999976543 35679999999999999999999999876 67899999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 259 ~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999998532 2235899999999999999999999998 9999999999999999999999999998765443
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
........+++.|+|||.+..+.++.++||||||+++|||++ |+.|+..
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 384 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence 332334457889999999999999999999999999999999 8888864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=308.06 Aligned_cols=203 Identities=30% Similarity=0.462 Sum_probs=164.1
Q ss_pred HHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccC-cCceeeeeeeeecCC--c
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGP--E 339 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~ 339 (492)
...++|++.++||+|+||.||++.. .+++.||||++... .....+.+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457899999999999999999985 46899999998643 3455667889999999997 999999999997554 6
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
.++||||++ ++|.+.+.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 799999997 588887743 35889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCC--------------------ccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 420 LFPEDI--------------------THISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 420 ~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.+.... ........||+.|+|||++.+ ..++.++|||||||+++||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 653311 112234579999999999876 678999999999999999999999997543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=306.32 Aligned_cols=202 Identities=24% Similarity=0.298 Sum_probs=165.8
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
.++|++.++||+|+||+||+++.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999965 788999999975432 346688999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc--EEEeecCCccccCCC
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT--AKIADFGLVRLFPED 424 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~Dfgl~~~~~~~ 424 (492)
+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999988543 35899999999999999999999998 999999999999987765 999999998743322
Q ss_pred CccccccccccccccchhhhccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEK-ADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
. ......||+.|+|||++.+..++.+ +||||||+++|||++|+.||......
T Consensus 172 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (361)
T 3uc3_A 172 S--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 224 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C
T ss_pred C--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH
Confidence 1 2234578999999999988888766 89999999999999999999765443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=305.48 Aligned_cols=209 Identities=27% Similarity=0.265 Sum_probs=173.1
Q ss_pred HHHHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC-----ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC
Q 011153 264 LEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG 337 (492)
Q Consensus 264 l~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 337 (492)
+....++|++.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 456678899999999999999999986 46889999998643 334567899999999999999999999999999
Q ss_pred CcceeEEeecCCCCchhhhhccC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQ-------------------------------------DVEPLSWEVRYKIILSTAEG 380 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~~~~~~~~~i~~~i~~~ 380 (492)
+..++||||+++++|.+++.... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999998884210 01123577788999999999
Q ss_pred HHHHhhcCCCCeEecCCCCCCeeeCCCC--cEEEeecCCccccCCCCc---cccccccccccccchhhhcc--CCCCcch
Q 011153 381 LAYLHEESKLRIIHRDIKLSNILLDEEF--TAKIADFGLVRLFPEDIT---HISATLAGTLGYMAPEYVVR--GKLTEKA 453 (492)
Q Consensus 381 l~yLH~~~~~~ivH~Dlk~~Nill~~~~--~~kl~Dfgl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~s 453 (492)
|+|||+.+ |+||||||+|||++.++ .+||+|||+++.+..... .......||+.|+|||.+.. ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 899999999986543221 12335678999999999865 6789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCC
Q 011153 454 DVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 454 Dv~slGvll~elltg~~p~~~~ 475 (492)
||||||+++|||++|+.||...
T Consensus 258 DiwslG~il~el~~g~~pf~~~ 279 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGV 279 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999998654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=293.62 Aligned_cols=201 Identities=28% Similarity=0.400 Sum_probs=177.0
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
.++|+..+.||+|+||.||++...+++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 3578889999999999999999888889999999765432 467899999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 999999988543 345899999999999999999999998 999999999999999999999999999866543222
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
......+++.|+|||.+....++.++||||||++++||++ |+.|+..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC
Confidence 2334567889999999998999999999999999999999 7888764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=306.80 Aligned_cols=205 Identities=17% Similarity=0.215 Sum_probs=169.7
Q ss_pred HhcccccCCcccccCcccEEEEEecC------CCEEEEEEeccCChhhH-----------HHHHHHHHHHhccCcCceee
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWV-----------DHFFNEVNLISGINHKNLVK 329 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~ 329 (492)
..++|++.++||+|+||.||++.+.. ++.||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998754 47899999876543211 12445666778889999999
Q ss_pred eeeeeecC----CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC
Q 011153 330 LLGCSITG----PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD 405 (492)
Q Consensus 330 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~ 405 (492)
+++++... ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998865 3478999999 99999988542 356999999999999999999999998 99999999999998
Q ss_pred --CCCcEEEeecCCccccCCCCccc------cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 406 --EEFTAKIADFGLVRLFPEDITHI------SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 406 --~~~~~kl~Dfgl~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
.++.+||+|||+++.+....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998765332111 1234599999999999999999999999999999999999999986433
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=308.63 Aligned_cols=204 Identities=28% Similarity=0.331 Sum_probs=175.4
Q ss_pred hcccccCCcccccCcccEEEEEe----cCCCEEEEEEeccCC----hhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCC
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNT----TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGP 338 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 338 (492)
.++|++.++||+|+||.||+++. .+++.||||+++... ....+.+.+|+++++.+ +||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999986 368999999986532 23345678899999999 6999999999999999
Q ss_pred cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCc
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~ 418 (492)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999998643 35899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccchhhhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
+.+............||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 267 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc
Confidence 8765444434445679999999999875 3478999999999999999999999976443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=302.36 Aligned_cols=207 Identities=25% Similarity=0.369 Sum_probs=161.5
Q ss_pred HHhcccccCCcccccCcccEEEEEecCC----CEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLPGG----EAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~~----~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (492)
...++|++.+.||+|+||.||++..... ..||||++... .....+.+.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 3456799999999999999999986543 27999998754 34556789999999999999999999999987766
Q ss_pred c------eeEEeecCCCCchhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcE
Q 011153 340 S------LLVYEFVPNQSLLDNLFVRQ---DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (492)
Q Consensus 340 ~------~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ 410 (492)
. ++|+||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 89999999999999886432 2236899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 411 KIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 411 kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 243 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence 9999999986644322 12224456889999999999999999999999999999999 88887653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=296.31 Aligned_cols=203 Identities=25% Similarity=0.329 Sum_probs=162.7
Q ss_pred HhcccccCCcccccCcccEEEEEecC----CCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
..++|++.+.||+|+||.||++.... +..||+|++... .....+.+.+|+.++++++||||+++++++ .++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence 35678999999999999999998643 446999998754 344567799999999999999999999987 456789
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999988543 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
............+|+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~ 221 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence 5543333334456889999999999999999999999999999997 88888654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=303.08 Aligned_cols=202 Identities=26% Similarity=0.427 Sum_probs=166.9
Q ss_pred hcccccCCcccccCcccEEEEEec-CCC----EEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGE----AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
.++|+..++||+|+||+||+|+.. +++ +||+|.+... .....+.+.+|+.++++++||||+++++++.++ ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 356889999999999999999854 444 3688887543 334567899999999999999999999999875 478
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+|+||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999988653 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCccc-cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 422 PEDITHI-SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 422 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
....... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 223 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence 5443222 224456889999999999999999999999999999999 99998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=304.88 Aligned_cols=211 Identities=24% Similarity=0.287 Sum_probs=182.1
Q ss_pred ccccCHHHHHHHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccC-----cCceee
Q 011153 256 KLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-----HKNLVK 329 (492)
Q Consensus 256 ~~~~~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv~ 329 (492)
...+++.......++|++.++||+|+||+||+++. .+++.||||++... ....+.+..|+.+++.++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34455566666678999999999999999999986 46889999998643 344566788999999886 999999
Q ss_pred eeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---
Q 011153 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE--- 406 (492)
Q Consensus 330 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~--- 406 (492)
+++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 999999999999999999 899999886533 345899999999999999999999998 999999999999975
Q ss_pred ----------------------CCcEEEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHH
Q 011153 407 ----------------------EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464 (492)
Q Consensus 407 ----------------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~e 464 (492)
++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 7899999999998654322 24578999999999999999999999999999999
Q ss_pred HHhCCCCCCCCC
Q 011153 465 VVCRKRINLFTQ 476 (492)
Q Consensus 465 lltg~~p~~~~~ 476 (492)
|++|+.||....
T Consensus 252 ll~g~~pf~~~~ 263 (360)
T 3llt_A 252 LYTGSLLFRTHE 263 (360)
T ss_dssp HHHSSCSCCCSS
T ss_pred HHHCCCCCCCCc
Confidence 999999997543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=296.90 Aligned_cols=197 Identities=30% Similarity=0.448 Sum_probs=164.6
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhc--cCcCceeeeeeeeecC----Ccce
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG--INHKNLVKLLGCSITG----PESL 341 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 341 (492)
.++|++.++||+|+||+||+++. +++.||||++... ....+.+|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46799999999999999999987 5889999998643 23455666666655 7999999999986543 4578
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEecCCCCCCeeeCCCCcEEEe
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH--------EESKLRIIHRDIKLSNILLDEEFTAKIA 413 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 413 (492)
+||||+++++|.+++. ...+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999983 346899999999999999999999 666 9999999999999999999999
Q ss_pred ecCCccccCCCCccc---cccccccccccchhhhccC------CCCcchhHHHHHHHHHHHHhC----------CCCCCC
Q 011153 414 DFGLVRLFPEDITHI---SATLAGTLGYMAPEYVVRG------KLTEKADVYSFGVVVIEVVCR----------KRINLF 474 (492)
Q Consensus 414 Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDv~slGvll~elltg----------~~p~~~ 474 (492)
|||+++......... .....||+.|+|||++... .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999998665433221 2244789999999998876 455799999999999999999 777755
Q ss_pred C
Q 011153 475 T 475 (492)
Q Consensus 475 ~ 475 (492)
.
T Consensus 236 ~ 236 (301)
T 3q4u_A 236 V 236 (301)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=292.30 Aligned_cols=201 Identities=22% Similarity=0.345 Sum_probs=177.1
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
..++|++.++||+|+||.||++... ++..+|+|++........+.+.+|++++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3567999999999999999999865 477899999987666667889999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee---CCCCcEEEeecCCccccC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~~ 422 (492)
|+++++|.+.+... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999888543 34899999999999999999999998 9999999999999 788999999999998765
Q ss_pred CCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
... ......||+.|+|||.+.+ .++.++||||||++++||++|+.||....
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Ccc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 432 2234578999999998754 58999999999999999999999987543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=298.02 Aligned_cols=207 Identities=29% Similarity=0.390 Sum_probs=178.9
Q ss_pred HhcccccCCcccccCcccEEEEEe------cCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCC
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGP 338 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 338 (492)
..++|+..+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++.+++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 456799999999999999999984 246789999997653 34467899999999999 9999999999999999
Q ss_pred cceeEEeecCCCCchhhhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQD---------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL 403 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nil 403 (492)
..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999865432 235899999999999999999999998 999999999999
Q ss_pred eCCCCcEEEeecCCccccCCCCccc-cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 011153 404 LDEEFTAKIADFGLVRLFPEDITHI-SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQ 476 (492)
Q Consensus 404 l~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~~ 476 (492)
++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||++++||++ |+.|+....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999998765543221 224457889999999999999999999999999999999 888886644
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=297.61 Aligned_cols=198 Identities=27% Similarity=0.333 Sum_probs=166.0
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 343 (492)
.++|+..++||+|+||+||+|... +++.||||++... .......+..|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999975 7899999998654 233344556666666555 999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+ +++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 678988875543 45899999999999999999999988 99999999999999999999999999886644
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|+.|+..
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 210 AG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred CC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 32 2234568999999998765 789999999999999999999877643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=298.10 Aligned_cols=205 Identities=31% Similarity=0.430 Sum_probs=180.7
Q ss_pred HHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
...++|++.+.||+|+||.||++... ++..||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34677999999999999999999975 47889999997543 34678999999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999988543 3356899999999999999999999998 999999999999999999999999999877655
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
.........+|+.|+|||.+....++.++||||||++++||++ |+.|+...
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~ 216 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4444445567889999999999999999999999999999999 88887653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=306.72 Aligned_cols=210 Identities=28% Similarity=0.375 Sum_probs=178.3
Q ss_pred HHHHhcccccCCcccccCcccEEEEEecC------CCEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CcCceeeeeeeee
Q 011153 264 LEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSI 335 (492)
Q Consensus 264 l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 335 (492)
++...++|+..+.||+|+||.||++.... ...||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34456789999999999999999998642 2479999997653 34567799999999999 8999999999999
Q ss_pred cCCcceeEEeecCCCCchhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 011153 336 TGPESLLVYEFVPNQSLLDNLFVRQ-----------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL 404 (492)
Q Consensus 336 ~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill 404 (492)
+++..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 9999999999999999999886432 1346899999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 011153 405 DEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQ 476 (492)
Q Consensus 405 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~~ 476 (492)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 99999999999999865443222 2224557889999999999999999999999999999999 888876543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=327.43 Aligned_cols=202 Identities=27% Similarity=0.283 Sum_probs=177.5
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcce
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 341 (492)
..++|++.++||+|+||+||+++.. +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3567999999999999999999865 5888999999753 234456788999999988 7999999999999999999
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999998654 35899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.... .......||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 493 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 493 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp CCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 3322 2234568999999999999999999999999999999999999999754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=303.05 Aligned_cols=197 Identities=31% Similarity=0.502 Sum_probs=171.8
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.+.|+..+.||+|+||+||+++. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35588899999999999999985 578899999997542 33456789999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||++ |+|.+.+... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 6787777433 246899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCccccccccccccccchhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ....||+.|+|||++. .+.++.++||||||+++|||++|+.|+...
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2 2457899999999985 567899999999999999999999998643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=302.90 Aligned_cols=200 Identities=25% Similarity=0.309 Sum_probs=174.4
Q ss_pred HhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCCh--------hhHHHHHHHHHHHhccCcCceeeeeeeeecC
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT--------QWVDHFFNEVNLISGINHKNLVKLLGCSITG 337 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 337 (492)
..++|++.+.||+|+||.||++.. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456799999999999999999985 5688999999875421 1344678899999999999999999999999
Q ss_pred CcceeEEeecCCC-CchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 011153 338 PESLLVYEFVPNQ-SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (492)
Q Consensus 338 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 416 (492)
+..++||||+..| +|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 88888743 345899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCccccccccccccccchhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvll~elltg~~p~~~ 474 (492)
+++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus 176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 9987654322 234578999999999988877 7899999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=291.62 Aligned_cols=200 Identities=30% Similarity=0.448 Sum_probs=164.4
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCC----hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT----TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.++|+..++||+|+||.||++... ++.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357889999999999999999975 7889999986543 23356789999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC--------CCcEEEeec
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE--------EFTAKIADF 415 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~--------~~~~kl~Df 415 (492)
|||+++++|.+++. ...+++..+..++.|++.||+|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999998873 346899999999999999999999987556999999999999986 778999999
Q ss_pred CCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 416 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
|++........ ....||+.|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 161 g~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 161 GLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred Ccccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99986544322 2456899999999999999999999999999999999999998653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=314.27 Aligned_cols=198 Identities=27% Similarity=0.369 Sum_probs=165.8
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC------
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ 338 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 338 (492)
.++|++.++||+|+||+||++... +++.||||++... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999854 6889999999754 4445677899999999999999999999997654
Q ss_pred cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCc
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~ 418 (492)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 45999999976 4555552 23889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+...... ......||+.|+|||++.+..++.++|||||||+++||++|+.||...+
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 212 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp -----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8665432 2345678999999999999999999999999999999999999997543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=297.32 Aligned_cols=200 Identities=27% Similarity=0.353 Sum_probs=176.6
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChh------hHHHHHHHHHHHhccCcCceeeeeeeeecCCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQ------WVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (492)
.++|++.+.||+|+||.||++... +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 466899999999999999999865 6889999998654321 357799999999999999999999999999999
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC----cEEEeecC
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFG 416 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfg 416 (492)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999998853 345899999999999999999999998 99999999999999887 79999999
Q ss_pred CccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
++........ .....||+.|+|||.+....++.++||||||++++||++|+.||...
T Consensus 165 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp TCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred cceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 9987654322 23456899999999999899999999999999999999999998653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=298.31 Aligned_cols=206 Identities=27% Similarity=0.363 Sum_probs=176.2
Q ss_pred HhcccccCCcccccCcccEEEEEec--------CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeec
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSIT 336 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 336 (492)
..++|++.+.||+|+||.||++... ++..||||++... .....+.+.+|+++++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3578999999999999999999863 4678999999765 344567799999999999 89999999999999
Q ss_pred CCcceeEEeecCCCCchhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 011153 337 GPESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL 403 (492)
Q Consensus 337 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nil 403 (492)
.+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999865432 235899999999999999999999998 999999999999
Q ss_pred eCCCCcEEEeecCCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 404 LDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 404 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 999999999999999876543321 1223456889999999998999999999999999999999 88888643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=298.75 Aligned_cols=218 Identities=27% Similarity=0.346 Sum_probs=183.1
Q ss_pred cccCHHHHHHHhcccccCCcccccCcccEEEEEe------cCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CcCcee
Q 011153 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLV 328 (492)
Q Consensus 257 ~~~~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv 328 (492)
..+....+....++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++.++ +||||+
T Consensus 15 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv 94 (316)
T 2xir_A 15 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94 (316)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCee
Confidence 3455566666778999999999999999999974 346789999997653 34456789999999999 799999
Q ss_pred eeeeeeecCC-cceeEEeecCCCCchhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 011153 329 KLLGCSITGP-ESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394 (492)
Q Consensus 329 ~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH 394 (492)
++++++...+ ..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+|
T Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H 171 (316)
T 2xir_A 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH 171 (316)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 9999987755 48999999999999999865432 223889999999999999999999998 999
Q ss_pred cCCCCCCeeeCCCCcEEEeecCCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 011153 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRIN 472 (492)
Q Consensus 395 ~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~ 472 (492)
|||||+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||++++||++ |+.|+
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999866543322 2234567889999999999999999999999999999998 99888
Q ss_pred CCCCC
Q 011153 473 LFTQN 477 (492)
Q Consensus 473 ~~~~~ 477 (492)
.....
T Consensus 252 ~~~~~ 256 (316)
T 2xir_A 252 PGVKI 256 (316)
T ss_dssp TTCCC
T ss_pred cccch
Confidence 66443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=295.99 Aligned_cols=198 Identities=29% Similarity=0.416 Sum_probs=165.6
Q ss_pred cccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecC
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (492)
++|++.+.||+|+||.||++... ++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 56888999999999999999875 688999998643 34578999999999999999999999887 45899999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc-EEEeecCCccccCCCCcc
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT-AKIADFGLVRLFPEDITH 427 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~-~kl~Dfgl~~~~~~~~~~ 427 (492)
+++|.+++........+++..++.++.||++||+|||+.+..+|+||||||+|||++.++. +||+|||++.......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-- 160 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-- 160 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence 9999999976555556889999999999999999999932234999999999999988886 7999999997554321
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....||+.|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 161 --~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 161 --TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred --ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 2346899999999999999999999999999999999999998754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=292.11 Aligned_cols=202 Identities=31% Similarity=0.461 Sum_probs=175.2
Q ss_pred HhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
..++|++.+.||+|+||.||++...+++.||||++..... ..+.+.+|+++++.++||||+++++++. .+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 3567899999999999999999988888999999975432 3567899999999999999999999876 4568999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999999884321 125899999999999999999999998 99999999999999999999999999987765443
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
.......+++.|+|||.+..+.++.++||||||++++||++ |+.|+..
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 213 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence 33334557889999999988899999999999999999999 8888764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.37 Aligned_cols=204 Identities=24% Similarity=0.339 Sum_probs=164.9
Q ss_pred HHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--------hhhHHHHHHHHHHHhccCcCceeeeeeeeec
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--------TQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 336 (492)
...++|.+.++||+|+||+||++... +++.||||++.... ......+.+|+++|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 44678999999999999999999864 68899999986532 122235889999999999999999999875
Q ss_pred CCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC---CcEEEe
Q 011153 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIA 413 (492)
Q Consensus 337 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~ 413 (492)
.+..++||||+++++|.+.+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 4557999999999999988743 346899999999999999999999998 9999999999999654 459999
Q ss_pred ecCCccccCCCCccccccccccccccchhhhcc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 414 DFGLVRLFPEDITHISATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 414 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
|||+++..... .......||+.|+|||++.. ..++.++||||||+++|||++|+.||......
T Consensus 285 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~ 350 (419)
T 3i6u_A 285 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 350 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS
T ss_pred ecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch
Confidence 99999876543 22335679999999999853 66888999999999999999999999765444
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.41 Aligned_cols=194 Identities=24% Similarity=0.362 Sum_probs=154.1
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC-----Cc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PE 339 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 339 (492)
.++|++.++||+|+||+||++... +++.||||++... .....+.+.+|+++|+.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 467999999999999999999864 6899999998653 344567899999999999999999999998543 56
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
.++||||+ +++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 79999998 5788888743 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCc--------------------------cccccccccccccchhhhc-cCCCCcchhHHHHHHHHHHHHhC
Q 011153 420 LFPEDIT--------------------------HISATLAGTLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVVCR 468 (492)
Q Consensus 420 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~slGvll~elltg 468 (492)
....... .......||+.|+|||++. ...++.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7643221 1123457899999999864 56799999999999999999994
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=294.43 Aligned_cols=203 Identities=30% Similarity=0.422 Sum_probs=169.9
Q ss_pred HhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC-----hhhHHHHHHHHHHHhccC---cCceeeeeeeeecC
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-----TQWVDHFFNEVNLISGIN---HKNLVKLLGCSITG 337 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 337 (492)
..++|++.++||+|+||+||+++. .+++.||||++.... ......+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999996 568899999986432 122345677887777664 99999999999876
Q ss_pred C-----cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEE
Q 011153 338 P-----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412 (492)
Q Consensus 338 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl 412 (492)
. ..++||||++ ++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4689999997 59988885433 334899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 413 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+|||+++....... .....||+.|+|||++.+..++.++||||||++++||++|+.||....
T Consensus 162 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 223 (308)
T 3g33_A 162 ADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223 (308)
T ss_dssp CSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred eeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999986654322 245678999999999999999999999999999999999999986543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=300.75 Aligned_cols=202 Identities=28% Similarity=0.426 Sum_probs=169.5
Q ss_pred cccccCCcccccCcccEEEEEec-CCCE----EEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
++|+..++||+|+||+||+|... +++. |++|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56888999999999999999864 4444 7888775432 334456789999999999999999999886 567889
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
|+||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999988543 345888999999999999999999998 9999999999999999999999999998775
Q ss_pred CCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 011153 423 EDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQ 476 (492)
Q Consensus 423 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~~ 476 (492)
..... ......+|+.|+|||.+..+.++.++||||||+++|||++ |+.||....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 44322 2334567889999999999999999999999999999999 999987543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=297.87 Aligned_cols=202 Identities=24% Similarity=0.304 Sum_probs=169.6
Q ss_pred cccccC-CcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEEe
Q 011153 269 NYFHES-NKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~-~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 345 (492)
+.|++. ++||+|+||.||++.. .+++.||||++........+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 557774 7899999999999985 47899999999876666677899999999885 79999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc---EEEeecCCccccC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT---AKIADFGLVRLFP 422 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfgl~~~~~ 422 (492)
|+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999998653 35889999999999999999999998 999999999999988776 9999999987654
Q ss_pred CCCc------cccccccccccccchhhhcc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 423 EDIT------HISATLAGTLGYMAPEYVVR-----GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 423 ~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.... .......||+.|+|||++.. ..++.++||||||++++||++|+.||....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 2211 11224568999999999875 568899999999999999999999997643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=309.40 Aligned_cols=205 Identities=27% Similarity=0.375 Sum_probs=176.4
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCC--cceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP--ESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 343 (492)
.++|++.++||+|+||+||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999865 58999999997543 334567889999999999999999999988765 66899
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee----CCCCcEEEeecCCcc
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVR 419 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~Dfgl~~ 419 (492)
|||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999866555555999999999999999999999998 9999999999999 778889999999998
Q ss_pred ccCCCCccccccccccccccchhhhcc--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 420 LFPEDITHISATLAGTLGYMAPEYVVR--------GKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||.....
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~ 228 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence 765432 2234578999999999865 5677899999999999999999999975443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=291.09 Aligned_cols=202 Identities=28% Similarity=0.393 Sum_probs=156.4
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35689999999999999999986 578999999986432 23356789999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
+||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999998853 2356899999999999999999999998 99999999999999999999999999986653
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
... ......||+.|+|||.+.+..++.++||||||++++||++|+.|+...
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 215 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence 322 122456899999999998888999999999999999999999998753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=302.70 Aligned_cols=199 Identities=24% Similarity=0.360 Sum_probs=168.0
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCc--CceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINH--KNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv 343 (492)
.++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++..++| |||+++++++.++...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4679999999999999999999988999999998654 34456789999999999986 9999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|| +.+++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++....
T Consensus 88 ~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 5688999988543 45899999999999999999999998 99999999999997 57899999999987654
Q ss_pred CCcc-ccccccccccccchhhhcc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 424 DITH-ISATLAGTLGYMAPEYVVR-----------GKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 424 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 3322 2335679999999999865 6789999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=299.20 Aligned_cols=193 Identities=25% Similarity=0.331 Sum_probs=151.0
Q ss_pred CCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccC-cCceeeeeeeeecCCcceeEEeecCCCC
Q 011153 274 SNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFVPNQS 351 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 351 (492)
.++||+|+||.||++... +++.||||++... ....+.+|+.+++.+. ||||+++++++.++...++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999865 6899999998643 3456789999999997 9999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC---cEEEeecCCccccCCCCccc
Q 011153 352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 352 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~Dfgl~~~~~~~~~~~ 428 (492)
|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++....... .
T Consensus 93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~ 165 (325)
T 3kn6_A 93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-P 165 (325)
T ss_dssp HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-c
Confidence 99988543 45899999999999999999999998 99999999999997665 899999999986554322 2
Q ss_pred cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.....||+.|+|||++.+..++.++||||||++++||++|+.||....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 335578999999999999999999999999999999999999997643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=296.76 Aligned_cols=198 Identities=26% Similarity=0.366 Sum_probs=172.6
Q ss_pred hcccccCCcccccCcccEEEEEecC-C-------CEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG-G-------EAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (492)
.++|+..+.||+|+||.||++.... + ..||+|++........+.+.+|++++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4678899999999999999998643 3 4699999987777777889999999999999999999999999999
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc--------EE
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT--------AK 411 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~--------~k 411 (492)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999998543 234899999999999999999999998 999999999999998887 99
Q ss_pred EeecCCccccCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 412 IADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 412 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
|+|||++...... ....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|+...
T Consensus 162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 9999998754332 23457889999999987 67899999999999999999976665543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=287.82 Aligned_cols=205 Identities=29% Similarity=0.403 Sum_probs=177.6
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.+++.++||||+++++++.+++..++|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999865 6899999998654 33446788999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++++|.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999998842 345899999999999999999999998 9999999999999999999999999998654322
Q ss_pred c-cccccccccccccchhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 426 T-HISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 426 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
. .......|++.|+|||.+.+..+ +.++||||||++++||++|+.||......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 214 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Confidence 1 22335678999999999887765 67899999999999999999999765443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=292.92 Aligned_cols=203 Identities=34% Similarity=0.509 Sum_probs=162.8
Q ss_pred HhcccccCCcccccCcccEEEEEecCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
..++|++.++||+|+||+||+++..+ .||||+++.. .....+.+.+|++++++++||||++++++. ..+..++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 45679999999999999999998653 5999998654 344567899999999999999999999965 566789999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999988843 3356899999999999999999999998 999999999999999999999999999765432
Q ss_pred C-ccccccccccccccchhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 425 I-THISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 425 ~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
. ........||+.|+|||.+. ...++.++||||||++++||++|+.||....+
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 230 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch
Confidence 2 22223457899999999986 56788999999999999999999999976443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=297.23 Aligned_cols=201 Identities=21% Similarity=0.267 Sum_probs=165.7
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
-++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467999999999999999999965 6889999998754 233457789999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
+||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999988543 35899999999999999999999998 99999999999999999999999999987655
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
..........+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC
Confidence 433333455789999999999999999999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=290.12 Aligned_cols=200 Identities=24% Similarity=0.361 Sum_probs=175.8
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999864 6889999998654 3445677889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc---EEEeecCCcccc
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT---AKIADFGLVRLF 421 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfgl~~~~ 421 (492)
||+++++|.+.+... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999998888543 35899999999999999999999998 999999999999986655 999999999766
Q ss_pred CCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
..... .....||+.|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 210 (284)
T 3kk8_A 159 NDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210 (284)
T ss_dssp CSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence 54322 23457899999999999999999999999999999999999998543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=294.70 Aligned_cols=201 Identities=24% Similarity=0.348 Sum_probs=169.7
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
++|++.++||+|+||+||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57899999999999999999975 58999999986543 3345678899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999887643 345899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
. ......+|+.|+|||.+.+ ..++.++||||||++++||++|+.||....
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 157 D-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 2 2234578999999999876 668999999999999999999999986644
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=301.04 Aligned_cols=212 Identities=29% Similarity=0.407 Sum_probs=179.9
Q ss_pred CHHHHHHHhcccccCCcccccCcccEEEEEec------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeee
Q 011153 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLG 332 (492)
Q Consensus 260 ~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~ 332 (492)
..++++...++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 34445566788999999999999999999754 36789999997543 344567899999999999999999999
Q ss_pred eeecCCcceeEEeecCCCCchhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC
Q 011153 333 CSITGPESLLVYEFVPNQSLLDNLFVRQ-------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD 405 (492)
Q Consensus 333 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~ 405 (492)
++.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~ 172 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA 172 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEc
Confidence 9999999999999999999999886422 2256799999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 406 EEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 406 ~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 243 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 243 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence 999999999999986543322 12224456889999999999999999999999999999999 7777754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=304.73 Aligned_cols=200 Identities=23% Similarity=0.352 Sum_probs=169.0
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccC--cCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGIN--HKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 343 (492)
.++|++.++||+|+||.||++...+++.||||++... .....+.+.+|+.+|+.++ ||||+++++++..++..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3569999999999999999999888999999998654 3455678999999999996 59999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|| +.+++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 5688999988543 35889999999999999999999988 99999999999995 57999999999987654
Q ss_pred CCcc-ccccccccccccchhhhcc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITH-ISATLAGTLGYMAPEYVVR-----------GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 3322 2335679999999999865 46889999999999999999999999653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=321.66 Aligned_cols=204 Identities=30% Similarity=0.430 Sum_probs=176.5
Q ss_pred HHHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 265 EKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 265 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
+...++|++.++||+|+||.||+|.+.++..||||+++.... ..+.|.+|+++|++++||||+++++++.+ +..++||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 344677889999999999999999998888899999976543 35679999999999999999999999876 6789999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 341 e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred ehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999999998532 2235889999999999999999999998 999999999999999999999999999876543
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
.........+++.|+|||.+..+.++.++||||||++||||++ |+.|+..
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~ 467 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2222233456789999999999999999999999999999999 8888864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=290.63 Aligned_cols=203 Identities=26% Similarity=0.360 Sum_probs=170.7
Q ss_pred HhcccccCCcccccCcccEEEEEecC----CCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
..++|+..+.||+|+||.||++...+ +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35678999999999999999998543 235999998765 34456789999999999999999999998764 5678
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+||||+++++|.+++... ...+++..+..++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999988543 245899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
............+++.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 5543333334567889999999998999999999999999999998 99998643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=300.18 Aligned_cols=197 Identities=26% Similarity=0.428 Sum_probs=166.2
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC------
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ 338 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 338 (492)
.++|+..+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999986 46899999998543 3344667899999999999999999999988664
Q ss_pred cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCc
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~ 418 (492)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 7899888753 35899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+..... .....+|+.|+|||++.+ ..++.++||||||++++||++|+.||....
T Consensus 176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 875432 234578999999999887 679999999999999999999999997543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=308.36 Aligned_cols=198 Identities=23% Similarity=0.342 Sum_probs=166.0
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC-----Cc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PE 339 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 339 (492)
.++|++.++||+|+||.||++... +++.||||++... .....+.+.+|+++|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467999999999999999999864 5788999999753 344567889999999999999999999999876 56
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
.++||||++ ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 599888843 345899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCcc---------------------ccccccccccccchhhh-ccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 011153 420 LFPEDITH---------------------ISATLAGTLGYMAPEYV-VRGKLTEKADVYSFGVVVIEVVCRKRIN 472 (492)
Q Consensus 420 ~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~slGvll~elltg~~p~ 472 (492)
........ ......||+.|+|||++ ....++.++|||||||+++||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76543211 12456789999999986 4566999999999999999999865444
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=289.89 Aligned_cols=202 Identities=19% Similarity=0.250 Sum_probs=175.7
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.++|++.+.||+|+||.||++.. .+++.||||++.... ..+.+.+|+.+++.+ +|+|++++++++.++...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999985 578899999986443 234688999999999 89999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc-----EEEeecCCccc
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT-----AKIADFGLVRL 420 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~Dfgl~~~ 420 (492)
|+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999998543 335899999999999999999999988 999999999999987776 99999999987
Q ss_pred cCCCCcc------ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 421 FPEDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 421 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
....... ......||+.|+|||.+.+..++.++||||||++++||++|+.||.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 6543221 12356789999999999999999999999999999999999999987543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=294.25 Aligned_cols=201 Identities=26% Similarity=0.438 Sum_probs=172.1
Q ss_pred hcccccCCcccccCcccEEEEEe-----cCCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC--Cc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PE 339 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 339 (492)
.++|+..++||+|+||.||++++ .+++.||||++... .....+.+.+|+++++.++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45688999999999999999983 36789999999754 334467899999999999999999999999876 56
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
.++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 789999999999999885432 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCc--cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 011153 420 LFPEDIT--HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINL 473 (492)
Q Consensus 420 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~ 473 (492)
....... .......+|..|+|||.+.+..++.++||||||++++||++|+.|+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 7654432 22334567889999999999999999999999999999999998854
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=288.39 Aligned_cols=201 Identities=33% Similarity=0.545 Sum_probs=170.0
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChh-------hHHHHHHHHHHHhccCcCceeeeeeeeecCCc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQ-------WVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (492)
.++|+..+.||+|+||.||+++. .+++.||+|++...... ..+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46789999999999999999986 47899999998654321 1267899999999999999999999986554
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc-----EEEee
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT-----AKIAD 414 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~D 414 (492)
++||||+++++|.+.+.. ....+++..++.++.|++.||+|||+++ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999888754 3346899999999999999999999875 45999999999999988776 99999
Q ss_pred cCCccccCCCCccccccccccccccchhhhc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 415 FGLVRLFPEDITHISATLAGTLGYMAPEYVV--RGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 415 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
||+++..... .....||+.|+|||.+. ...++.++||||||+++|||++|+.||.....
T Consensus 173 fg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 173 FGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp CTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 9999754332 23457899999999983 45678999999999999999999999976443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=310.46 Aligned_cols=199 Identities=19% Similarity=0.232 Sum_probs=163.9
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHH---HHHhccCcCceeeee-------ee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEV---NLISGINHKNLVKLL-------GC 333 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 333 (492)
.++|++.+.||+|+||+||+|+. .+++.||||++... .....+.+.+|+ ++++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 56788999999999999999996 56899999999743 444567899999 555666899999998 55
Q ss_pred eecCC-----------------cceeEEeecCCCCchhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 011153 334 SITGP-----------------ESLLVYEFVPNQSLLDNLFVRQD----VEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392 (492)
Q Consensus 334 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~i 392 (492)
+.+.+ ..++||||+ +|+|.+++..... ...+++..++.++.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 54443 278999999 6899998864321 123446888899999999999999998 9
Q ss_pred EecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccccccccccccchhhhccC-----------CCCcchhHHHHHHH
Q 011153 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG-----------KLTEKADVYSFGVV 461 (492)
Q Consensus 393 vH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~slGvl 461 (492)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++... .++.++||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985433 2234567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCC
Q 011153 462 VIEVVCRKRINLFT 475 (492)
Q Consensus 462 l~elltg~~p~~~~ 475 (492)
+|||++|+.||...
T Consensus 303 l~elltg~~Pf~~~ 316 (377)
T 3byv_A 303 IYWIWCADLPITKD 316 (377)
T ss_dssp HHHHHHSSCCC---
T ss_pred HHHHHHCCCCCccc
Confidence 99999999998653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=290.77 Aligned_cols=202 Identities=27% Similarity=0.354 Sum_probs=170.6
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.++|.+.++||+|+||.||++.. .++..+|+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 35689999999999999999986 468899999987543 3346789999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee---CCCCcEEEeecCCcccc
Q 011153 346 FVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLF 421 (492)
Q Consensus 346 ~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~ 421 (492)
|+++++|.+.+... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999888543 23456899999999999999999999998 9999999999999 45688999999999866
Q ss_pred CCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.... ......||+.|+|||.+. +.++.++||||||++++||++|+.||...
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~ 228 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence 5432 223457899999999874 67899999999999999999999998643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=301.94 Aligned_cols=200 Identities=30% Similarity=0.412 Sum_probs=158.8
Q ss_pred ccccCCcccccCcccEEEEEec--CC--CEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeec-CCcceeE
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP--GG--EAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT-GPESLLV 343 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~--~~--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv 343 (492)
.|+..++||+|+||+||+|... ++ ..||||.+... .....+.+.+|+.++++++||||+++++++.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4667789999999999999864 22 35899998654 34556789999999999999999999998654 5578999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999853 3345889999999999999999999998 99999999999999999999999999986543
Q ss_pred CCcc---ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhC-CCCCCC
Q 011153 424 DITH---ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCR-KRINLF 474 (492)
Q Consensus 424 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg-~~p~~~ 474 (492)
.... ......+|+.|+|||.+.+..++.++||||||+++|||++| .+|+..
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~ 299 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCC
Confidence 3211 12234578899999999999999999999999999999995 555543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=289.78 Aligned_cols=203 Identities=29% Similarity=0.400 Sum_probs=169.2
Q ss_pred hcccccCCcccccCcccEEEEEecC----CCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeee-cCCcce
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSI-TGPESL 341 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 341 (492)
..+|+..++||+|+||.||+|...+ ...+|+|.+... .....+.+.+|+.++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568889999999999999998643 225899998754 3455678999999999999999999999854 556788
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999998853 3455899999999999999999999998 999999999999999999999999999866
Q ss_pred CCCCcc---ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 422 PEDITH---ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 422 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
...... ......+|+.|+|||.+.+..++.++||||||++++||++|+.|+...
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 235 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 443211 122456788999999999999999999999999999999966655443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=290.78 Aligned_cols=199 Identities=29% Similarity=0.398 Sum_probs=171.9
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467899999999999999999865 57789999986532 23356788999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++++|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999888543 34899999999999999999999988 99999999999999999999999999865433
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.. .....|++.|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 210 (279)
T 3fdn_A 162 SR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence 22 23457899999999999999999999999999999999999998653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=290.30 Aligned_cols=201 Identities=29% Similarity=0.381 Sum_probs=172.2
Q ss_pred cccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCC
Q 011153 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
|....+||+|+||.||++.. .+++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 44456899999999999985 56889999999877666678899999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-CCcEEEeecCCccccCCCCccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~ 428 (492)
++|.+++........+++..+..++.||+.||+|||+.+ ++|+||||+||+++. ++.+||+|||++........ .
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~ 179 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-C 179 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-c
Confidence 999999876555556789999999999999999999998 999999999999987 89999999999986644321 2
Q ss_pred cccccccccccchhhhccCC--CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 429 SATLAGTLGYMAPEYVVRGK--LTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.....|++.|+|||.+.... ++.++||||||+++|||++|+.||...
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 23457899999999987654 789999999999999999999998643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=289.96 Aligned_cols=201 Identities=25% Similarity=0.343 Sum_probs=176.9
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.++|...+.||+|+||.||++... +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467899999999999999999975 5788999998654 334567789999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999887543 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
... ......||+.|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 218 (294)
T 2rku_A 168 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218 (294)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred Ccc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 322 223456899999999999888999999999999999999999998653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=296.19 Aligned_cols=201 Identities=25% Similarity=0.343 Sum_probs=177.3
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.++|.+.+.||+|+||.||++... +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999865 5788999998654 334567789999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999887543 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 194 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 194 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred Ccc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 322 223457899999999999999999999999999999999999998653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=299.14 Aligned_cols=205 Identities=23% Similarity=0.378 Sum_probs=177.3
Q ss_pred HHHHHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh--------hhHHHHHHHHHHHhcc-CcCceeeeee
Q 011153 263 TLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT--------QWVDHFFNEVNLISGI-NHKNLVKLLG 332 (492)
Q Consensus 263 ~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~ 332 (492)
......++|++.+.||+|+||.||++... +|+.||||++..... ...+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34455677999999999999999999975 799999999865431 2245688999999999 8999999999
Q ss_pred eeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEE
Q 011153 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412 (492)
Q Consensus 333 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl 412 (492)
++...+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999988543 35899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCccccccccccccccchhhhcc------CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR------GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 413 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
+|||++..+.... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 9999998765432 2235678999999998863 35888999999999999999999998653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=289.51 Aligned_cols=200 Identities=29% Similarity=0.432 Sum_probs=177.3
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.+.|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 45689999999999999999985 468899999997543 3456789999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++++|.+++. ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999883 246899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ......|++.|+|||.+.+..++.++||||||++++||++|+.|+...
T Consensus 174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 222 (303)
T 3a7i_A 174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222 (303)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence 2 223457899999999999999999999999999999999999998643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=298.24 Aligned_cols=202 Identities=28% Similarity=0.385 Sum_probs=176.6
Q ss_pred hcccccCCcccccCcccEEEEEe-----cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeee--cCCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI--TGPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 340 (492)
.++|+..++||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36789999999999999999983 357889999998877777788999999999999999999999887 44567
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 89999999999999885432 34899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCcc--ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 421 FPEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 421 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
....... ......+|+.|+|||.+.+..++.++||||||++++||++|+.|+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 6543322 22345678889999999999999999999999999999999999754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=303.89 Aligned_cols=197 Identities=24% Similarity=0.284 Sum_probs=160.9
Q ss_pred cccccC-CcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHh-ccCcCceeeeeeeeec----CCcce
Q 011153 269 NYFHES-NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLIS-GINHKNLVKLLGCSIT----GPESL 341 (492)
Q Consensus 269 ~~~~~~-~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~~ 341 (492)
++|.+. ++||+|+||+||++... +++.||||++... ..+.+|++++. ..+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 345554 78999999999999864 6889999998632 35678888874 4589999999998875 56789
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCcEEEeecCCc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLV 418 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgl~ 418 (492)
+||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999998643 2345899999999999999999999988 999999999999987 789999999999
Q ss_pred cccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+...... ......||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 8654322 2235678999999999999999999999999999999999999997543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=289.17 Aligned_cols=204 Identities=28% Similarity=0.396 Sum_probs=172.0
Q ss_pred ccccCCcccccCcccEEEEEec-CCC---EEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcc-eeE
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGE---AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES-LLV 343 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~---~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 343 (492)
.|+..++||+|+||+||+|... +++ .+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4666789999999999999853 232 6999998754 344567899999999999999999999999877665 899
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
+||+.+++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999998854 3456899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCc---cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 424 DIT---HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 424 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
... .......+|+.|+|||.+.+..++.++||||||++++||++|+.|+....+.
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~ 234 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH
Confidence 321 1122456789999999999999999999999999999999977776554333
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=300.14 Aligned_cols=201 Identities=18% Similarity=0.215 Sum_probs=165.6
Q ss_pred hcccccCCcccccCcccEEEEEec----CCCEEEEEEeccCChh-----------hHHHHHHHHHHHhccCcCceeeeee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYNTTQ-----------WVDHFFNEVNLISGINHKNLVKLLG 332 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 332 (492)
.++|++.+.||+|+||.||++... ++..+|||++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999975 5778999998765322 1224678889999999999999999
Q ss_pred eeec----CCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC
Q 011153 333 CSIT----GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408 (492)
Q Consensus 333 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~ 408 (492)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9987 67889999999 999999885433 6899999999999999999999998 99999999999998877
Q ss_pred --cEEEeecCCccccCCCCc------cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 409 --TAKIADFGLVRLFPEDIT------HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 409 --~~kl~Dfgl~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.+||+|||+++.+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 999999999986643221 1123457899999999999999999999999999999999999999653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=299.83 Aligned_cols=198 Identities=22% Similarity=0.314 Sum_probs=170.6
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEE
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 344 (492)
..++|++.+.||+|+||.||++... +++.||||++..... ...+|++++.++ +||||+++++++.+++..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999865 688999999975533 245688888887 7999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC----CcEEEeecCCccc
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE----FTAKIADFGLVRL 420 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~Dfgl~~~ 420 (492)
||+++|+|.+.+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999998854 345899999999999999999999998 9999999999998433 3599999999987
Q ss_pred cCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 654322 233567899999999998888999999999999999999999999754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=288.29 Aligned_cols=200 Identities=26% Similarity=0.338 Sum_probs=173.0
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh------hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT------QWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (492)
.++|++.+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356899999999999999999875 689999999865421 1367899999999999999999999999999999
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC----cEEEeecC
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFG 416 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfg 416 (492)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999988543 35899999999999999999999998 99999999999998877 89999999
Q ss_pred CccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
++........ .....+++.|+|||.+....++.++||||||++++||++|+.||...
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 214 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 214 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence 9986644321 23456899999999999899999999999999999999999998653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=294.71 Aligned_cols=213 Identities=22% Similarity=0.331 Sum_probs=179.0
Q ss_pred cccCHHHHHHHhcccccC-CcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcc-CcCceeeee
Q 011153 257 LNFSYETLEKATNYFHES-NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGI-NHKNLVKLL 331 (492)
Q Consensus 257 ~~~~~~~l~~~~~~~~~~-~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~ 331 (492)
.+..+...+...++|.+. ++||+|+||.||++... +++.||||++... .......+.+|+.++..+ .||||++++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 344555566677778877 88999999999999865 6899999998754 233467889999999999 569999999
Q ss_pred eeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CC
Q 011153 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EF 408 (492)
Q Consensus 332 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~ 408 (492)
+++.+.+..++||||+++++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBC
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCC
Confidence 9999999999999999999999887432 3356899999999999999999999998 999999999999987 78
Q ss_pred cEEEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 409 TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 409 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.+||+|||+++....... .....||+.|+|||++....++.++||||||++++||++|+.||...
T Consensus 172 ~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp CEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cEEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999987654322 23457899999999999999999999999999999999999998653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=288.78 Aligned_cols=201 Identities=25% Similarity=0.375 Sum_probs=172.1
Q ss_pred cccccCC-cccccCcccEEEEEec---CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 269 NYFHESN-KLGQGGSGSVYKGTLP---GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 269 ~~~~~~~-~iG~G~fG~Vy~~~~~---~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
++|.+.+ .||+|+||.||++... ++..||||+++.. .....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4455555 8999999999999853 5778999999765 344567899999999999999999999998 55678999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999998843 3456899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccc--cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 424 DITHI--SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 424 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
..... .....+|+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 217 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 33221 223456889999999988899999999999999999998 99998654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=286.36 Aligned_cols=199 Identities=24% Similarity=0.318 Sum_probs=171.3
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC--CcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 343 (492)
.++|+..+.||+|+||.||+++.. ++.||||++... .....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 356889999999999999999986 788999999754 344567799999999999999999999999877 678999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++++|.+++... ....+++..++.++.||+.||+|||+.+ .+++||||||+|||++.++.++|+|||+......
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999998643 2336899999999999999999999864 4599999999999999999999999988754322
Q ss_pred CCccccccccccccccchhhhccCCCCc---chhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTE---KADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDv~slGvll~elltg~~p~~~~ 475 (492)
....+|+.|+|||.+.+..++. ++||||||+++|||++|+.||...
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 2346799999999998765544 799999999999999999998653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=297.22 Aligned_cols=201 Identities=25% Similarity=0.357 Sum_probs=165.5
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChh-hHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
++|+..++||+|+||+||++... +++.||||++...... ....+.+|+++++.++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 56889999999999999999865 6889999999654322 222456899999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 5888877543 345899999999999999999999998 99999999999999999999999999986543322
Q ss_pred cccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
......+|+.|+|||++.+ ..++.++||||||++++||++|+.||....
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 156 -TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2234568999999999876 568999999999999999999999997643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=296.00 Aligned_cols=203 Identities=28% Similarity=0.407 Sum_probs=170.3
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
.++|+..+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467899999999999999999865 58899999986543 334566889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999888876532 235899999999999999999999998 999999999999999999999999999865443
Q ss_pred CccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
.. ......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||....+
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 22 22345689999999998775 689999999999999999999999876543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=295.81 Aligned_cols=203 Identities=25% Similarity=0.400 Sum_probs=171.0
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecC-------
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG------- 337 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 337 (492)
.++|++.++||+|+||.||+++. .+++.||||++.... ......+.+|+++++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999996 578999999986543 23356788999999999999999999998874
Q ss_pred -CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 011153 338 -PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (492)
Q Consensus 338 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 416 (492)
+..++||||+++ +|.+.+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 457899999975 77666643 2345899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCc---cccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 417 LVRLFPEDIT---HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 417 l~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+++.+..... .......||+.|+|||++.+ ..++.++||||||++++||++|+.||....
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9987653221 12234578999999999876 457999999999999999999999987543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=295.05 Aligned_cols=212 Identities=24% Similarity=0.379 Sum_probs=167.1
Q ss_pred HHHHHHHhcccccCCcccccCcccEEEEEec----CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeee
Q 011153 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCS 334 (492)
Q Consensus 261 ~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 334 (492)
.+.+....++|.+.+.||+|+||.||++... .+..||+|++... .....+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3444455678999999999999999999754 2447999998754 344567799999999999999999999999
Q ss_pred ecCCc-----ceeEEeecCCCCchhhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC
Q 011153 335 ITGPE-----SLLVYEFVPNQSLLDNLFVR---QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406 (492)
Q Consensus 335 ~~~~~-----~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~ 406 (492)
.+.+. .++|+||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcC
Confidence 87653 48999999999999988533 23456999999999999999999999988 999999999999999
Q ss_pred CCcEEEeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 407 EFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 407 ~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 253 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 99999999999986644322 12234457889999999999999999999999999999999 77777653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=293.41 Aligned_cols=199 Identities=27% Similarity=0.389 Sum_probs=172.9
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
.++|++.+.||+|+||.||+++.. +++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467899999999999999999864 6899999999866555556789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee---CCCCcEEEeecCCccccCC
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~~~ 423 (492)
+++++|.+.+... ..+++..+..++.||+.||.|||+.+ ++||||||+||++ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999888543 35889999999999999999999998 9999999999999 7889999999999875433
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ......||+.|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 2 123456899999999999999999999999999999999999998643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=301.63 Aligned_cols=199 Identities=24% Similarity=0.395 Sum_probs=175.0
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.++|++.++||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467899999999999999999865 6889999999765 34456789999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
|+++++|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999998543 3588999999999999999999985 7 999999999999999999999999998754322
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
......||+.|+|||++.+..++.++||||||++++||++|+.||...
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 123457899999999999999999999999999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=288.90 Aligned_cols=198 Identities=27% Similarity=0.369 Sum_probs=174.8
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56899999999999999999865 57789999986432 233567899999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 999999999988543 35899999999999999999999988 999999999999999999999999998765432
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. .....|++.|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 168 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 168 R---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp C---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred c---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 2 23457899999999999999999999999999999999999998653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=295.30 Aligned_cols=202 Identities=27% Similarity=0.415 Sum_probs=167.0
Q ss_pred hcccccCCcccccCcccEEEEEecC-----CCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~-----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
..+|+..++||+|+||.||+|.... +..||||++... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567778999999999999998643 235999999765 3344567899999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999988543 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCccc--cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 422 PEDITHI--SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 422 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
....... .....+|+.|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 5432211 123345789999999999999999999999999999999 9999854
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=296.14 Aligned_cols=202 Identities=24% Similarity=0.331 Sum_probs=176.4
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhh-----------------HHHHHHHHHHHhccCcCceeee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQW-----------------VDHFFNEVNLISGINHKNLVKL 330 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l 330 (492)
.++|++.+.||+|+||.||++.. +++.||||++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46799999999999999999998 89999999986432211 1789999999999999999999
Q ss_pred eeeeecCCcceeEEeecCCCCchhh------hhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCee
Q 011153 331 LGCSITGPESLLVYEFVPNQSLLDN------LFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNIL 403 (492)
Q Consensus 331 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nil 403 (492)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||.|||+ .+ ++||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 422 225679999999999999999999998 77 999999999999
Q ss_pred eCCCCcEEEeecCCccccCCCCccccccccccccccchhhhccC-CCCc-chhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 404 LDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTE-KADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 404 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
++.++.+||+|||++...... ......+++.|+|||.+.+. .++. ++||||||++++||++|+.||.....
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999876443 22355789999999999877 6666 99999999999999999999986554
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=298.35 Aligned_cols=209 Identities=25% Similarity=0.318 Sum_probs=170.5
Q ss_pred CHHHHHHHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCC-----------hhhHHHHHHHHHHHhccCcCcee
Q 011153 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT-----------TQWVDHFFNEVNLISGINHKNLV 328 (492)
Q Consensus 260 ~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~-----------~~~~~~~~~E~~~l~~l~h~niv 328 (492)
...++....++|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3556777889999999999999999999998889999999985432 12247799999999999999999
Q ss_pred eeeeeeecC-----CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 011153 329 KLLGCSITG-----PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL 403 (492)
Q Consensus 329 ~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nil 403 (492)
++++++... ...++||||++ ++|.+.+.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998543 35689999997 688877753 3346899999999999999999999998 999999999999
Q ss_pred eCCCCcEEEeecCCccccCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 404 LDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 404 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
++.++.+||+|||+++...... ......+|+.|+|||.+.+ ..++.++||||||++++||++|+.||....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999997544332 2234578999999999877 678999999999999999999999997643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=292.87 Aligned_cols=199 Identities=31% Similarity=0.451 Sum_probs=171.5
Q ss_pred cccccCCcccccCcccEEEEEec-----CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecC--Ccc
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-----GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PES 340 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 340 (492)
++|++.++||+|+||+||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 34589999999999999988642 57889999997653 34567799999999999999999999999874 567
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++||||+++++|.+++... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 111 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 8999999999999988432 3899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCcc--ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 421 FPEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 421 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
....... ......+|+.|+|||.+.+..++.++||||||++++||++|+.|+..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 7544321 22345678899999999999999999999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=294.62 Aligned_cols=202 Identities=26% Similarity=0.423 Sum_probs=165.3
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCE----EEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEA----VAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~----vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
.++|++.++||+|+||.||++... +++. |++|.+... .....+.+.+|+.+++.++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 366899999999999999999854 4443 577777543 3445678999999999999999999999998754 78
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+|+|++++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999988643 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 422 PEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 422 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 223 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 543222 1223456889999999999999999999999999999999 99988654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=298.61 Aligned_cols=197 Identities=26% Similarity=0.403 Sum_probs=155.1
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC------C
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------P 338 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 338 (492)
.++|+..+.||+|+||.||++.. .+++.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46799999999999999999985 56889999998653 334567788999999999999999999998754 5
Q ss_pred cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCc
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~ 418 (492)
..++|+|++ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 678999999 6889887732 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+..... .....||+.|+|||++.+ ..++.++||||||++++||++|+.||....
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 865432 234578999999999877 678999999999999999999999997644
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=287.57 Aligned_cols=199 Identities=25% Similarity=0.320 Sum_probs=171.0
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCccee
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 342 (492)
..++|++.+.||+|+||.||++... +++.||||++... .......+.+|+..+..+ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467999999999999999999875 7899999998754 334456788999999999 99999999999999999999
Q ss_pred EEeecCCCCchhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC--------------
Q 011153 343 VYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-------------- 407 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-------------- 407 (492)
||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999986432 2256899999999999999999999998 9999999999999844
Q ss_pred -----CcEEEeecCCccccCCCCccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCC
Q 011153 408 -----FTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINL 473 (492)
Q Consensus 408 -----~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~ 473 (492)
..+||+|||++....... ...||+.|+|||.+.+. .++.++||||||++++||++|++|+.
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 479999999998765432 23589999999998766 56689999999999999999998754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=292.60 Aligned_cols=205 Identities=23% Similarity=0.299 Sum_probs=173.2
Q ss_pred HhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeee----cCCcce
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI----TGPESL 341 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~ 341 (492)
..++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|+++++.++||||+++++++. .....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 356799999999999999999986 578999999997777777788999999999999999999999987 334678
Q ss_pred eEEeecCCCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 342 LVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
+|+||+++++|.+++... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999988642 23466899999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCCcc--------ccccccccccccchhhhccCC---CCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 421 FPEDITH--------ISATLAGTLGYMAPEYVVRGK---LTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 421 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
....... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 5322111 011345799999999887544 68899999999999999999999853
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=294.59 Aligned_cols=202 Identities=30% Similarity=0.449 Sum_probs=175.1
Q ss_pred hcccccCCcccccCcccEEEEEe-----cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC--cc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP--ES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 340 (492)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45688999999999999999983 358899999998777777788999999999999999999999887654 67
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 8999999999999998643 245899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCcc--ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 421 FPEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 421 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
....... ......++..|+|||.+.+..++.++||||||++++||++|+.|+..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 6544321 12234567889999999988899999999999999999999988753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=291.36 Aligned_cols=204 Identities=25% Similarity=0.329 Sum_probs=169.8
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--------hhhHHHHHHHHHHHhccCcCceeeeeeeeecC
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--------TQWVDHFFNEVNLISGINHKNLVKLLGCSITG 337 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 337 (492)
..++|++.+.||+|+||.||++... +++.||||++.... ......+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999864 57899999986432 12234688999999999999999999998765
Q ss_pred CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc---EEEee
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT---AKIAD 414 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~D 414 (492)
+ .++||||+++++|.+.+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 8999999999999988743 346899999999999999999999998 999999999999987654 99999
Q ss_pred cCCccccCCCCccccccccccccccchhhhc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 415 FGLVRLFPEDITHISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 415 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||.......
T Consensus 161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 226 (322)
T 2ycf_A 161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226 (322)
T ss_dssp CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS
T ss_pred Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH
Confidence 99998765432 223456899999999874 4678899999999999999999999997655443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=318.62 Aligned_cols=195 Identities=26% Similarity=0.384 Sum_probs=164.4
Q ss_pred cccccCcccEEEEEec---CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCCCC
Q 011153 276 KLGQGGSGSVYKGTLP---GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQS 351 (492)
Q Consensus 276 ~iG~G~fG~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 351 (492)
+||+|+||.||+|... ++..||||+++... ....+.+.+|+++|++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 45679999997653 3456789999999999999999999999876 56899999999999
Q ss_pred chhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc--c
Q 011153 352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI--S 429 (492)
Q Consensus 352 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~--~ 429 (492)
|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......... .
T Consensus 422 L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 9998853 3456899999999999999999999998 9999999999999999999999999998765432221 1
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQ 476 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~~ 476 (492)
....+|+.|+|||++..+.++.++|||||||++|||++ |+.||....
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 12345689999999999999999999999999999998 999987543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=287.60 Aligned_cols=197 Identities=28% Similarity=0.462 Sum_probs=171.9
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeec---------
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--------- 336 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 336 (492)
...+|+..+.||+|+||.||++... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4467999999999999999999975 78999999997654 356789999999999999999998854
Q ss_pred -------CCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc
Q 011153 337 -------GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409 (492)
Q Consensus 337 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~ 409 (492)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||+++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 345789999999999999986432 346899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 011153 410 AKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINL 473 (492)
Q Consensus 410 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~ 473 (492)
+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred EEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 99999999987654322 234568999999999999999999999999999999999998864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=297.23 Aligned_cols=204 Identities=25% Similarity=0.374 Sum_probs=164.6
Q ss_pred HHHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCCh--hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 265 EKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 265 ~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
....++|++.++||+|+||+||++.. .+++.||||++..... ...+.+.+|++++++++||||+++++++.+++..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 34457899999999999999999985 4688999999975432 33456789999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee-----CCCCcEEEeecC
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL-----DEEFTAKIADFG 416 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill-----~~~~~~kl~Dfg 416 (492)
+||||++ ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 110 lv~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999997 4898888543 34899999999999999999999998 9999999999999 455669999999
Q ss_pred CccccCCCCccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+++....... ......+|+.|+|||++.+. .++.++||||||++++||++|+.||....
T Consensus 183 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 242 (329)
T 3gbz_A 183 LARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242 (329)
T ss_dssp HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 9987654322 22345679999999998874 48999999999999999999999986543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=296.21 Aligned_cols=207 Identities=26% Similarity=0.337 Sum_probs=161.8
Q ss_pred HHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccC-cCceeeeeeeee--------
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSI-------- 335 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-------- 335 (492)
....+|++.++||+|+||.||+++. .+++.||||++........+.+.+|+.++.++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3356799999999999999999996 468999999997777777788999999999996 999999999984
Q ss_pred cCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 011153 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (492)
Q Consensus 336 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 415 (492)
.....++|+||++ |+|.+++........+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 3334689999996 789888865445567999999999999999999999874 45999999999999999999999999
Q ss_pred CCccccCCCCccc-----------cccccccccccchhhh---ccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 416 GLVRLFPEDITHI-----------SATLAGTLGYMAPEYV---VRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 416 gl~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
|+++......... .....+|+.|+|||++ .+..++.++||||||+++|||++|+.||..
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 9998765432211 1134589999999998 566789999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=287.37 Aligned_cols=202 Identities=28% Similarity=0.376 Sum_probs=171.5
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeec----CCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 340 (492)
.+.|+..+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345788889999999999999864 6788999998654 34556789999999999999999999998865 3457
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC-CCCcEEEeecCCcc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVR 419 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgl~~ 419 (492)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ +++.+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 8999999999999998543 45889999999999999999999875 4599999999999997 78999999999997
Q ss_pred ccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
...... .....||+.|+|||.+. +.++.++||||||++++||++|+.||....+
T Consensus 181 ~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 234 (290)
T 1t4h_A 181 LKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN 234 (290)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred cccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc
Confidence 554432 23456899999999775 5689999999999999999999999976433
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=296.56 Aligned_cols=202 Identities=26% Similarity=0.352 Sum_probs=166.8
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChh-----hHHHHHHHHHHHhccCcCceeeeeeeeecCCcc
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQ-----WVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (492)
..++|+..+.||+|+||.||++... +++.||||++...... ..+.+.+|+++++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4567999999999999999999965 5899999998653221 234688999999999999999999999999999
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++||||+++ +|.+.+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 78777743 3345888899999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 421 FPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
...... ......+|+.|+|||.+.+. .++.++||||||+++|||++|++|+...
T Consensus 162 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 162 FGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp TTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 654322 23345789999999998764 5889999999999999999999887654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=304.76 Aligned_cols=200 Identities=26% Similarity=0.362 Sum_probs=164.2
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC------cc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 340 (492)
..+|+..++||+|+||.||+++.. +++.||||++..... ...+|+++|+.++||||+++++++.... ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346889999999999999999975 689999999865432 2347999999999999999999885422 25
Q ss_pred eeEEeecCCCCchhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-CcEEEeecCCc
Q 011153 341 LLVYEFVPNQSLLDNLFV-RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLV 418 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfgl~ 418 (492)
++||||+++ +|.+.+.. ......+++..+..++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 689999975 55554432 233456899999999999999999999988 9999999999999965 67899999999
Q ss_pred cccCCCCccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
+....... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~ 262 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 262 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 87644322 2345789999999998765 789999999999999999999999976543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=302.80 Aligned_cols=201 Identities=23% Similarity=0.340 Sum_probs=166.8
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc------ce
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE------SL 341 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 341 (492)
..+|+..++||+|+||+||+++...+..+|+|++..... ...+|+++++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 456899999999999999999987777799998865432 22379999999999999999999865443 67
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC-CCCcEEEeecCCccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRL 420 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgl~~~ 420 (492)
+||||++++.+............+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987544433332334456899999999999999999999998 99999999999998 799999999999987
Q ss_pred cCCCCccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 421 FPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
...... .....+|+.|+|||++.+. .++.++|||||||+++||++|+.||.....
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 247 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 644322 2345789999999998765 589999999999999999999999976543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=309.86 Aligned_cols=199 Identities=28% Similarity=0.372 Sum_probs=175.0
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.++|+..++||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999865 78999999986532 34567899999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee---CCCCcEEEeecCCccc
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRL 420 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgl~~~ 420 (492)
+||+++++|.+.+... ..+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999888543 45899999999999999999999998 9999999999999 5678999999999987
Q ss_pred cCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
+.... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||...
T Consensus 179 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 230 (484)
T 3nyv_A 179 FEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA 230 (484)
T ss_dssp BCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC
Confidence 65432 2234579999999998765 7999999999999999999999998654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=300.09 Aligned_cols=203 Identities=23% Similarity=0.330 Sum_probs=167.2
Q ss_pred HHHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecC------
Q 011153 265 EKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------ 337 (492)
Q Consensus 265 ~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 337 (492)
+...++|++.++||+|+||+||++.. .+++.||||++...... ..+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45567899999999999999999985 57899999998654322 34799999999999999999998543
Q ss_pred --------------------------------CcceeEEeecCCCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 011153 338 --------------------------------PESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYL 384 (492)
Q Consensus 338 --------------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yL 384 (492)
...++||||++ ++|.+.+... .....+++..+..++.||+.||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 23779999998 5877766431 2345689999999999999999999
Q ss_pred hhcCCCCeEecCCCCCCeeeC-CCCcEEEeecCCccccCCCCccccccccccccccchhhhccC-CCCcchhHHHHHHHH
Q 011153 385 HEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVV 462 (492)
Q Consensus 385 H~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll 462 (492)
|+.+ |+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||||+++
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9988 99999999999997 689999999999987644332 2345689999999998765 489999999999999
Q ss_pred HHHHhCCCCCCCCCC
Q 011153 463 IEVVCRKRINLFTQN 477 (492)
Q Consensus 463 ~elltg~~p~~~~~~ 477 (492)
+||++|+.||.....
T Consensus 233 ~ell~g~~pf~~~~~ 247 (383)
T 3eb0_A 233 GELILGKPLFSGETS 247 (383)
T ss_dssp HHHHHSSCSSCCSSH
T ss_pred HHHHhCCCCCCCCCh
Confidence 999999999976543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=289.43 Aligned_cols=197 Identities=21% Similarity=0.325 Sum_probs=171.3
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccC-cCceeeeeeeeec--CCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSIT--GPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 343 (492)
.++|++.++||+|+||+||++.. .+++.||||++.... .+.+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36789999999999999999985 578999999986443 467889999999997 9999999999987 5677899
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-cEEEeecCCccccC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFP 422 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~ 422 (492)
|||+++++|.+++. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999988873 3889999999999999999999998 99999999999999776 89999999998765
Q ss_pred CCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
.... .....+++.|+|||.+.+ ..++.++||||||++++||++|+.||....+.
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 237 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch
Confidence 4322 234578999999999877 67899999999999999999999999665443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=289.91 Aligned_cols=201 Identities=25% Similarity=0.423 Sum_probs=165.7
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeee-----------
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI----------- 335 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 335 (492)
.++|++.+.||+|+||.||++... +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467899999999999999999976 48899999998777777888999999999999999999998874
Q ss_pred ---cCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC-CCCcEE
Q 011153 336 ---TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAK 411 (492)
Q Consensus 336 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~k 411 (492)
+....++||||++ ++|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3456789999997 69988873 245899999999999999999999998 99999999999997 677999
Q ss_pred EeecCCccccCCCCcc--ccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 412 IADFGLVRLFPEDITH--ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 412 l~Dfgl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
|+|||+++........ ......+|+.|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999876433211 1224457899999998865 678999999999999999999999997644
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=307.21 Aligned_cols=199 Identities=28% Similarity=0.374 Sum_probs=169.6
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
.++|+..++||+|+||+||+++.. ++..||||++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456999999999999999999965 68899999987542 334567899999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCcEEEeecCCcccc
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLVRLF 421 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgl~~~~ 421 (492)
||+++++|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999998888543 35889999999999999999999998 999999999999976 455999999999876
Q ss_pred CCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.... ......||+.|+|||++. +.++.++|||||||++|||++|+.||...
T Consensus 190 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 240 (494)
T 3lij_A 190 ENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ 240 (494)
T ss_dssp BTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 5432 223467999999999875 67999999999999999999999998654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=288.69 Aligned_cols=203 Identities=24% Similarity=0.370 Sum_probs=165.9
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.++|++.+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45799999999999999999986 57899999999753 344567789999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 344 YEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
|||+++++|.+++... .....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999988542 23456899999999999999999999998 9999999999999999999999999988664
Q ss_pred CCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 238 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 238 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 4322 22345689999999999999999999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.24 Aligned_cols=200 Identities=28% Similarity=0.394 Sum_probs=172.9
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
..++|++.++||+|+||+||++... +++.||||++... .......+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999865 7899999998643 233467789999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC---CCCcEEEeecCCccc
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRL 420 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgl~~~ 420 (492)
|||+++++|.+.+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999888544 35899999999999999999999998 99999999999995 456899999999986
Q ss_pred cCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
..... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 225 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 65432 2234579999999998764 6999999999999999999999998653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=291.99 Aligned_cols=206 Identities=29% Similarity=0.364 Sum_probs=171.6
Q ss_pred HhcccccCCcccccCcccEEEEEe------cCCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (492)
..++|++.+.||+|+||.||++.. .+++.||||++... .......+.+|+.++++++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 356799999999999999999984 24678999999654 34556678999999999999999999999999999
Q ss_pred ceeEEeecCCCCchhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCcEEE
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQD----VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKI 412 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl 412 (492)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999865432 245899999999999999999999998 999999999999984 456999
Q ss_pred eecCCccccCCCC-ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 413 ADFGLVRLFPEDI-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 413 ~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
+|||++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 9999997543322 122234567899999999999999999999999999999998 88887643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=296.62 Aligned_cols=198 Identities=26% Similarity=0.357 Sum_probs=162.7
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC------
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ 338 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 338 (492)
.++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367999999999999999999864 6889999999753 3445567889999999999999999999987665
Q ss_pred cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCc
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~ 418 (492)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 56999999974 7777763 24889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+...... ......||+.|+|||++.+..++.++||||||++++||++|+.||....
T Consensus 175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 8654322 2234578999999999999999999999999999999999999987543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=291.19 Aligned_cols=207 Identities=29% Similarity=0.405 Sum_probs=158.8
Q ss_pred HHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
...++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 4467899999999999999999985 468899999986543 34456788999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCc
Q 011153 344 YEFVPNQSLLDNLFVR-----QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~-----~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~ 418 (492)
|||+++++|.+++... .....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999988531 23456899999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCc----cccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 419 RLFPEDIT----HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 419 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
........ .......||+.|+|||.+.. ..++.++||||||++++||++|+.||...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 76543211 11234568999999999876 56899999999999999999999998754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=286.95 Aligned_cols=202 Identities=31% Similarity=0.435 Sum_probs=172.0
Q ss_pred HHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
...++|++.+.||+|+||.||++... +++.||||++.... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 44677999999999999999999865 58999999997543 3467899999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999988532 345899999999999999999999998 999999999999999999999999999866543
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.. ......|++.|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 22 223457899999999999999999999999999999999999998653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=289.96 Aligned_cols=203 Identities=26% Similarity=0.380 Sum_probs=170.8
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
..++|++.+.||+|+||.||++... +++.||+|++........+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3567999999999999999999975 588999999987766677889999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++++|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999887543 235899999999999999999999998 9999999999999999999999999875332111
Q ss_pred ccccccccccccccchhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.......||+.|+|||.+. ...++.++||||||++++||++|+.|+...
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 225 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 1122456899999999884 567899999999999999999999998753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=289.27 Aligned_cols=200 Identities=33% Similarity=0.493 Sum_probs=162.9
Q ss_pred HHHHHHHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhcc--CcCceeeeeeeeecC-
Q 011153 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI--NHKNLVKLLGCSITG- 337 (492)
Q Consensus 261 ~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~- 337 (492)
........++|++.++||+|+||.||+++.. ++.||||++.... ...+.+|.+++..+ +||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 3344455678999999999999999999876 8899999985432 33455566665554 999999999999877
Q ss_pred ---CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEecCCCCCCeeeCCCCc
Q 011153 338 ---PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES-----KLRIIHRDIKLSNILLDEEFT 409 (492)
Q Consensus 338 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~-----~~~ivH~Dlk~~Nill~~~~~ 409 (492)
...++||||+++++|.+++.. ..+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 678999999999999999843 25899999999999999999999870 113999999999999999999
Q ss_pred EEEeecCCccccCCCCccc---cccccccccccchhhhccCCCCcc------hhHHHHHHHHHHHHhC
Q 011153 410 AKIADFGLVRLFPEDITHI---SATLAGTLGYMAPEYVVRGKLTEK------ADVYSFGVVVIEVVCR 468 (492)
Q Consensus 410 ~kl~Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDv~slGvll~elltg 468 (492)
+||+|||+++......... .....||+.|+|||++.+.....+ +||||||+++|||++|
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 9999999997665433221 124578999999999987766654 9999999999999999
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=305.91 Aligned_cols=201 Identities=30% Similarity=0.448 Sum_probs=172.6
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh-------------hhHHHHHHHHHHHhccCcCceeeeee
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-------------QWVDHFFNEVNLISGINHKNLVKLLG 332 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 332 (492)
..++|++.++||+|+||+||++... +++.||||++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3577999999999999999999865 578999999865321 33567899999999999999999999
Q ss_pred eeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC---c
Q 011153 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---T 409 (492)
Q Consensus 333 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~---~ 409 (492)
++.+....++||||+++++|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999888543 35899999999999999999999998 99999999999998775 6
Q ss_pred EEEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 410 AKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 410 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+||+|||+++...... ......||+.|+|||++. +.++.++||||||+++|||++|+.||....
T Consensus 188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999998765432 223557999999999876 579999999999999999999999997543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=286.97 Aligned_cols=207 Identities=26% Similarity=0.380 Sum_probs=173.3
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeee--cCCccee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSI--TGPESLL 342 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 342 (492)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999865 6899999999754 3445677999999999999999999999875 4567899
Q ss_pred EEeecCCCCchhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 343 VYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEES--KLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ..+++||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999886532 3455899999999999999999999975 2349999999999999999999999999998
Q ss_pred ccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+...
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 7654322 123456899999999999989999999999999999999999998654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=295.52 Aligned_cols=203 Identities=23% Similarity=0.360 Sum_probs=172.7
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC-----Ccc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 340 (492)
.++|++.++||+|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 467999999999999999999864 6788999999754 334457789999999999999999999998755 367
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++|+||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 89999997 588887743 34899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCccc--cccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 421 FPEDITHI--SATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 421 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
........ .....||+.|+|||++.+ ..++.++||||||++++||++|+.||......
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 238 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH
Confidence 65432221 234578999999998765 45899999999999999999999999765443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=284.74 Aligned_cols=198 Identities=26% Similarity=0.387 Sum_probs=166.6
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57889999999999999999975 78999999986542 234567899999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 999999999988543 34889999999999999999999998 999999999999999999999999999866543
Q ss_pred CccccccccccccccchhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvll~elltg~~p~~~ 474 (492)
. ......+++.|+|||.+.+..+ +.++||||||++++||++|+.||..
T Consensus 165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 213 (276)
T 2h6d_A 165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 2 1234568999999999887765 5899999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=300.32 Aligned_cols=201 Identities=21% Similarity=0.267 Sum_probs=172.6
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhcc------CcCceeeeeeeeecCCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI------NHKNLVKLLGCSITGPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 340 (492)
..+|++.++||+|+||+||++... +++.||||++... ....+.+.+|+++++.+ .|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 467999999999999999999864 5889999999654 33456677888888776 577999999999999999
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc--EEEeecCCc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT--AKIADFGLV 418 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~Dfgl~ 418 (492)
++||||++ ++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 6888887553 3345899999999999999999999998 999999999999999887 999999999
Q ss_pred cccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.
T Consensus 250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 250 CYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 765432 22457899999999999999999999999999999999999998765433
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=289.21 Aligned_cols=201 Identities=26% Similarity=0.371 Sum_probs=169.7
Q ss_pred hcccccCC-cccccCcccEEEEEe---cCCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 268 TNYFHESN-KLGQGGSGSVYKGTL---PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 268 ~~~~~~~~-~iG~G~fG~Vy~~~~---~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
.++|++.+ .||+|+||.||++.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 999999999999964 246789999997543 33467899999999999999999999998 667789
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 999999999999998543 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCccc--cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 422 PEDITHI--SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 422 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
....... .....+++.|+|||.+....++.++||||||+++|||++ |+.|+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 224 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 5443221 123346789999999988889999999999999999999 99998653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=283.48 Aligned_cols=204 Identities=22% Similarity=0.286 Sum_probs=168.7
Q ss_pred HHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeee-ecCCcceeE
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS-ITGPESLLV 343 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv 343 (492)
...++|++.+.||+|+||.||+++. .+++.||||++..... .+.+.+|+++++.++|++++..++.+ .+.+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3457899999999999999999986 5688999998754432 24588999999999988877776655 566677999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee---CCCCcEEEeecCCccc
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRL 420 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgl~~~ 420 (492)
|||+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+++.
T Consensus 84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 9999 99999988532 335899999999999999999999998 9999999999999 7889999999999987
Q ss_pred cCCCCc------cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 421 FPEDIT------HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 421 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 654332 122356789999999999999999999999999999999999999986443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=298.53 Aligned_cols=199 Identities=17% Similarity=0.221 Sum_probs=169.8
Q ss_pred hcccccCCcccccCcccEEEEEecC---------CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceee---------
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG---------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK--------- 329 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 329 (492)
.++|++.+.||+|+||.||++.... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4679999999999999999998753 789999998654 36889999999999999998
Q ss_pred ------eeeeeec-CCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 011153 330 ------LLGCSIT-GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI 402 (492)
Q Consensus 330 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Ni 402 (492)
+++++.. +...++||||+ +++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 5566665 67789999999 99999998643 2356999999999999999999999998 99999999999
Q ss_pred eeCCCC--cEEEeecCCccccCCCCcc------ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 403 LLDEEF--TAKIADFGLVRLFPEDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 403 ll~~~~--~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
|++.++ .+||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999866533211 11345789999999999999999999999999999999999999987
Q ss_pred CC
Q 011153 475 TQ 476 (492)
Q Consensus 475 ~~ 476 (492)
..
T Consensus 271 ~~ 272 (352)
T 2jii_A 271 CL 272 (352)
T ss_dssp GT
T ss_pred CC
Confidence 54
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=294.33 Aligned_cols=197 Identities=31% Similarity=0.496 Sum_probs=159.6
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHH--HhccCcCceeeeeeeee-----cCCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNL--ISGINHKNLVKLLGCSI-----TGPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~-----~~~~~ 340 (492)
.++|++.++||+|+||.||+++. +++.||||++.... ...+..|.++ +..++||||+++++.+. .....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46789999999999999999976 57899999996543 2344444444 55689999999998543 22356
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc---------CCCCeEecCCCCCCeeeCCCCcEE
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE---------SKLRIIHRDIKLSNILLDEEFTAK 411 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~---------~~~~ivH~Dlk~~Nill~~~~~~k 411 (492)
++||||+++++|.+++... ..++..+..++.||+.||+|||+. + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 8999999999999998443 348899999999999999999998 6 99999999999999999999
Q ss_pred EeecCCccccCCCCc-------cccccccccccccchhhhcc-------CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 412 IADFGLVRLFPEDIT-------HISATLAGTLGYMAPEYVVR-------GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 412 l~Dfgl~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
|+|||+++.+..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+...
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 999999987653221 11224569999999999876 35667899999999999999998887543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.05 Aligned_cols=201 Identities=24% Similarity=0.403 Sum_probs=154.0
Q ss_pred cccc-CCcccccCcccEEEEEec---CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeec--CCcceeE
Q 011153 270 YFHE-SNKLGQGGSGSVYKGTLP---GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPESLLV 343 (492)
Q Consensus 270 ~~~~-~~~iG~G~fG~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 343 (492)
.|++ .++||+|+||+||+++.. +++.||||++.... ....+.+|+.+|++++||||+++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3555 568999999999999865 57889999996543 23468899999999999999999999954 6678999
Q ss_pred EeecCCCCchhhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee----CCCCcEEEe
Q 011153 344 YEFVPNQSLLDNLFVR------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIA 413 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~------~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~ 413 (492)
|||++ ++|.+.+... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99996 4777766422 12335899999999999999999999998 9999999999999 678899999
Q ss_pred ecCCccccCCCCc--cccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 414 DFGLVRLFPEDIT--HISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 414 Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999987654322 222356789999999998874 58999999999999999999999997543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=290.73 Aligned_cols=201 Identities=29% Similarity=0.389 Sum_probs=168.8
Q ss_pred cccccCCcccccCcccEEEEEec-CCCE--EEEEEeccC-ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEA--VAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~--vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 343 (492)
++|+..+.||+|+||.||+++.. ++.. +++|.+... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67889999999999999999864 4554 499988653 334456789999999999 999999999999999999999
Q ss_pred EeecCCCCchhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcE
Q 011153 344 YEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ 410 (492)
|||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986432 2356899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 411 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
||+|||+++..... .......+++.|+|||.+....++.++||||||++++||++ |+.||..
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 244 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC
Confidence 99999998743321 11223456889999999988889999999999999999998 9998854
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=284.31 Aligned_cols=201 Identities=25% Similarity=0.355 Sum_probs=174.6
Q ss_pred HhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---------hhhHHHHHHHHHHHhccC-cCceeeeeeeee
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---------TQWVDHFFNEVNLISGIN-HKNLVKLLGCSI 335 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 335 (492)
..++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3577999999999999999999875 68899999986543 123456889999999995 999999999999
Q ss_pred cCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 011153 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (492)
Q Consensus 336 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 415 (492)
+.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 999999999999999999988543 35899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCccccccccccccccchhhhc------cCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 416 GLVRLFPEDITHISATLAGTLGYMAPEYVV------RGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 416 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
|++....... ......+++.|+|||.+. ...++.++||||||++++||++|+.|+...
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 9998765432 223456899999999885 456889999999999999999999998643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=286.12 Aligned_cols=201 Identities=25% Similarity=0.335 Sum_probs=158.4
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC-h-hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-T-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~-~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
.++|+..++||+|+||+||++.. .+++.||||++.... . ...+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46799999999999999999986 578899999997542 2 22334455556688899999999999999999999999
Q ss_pred eecCCCCchhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 345 EFVPNQSLLDNLFV-RQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 345 e~~~~gsL~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
||++ ++|.+++.. ......+++..+..++.||+.||+|||++ + ++||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 588776643 22345699999999999999999999997 7 9999999999999999999999999998665
Q ss_pred CCCccccccccccccccchhhh----ccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYV----VRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.... .....||+.|+|||.+ ....++.++||||||++++||++|+.||..
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 4322 2234689999999996 456789999999999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=282.44 Aligned_cols=201 Identities=23% Similarity=0.295 Sum_probs=171.4
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeee-ecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS-ITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 345 (492)
.++|++.+.||+|+||.||+++. .+++.||||++..... .+.+.+|+.+++.++|++++..+..+ .+++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46799999999999999999996 5788999999865433 24688999999999998877666655 56667799999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee---CCCCcEEEeecCCccccC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~~ 422 (492)
|+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 99999988533 245899999999999999999999998 9999999999999 488999999999998765
Q ss_pred CCCcc------ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 423 EDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 423 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 44321 1235578999999999999999999999999999999999999998643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=292.58 Aligned_cols=210 Identities=23% Similarity=0.310 Sum_probs=162.5
Q ss_pred HHHHHHHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc
Q 011153 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (492)
Q Consensus 261 ~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (492)
.+......++|++.++||+|+||.||+++.. +++.||||++.... .....+.+|++.+..++||||+++++++.....
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3445667789999999999999999999864 68999999986543 233456788888999999999999999876443
Q ss_pred -------ceeEEeecCCCCchhhhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeEecCCCCCCeeeCC-CC
Q 011153 340 -------SLLVYEFVPNQSLLDNLF-VRQDVEPLSWEVRYKIILSTAEGLAYLH--EESKLRIIHRDIKLSNILLDE-EF 408 (492)
Q Consensus 340 -------~~lv~e~~~~gsL~~~l~-~~~~~~~~~~~~~~~i~~~i~~~l~yLH--~~~~~~ivH~Dlk~~Nill~~-~~ 408 (492)
.++||||+++ +|.+.+. .......+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence 6899999986 4444332 2244566899999999999999999999 777 999999999999986 89
Q ss_pred cEEEeecCCccccCCCCccccccccccccccchhhhccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 409 TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 409 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
.+||+|||+++....... .....||+.|+|||++.+.. ++.++||||||+++|||++|+.||.....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence 999999999987654332 23456899999999986654 89999999999999999999999976543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=298.56 Aligned_cols=198 Identities=10% Similarity=0.055 Sum_probs=151.8
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh---hhHHHHHHHHHHHhcc--CcCceeeee-------eee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT---QWVDHFFNEVNLISGI--NHKNLVKLL-------GCS 334 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 334 (492)
...|+..++||+|+||.||++... +++.||||++..... ...+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 455889999999999999999964 788999999977542 3455677885544444 699988755 333
Q ss_pred ecC-----------------CcceeEEeecCCCCchhhhhccCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCCC
Q 011153 335 ITG-----------------PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVR------YKIILSTAEGLAYLHEESKLR 391 (492)
Q Consensus 335 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~------~~i~~~i~~~l~yLH~~~~~~ 391 (492)
... ...++||||++ ++|.+++..... .+++..+ +.++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 322 23699999998 899999865322 2344455 677899999999999998
Q ss_pred eEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccccccccccccchhhhcc--CCCCcchhHHHHHHHHHHHHhCC
Q 011153 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRK 469 (492)
Q Consensus 392 ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvll~elltg~ 469 (492)
|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++||||||+++|||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998664321 13456799999999987 67999999999999999999999
Q ss_pred CCCCCC
Q 011153 470 RINLFT 475 (492)
Q Consensus 470 ~p~~~~ 475 (492)
.||...
T Consensus 291 ~Pf~~~ 296 (371)
T 3q60_A 291 LPFGLV 296 (371)
T ss_dssp CSTTBC
T ss_pred CCCCCc
Confidence 998765
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=283.08 Aligned_cols=203 Identities=22% Similarity=0.227 Sum_probs=168.8
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC----hhhHHHHHHHHHHHhccCcCceeeeeeeee--cCCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT----TQWVDHFFNEVNLISGINHKNLVKLLGCSI--TGPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 340 (492)
.++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 467999999999999999999964 68899999996542 234677999999999999999999999984 45578
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++||||++++ |.+.+... ....+++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999876 66666443 3456899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCC-ccccccccccccccchhhhccCC--CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 421 FPEDI-THISATLAGTLGYMAPEYVVRGK--LTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 421 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
..... ........||+.|+|||++.+.. ++.++||||||++++||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 64322 12223456899999999987644 377999999999999999999998753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=289.34 Aligned_cols=206 Identities=29% Similarity=0.387 Sum_probs=172.9
Q ss_pred cCHHHHHHHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhc--cCcCceeeeeeeeec
Q 011153 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG--INHKNLVKLLGCSIT 336 (492)
Q Consensus 259 ~~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~ 336 (492)
..........++|++.+.||+|+||.||+++.. ++.||||++... ..+.+.+|++++.. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 344445566788999999999999999999874 889999998643 34567788888877 799999999999987
Q ss_pred CC----cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEecCCCCCCeee
Q 011153 337 GP----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH--------EESKLRIIHRDIKLSNILL 404 (492)
Q Consensus 337 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivH~Dlk~~Nill 404 (492)
.. ..++||||+++++|.+++.. ..+++..++.++.||+.||+||| +.+ |+||||||+|||+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll 180 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV 180 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence 76 78999999999999999854 25899999999999999999999 666 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCcc---ccccccccccccchhhhccCC------CCcchhHHHHHHHHHHHHhC-------
Q 011153 405 DEEFTAKIADFGLVRLFPEDITH---ISATLAGTLGYMAPEYVVRGK------LTEKADVYSFGVVVIEVVCR------- 468 (492)
Q Consensus 405 ~~~~~~kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~slGvll~elltg------- 468 (492)
+.++.+||+|||++......... ......||+.|+|||.+.... ++.++||||||+++|||++|
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 99999999999999866544322 123457899999999987652 33689999999999999999
Q ss_pred ---CCCCCCC
Q 011153 469 ---KRINLFT 475 (492)
Q Consensus 469 ---~~p~~~~ 475 (492)
+.||...
T Consensus 261 ~~~~~p~~~~ 270 (342)
T 1b6c_B 261 EDYQLPYYDL 270 (342)
T ss_dssp CCCCCTTTTT
T ss_pred cccccCcccc
Confidence 6676554
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=296.16 Aligned_cols=201 Identities=25% Similarity=0.334 Sum_probs=171.3
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccC--------cCceeeeeeeee---
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN--------HKNLVKLLGCSI--- 335 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 335 (492)
.++|++.++||+|+||+||+++. .+++.||||++... ....+.+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46799999999999999999985 46889999999643 344667889999999985 788999999987
Q ss_pred -cCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCCeeeCCCC-----
Q 011153 336 -TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEF----- 408 (492)
Q Consensus 336 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~----- 408 (492)
.....++||||+ +++|.+.+... ....+++..++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 556789999999 66776666443 334689999999999999999999998 7 99999999999999775
Q ss_pred --------------------------------------------cEEEeecCCccccCCCCccccccccccccccchhhh
Q 011153 409 --------------------------------------------TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444 (492)
Q Consensus 409 --------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~ 444 (492)
.+||+|||++...... .....||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999876543 2345789999999999
Q ss_pred ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 445 VRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 445 ~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
.+..++.++||||||+++|||++|+.||......
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 299 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGE 299 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCccc
Confidence 9999999999999999999999999999765443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.46 Aligned_cols=194 Identities=27% Similarity=0.375 Sum_probs=163.5
Q ss_pred CcccccCcccEEEEEec---CCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLP---GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
++||+|+||.||+|.+. .++.||||+++... ....+.+.+|+++|++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 45789999997543 344678999999999999999999999986 4568899999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc--
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH-- 427 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-- 427 (492)
++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999853 345899999999999999999999998 999999999999999999999999999876543321
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
......+|+.|+|||++....++.++|||||||++|||++ |+.||...
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 576 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2223456789999999999999999999999999999998 99998653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=291.63 Aligned_cols=209 Identities=28% Similarity=0.375 Sum_probs=170.3
Q ss_pred CHHHHHHHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeeec-
Q 011153 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSIT- 336 (492)
Q Consensus 260 ~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 336 (492)
++..+....++|++.+.||+|+||.||++.. .+++.||||++..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3334445678899999999999999999986 4689999999865433 356788999999999 89999999999986
Q ss_pred -----CCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEE
Q 011153 337 -----GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK 411 (492)
Q Consensus 337 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~k 411 (492)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 45789999999999999988643 2346899999999999999999999998 99999999999999999999
Q ss_pred EeecCCccccCCCCccccccccccccccchhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 412 IADFGLVRLFPEDITHISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 412 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
|+|||++........ ......|++.|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 170 l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 999999886543321 123456899999999987 56789999999999999999999999854
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=284.21 Aligned_cols=202 Identities=31% Similarity=0.481 Sum_probs=163.4
Q ss_pred hcccccCCcccccCcccEEEEEec--CCC--EEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP--GGE--AVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~--~~~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (492)
.++|++.+.||+|+||+||+++.. +++ .||||+++.. .....+.+.+|++++++++||||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467899999999999999999853 333 6899988654 3345678999999999999999999999988754 8
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++|+||+++++|.+++... ...+++..+..++.||+.||.|||+++ ++|+||||+|||++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999988643 245889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCcc--ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 421 FPEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 421 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
....... ......+|+.|+|||.+....++.++||||||++++||++ |+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 6543322 1224457889999999998889999999999999999999 89888643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=289.20 Aligned_cols=201 Identities=26% Similarity=0.393 Sum_probs=170.0
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC-----Ccc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 340 (492)
.++|++.+.||+|+||.||++... +++.||||++... .......+.+|+++++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467999999999999999999865 6889999999654 334456788999999999999999999987754 677
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++|+||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 588888743 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCcc---------ccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 421 FPEDITH---------ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 421 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
....... ......||+.|+|||++.. ..++.++||||||++++||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 6532211 1123468999999998765 678999999999999999999999987543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=284.18 Aligned_cols=197 Identities=28% Similarity=0.434 Sum_probs=163.7
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecC-CcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-PESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 346 (492)
.++|+..+.||+|+||.||++... ++.||||++.... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467899999999999999999875 7899999986543 456789999999999999999999987654 478999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++++|.+++.... ...+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999999885432 223788999999999999999999998 9999999999999999999999999987554322
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
....+++.|+|||.+.+..++.++||||||++++||++ |+.|+...
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 218 (278)
T 1byg_A 172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 23356889999999999999999999999999999998 88888653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=291.74 Aligned_cols=196 Identities=26% Similarity=0.402 Sum_probs=167.0
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcc----
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES---- 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 340 (492)
.++|...+.||+|+||.||++... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467889999999999999999864 6889999999754 334467789999999999999999999999877765
Q ss_pred --eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCc
Q 011153 341 --LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (492)
Q Consensus 341 --~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~ 418 (492)
++||||++ ++|.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 57777662 23899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+..... .....+|+.|+|||++.+ ..++.++||||||++++||++|+.||....
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 865433 234568999999999887 678999999999999999999999997543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=287.33 Aligned_cols=203 Identities=28% Similarity=0.423 Sum_probs=171.1
Q ss_pred HhcccccCCcccccCcccEEEEEe--cCCCEEEEEEeccCC--hhhHHHHHHHHHHHhcc---CcCceeeeeeeee----
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTL--PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGI---NHKNLVKLLGCSI---- 335 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~--~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 335 (492)
..++|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 467889999986432 22234566787777666 8999999999987
Q ss_pred -cCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEee
Q 011153 336 -TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD 414 (492)
Q Consensus 336 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 414 (492)
.....++|+||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 5567889999998 69998885433 345899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 415 FGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 415 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
||+++...... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99998654322 2234578999999999999999999999999999999999999987543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=285.22 Aligned_cols=200 Identities=24% Similarity=0.339 Sum_probs=173.4
Q ss_pred hcccccCCcccccCcccEEEEEe--cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCc------eeeeeeeeecCCc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL--PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN------LVKLLGCSITGPE 339 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 339 (492)
.++|++.+.||+|+||.||++.. .+++.||||++... ....+.+.+|+++++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46799999999999999999986 36789999998643 344567889999999887665 9999999999999
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-------------
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE------------- 406 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~------------- 406 (492)
.++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88999888543 3346899999999999999999999998 999999999999987
Q ss_pred ------CCcEEEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 407 ------EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 407 ------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 678999999999865432 2345789999999999999999999999999999999999999976543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=311.49 Aligned_cols=203 Identities=24% Similarity=0.320 Sum_probs=169.7
Q ss_pred HHhcccccCCcccccCcccEEEEEecC----CCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcc
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (492)
...++|++.+.||+|+||.||+|.... +..||||++... .....+.+.+|+.++++++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 345678889999999999999998642 457999998754 3444578999999999999999999999885 5678
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999988543 345899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
.............+|+.|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 595 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 65543333334557889999999999999999999999999999997 8888764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=287.58 Aligned_cols=196 Identities=26% Similarity=0.399 Sum_probs=166.6
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc-----
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE----- 339 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 339 (492)
.++|...+.||+|+||.||++... +|+.||||++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367889999999999999999864 6889999999654 33445678999999999999999999999987664
Q ss_pred -ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCc
Q 011153 340 -SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (492)
Q Consensus 340 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~ 418 (492)
.++||||++ ++|.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 389999997 58877662 24899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+..... .....+|+.|+|||.+.+ ..++.++||||||++++||++|+.||....
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 865432 224568999999999877 678999999999999999999999997644
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=295.60 Aligned_cols=203 Identities=23% Similarity=0.303 Sum_probs=172.2
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCc-CceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 345 (492)
.++|++.++||+|+||.||++.. .+++.||||++..... ...+.+|+++++.++| ++|..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46799999999999999999985 5789999998765433 2358899999999987 556666666677888899999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee---CCCCcEEEeecCCccccC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~~ 422 (492)
|+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999988542 345899999999999999999999998 9999999999999 588999999999998765
Q ss_pred CCCcc------ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 423 EDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 423 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
..... ......||+.|+|||.+.+..++.++||||||++||||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~ 219 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch
Confidence 43321 122567999999999999999999999999999999999999999875543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=287.83 Aligned_cols=209 Identities=22% Similarity=0.354 Sum_probs=170.7
Q ss_pred cCHHHHHHHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccC--cCceeeeeeee
Q 011153 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGIN--HKNLVKLLGCS 334 (492)
Q Consensus 259 ~~~~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~ 334 (492)
+.+..+....++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3334444556789999999999999999999888999999998654 3445678999999999997 59999999999
Q ss_pred ecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEee
Q 011153 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD 414 (492)
Q Consensus 335 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 414 (492)
.+++..++||| +.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++ +.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 99999999999 6688999988543 35889999999999999999999998 999999999999964 8999999
Q ss_pred cCCccccCCCCcc-ccccccccccccchhhhcc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 415 FGLVRLFPEDITH-ISATLAGTLGYMAPEYVVR-----------GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 415 fgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
||+++........ ......|++.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 9999866543222 1234568999999999865 46888999999999999999999998653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=278.57 Aligned_cols=201 Identities=28% Similarity=0.391 Sum_probs=173.2
Q ss_pred HHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
...++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34567999999999999999999875 6889999998654 23456789999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC---CcEEEeecCCcc
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVR 419 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Dfgl~~ 419 (492)
|+||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999998887543 35899999999999999999999998 9999999999999754 479999999998
Q ss_pred ccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....... .....+++.|+|||.+.+ .++.++||||||++++||++|+.||...
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (287)
T 2wei_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (287)
T ss_dssp TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence 6654322 223458899999998764 5899999999999999999999998653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=279.35 Aligned_cols=194 Identities=27% Similarity=0.444 Sum_probs=161.2
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeec----------
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT---------- 336 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 336 (492)
.++|++.+.||+|+||.||+++. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 46789999999999999999996 47899999998643 3446788999999999999999999998865
Q ss_pred ---CCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEe
Q 011153 337 ---GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413 (492)
Q Consensus 337 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 413 (492)
....++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 34678999999999999998643 245788999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCC-------------ccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHh
Q 011153 414 DFGLVRLFPEDI-------------THISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467 (492)
Q Consensus 414 Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~ellt 467 (492)
|||++....... ........||+.|+|||.+.+. .++.++||||||+++|||++
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 999998654321 1112345689999999998764 78999999999999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=282.92 Aligned_cols=201 Identities=27% Similarity=0.374 Sum_probs=151.6
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHH-HHhccCcCceeeeeeeeecCCcceeEE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
.++|+..+.||+|+||.||++... +++.||||++.... ......+..|+. +++.++||||+++++++.+++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467889999999999999999874 68899999997653 334455666666 778889999999999999999999999
Q ss_pred eecCCCCchhhhhc--cCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 345 EFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 345 e~~~~gsL~~~l~~--~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
||+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 77766642 12345689999999999999999999998 7 999999999999999999999999999866
Q ss_pred CCCCccccccccccccccchhhh----ccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYV----VRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
..... .....||+.|+|||.+ ....++.++||||||+++|||++|+.||..
T Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 44322 2234689999999998 456789999999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=295.44 Aligned_cols=200 Identities=27% Similarity=0.346 Sum_probs=157.2
Q ss_pred cccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEEeec
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
+.|...++||+|+||+||.....+|+.||||++.... .+.+.+|+.++.++ +||||+++++++.+++..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 4466678899999999987766779999999986532 45678999999876 8999999999999999999999999
Q ss_pred CCCCchhhhhccCCCC----CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-------------CcE
Q 011153 348 PNQSLLDNLFVRQDVE----PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-------------FTA 410 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~----~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~-------------~~~ 410 (492)
+ ++|.+++....... ..++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999886543211 1133345789999999999999998 9999999999999654 489
Q ss_pred EEeecCCccccCCCCcc---ccccccccccccchhhhcc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 411 KIADFGLVRLFPEDITH---ISATLAGTLGYMAPEYVVR-------GKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 411 kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||+++||++ |+.||...
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 99999999877554322 1234579999999999865 678999999999999999999 88888643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=286.83 Aligned_cols=204 Identities=25% Similarity=0.289 Sum_probs=171.7
Q ss_pred HHHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccC-cC-----ceeeeeeeeecC
Q 011153 265 EKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HK-----NLVKLLGCSITG 337 (492)
Q Consensus 265 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~ 337 (492)
....++|++.++||+|+||+||++... +++.||||++... ....+.+.+|+++++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 345678999999999999999999865 6788999999743 334567788888888874 44 499999999999
Q ss_pred CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC--CCCcEEEeec
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD--EEFTAKIADF 415 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~Df 415 (492)
+..++||||++ ++|.+++.... ...+++..+..++.||+.||.|||++ ..+|+||||||+|||++ .++.+||+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999996 59998886543 34589999999999999999999953 13499999999999994 5788999999
Q ss_pred CCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 416 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 206 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 206 GSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999876443 234578999999999999999999999999999999999999998654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=286.49 Aligned_cols=205 Identities=22% Similarity=0.336 Sum_probs=168.6
Q ss_pred HHHHHHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc
Q 011153 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE 339 (492)
Q Consensus 262 ~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 339 (492)
...+...++|++.+.||+|+||.||++...+ .+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3344456789999999999999999998753 59999986542 3334568899999999999999999999999999
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
.++|+||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ ++||||||+|||++ ++.+||+|||++.
T Consensus 104 ~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp EEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred eEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 9999999999999998843 2346889999999999999999999998 99999999999998 6799999999987
Q ss_pred ccCCCC----ccccccccccccccchhhhcc---------CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 420 LFPEDI----THISATLAGTLGYMAPEYVVR---------GKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 420 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
...... ........|++.|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 245 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 553211 111224468999999999864 4578899999999999999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.11 Aligned_cols=202 Identities=28% Similarity=0.384 Sum_probs=174.6
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeec------CCc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT------GPE 339 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 339 (492)
.++|++.++||+|+||.||++.. .+++.||||++... .....+.+.+|++++++++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36799999999999999999986 46889999998754 44556779999999999999999999998765 667
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc---EEEeecC
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT---AKIADFG 416 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfg 416 (492)
.++||||+++++|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976555557899999999999999999999988 999999999999987664 9999999
Q ss_pred CccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 998765432 22346789999999999999999999999999999999999999853
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=291.53 Aligned_cols=191 Identities=17% Similarity=0.182 Sum_probs=158.8
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCC--------hhhHHHHHHHHHHHhccC---------cCceeee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--------TQWVDHFFNEVNLISGIN---------HKNLVKL 330 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l 330 (492)
.++|++.++||+|+||+||+++. +++.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46688999999999999999988 67999999997542 223477889999998886 5555555
Q ss_pred e-----------------eeeec-------------CCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHH
Q 011153 331 L-----------------GCSIT-------------GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380 (492)
Q Consensus 331 ~-----------------~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~ 380 (492)
. +++.+ .+..++||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 4 44443 6788999999999987777632 458999999999999999
Q ss_pred HHHHh-hcCCCCeEecCCCCCCeeeCCCC--------------------cEEEeecCCccccCCCCcccccccccccccc
Q 011153 381 LAYLH-EESKLRIIHRDIKLSNILLDEEF--------------------TAKIADFGLVRLFPEDITHISATLAGTLGYM 439 (492)
Q Consensus 381 l~yLH-~~~~~~ivH~Dlk~~Nill~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~ 439 (492)
|+||| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.||
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~ 244 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence 99999 888 99999999999999887 8999999999866432 347899999
Q ss_pred chhhhccCCCCcchhHHHHHHH-HHHHHhCCCCCC
Q 011153 440 APEYVVRGKLTEKADVYSFGVV-VIEVVCRKRINL 473 (492)
Q Consensus 440 aPE~~~~~~~~~~sDv~slGvl-l~elltg~~p~~ 473 (492)
|||++.+.. +.++|||||+++ ..++++|..|+.
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 999987665 899999998766 778899998874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=310.53 Aligned_cols=192 Identities=24% Similarity=0.336 Sum_probs=166.2
Q ss_pred hcccccCCcccccCcccEEEEEec--CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc-----
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP--GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE----- 339 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~--~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 339 (492)
.++|++.++||+|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367999999999999999999875 5889999998654 34556678999999999999999999999987766
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
.++||||+++++|.+.+.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999886622 5899999999999999999999998 9999999999999986 99999999998
Q ss_pred ccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
..... ....||+.|+|||++.++. +.++||||||++++||++|..|+..
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 76543 3456899999999887654 8999999999999999999988754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=284.10 Aligned_cols=202 Identities=28% Similarity=0.363 Sum_probs=164.0
Q ss_pred HHHHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCCh------hhHHHHHHHHHHHhcc----CcCceeeeee
Q 011153 264 LEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT------QWVDHFFNEVNLISGI----NHKNLVKLLG 332 (492)
Q Consensus 264 l~~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~ 332 (492)
.+...++|++.+.||+|+||.||++.. .+++.||||++..... .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999986 4688999999965432 1233466799999888 8999999999
Q ss_pred eeecCCcceeEEee-cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC-CCCcE
Q 011153 333 CSITGPESLLVYEF-VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTA 410 (492)
Q Consensus 333 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~ 410 (492)
++.+.+..++|+|+ +++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 7899999988653 35899999999999999999999998 99999999999998 88999
Q ss_pred EEeecCCccccCCCCccccccccccccccchhhhccCCCC-cchhHHHHHHHHHHHHhCCCCCCC
Q 011153 411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT-EKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 411 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~slGvll~elltg~~p~~~ 474 (492)
||+|||++....... .....|++.|+|||++.+..+. .++||||||++++||++|+.||..
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 999999998765432 2345689999999999877765 489999999999999999999854
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=281.05 Aligned_cols=199 Identities=21% Similarity=0.299 Sum_probs=170.8
Q ss_pred hcccccCCcccccCcccEEEEEec-CC-CEEEEEEeccCChhhHHHHHHHHHHHhccCcCc------eeeeeeeeecCCc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GG-EAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN------LVKLLGCSITGPE 339 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 339 (492)
.++|++.+.||+|+||+||++... ++ +.||||+++.. ....+.+.+|+.+++.++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 467999999999999999999864 34 68999998643 344567889999999998776 9999999999999
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee---------------
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL--------------- 404 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill--------------- 404 (492)
.++||||+ +++|.+.+... ....+++..+..++.||+.||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 66777766443 3346899999999999999999999988 9999999999999
Q ss_pred ----CCCCcEEEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 405 ----DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 405 ----~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 567899999999998654332 34578999999999999999999999999999999999999997644
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=284.47 Aligned_cols=200 Identities=26% Similarity=0.362 Sum_probs=171.7
Q ss_pred HHhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChh------hHHHHHHHHHHHhccC--cCceeeeeeeeec
Q 011153 266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQ------WVDHFFNEVNLISGIN--HKNLVKLLGCSIT 336 (492)
Q Consensus 266 ~~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~ 336 (492)
...++|++.++||+|+||.||++.. .+++.||||++...... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457799999999999999999985 56889999998654321 2345778999999996 5999999999999
Q ss_pred CCcceeEEeecCC-CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC-CCCcEEEee
Q 011153 337 GPESLLVYEFVPN-QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIAD 414 (492)
Q Consensus 337 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~D 414 (492)
++..++|+|++.+ ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999976 8999888543 45899999999999999999999998 99999999999998 789999999
Q ss_pred cCCccccCCCCccccccccccccccchhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 415 FGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 415 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvll~elltg~~p~~~ 474 (492)
||+++...... .....||+.|+|||++....+ +.++||||||+++|||++|+.||..
T Consensus 194 fg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 194 FGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp CTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred Ccccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 99998765432 224568999999999987776 6789999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=286.35 Aligned_cols=199 Identities=23% Similarity=0.301 Sum_probs=167.9
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccC-----------cCceeeeeeeee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-----------HKNLVKLLGCSI 335 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 335 (492)
.++|++.+.||+|+||+||+++. .+++.||||++... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35799999999999999999986 56889999998643 334567889999998886 899999999988
Q ss_pred cCC----cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCCeeeC-----
Q 011153 336 TGP----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLD----- 405 (492)
Q Consensus 336 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~----- 405 (492)
..+ ..++|||++ +++|.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 678999999 889998885533 34589999999999999999999997 7 99999999999994
Q ss_pred -CCCcEEEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 406 -EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 406 -~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 44589999999998765432 24578999999999999999999999999999999999999997543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=277.08 Aligned_cols=200 Identities=26% Similarity=0.372 Sum_probs=150.4
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCCh-hh-HHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-QW-VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~-~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
.++|+..+.||+|+||.||++... +++.||||++..... .. .+.+.++..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 466888999999999999999975 689999999976532 22 333445556788889999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
||+ ++.+...... ....+++..+..++.||+.||.|||+. + ++|+||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4444433322 234589999999999999999999985 7 99999999999999999999999999976544
Q ss_pred CCccccccccccccccchhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
... .....+++.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 178 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 178 DKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred Ccc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 321 23456899999999984 456889999999999999999999998753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=281.62 Aligned_cols=197 Identities=22% Similarity=0.295 Sum_probs=145.2
Q ss_pred hcccccCC-cccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeec----CCcce
Q 011153 268 TNYFHESN-KLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPESL 341 (492)
Q Consensus 268 ~~~~~~~~-~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 341 (492)
.++|.+.+ +||+|+||.||++... +++.||||++..... ...+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46788754 6999999999999865 689999999865321 12222334567799999999999876 44578
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCcEEEeecCCc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLV 418 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgl~ 418 (492)
+||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999998643 2346999999999999999999999998 999999999999976 456999999999
Q ss_pred cccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
+...... .....+|+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 179 KETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred eeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 8654322 23456899999999998888999999999999999999999998653
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=290.91 Aligned_cols=198 Identities=25% Similarity=0.329 Sum_probs=157.5
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
..+|+..++||+|+||+|+.....+++.||||++..... ..+.+|+++|+++ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 456888999999999997665566789999999965432 2456899999999 899999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-----CCcEEEeecCCcccc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-----EFTAKIADFGLVRLF 421 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~Dfgl~~~~ 421 (492)
++ ++|.+++.... ....+..+..++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++..
T Consensus 100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 59988885433 22344456789999999999999998 999999999999953 346889999999876
Q ss_pred CCCCc--cccccccccccccchhhhc---cCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 422 PEDIT--HISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 422 ~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
..... .......||+.|+|||++. ...++.++|||||||+++||++ |+.||..
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~ 232 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence 54322 1223567999999999987 4567889999999999999999 8888754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=263.95 Aligned_cols=173 Identities=12% Similarity=0.026 Sum_probs=151.0
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.++|++.+.||+|+||.||++... +++.||||++.... .+..+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999975 48899999997543 34457899999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++++|.+++.. . .....+.+++.||+.||+|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999998832 1 355678899999999999999998 9999999999999999999998443
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
|++ +++.++||||||+++|||++|+.||....
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 333 36889999999999999999999987543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.6e-33 Score=281.50 Aligned_cols=200 Identities=18% Similarity=0.203 Sum_probs=154.3
Q ss_pred HhcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCc-Cceeeee----------
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINH-KNLVKLL---------- 331 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~---------- 331 (492)
.++.|...++||+|+||+||+++. .+|+.||||++.... ....+.+.+|+.+++.++| +|.....
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345578889999999999999994 578999999987432 2336789999999999977 3221111
Q ss_pred -----------eeeec-----CCcceeEEeecCCCCchhhhhc----cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 011153 332 -----------GCSIT-----GPESLLVYEFVPNQSLLDNLFV----RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391 (492)
Q Consensus 332 -----------~~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ 391 (492)
.+... ....+++|+++ +++|.+++.. ......+++..++.++.||++||+|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 11111 12345666654 6889887731 223455788899999999999999999998
Q ss_pred eEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccccccccccccchhhh----------ccCCCCcchhHHHHHHH
Q 011153 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV----------VRGKLTEKADVYSFGVV 461 (492)
Q Consensus 392 ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv~slGvl 461 (492)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999998865433 334567 999999999 55568889999999999
Q ss_pred HHHHHhCCCCCCCC
Q 011153 462 VIEVVCRKRINLFT 475 (492)
Q Consensus 462 l~elltg~~p~~~~ 475 (492)
+|||++|+.||...
T Consensus 307 l~elltg~~Pf~~~ 320 (413)
T 3dzo_A 307 IYWIWCADLPNTDD 320 (413)
T ss_dssp HHHHHHSSCCCCTT
T ss_pred HHHHHHCCCCCCCc
Confidence 99999999998764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=257.23 Aligned_cols=174 Identities=24% Similarity=0.309 Sum_probs=149.2
Q ss_pred cccccC-CcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHH-hccCcCceeeeeeeeec----CCcce
Q 011153 269 NYFHES-NKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLI-SGINHKNLVKLLGCSIT----GPESL 341 (492)
Q Consensus 269 ~~~~~~-~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~ 341 (492)
++|.+. +.||+|+||.||++.. .+++.||+|++... ..+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 446665 7899999999999986 56889999998542 4567888887 66699999999999876 66789
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCcEEEeecCCc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLV 418 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgl~ 418 (492)
+||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999998653 3346899999999999999999999998 999999999999998 789999999998
Q ss_pred cccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.... +..++.++||||||+++|||++|+.||..
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~ 200 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYS 200 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 6432 23467799999999999999999999854
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-31 Score=276.92 Aligned_cols=184 Identities=20% Similarity=0.197 Sum_probs=129.1
Q ss_pred ccccCcccEEEEE-ecCCCEEEEEEeccCC----------hhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeEE
Q 011153 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNT----------TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 277 iG~G~fG~Vy~~~-~~~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 344 (492)
.+.|++|.+..++ .-.|+.+++|.+.... ....++|.+|+++|+++ .|+||++++++++++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666555543 3358889999986531 23346799999999999 7999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||++|++|.+.+.. .++++.. +|+.||+.||+|+|+++ ||||||||+|||+++++.+||+|||+++....+
T Consensus 322 Eyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999954 3446654 58899999999999998 999999999999999999999999999876554
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRI 471 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p 471 (492)
.. ...+.+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 393 ~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Cc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 32 2345689999999998754 567789999999998877655443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=253.67 Aligned_cols=184 Identities=15% Similarity=0.151 Sum_probs=146.2
Q ss_pred ccCCcccccCcccEEEEEecCCCEEEEEEeccCCh--------hhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT--------QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 272 ~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
...++||+|+||+||++.. .++.+++|+...... ...+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4567899999999999954 478889998643211 1234589999999999999999777777788888999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++++|.+++.. +..++.||++||+|||+++ |+||||||+|||+++ .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999998843 4589999999999999998 999999999999999 999999999997755
Q ss_pred CCccc------cccccccccccchhhhcc--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 011153 424 DITHI------SATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRKRIN 472 (492)
Q Consensus 424 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDv~slGvll~elltg~~p~ 472 (492)
..... .....||+.|||||++.. ..|+...|+|+..+-.++.+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32221 235679999999999876 56788899999999999988887664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-24 Score=207.04 Aligned_cols=162 Identities=17% Similarity=0.121 Sum_probs=126.5
Q ss_pred HHHHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCCh------------------hhHHHHHHHHHHHhccCcC
Q 011153 264 LEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT------------------QWVDHFFNEVNLISGINHK 325 (492)
Q Consensus 264 l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~h~ 325 (492)
+......|++.+.||+|+||.||++...+|+.||||.++.... .....+.+|+.++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3444556777899999999999999997789999999964321 13456899999999999
Q ss_pred ceeeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC
Q 011153 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD 405 (492)
Q Consensus 326 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~ 405 (492)
| +++.+++ +.+..++||||+++++|.+ +.. .....++.||+.||.|||+.+ |+||||||+|||++
T Consensus 163 ~-~~v~~~~-~~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 G-LAVPKVY-AWEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 227 (282)
T ss_dssp T-SSSCCEE-EEETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred C-CCcCeEE-eccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence 4 6666644 3466799999999999988 411 124479999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCccccCCCCccccccccccccccchhhhcc----------CCCCcchhHHH
Q 011153 406 EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR----------GKLTEKADVYS 457 (492)
Q Consensus 406 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~sDv~s 457 (492)
++.+||+|||+++. +..++|||++.. ..+...+|+|.
T Consensus 228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp -TTEEEECCCTTCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred -CCcEEEEECCCCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99999999999863 234688998743 34455566654
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.3e-21 Score=156.17 Aligned_cols=102 Identities=22% Similarity=0.408 Sum_probs=86.8
Q ss_pred ccceeecCCCCCCCchhHHHHHHHHHHHHHHHhhcCC-ceeeeeecccCCCceEEEEEeecCCCChhhHHHHHHHHHHhh
Q 011153 88 QDRTVCGSKDFGGNNTVFGANAIELVRNLSVQAVKND-GFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRI 166 (492)
Q Consensus 88 ~~~~~~~~~~~~~~~~~f~~~~~~l~~~l~~~a~~~~-~~~~~~~~~~~~~~~vy~l~qC~~dl~~~~C~~Cl~~~~~~~ 166 (492)
..+..|++.+++. ++.|+.+++.||+.|+..++.++ +|+++..+. .++++||||+||+||+++++|..||+.++.++
T Consensus 5 ~v~~~Cn~~~~t~-~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~-~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~ 82 (108)
T 3a2e_A 5 FVSSACNTQKIPS-GSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGS-GGAPTAYGRATCKQSISQSDCTACLSNLVNRI 82 (108)
T ss_dssp EEEEEECSSBCCT-TCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCS-TTCCCEEEEEEECTTSCHHHHHHHHHHHHTTH
T ss_pred eeeeecCCCccCC-CChHHHHHHHHHHHHHhhCccccCCceEeeccC-CCCceEEEEEEEcCCCCHHHHHHHHHHHHHHH
Confidence 4466798777664 67899999999999999987654 466665543 56689999999999999999999999999999
Q ss_pred hhcc-CCCCceeeCCccccccccccc
Q 011153 167 ASCT-QKEEGRVLNAGCYLRYSTQRF 191 (492)
Q Consensus 167 ~~c~-~~~~g~v~~~~C~~ry~~~~f 191 (492)
+.|| ++++|+|++++|++|||+++|
T Consensus 83 ~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 83 FSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHCCCCceEEEECCCEEEEEeCCcC
Confidence 9855 589999999999999999987
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-20 Score=177.75 Aligned_cols=138 Identities=17% Similarity=0.149 Sum_probs=106.2
Q ss_pred ccccCCcccccCcccEEEEEe-cCCCE--EEEEEeccCChh------------------------hHHHHHHHHHHHhcc
Q 011153 270 YFHESNKLGQGGSGSVYKGTL-PGGEA--VAVKRLFYNTTQ------------------------WVDHFFNEVNLISGI 322 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~-~~~~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l 322 (492)
.|++.+.||+|+||.||++.. .+|+. ||||+++..... ....+.+|+..|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367788999999999999997 67888 999987543211 123678999999999
Q ss_pred CcCce--eeeeeeeecCCcceeEEeecCC-C----CchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEe
Q 011153 323 NHKNL--VKLLGCSITGPESLLVYEFVPN-Q----SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH-EESKLRIIH 394 (492)
Q Consensus 323 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH-~~~~~~ivH 394 (492)
.|+++ ..+++. ...+|||||+.+ | +|.+.... .++..+..++.|++.+|.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88864 333332 467899999942 4 45544321 123456789999999999999 887 999
Q ss_pred cCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 395 RDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 395 ~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
|||||.|||+++ .++|+|||++....
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCC
Confidence 999999999998 99999999997553
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-20 Score=152.16 Aligned_cols=76 Identities=21% Similarity=0.478 Sum_probs=66.5
Q ss_pred CCcccchhcc--ccEEEeeC-CCCCceEEEEecCCCCChhhhHHHHHHHHHHHHhhCCCCCCcccEEEEccceEEEEccC
Q 011153 2 DIVTPLIARQ--RYAAVVNG-TGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDY 78 (492)
Q Consensus 2 ~~l~~~~~~~--~~~~~~~g-~~~~~vygl~~C~~d~~~~~C~~Cl~~a~~~~~~~c~~~~~~~~~~~~~~~C~~ry~~~ 78 (492)
++|+++++.+ +|+++..| .++++||||+|||||+++++|+.||+.|+.+++++||++ +||+||++.|++|||++
T Consensus 30 ~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~~C~~~---~g~~i~~~~C~lRY~~~ 106 (108)
T 3a2e_A 30 ADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFSICNNA---IGARVQLVDCFIQYEQR 106 (108)
T ss_dssp HHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHHHTTSB---SSEEEEETTEEEEEESS
T ss_pred HHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHHHCCCC---ceEEEECCCEEEEEeCC
Confidence 4566666655 46666654 456999999999999999999999999999999999997 99999999999999999
Q ss_pred CC
Q 011153 79 DF 80 (492)
Q Consensus 79 ~f 80 (492)
+|
T Consensus 107 ~F 108 (108)
T 3a2e_A 107 SF 108 (108)
T ss_dssp CC
T ss_pred cC
Confidence 98
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1e-17 Score=165.13 Aligned_cols=141 Identities=15% Similarity=0.123 Sum_probs=98.2
Q ss_pred cccccCCcccccCcccEEEEEecCCCEEEEEEeccCCh--------------hhHHHHHHHHHHHhccCcCceeeeeeee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT--------------QWVDHFFNEVNLISGINHKNLVKLLGCS 334 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~~~~ 334 (492)
.-|++.++||+|+||.||+|...+|+.||||+++.... ........++++.....|+|+++++...
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34889999999999999999999999999998754210 0011122223333333344444433222
Q ss_pred ec------CCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC
Q 011153 335 IT------GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408 (492)
Q Consensus 335 ~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~ 408 (492)
.. ....+|||||+++++|.+.... .....++.||+.+|.|||+.+ ||||||||.|||+++++
T Consensus 175 v~vp~p~~~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 175 FPVPEPIAQSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEK 242 (397)
T ss_dssp CSCCCEEEEETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEE
T ss_pred CCCCeeeeccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCC
Confidence 11 1234799999999888654311 123467899999999999988 99999999999998776
Q ss_pred ----------cEEEeecCCcccc
Q 011153 409 ----------TAKIADFGLVRLF 421 (492)
Q Consensus 409 ----------~~kl~Dfgl~~~~ 421 (492)
.+.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3899999977543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.9e-12 Score=122.36 Aligned_cols=144 Identities=17% Similarity=0.061 Sum_probs=111.5
Q ss_pred HhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccC-cCceeeeeeeeecCCcceeEEe
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 345 (492)
.-..|+....++.|+.+.||+.... ++.+++|............+.+|+++++.+. +..+.+++++..+.+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3345777778888888999999865 6889999986532222346889999999884 6778899999888888999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES------------------------------------- 388 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~------------------------------------- 388 (492)
|++|.+|.+.+. +......++.+++++|+.||+..
T Consensus 91 ~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 91 EADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred ecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999876531 11123467889999999999811
Q ss_pred -------------------CCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 389 -------------------KLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 389 -------------------~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1459999999999999876666799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=2e-11 Score=114.87 Aligned_cols=129 Identities=19% Similarity=0.221 Sum_probs=97.9
Q ss_pred cccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCc--eeeeeeeeecCCcceeEEeecCCCCchhh
Q 011153 278 GQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN--LVKLLGCSITGPESLLVYEFVPNQSLLDN 355 (492)
Q Consensus 278 G~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 355 (492)
+.|..+.||+....+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+++.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 456669999998877888999987543 2346788999999886544 456888888777889999999998884
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------------
Q 011153 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES----------------------------------------------- 388 (492)
Q Consensus 356 l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~----------------------------------------------- 388 (492)
... .+ ...++.++++.|..||+..
T Consensus 104 ~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 104 SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 211 11 2356778888888888743
Q ss_pred --------CCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 389 --------KLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 389 --------~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.09 E-value=4.1e-10 Score=111.40 Aligned_cols=142 Identities=18% Similarity=0.245 Sum_probs=106.5
Q ss_pred cCCcccccCcccEEEEEecCCCEEEEEEec--cCC-hhhHHHHHHHHHHHhccC--cCceeeeeeeeecC---CcceeEE
Q 011153 273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLF--YNT-TQWVDHFFNEVNLISGIN--HKNLVKLLGCSITG---PESLLVY 344 (492)
Q Consensus 273 ~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 344 (492)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999998764 678888775 322 122456888999999886 45678888887766 3478999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES------------------------------------ 388 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~------------------------------------ 388 (492)
||+++..+.+.. ...++...+..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998775422 234678888899999999999999731
Q ss_pred -------------------CCCeEecCCCCCCeeeCCCCc--EEEeecCCccc
Q 011153 389 -------------------KLRIIHRDIKLSNILLDEEFT--AKIADFGLVRL 420 (492)
Q Consensus 389 -------------------~~~ivH~Dlk~~Nill~~~~~--~kl~Dfgl~~~ 420 (492)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.04 E-value=3.1e-10 Score=109.55 Aligned_cols=184 Identities=19% Similarity=0.178 Sum_probs=121.7
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhcc-CcCc--eeeeeeeeecCC---cceeEEeec
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKN--LVKLLGCSITGP---ESLLVYEFV 347 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~e~~ 347 (492)
.+.++.|....||+.. ..+++|+.... .....+.+|.++|+.+ .+.. +.+.+......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568899999999863 56888876432 3456788999999887 3332 344444443333 347899999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc----------------------------------------
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE---------------------------------------- 387 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~---------------------------------------- 387 (492)
+|.+|.+... ..++.+++..++.++++.|+.||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988865332 2366777788888888888888861
Q ss_pred ---------------CCCCeEecCCCCCCeeeCC--CCcEEEeecCCccccCCCCccccccccccccc---cchhhhcc-
Q 011153 388 ---------------SKLRIIHRDIKLSNILLDE--EFTAKIADFGLVRLFPEDITHISATLAGTLGY---MAPEYVVR- 446 (492)
Q Consensus 388 ---------------~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~- 446 (492)
..+.++|+|++|.||++++ +..+.|+||+.+..-..... .. ..... ..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l~----~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-FI----SLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-HH----TTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-HH----HHHhhccccCHHHHHHH
Confidence 1245899999999999988 55688999998764322100 00 00000 12222110
Q ss_pred ----CCC---------CcchhHHHHHHHHHHHHhCCCCCC
Q 011153 447 ----GKL---------TEKADVYSFGVVVIEVVCRKRINL 473 (492)
Q Consensus 447 ----~~~---------~~~sDv~slGvll~elltg~~p~~ 473 (492)
+.. ....+.|+++.+++++.+|+.++.
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 111 123689999999999999987753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=1.1e-06 Score=84.67 Aligned_cols=136 Identities=19% Similarity=0.179 Sum_probs=93.2
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcC---ceeeeeeeee-cCCcceeEEeecCC
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK---NLVKLLGCSI-TGPESLLVYEFVPN 349 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 349 (492)
.+.++.|....||+. ++.+++|+.. .......+.+|.++|+.+.+. .+.+.+.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 345788888899987 5678888753 233456788999999998642 3556666653 44567899999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc------------------------------------------
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE------------------------------------------ 387 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~------------------------------------------ 387 (492)
.++.+... ..++......++.++++.|+.||+.
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88865321 1133444445555555555555542
Q ss_pred ---------------CCCCeEecCCCCCCeeeCC---CCc-EEEeecCCccc
Q 011153 388 ---------------SKLRIIHRDIKLSNILLDE---EFT-AKIADFGLVRL 420 (492)
Q Consensus 388 ---------------~~~~ivH~Dlk~~Nill~~---~~~-~kl~Dfgl~~~ 420 (492)
..+.++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 455 48999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=7.2e-07 Score=87.79 Aligned_cols=81 Identities=10% Similarity=0.014 Sum_probs=55.8
Q ss_pred CCcc-cccCcccEEEEEec-------CCCEEEEEEeccCC---hhhHHHHHHHHHHHhccC-c--CceeeeeeeeecC--
Q 011153 274 SNKL-GQGGSGSVYKGTLP-------GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGIN-H--KNLVKLLGCSITG-- 337 (492)
Q Consensus 274 ~~~i-G~G~fG~Vy~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 337 (492)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88889999988754 25678888764332 101245778888888874 3 3466777776654
Q ss_pred -CcceeEEeecCCCCchh
Q 011153 338 -PESLLVYEFVPNQSLLD 354 (492)
Q Consensus 338 -~~~~lv~e~~~~gsL~~ 354 (492)
+..++|||++++..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=1.6e-06 Score=81.77 Aligned_cols=135 Identities=19% Similarity=0.160 Sum_probs=94.1
Q ss_pred cccccCcc-cEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccC-cCceeeeeeeeecCCcceeEEeecCCCCc
Q 011153 276 KLGQGGSG-SVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFVPNQSL 352 (492)
Q Consensus 276 ~iG~G~fG-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 352 (492)
.+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +-.+.++++++.+++..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34455555 58988754 4667889976432 3456788999888773 33467788888888899999999999887
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 011153 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES-------------------------------------------- 388 (492)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~-------------------------------------------- 388 (492)
.+..... ......+..+++..|+-||+..
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 6654211 1122345555666666666421
Q ss_pred -----------CCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 389 -----------KLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 389 -----------~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
.+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12389999999999999887778999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=6.1e-06 Score=82.42 Aligned_cols=75 Identities=12% Similarity=0.096 Sum_probs=49.6
Q ss_pred CCcccccCcccEEEEEec-CCCEEEEEEeccCCh-------hhHHHHHHHHHHHhccCc--Cc-eeeeeeeeecCCccee
Q 011153 274 SNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-------QWVDHFFNEVNLISGINH--KN-LVKLLGCSITGPESLL 342 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 342 (492)
.+.||.|..+.||++... +++.++||....... ...+.+..|.++++.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999764 468899998643211 123456788888887742 33 3445543 4556789
Q ss_pred EEeecCCC
Q 011153 343 VYEFVPNQ 350 (492)
Q Consensus 343 v~e~~~~g 350 (492)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.99 E-value=1.8e-05 Score=76.91 Aligned_cols=141 Identities=16% Similarity=0.188 Sum_probs=79.2
Q ss_pred CcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccC-----cCceeeee-e--eeecCCcceeEEee
Q 011153 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-----HKNLVKLL-G--CSITGPESLLVYEF 346 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e~ 346 (492)
+.|+.|..+.||+....++ .+++|+.... . ..+..|..+++.+. .|.++... | +....+..++++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677899999887655 4889988652 1 23334555554442 34443311 1 11245567899999
Q ss_pred cCCCCch--------------hhhhcc-CCC----------CCCCHHHH-------------------------------
Q 011153 347 VPNQSLL--------------DNLFVR-QDV----------EPLSWEVR------------------------------- 370 (492)
Q Consensus 347 ~~~gsL~--------------~~l~~~-~~~----------~~~~~~~~------------------------------- 370 (492)
+++..+. ..++.. ... ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986553 011110 000 01123211
Q ss_pred HHHHHHHHHHHHHHhh----------cCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 371 YKIILSTAEGLAYLHE----------ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 371 ~~i~~~i~~~l~yLH~----------~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
..+...+..++.+|++ .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223445666763 1235699999999999998888999999998753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.92 E-value=2.4e-05 Score=78.75 Aligned_cols=79 Identities=13% Similarity=0.128 Sum_probs=49.2
Q ss_pred CCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccccccc-cccccccchhhhccC---CCCcchhHHHHHHHHHH
Q 011153 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL-AGTLGYMAPEYVVRG---KLTEKADVYSFGVVVIE 464 (492)
Q Consensus 389 ~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~sDv~slGvll~e 464 (492)
...++|+|++|.|||++.++ ++|+||+.+..-.....- .... .-...|.+|+..... ......++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 35699999999999998876 999999987643211100 0000 012346666654321 11224566688888888
Q ss_pred HHhCC
Q 011153 465 VVCRK 469 (492)
Q Consensus 465 lltg~ 469 (492)
.+.++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.83 E-value=4.4e-05 Score=72.51 Aligned_cols=80 Identities=16% Similarity=0.173 Sum_probs=58.3
Q ss_pred cccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccC-c--CceeeeeeeeecCCcceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-H--KNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~e 345 (492)
......+.+|.|..+.||+.++.+|+.+.+|+...........|..|...|+.+. . -.+.+.++. +..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 3455567899999999999999999999999876554444456788999888773 2 124444443 24589999
Q ss_pred ecCCCCc
Q 011153 346 FVPNQSL 352 (492)
Q Consensus 346 ~~~~gsL 352 (492)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00022 Score=68.35 Aligned_cols=139 Identities=17% Similarity=0.133 Sum_probs=92.7
Q ss_pred cCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccC---cCceeeeeeeeecCCcceeEEeecCC
Q 011153 273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN---HKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 273 ~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
..+.|+.|....+|+.... ++.+++|+.... ....+..|...|+.+. ...+.+++.+....+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 3467899999999998864 678888977533 3556888999888873 35688888888877889999999998
Q ss_pred CCchh-----------hhhccCC---C----------------CCCCHHHHHH---HH----------------HHHHHH
Q 011153 350 QSLLD-----------NLFVRQD---V----------------EPLSWEVRYK---II----------------LSTAEG 380 (492)
Q Consensus 350 gsL~~-----------~l~~~~~---~----------------~~~~~~~~~~---i~----------------~~i~~~ 380 (492)
..+.. .++.... . -.-+|..... +. ..+..-
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76531 1122111 0 0124544321 11 111111
Q ss_pred H-HHHhh-cCCCCeEecCCCCCCeeeCCCCcEEEeecC
Q 011153 381 L-AYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFG 416 (492)
Q Consensus 381 l-~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg 416 (492)
+ ..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 23432 2357799999999999999887 8899984
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00031 Score=67.65 Aligned_cols=158 Identities=12% Similarity=0.128 Sum_probs=85.8
Q ss_pred cCHHHHHHHhccccc-----CCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCc--eeeee
Q 011153 259 FSYETLEKATNYFHE-----SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN--LVKLL 331 (492)
Q Consensus 259 ~~~~~l~~~~~~~~~-----~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 331 (492)
++.+++...-..|.. .+.|+.|....+|+....++ .+++|...... ..+.+..|+.++..+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344555555455544 23466788889999887655 57889876521 1224556777776664222 23333
Q ss_pred ee------eecCCcceeEEeecCCCCchh--------------hhhcc-CCC-----CCC---CHHHHHHH---------
Q 011153 332 GC------SITGPESLLVYEFVPNQSLLD--------------NLFVR-QDV-----EPL---SWEVRYKI--------- 373 (492)
Q Consensus 332 ~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~-~~~-----~~~---~~~~~~~i--------- 373 (492)
.. ....+..+++++|+++..+.. .++.. ... ... .|.....-
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 112345689999999866421 01111 000 001 12221110
Q ss_pred ---HHHHHHHHHHHhhc----CCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 374 ---ILSTAEGLAYLHEE----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 374 ---~~~i~~~l~yLH~~----~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
...+...++.+++. ....++|+|+++.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 01133445555532 23469999999999999887666899999875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00043 Score=66.02 Aligned_cols=71 Identities=11% Similarity=0.096 Sum_probs=44.7
Q ss_pred CCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCce-eeeeeeeecCCcceeEEeec-CCCC
Q 011153 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVYEFV-PNQS 351 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gs 351 (492)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+...++ .++++. +.+..++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 667888999999998 56888887643222 1123467777777643333 345543 344568999999 6655
Q ss_pred c
Q 011153 352 L 352 (492)
Q Consensus 352 L 352 (492)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00038 Score=70.04 Aligned_cols=73 Identities=21% Similarity=0.309 Sum_probs=49.7
Q ss_pred CCcccccCcccEEEEEecC--------CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCce-eeeeeeeecCCcceeEE
Q 011153 274 SNKLGQGGSGSVYKGTLPG--------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVY 344 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 344 (492)
.+.|+.|....+|+....+ ++.+++|+...... .+.+.+|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567888889999998653 47899998843211 1456689998888854344 556665532 3899
Q ss_pred eecCCCCc
Q 011153 345 EFVPNQSL 352 (492)
Q Consensus 345 e~~~~gsL 352 (492)
||+++.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.001 Score=65.56 Aligned_cols=142 Identities=18% Similarity=0.165 Sum_probs=83.6
Q ss_pred CCcccccCcccEEEEEec--------CCCEEEEEEeccCChhhHHHHHHHHHHHhccC-cCceeeeeeeeecCCcceeEE
Q 011153 274 SNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 344 (492)
.+.|..|-...+|+.... +++.+.+|+.-.. ......+.+|.++++.+. +.-..++++.+.+ .+|+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 345777888899998865 2468899986332 223456678999988874 3223556666543 2999
Q ss_pred eecCCCCchhhh-----------------hccC--CCCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 011153 345 EFVPNQSLLDNL-----------------FVRQ--DVEPLS--WEVRYKIILSTAE-------------------GLAYL 384 (492)
Q Consensus 345 e~~~~gsL~~~l-----------------~~~~--~~~~~~--~~~~~~i~~~i~~-------------------~l~yL 384 (492)
||+++..|...- +... -..+.. +.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 999986654210 1110 011222 4555555544321 22333
Q ss_pred h----hc-CCCCeEecCCCCCCeeeCCC----CcEEEeecCCccc
Q 011153 385 H----EE-SKLRIIHRDIKLSNILLDEE----FTAKIADFGLVRL 420 (492)
Q Consensus 385 H----~~-~~~~ivH~Dlk~~Nill~~~----~~~kl~Dfgl~~~ 420 (492)
. .. ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 21 23469999999999999876 7899999998763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0024 Score=61.41 Aligned_cols=141 Identities=12% Similarity=0.058 Sum_probs=79.7
Q ss_pred cccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCc--eeeeeee-----eecCCcceeEEeecC
Q 011153 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN--LVKLLGC-----SITGPESLLVYEFVP 348 (492)
Q Consensus 276 ~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~~~ 348 (492)
.++ |....||+....+|+.+++|....... ....+..|..++..+.... +.+++.. ...++..++++|+++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 466 778899998877777899998863311 2345667888777764222 3444443 112344578999998
Q ss_pred CCCchh----h----------hhcc-C-----CCCCCCHHHH----------------------HHHHHHHHHHHHHHhh
Q 011153 349 NQSLLD----N----------LFVR-Q-----DVEPLSWEVR----------------------YKIILSTAEGLAYLHE 386 (492)
Q Consensus 349 ~gsL~~----~----------l~~~-~-----~~~~~~~~~~----------------------~~i~~~i~~~l~yLH~ 386 (492)
+..+.. . ++.. . .....++... ...+..++..+.-+..
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 755431 0 1110 0 0111222211 1111122222221111
Q ss_pred -cCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 387 -ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 387 -~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
.....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234589999999999999 4 899999987753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0018 Score=62.66 Aligned_cols=33 Identities=27% Similarity=0.380 Sum_probs=27.9
Q ss_pred CCCeEecCCCCCCeeeCCC----CcEEEeecCCcccc
Q 011153 389 KLRIIHRDIKLSNILLDEE----FTAKIADFGLVRLF 421 (492)
Q Consensus 389 ~~~ivH~Dlk~~Nill~~~----~~~kl~Dfgl~~~~ 421 (492)
...++|+|+.+.|||++.+ ..+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3569999999999999875 68999999987643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0013 Score=66.65 Aligned_cols=74 Identities=14% Similarity=0.022 Sum_probs=47.3
Q ss_pred CCcccccCcccEEEEEecC-CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCce-eeeeeeeecCCcceeEEeecCCCC
Q 011153 274 SNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVYEFVPNQS 351 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs 351 (492)
.+.|+.|-...+|+....+ +..+++|+......... ...+|..++..+...++ .++++.+. + .+|+||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4567888889999998765 46788888744322211 12578888888854444 46666653 2 35999998755
Q ss_pred c
Q 011153 352 L 352 (492)
Q Consensus 352 L 352 (492)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0014 Score=64.38 Aligned_cols=74 Identities=11% Similarity=0.113 Sum_probs=44.6
Q ss_pred CCcccccCcccEEEEEecC---------CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCc-eeeeeeeeecCCcceeE
Q 011153 274 SNKLGQGGSGSVYKGTLPG---------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN-LVKLLGCSITGPESLLV 343 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 343 (492)
.+.|+.|....+|+....+ ++.+++|+....... ......|..+++.+...+ ..++++.. ..++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 3457778888999988654 267888877543222 122457888888775334 33555543 24789
Q ss_pred EeecCCCCc
Q 011153 344 YEFVPNQSL 352 (492)
Q Consensus 344 ~e~~~~gsL 352 (492)
+||+++..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.012 Score=57.02 Aligned_cols=32 Identities=31% Similarity=0.402 Sum_probs=28.1
Q ss_pred CCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 389 ~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35699999999999999888899999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.31 E-value=0.074 Score=52.99 Aligned_cols=141 Identities=13% Similarity=0.190 Sum_probs=83.8
Q ss_pred CCcccccCcccEEEEEecC--------CCEEEEEEeccCChhhHHHHHHHHHHHhccCcCc-eeeeeeeeecCCcceeEE
Q 011153 274 SNKLGQGGSGSVYKGTLPG--------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN-LVKLLGCSITGPESLLVY 344 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 344 (492)
.+.|..|-...+|+....+ ++.+++|+....... .-...+|..+++.+...+ ..++++.+ ..++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 3456778888999988753 578899886443322 122357888887774333 34455433 247899
Q ss_pred eecCCCCchhh-h----------------hc--------cC--CCCCCCHHHHHHHHHHH-------------------H
Q 011153 345 EFVPNQSLLDN-L----------------FV--------RQ--DVEPLSWEVRYKIILST-------------------A 378 (492)
Q Consensus 345 e~~~~gsL~~~-l----------------~~--------~~--~~~~~~~~~~~~i~~~i-------------------~ 378 (492)
||+++..|... + +. .. ...+.-+.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998665311 0 00 00 11122244444443322 1
Q ss_pred HHHHHHh---------------------hcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 379 EGLAYLH---------------------EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 379 ~~l~yLH---------------------~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
..+..|. ......++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2223332 112346899999999999 7788999999998763
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.92 E-value=0.21 Score=49.30 Aligned_cols=30 Identities=30% Similarity=0.386 Sum_probs=25.3
Q ss_pred CeEecCCCCCCeee------CCCCcEEEeecCCccc
Q 011153 391 RIIHRDIKLSNILL------DEEFTAKIADFGLVRL 420 (492)
Q Consensus 391 ~ivH~Dlk~~Nill------~~~~~~kl~Dfgl~~~ 420 (492)
.++|+|+.+.|||+ +++..+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567899999998763
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.85 E-value=0.17 Score=32.27 Aligned_cols=6 Identities=50% Similarity=1.259 Sum_probs=2.5
Q ss_pred HHHhhh
Q 011153 229 FFVRRK 234 (492)
Q Consensus 229 ~~~~r~ 234 (492)
++++||
T Consensus 33 ~~~RRr 38 (44)
T 2ks1_B 33 LFMRRR 38 (44)
T ss_dssp HHHHTT
T ss_pred HHhhhh
Confidence 344443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=89.95 E-value=0.11 Score=33.02 Aligned_cols=14 Identities=14% Similarity=0.308 Sum_probs=5.4
Q ss_pred HHHHHHHHHHHhhh
Q 011153 221 LLVFSLVAFFVRRK 234 (492)
Q Consensus 221 l~v~~l~~~~~~r~ 234 (492)
++++.++++++.||
T Consensus 24 ~vi~~l~~~~~~RR 37 (44)
T 2jwa_A 24 VVVLGVVFGILIKR 37 (44)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhheeh
Confidence 33333333433333
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=89.72 E-value=0.66 Score=41.24 Aligned_cols=106 Identities=15% Similarity=0.074 Sum_probs=66.7
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcccc
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 429 (492)
-+|.+.|... ..++++++++.++.|.+..|.-+-... .+ ..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 3677777543 467999999999999999887762211 01 1223456899999999988764 1110
Q ss_pred ccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 430 ~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
.....+.+||... ...+.+.=|||||+++|.-+-=..|...
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e 138 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE 138 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc
Confidence 0122456888642 3456788999999999998876666443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.33 E-value=0.32 Score=30.97 Aligned_cols=8 Identities=50% Similarity=0.912 Sum_probs=3.3
Q ss_pred HHHhhhhh
Q 011153 229 FFVRRKLL 236 (492)
Q Consensus 229 ~~~~r~~~ 236 (492)
++++||+.
T Consensus 32 ~~~RRRr~ 39 (44)
T 2l2t_A 32 VYVRRKSI 39 (44)
T ss_dssp HHHHTTCS
T ss_pred HHhhhhhh
Confidence 34444433
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.24 E-value=0.089 Score=53.13 Aligned_cols=61 Identities=7% Similarity=0.009 Sum_probs=18.1
Q ss_pred ccCCcccccCcccEEEEEecC-CCEEEE------EEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeee
Q 011153 272 HESNKLGQGGSGSVYKGTLPG-GEAVAV------KRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335 (492)
Q Consensus 272 ~~~~~iG~G~fG~Vy~~~~~~-~~~vav------K~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 335 (492)
...+.|| ||.||+|.+.. ..+||| |..+.. +.+....|.+|..+++.++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456676 99999998764 357888 766543 2333457889999999999999999988654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.37 E-value=2.5 Score=37.40 Aligned_cols=117 Identities=8% Similarity=0.026 Sum_probs=74.9
Q ss_pred CcCceeeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 011153 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI 402 (492)
Q Consensus 323 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Ni 402 (492)
.||++++. .+-.+++...+.++.-+ +...+- ....++...+++++.+|+.-..+++. -+|--|+|.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 57887766 35555555555555433 222221 12346788899999999887766654 47888999999
Q ss_pred eeCCCCcEEEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 403 LLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 403 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
+++.++.+++.-.|+-..+ +|. ..+...=.-.+=+++..++++|..|..
T Consensus 111 ~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp EECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999999877753321 111 112223334556777788888777653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.05 E-value=1.8 Score=38.38 Aligned_cols=83 Identities=6% Similarity=0.035 Sum_probs=56.5
Q ss_pred CcCceeeeeeeeecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCeEecCCCCCC
Q 011153 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA-YLHEESKLRIIHRDIKLSN 401 (492)
Q Consensus 323 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~-yLH~~~~~~ivH~Dlk~~N 401 (492)
.||++ -..+-.+++...+.++.-+++--...+ ..++...+++++.+|+.-.. +++. -+|--|+|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57777 333345556655655544332222222 23678889999988887666 5554 5788899999
Q ss_pred eeeCCCCcEEEeecCCc
Q 011153 402 ILLDEEFTAKIADFGLV 418 (492)
Q Consensus 402 ill~~~~~~kl~Dfgl~ 418 (492)
++++.++.++|.-.|+-
T Consensus 115 L~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVK 131 (219)
T ss_dssp EEECTTCCEEESCCEET
T ss_pred EEEeCCCcEEEEEcCCc
Confidence 99999999999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 492 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 9e-61
Identities = 65/200 (32%), Positives = 106/200 (53%), Gaps = 10/200 (5%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G+VYKG G AV + + T Q + F NEV ++ H N++ +G S
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
T P+ +V ++ SL +L + + I TA+G+ YLH +S IIH
Sbjct: 74 -TAPQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAPEYVV---RGKLT 450
RD+K +NI L E+ T KI DFGL + +H L+G++ +MAPE + + +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 451 EKADVYSFGVVVIEVVCRKR 470
++DVY+FG+V+ E++ +
Sbjct: 188 FQSDVYAFGIVLYELMTGQL 207
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-60
Identities = 50/209 (23%), Positives = 99/209 (47%), Gaps = 10/209 (4%)
Query: 264 LEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISG 321
+E + F + ++LG G G V+K + P G +A K + + + E+ ++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
N +V G + E + E + SL L + + ++ K+ ++ +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
YL K +I+HRD+K SNIL++ K+ DFG+ + + + + GT YM+P
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSP 172
Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
E + + ++D++S G+ ++E+ +
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-58
Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 6/215 (2%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
++G G G V+ G + VA+K + + F E ++ ++H LV+L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G + LV+EF+ + L D ++R + E + L EG+AYL E
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--- 120
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
+IHRD+ N L+ E K++DFG+ R +D S + + +PE + +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 451 EKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
K+DV+SFGV++ EV +I +++ +++ +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-57
Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 6/217 (2%)
Query: 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
+LG G G V+ G G VAVK L + D F E NL+ + H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
+L P ++ E++ N SL+D L + L+ + AEG+A++ E +
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERN 129
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK 448
IHRD++ +NIL+ + + KIADFGL RL ++ + + APE + G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 449 LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
T K+DV+SFG+++ E+V RI + ++Q +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-56
Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 6/228 (2%)
Query: 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNL 318
+ + E KLGQG G V+ GT G VA+K L T + F E +
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQV 65
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA 378
+ + H+ LV+L ++ +V E++ SLLD + + L + A
Sbjct: 66 MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIA 123
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY 438
G+AY+ ++ +HRD++ +NIL+ E K+ADFGL RL ++ + +
Sbjct: 124 SGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVI 486
APE + G+ T K+DV+SFG+++ E+ + R+ + +L V
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-55
Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 6/200 (3%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+LG G G V G G VA+K + + D F E ++ ++H+ LV+L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
G ++ E++ N LL+ L + + ++ E + YL +
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK--- 119
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
+ +HRD+ N L++++ K++DFGL R +D S + + PE ++ K +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 451 EKADVYSFGVVVIEVVCRKR 470
K+D+++FGV++ E+ +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGK 199
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (464), Expect = 2e-54
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 18/210 (8%)
Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGIN 323
F + ++G G G+VY + E VA+K++ + + EV + +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
H N ++ GC + + LV E+ + ++ PL + +GLAY
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAY 130
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
LH +IHRD+K NILL E K+ DFG + + + GT +MAPE
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEV 182
Query: 444 VV---RGKLTEKADVYSFGVVVIEVVCRKR 470
++ G+ K DV+S G+ IE+ RK
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 5e-54
Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 15/219 (6%)
Query: 261 YETLEKATN---YFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEV 316
YE + + N ++ +LG G G VYK A K + + + ++ + E+
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
++++ +H N+VKLL ++ EF ++ + + PL+ +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQ 118
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
T + L YLH+ +IIHRD+K NIL + K+ADFG+ I + GT
Sbjct: 119 TLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD-SFIGTP 174
Query: 437 GYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKR 470
+MAPE V+ KADV+S G+ +IE+ +
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (458), Expect = 1e-53
Identities = 60/245 (24%), Positives = 108/245 (44%), Gaps = 23/245 (9%)
Query: 259 FSYETLEKATNYFHES---------NKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNT 305
F++E +A F + +G G G V G L VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 306 T-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
T + F +E +++ +H N++ L G +++ EF+ N SL F+RQ+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ 124
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
+ ++ A G+ YL + +HRD+ NIL++ K++DFGL R +D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 425 ITHISATLA----GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCS 480
+ + T A + + APE + K T +DV+S+G+V+ EV+ + +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
Query: 481 ILQTV 485
++ +
Sbjct: 242 VINAI 246
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-53
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 12/216 (5%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G+G G V G G + VAVK + F E ++++ + H NLV+L
Sbjct: 9 LKLLQTIGKGEFGDVMLGDYRGNK-VAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 331 LGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
LG + L +V E++ SL+D L + L + K L E + YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 122
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
+HRD+ N+L+ E+ AK++DFGL + T + + APE + K
Sbjct: 123 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----TGKLPVKWTAPEALREKKF 177
Query: 450 TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
+ K+DV+SFG+++ E+ R+ ++ V
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 213
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (453), Expect = 5e-53
Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 6/212 (2%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNL 318
+Y+ E +KLG G G VY+G VAVK L +T + V+ F E +
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 66
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA 378
+ I H NLV+LLG P ++ EF+ +LLD L + + +S V + +
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQIS 125
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY 438
+ YL K IHRD+ N L+ E K+ADFGL RL D A + +
Sbjct: 126 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
APE + K + K+DV++FGV++ E+
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 5e-53
Identities = 60/204 (29%), Positives = 84/204 (41%), Gaps = 13/204 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKN 326
F LG+G G+VY +A+K L EV + S + H N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
+++L G L+ E+ P ++ L Q + + I A L+Y H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 124
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
R+IHRDIK N+LL KIADFG P TL GTL Y+ PE +
Sbjct: 125 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEG 178
Query: 447 GKLTEKADVYSFGVVVIEVVCRKR 470
EK D++S GV+ E + K
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKP 202
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-52
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 270 YFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKN 326
+ ++G+G +VYKG VA L T F E ++ G+ H N
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 327 LVKLLGCSITGPES----LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
+V+ + + +LV E + + +L L + + +V +GL
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQ 126
Query: 383 YLHEESKLRIIHRDIKLSNILL-DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
+LH + IIHRD+K NI + + KI D GL L + GT +MAP
Sbjct: 127 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAP 182
Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
E + K E DVY+FG+ ++E+ +
Sbjct: 183 E-MYEEKYDESVDVYAFGMCMLEMATSEY 210
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (451), Expect = 1e-52
Identities = 67/259 (25%), Positives = 106/259 (40%), Gaps = 32/259 (12%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWV- 309
LN +LE N +G+G G V++ PG VAVK L + +
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 310 DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF------------ 357
F E L++ ++ N+VKLLG G L++E++ L + L
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 358 ---------VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
PLS + I A G+AYL E + +HRD+ N L+ E
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENM 177
Query: 409 TAKIADFGLVR-LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
KIADFGL R ++ D A + +M PE + + T ++DV+++GVV+ E+
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 468 RKRINLFTQNSCSILQTVI 486
+ ++ V
Sbjct: 238 YGLQPYYGMAHEEVIYYVR 256
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-51
Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 10/213 (4%)
Query: 266 KATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGI 322
+A +Y +G G G K G+ + K L Y T +EVNL+ +
Sbjct: 2 RAEDY-EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 323 NHKNLVKLLGCSITGPESLL--VYEFVPNQSLLDNLF-VRQDVEPLSWEVRYKIILSTAE 379
H N+V+ I + L V E+ L + ++ + L E +++
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 380 GLAYLHEESK--LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
L H S ++HRD+K +N+ LD + K+ DFGL R+ D T + GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPY 179
Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
YM+PE + R EK+D++S G ++ E+
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 212
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 9e-51
Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 14/205 (6%)
Query: 273 ESNKLGQGGSGSVYKGTLPG---GEAVAVKRLFYNTTQ--WVDHFFNEVNLISGINHKNL 327
E +LG G G+V KG + VAVK L D E N++ +++ +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
V+++G +LV E L L + + + +++ + G+ YL E
Sbjct: 71 VRMIGI-CEAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES 126
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT--LAGTLGYMAPEYVV 445
+HRD+ N+LL + AKI+DFGL + D + A + + APE +
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 446 RGKLTEKADVYSFGVVVIEVVCRKR 470
K + K+DV+SFGV++ E +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQ 208
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-50
Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 10/220 (4%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
+ LG+G G V EAVAVK + ++ E+ + +NH+N+V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
K G G L E+ L D + + + G+ YLH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG-- 121
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEYVVRG 447
+ I HRDIK N+LLDE KI+DFGL +F + + + GTL Y+APE + R
Sbjct: 122 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 448 KL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVI 486
+ E DV+S G+V+ ++ + +SC
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 220
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 4e-50
Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 12/226 (5%)
Query: 266 KATNYFHESNKLGQGGSGSVYKGTL---PGGEAVAVKRLFYNTTQW-VDHFFNEVNLISG 321
K N +LG G GSV +G VA+K L T + + E ++
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
+++ +V+L+G +LV E L F+ E + +++ + G+
Sbjct: 66 LDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGM 122
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA--TLAGTLGYM 439
YL E++ +HRD+ N+LL AKI+DFGL + D ++ +A L +
Sbjct: 123 KYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
APE + K + ++DV+S+GV + E + + ++ +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 225
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-50
Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 9/197 (4%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
K+GQG SG+VY + G+ VA++++ + NE+ ++ + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
+ G E +V E++ SL D + + + + L +LH ++I
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
HRDIK NILL + + K+ DFG + + S T+ GT +MAPE V R K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEVVTRKAYGPKV 197
Query: 454 DVYSFGVVVIEVVCRKR 470
D++S G++ IE++ +
Sbjct: 198 DIWSLGIMAIEMIEGEP 214
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-49
Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 14/226 (6%)
Query: 270 YFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINH 324
H + +G+G G VY GTL AVK L T V F E ++ +H
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 325 KNLVKLLGCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
N++ LLG + S L+V ++ + L + F+R + + + L A+G+ +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE---DITHISATLAGTLGYMA 440
L + + +HRD+ N +LDE+FT K+ADFGL R + D H + +MA
Sbjct: 146 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVI 486
E + K T K+DV+SFGV++ E++ R N+ I ++
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 248
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-49
Identities = 65/236 (27%), Positives = 104/236 (44%), Gaps = 26/236 (11%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFF-NEVNLISGINHKNLVKLLGCS 334
+G+G G V++G G E VAVK ++ + F E+ + H+N++ +
Sbjct: 10 SIGKGRFGEVWRGKWRG-EEVAVKIF--SSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 335 I----TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE--- 387
T + LV ++ + SL D L + ++ E K+ LSTA GLA+LH E
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 388 --SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMAPE 442
K I HRD+K NIL+ + T IAD GL I GT YMAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 443 Y------VVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVILLTWNI 492
+ + ++AD+Y+ G+V E+ R I ++ ++ ++
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 8e-49
Identities = 58/231 (25%), Positives = 106/231 (45%), Gaps = 13/231 (5%)
Query: 263 TLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-----AVAVKRLFYNTTQW-VDHFFNEV 316
T E + +G G G VYKG L VA+K L T+ F E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
++ +H N+++L G +++ E++ N +L F+R+ S ++
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRG 118
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI--THISATLAG 434
A G+ YL + +HRD+ NIL++ K++DFGL R+ +D T+ ++
Sbjct: 119 IAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
+ + APE + K T +DV+SFG+V+ EV+ + ++ +++ +
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 226
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-48
Identities = 56/240 (23%), Positives = 97/240 (40%), Gaps = 32/240 (13%)
Query: 276 KLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGI-NHKNL 327
LG G G V T G VAVK L + +E+ +++ + +H+N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVR--------------------QDVEPLSW 367
V LLG L++E+ LL+ L + +D+ L++
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
E A+G+ +L + +HRD+ N+L+ KI DFGL R D +
Sbjct: 164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 428 -ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVI 486
+ + +MAPE + G T K+DV+S+G+++ E+ + +I
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-48
Identities = 66/225 (29%), Positives = 97/225 (43%), Gaps = 15/225 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPG----GEAVAVKRL---FYNTTQWVDHFFNEVNLISGIN 323
KLG G G V +G +VAVK L + + +D F EVN + ++
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
H+NL++L G +T P +V E P SLLD L Q + + AEG+ Y
Sbjct: 70 HRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGY 126
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT--LAGTLGYMAP 441
L + R IHRD+ N+LL KI DFGL+R P++ H + AP
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVI 486
E + + +D + FGV + E+ + N IL +
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 228
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 5e-48
Identities = 58/233 (24%), Positives = 97/233 (41%), Gaps = 23/233 (9%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGG---EAVAVKRL-FYNTTQWVDHFFNEVNLISGI-NHK 325
+ +G+G G V K + A+KR+ Y + F E+ ++ + +H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVE-------------PLSWEVRYK 372
N++ LLG L E+ P+ +LLD L + +E LS +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
A G+ YL + + IHRD+ NIL+ E + AKIADFGL R +
Sbjct: 132 FAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR- 187
Query: 433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
+ +MA E + T +DV+S+GV++ E+V + + +
Sbjct: 188 -LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 3e-47
Identities = 67/261 (25%), Positives = 108/261 (41%), Gaps = 28/261 (10%)
Query: 250 VAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFY 303
V ++ ++L + ++ E N LG G G V + T G VAVK L
Sbjct: 5 VYIDPTQLPYDHK-WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 63
Query: 304 NTTQW-VDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD 361
+ + +E+ ++S + NH N+V LLG G +L++ E+ LL+ L ++D
Sbjct: 64 SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 362 VE---------------PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406
L E A+G+A+L + IHRD+ NILL
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH 180
Query: 407 EFTAKIADFGLVRLFPEDITHISATLA-GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
KI DFGL R D ++ A + +MAPE + T ++DV+S+G+ + E+
Sbjct: 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
Query: 466 VCRKRINLFTQNSCSILQTVI 486
S +I
Sbjct: 241 FSLGSSPYPGMPVDSKFYKMI 261
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 4e-47
Identities = 48/205 (23%), Positives = 81/205 (39%), Gaps = 11/205 (5%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKN 326
F LG+G +V L A+K L V + E +++S ++H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
VKL + + N LL + + L YLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEYVV 445
IIHRD+K NILL+E+ +I DFG ++ PE + + GT Y++PE +
Sbjct: 127 ---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 446 RGKLTEKADVYSFGVVVIEVVCRKR 470
+ +D+++ G ++ ++V
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLP 208
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 164 bits (417), Expect = 4e-47
Identities = 45/198 (22%), Positives = 79/198 (39%), Gaps = 10/198 (5%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V++ T G A K + + E+ +S + H LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
E +++YEF+ L + + + +S + + + +GL ++HE +H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVH 147
Query: 395 RDIKLSNILL--DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
D+K NI+ K+ DFGL + T GT + APE +
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYY 205
Query: 453 ADVYSFGVVVIEVVCRKR 470
D++S GV+ ++
Sbjct: 206 TDMWSVGVLSYILLSGLS 223
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 7e-47
Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTT-QWVDHFFNEVNLISGINH 324
F + LG G G+VYKG +P GE VA+K L T+ + +E +++ +++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
++ +LLG +T L+ + +P LLD + +D + + + A+G+ YL
Sbjct: 71 PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYL 127
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
+ R++HRD+ N+L+ KI DFGL +L E+ + + + +MA E
Sbjct: 128 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 444 VVRGKLTEKADVYSFGVVVIEVVCRKR 470
++ T ++DV+S+GV V E++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS 211
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 8e-47
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 11/216 (5%)
Query: 276 KLGQGGSGSVYKGTLPG----GEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKL 330
+G+G G V++G AVA+K T+ V + F E + +H ++VKL
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
+G IT ++ E L F++ L + LAYL
Sbjct: 74 IGV-ITENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLES---K 127
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
R +HRDI N+L+ K+ DFGL R + + ++ + +MAPE + + T
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 451 EKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVI 486
+DV+ FGV + E++ + ++ +
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 223
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 157 bits (397), Expect = 3e-44
Identities = 48/198 (24%), Positives = 82/198 (41%), Gaps = 10/198 (5%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V++ G K + NE+++++ ++H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
E +L+ EF+ L D + + +S + EGL ++HE I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFD--RIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVH 150
Query: 395 RDIKLSNILLD--EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
DIK NI+ + + + KI DFGL D I T + APE V R +
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPVGFY 208
Query: 453 ADVYSFGVVVIEVVCRKR 470
D+++ GV+ ++
Sbjct: 209 TDMWAIGVLGYVLLSGLS 226
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-43
Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 18/231 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQW-VDHFFNEVNLISGIN 323
S +LGQG G VY+G G VA+K + + F NE +++ N
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD-------VEPLSWEVRYKIILS 376
++V+LLG G +L++ E + L L + + P S ++
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGT 435
A+G+AYL+ + +HRD+ N ++ E+FT KI DFG+ R E D
Sbjct: 142 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVI 486
+ +M+PE + G T +DV+SFGVV+ E+ ++ +L+ V+
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 152 bits (385), Expect = 2e-42
Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 17/209 (8%)
Query: 269 NYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRL---FYNTTQWVDHFFNEVNLIS---G 321
N F +G+GG G VY G+ A+K L Q NE ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
+ +V + T + + + + L +L S GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGL 120
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
++H +++RD+K +NILLDE +I+D GL F + H S GT GYMAP
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 174
Query: 442 EYVVRGK-LTEKADVYSFGVVVIEVVCRK 469
E + +G AD +S G ++ +++
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 150 bits (379), Expect = 5e-42
Identities = 50/204 (24%), Positives = 83/204 (40%), Gaps = 14/204 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKN 326
F LG G G V+ G A+K L + V+H +E ++S + H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
++++ G + ++ +++ L L Q + + L
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LALEY 119
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
II+RD+K NILLD+ KI DFG + P+ TL GT Y+APE V
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY----TLCGTPDYIAPEVVST 175
Query: 447 GKLTEKADVYSFGVVVIEVVCRKR 470
+ D +SFG+++ E++
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (378), Expect = 6e-42
Identities = 48/212 (22%), Positives = 89/212 (41%), Gaps = 7/212 (3%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW-VDHFFNEVNL 318
++ E + + + LG G V + VA+K + + NE+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA 378
+ I H N+V L +G L+ + V L D + + + ++I
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVL 117
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY 438
+ + YLH+ + + L LDE+ I+DFGL ++ ED + +T GT GY
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGY 175
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
+APE + + ++ D +S GV+ ++C
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-41
Identities = 40/198 (20%), Positives = 75/198 (37%), Gaps = 11/198 (5%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
LG+G G V++ + K + T E+++++ H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
+ E ++++EF+ + + + L+ + E L +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFE--RINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 395 RDIKLSNILLD--EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
DI+ NI+ T KI +FG R L Y APE ++
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 453 ADVYSFGVVVIEVVCRKR 470
D++S G +V ++
Sbjct: 184 TDMWSLGTLVYVLLSGIN 201
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 147 bits (371), Expect = 3e-41
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGIN 323
++ + LG GG V+ L VAVK L + F E + +N
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 324 HKNLVKLLGCSIT----GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
H +V + GP +V E+V +L D + P++ + ++I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQ 122
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI--SATLAGTLG 437
L + H+ IIHRD+K +NI++ K+ DFG+ R + + +A + GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
Y++PE + ++DVYS G V+ EV+ +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-41
Identities = 48/225 (21%), Positives = 91/225 (40%), Gaps = 10/225 (4%)
Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHK 325
+ + +G+G G V VA+K++ + + E+ ++ H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
N++ + + ++ + +L+ + LS + + GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA--TLAGTLGYMAPEY 443
++HRD+K SN+LL+ KI DFGL R+ D H T Y APE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 444 VVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVIL 487
++ K T+ D++S G ++ E++ + +F IL
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRP--IFPGKHYLDQLNHIL 226
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 7e-41
Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 27/220 (12%)
Query: 275 NKLGQGGSGSVYKGTLPG--------GEAVAVKRLFYNTTQW-VDHFFNEVNLISGI-NH 324
LG+G G V G VAVK L + T+ + +E+ ++ I H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVR-------------QDVEPLSWEVRY 371
KN++ LLG ++ E+ +L + L R E LS +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI-SA 430
A G+ YL + + IHRD+ N+L+ E+ KIADFGL R + +
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
+ +MAPE + T ++DV+SFGV++ E+
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 7e-40
Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 15/215 (6%)
Query: 266 KATNYFHESNKLGQGGSGSVYKGT--LPGGEAVAVKRLFYNTTQ--WVDHFFNEVNL--- 318
+A + ++G+G G V+K GG VA+KR+ T + EV +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLL---DNLFVRQDVEPLSWEVRYKIIL 375
+ H N+V+L + + + + + E ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
GL +LH R++HRD+K NIL+ K+ADFGL R++ + ++ T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT--SVVVT 178
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
L Y APE +++ D++S G + E+ RK
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 7e-40
Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVD-----HFFNEVNLISGINHKNLV 328
+ LG+G +VYK + VA+K++ E+ L+ ++H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
LL LV++F+ + ++ + L+ +L T +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK 448
I+HRD+K +N+LLDE K+ADFGL + F + T Y APE + +
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ-VVTRWYRAPELLFGAR 176
Query: 449 L-TEKADVYSFGVVVIEVVCRK 469
+ D+++ G ++ E++ R
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV 198
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 8e-40
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K RL T E++L+ +NH N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
VKLL T + LV+EF+ L + + + + +GLA+ H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
R++HRD+K N+L++ E K+ADFGL R F + + TL Y APE ++
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVVTLWYRAPEILLGC 177
Query: 448 K-LTEKADVYSFGVVVIEVVCRKR 470
K + D++S G + E+V R+
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-39
Identities = 58/219 (26%), Positives = 91/219 (41%), Gaps = 26/219 (11%)
Query: 275 NKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNL 327
LG+G G V + G VAVK L T +E+ ++ I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 328 VKLLG--CSITGPESLLVYEFVPNQSLLDNLFVRQDV-------------EPLSWEVRYK 372
V L C+ G +++ EF +L L +++ + L+ E
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI-SAT 431
A+G+ +L + IHRD+ NILL E+ KI DFGL R +D ++
Sbjct: 139 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 432 LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
L +MAPE + T ++DV+SFGV++ E+
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 141 bits (356), Expect = 3e-39
Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 25/216 (11%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTT---------QWVDHFFNEVNLIS 320
+ LG+G S V + P + AVK + + + EV+++
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 321 GIN-HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
++ H N+++L T LV++ + L D L + LS + KI+ + E
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLE 121
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
+ LH+ L I+HRD+K NILLD++ K+ DFG + GT Y+
Sbjct: 122 VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYL 176
Query: 440 APEYV------VRGKLTEKADVYSFGVVVIEVVCRK 469
APE + ++ D++S GV++ ++
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-38
Identities = 53/205 (25%), Positives = 84/205 (40%), Gaps = 12/205 (5%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLIS-GINHK 325
F LG+G G V+ + A+K L V+ E ++S H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
L + T V E++ L+ ++ Q GL +LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
I++RD+KL NILLD++ KIADFG+ + + T GT Y+APE ++
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN-TFCGTPDYIAPEILL 176
Query: 446 RGKLTEKADVYSFGVVVIEVVCRKR 470
K D +SFGV++ E++ +
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (349), Expect = 3e-38
Identities = 51/201 (25%), Positives = 84/201 (41%), Gaps = 8/201 (3%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLV 328
+H K+G+G G VYK GE A+K++ E++++ + H N+V
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
KL T +LV+E + L +L G+AY H+
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD-- 118
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK 448
R++HRD+K N+L++ E KIADFGL R F + + + + K
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 449 LTEKADVYSFGVVVIEVVCRK 469
+ D++S G + E+V
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGT 198
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-37
Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 18/209 (8%)
Query: 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+ ++ +G G G VY+ L GE VA+K++ Q E+ ++ ++H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 330 LLGCSITGPES------LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
L + E LV ++VP + + L + LAY
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 384 LHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
+H I HRDIK N+LLD + K+ DFG + ++ + + Y APE
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAPE 192
Query: 443 YVVRG-KLTEKADVYSFGVVVIEVVCRKR 470
+ T DV+S G V+ E++ +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-36
Identities = 48/211 (22%), Positives = 80/211 (37%), Gaps = 20/211 (9%)
Query: 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVN-LISGINHKN 326
+Y S LG G +G V + E A+K L Q EV +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPH 66
Query: 327 LVKLLGCSITGPES----LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
+V+++ L+V E + L + + + +I+ S E +
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFS-RIQDRGDQAFTEREASEIMKSIGEAIQ 125
Query: 383 YLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
YLH + I HRD+K N+L K+ DFG + + T T Y+
Sbjct: 126 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT--TPCYTPYYV 180
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
APE + K + D++S GV++ ++C
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 6e-36
Identities = 49/206 (23%), Positives = 81/206 (39%), Gaps = 19/206 (9%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLF------YNTTQWVDHFFNEVNLISGIN--HKN 326
LG GG GSVY G + VA+K + + EV L+ ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
+++LL +L+ E L + + L E+ E + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN 128
Query: 387 ESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
++HRDIK NIL+D K+ DFG L + + GT Y PE++
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRVYSPPEWIR 182
Query: 446 RGKL-TEKADVYSFGVVVIEVVCRKR 470
+ A V+S G+++ ++VC
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDI 208
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 6e-36
Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 22/222 (9%)
Query: 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL------FYNTTQWVDH 311
F E ++ +Y+ +LG G V K G A K + +
Sbjct: 3 FRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
EV+++ I H N++ L + +L+ E V L D L ++ L+ E
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEAT 116
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE----FTAKIADFGLVRLFPEDITH 427
+ + G+ YLH L+I H D+K NI+L + KI DFGL +
Sbjct: 117 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--N 171
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
+ GT ++APE V L +AD++S GV+ ++
Sbjct: 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 7e-36
Identities = 54/204 (26%), Positives = 76/204 (37%), Gaps = 11/204 (5%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKN 326
F LG+G G V G A+K L V H E ++ H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
L L T V E+ L +L + E L YLH
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHS 123
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
+++RDIKL N++LD++ KI DFGL + D T GT Y+APE +
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLED 179
Query: 447 GKLTEKADVYSFGVVVIEVVCRKR 470
D + GVV+ E++C +
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 132 bits (333), Expect = 9e-36
Identities = 44/206 (21%), Positives = 75/206 (36%), Gaps = 19/206 (9%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-C 333
K+G G G +Y GT + GE VA+K T E + + + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
G +++V E + F + S + + + Y+H I
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS---KNFI 125
Query: 394 HRDIKLSNIL---LDEEFTAKIADFGLVRLFPEDITHI------SATLAGTLGYMAPEYV 444
HRD+K N L + I DFGL + + + TH + L GT Y +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 445 VRGKLTEKADVYSFGVVVIEVVCRKR 470
+ + + + D+ S G V++
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSL 211
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (336), Expect = 1e-35
Identities = 52/242 (21%), Positives = 93/242 (38%), Gaps = 25/242 (10%)
Query: 233 RKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LP 291
++ L K +E + N ++L+ ++ ++ LG G G V
Sbjct: 16 KEFLAKAKEDFLKKWETPSQNTAQLD-QFDRIKT----------LGTGSFGRVMLVKHKE 64
Query: 292 GGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
G A+K L + ++H NE ++ +N LVKL +V E+V
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
+ +L S YLH L +I+RD+K N+L+D++
Sbjct: 125 GGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 409 TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCR 468
++ DFG + TL GT +APE ++ + D ++ GV++ E+
Sbjct: 179 YIQVTDFGFAKRVKGRTW----TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 469 KR 470
Sbjct: 235 YP 236
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-35
Identities = 49/225 (21%), Positives = 90/225 (40%), Gaps = 9/225 (4%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFY--NTTQWVDHFFNEVNLISGINHKNL 327
+ + K+G+G G+V+K E VA+KR+ + E+ L+ + HKN+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
V+L + + LV+EF D++ E+ + +GL + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCHSR 120
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
++HRD+K N+L++ K+A+FGL R F + SA +
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 448 KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVILLTWNI 492
+ D++S G + E+ R + L+ + L
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 130 bits (327), Expect = 6e-35
Identities = 35/207 (16%), Positives = 76/207 (36%), Gaps = 21/207 (10%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGC 333
++G+G G +++GT L + VA+K +E + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
G ++LV + + + S + + +HE ++
Sbjct: 70 GQEGLHNVLVIDLLGP---SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLV 123
Query: 394 HRDIKLSNILLDEEFT-----AKIADFGLVRLFPEDITHI------SATLAGTLGYMAPE 442
+RDIK N L+ + + DFG+V+ + + +T L+GT YM+
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRK 469
+ + + + D+ + G V + +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGS 210
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 5e-34
Identities = 51/232 (21%), Positives = 95/232 (40%), Gaps = 23/232 (9%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNL 327
+ + K+GQG G V+K G+ VA+K++ + E+ ++ + H+N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 328 VKLLGCSITGPES--------LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
V L+ T LV++F + V + +++
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLN 128
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTL 436
GL Y+H +I+HRD+K +N+L+ + K+ADFGL R F + TL
Sbjct: 129 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 437 GYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVIL 487
Y PE ++ + D++ G ++ E+ R + N+ +I
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP--IMQGNTEQHQLALIS 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-33
Identities = 54/241 (22%), Positives = 101/241 (41%), Gaps = 18/241 (7%)
Query: 256 KLNFSYETLEKAT----NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQW 308
+ F + + K + + +G G G+V G VA+K+L+ + + +
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVR-QDVEPLSW 367
+ E+ L+ + H+N++ LL +F + + E L
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE 120
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
+ ++ +GL Y+H IIHRD+K N+ ++E+ KI DFGL R ++T
Sbjct: 121 DRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT- 176
Query: 428 ISATLAGTLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVI 486
T Y APE ++ + T+ D++S G ++ E++ K LF + I
Sbjct: 177 ---GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT--LFKGSDHLDQLKEI 231
Query: 487 L 487
+
Sbjct: 232 M 232
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 7e-30
Identities = 56/207 (27%), Positives = 86/207 (41%), Gaps = 17/207 (8%)
Query: 275 NKLGQGGSGSVYKGTLPG----GEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHK- 325
LG G G V+ G+ A+K L + +H E ++ I
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
LV L T + L+ +++ L +L R+ + + L +LH
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLH 146
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
+ L II+RDIKL NILLD + DFGL + F D T + GT+ YMAP+ V
Sbjct: 147 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 446 RGK--LTEKADVYSFGVVVIEVVCRKR 470
G + D +S GV++ E++
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-28
Identities = 52/202 (25%), Positives = 81/202 (40%), Gaps = 8/202 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNL 327
+ +G G G V VA+K+L + + E+ L+ +NHKN+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
+ LL + L+D + L E ++ G+ +LH
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
IIHRD+K SNI++ + T KI DFGL R T Y APE ++
Sbjct: 139 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVILGM 193
Query: 448 KLTEKADVYSFGVVVIEVVCRK 469
E D++S G ++ E+V K
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHK 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 108 bits (271), Expect = 6e-27
Identities = 44/231 (19%), Positives = 87/231 (37%), Gaps = 23/231 (9%)
Query: 249 QVAVNKSKLNFSYETLEKATNY---FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN 304
V ++ + + YE+ + KLG+G V++ + E V VK L
Sbjct: 12 DVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--- 68
Query: 305 TTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESL--LVYEFVPNQSLLDNLFVRQD 361
E+ ++ + N++ L LV+E V N
Sbjct: 69 KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----- 123
Query: 362 VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRL 420
+ L+ + + L Y H + I+HRD+K N+++D E ++ D+GL
Sbjct: 124 -QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179
Query: 421 FPEDITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKR 470
+ + + + PE +V ++ D++S G ++ ++ RK
Sbjct: 180 YHPGQEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 9e-27
Identities = 54/225 (24%), Positives = 100/225 (44%), Gaps = 23/225 (10%)
Query: 254 KSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQWVD 310
+ +LN +T+ + + + +G G GSV G VAVK+L + +
Sbjct: 6 RQELN---KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 311 HFFNEVNLISGINHKNLVKLLGC-----SITGPESLLVYEFVPNQSLLDNLFVRQDVEPL 365
+ E+ L+ + H+N++ LL S+ + + + L + + L
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKL 118
Query: 366 SWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
+ + +I GL Y+H IIHRD+K SN+ ++E+ KI DFGL R +++
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175
Query: 426 THISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRK 469
T T Y APE ++ + D++S G ++ E++ +
Sbjct: 176 T----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 101 bits (252), Expect = 3e-24
Identities = 43/214 (20%), Positives = 77/214 (35%), Gaps = 27/214 (12%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
KLG G +V+ + VA+K + + + +E+ L+ +N + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 335 ITGPESLLVYEFVPNQSLL-------------DNLFVRQDVEPLSWEVRYKIILSTAEGL 381
LL + + + L + + + +I GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEE------FTAKIADFGLVRLFPEDITHISATLAGT 435
Y+H IIH DIK N+L++ KIAD G + E T+ T
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI----QT 192
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
Y +PE ++ AD++S ++ E++
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.2 bits (210), Expect = 8e-20
Identities = 30/202 (14%), Positives = 64/202 (31%), Gaps = 28/202 (13%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD----------HFFNEVNLISGINH 324
+G+G +V+ VK T + HF +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
+ L KL G ++ P+ +L L +++ + E +++ E +A
Sbjct: 66 RALQKLQGLAV--PKVYAWEGNA----VLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT--LAGTLGYMAPE 442
+ I+H D+ N+L+ E I DF ++ L + +
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV----EVGEEGWREILERDVRNIITY 171
Query: 443 YVVRGKLTEKADVYSFGVVVIE 464
+ + D+ S +++
Sbjct: 172 F--SRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 492 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.57 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.0 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.76 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.1 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.67 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.02 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=359.62 Aligned_cols=205 Identities=30% Similarity=0.421 Sum_probs=177.3
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
++|++.++||+|+||+||+++. .+++.||||++.... .+..+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5689999999999999999986 468999999997543 33456789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC-
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI- 425 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 425 (492)
+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999884 3346999999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccccchhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
........||+.|||||++.+..+ +.++|||||||++|||++|+.||....+..
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 213 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 213 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH
Confidence 223446789999999999988876 567999999999999999999997655443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=359.89 Aligned_cols=209 Identities=27% Similarity=0.424 Sum_probs=170.5
Q ss_pred cccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecC
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (492)
++|+..++||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5688899999999999999999888899999997643 335689999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 428 (492)
+|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.........
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999987543 356899999999999999999999988 9999999999999999999999999998776554444
Q ss_pred cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcHHH
Q 011153 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQ 483 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~~~~~~ 483 (492)
.....||+.|||||++.++.++.++|||||||++|||+|++.|+....+...+++
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~ 213 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 213 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 4456789999999999999999999999999999999997666554433333333
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=360.22 Aligned_cols=199 Identities=28% Similarity=0.436 Sum_probs=179.7
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
++|+..++||+|+||+||+++. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999985 568999999997766556778999999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 99999987743 35899999999999999999999998 99999999999999999999999999987754432
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
......||+.|||||++.++.++.++|||||||++|||++|+.||...
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 219 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC
Confidence 234567999999999999999999999999999999999999998653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-47 Score=364.07 Aligned_cols=209 Identities=31% Similarity=0.432 Sum_probs=183.9
Q ss_pred HHHHhcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 264 LEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 264 l~~~~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
++...++|++.++||+|+||+||+|++. +++.||||+++.+.. ..++|.+|+++|++++|||||++++++.+++..++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3444577899999999999999999875 588899999875543 45789999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
||||+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++...
T Consensus 91 v~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 91 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999988653 3456899999999999999999999988 9999999999999999999999999999876
Q ss_pred CCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
.+.........|++.|||||++.++.++.++|||||||++|||++|+.|+....+
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~ 221 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 221 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch
Confidence 6554444456789999999999999999999999999999999998888765443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=362.22 Aligned_cols=205 Identities=31% Similarity=0.479 Sum_probs=178.7
Q ss_pred HhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
..++|++.++||+|+||+||+|++++++.||||+++.... ..+.|.+|+++|++++|||||++++++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 3467889999999999999999998888999999975443 35679999999999999999999998754 567999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++|+|.+++.... ...+++..+++++.||++||+|||+++ |+||||||+||||++++.+||+|||+++.......
T Consensus 89 ~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc
Confidence 99999998774432 235899999999999999999999988 99999999999999999999999999998766544
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
.......||+.|||||++..+.++.++|||||||++|||+||+.|+....+
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~ 215 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC
Confidence 444566789999999999999999999999999999999998777655433
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=353.69 Aligned_cols=198 Identities=30% Similarity=0.407 Sum_probs=177.1
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.+.||+|+||+||+++.. +++.||+|++... .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999974 6889999998643 2344667899999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999988543 35899999999999999999999998 999999999999999999999999999866543
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 160 R---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp C---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred c---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 2 23567999999999999999999999999999999999999998643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=354.76 Aligned_cols=202 Identities=33% Similarity=0.499 Sum_probs=169.8
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.++|++.++||+|+||+||+|+.+ ..||||+++.. +.+..+.|.+|+++|++++|||||++++++. ++..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 467889999999999999999865 36999998654 4556778999999999999999999999875 457899999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+++|+|.+++... ...+++..++.++.||++||+|||+++ ||||||||+|||++.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999988543 345899999999999999999999988 9999999999999999999999999998765432
Q ss_pred c-cccccccccccccchhhhcc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 426 T-HISATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 426 ~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
. .......||+.|||||++.. +.++.++|||||||++|||+||+.||....+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 2 23345679999999999864 4589999999999999999999999876443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=356.74 Aligned_cols=202 Identities=27% Similarity=0.400 Sum_probs=178.6
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
+.|++.++||+|+||+||+|+. .+++.||||++........+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5689999999999999999986 468899999998777777788999999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 999999887543 345899999999999999999999998 9999999999999999999999999997653321 1
Q ss_pred ccccccccccccchhhhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 428 ISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
......||+.|||||++. ...++.++|||||||++|||++|+.||....
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~ 219 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC
Confidence 223567999999999984 4568899999999999999999999987543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=353.34 Aligned_cols=206 Identities=25% Similarity=0.378 Sum_probs=166.5
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeec--CCcceeE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPESLLV 343 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 343 (492)
++|++.+.||+|+||+||+++. .+|+.||||++... +....+.+.+|+++|++++|||||++++++.+ ++..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5699999999999999999986 56899999998654 34456778999999999999999999999865 4567899
Q ss_pred EeecCCCCchhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCCeeeCCCCcEEEeecCCccc
Q 011153 344 YEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEES--KLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 420 (492)
|||+++|+|.+++... .....+++..++.++.||+.||+|||+.+ ..+|+||||||+|||+++++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999988543 23456999999999999999999999864 23599999999999999999999999999987
Q ss_pred cCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
+..... ......||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~ 217 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC
Confidence 754332 234568999999999999999999999999999999999999998653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=364.72 Aligned_cols=200 Identities=25% Similarity=0.408 Sum_probs=177.5
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.++|++.++||+|+||+||+++. .+|+.||+|+++.. .....+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 56899999999999999999996 46889999999765 34445789999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
|+++|+|.+++... ..+++..+..++.||+.||.|||+. + |+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 99999999998643 3589999999999999999999974 7 999999999999999999999999999865432
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
...+.+||+.|||||++.+.+++.++||||+||+++||++|+.||....
T Consensus 159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2235689999999999999999999999999999999999999997644
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-46 Score=354.73 Aligned_cols=201 Identities=22% Similarity=0.313 Sum_probs=175.8
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.+.||+|+||+||+++. .+++.||||++... .....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5699999999999999999986 56899999998643 2344567999999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++|+|.+++... +.+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999887543 45899999999999999999999998 999999999999999999999999999877543
Q ss_pred C-ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 I-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ........||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 2 22334568999999999999999999999999999999999999999753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-45 Score=344.45 Aligned_cols=202 Identities=24% Similarity=0.370 Sum_probs=180.2
Q ss_pred cccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecC
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 348 (492)
++|+..++||+|+||+||+|+.++++.||||+++.... ..+.|++|+.++++++||||++++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57899999999999999999998888999999976543 35689999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc
Q 011153 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428 (492)
Q Consensus 349 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 428 (492)
+|+|.+++... ...+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99999887543 345889999999999999999999988 9999999999999999999999999998776554444
Q ss_pred cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 011153 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQ 476 (492)
Q Consensus 429 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~~ 476 (492)
.....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~ 206 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC
Confidence 445678999999999999999999999999999999998 788876543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=347.87 Aligned_cols=199 Identities=28% Similarity=0.374 Sum_probs=170.0
Q ss_pred cccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeec----CCcceeE
Q 011153 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPESLLV 343 (492)
Q Consensus 271 ~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 343 (492)
|+..++||+|+||+||+|+.. +++.||+|++... .....+.+.+|+++|++++|||||++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 456678999999999999865 6889999998654 34456779999999999999999999999865 3456899
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC-CCCcEEEeecCCccccC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFP 422 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgl~~~~~ 422 (492)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ ++|+||||||+|||++ +++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999988543 45899999999999999999999875 5699999999999996 57899999999998654
Q ss_pred CCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
.. ......||+.|||||++. ++++.++|||||||++|||++|+.||....+
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~ 217 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN 217 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred CC---ccCCcccCccccCHHHhC-CCCCCcCchhhHHHHHHHHHHCCCCCCCccc
Confidence 33 233568999999999875 5699999999999999999999999975443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-45 Score=353.35 Aligned_cols=202 Identities=27% Similarity=0.417 Sum_probs=163.4
Q ss_pred cccccCCcccccCcccEEEEEecC-CC---EEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPG-GE---AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~---~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
.+|++.++||+|+||+||+|+... ++ .||||++... .....+.|.+|+++|++++|||||++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 446677899999999999998642 32 5899988654 445567899999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999987753 3346899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCccc----cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 424 DITHI----SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 424 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
..... .....||+.|||||.+.++.++.++|||||||++|||+| |+.||...
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 33221 113457899999999999999999999999999999998 78888643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=349.53 Aligned_cols=211 Identities=29% Similarity=0.441 Sum_probs=174.8
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
.++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.+|++++|||||++++++. ++..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 36799999999999999999999888899999996543 33578999999999999999999999985 45689999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++|+|..++.... ...++|..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++........
T Consensus 94 ~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999988875432 235899999999999999999999998 999999999999999999999999999877655444
Q ss_pred ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcHHHH
Q 011153 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQT 484 (492)
Q Consensus 428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~~~~~~~ 484 (492)
......||+.|+|||++..+.++.++||||||+++|||++|+.|+........++..
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~ 226 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 226 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 444567899999999999999999999999999999999988887765544444443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-45 Score=347.89 Aligned_cols=204 Identities=26% Similarity=0.414 Sum_probs=168.4
Q ss_pred cccccCCcccccCcccEEEEEecCC-----CEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGG-----EAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
..|+..++||+|+||+||+|.+.+. ..||||++... .......|.+|+++|++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5688899999999999999986532 36999999754 34445679999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
||||+.++++.+.+... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999998876433 346899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCcc--ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 423 EDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 423 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
..... ......||+.|||||++.++.++.++|||||||++|||++++.|+....+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~ 218 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 218 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC
Confidence 43222 22245689999999999999999999999999999999998877765443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-45 Score=346.65 Aligned_cols=202 Identities=25% Similarity=0.373 Sum_probs=172.8
Q ss_pred cccccCC-cccccCcccEEEEEec---CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeE
Q 011153 269 NYFHESN-KLGQGGSGSVYKGTLP---GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 269 ~~~~~~~-~iG~G~fG~Vy~~~~~---~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 343 (492)
+++...+ +||+|+||+||+|... ++..||||+++.. .....+.|.+|+++|++++|||||++++++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 4999999999999764 3447999999765 34456789999999999999999999999865 568999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++|+|.+++.. ....+++..+++++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998743 3346899999999999999999999988 99999999999999999999999999987755
Q ss_pred CCccc--cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 011153 424 DITHI--SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQ 476 (492)
Q Consensus 424 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~~ 476 (492)
..... .....||+.|||||++..+.++.++|||||||++|||+| |+.||....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 43222 234568999999999999999999999999999999998 899987543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-44 Score=355.25 Aligned_cols=201 Identities=22% Similarity=0.298 Sum_probs=180.2
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
-++|++.++||+|+||+||+++. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999986 56899999999877766678899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC--CCCcEEEeecCCccccCCC
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD--EEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~Dfgl~~~~~~~ 424 (492)
+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999988843 3346999999999999999999999998 99999999999995 4678999999999876554
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.. .....||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 180 ~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 228 (350)
T d1koaa2 180 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 228 (350)
T ss_dssp SC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence 32 33567999999999999999999999999999999999999998643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=353.26 Aligned_cols=209 Identities=26% Similarity=0.400 Sum_probs=175.6
Q ss_pred HhcccccCCcccccCcccEEEEEecC-C-----CEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCC
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTLPG-G-----EAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGP 338 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~~~-~-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 338 (492)
..++|++.++||+|+||+||+|+... + ..||||++... .......+.+|+.+|.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 34678999999999999999998643 2 26999998654 344556789999999998 8999999999999999
Q ss_pred cceeEEeecCCCCchhhhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQD--------------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK 398 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk 398 (492)
..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 99999999999999999865432 245899999999999999999999988 9999999
Q ss_pred CCCeeeCCCCcEEEeecCCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 011153 399 LSNILLDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQ 476 (492)
Q Consensus 399 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~~ 476 (492)
|+|||++.++.+||+|||+++........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876544332 2335668999999999999999999999999999999998 788886544
Q ss_pred CC
Q 011153 477 NS 478 (492)
Q Consensus 477 ~~ 478 (492)
..
T Consensus 272 ~~ 273 (325)
T d1rjba_ 272 VD 273 (325)
T ss_dssp CS
T ss_pred HH
Confidence 33
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-45 Score=351.79 Aligned_cols=196 Identities=30% Similarity=0.470 Sum_probs=172.5
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC---hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
..|+..+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4589999999999999999985 568889999987543 344567899999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 99999988765533 245899999999999999999999998 999999999999999999999999999865432
Q ss_pred Cccccccccccccccchhhhcc---CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....||+.|||||++.+ +.++.++|||||||++|||++|+.||...
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~ 217 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC
Confidence 34579999999999864 56899999999999999999999998653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-44 Score=350.10 Aligned_cols=200 Identities=25% Similarity=0.365 Sum_probs=161.1
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
.+.|++.++||+|+||+||+++.. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 466999999999999999999864 68999999997543 2334568899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC---CCCcEEEeecCCccccC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFP 422 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgl~~~~~ 422 (492)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999853 346999999999999999999999998 99999999999994 57899999999998664
Q ss_pred CCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
... ......||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 212 (307)
T d1a06a_ 162 PGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence 432 233567999999999999999999999999999999999999998653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.5e-44 Score=352.78 Aligned_cols=200 Identities=25% Similarity=0.319 Sum_probs=179.6
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeec
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 347 (492)
++|++.++||+|+||+||+++. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5699999999999999999986 579999999998776666678899999999999999999999999999999999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC--CCCcEEEeecCCccccCCCC
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD--EEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~Dfgl~~~~~~~~ 425 (492)
++|+|.+.+.. ....+++..+..++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+++.+....
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999887632 3446999999999999999999999998 99999999999997 67899999999998776543
Q ss_pred ccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
......||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 231 (352)
T d1koba_ 184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 231 (352)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 234567899999999999999999999999999999999999999643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=353.00 Aligned_cols=201 Identities=27% Similarity=0.313 Sum_probs=179.3
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.+.||+|+||+||+++. .+++.||||++.+. .....+.+.+|+.+|++++||||+++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999986 57999999999653 2344677899999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999988543 35889999999999999999999998 999999999999999999999999999865443
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
.. .....+||+.|||||++.+..++.++|||||||++|||++|++||....
T Consensus 159 ~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence 22 2345789999999999999999999999999999999999999997643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-44 Score=349.25 Aligned_cols=197 Identities=27% Similarity=0.372 Sum_probs=176.5
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.++||+|+||+||+++. .+|+.||||+++.. .....+.+.+|+.+|+.++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5689999999999999999996 56899999999653 2344678999999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+++|+|...+... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999998887543 34788889999999999999999998 999999999999999999999999999876543
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ....||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 204 (316)
T d1fota_ 158 T----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 204 (316)
T ss_dssp B----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred c----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc
Confidence 2 3568999999999999999999999999999999999999999654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=344.07 Aligned_cols=194 Identities=27% Similarity=0.378 Sum_probs=165.1
Q ss_pred CcccccCcccEEEEEecC---CCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEeecCC
Q 011153 275 NKLGQGGSGSVYKGTLPG---GEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349 (492)
Q Consensus 275 ~~iG~G~fG~Vy~~~~~~---~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 349 (492)
++||+|+||+||+|.+.+ ++.||||+++.. +....+.|.+|+++|++++|||||++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998643 457999999653 33446789999999999999999999999864 567899999999
Q ss_pred CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCccc-
Q 011153 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI- 428 (492)
Q Consensus 350 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~- 428 (492)
|+|.+++... ..+++..+++++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 9999988543 45899999999999999999999988 9999999999999999999999999998765443322
Q ss_pred -cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 429 -SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 429 -~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
.....||+.|||||.+..+.++.++|||||||++|||+| |+.||...
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~ 214 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC
Confidence 234578999999999999999999999999999999998 88888653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=341.35 Aligned_cols=200 Identities=27% Similarity=0.331 Sum_probs=177.2
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC------hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT------TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 340 (492)
.++|++.+.||+|+||+||+++. .+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999996 578999999986432 22357899999999999999999999999999999
Q ss_pred eeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC----cEEEeecC
Q 011153 341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFG 416 (492)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfg 416 (492)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999988543 35899999999999999999999998 99999999999998776 59999999
Q ss_pred CccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
+++...... ......||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 219 (293)
T d1jksa_ 163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219 (293)
T ss_dssp TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence 998765432 233567899999999999999999999999999999999999999754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-44 Score=346.81 Aligned_cols=210 Identities=30% Similarity=0.430 Sum_probs=178.9
Q ss_pred HHHHHHhcccccCCcccccCcccEEEEEec------CCCEEEEEEeccCC-hhhHHHHHHHHHHHhccCcCceeeeeeee
Q 011153 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCS 334 (492)
Q Consensus 262 ~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 334 (492)
.+++.+.++|++.+.||+|+||+||+|+.. +++.||||+++... .+..++|.+|+++|++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 344556788999999999999999999864 35689999997653 34467799999999999999999999999
Q ss_pred ecCCcceeEEeecCCCCchhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 011153 335 ITGPESLLVYEFVPNQSLLDNLFVRQD---------------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393 (492)
Q Consensus 335 ~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iv 393 (492)
.+.+..++|+||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ +|
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 999999999999999999999864321 235899999999999999999999988 99
Q ss_pred ecCCCCCCeeeCCCCcEEEeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 011153 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRIN 472 (492)
Q Consensus 394 H~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~ 472 (492)
||||||+|||++.++.+||+|||+++...+... .......+++.|+|||.+.+..++.++|||||||++|||++|..|+
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999999999999999999999999986644322 2233567899999999999999999999999999999999997654
Q ss_pred CC
Q 011153 473 LF 474 (492)
Q Consensus 473 ~~ 474 (492)
..
T Consensus 243 ~~ 244 (301)
T d1lufa_ 243 YY 244 (301)
T ss_dssp TT
T ss_pred CC
Confidence 43
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-43 Score=348.35 Aligned_cols=197 Identities=24% Similarity=0.310 Sum_probs=177.5
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 344 (492)
++|++.++||+|+||+||+++. .+|+.||||++... .....+.+.+|+++|+.++|||||++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999986 47999999998643 2344567899999999999999999999999999999999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 424 (492)
||+.+|+|.+.+... ..+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999988544 35899999999999999999999998 999999999999999999999999999876543
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ....||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 195 ~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 195 T----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp B----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence 2 3467999999999999999999999999999999999999999643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.8e-43 Score=344.88 Aligned_cols=201 Identities=24% Similarity=0.263 Sum_probs=172.2
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccCC---hhhHHHHH---HHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFF---NEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
++|++.++||+|+||+||+++.. +|+.||||++.... ......+. +|+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999864 68999999985431 12222333 4577788889999999999999999999
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999988543 45789999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
.... .....||+.|||||++.. ..++.++|||||||+||||++|+.||......
T Consensus 158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 212 (364)
T d1omwa3 158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212 (364)
T ss_dssp SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred CCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH
Confidence 5432 235679999999999975 46899999999999999999999999765433
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-43 Score=333.57 Aligned_cols=203 Identities=24% Similarity=0.327 Sum_probs=162.3
Q ss_pred hcccccCCcccccCcccEEEEEecC----CCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
.++|++.+.||+|+||+||+|+... +..||||+++.. .....+.|.+|+++|++++|||||++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4678999999999999999998643 346899988654 3444677999999999999999999999985 567899
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
||||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 v~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 99999999998876443 346899999999999999999999998 9999999999999999999999999998776
Q ss_pred CCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 011153 423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQ 476 (492)
Q Consensus 423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~~ 476 (492)
...........||+.|+|||.+..+.++.++|||||||++|||++ |++|+....
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence 544444455678999999999999999999999999999999998 677776543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.1e-43 Score=335.92 Aligned_cols=202 Identities=25% Similarity=0.384 Sum_probs=168.9
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCc----
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE---- 339 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 339 (492)
.++|++.+.||+|+||+||+++. .+++.||||+++.. +.+..+.+.+|+++++.++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999985 57889999999754 33445679999999999999999999999886553
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
.++||||+++++|.+.+... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++..+|+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 68999999999999887543 35899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCc--cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 420 LFPEDIT--HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 420 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
....... .......||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 217 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 217 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc
Confidence 6543322 2234567999999999999999999999999999999999999998653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-43 Score=339.13 Aligned_cols=200 Identities=26% Similarity=0.344 Sum_probs=175.0
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC---ChhhHHHHHHHHHHHh-ccCcCceeeeeeeeecCCcceeE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLIS-GINHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 343 (492)
++|++.++||+|+||+||+|+.. +++.||||+++.. .....+.+.+|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 56899999999999999999864 6889999999653 2334566777777665 68999999999999999999999
Q ss_pred EeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCC
Q 011153 344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 423 (492)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999998543 34789999999999999999999998 99999999999999999999999999986554
Q ss_pred CCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~ 206 (320)
T d1xjda_ 156 GDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 206 (320)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC
Confidence 322 233567999999999999999999999999999999999999999654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=337.44 Aligned_cols=201 Identities=26% Similarity=0.429 Sum_probs=167.1
Q ss_pred cccccCCcccccCcccEEEEEec-CCC----EEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCccee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGE----AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 342 (492)
.+|++.++||+|+||+||+|... +|+ +||+|+++.. +.+..+.|.+|++++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35899999999999999999864 444 5899988654 445577899999999999999999999999764 5678
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccC
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 422 (492)
++|++.+++|.+.+... ...+++..+++++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999998877543 456899999999999999999999988 9999999999999999999999999998775
Q ss_pred CCCccc-cccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 423 EDITHI-SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 423 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
...... .....||+.|||||++.++.++.++|||||||++|||+| |+.|+...
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~ 217 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 443322 234568999999999999999999999999999999999 66776543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.1e-42 Score=329.08 Aligned_cols=200 Identities=26% Similarity=0.373 Sum_probs=175.4
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCCh---------hhHHHHHHHHHHHhccC-cCceeeeeeeeecC
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT---------QWVDHFFNEVNLISGIN-HKNLVKLLGCSITG 337 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 337 (492)
++|++.+.||+|+||+||+++. .+++.||||++..... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5789999999999999999986 5788999999865421 22346889999999997 99999999999999
Q ss_pred CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCC
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl 417 (492)
+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 9999999999999999999543 45899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccchhhhcc------CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 418 VRLFPEDITHISATLAGTLGYMAPEYVVR------GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 418 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
++.+.... ......||+.|+|||.+.. ..++.++||||+||+++||++|+.||....
T Consensus 157 a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 157 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 98775532 2345679999999999863 346889999999999999999999997543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=333.88 Aligned_cols=211 Identities=28% Similarity=0.342 Sum_probs=167.3
Q ss_pred HHHHHHhcccccCCcccccCcccEEEEEec------CCCEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CcCceeeeeee
Q 011153 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGC 333 (492)
Q Consensus 262 ~~l~~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 333 (492)
..++...++|++.++||+|+||+||+|+.. +++.||||+++.. .....+.+.+|...+.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 333344578999999999999999999853 2457999999754 344566788888888777 68999999998
Q ss_pred eecC-CcceeEEeecCCCCchhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 011153 334 SITG-PESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKL 399 (492)
Q Consensus 334 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~ 399 (492)
+.+. ...++||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ |+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 7765 467899999999999999865321 345899999999999999999999988 99999999
Q ss_pred CCeeeCCCCcEEEeecCCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCC-CCCCC
Q 011153 400 SNILLDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR-INLFT 475 (492)
Q Consensus 400 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~-p~~~~ 475 (492)
+||||++++.+||+|||+++........ ......||+.|||||++.++.++.++|||||||++|||++|.. |+...
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999876543322 2335679999999999999999999999999999999999865 45433
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-42 Score=334.50 Aligned_cols=201 Identities=20% Similarity=0.263 Sum_probs=176.6
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
.++|++.+.||+|+||+||++... +++.||||+++....+ ...+.+|+++|+.++|||||++++++.+++..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 367899999999999999999864 6889999999765433 45688999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC--CcEEEeecCCccccCCC
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE--FTAKIADFGLVRLFPED 424 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~Dfgl~~~~~~~ 424 (492)
+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999998843 2346899999999999999999999998 9999999999999854 58999999999876543
Q ss_pred CccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
. ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 158 ~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~ 207 (321)
T d1tkia_ 158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred C--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC
Confidence 2 2335678999999999999999999999999999999999999997644
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=328.37 Aligned_cols=197 Identities=28% Similarity=0.434 Sum_probs=162.9
Q ss_pred hcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecC-CcceeEEee
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-PESLLVYEF 346 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 346 (492)
.++|+..++||+|+||.||+|+++ |..||||+++.+. ..+.|.+|++++++++||||++++|++.++ +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 356788899999999999999985 7789999996543 456799999999999999999999988654 567999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+++|+|.+++.... ...+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~- 157 (262)
T d1byga_ 83 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 157 (262)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC-
Confidence 99999999986432 234899999999999999999999987 9999999999999999999999999998654322
Q ss_pred cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~~ 475 (492)
....+|+.|+|||++.++.++.++||||||+++|||+| |+.|+...
T Consensus 158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~ 204 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC
Confidence 23467889999999999999999999999999999999 56555443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-42 Score=331.12 Aligned_cols=206 Identities=29% Similarity=0.403 Sum_probs=170.7
Q ss_pred CCcccccCcccEEEEEecCC----CEEEEEEecc-CChhhHHHHHHHHHHHhccCcCceeeeeeeeec-CCcceeEEeec
Q 011153 274 SNKLGQGGSGSVYKGTLPGG----EAVAVKRLFY-NTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT-GPESLLVYEFV 347 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~----~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 347 (492)
.++||+|+||+||+|++.++ ..||||+++. .+....++|.+|+++|++++||||++++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 56899999999999987532 2589999975 355567889999999999999999999999875 45789999999
Q ss_pred CCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCcc
Q 011153 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427 (492)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 427 (492)
++++|.+++.. ....+++..+++++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998754 3345788899999999999999999988 999999999999999999999999999876543222
Q ss_pred ---ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcHHHH
Q 011153 428 ---ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQT 484 (492)
Q Consensus 428 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~~~~~~~ 484 (492)
......||+.|+|||.+..+.++.++||||||+++|||++|+.||....+..++...
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~ 246 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 246 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHH
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence 223457899999999999999999999999999999999999888765443333333
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=328.78 Aligned_cols=200 Identities=31% Similarity=0.490 Sum_probs=162.6
Q ss_pred cccccCCcccccCcccEEEEEec--CCC--EEEEEEeccC---ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcce
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP--GGE--AVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL 341 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~--~~~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 341 (492)
++|++.+.||+|+||+||+|+.. +++ .||||++... ..+..+.|.+|+++|++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56899999999999999999853 233 6899988653 34456789999999999999999999999965 5678
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
+||||+++++|.+.+... ...+++..+++++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999877543 245899999999999999999999988 999999999999999999999999999977
Q ss_pred CCCCcc--ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 422 PEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 422 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
...... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~ 217 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 217 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC
Confidence 544322 2234567889999999999999999999999999999998 7888753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-42 Score=330.98 Aligned_cols=196 Identities=27% Similarity=0.350 Sum_probs=165.4
Q ss_pred cCCcccccCcccEEEEEe-cCCCEEEEEEeccCChh-----hHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 273 ESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQ-----WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 273 ~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
.+++||+|+||+||+++. .+|+.||||+++..... ..+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999996 46899999998654321 234688999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
++++++.... .....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9887776554 33456888999999999999999999998 99999999999999999999999999987655432
Q ss_pred cccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. .....||+.|||||++... .++.++|||||||++|||++|+.||...
T Consensus 156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 156 A-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp C-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 2 2345789999999998754 5799999999999999999999988654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-42 Score=333.29 Aligned_cols=201 Identities=29% Similarity=0.408 Sum_probs=169.5
Q ss_pred cccccCCcccccCcccEEEEEecC-CC--EEEEEEeccC-ChhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCCcceeE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPG-GE--AVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV 343 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 343 (492)
++|++.++||+|+||+||+|++.+ +. .||||++... ..+..+.|.+|+++|.++ +|||||++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 568889999999999999998754 43 4788888543 444566899999999999 799999999999999999999
Q ss_pred EeecCCCCchhhhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcE
Q 011153 344 YEFVPNQSLLDNLFVR-------------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (492)
Q Consensus 344 ~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ 410 (492)
|||+++|+|.++++.. .....+++..+.+++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998643 23467999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 411 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
||+|||+++....... .....||..|+|||.+.++.++.++|||||||++|||++|..|+..
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~ 228 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence 9999999986543222 2244689999999999999999999999999999999998765443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=329.72 Aligned_cols=210 Identities=29% Similarity=0.379 Sum_probs=179.6
Q ss_pred HhcccccCCcccccCcccEEEEEe------cCCCEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CcCceeeeeeeeecCC
Q 011153 267 ATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGP 338 (492)
Q Consensus 267 ~~~~~~~~~~iG~G~fG~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 338 (492)
..++|++.++||+|+||.||+|++ .+++.||||+++... ......|.+|+.+++++ +|||||++++++.+++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 356788999999999999999975 245689999997653 34556799999999999 6999999999999999
Q ss_pred cceeEEeecCCCCchhhhhccC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQ---------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL 403 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nil 403 (492)
..++||||+++|+|.+++.... ....+++..+++++.||++||+|||+++ ++||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 9999999999999999986543 2346899999999999999999999998 999999999999
Q ss_pred eCCCCcEEEeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 404 LDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 404 l~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
++.++.+||+|||+++....... .......||+.|+|||.+.++.++.++||||||+++|||+|++.|+....+..
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999987765433 23345678999999999999999999999999999999999666655444433
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=329.42 Aligned_cols=207 Identities=29% Similarity=0.416 Sum_probs=177.5
Q ss_pred HHHhcccccCCcccccCcccEEEEEec------CCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC
Q 011153 265 EKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG 337 (492)
Q Consensus 265 ~~~~~~~~~~~~iG~G~fG~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 337 (492)
+...++|+..++||+|+||+||+|.+. ++..||||+++.. ..+....|.+|++++++++||||+++++++..+
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 334578899999999999999999763 3568999999754 344456789999999999999999999999999
Q ss_pred CcceeEEeecCCCCchhhhhcc-------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcE
Q 011153 338 PESLLVYEFVPNQSLLDNLFVR-------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~ 410 (492)
+..++||||+++|+|.+++... .....+++..+.+++.|+++||.|||+++ |+||||||+|||+++++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceE
Confidence 9999999999999999987532 23345799999999999999999999987 9999999999999999999
Q ss_pred EEeecCCccccCCCCcc-ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 411 KIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 411 kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
||+|||+++........ ......+|+.|+|||.+.++.++.++||||||+++|||+||+.|+..
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~ 237 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC
Confidence 99999999876543322 23345689999999999999999999999999999999999755443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=326.53 Aligned_cols=204 Identities=28% Similarity=0.370 Sum_probs=170.9
Q ss_pred hcccccCCcccccCcccEEEEEecC--------CCEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CcCceeeeeeeeecC
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLPG--------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG 337 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 337 (492)
.++|++.+.||+|+||.||+|+... +..||||+++.+. .....++.+|+..+.++ +|||||++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4678899999999999999998532 2369999997654 34467889999999888 899999999999999
Q ss_pred CcceeEEeecCCCCchhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL 404 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill 404 (492)
+..++||||+++|+|.+++..... ...+++..+++++.||+.||+|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999965432 346899999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecCCccccCCCCc-cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 011153 405 DEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF 474 (492)
Q Consensus 405 ~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~ellt-g~~p~~~ 474 (492)
+.++.+||+|||+++....... .......+|+.|+|||.+.++.++.++||||||+++|||++ |++|+..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence 9999999999999987654332 22345678999999999999999999999999999999998 5666543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=328.60 Aligned_cols=200 Identities=31% Similarity=0.379 Sum_probs=162.3
Q ss_pred cccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC----cceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----ESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 344 (492)
+.|...++||+|+||+||+|++ +|+.||||++...... ...+..|+..+..++|||||++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4577788999999999999987 4789999998644321 222334555567789999999999998654 468999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-----~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
||+++|+|.+++... .++|..+++++.|++.||+|||+. +..+|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999542 489999999999999999999974 12459999999999999999999999999998
Q ss_pred ccCCCCcc---ccccccccccccchhhhccCC------CCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 420 LFPEDITH---ISATLAGTLGYMAPEYVVRGK------LTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 420 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
........ ......||+.|||||++.+.. ++.++|||||||+||||+||..|+..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 76543322 223567999999999987543 56789999999999999999988754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=332.80 Aligned_cols=196 Identities=24% Similarity=0.287 Sum_probs=168.2
Q ss_pred cccccCC-cccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhc-cCcCceeeeeeeeec----CCcce
Q 011153 269 NYFHESN-KLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISG-INHKNLVKLLGCSIT----GPESL 341 (492)
Q Consensus 269 ~~~~~~~-~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~ 341 (492)
++|++.+ .||+|+||+||+|+. .+++.||||+++.. ..+.+|+.++.+ .+|||||++++++.+ +...+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5677764 699999999999986 57899999998542 456789998655 489999999999865 45679
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCcEEEeecCCc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLV 418 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgl~ 418 (492)
+||||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||++
T Consensus 86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 999999999999998643 2346999999999999999999999998 999999999999975 567999999999
Q ss_pred cccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
+....... .....||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~ 216 (335)
T d2ozaa1 162 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216 (335)
T ss_dssp EECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred eeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence 87654332 34567999999999999999999999999999999999999999654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=326.62 Aligned_cols=201 Identities=30% Similarity=0.471 Sum_probs=170.8
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
++|++.++||+|+||+||+|+. .+++.||||+++... ....+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999986 578999999996543 2346789999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
|+.++ +.+.+.. .....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~-~~~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEE-HHHHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCc-hhhhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99754 4444432 33456999999999999999999999998 9999999999999999999999999998765443
Q ss_pred ccccccccccccccchhhhccCC-CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 426 THISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. ......||+.|+|||.+.... ++.++|||||||++|||++|+.||...
T Consensus 157 ~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 157 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp B-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred c-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 2 233557999999999887766 478999999999999999999998654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.4e-41 Score=322.52 Aligned_cols=200 Identities=28% Similarity=0.387 Sum_probs=171.4
Q ss_pred cccccCCcccccCcccEEEEEecCCCEEEEEEeccCC--hhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 346 (492)
++|++.++||+|+||+||+|+.++++.||||++.... ....+.+.+|+.+|++++||||+++++++.+++..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5799999999999999999999999999999996543 33367899999999999999999999999999999999999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCCc
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 426 (492)
+.++.+.... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9877666554 33456999999999999999999999988 99999999999999999999999999987654322
Q ss_pred cccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 427 HISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 427 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
. .....+++.|+|||.+... .++.++|||||||+++||++|+.||...
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 156 K-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred c-cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 2 2344689999999998764 5689999999999999999999998654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=323.51 Aligned_cols=198 Identities=26% Similarity=0.350 Sum_probs=168.1
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCCh------hhHHHHHHHHHHHhccC--cCceeeeeeeeecCC
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT------QWVDHFFNEVNLISGIN--HKNLVKLLGCSITGP 338 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 338 (492)
.++|++.++||+|+||+||+|+. .+++.||||++..... ....++.+|+.+|++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999986 5789999999864321 12234678999999986 899999999999999
Q ss_pred cceeEEeecCC-CCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-CCcEEEeecC
Q 011153 339 ESLLVYEFVPN-QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFG 416 (492)
Q Consensus 339 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg 416 (492)
..++||||+.+ +++.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 466666643 245899999999999999999999998 999999999999985 5799999999
Q ss_pred CccccCCCCccccccccccccccchhhhccCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 417 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~slGvll~elltg~~p~~~ 474 (492)
+++..... ......||+.|||||++....+ +.++|||||||++|||++|+.||..
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 99865443 2335679999999999988776 5678999999999999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=322.38 Aligned_cols=202 Identities=26% Similarity=0.385 Sum_probs=167.7
Q ss_pred hcccccCCcccccCcccEEEEEe-cC-CCEEEEEEeccCC--hhhHHHHHHHHHHHhcc---CcCceeeeeeeeec----
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PG-GEAVAVKRLFYNT--TQWVDHFFNEVNLISGI---NHKNLVKLLGCSIT---- 336 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 336 (492)
.++|++.++||+|+||+||+++. .+ ++.||||+++... ......+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999986 34 5679999986532 22334566788777665 79999999998853
Q ss_pred -CCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 011153 337 -GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415 (492)
Q Consensus 337 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 415 (492)
....++++||++++.+.... ......+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~--~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH--HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhh--hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 34678999999887665433 234456899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 416 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
|+++..... .......||+.|||||++.+.+++.++||||+||++|||++|+.||....
T Consensus 161 g~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 161 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 998865432 23346689999999999999999999999999999999999999997543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=319.69 Aligned_cols=202 Identities=23% Similarity=0.356 Sum_probs=168.7
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC-ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC----cce
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----ESL 341 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 341 (492)
+.+|++.++||+|+||+||+|.. .+|+.||||++... .....+.+.+|+++|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999985 57999999999754 3445678899999999999999999999987654 335
Q ss_pred eEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcccc
Q 011153 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421 (492)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 421 (492)
++++++.+++|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 66677889999998853 25899999999999999999999998 999999999999999999999999999866
Q ss_pred CCCCcc--ccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 422 PEDITH--ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 422 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
...... ......||+.|+|||++.. ..++.++||||+||+++||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 443221 2345679999999999854 567889999999999999999999986543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-40 Score=322.23 Aligned_cols=199 Identities=26% Similarity=0.358 Sum_probs=165.7
Q ss_pred ccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC------ccee
Q 011153 270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ESLL 342 (492)
Q Consensus 270 ~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 342 (492)
.|+..++||+|+||+||+++.. +++.||||++..... .+.+|+++|++++||||+++++++.... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888999999999999999964 689999999976532 2347999999999999999999986432 3679
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-cEEEeecCCcccc
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLF 421 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~ 421 (492)
||||++++.+............+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987654444433345567999999999999999999999988 99999999999999775 8999999999876
Q ss_pred CCCCccccccccccccccchhhhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 422 PEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 422 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
..... .....||+.|+|||.+.+ ..++.++||||+||+++||++|+.||.....
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH
Confidence 54332 234678999999998875 4689999999999999999999999976543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=315.87 Aligned_cols=200 Identities=25% Similarity=0.378 Sum_probs=166.7
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeec--------C
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--------G 337 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 337 (492)
++|++.++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6799999999999999999996 57999999998544 33445678999999999999999999998865 3
Q ss_pred CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCC
Q 011153 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417 (492)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl 417 (492)
...++||||++++.+.... .....++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 4578999999877665443 34456889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCcc---ccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 011153 418 VRLFPEDITH---ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLF 474 (492)
Q Consensus 418 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~ 474 (492)
++.+...... ......||+.|+|||.+... .++.++|||||||+++||++|+.||..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 9866543221 22245799999999998765 689999999999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-39 Score=310.55 Aligned_cols=203 Identities=19% Similarity=0.255 Sum_probs=172.8
Q ss_pred hcccccCCcccccCcccEEEEEec-CCCEEEEEEeccCChhhHHHHHHHHHHHhccCc-CceeeeeeeeecCCcceeEEe
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 345 (492)
.++|++.++||+|+||+||+|+.. +++.||||++..... ...+.+|++.++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 357999999999999999999964 688999998855432 2457788999999965 899999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-----CCcEEEeecCCccc
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-----EFTAKIADFGLVRL 420 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~Dfgl~~~ 420 (492)
|+ +++|.+.+... ...+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 68998877543 345899999999999999999999998 999999999999964 57899999999987
Q ss_pred cCCCCcc------ccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 421 FPEDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 421 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
+...... ......||+.|||||.+.+..++.++||||||+++|||++|+.||......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~ 219 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch
Confidence 6543211 223567999999999999999999999999999999999999999765443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-39 Score=310.33 Aligned_cols=210 Identities=24% Similarity=0.354 Sum_probs=179.0
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCCcceeEEe
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE 345 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 345 (492)
++|++.++||+|+||+||+|+. .+++.||||+++.. .....+++.+|+.+|+.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999996 57889999998654 33456789999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCccccCCCC
Q 011153 346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425 (492)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 425 (492)
++.+++|...+. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999988877663 3356789999999999999999999998 9999999999999999999999999998765443
Q ss_pred ccccccccccccccchhhhccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcHHHHH
Q 011153 426 THISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485 (492)
Q Consensus 426 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvll~elltg~~p~~~~~~~~~~~~~~ 485 (492)
.. .....+++.|+|||.+.... ++.++|||||||+++||++|+.||....+..+.+..+
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~ 215 (292)
T d1unla_ 156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_dssp SC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHH
T ss_pred cc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 22 23445788999999987665 6899999999999999999999986654444444443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-39 Score=317.91 Aligned_cols=197 Identities=26% Similarity=0.433 Sum_probs=164.3
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecCC------
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ 338 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 338 (492)
.++|++.++||+|+||+||++.. .+|+.||||+++.. +....+.+.+|+++|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46799999999999999999986 46999999999753 3445678899999999999999999999998655
Q ss_pred cceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCc
Q 011153 339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418 (492)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~ 418 (492)
..++||||+ +.+|..... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 468999999 556665553 235999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 419 RLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
+...... +...||+.|+|||.+.+. .++.++||||+||+++||++|+.||....
T Consensus 169 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 169 RQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp EECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 8765432 346789999999998764 56899999999999999999999997653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-40 Score=318.32 Aligned_cols=205 Identities=27% Similarity=0.332 Sum_probs=176.1
Q ss_pred cccccCCcccccCcccEEEEEe----cCCCEEEEEEeccC----ChhhHHHHHHHHHHHhccCc-CceeeeeeeeecCCc
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYN----TTQWVDHFFNEVNLISGINH-KNLVKLLGCSITGPE 339 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~----~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 339 (492)
++|++.++||+|+||+||++.. .+|+.||||+++.. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999974 24789999998643 22345678899999999977 899999999999999
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
.++++||+.+++|.+++.... .+.......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999885443 4678889999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCccccccccccccccchhhhccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 011153 420 LFPEDITHISATLAGTLGYMAPEYVVRG--KLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479 (492)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~slGvll~elltg~~p~~~~~~~~ 479 (492)
.+............|++.|++||.+... .++.++|||||||+|+||++|+.||......+
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 7765544445567899999999998764 46789999999999999999999987654443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-38 Score=309.91 Aligned_cols=195 Identities=21% Similarity=0.326 Sum_probs=168.4
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccC-cCceeeeeeeeecC--CcceeEE
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITG--PESLLVY 344 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 344 (492)
++|++.++||+|+||+||+|+. .+++.||||+++... .+.+.+|+++|+.++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999986 568899999986543 457889999999995 99999999998743 4678999
Q ss_pred eecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-cEEEeecCCccccCC
Q 011153 345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPE 423 (492)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~ 423 (492)
||+++++|.... +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997654 35899999999999999999999998 99999999999998655 699999999987654
Q ss_pred CCccccccccccccccchhhhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 011153 424 DITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQN 477 (492)
Q Consensus 424 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~slGvll~elltg~~p~~~~~~ 477 (492)
... .....+|+.|+|||.+... .++.++||||+|++++||++|+.||....+
T Consensus 183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred CCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 332 2456789999999998765 479999999999999999999999876544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-38 Score=307.63 Aligned_cols=202 Identities=23% Similarity=0.294 Sum_probs=166.0
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCceeee-eeeeecCCcceeEEee
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL-LGCSITGPESLLVYEF 346 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~~lv~e~ 346 (492)
++|++.++||+|+||+||+|+. .+++.||||++..... .+++.+|+++++.++|+|++.. ..+..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999986 5688999998865433 2457899999999987765554 5556677788899999
Q ss_pred cCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC---CCCcEEEeecCCccccCC
Q 011153 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPE 423 (492)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgl~~~~~~ 423 (492)
+ +++|.+.+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+++.+..
T Consensus 85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 5566655533 3346899999999999999999999998 99999999999985 456799999999997754
Q ss_pred CCc------cccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 011153 424 DIT------HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478 (492)
Q Consensus 424 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~~~ 478 (492)
... .......||+.|||||.+.+..++.++|||||||++|||++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~ 219 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchH
Confidence 322 1233567999999999999999999999999999999999999999765443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-38 Score=307.74 Aligned_cols=198 Identities=25% Similarity=0.377 Sum_probs=166.9
Q ss_pred hcccccCCcccccCcccEEEEEe-cCCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC-----Cc
Q 011153 268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PE 339 (492)
Q Consensus 268 ~~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 339 (492)
+++|++.++||+|+||+||+++. .+|+.||||++... +....+.+.+|+++|+.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56799999999999999999985 57999999999754 334456789999999999999999999998643 34
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
.+++++++.+++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5778888999999998832 35999999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCccccccccccccccchhhhccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 420 LFPEDITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
..... .....|++.|+|||.+.+.. ++.++|||||||+++||++|+.||...+
T Consensus 170 ~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 170 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 54332 23567899999999877654 6889999999999999999999986543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=307.41 Aligned_cols=197 Identities=27% Similarity=0.363 Sum_probs=159.6
Q ss_pred cccccCCcccccCcccEEEEEec-CCCEEEEEEeccC--ChhhHHHHHHHHHHHhccCcCceeeeeeeeecC------Cc
Q 011153 269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------PE 339 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 339 (492)
++|++.++||+|+||+||+|... +|+.||||++... +....+.+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999965 6899999999754 344456789999999999999999999998643 56
Q ss_pred ceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
.++||||+.++.+ +.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 7999999976544 4442 34899999999999999999999998 9999999999999999999999999988
Q ss_pred ccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 011153 420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476 (492)
Q Consensus 420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~~ 476 (492)
...... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||...+
T Consensus 168 ~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 654432 2345578999999999999999999999999999999999999986543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-33 Score=277.20 Aligned_cols=199 Identities=23% Similarity=0.245 Sum_probs=162.8
Q ss_pred cccccCCcccccCcccEEEEEe-cCCCEEEEEEeccCChhhHHHHHHHHHHHhccC-----------cCceeeeeeeeec
Q 011153 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-----------HKNLVKLLGCSIT 336 (492)
Q Consensus 269 ~~~~~~~~iG~G~fG~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 336 (492)
.+|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3589999999999999999986 578999999997543 23467788999888775 5789999988765
Q ss_pred C--CcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCC-----
Q 011153 337 G--PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEF----- 408 (492)
Q Consensus 337 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nill~~~~----- 408 (492)
. ...++++++...+..............+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4556777777666655555455566778999999999999999999998 65 99999999999998654
Q ss_pred -cEEEeecCCccccCCCCccccccccccccccchhhhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 011153 409 -TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475 (492)
Q Consensus 409 -~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~slGvll~elltg~~p~~~~ 475 (492)
.++++|||.+....... ....||+.|+|||++....++.++||||+||+++||++|+.||...
T Consensus 169 ~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 49999999987654322 3457899999999999999999999999999999999999998754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2e-24 Score=192.94 Aligned_cols=164 Identities=16% Similarity=0.137 Sum_probs=121.3
Q ss_pred ccCCcccccCcccEEEEEecCCCEEEEEEeccCCh------------------hhHHHHHHHHHHHhccCcCceeeeeee
Q 011153 272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT------------------QWVDHFFNEVNLISGINHKNLVKLLGC 333 (492)
Q Consensus 272 ~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 333 (492)
.+.++||+|+||+||+|+..+|+.||||+++.... .......+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45789999999999999988899999998753211 112234578889999999999988765
Q ss_pred eecCCcceeEEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCcEEEe
Q 011153 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413 (492)
Q Consensus 334 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 413 (492)
. ..+++|||+++..+.+ ++.....+++.|++.+|+|||+.+ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 3479999998765543 223335678999999999999998 9999999999999865 58999
Q ss_pred ecCCccccCCCCccccccccccccccc------hhhhccCCCCcchhHHHHHHHHH
Q 011153 414 DFGLVRLFPEDITHISATLAGTLGYMA------PEYVVRGKLTEKADVYSFGVVVI 463 (492)
Q Consensus 414 Dfgl~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDv~slGvll~ 463 (492)
|||++.....+... .|.. .| ...+.|+.++|+||+.--++
T Consensus 145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWR---------EILERDVRNIIT-YFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHH---------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCcH---------HHHHHHHHHHHH-HHcCCCCCcccHHHHHHHHh
Confidence 99998765433211 1111 11 12466788999999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.57 E-value=1.4e-07 Score=86.39 Aligned_cols=147 Identities=18% Similarity=0.081 Sum_probs=97.0
Q ss_pred HHHHhcccccCCcccccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccC-cCceeeeeeeeecCCccee
Q 011153 264 LEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLL 342 (492)
Q Consensus 264 l~~~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 342 (492)
+...-..|+..+..+-++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+...++..++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 333344555555444444568998865 45667888876554444556778888877663 4346677777778888899
Q ss_pred EEeecCCCCchhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 011153 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES---------------------------------- 388 (492)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~---------------------------------- 388 (492)
||+++++.++.+..... .. ...++.++++.|+.||+..
T Consensus 88 v~~~l~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEeccccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999998775543111 11 2234455555555565421
Q ss_pred ----------------------CCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 389 ----------------------KLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 389 ----------------------~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
...++|+|+.|.|||++++...-|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987767799999765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.00 E-value=1.3e-05 Score=72.21 Aligned_cols=130 Identities=21% Similarity=0.255 Sum_probs=85.1
Q ss_pred cccccCc-ccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCc--CceeeeeeeeecCCcceeEEeecCCCCc
Q 011153 276 KLGQGGS-GSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH--KNLVKLLGCSITGPESLLVYEFVPNQSL 352 (492)
Q Consensus 276 ~iG~G~f-G~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL 352 (492)
.+..|.. ..||+....++..+++|....... ..+..|...++.+.. -.+.+++.+..+++..++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445543 578999988888889997654432 346677777776632 3356677777888888999999988766
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh----------------------------------------------
Q 011153 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE---------------------------------------------- 386 (492)
Q Consensus 353 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~yLH~---------------------------------------------- 386 (492)
.+.. .... .++.++.+.|+-||+
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4321 1111 112222233333332
Q ss_pred -----c----CCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 387 -----E----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 387 -----~----~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
. ..+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 12348999999999999987777899999765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.76 E-value=4.9e-05 Score=73.23 Aligned_cols=77 Identities=13% Similarity=0.102 Sum_probs=49.1
Q ss_pred CCcccccCcccEEEEEecC-CCEEEEEEeccC-------ChhhHHHHHHHHHHHhccC-c--CceeeeeeeeecCCccee
Q 011153 274 SNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYN-------TTQWVDHFFNEVNLISGIN-H--KNLVKLLGCSITGPESLL 342 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~-~~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 342 (492)
.+.||.|....||+....+ ++.++||.-... -+...++...|.+.|+.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4468999999999998754 678999975321 1112334556888777662 2 345555543 5567789
Q ss_pred EEeecCCCCc
Q 011153 343 VYEFVPNQSL 352 (492)
Q Consensus 343 v~e~~~~gsL 352 (492)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.10 E-value=0.001 Score=61.91 Aligned_cols=134 Identities=13% Similarity=0.075 Sum_probs=76.4
Q ss_pred ccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCce--eeeee-----eeecCCcceeEEeecCCCCchh-
Q 011153 283 GSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL--VKLLG-----CSITGPESLLVYEFVPNQSLLD- 354 (492)
Q Consensus 283 G~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~~- 354 (492)
-.||+.+..+|+.+++|..+... ...+++..|...+..|....+ +..+. .....+..+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 57999999999999999886542 234567788888877743322 11111 2234455678999987644321
Q ss_pred ---hh----------hc----c--CCCCCCCH----------------------HHHHHHHHHHHHHHHHH-hhcCCCCe
Q 011153 355 ---NL----------FV----R--QDVEPLSW----------------------EVRYKIILSTAEGLAYL-HEESKLRI 392 (492)
Q Consensus 355 ---~l----------~~----~--~~~~~~~~----------------------~~~~~i~~~i~~~l~yL-H~~~~~~i 392 (492)
.+ +. . ......++ ......+..+...+.-+ .+.....+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 01 00 0 00011111 11222233333332222 12224568
Q ss_pred EecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 393 IHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 393 vH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
||+|+.+.|||++++ ..++||+-+.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ecCCCCcccEEEeCC--ceEEechhcc
Confidence 999999999999754 4589999775
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.67 E-value=0.0022 Score=61.22 Aligned_cols=74 Identities=20% Similarity=0.311 Sum_probs=48.7
Q ss_pred CCcccccCcccEEEEEecCC--------CEEEEEEeccCChhhHHHHHHHHHHHhccCcCce-eeeeeeeecCCcceeEE
Q 011153 274 SNKLGQGGSGSVYKGTLPGG--------EAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVY 344 (492)
Q Consensus 274 ~~~iG~G~fG~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 344 (492)
.+.|+.|-.-.+|+...+++ +.|.+++.- .... .....+|..+++.+.-.++ .++++++. -.+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence 35678888889999986543 456666654 2222 3345688888888853344 46676664 26899
Q ss_pred eecCCCCch
Q 011153 345 EFVPNQSLL 353 (492)
Q Consensus 345 e~~~~gsL~ 353 (492)
||+++..|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999875553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.02 E-value=0.021 Score=52.18 Aligned_cols=158 Identities=11% Similarity=0.038 Sum_probs=80.3
Q ss_pred cCHHHHHHHhcccccCCcc-----cccCcccEEEEEecCCCEEEEEEeccCChhhHHHHHHHHHHHhccCcCcee--eee
Q 011153 259 FSYETLEKATNYFHESNKL-----GQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV--KLL 331 (492)
Q Consensus 259 ~~~~~l~~~~~~~~~~~~i-----G~G~fG~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv--~l~ 331 (492)
.+.++++..-..|.+++.. ..|---+.|+.+.++|+ +++|+...... .+.+..|++++..+...++. ..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 4566777777778765543 35555778998877655 88898754321 23344566666666332221 111
Q ss_pred e------eeecCCcceeEEeecCCCCchhhh--------------hcc------CCCCC------------------CCH
Q 011153 332 G------CSITGPESLLVYEFVPNQSLLDNL--------------FVR------QDVEP------------------LSW 367 (492)
Q Consensus 332 ~------~~~~~~~~~lv~e~~~~gsL~~~l--------------~~~------~~~~~------------------~~~ 367 (492)
. +.........++.++.+......- +.. ..... ...
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 111233445566666553332100 000 00000 000
Q ss_pred HHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCcEEEeecCCcc
Q 011153 368 EVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419 (492)
Q Consensus 368 ~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl~~ 419 (492)
......+..+...+.-.+. .-..++||+|+.+.||+++.+...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1111222222222332222 123469999999999999988777899999875
|